<SEC-DOCUMENT>0001140361-22-007247.txt : 20220301
<SEC-HEADER>0001140361-22-007247.hdr.sgml : 20220301
<ACCEPTANCE-DATETIME>20220301112645
ACCESSION NUMBER:		0001140361-22-007247
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		110
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220301
DATE AS OF CHANGE:		20220301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			U S PHYSICAL THERAPY INC /NV
		CENTRAL INDEX KEY:			0000885978
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				760364866
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11151
		FILM NUMBER:		22695266

	BUSINESS ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
		BUSINESS PHONE:		7132977000

	MAIL ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>brhc10034321_10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:usph="http://usph.com/20211231" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="background-color: #ffffff; color: #000000;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_dd0adf1d21a34bc6bfbdff6323f3552c" contextRef="c20210101to20211231" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_eaa2eca240174997b7454eff11917b4a" contextRef="c20210101to20211231" format="ixt:datemonthday">12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="Fact_f0b58e628f0c41068609c3086c6d1c60" contextRef="c20210101to20211231">2021</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="Fact_1a02d041c664420dae8094f8e12bafd8" contextRef="c20210101to20211231">FY</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_1f6f6ed096094570aff6730404ad4533" contextRef="c20210101to20211231">U S PHYSICAL THERAPY INC /NV</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_8794823c7a6d4dc8a98432671f91c8a6" contextRef="c20210101to20211231">0000885978</ix:nonNumeric><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_ff866f137ca54505be4c4f424e18c9dd" contextRef="c20210101to20211231">NV</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_331d90dd871243119409f00f669d2f5a" contextRef="c20210101to20211231">TX</ix:nonNumeric><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_9e406021f6644e219c3b143ef1491cbb" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2021AcquisitionMember" unitRef="U006" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_fcd7d7afc36c4146ae8996c5533e716f" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember" unitRef="U006" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_f2ab670c292849e0a6da2f6f425f8ab8" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember" unitRef="U006" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_8fc8c722672b4497be0c04af98353c23" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember" unitRef="U006" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_b50371aded1746619d40d044e9a29674" contextRef="c20180831to20180831_BusinessAcquisitionAxis_April2019AcquisitionMember" unitRef="U006" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember" unitRef="U006" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_d7b298373dc646968960932c7a99c477" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember" unitRef="U006" xsi:nil="true"></ix:nonFraction><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_20d1e6de339f4109b6e30d66a9ab05cd" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_8dba1636fbb14fd492a5df628ebe9b1c" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_88c34f0df7f44d898218c12bf8c8a138" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="Fact_054bc4ad0f534600aebe5987db19283e" contextRef="c20210101to20211231_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_61e076fe690248718f13697be1324500" contextRef="c20210101to20211231_TitleOfIndividualAxis_EmployeeMember">P4Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_139391eb54254fc583112777fb6d273d" contextRef="c20210101to20211231_TitleOfIndividualAxis_DirectorMember">P1Y</ix:nonNumeric><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_9ccb1564cfba40339b352148e6a9107a" contextRef="c20210101to20211231_BusinessAcquisitionAxis_April2019AcquisitionMember" unitRef="U006" xsi:nil="true"></ix:nonFraction><ix:nonNumeric name="usph:TermOfEmploymentAgreement" id="Fact_0d92bcc8360a42b4b9b9cf260432b9cf" contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="usph:NonCompeteAgreementBasicTerm" id="Fact_0b4b01dde9444fa395f3ee7e597f70c6" contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">P5Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="Fact_b89ef7a81a69420b8fe8694136cd02d4" contextRef="c20210101to20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">2017 2018 2019 2020</ix:nonNumeric><ix:nonNumeric name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="Fact_19a08fedb1b74db5a6b4b517c5b42088" contextRef="c20210101to20211231_IncomeTaxAuthorityAxis_ForeignCountryMember">2018 2019 2020</ix:nonNumeric><ix:nonNumeric name="usph:RestrictedPeriodToEmployeesOnTheStockGranted" id="Fact_bc274c91f2484d4a9acb65f2349c1f1a" contextRef="c20210101to20211231_TitleOfIndividualAxis_EmployeesMember">P4Y</ix:nonNumeric><ix:nonNumeric name="dei:AuditorFirmId" id="Fact_e5031b4fde974c0ab8fd6effd4a5c369" contextRef="c20210101to20211231">248</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="usph-20211231.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20210101to20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ProductOrServiceAxis_NetPatientRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_September2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2020AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:June2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2020AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:December2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:February2020AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_April2019AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:April2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_September2020AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2020AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_September2019AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_November2020AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2020AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_March2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_February2020AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:February2020AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_June2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:June2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_September2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_December2021AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:December2021AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180831_BusinessAcquisitionAxis_April2019AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:April2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_MultiClinicPracticesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:MultiClinicPracticesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180831to20180831_BusinessAcquisitionAxis_April2019AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:April2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-27</xbrli:startDate><xbrli:endDate>2020-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-30</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_ManagementContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200430_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ProductOrServiceAxis_OtherRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ProductOrServiceAxis_ManagementContractRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_ManagementContractRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_ManagementContractRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_UnusualOrInfrequentItemAxis_FromTwoThousandSeventeenThroughTwoThousandNineteenMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandSeventeenThroughTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usph:CentersForMedicareAndMedicaidServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20151102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2015-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20130401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211102_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usph:CentersForMedicareAndMedicaidServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-02-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20241231_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_MeasurementInputTypeAxis_MeasurementInputDiscountRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_TitleOfIndividualAxis_EmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_TitleOfIndividualAxis_OfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_TitleOfIndividualAxis_DirectorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_April2019AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:April2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementAndServicesContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_OwnershipAxis_PreviousOwnersMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_OwnershipAxis_PreviousOwnersMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-30</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-30</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ReturnToWorkAndErgonomicServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ReturnToWorkAndErgonomicServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200930_BusinessAcquisitionAxis_ManagementContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201130_OwnershipAxis_PreviousOwnersMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-30</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201130_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AprilTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-11</xbrli:startDate><xbrli:endDate>2019-04-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AprilTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:SeptemberTwoThousandTwentyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:SeptemberTwoThousandTwentyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-11</xbrli:startDate><xbrli:endDate>2019-04-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190930to20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerAndReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:CustomerAndReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ProgressiveHealthCompaniesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ProgressiveHealthCompaniesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_DebtInstrumentAxis_PromissoryNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_DebtInstrumentAxis_PromissoryNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211130_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_IncomeTaxAuthorityAxis_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20160316_PlanNameAxis_AmendedTwoThousandThreePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20160317_PlanNameAxis_AmendedTwoThousandThreePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">usph:NonQualifiedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedNineteenNinetyNinePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_TitleOfIndividualAxis_ExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_TitleOfIndividualAxis_EmployeesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20090331_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2009-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20081231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2008-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20090301to20090331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2009-03-01</xbrli:startDate><xbrli:endDate>2009-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191029to20191029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-29</xbrli:startDate><xbrli:endDate>2019-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220131_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>usph:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>usph:Clinic</xbrli:measure></xbrli:unit><xbrli:unit id="U007"><xbrli:measure>usph:Contract</xbrli:measure></xbrli:unit><xbrli:unit id="U008"><xbrli:measure>usph:Partnership</xbrli:measure></xbrli:unit><xbrli:unit id="U009"><xbrli:measure>usph:Location</xbrli:measure></xbrli:unit><xbrli:unit id="U010"><xbrli:measure>usph:Installment</xbrli:measure></xbrli:unit><xbrli:unit id="U011"><xbrli:measure>usph:Region</xbrli:measure></xbrli:unit><xbrli:unit id="U012"><xbrli:measure>usph:State</xbrli:measure></xbrli:unit><xbrli:unit id="U013"><xbrli:measure>usph:Operation</xbrli:measure></xbrli:unit><xbrli:unit id="U014"><xbrli:measure>usph:Officer</xbrli:measure></xbrli:unit><xbrli:unit id="U015"><xbrli:measure>usph:Defendant</xbrli:measure></xbrli:unit><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_27a094a9eace4a64be08154bf989f82e" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_f80eff9fe13e4df08a15f7acb274fc5e" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_bfb19040c12b4373b120a149674ff028" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_f75bbdaed45746e78fee56e41cedb979" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_f1dfaea40e90417ab9618457098915f7" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_76c42aa88a124b4db6f0502587ec6f42" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_9d4aac14de6549938264f58e705c3aa7" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_d9d8787977f14988ac98b2fccb95a943" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_2c2db17745e24c4eb66135c92aad7b8a" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_24336172ac1f4c7b87d22bacbbbd45fc" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_11d862d2defd4dca8c3f3c891cae62ca" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_63bd36af48894270815cc46c963ba2db" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_09256687656b4cb0829a3bba208bbd0b" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_9d349ef66f714b458c14a80861d985df" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_e730f71471494b67be39a111ddb754e1" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_aaf9411d8f9e4e009c9335f0ff382bdf" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_d5231447dfa54dcf8bc822f06da3d57d" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_6ccec2bf85c84363a31b411049754947" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_46c4521940754dddb49b9e190cced525" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_5537f26b563e45e3ba14cc86cb093d9e" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_c24ffdcebb2d493696e3a422d9966828" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_55629db4c4fb4f3d94188cadc2e92208" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_1cdd8b720f4a44a082c6939bf4b22496" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_e49d6261833247f2947adece9f7d5a9f" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_01ef1578c3654cdb9d9b1052ecedc226" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_71308383dd34492c907897ee2a3d7c84" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_2e55eaf9bd1a44fba6fdc7aa37f488f4" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_1dfbb6b5fc4b48afade4b5fb290ba8f7" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_494bf47a05ff4579a733449bea643c70" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_bd807fe1634b42079b82b93a313c6f0c" toRefs="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_cccd0aebc3cd4a079b94f19491d12216" toRefs="Foot_8632189867454c27a153d70883a46e78" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_8ebe68ea117342b08f53feddf56f59df" toRefs="Foot_8632189867454c27a153d70883a46e78" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_2d8530006ec74a9781d163ce2d72292d" toRefs="Foot_aeaed244265844d580a05be145ffd595" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_37c9d93f7a2345308c093a2c7e4106c9" toRefs="Foot_aeaed244265844d580a05be145ffd595" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_9e406021f6644e219c3b143ef1491cbb" toRefs="Foot_b182115cb6ef4d009deff873b8909b51" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_fcd7d7afc36c4146ae8996c5533e716f" toRefs="Foot_b182115cb6ef4d009deff873b8909b51" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_f2ab670c292849e0a6da2f6f425f8ab8" toRefs="Foot_b182115cb6ef4d009deff873b8909b51" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_8fc8c722672b4497be0c04af98353c23" toRefs="Foot_b182115cb6ef4d009deff873b8909b51" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_b50371aded1746619d40d044e9a29674" toRefs="Foot_b182115cb6ef4d009deff873b8909b51" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_9ccb1564cfba40339b352148e6a9107a" toRefs="Foot_b182115cb6ef4d009deff873b8909b51" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f" toRefs="Foot_089e16638e954876a030f33789a71503" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_d7b298373dc646968960932c7a99c477" toRefs="Foot_089e16638e954876a030f33789a71503" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f" toRefs="Foot_daa3f0e35dde4f99997e6a382a591d10" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_d7b298373dc646968960932c7a99c477" toRefs="Foot_daa3f0e35dde4f99997e6a382a591d10" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_0ce3ac6e75f540dab212aacd9f1cb8fb" toRefs="Foot_48f584180c61464eac6330240454329a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_bc6028d882ea464b935160a3eb31031e" toRefs="Foot_48f584180c61464eac6330240454329a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_dc991caa78a94c51a59fc0fa43e35e3d" toRefs="Foot_48f584180c61464eac6330240454329a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_bc6028d882ea464b935160a3eb31031e" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_c01876b255b44fc4addc1ae57a419973" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_f380bf553cd346c2a31ac62f1d843646" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_8de08e8ccc1c42ecaf1889065dc51e35" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_e8f8cd6e34b64aacafe0bf288bec27e7" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship></ix:resources></ix:header></div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><span style="font-size: 14pt; font-family: 'Times New Roman';">UNITED STATES</span><span style="font-size: 12pt; font-family: 'Times New Roman';"><br />
      </span><span style="font-size: 14pt; font-family: 'Times New Roman';">SECURITIES AND EXCHANGE COMMISSION</span><span style="font-size: 12pt; font-family: 'Times New Roman';"><br />
      </span>Washington, D.C. 20549</div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">Form <ix:nonNumeric name="dei:DocumentType" id="Fact_8b138bc4a508432bad32abdc4fc5d1f6" contextRef="c20210101to20211231">10-K</ix:nonNumeric></div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Mark One)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:DocumentAnnualReport" id="Fact_0c9ac8549f9a496ea33e2c62c660a38f" contextRef="c20210101to20211231" format="ixt-sec:boolballotbox">&#x2611;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR THE FISCAL YEAR ENDED <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_66f316006bb241c0af1068a078c78362" contextRef="c20210101to20211231" format="ixt:datemonthdayyearen">DECEMBER 31, 2021</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">OR</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:DocumentTransitionReport" id="Fact_34d6795bfcf44e0781b936b6805a9cdc" contextRef="c20210101to20211231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR THE TRANSITION PERIOD FROM <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span>TO<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMMISSION FILE NUMBER <ix:nonNumeric name="dei:EntityFileNumber" id="Fact_57f4bcc21af54b69b0e85816e88af797" contextRef="c20210101to20211231">1-11151</ix:nonNumeric></div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 24pt; font-family: 'Times New Roman';"><span style="-sec-ix-hidden:Fact_1f6f6ed096094570aff6730404ad4533">U.S. PHYSICAL THERAPY, INC.</span></span><span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</span></div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_ff866f137ca54505be4c4f424e18c9dd">NEVADA</span></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_dfe23e55c54043568a333e75511aa657" contextRef="c20210101to20211231">76-0364866</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(STATE OR OTHER JURISDICTION OF INCORPORATION<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>OR ORGANIZATION)</div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(I.R.S. EMPLOYER IDENTIFICATION NO.)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_38473952475c4647b1e37e394c412845" contextRef="c20210101to20211231">1300 WEST SAM HOUSTON PARKWAY SOUTH</ix:nonNumeric>,<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_5fce8db17a5e46649d62710e69ad6820" contextRef="c20210101to20211231">SUITE 300</ix:nonNumeric>,<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_227c5371c2864e8fab46898c42d4f34f" contextRef="c20210101to20211231">HOUSTON</ix:nonNumeric>, <span style="-sec-ix-hidden:Fact_331d90dd871243119409f00f669d2f5a">TEXAS</span></div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_2f2a0d2f61a544ccb96ab7bdad3de92e" contextRef="c20210101to20211231">77042</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)</div>
          </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(ZIP CODE)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REGISTRANT&#8217;S TELEPHONE NUMBER, INCLUDING AREA CODE: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_7942a8ca5f714a4384084ccac8a62dd4" contextRef="c20210101to20211231">713</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_6f67df2778674ef096d48567aafa8365" contextRef="c20210101to20211231">297-7000</ix:nonNumeric><span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE EXCHANGE ACT:</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 40%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Title of Each Class</span></div>
          </td>

    <td style="width: 18%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Trading Symbol</span></div>
          </td>

    <td style="width: 42%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Name of Each Exchange on Which Registered</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 40%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_664d610ad8d44307b867cb6e0f497ea0" contextRef="c20210101to20211231">Common Stock, $.01 par value</ix:nonNumeric></div>
          </td>

    <td style="width: 18%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_f4403032586e4456a16561f63de366bb" contextRef="c20210101to20211231">USPH</ix:nonNumeric></div>
          </td>

    <td style="width: 42%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_1a4c883fd0ac4c998932d014b7f2e50b" contextRef="c20210101to20211231" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE EXCHANGE ACT: NONE</div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span>&#160;<ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" id="Fact_1c2b4b221c644bfba8b601c63bff5025" contextRef="c20210101to20211231">No</ix:nonNumeric>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';">&#9745;</span></div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span>&#160;<ix:nonNumeric name="dei:EntityVoluntaryFilers" id="Fact_92e6b7fcda014bd2bc7afe6a49eab002" contextRef="c20210101to20211231">No</ix:nonNumeric><span style="font-size: 10pt; font-family: 'Times New Roman';">&#9745;</span></div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange
      Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="Fact_893fd61509bc4904b3c8245576a16e1b" contextRef="c20210101to20211231">Yes</ix:nonNumeric>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';">&#9745;</span> No <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span></div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted
      pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="Fact_70bd826fc0a14ec687b4c6a35bf281ce" contextRef="c20210101to20211231">Yes</ix:nonNumeric>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';">&#9745;</span> No <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span></div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
      reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27.49%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityFilerCategory" id="Fact_a3a3951176bf4f89b92a67eaa47f960e" contextRef="c20210101to20211231" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonNumeric></div>
          </td>

    <td style="width: 34.49%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#9745;</div>
          </td>

    <td style="width: 22.99%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Accelerated filer</div>
          </td>

    <td style="width: 15.04%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#9744;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 27.49%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-accelerated filer</div>
          </td>

    <td style="width: 34.49%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744; </span>(Do not check if a smaller reporting company)</div>
          </td>

    <td style="width: 22.99%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Smaller reporting company</div>
          </td>

    <td style="width: 15.04%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntitySmallBusiness" id="Fact_febaeed46c4c4d57a720991d62e47ae9" contextRef="c20210101to20211231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 27.49%; vertical-align: top;">&#160;</td>

    <td style="width: 34.49%; vertical-align: bottom;">&#160;</td>

    <td style="width: 22.99%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company</div>
          </td>

    <td style="width: 15.04%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_c354f2bc62d740b6bd2578a41b5818e6" contextRef="c20210101to20211231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
      complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#8201;<span style="font-size: 10pt; font-family: 'Times New Roman';">&#9744;</span></div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Indicate by check mark whether the registrant has filed a report on
        and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued
        its audit report.&#160;&#160; <ix:nonNumeric name="dei:IcfrAuditorAttestationFlag" id="Fact_c5bccef27fa84c5494f13829d14c69c7" contextRef="c20210101to20211231" format="ixt-sec:boolballotbox">&#x2611;</ix:nonNumeric></span></div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#8201;<span style="font-size: 10pt; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:EntityShellCompany" id="Fact_cc5d4fdf8e6f4b869b31c10e024d3a7e" contextRef="c20210101to20211231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span> No <span style="font-size: 10pt; font-family: 'Times New Roman';">&#9745;</span></div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The aggregate market value of the shares of the registrant&#8217;s common stock held by non-affiliates of the registrant at June 30, 2021
      was $<ix:nonFraction name="dei:EntityPublicFloat" id="Fact_9273df2b594f4c92b6c6c6a4f0ecb9a9" contextRef="c20210630" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">838</ix:nonFraction> million based on the closing sale price reported on the NYSE for the registrant&#8217;s common stock on June 30, 2021, the last business
      day of the registrant&#8217;s most recently completed second fiscal quarter. For purposes of this computation, all executive officers, directors and 5% or greater beneficial owners of the registrant were deemed to be affiliates. Such determination should
      not be deemed an admission that such executive officers, directors and beneficial owners are, in fact, affiliates of the registrant.</div>

    <div><br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">As of March 1, 2022, the number of shares outstanding of the registrant&#8217;s common stock, par value $.01 per share, was: <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" id="Fact_7c7130a0c3a84205a3be0c8549eb707a" contextRef="c20220301" unitRef="U002" decimals="INF" scale="0" format="ixt:numdotdecimal">12,950,588</ix:nonFraction>.</div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DOCUMENTS INCORPORATED BY REFERENCE</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 73.16%; vertical-align: bottom;">
              <div style="text-align: left; margin-left: 189pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">DOCUMENT</span></div>
            </td>

    <td style="width: 26.84%; vertical-align: bottom;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">PART OF FORM 10-K</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 73.16%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 26.84%; vertical-align: bottom;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 73.16%; vertical-align: bottom;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Portions of Definitive Proxy Statement for the 2021 Annual Meeting of Shareholders</div>
            </td>

    <td style="width: 26.84%; vertical-align: bottom;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Part III</div>
            </td>

  </tr>


</table>
    </div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div class="DSPFPageFooter">
        <div><br />
        </div>

      </div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div class="DSPFPageHeader">
        <div><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><a id="TableofContents"><!--Anchor--></a>Table of Contents</div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: bottom;">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Page</div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">PART I</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 1.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#BUSINESS">Business</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">2<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 1A.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#RISKFACTORS.">Risk Factors</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">12</div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 1B.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#UNRESOLVEDSTAFFCOMMENTS.">Unresolved Staff Comments</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">18<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 2.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#PROPERTIES.">Properties</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">18<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 3.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#LEGALPROCEEDINGS.">Legal Proceedings</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">19<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 4.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#MINESAFETYDISCLOSURES.">Mine Safety Disclosures</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">19<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">PART II</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 5.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#MARKETFORREGISTRANTSCOMMO">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">19<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 6.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#MANAGEMENTSDISCUSSIONANDA">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">22</div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 7.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#QUANTITATIVEANDQUALITATIV">Quantitative and Qualitative Disclosures About Market Risk</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">36<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 8.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#FINANCIALSTATEMENTSANDSUP">Financial Statements and Supplementary Data</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">37<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#NOTES">Notes to Consolidated Financial Statements</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">44<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 9.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#CHANGESINANDDISAGREEMENTS">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">67<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 9A.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#CONTROLSANDPROCEDURES.">Controls and Procedures</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">67</div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 9B.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#OTHERINFORMATION.">Other Information</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">68</div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">PART III</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 10.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#DIRECTORSEXECUTIVEOFFICER">Directors, Executive Officers and Corporate Governance</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">68</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 11.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#EXECUTIVECOMPENSATION.">Executive Compensation</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">68</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 12.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#SECURITYOWNERSHIPOFCERTAI">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">68</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 13.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#CERTAINRELATIONSHIPSANDRE">Certain Relationships and Related Transactions, and Director Independence</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">69<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 14.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#PRINCIPALACCOUNTANTFEESAN">Principal Accountant Fees and Services</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">69<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">PART IV</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 15.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#EXHIBITSANDFINANCIALSTATE">Exhibits and Financial Statement Schedules</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">69<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; text-align: center; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Item 16.</div>
              </td>

    <td style="width: 85%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#Form10-KSummary">Form 10-K Summary</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;">69<br />
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 85%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 5.19%; vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="#SIGNATURES">Signatures</a></div>
              </td>

    <td style="width: 5.19%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">76<br />
                </div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <!--PROfilePageNumberReset%Num%1%%%-->
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">FORWARD-LOOKING STATEMENTS</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We make statements in this report that are considered forward-looking statements within the meaning given such term under Section 21E of the Securities Exchange
          Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements contain forward-looking information relating to the financial condition, results of operations, plans, objectives, future performance and business of our Company. These statements
          (often using words such as &#8220;believes&#8221;, &#8220;expects&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;appear&#8221;, &#8220;should&#8221; and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we project. Included among such statements
          are those relating to opening clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions, and actual results could differ materially from those anticipated
          in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">the multiple effects of the impact of public health crises and epidemics/pandemics, such as the novel strain of COVID-19 and its variants, for which the total financial magnitude cannot be
                  currently estimated;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification and/or enrollment status&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">changes in reimbursement rates or payment methods from third party payors including government agencies, and changes in the deductibles and co-pays owed by patients&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible
                  write-down or write-off of goodwill and other intangible assets;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">the impact of COVID-19 related vaccination and/or testing mandates at the federal, state and/or local level, which could have an adverse impact on staffing, revenue, costs and the results of
                  operations:</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">changes as the result of government enacted national healthcare reform&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">business and regulatory conditions including federal and state regulations&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">governmental and other third party payor inspections, reviews, investigations and audits, which may result in sanctions or reputational harm and increased costs&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">revenue and earnings expectations&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">legal actions, which could subject us to increased operating costs and uninsured liabilities&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">general economic conditions&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">availability and cost of qualified physical therapists&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">personnel productivity and retaining key personnel&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">competitive environment in the industrial injury prevention services business, which could result in the termination or non-renewal of contractual service arrangements and other adverse financial
                  consequences for that service line;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">acquisitions, and the successful integration of the operations of the acquired businesses;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">impact on the business and cash reserves resulting from retirement or resignation of key partners and resulting purchase of their non-controlling interest (minority interests);</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">maintaining our information technology systems with adequate safeguards to protect against cyber-attacks&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">a security breach of our or our third party vendors&#8217; information technology systems may subject us to potential legal action and reputational harm and may result in a violation of the Health
                  Insurance Portability and Accountability Act of 1996 of the Health Information Technology for Economic and Clinical Health Act;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">maintaining clients for which we perform management and other services, as a breach or termination of those contractual arrangements by such clients could cause operating results to be less than
                  expected;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">maintaining adequate internal controls;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">maintaining necessary insurance coverage&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">availability, terms, and use of capital&#894; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">weather and other seasonal factors.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see the other sections of this report
          and our other periodic reports filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this report. Except
          as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement may no longer be accurate.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">1</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">PART I</div>

        <div>&#160;</div>

        <div>
          <a id="BUSINESS"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                  <div style="text-align: left;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 1.</span></div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left;"><!--Anchor--><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">BUSINESS.</span></div>
                </td>

  </tr>


</table>
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">GENERAL</div>

        <div style="text-indent: 36pt; font-family: 'Times New Roman';"><span style="color: #000000;"> <br />
          </span></div>

        <div style="font-family: 'Times New Roman'; text-indent: 18pt;">
          <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">U.S. Physical Therapy, Inc. and subsidiaries (&#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;
              or the &#8220;Company&#8221;), operates its business through two reportable business segments. Our reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Through our subsidiaries, we
              operate outpatient physical therapy clinics that provide pre-and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurological-related injuries and rehabilitation of injured workers.
              We also have a majority interest </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">in businesses </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">which </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">are</span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> leading provider</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">s</span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"> of industrial injury prevention services. Services provided in this business include onsite injury prevention and rehabilitation, performance optimization,
              post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients
              include large insurers and their contractors. These services are performed through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs). </span>Prior to the
            second quarter of 2020, we operated as a single segment. All prior year segment information has been reclassified to conform to the current segment presentation.</div>

        </div>

        <div><br />
        </div>

        <div style="text-indent: 20pt; font-family: 'Times New Roman';"><span style="color: #000000;">We were re-incorporated in April 1992 under the laws of the State of Nevada and have operating subsidiaries organized in various states in the form of
            limited partnerships, limited liability companies and wholly-owned corporations. This description of our business should be read in conjunction with our financial statements and the related notes contained in Item 8 in this Annual Report on
            Form 10-K. Our principal executive offices are located at 1300 West Sam Houston Parkway South, Suite 300, Houston, Texas 77042. Our telephone number is (713) 297-7000. Our website is </span><span style="text-decoration: underline;">www.usph.com</span><span style="color: #000000;">.</span></div>

        <div><br />
        </div>

        <div style="font-family: 'Times New Roman';">Acquisitions of Businesses and Acquired Interests</div>

        <div><br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">
          <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During the last three years we completed the acquisitions of seven clinic practices and t<span style="font-family: 'Times New Roman'; font-size: 10pt;">hree</span> industrial injury prevention services businesses as detailed below.</div>

        </div>

        <div>
          <div> <br />
          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.87%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: left;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Date</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.83%; vertical-align: top; border-bottom: #000000 2px solid;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">% Interest<br />
                    Acquired</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; border-bottom: #000000 2px solid;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Number of</div>
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Clinics</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">December 2021 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2021</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2021 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2021</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.83%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2021 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2021</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">100%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">June 2021 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">June 30, 2021</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.83%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 2021 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 31, 2021</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.83%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.83%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65% ***</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">67%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 17.82%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.87%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">April 2019 Acquisition</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">April 11, 2019</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.83%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">100%</div>
                </td>

    <td style="width: 4.22%; vertical-align: top;">&#160;</td>

    <td style="width: 17.82%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services business</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The business includes six management contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term
                    of five years.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based
                    on the initial purchase transaction.</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

        </div>

        <div style="font-family: 'Times New Roman'; font-weight: bold;">Physical Therapy Operations</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We primarily operate through subsidiary clinic partnerships in which we generally own a 1% general partnership interest and a 10% to 99% limited partnership
          interest and the managing therapist(s) of the clinics owns the remaining limited partnership interest in the majority of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, we operate some clinics through
          wholly-owned subsidiaries under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">2</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We continue to seek to attract for employment physical therapists who have established relationships with physicians and other
          referral sources by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by us, the prior owners
          typically continue on as employees to manage the clinic operations, retaining a non-controlling ownership interest in the clinics and receiving a competitive salary for managing the clinic operations. In addition, we have developed satellite
          clinic facilities as part of existing Clinic Partnerships<span style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</span>and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned
          Facilities operate more than one clinic location. During 2022, we intend to continue to acquire multi-clinic practices and to continue to develop outpatient physical therapy clinics as satellites in existing partnerships, along with increasing
          our patient volume through marketing and new programs.</div>

        <div><br />
        </div>

        <div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Therapists at our clinics initially perform a comprehensive evaluation of each patient, which is then followed by a treatment
          plan specific to the injury as prescribed by the patient&#8217;s physician. The treatment plan may include a number of procedures, including therapeutic exercise, manual therapy techniques, ultrasound, electrical stimulation, hot packs, iontophoresis,
          education on management of daily life skills and home exercise programs. A clinic&#8217;s business primarily comes from referrals by local physicians. The principal sources of payment for the clinics&#8217; services are managed care programs, commercial
          health insurance, Medicare/Medicaid and workers&#8217; compensation insurance.</div>

        <div>&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Besides the multi-clinic acquisitions referenced in the table above, during 2021 and 2020 we purchased the assets and business of three physical therapy clinics in
          separate transactions. The clinics operate as satellite clinics of three of our existing clinic partnerships.</div>

        <div style="text-indent: 18pt;">&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">During the year ended December 31, 2021, we sold two clinics. The aggregate sales price was $0.1 million. During the year ended December 31, 2020, we sold 14
          previously closed clinics. The aggregate sales price was $1.1 million, of which $0.7 million was paid in cash and $0.4 million in a note receivable payable in two equal installments of principal and any accrued interest.&#160; The first payment was
          received in June 2021 and the next payment is due on June 15, 2022.</div>

        <div style="text-indent: 18pt;">&#160;</div>

        <div style="font-family: 'Times New Roman'; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">At December 31, 2021, we operated 591 clinics in 39 states. Our highest concentration of clinics are in the following states: Texas, Tennessee,
            Michigan, Virginia, Florida, Oregon, Maryland, Georgia, Pennsylvania, Arizona, Idaho, Missouri</span> and <span style="color: rgb(0, 0, 0);">South Carolina. In addition to our 591 clinics, on December 31, 2021, we also managed 35 physical
            therapy practices for unrelated physician groups and hospitals.</span></div>

        <div style="text-indent: 20pt;"><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold; text-indent: 18pt;">Our Clinics</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Most of our clinics are operated as Clinic Partnerships in which we own the general partnership interest and a majority of the limited partnership interests. The
          managing healthcare practitioner of the clinics usually owns a portion of the limited partnership interests. Generally, the therapist partners have no interest in the net losses of Clinic Partnerships, except to the extent of their capital
          accounts. Since we also develop satellite clinic facilities of existing clinics, most Clinic Partnerships consist of more than one clinic location. As of December 31, 2021, through wholly-owned subsidiaries, we owned a 1% general partnership
          interest in all the Clinic Partnerships. Our limited partnership interests range from 10% to 99% in the Clinic Partnerships. For the vast majority of the Clinic Partnerships, the managing healthcare practitioner is a physical therapist who owns
          the remaining limited partnership interest in the Clinic Partnership.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">For our Clinic Partnership agreements related to those in which we acquired a majority interest, generally, the prior management continues to own a 10% to 50%
          interest.</div>

        <div><br />
        </div>

        <div style="font-family: 'Times New Roman'; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">Typically, each therapist partner or director, including those employed by Clinic Partnerships in which we acquired a majority interest, enters into
            an employment agreement for a term of up to five years with their Clinic Partnership. Each agreement typically provides for a covenant not to compete during the period of his or her employment and for up to two years thereafter. Under each
            employment agreement, the therapist partner receives a base salary and may receive a bonus based on the net revenues or profits generated by their Clinic Partnership or specific clinic. In the case of Clinic Partnerships, the therapist partner
            receives earnings distributions based upon their ownership interest. Upon termination of employment, we typically have the right to purchase the therapist&#8217;s partnership interest in Clinic Partnerships</span>; for those Clinic Partnerships we
          created in connection with an acquisition, our partner also has the right to cause us to purchase their interest upon termination of their employment. </div>

        <div><br />
        </div>

        <div style="font-family: 'Times New Roman'; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">In connection with most </span>of our acquired clinics, in the event that a limited minority partner&#8217;s employment ceases and certain requirements
          are met as detailed in the respective limited partnership agreements, we have a call right (the &#8220;Call Right&#8221;) and the selling entity or individual has a put right (the &#8220;Put Right&#8221;) with respect to the partner&#8217;s limited partnership interests. The
          Put Right and the Call Right do not expire, even upon an individual partner&#8217;s death, and contain no mandatory redemption feature. The purchase price of the partner&#8217;s limited partnership interest upon exercise of the Put Right or the Call Right is
          calculated at a predetermined multiple of earnings performance as detailed in the respective agreements.</div>

        <div style="text-indent: 20pt; font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">3</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Each Clinic Partnership maintains an independent local identity, while at the same time enjoying the benefits of national purchasing, negotiated third-party payor
          contracts, centralized support services and management practices. Under a management agreement, one of our subsidiaries provides a variety of support services to each clinic, including supervision of site selection, construction, clinic design
          and equipment selection, establishment of accounting systems and billing procedures and training of office support personnel, processing of accounts payable, operational direction, auditing of regulatory compliance, payroll, benefits
          administration, accounting services, legal services, quality assurance and marketing support.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Our typical clinic occupies 1,000 to 7,000 square feet of leased space in an office building or shopping center. There are 17 clinics occupying space in the range
          of over 7,000 square feet to 13,500 square feet. We attempt to lease ground level space for patient ease of access to our clinics.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Typical minimum staff at a clinic consists of a licensed physical therapist and an office manager. As patient visits grow, staffing may also include additional
          physical therapists, occupational therapists, therapy assistants, aides, exercise physiologists, athletic trainers and office personnel. Therapy services are performed under the supervision of a licensed therapist.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We provide services at our clinics on an outpatient basis. Patients are usually treated for approximately one hour per day, two to three times a week, typically
          for two to six weeks. We generally charge for treatment on a per procedure basis. Medicare patients are charged based on prescribed time increments and Medicare billing standards. In addition, our clinics will develop, when appropriate,
          individual maintenance and self-management exercise programs to be continued after treatment. We continually assess the potential for developing new services and expanding the methods of providing our existing services in the most efficient
          manner while providing high quality patient care.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold; text-indent: 18pt;">Factors Influencing Demand For Physical Therapy Services</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We believe that the following factors, among others, influence the growth of outpatient physical therapy services:</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Economic Benefits of Therapy Services. </span>Purchasers and providers of healthcare services, such as insurance companies,
          health maintenance organizations, businesses and industries, continuously seek cost savings for traditional healthcare services. We believe that our therapy services provide a cost-effective way to prevent short-term disabilities from becoming
          chronic conditions, to help avoid invasive procedures, to speed recovery from surgery and musculoskeletal injuries and eliminate or minimize the need for opioids.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Earlier Hospital Discharge. </span>Changes in health insurance reimbursement, both public and private, have encouraged the
          earlier<span style="font-style: italic;">&#160;</span>discharge of patients to reduce costs. We believe that early hospital discharge practices foster greater demand for outpatient physical therapy services.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Aging Population. </span>In general, the elderly population has a greater incidence of disability compared to the population as
          a whole.<span style="font-style: italic;">&#160;</span>As this segment of the population continues to grow, we believe that demand for rehabilitation services will expand.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Increase in Obesity</span>. Two of every three American men are considered to be overweight or obese and the rate continues to
          grow.<span style="font-style: italic;">&#160;</span>The strain on a person&#8217;s body can be significant. Physical therapy services help the obese become more active and fit by teaching them how to move in ways that are pain free.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold; text-indent: 18pt;">Marketing</div>

        <div style="text-indent: 18pt;">&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We focus our marketing efforts primarily on physicians, including orthopedic surgeons, neurosurgeons, physiatrists, internal medicine physicians, podiatrists,
          occupational medicine physicians and general practitioners. In marketing to the physician community, we emphasize our commitment to quality patient care and regular communication with physicians regarding patient progress. We employ personnel to
          assist clinic directors in developing and implementing marketing plans for the physician community and to assist in establishing relationships with health maintenance organizations, preferred provider organizations, case managers and insurance
          companies.</div>

        <div><br />
        </div>

        <div style="font-family: 'Times New Roman'; font-weight: bold;">Industrial Injury Prevention Services</div>

        <div><br />
        </div>

        <div style="font-family: 'Times New Roman'; text-indent: 18pt;">Services provided in the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post offer employment testing,
          functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their
          contractors. Our Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and ATCs.</div>

        <div>
          <div><br />
          </div>

        </div>

        <div style="font-family: 'Times New Roman'; text-indent: 18pt;">In March 2017, we acquired a 55% interest in an initial industrial injury prevention services business. On April 30, 2018, we acquired a 65% interest in another business in the
          industrial injury prevention sector. On April 30, 2018, we combined the two businesses.&#160; After the combination, we owned a 59.45% interest in the combined business, Briotix Health, Limited Partnership (&#8220;Briotix Health&#8221;).</div>

        <div style="text-indent: 36pt; font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">4</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="font-family: 'Times New Roman'; text-indent: 18pt;">On April 11, 2019, we acquired 100% of a third company that is a provider of industrial injury prevention services. The acquired company specializes in delivering injury prevention and
          care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network in 45 states including onsite at eleven client locations. The business was then combined with Briotix
          Health increasing our ownership position in the partnership to approximately 76.0%.</div>

        <div><br />
        </div>

        <div>
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On September 30, 2021, we acquired a company that specializes in return-to-work and ergonomic services, among other offerings and contributed those
            assets to industrial injury prevention services subsidiary. Subsequent to this acquisition and the purchase of the redeemable non-controlling interest of one of the limited partners, our ownership in Briotix Health is approximately 85%.</div>

          <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
          </div>

        </div>

        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On November 30, 2021, we acquired an approximate 70.0% interest in a leading provider of industrial injury prevention services. The founders and
          owners retained the remaining interest. The initial purchase price for the approximate 70% equity interest, not inclusive of a $2.0 million contingent payment in conjunction with the acquisition if specified future operational objectives are met,
          was approximately $63.2 million<span style="font-family: 'Times New Roman'; font-size: 10pt;">.</span></div>

        <div style="text-align: justify; margin-right: 18pt; font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">SOURCES OF REVENUE</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold; text-indent: 18pt;">Physical Therapy Operations</div>

        <div style="margin-left: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Payor sources for physical therapy operations are primarily managed care programs, commercial health insurance, Medicare/Medicaid and workers&#8217; compensation
          insurance. Commercial health insurance, Medicare and managed care programs generally provide coverage to patients utilizing our clinics after payment by the patients of normal deductibles and co-insurance payments. Workers&#8217; compensation laws
          generally require employers to provide, directly or indirectly through insurance, costs of medical rehabilitation for their employees from work-related injuries and disabilities and, in some jurisdictions, mandatory vocational rehabilitation,
          usually without any deductibles, co-payments or cost sharing. Treatments for patients who are parties to personal injury cases are generally paid from the proceeds of settlements with insurance companies or from favorable judgments. If an
          unfavorable judgment is received, collection efforts are generally not pursued against the patient and the patient&#8217;s account is written-off against established reserves. Bad debt reserves relating to all receivable types are regularly reviewed
          and adjusted as appropriate.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The following table shows our payor mix for the years ended ($ in thousands):</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
                <div style="text-align: center; font-family: 'Times New Roman';">December 31, 2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
                <div style="text-align: center; font-family: 'Times New Roman';">December 31, 2020</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
                <div style="text-align: center; font-family: 'Times New Roman';">December 31, 2019</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Payor</span></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-family: 'Times New Roman';">
                  <div>Net Patient</div>
                  Revenue</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-family: 'Times New Roman';">Percentage</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-family: 'Times New Roman';">
                  <div>Net Patient</div>
                  Revenue</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-family: 'Times New Roman';">Percentage</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-family: 'Times New Roman';">
                  <div>Net Patient</div>
                  Revenue</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-family: 'Times New Roman';">Percentage</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="font-family: 'Times New Roman';">
                  <div style="text-indent: -9pt; margin-left: 9pt;">Managed Care Programs/ Commercial Health Insurance</div>
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">209,129</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">47.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">177,877</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">47.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">204,051</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">47.1</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; white-space: nowrap;">
                <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Medicare/Medicaid</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">155,122</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">35.4</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">118,030</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">31.6</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">132,611</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">30.6</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Workers' Compensation Insurance</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">44,549</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">10.2</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">48,628</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">13.0</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">63,542</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">14.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;">
                <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Other</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">29,530</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">6.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">28,805</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">7.7</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">33,141</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">7.6</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="font-family: 'Times New Roman'; margin-left: 9pt;">Total</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">438,330</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">100.0</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">373,340</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">100.0</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">433,345</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">100.0</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="font-family: 'Times New Roman';">%</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Our physical therapy business depends to a significant extent on our relationships with commercial health insurers, health maintenance organizations, preferred
          provider organizations and workers&#8217; compensation insurers. In some geographical areas, our clinics must be approved as providers by key health maintenance organizations and preferred provider plans to obtain payments. Failure to obtain or
          maintain these approvals would adversely affect financial results.</div>

        <div>&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">5</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December&#160;31, 2021, approximately 37.3% of our visits and 35.4% of our net patient revenue was from patients with Medicare
            or Medicaid program coverage. To receive Medicare reimbursement, a facility (Medicare Certified Rehabilitation Agency) or the individual therapist (Physical/Occupational Therapist in Private Practice) must meet applicable participation
            conditions set by the Department of Health and Human Services (&#8220;HHS&#8221;) relating to the type of facility, equipment, recordkeeping, personnel and standards of medical care, and also must comply with all state and local laws. HHS, through Centers
            for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) and designated agencies, periodically inspects or surveys clinics/providers for approval and/or compliance. <span style="font-family: 'Times New Roman'; font-size: 10pt;"> Failure of our
              subsidiaries to obtain or maintain certifications as Medicare providers or failure to enroll as a group of physical/occupational therapists in a private practice could adversely affect financial results.</span></div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8220;MPFS&#8221;). For services provided in 2017 through
          2019, a 0.5% increase was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">In the 2020 MPFS Final Rule, CMS revised coding, documentation guidelines, and increased the code values for office/outpatient evaluation and management (E/M)
          codes and cuts to other codes to maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office visit codes and cuts to other specialty codes to maintain budget neutrality. As
          a result, CMS projected a 9% decrease in fee schedule payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the Consolidated Appropriations Act, 2021, and reimbursement for the codes
          applicable to physical/occupational therapy services provided by our clinics received an estimated 3.5% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020.</div>

        <div><br />
        </div>

        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">In the 2022 MPFS Final Rule published on November 2, 2021, there was to be an approximately 3.75% reduction to Medicare payments for
            physical/occupational therapy services.&#160; This was due to the expiration of the additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021. However, this reduction was addressed in
            the Protecting Medicare and American Farmers from Sequester Cuts Act (&#8220;2021 Act&#8221;) signed into law on December 10, 2021.&#160; Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year
            of 2022 will be approximately 0.75%.</div>

          <div><br />
          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">In addition, the Consolidated Appropriations Act, 2021 includes reductions in Medicare payment rates of approximately 3% in each of calendar years 2023 and 2024,
          unless regulatory or Congressional action results in modifications to such rates as has occurred in 2021 and 2022.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years and requires automatic reductions
          in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan
          Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through
          fiscal year 2027. The CARES Act suspended the 2% payment reduction to Medicare payments for dates of service from May 1, 2020 through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the 2% payment reduction until
          March 31, 2021. On April 14, 2021, additional legislation was enacted that waived the 2% payment reduction for the remainder of calendar 2021. The 2021 Act, which was signed into law on December 10, 2021, included a three-month extension of the
          2% sequester relief applied to all Medicare payments through March 31, 2022, followed by three months of 1% sequester relief through June 30, 2022.&#160; Sequester relief is scheduled to then end on June 30, 2022.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8216;&#8216;MCTRA&#8217;&#8217;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures
          during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services; a separate $3,700
          threshold is applied to the Occupational Therapy. The Medicare Access and CHIP Reauthorization Act of 2015 (&#8220;MACRA&#8221;) directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the
          $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to
          $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for 2028 and in subsequent years the threshold amount will increase based on the corresponding
          percentage increase in the MEI for such subsequent year.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">CMS adopted a multiple procedure payment reduction (&#8216;&#8216;MPPR&#8217;&#8217;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all
          outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&#8216;&#8216;RVU&#8217;&#8217;)
          for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient,
          regardless of whether those therapy services are furnished in separate sessions. In 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%.</div>

        <div style="text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">6</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Medicare claims for outpatient therapy services furnished by therapist assistants on or after January 1, 2020 must include a modifier indicating the service was
          furnished by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapist assistant are paid at an amount equal to 85% of the payment amount otherwise applicable for the service.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. We believe
          that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on our
          financial statements as of December 31, 2021. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the
          Medicare program. For the year ended December 31, 2021 and 2020, respectively, net patient revenue from Medicare were approximately $134.4 million and $101.6 million, respectively.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold; text-indent: 18pt;">Industrial Injury Prevention Services</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Services provided in this business include onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional
          capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their contractors. These
          services are performed through Industrial Sports Medicine Professionals, consisting of both physical therapists and ATCs.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">REGULATION AND HEALTHCARE REFORM</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Numerous federal, state and local regulations regulate healthcare services and those who provide them. Some states into which we may expand have laws requiring
          facilities employing health professionals and providing health-related services to be licensed and, in some cases, to obtain a certificate of need (that is, demonstrating to a state regulatory authority the need for, and financial feasibility of,
          new facilities or the commencement of new healthcare services). Only one of the states in which we currently operate requires a certificate of need for the operation of our physical therapy business functions. Our therapists and/or clinics,
          however, are required to be licensed, as determined by the state in which they provide services. Failure to obtain or maintain any required certificates, approvals or licenses could have a material adverse effect on our business, financial
          condition and results of operations.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Regulations Controlling Fraud and Abuse. </span>Various federal and state laws regulate financial relationships involving
          providers of<span style="font-style: italic;">&#160;</span>healthcare services. These laws include Section 1128B(b) of the Social Security Act (42 U.S. C. &#167; 1320a-7b[b]) (the &#8220;Fraud and Abuse Law&#8221;), under which civil and criminal penalties can be
          imposed upon persons who, among other things, offer, solicit, pay or receive remuneration in return for (i) the referral of patients for the rendering of any item or service for which payment may be made, in whole or in part, by a Federal health
          care program (including Medicare and Medicaid); or (ii) purchasing, leasing, ordering, or arranging for or recommending purchasing, leasing, ordering any good, facility, service, or item for which payment may be made, in whole or in part, by a
          Federal health care program (including Medicare and Medicaid). We believe that our business procedures and business arrangements are in compliance with these provisions. However, the provisions are broadly written and the full extent of their
          specific application to specific facts and arrangements to which we are a party is uncertain and difficult to predict. In addition, several states have enacted state laws similar to the Fraud and Abuse Law, which may be more restrictive than the
          federal Fraud and Abuse Law.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The Office of the Inspector General (&#8220;OIG&#8221;) of HHS has issued regulations describing compensation financial arrangements that fall within a &#8220;Safe Harbor&#8221; and,
          therefore, are not viewed as illegal remuneration under the Fraud and Abuse Law. Failure to fall within a Safe Harbor does not mean that the Fraud and Abuse Law has been violated; however, the OIG has indicated that failure to fall within a Safe
          Harbor may subject an arrangement to increased scrutiny under a &#8220;facts and circumstances&#8221; test.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The OIG also has issued special fraud alerts and special advisory bulletins to remind the provider community of the importance and application of certain aspects
          of the Fraud and Abuse Law. One of the OIG special fraud alerts related to the rental of space in physician offices by persons or entities to which the physicians refer patients. The OIG&#8217;s stated concern in these arrangements is that rental
          payments may be disguised kickbacks to the physician-landlords to induce referrals. We rent clinic space for some of our clinics from referring physicians and have taken the steps that we believe are necessary to ensure that all leases comply to
          the extent possible and applicable, with the space rental Safe Harbor to the Fraud and Abuse Law.</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">One of the OIG&#8217;s special advisory bulletins addressed certain complex contractual arrangements for the provision of items and services. This special advisory
          bulletin identified several characteristics commonly exhibited by suspect arrangements, the existence of one or more of which could indicate a prohibited arrangement to the OIG. Generally, the indicia of a suspect contractual joint venture as
          identified by the special advisory bulletin and an associated OIG advisory opinion include the following:</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">7</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;"><span style="text-decoration: underline;">New Line of Business.</span></span> A provider in one line of business (&#8220;Owner&#8221;) expands into a new line of business that can be provided to the
          Owner&#8217;s existing patients, with another party who currently provides the same or similar item or service as the new business (&#8220;Manager/Supplier&#8221;).</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;"><span style="text-decoration: underline;"> <br />
            </span></span></div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;"><span style="text-decoration: underline;">Captive Referral Base.</span></span> The arrangement predominantly or exclusively serves the Owner&#8217;s existing patient base (or patients under the
          control or influence of the Owner).</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;"><span style="text-decoration: underline;">Little or No Bona Fide Business Risk</span></span>. The Owner&#8217;s primary contribution to the venture is referrals; it makes little or no financial or
          other investment in the business, delegating the entire operation to the Manager/Supplier, while retaining profits generated from its captive referral base.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;"><span style="text-decoration: underline;">Status of the Manager/Supplier</span></span>. The Manager/Supplier is a would-be competitor of the Owner&#8217;s new line of business and would normally
          compete for the captive referrals. It has the capacity to provide virtually identical services in its own right and bill insurers and patients for them in its own name.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;"><span style="text-decoration: underline;">Scope of Services Provided by the Manager/Supplier</span></span>. The Manager/Supplier provides all, or many, of the new business&#8217; key services.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;"><span style="text-decoration: underline;">Remuneration</span></span>. The practical effect of the arrangement, viewed in its entirety, is to provide the Owner the opportunity to bill
          insurers and patients for business otherwise provided by the Manager/Supplier. The remuneration from the venture to the Owner (i.e., the profits of the venture) takes into account the value and volume of business the Owner generates.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;"><span style="text-decoration: underline;">Exclusivity</span></span>. The arrangement bars the Owner from providing items or services to any patients other than those coming from Owner and/or
          bars the Manager/Supplier from providing services in its own right to the Owner&#8217;s patients.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Due to the nature of our business operations, many of our management service arrangements exhibit one or more of these characteristics. However, we believe we have
          taken steps regarding the structure of such arrangements as necessary to sufficiently distinguish them from these suspect ventures, and to comply with the requirements of the Fraud and Abuse Law. However, if the OIG believes we have entered into
          a prohibited contractual joint venture, it could have an adverse effect on our business, financial condition and results of operations.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Although the business of managing physician-owned and hospital-owned physical therapy facilities is regulated by the Fraud and Abuse Law, the manner in which we
          contract with such facilities often falls outside the complete scope of available Safe Harbors. We believe our arrangements comply with the Fraud and Abuse Law, even though federal courts provide limited guidance as to the application of the
          Fraud and Abuse Law to these arrangements. If our management contracts are held to violate the Fraud and Abuse Law, it could have an adverse effect on our business, financial condition and results of operations.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Stark Law. </span>Provisions of the Omnibus Budget Reconciliation Act of 1993 (42 U.S.C. &#167; 1395nn) (the &#8220;Stark Law&#8221;) prohibit
          referrals by a physician of &#8220;designated health services&#8221; which are payable, in whole or in part, by Medicare or Medicaid, to an entity in which the physician or the physician&#8217;s immediate family member has an investment interest or other financial
          relationship, subject to several exceptions. Unlike the Fraud and Abuse Law, the Stark Law is a strict liability statute. Proof of intent to violate the Stark Law is not required. Physical therapy and occupational therapy services are among the
          &#8220;designated health services&#8221;. Further, the Stark Law has application to our management contracts with individual physicians and physician groups, as well as, any other financial relationship between us and referring physicians, including medical
          advisor arrangements and any financial transaction resulting from a clinic acquisition. The Stark Law also prohibits billing for services rendered pursuant to a prohibited referral. Several states have enacted laws similar to the Stark Law. These
          state laws may cover all (not just Medicare and Medicaid) patients. As with the Fraud and Abuse Law, we consider the Stark Law in planning our clinics, establishing contractual and other arrangements with physicians, marketing and other
          activities, and believe that our operations are in compliance with the Stark Law. If we violate the Stark Law or any similar state laws, our financial results and operations could be adversely affected. Penalties for violations include denial of
          payment for the services, significant civil monetary penalties, and exclusion from the Medicare and Medicaid programs.</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">HIPAA. </span>In an effort to further combat healthcare fraud and protect patient confidentially, Congress included several
          anti-fraud measures in the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;). HIPAA created a source of funding for fraud control to coordinate federal, state and local healthcare law enforcement programs, conduct
          investigations, provide guidance to the healthcare industry concerning fraudulent healthcare practices, and establish a national data bank to receive and report final adverse actions. HIPAA also criminalized certain forms of health fraud against
          all public and private payors. Additionally, HIPAA mandates the adoption of standards regarding the exchange of healthcare information in an effort to ensure the privacy and electronic security of patient information and standards relating to the
          privacy of health information. Sanctions for failing to comply with HIPAA include criminal penalties and civil sanctions. In February of 2009, the American Recovery and Reinvestment Act of 2009 (&#8220;ARRA&#8221;) was signed into law. Title XIII of ARRA,
          the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;), provided for substantial Medicare and Medicaid incentives for providers to adopt electronic health records (&#8220;EHRs&#8221;) and grants for the development of health
          information exchange (&#8220;HIE&#8221;). Recognizing that HIE and EHR systems will not be implemented unless the public can be assured that the privacy and security of patient information in such systems is protected, HITECH also significantly expanded the
          scope of the privacy and security requirements under HIPAA. Most notable are the mandatory breach notification requirements and a heightened enforcement scheme that includes increased penalties, and which now apply to business associates as well
          as to covered entities. In addition to HIPAA, a number of states have adopted laws and/or regulations applicable in the use and disclosure of individually identifiable health information that can be more stringent than comparable provisions under
          HIPAA.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">8</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We believe that our operations comply with applicable standards for privacy and security of protected healthcare information. We cannot predict what negative
          effect, if any, HIPAA/HITECH or any applicable state law or regulation will have on our business.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Other Regulatory Factors. </span>Political, economic and regulatory influences are fundamentally changing the healthcare
          industry in the United States. Congress, state legislatures and the private sector continue to review and assess alternative healthcare delivery and payment systems. Potential alternative approaches could include mandated basic healthcare
          benefits, controls on healthcare spending through limitations on the growth of private health insurance premiums and Medicare and Medicaid spending, the creation of large insurance purchasing groups, and price controls. Legislative debate is
          expected to continue in the future and market forces are expected to demand only modest increases or reduced costs. For instance, managed care entities are demanding lower reimbursement rates from healthcare providers and, in some cases, are
          requiring or encouraging providers to accept capitated payments that may not allow providers to cover their full costs or realize traditional levels of profitability. We cannot reasonably predict what impact the adoption of federal or state
          healthcare reform measures or future private sector reform may have on our business.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMPETITION</div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The healthcare industry, including the physical therapy business and the industrial injury prevention services business are
          highly competitive. The physical therapy business as well as the industrial injury prevention services business are both highly fragmented with no company having a significant market share nationally. We believe that we are one of the largest
          national outpatient physical therapy services providers.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Competitive factors affecting our business include quality of care, cost, treatment outcomes, convenience of location, and relationships with, and ability to meet
          the needs of, referral and payor sources. Our clinics compete, directly or indirectly, with many types of healthcare providers including the physical therapy departments of hospitals, private therapy clinics, physician-owned therapy clinics, and
          chiropractors. We may face more intense competition if consolidation of the therapy industry continues.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We believe that our strategy of providing key therapists in a community with an opportunity to participate in ownership or clinic profitability provides us with a
          competitive advantage by helping to ensure the commitment of local management to the success of the clinic.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We also believe that our competitive position is enhanced by our strategy of locating our clinics, when possible, on the ground floor of buildings and shopping
          centers with nearby parking, thereby making the clinics more easily accessible to patients. We offer convenient hours. We also attempt to make the decor in our clinics less institutional and more aesthetically pleasing than traditional hospital
          clinics.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">ENFORCEMENT ENVIRONMENT</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">In recent years, federal and state governments have launched several initiatives aimed at uncovering behavior that violates the federal civil and criminal laws
          regarding false claims and fraudulent billing and coding practices. Such laws require providers to adhere to complex reimbursement requirements regarding proper billing and coding in order to be compensated for their services by government
          payors. Our compliance program requires adherence to applicable law and promotes reimbursement education and training&#894; however, a determination that our clinics&#8217; billing and coding practices are false or fraudulent could have a material adverse
          effect on us.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">As a result of our participation in the Medicare and Medicaid programs, we are subject to various governmental inspections, reviews, audits and investigations to
          verify our compliance with these programs and applicable laws and regulations. In addition, our prior Corporate Integrity Agreement, which expired in February 2021, required annual audits to be performed by an independent review organization on a
          small sample of our clinics, the results of which were reported to the federal government. See &#8220;-Compliance Program&#8212;Corporate Integrity Agreement&#8221; for more on the Corporate Integrity Agreement (&#8220;CIA&#8221;). Managed care payors may also reserve the
          right to conduct audits. An adverse inspection, review, audit or investigation could result in: refunding amounts we have been paid; fines penalties and/or revocation of billing privileges for the affected clinics; the imposition of a new
          Corporate Integrity Agreement; exclusion from participation in the Medicare or Medicaid programs or one or more managed care payor networks; or damage to our reputation.</div>

        <div style="text-indent: 18pt;">&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We and our clinics are subject to federal and state laws prohibiting entities and individuals from knowingly and willfully making claims to Medicare, Medicaid and
          other governmental programs and third party payors that contain false or fraudulent information. The federal False Claims Act encourages private individuals to file suits on behalf of the government against healthcare providers such as us. As
          such suits are generally filed under seal with a court to allow the government adequate time to investigate and determine whether it will intervene in the action, the implicated healthcare providers often are unaware of the suit until the
          government has made its determination and the seal is lifted. Violations or alleged violations of such laws, and any related lawsuits, could result in (i) exclusion from participation in Medicare, Medicaid and other federal healthcare programs,
          or (ii) significant financial or criminal sanctions, resulting in the possibility of substantial financial penalties for small billing errors that are replicated in a large number of claims, as each individual claim could be deemed a separate
          violation. In addition, many states also have enacted similar statutes, which may include criminal penalties, substantial fines, and treble damages.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">9</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">COMPLIANCE PROGRAM</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Our Compliance Program. </span>Our ongoing success depends upon our reputation for quality service and ethical business
          practices. We operate in a highly regulated environment with many federal, state and local laws and regulations. We take a proactive interest in understanding and complying with the laws and regulations that apply to our business.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Our Board of Directors (the &#8220;Board&#8221;) has adopted a Code of Business Conduct and Ethics and a set of Corporate Governance Guidelines to clarify the ethical
          standards under which the Board and management carry out their duties. In addition, the Board has created a Compliance Committee of the Board (&#8220;Compliance Committee&#8221;) whose purpose is to assist the Board in discharging their oversight
          responsibilities with respect to compliance with federal and state laws and regulations relating to healthcare.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We have issued a Compliance Manual and created compliance training materials, hand-outs and an on-line testing program. These tools were prepared to ensure that
          every employee of our Company and subsidiaries has a clear understanding of our mutual commitment to high standards of professionalism, honesty, fairness and compliance with the law in conducting business. These standards are administered by our
          Chief Compliance Officer (&#8220;CCO&#8221;), who has the responsibility for the day-to-day oversight, administration and development of our compliance program. The CCO, internal and external counsel, management and the Compliance Committee review our
          policies and procedures for our compliance program from time to time in an effort to improve operations and to ensure compliance with requirements of standards, laws and regulations and to reflect the on-going compliance focus areas which have
          been identified by management, counsel or the Compliance Committee. We also have established systems for reporting potential violations, educating our employees, monitoring and auditing compliance and handling enforcement and discipline.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Committees. </span>Our Compliance Committee, appointed by the Board, consists of four independent directors. The Compliance
          Committee has general oversight of our Company&#8217;s compliance with the legal and regulatory requirements regarding healthcare operations. The Compliance Committee relies on the expertise and knowledge of management, the CCO and other compliance and
          legal personnel. The CCO regularly communicates with the Chairman of the Compliance Committee. The Compliance Committee meets at least four times a year or more frequently as necessary to carry out its responsibilities and reports regularly to
          the Board regarding its actions and recommendations.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We also have an Internal Compliance Committee, which is comprised of Company leaders in the areas of operations, clinical services, finance, human resources,
          legal, information technology and credentialing. The Internal Compliance Committee has the responsibility for evaluating and assessing Company areas of risk relating to compliance with federal and state healthcare laws, and generally to assist
          the CCO. The Internal Compliance Committee meets at least four times a year or more frequently as necessary to carry out its responsibilities. In addition, management has appointed a team to address our Company&#8217;s compliance with HIPAA. The HIPAA
          team consists of a security officer and employees from our legal, information systems, finance, operations, compliance, business services and human resources departments. The team prepares assessments and makes recommendations regarding
          operational changes and/or new systems, if needed, to comply with HIPAA.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Each clinic certified as a Medicare Rehabilitation Agency has a formally appointed governing body composed of a member of our management and the
          director/administrator of the clinic. The governing body retains legal responsibility for the overall conduct of the clinic. The members confer regularly and discuss, among other issues, clinic compliance with applicable laws and regulations. In
          addition, there are Professional Advisory Committees which serve as Infection Control Committees. These committees meet in the facilities and function as advisors.<br />
          <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We have in place a Risk Management Committee consisting of, among others, the CCO, the Vice President of Human Resources, and other legal, compliance and
          operations personnel. This committee reviews and monitors all employee and patient incident reports and provides clinic personnel with actions to be taken in response to the reports.<br />
          <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Reporting Violations. </span>In order to facilitate our employees&#8217; ability to report in confidence, anonymously and without
          retaliation any perceived improper work-related activities, accounting irregularities and other violations of our compliance program, we have set up an independent national compliance hotline. The compliance hotline is available to receive
          confidential reports of wrongdoing Monday through Friday (excluding holidays), 24 hours a day. The compliance hotline is staffed by experienced third party professionals trained to utilize utmost care and discretion in handling sensitive issues
          and confidential information. The information received is documented and forwarded timely to the CCO, who, together with the Compliance Committee, has the power and resources to investigate and resolve matters of improper conduct.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Educating Our Employees. </span>We utilize numerous methods to train our employees in compliance related issues, including an
          online learning management system. All employees complete a comprehensive training program comprised of numerous modules relating to our business and proper practices when newly hired and annually thereafter. The directors/administrators also
          provide periodic &#8220;refresher&#8221; training for existing employees and one-on-one comprehensive training with new hires. The corporate compliance group responds to questions from clinic personnel and conducts frequent teleconference meetings, webinars
          and training sessions on a variety of compliance related topics.</div>

        <div style="text-indent: 18pt;">&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">When a clinic opens, we provide a package of compliance materials containing manuals and detailed instructions for meeting Medicare Conditions of Participation
          Standards and other compliance requirements. During follow up training with the director/administrator of the clinic, compliance department staff explain various details regarding requirements and compliance standards. Compliance staff will
          remain in contact with the director/administrator while the clinic is implementing compliance standards and will provide any assistance required. All new office managers receive training (including Medicare, regulatory and corporate compliance,
          insurance billing, charge entry and transaction posting and coding, daily, weekly and monthly accounting reports) from the training staff at the corporate office. The corporate compliance group will assist in continued compliance, including
          guidance to the clinic staff with regard to Medicare certifications, state survey requirements and responses to any inquiries from regulatory agencies.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">10</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Monitoring and Auditing Clinic Operational Compliance. </span>We have in place audit programs and other procedures to monitor
          and audit clinic operational compliance with applicable policies and procedures. We employ internal auditors who, as part of their job responsibilities, conduct periodic audits of each clinic. Most clinics are audited at least once every 24
          months and additional focused audits are performed as deemed necessary. During these audits, particular attention is given to compliance with Medicare and internal policies, Federal and state laws and regulations, third party payor requirements,
          and patient chart documentation, billing, reporting, record keeping, collections and contract procedures. The audits are conducted on site or remotely and include interviews with the employees involved in management, operations, billing and
          accounts receivable.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Formal audit reports are prepared and reviewed with corporate management and the Compliance Committee. Each clinic director/administrator receives a letter
          instructing them of any corrective measures required. Each clinic director/administrator then works with the compliance team and operations to ensure such corrective measures are achieved.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Handling Enforcement and Discipline. </span>It is our policy that any employee who fails to comply with compliance program
          requirements or who negligently or deliberately fails to comply with known laws or regulations specifically addressed in our compliance program should be subject to disciplinary action up to and including discharge from employment. The Compliance
          Committee, compliance staff, human resources staff and management investigate violations of our compliance program and impose disciplinary action as considered appropriate.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"><span style="font-style: italic;">Corporate Integrity Agreement. </span>We also performed certain additional compliance related functions pursuant to CIA that we
          entered into with the OIG. The CIA, which became effective as of December 21, 2015, and expired in February 2021, outlined certain specific requirements relating to compliance oversight and program implementation, as well as periodic reporting.
          In addition, pursuant to the CIA, an independent review organization annually performed a Medicare billing and coding audit on a small group of randomly selected Company clinics. Our Compliance Program was modified so as to comply with the
          requirements of the CIA. The term of the CIA was five years and expired in February 2021.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">EMPLOYEES</div>

        <div style="text-indent: 13.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Our strategy is to acquire physical therapy practices, develop outpatient physical therapy clinics as satellites within existing partnerships, acquire industrial
          injury prevention services businesses, and continue to support the growth of our existing businesses requires a talented workforce that can grow with us. As of December 31, 2021, we employed approximately 5,500 people nationwide, of which
          approximately 3,000 were full-time employees.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">It is crucial that we continue to attract and retain top talent. To attract and retain talented employees, we strive to make our corporate office and all of our
          practices and businesses a diverse and healthy workplace, with opportunities for our employees to receive continuing education, skill development, encouragement to grow and develop their career, all supported by competitive compensation,
          incentives, and benefits. Our clinical professionals are all licensed and a vast majority have advanced degrees. Our operational leadership teams have long-standing relationships with local and regional universities, professional affiliations,
          and other applicable sources that provide our practices with a talent pipeline.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We provide competitive compensation and benefits programs to help meet our employees&#8217; needs in the practices and communities in which they serve. These programs
          (which can vary by practice and employment classification) include incentive compensation plans, a 401(k) plan, healthcare and insurance benefits, health savings and flexible spending accounts, paid time off, family leave, education assistance,
          mental health and other employee assistance benefits.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We invest resources to develop the talent needed to support our business strategy. Resources include a multitude of training and development programs delivered
          internally and externally, online and instructor-led, and on-the-job learning formats.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We expect to continue adding personnel in the future as we focus on potential acquisition targets and organic growth opportunities.</div>

        <div style="text-indent: 13.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">11</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold; text-indent: 18pt;">AVAILABLE INFORMATION</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section
          13(a) or 15(d) of the Exchange Act are made available free of charge on our internet website at <span style="text-decoration: underline;">www.usph.com </span>as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.</div>

        <div>&#160;</div>

        <a id="RISKFACTORS."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 1A.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"><!--Anchor-->RISK FACTORS.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Our business, operations and financial condition are subject to various risks. Some of these risks are described below, and readers of this Annual Report on Form
          10-K should take such risks into account in evaluating our Company or making any decision to invest in us. This section does not describe all risks applicable to our Company, our industry or our business, and it is intended only as a summary of
          material factors affecting our business.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Risks related to our business and operations</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We are subject to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (&#8220;COVID-19&#8221;).</div>

        <div>&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Our operations expose us to risks associated with public health crises and epidemics/pandemics, such as COVID-19 that has spread globally. Since early 2020, the
          continued spread has led to disruption and volatility in the global capital markets, which increases the cost of, and adversely impacts access to, capital and increases economic uncertainty.</div>

        <div style="text-indent: 18pt;">&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">COVID-19 is having, and will continue to have, an adverse impact on our operations and supply chains, including a temporary loss of physical therapists and other
          employees who are infected or quarantined for a period of time, an increase in cancellations of physical therapy patient appointments and a decline in the scheduling of new or additional patient appointments. Due to these impacts and measures, we
          have experienced, and will continue to experience, significant and unpredictable impact on employees and reductions and cancellations of our patient visits.</div>

        <div style="text-indent: 18pt;">&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Starting in mid-2021, certain local jurisdictions have imposed vaccination and/or mask mandates, and many of the Company&#8217;s clinics and their employees are now
          subject to a vaccination mandate promulgated by CMS as a condition of continued participation in the Medicare and Medicaid programs as a certified rehabilitation agency. At this time, it is not possible to predict the impact of these and other
          similar mandates on the Company or its workforce. These and other mandates may result in employee attrition and could have a material adverse effect on our business, including future revenue, costs, and results of operations.</div>

        <div><br />
        </div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Decreases in Medicare reimbursement rate may adversely affect our financial results.</div>

        <div><br />
        </div>

        <div style="text-align: left; text-indent: 22.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The Medicare program reimburses outpatient rehabilitation
            providers based on the Medicare Physician Fee Schedule (&#8220;MPFS&#8221;).&#160; On an annual basis, our reimbursement under the MPFS is subject to changes, which </span>could <span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">include reductions in such reimbursement amounts. &#160;</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">The Company estimates that the Medicare rate reduction for the full year of 2022 will be approximately 0.75%. See
            &#8220;Business&#8212;Sources of Revenue &#8211; Physical Therapy Services&#8221; in Item 1 for more information.&#160; </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The Consolidated Appropriations Act of 2021, includes
            reductions in Medicare payment rates of approximately 3% in each of calendar years 2023 and 2024, which would be instituted unless regulatory or Congressional action results in modifications to such rates as occurred in 2021 and 2022.&#160; &#160;</span></div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">&#160;In addition, the Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years and requires
          automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap.&#160; Congress has taken action to waive the 2% payment reduction during
          2021 and continuing through March 31, 2022, followed by three months of 1% sequester relief through June 30, 2022.&#160; Sequester relief is scheduled to then end on June 30, 2022.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Furthermore, Medicare claims for outpatient therapy services furnished by therapist assistants on or after January 1, 2020, must include a modifier indicating the
          service was furnished by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapist assistant are paid at an amount equal to 85% of the payment amount otherwise applicable for the
          service.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">
          <div style="text-align: left; text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex
            and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations <span style="font-family: 'Times New Roman'; font-size: 10pt;">governing the services we provide to
              Medicare patients </span>and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that <span style="font-family: 'Times New Roman'; font-size: 10pt;">could</span> have a material effect on
            our financial statements as of December 31, 2021. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from
            the Medicare program. For the years ended December 31, 2021, and 2020, respectively, net patient revenue from Medicare were approximately $134.4 million and $101.6 million, respectively.&#160;</div>

          <div><br />
          </div>

          <div>
            <div style="text-align: left; text-indent: 22.5pt; font-family: 'Times New Roman'; font-size: 10pt;">Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, we may not continue to receive
              reimbursement rates from Medicare that sufficiently compensate us for our services or, in some instances, cover our operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a material adverse effect
              on our revenue, financial condition, and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect our
              business, financial condition and results of operations.</div>

            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>

          </div>

        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">12</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We expect the federal and state governments to continue their efforts to contain growth in Medicaid expenditures, which could adversely affect
          our revenue and profitability.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Medicaid spending has increased rapidly in recent years, becoming a significant component of state budgets. This, combined with slower state revenue growth, has
          led both the federal government and many states to institute measures aimed at controlling the growth of Medicaid spending, and in some instances reducing aggregate Medicaid spending. We expect these state and federal efforts to continue for the
          foreseeable future. Furthermore, not all of the states in which we operate, most notably Texas, have elected to expand Medicaid as part of federal healthcare reform legislation. There can be no assurance that the program, on the current terms or
          otherwise, will continue for any particular period of time beyond the foreseeable future. If Medicaid reimbursement rates are reduced or fail to increase as quickly as our costs, or if there are changes in the rules governing the Medicaid program
          that are disadvantageous to our businesses, our business and results of operations could be materially and adversely affected.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Revenue we receive from Medicare and Medicaid is subject to potential retroactive reduction.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Payments we receive from Medicare and Medicaid can be retroactively adjusted after examination during the claims settlement process or as a result of post-payment
          audits. Payors may disallow our requests for reimbursement, or recoup amounts previously reimbursed, based on determinations by the payors or their third-party audit contractors that certain costs are not reimbursable because either adequate or
          additional documentation was not provided or because certain services were not covered or deemed to not be medically necessary. Significant adjustments, recoupments or repayments of our Medicare or Medicaid revenue, and the costs associated with
          complying with investigative audits by regulatory and governmental authorities, could adversely affect our financial condition and results of operations.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Additionally, from time to time we become aware, either based on information provided by third parties and/or the results of internal audits, of payments from
          payor sources that were either wholly or partially in excess of the amount that we should have been paid for the service provided. Overpayments may result from a variety of factors, including insufficient documentation supporting the services
          rendered or medical necessity of the services or other failures to document the satisfaction of the necessary conditions of payment. We are required by law in most instances to refund the full amount of the overpayment after becoming aware of it,
          and failure to do so within requisite time limits imposed by the law could lead to significant fines and penalties being imposed on us. Furthermore, our initial billing of and payments for services that are unsupported by the requisite
          documentation and satisfaction of any other conditions of payment, regardless of our awareness of the failure at the time of the billing or payment, could expose us to significant fines and penalties. We, and/or certain of our operating
          companies, could also be subject to exclusion from participation in the Medicare or Medicaid programs in some circumstances as well, in addition to any monetary or other fines, penalties or sanctions that we may incur under applicable federal
          and/or state law. Our repayment of any such amounts, as well as any fines, penalties or other sanctions that we may incur, could be significant and could have a material and adverse effect on our results of operations and financial condition.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">From time to time we are also involved in various external governmental investigations, audits and reviews. Reviews, audits and investigations of this sort can
          lead to government actions, which can result in the assessment of damages, civil or criminal fines or penalties, or other sanctions, including restrictions or changes in the way we conduct business, loss of licensure or exclusion from
          participation in government programs. Failure to comply with applicable laws, regulations and rules could have a material and adverse effect on our results of operations and financial condition. Furthermore, becoming subject to these governmental
          investigations, audits and reviews can also require us to incur significant legal and document production expenses as we cooperate with the government authorities, regardless of whether the particular investigation, audit or review leads to the
          identification of underlying issues.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">As a result of increased post-payment reviews of claims we submit to Medicare for our services, we may incur additional costs and may be
          required to repay amounts already paid to us.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We are subject to regular post-payment inquiries, investigations and audits of the claims we submit to Medicare for payment for our services. These post-payment
          reviews have increased as a result of government cost-containment initiatives. These additional post-payment reviews may require us to incur additional costs to respond to requests for records and to pursue the reversal of payment denials, and
          ultimately may require us to refund amounts paid to us by Medicare that are determined to have been overpaid.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">For a further description of this and other laws and regulations involving governmental reimbursements, see &#8220;Business&#8212;Sources of Revenue&#8221; and &#8220;&#8212;Regulation and
          Healthcare Reform&#8221; in Item 1.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">An economic downturn, state budget pressures, sustained unemployment and continued deficit spending by the federal government may result in a
          reduction in reimbursement and covered services.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">An economic downturn, including the consequences of a pandemic, such as COVID-19, could have a detrimental effect on our revenues. Historically, state budget
          pressures have translated into reductions in state spending. Given that Medicaid outlays are a significant component of state budgets, we can expect continuing cost containment pressures on Medicaid outlays for our services in the states in which
          we operate. In addition, an economic downturn, coupled with sustained unemployment, may also impact the number of enrollees in managed care programs as well as the profitability of managed care companies, which could result in reduced
          reimbursement rates.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">13</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">The existing federal deficit, as well as deficit spending by federal and state governments as the result of adverse developments in the economy or other reasons,
          can lead to continuing pressure to reduce governmental expenditures for other purposes, including government-funded programs in which we participate, such as Medicare and Medicaid. Such actions in turn may adversely affect our results of
          operations.</div>

        <div style="text-indent: 18pt;"><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We depend upon reimbursement by third-party payors.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Substantially all of our revenues are derived from private and governmental third-party payors. In 2021, approximately 62.8% of our revenues were derived
          collectively from managed care plans, commercial health insurers, workers&#8217; compensation payors, and other private pay revenue sources while approximately 37.2% of our revenues were derived from Medicare and Medicaid. Initiatives undertaken by
          industry and government to contain healthcare costs affect the profitability of our clinics. These payors attempt to control healthcare costs by contracting with healthcare providers to obtain services on a discounted basis. We believe that this
          trend will continue and may limit reimbursement for healthcare services. If insurers or managed care companies from whom we receive substantial payments were to reduce the amounts they pay for services, our profit margins may decline, or we may
          lose patients if we choose not to renew our contracts with these insurers at lower rates. In addition, in certain geographical areas, our clinics must be approved as providers by key health maintenance organizations and preferred provider plans.
          Failure to obtain or maintain these approvals would adversely affect our financial results.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">
          <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In recent years, through legislative and regulatory actions, the federal government has made substantial changes to various
            payment systems under the Medicare program. See &#8220;Business&#8212;Sources of Revenue<span style="font-family: 'Times New Roman'; font-size: 10pt;"> &#8211; Physical Therapy Services</span>&#8221; in Item 1 for more information including changes to Medicare
            reimbursement. Additional reforms or other changes to these payment systems may be proposed or adopted, either by the U.S. Congress or by CMS, including bundled payments, outcomes-based payment methodologies and a shift away from traditional
            fee-for-service reimbursement. If revised regulations are adopted, the availability, methods and rates of Medicare reimbursements for services of the type furnished at our facilities could change. Some of these changes and proposed changes
            could adversely affect our business strategy, operations and financial results.</div>

        </div>

        <div>&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Impact on the business and cash reserves resulting from retirement or resignation of key partners and resulting purchase of their
          non-controlling interests (minority interests).</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">As described in Note 5, the redeemable non-controlling interests in our partnerships are held by our partners. Upon the occurrence of certain events, such as
          retirement or other termination of employment, partners from acquired partnerships may have the right to exercise a &#8220;put&#8221; to cause us to purchase their redeemable non-controlling interests. Depending on the amount and timing of the exercise of
          any &#8220;put&#8221; rights, the funds required could have an adverse impact on our capital structure.</div>

        <div><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Healthcare reform legislation may affect our business.</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">In recent years, many legislative proposals have been introduced or proposed in Congress and in some state legislatures that would affect major changes in the
          healthcare system, either nationally or at the state level. At the federal level, Congress has continued to propose or consider healthcare budgets that substantially reduce payments under the Medicare programs. See &#8220;Business&#8212;Sources of Revenue&#8221;
          in Item 1 for more information. The ultimate content, timing or effect of any healthcare reform legislation and the impact of potential legislation on us is uncertain and difficult, if not impossible, to predict. That impact may be material to
          our business, financial condition or results of operations.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Our operations are subject to extensive regulation.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The healthcare industry is subject to extensive federal, state and local laws and regulations relating to:</div>

        <div>&#160;</div>

        <div>
          <div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="width: 18pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">facility and professional licensure/permits, including certificates of need;</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">conduct of operations, including financial relationships among healthcare providers, Medicare fraud and abuse, and physician self-referral;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">addition of facilities and services; and</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">coding, </span>billing and payment for services.</div>
                </div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">14</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">In recent years, there have been heightened coordinated civil and criminal enforcement efforts by both federal and state government agencies relating to the
          healthcare industry. We believe we are in substantial compliance with all laws, but differing interpretations or enforcement of these laws and regulations could subject our current practices to allegations of impropriety or illegality or could
          require us to make changes in our methods of operations, facilities, equipment, personnel, services and capital expenditure programs and increase our operating expenses. If we fail to comply with these extensive laws and government regulations,
          we could become ineligible to receive government program reimbursement, suffer civil or criminal penalties or be required to make significant changes to our operations. In addition, we could be forced to expend considerable resources responding
          to an investigation or other enforcement action under these laws or regulations. For a more complete description of certain of these laws and regulations, see &#8220;Business&#8212;Regulation and Healthcare Reform&#8221; and &#8220;Business&#8212;Compliance Program&#8221; in Item
          1.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Both federal and state regulatory agencies inspect, survey and audit our facilities to review our compliance with these laws and
          regulations. While our facilities intend to comply with the existing licensing, Medicare certification requirements and accreditation standards, there can be no assurance that these regulatory authorities will determine that all applicable
          requirements are fully met at any given time. A determination by any of these regulatory authorities that a facility is not in compliance with these requirements could lead to the imposition of requirements that the facility takes corrective
          action, assessment of fines and penalties, or loss of licensure or Medicare certification of accreditation. These consequences could have an adverse effect on us.</div>

        <div><br />
        </div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Our operations are subject to investigations, legal actions and proceedings that could result in an adverse
          impact on our business and financial position.</div>

        <div><br />
        </div>

        <div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Healthcare providers are subject to investigations, legal actions and proceedings, as well as lawsuits under the qui tam
          provisions of the federal False Claims Act, based on claims that the provider failed to comply with applicable laws and regulations that govern coding and the submission of claims for services provided to Medicare patients, among other things.
          These matters can involve significant costs, monetary damages and penalties. We have been subject to these proceedings in the past, and future proceedings could result in an adverse impact on our business and financial results.</div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We face inspections, reviews, audits and investigations under federal and state government programs and contracts. These audits could have
          adverse findings that may negatively affect our business.</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">As a result of our participation in the Medicare and Medicaid programs, we are subject to various governmental inspections, reviews, audits and investigations to
          verify our compliance with these programs and applicable laws and regulations. Managed care payors may also reserve the right to conduct audits. An adverse inspection, review, audit or investigation could result in:</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">refunding amounts we have been paid pursuant to the Medicare or Medicaid programs or from managed care payors;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">state or federal agencies imposing fines, penalties and other sanctions on us;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">temporary suspension of payment for new patients to the facility or agency;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">decertification or exclusion from participation in the Medicare or Medicaid programs or one or more managed care payor networks;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">the imposition of a new Corporate Integrity Agreement;</div>
                </div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">damage to our reputation;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">the revocation of a facility&#8217;s or agency&#8217;s license&#894; and</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">loss of certain rights under, or termination of, our contracts with managed care payors.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">If adverse inspections, reviews, audits or investigations occur and any of the results noted above occur, it could have a material adverse effect on our business
          and operating results.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Our facilities are subject to extensive federal and state laws and regulations relating to the privacy of individually identifiable
          information.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">HIPAA required the HHS to adopt standards to protect the privacy and security of individually identifiable health-related information. The department released
          final regulations containing privacy standards in 2000 and published revisions to the final regulations in 2002. The privacy regulations extensively regulate the use and disclosure of individually identifiable health-related information. The
          regulations also provide patients with significant rights related to understanding and controlling how their health information is used or disclosed. The security regulations require healthcare providers to implement administrative, physical and
          technical practices to protect the security of individually identifiable health information that is maintained or transmitted electronically. HITECH, which was signed into law in 2009, enhanced the privacy, security and enforcement provisions of
          HIPAA by, among other things establishing security breach notification requirements, allowing enforcement of HIPAA by state attorneys general, and increasing penalties for HIPAA violations. Violations of HIPAA or HITECH could result in civil or
          criminal penalties.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">In addition to HIPAA, there are numerous federal and state laws and regulations addressing patient and consumer privacy concerns, including unauthorized access or
          theft of personal information. State statutes and regulations vary from state to state. Lawsuits, including class actions and action by state attorneys general, directed at companies that have experienced a privacy or security breach also can
          occur.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We have established policies and procedures in an effort to ensure compliance with these privacy related requirements. However, if there is a breach, we may be
          subject to various penalties and damages and may be required to incur costs to mitigate the impact of the breach on affected individuals.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">15</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">In conducting our business, we are required to comply with applicable laws regarding fee-splitting and the corporate practice of medicine.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Some states prohibit the &#8220;corporate practice of therapy&#8221; that restricts business corporations from providing physical therapy services through the direct
          employment of therapist physicians or from exercising control over medical decisions by therapists. The laws relating to corporate practice vary from state to state and are not fully developed in each state in which we have facilities. Typically,
          however, professional corporations owned and controlled by licensed professionals are exempt from corporate practice restrictions and may employ therapists to furnish professional services. Those professional corporations may be managed by
          business corporations, such as the Company. </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Some states also prohibit entities from engaging in certain financial arrangements, such as fee-splitting, with physicians or therapists. The laws relating to
          fee-splitting also vary from state to state and are not fully developed. Generally, these laws restrict business arrangements that involve a physician or therapist sharing medical fees with a referral source, but in some states, these laws have
          been interpreted to extend to management agreements between physicians or therapists and business entities under some circumstances.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We believe that our current and planned activities do not constitute fee-splitting or the unlawful corporate practice of medicine as contemplated by these state
          laws. However, there can be no assurance that future interpretations of such laws will not require structural and organizational modification of our existing relationships with the practices. If a court or regulatory body determines that we have
          violated these laws or if new laws are introduced that would render our arrangements illegal, we could be subject to civil or criminal penalties, our contracts could be found legally invalid and unenforceable (in whole or in part), or we could be
          required to restructure our contractual arrangements with our affiliated physicians and other licensed providers.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We may be adversely affected by a security breach, such as a cyber-attack, which may cause a violation of HIPAA or HITECH and subject us to
          potential legal and reputational harm.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">In the normal course of business, our information technology systems hold sensitive patient information including patient demographic data and other protected
          health information, which is subject to HIPAA and HITECH. We also contract with third-party vendors to maintain and store our patients&#8217; individually identifiable health information. Numerous state and federal laws and regulations address privacy
          and information security concerns resulting from our access to our patient&#8217;s and employee&#8217;s personal information.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Our information technology systems and those of our vendors that process, maintain, and transmit such data are subject to computer viruses, cyber-attacks, or
          breaches. We adhere to policies and procedures designed to ensure compliance with HIPAA and other privacy and information security laws and require our third-party vendors to do so as well. If, however, we or our third-party vendors experience a
          breach, loss, or other compromise of unsecured protected health information or other personal information, such an event could result in significant civil and criminal penalties, lawsuits, reputational harm, and increased costs to us, any of
          which could have a material adverse effect on our financial condition and results of operations.</div>

        <div style="text-align: center;"><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Furthermore, while our information technology systems, and those of our third-party vendors, are maintained with safeguards protecting against cyber-attacks. A
          cyber-attack that bypasses our information technology security systems, or those of our third-party vendors, could result in a material adverse effect on our business, financial condition, results of operations, or cash flows. In addition, our
          future results could be adversely affected due to the theft, destruction, loss, misappropriation, or release of protected health information, other confidential data or proprietary business information, operational or business delays resulting
          from the disruption of information technology systems and subsequent mitigation activities, or regulatory action taken as a result of such incident. We provide our employees training and regular reminders on important measures they can take to
          prevent breaches. We routinely identify attempts to gain unauthorized access to our systems. However, given the rapidly evolving nature and proliferation of cyber threats, there can be no assurance our training and network security measures or
          other controls will detect, prevent, or remediate security or data breaches in a timely manner or otherwise prevent unauthorized access to, damage to, or interruption of our systems and operations. Accordingly, we may be vulnerable to losses
          associated with the improper functioning, security breach, or unavailability of our information systems as well as any systems used in acquired operations.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We depend upon the cultivation and maintenance of relationships with the physicians in our markets.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Our success is dependent upon referrals from physicians in the communities our clinics serve and our ability to maintain good relations with these physicians and
          other referral sources. Physicians referring patients to our clinics are free to refer their patients to other therapy providers or to their own physician owned therapy practice. If we are unable to successfully cultivate and maintain strong
          relationships with physicians and other referral sources, our business may decrease and our net operating revenues may decline.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">16</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We depend upon our ability to recruit and retain experienced physical therapists.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Our revenue generation is dependent upon referrals from physicians in the communities our clinics serve, and our ability to maintain good relations with these
          physicians. Our therapists are the front line for generating these referrals and we are dependent on their talents and skills to successfully cultivate and maintain strong relationships with these physicians. If we cannot recruit and retain our
          base of experienced and clinically skilled therapists, our business may decrease and our net operating revenues may decline. Periodically, we have clinics in isolated communities that are temporarily unable to operate due to the unavailability of
          a therapist who satisfies our standards.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We may also experience increases in our labor costs, primarily due to higher wages and greater benefits required to attract and retain qualified healthcare
          personnel, and such increases may adversely affect our profitability. Furthermore, while we attempt to manage overall labor costs in the most efficient way, our efforts to manage them may have limited effectiveness and may lead to increased
          turnover and other challenges.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Failure to maintain effective internal control over our financial reporting could have an adverse effect on our ability to report our financial
          results on a timely and accurate basis.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We are required to produce our consolidated financial statements in accordance with the requirements of accounting principles generally accepted in the United
          States of America. Effective internal control over financial reporting is necessary for us to provide reliable financial reports, to help mitigate the risk of fraud and to operate successfully. We are required by federal securities laws to
          document and test our internal control procedures in order to satisfy the requirements of the Sarbanes-Oxley Act of 2002, which requires annual management assessments of the effectiveness of our internal control over financial reporting.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Testing and maintaining our internal control over financial reporting can be expensive and divert our management&#8217;s attention from other matters that are important
          to our business. We may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with applicable law, or our independent registered public accounting firm may not be able to issue
          an unqualified attestation report if we conclude that our internal control over financial reporting is not effective. If we fail to maintain effective internal control over financial reporting, or our independent registered public accounting firm
          is unable to provide us with an unqualified attestation report on our internal control, we could be required to take costly and time-consuming corrective measures, be required to restate the affected historical financial statements, be subjected
          to investigations and/or sanctions by federal and state securities regulators, and be subjected to civil lawsuits by security holders. Any of the foregoing could also cause investors to lose confidence in our reported financial information and in
          us and would likely result in a decline in the market price of our stock and in our ability to raise additional financing if needed in the future.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Our revenues may fluctuate due to weather.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We have a significant number of clinics in states that normally experience snow and ice during the winter months. Also, a significant number of our clinics are
          located in states along the Gulf Coast and Atlantic Coast which are subject to periodic winter storms, hurricanes and other severe storm systems. Periods of severe weather may cause physical damage to our facilities or prevent our staff or
          patients from traveling to our clinics, which may cause a decrease in our net operating revenues.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We operate in a highly competitive industry.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We encounter competition from local, regional or national entities, some of which have superior resources or other competitive advantages. Intense competition may
          adversely affect our business, financial condition or results of operations. For a more complete description of this competitive environment, see &#8220;Business&#8212;Competition&#8221; in Item 1. An adverse effect on our business, financial condition or results
          of operations may require us to write down goodwill.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">We may incur closure costs and losses.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">The competitive, economic or reimbursement conditions in our markets in which we operate may require us to reorganize or to close certain clinics. In the event a
          clinic is reorganized or closed, we may incur losses and closure costs. The closure costs and losses may include, but are not limited to, lease obligations, severance, and write-down or write-off of goodwill and other intangible assets.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">17</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Future acquisitions may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities.<br />
          <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">As part of our growth strategy, we intend to continue pursuing acquisitions of outpatient physical therapy clinics and industrial injury prevention services
          businesses. Acquisitions may involve significant cash expenditures, potential debt incurrence and operational losses, dilutive issuances of equity securities and expenses that could have an adverse effect on our financial condition and results of
          operations. Acquisitions involve numerous risks, including:</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">the difficulty and expense of integrating acquired personnel into our business;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">the diversion of management&#8217;s time from existing operations&#894;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">the potential loss of key employees of acquired companies;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">the difficulty of assignment and/or procurement of managed care contractual arrangements; and</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">the assumption of the liabilities and exposure to unforeseen liabilities of acquired companies, including liabilities for failure to comply with healthcare regulations.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="font-family: 'Times New Roman';"><span style="font-weight: bold; font-style: italic;">Employer and other contracted customers may terminate their relationship with us which could adversely affect the business</span>.</div>

        <div><br />
        </div>

        <div style="font-family: 'Times New Roman'; text-indent: 18pt;">In our industrial injury prevention services business, we perform services for large employers and their employees pursuant to contracts and other services agreement.&#160; These contracts
          and other services agreements are able to be terminated by the employer-clients on little or short notice, and either a breach or termination of those contractual arrangements by such clients could cause operating results to be less than
          expected. Similarly, in our rehabilitation business, we have management and other services agreements with hospitals, physician groups and other ancillary providers; either a breach or termination of those contractual arrangements by such clients
          could cause operating results to be less than expected.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Risks related to our common stock</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Issuance of shares in connection with financing transactions or under stock incentive plans will dilute current stockholders.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pursuant to our stock incentive plans, our Compensation Committee of the Board, consisting solely of independent directors, is authorized to grant stock awards to
          our employees, directors and consultants. Shareholders will incur dilution upon the exercise of any outstanding stock awards or the grant of any restricted stock. In addition, if we raise additional funds by issuing additional common stock, or
          securities convertible into or exchangeable or exercisable for common stock, further dilution to our existing stockholders will result, and new investors could have rights superior to existing stockholders.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">The number of shares of our common stock eligible for future sale could adversely affect the market price of our stock.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">At December 31, 2021, we had reserved approximately 172,600 shares for future equity grants. We may issue additional restricted securities or register additional
          shares of common stock under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in the future. The issuance of a significant number of shares of common stock upon the exercise of stock options or the availability for sale, or sale, of
          a substantial number of the shares of common stock eligible for future sale under effective registration statements, under Rule 144 or otherwise, could adversely affect the market price of the common stock.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Provisions in our articles of incorporation and bylaws could delay or prevent a change in control of our company, even if that change would be
          beneficial to our stockholders.<br />
          <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Certain provisions of our articles of incorporation and bylaws may delay, discourage, prevent or render more difficult an attempt to obtain control of our company,
          whether through a tender offer, business combination, proxy contest or otherwise. These provisions include the charter authorization of &#8220;blank check&#8221; preferred stock and a restriction on the ability of stockholders to call a special meeting.</div>

        <div>&#160;</div>

        <a id="UNRESOLVEDSTAFFCOMMENTS."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 58.5pt; vertical-align: top; align: right;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 1B.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"><!--Anchor-->UNRESOLVED STAFF COMMENTS.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">None</div>

        <div>&#160;</div>

        <a id="PROPERTIES."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 58.5pt; vertical-align: top; align: right;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 2.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"><!--Anchor-->PROPERTIES.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We lease the properties used for our clinics under non-cancelable operating leases with terms ranging from one to five years, with the exception of the property
          for one clinic which we own. We intend to lease the premises for any new clinic locations except in rare instances where leasing is not a cost-effective alternative. Our typical clinic occupies 1,000 to 7,000 square feet. There are 17 clinics
          occupying space in the range of over 7,000 square feet to 13,500 square feet.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">18</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We also lease our executive offices located in Houston, Texas, under a non-cancelable operating lease expiring in February 2028. We currently lease approximately
          44,000 square feet of space (including allocations for common areas) at our executive offices.</div>

        <div><br />
        </div>

        <a id="LEGALPROCEEDINGS."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 58.5pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 3.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"><!--Anchor-->LEGAL PROCEEDINGS.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We are a party to various legal actions, proceedings, and claims (some of which are not insured), and regulatory and other governmental audits and investigations
          in the ordinary course of our business. We cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject us to sanctions, damages,
          recoupments, fines, and other penalties. The Department of Justice, CMS, or other federal and state enforcement and regulatory agencies may conduct additional investigations related to our businesses in the future that may, either individually or
          in the aggregate, have a material adverse effect on our business, financial position, results of operations, and liquidity.</div>

        <div><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal for some
          time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award
          bounties to private plaintiffs who successfully bring the suits. We have been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Settlement of a Legal Matter</div>

        </div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">On August 19, 2019, we received notice of a qui tam lawsuit (&#8220;the Complaint&#8221;) filed by a relator on behalf of the United States, titled U.S. ex rel. Bonnie Elsdon,
          v. U.S. Physical Therapy, Inc., U.S. Physical Therapy, Ltd., Rehab Partners #2, Inc., The Hale Hand Center, Limited Partnership (the &#8220;Hale Partnership&#8221;), and Suzanne Hale.&#160;&#160; This whistleblower lawsuit was filed in the U.S. District Court for the
          Southern District of Texas, seeking damages and civil penalties under the federal False Claim Act.&#160; This lawsuit was originally filed under seal by a former employee of The Hale Hand Center, Limited Partnership (&#8220;Hale Partnership&#8221;), a
          majority-owned subsidiary of the Company, on May 25, 2018.&#160; The U.S Government declined to intervene in the case and unsealed the Complaint on July 17, 2019.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">The Complaint alleged that the Hale Partnership engaged in conduct to purposely &#8220;upcode&#8221; its billings for services provided to Medicare patients. The plaintiff -
          relator also claimed that similar false claims occurred on other days and at other Company-owned partnerships.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">On October 3, 2019, we filed Motions to Dismiss based on numerous grounds on behalf of each of the named defendants. On October 29, 2019, the plaintiff-relator
          dismissed three of the named defendants, Rehab Partners #2, Inc., U.S. Physical Therapy, Ltd., and Suzanne Hale. The Motions to Dismiss were denied on November 30, 2020.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In January 2022, <span style="font-family: 'Times New Roman'; font-size: 10pt;">to avoid the legal fees and discovery costs in defending this
              matter and the uncertainty of protracted litigation, </span>the Company entered into a settlement agreement with the plaintiff-relator. In the settlement agreement, the plaintiff-relator released all defendants from liability for all conduct
            alleged in the Complaint, and the Company admitted no liability or wrongdoing.&#160; In connection with the settlement, the Office of the United States Attorney for the Southern District of Texas agreed to a dismissal of the claims against the Hale
            Partnership and the Company. Under the terms of the settlement, the Company agreed to make payments to the government, the plaintiff-relator and her counsel. Such payments, in the aggregate, amounted to $2.<span style="font-family: 'Times New Roman'; font-size: 10pt;">75</span> million<span style="font-family: 'Times New Roman'; font-size: 10pt;"> of which $2.6 million was recorded as an expense in 2021</span>.</div>

        </div>

        <div>&#160;</div>

        <a id="MINESAFETYDISCLOSURES."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; align: right;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 4.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"><!--Anchor-->MINE SAFETY DISCLOSURES.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Not Applicable.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">PART II</div>

        <div>&#160;</div>

        <a id="MARKETFORREGISTRANTSCOMMO"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; align: right;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 5.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"><!--Anchor-->MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND
                  ISSUER PURCHASES OF EQUITY SECURITIES.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Our common stock has traded on the New York Stock Exchange (&#8220;NYSE&#8221;) since August&#160;14, 2012 under the symbol &#8220;USPH.&#8221; Prior to that, our common
            stock was traded on the Nasdaq Global Select Market under the symbol &#8220;USPH&#8221;. As of March&#160;1, 2022, there were <span style="font-family: 'Times New Roman'; font-size: 10pt;">88</span> holders of record of our outstanding common stock.</div>

        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">19</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">DIVIDENDS</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">On February 22, 2022, our Board of Directors declared a dividend of $0.41 per share which will be paid on April 8, 2022 to shareholders of record as of March 14,
          2022. During 2021, we paid a quarterly dividend of $0.35 for the first and second quarters and $0.38 per share for each of the third and fourth quarters, totaling $1.46 per share for the year, which amounted to total aggregate cash payments of
          dividends to holders of our common stock in 2021 of approximately $18.8 million. During 2020, we paid a cash dividend for the first quarter of 2020 of $0.32 per share on all shares of common stock issued and outstanding as of April 17, 2020 which
          amounted to $4.1 million. In March 2020, our Board of Directors announced the suspension of any further dividends in 2020. During 2019, we paid a quarterly dividend of $0.27 for the first and second quarters and $0.30 per share for the third and
          fourth quarters, totaling $1.14 per share for the year, which amounted to total aggregate cash payments of dividends to holders of our common stock in 2019 of approximately $14.5 million. We are currently restricted from paying dividends on our
          common stock in excess of $50,000,000 in any fiscal year on our common stock under the Credit Agreement (as defined in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital
          Resources&#8221;).</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">20</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">FIVE YEAR PERFORMANCE GRAPH</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The performance graph and related description shall not be deemed incorporated by reference into any filing under the Securities Act or under the Exchange Act,
          except to the extent that we specifically incorporate this information by reference. In addition, the performance graph and the related description shall not be deemed &#8220;soliciting material&#8221; or &#8220;filed&#8221; with the SEC or subject to Regulation 14A or
          14C.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">On August 14, 2012, our common stock began trading on NYSE. The following performance graph compares the cumulative total stockholder return of our common stock to
          The NYSE Composite Index and the NYSE Health Care Index for the period from December 31, 2016 through December 31, 2021. The graph assumes that $100 was invested in our common stock and the common stock of each of the companies listed on The NYSE
          Composite Index and The NYSE Health Care Index on December 31, 2016 and that any dividends were reinvested.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Comparison of Five Years Cumulative Total Return for the Year Ended December 31, 2021</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="text-align: center;"><img width="645" height="476" src="image00002.jpg" alt="graphic" /></div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8201;</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 40%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">12/16</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); text-align: center;" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">12/17</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); text-align: center;" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">12/18</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); text-align: center;" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">12/19</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); text-align: center;" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">12/20</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); text-align: center;" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">12/21</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 40%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U.S Physical Therapy. Incs.</div>
              </td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">100</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">103</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">146</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">156</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">171</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">136</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 40%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">NYSE Composite</div>
              </td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">100</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">116</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">103</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">123</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">131</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">155</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 40%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">NYSE Healthcare Index</div>
              </td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">100</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">119</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">127</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">151</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">168</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman';">203</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">21</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <a id="MANAGEMENTSDISCUSSIONANDA"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; align: right;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 6.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"><!--Anchor-->MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
                  OF OPERATIONS.</div>
              </td>

  </tr>


</table>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">EXECUTIVE SUMMARY</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Our Business.</div>

        <div><br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Our reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Through our subsidiaries, we operate
          outpatient physical therapy clinics that provide pre-and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurological-related injuries and rehabilitation of injured workers. We also
          have majority interests in companies which are leading providers of industrial injury prevention services. Services provided in these businesses include onsite injury prevention and rehabilitation, performance optimization, post-offer employment
          testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their
          contractors. These services are performed through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).</div>

        <div><br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">During the last three years we completed the acquisitions of seven multi-clinic practices and three industrial injury prevention services businesses as detailed
          below:</div>

        <div><br />
        </div>

        <div style="clear: both;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 46.96%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">% Interest</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Acquired</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Number of</div>
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Clinics</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">December 2021 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2021</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">November 2021 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2021</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">September 2021 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2021</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">100%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">*</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">June 2021 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">June 30, 2021</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">65%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">8</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">March 2021 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">March 31, 2021</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">6</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">**</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">65% ***</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">4</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td style="width: 19.43%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td style="width: 11.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">67%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td style="width: 11.64%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.96%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">April 2019 Acquisition</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 19.43%; vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">April 11, 2019</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.03%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">100%</div>
                </td>

    <td style="width: 2.83%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 11.64%; vertical-align: middle; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</div>
                </td>

    <td style="width: 2.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;">
          <div>
            <div> <br />
            </div>

            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention business</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">The business includes six management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of
                      five years.</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnershipsrange from 10.0% to 83.8%, with an overall 65.0% based on the initial
                      purchase transaction.</div>
                  </td>

  </tr>


</table>
            <div> <br />
            </div>

          </div>

        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Besides the multi-clinic acquisitions referenced in the table above, during 2021 and 2020, we purchased the assets and business of three physical therapy clinics
          in separate transactions. The clinics operate as satellite clinics of three of our existing clinic partnerships.</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">During the year ended December 31, 2021, we sold two clinics. The aggregate sales price was $0.1 million. During the year ended December 31, 2020, we sold 14
          previously closed clinics. The aggregate sales price was $1.1 million, of which $0.7 million was paid in cash and $0.4 million in a note receivable, payable in two equal installments of principal and any accrued interest.&#160; The first payment was
          received in June 2021 and the next payment is due on June 15, 2022.</div>

        <div>&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">22</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We intend to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Impact of COVID-19</div>

        <div><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">As previously disclosed in a series of filings with the SEC and further described in detail in our Quarterly Reports on Form 10-Q for the first three quarters of
          2020 and our Annual Report on Form 10-K for the year ended December 31, 2020, our results were negatively impacted by the effects of the COVID-19 pandemic in 2020. For the 2021 period as compared to the 2020 period, the increase in revenues and
          expenses are primarily due to our business returning to and now exceeding pre-pandemic results.</div>

        <div><br />
        </div>

        <div style="text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We have put preparedness plans in place at our facilities to maintain continuity of operations, while also taking steps to keep employees and patients safe. In
          line with recommendations to reduce large gatherings and increase social distancing, we continue to allow a large number of office-based employees to work remotely. We are monitoring the situation and will adjust work environments accordingly.</div>

        <div style="text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">In March 2020 in response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES
          Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions,
          temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property, and the creation of certain
          payroll tax credits associated with the retention of employees.</div>

        <div><br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We have received a number of benefits under the CARES Act including, but not limited to:</div>

        <div>&#160;</div>

        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">The CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing Medicare Accelerated and Advance Payments Program (&#8220;MAAPP funds&#8221;)
                    during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. We applied for and received approval to receive MAAP funds from Centers for Medicare
                    &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. We recorded the $14.1 million in advance payments received as a liability. During the quarter ended March 31, 2021, we repaid the MAAPP funds of $14.1 million rather than applying them to
                    future services performed.</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">We elected to defer depositing the employer&#8217;s share of Social Security taxes for payments due from March 27, 2020, through December 31, 2020, interest-free and penalty-free. In
                    December 2021, we paid $4.1 million related to these deferred payments.&#160; As of December 31, 2021, $4.2 million related to these deferred payments is included in accrued liabilities.</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">The CARES Act provided additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0 billion in
                    appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care
                    providers for lost revenues and health care related expenses that are attributable to COVID-19. For the years ended December 31, 2021, and December 31, 2020, the Company&#8217;s consolidated subsidiaries recorded income of approximately $4.6
                    million and $13.5 million, respectively, of payments under the CARES Act (&#8220;Relief Funds&#8221;). Under the Company&#8217;s accounting policy, these payments were recorded as Other income &#8211; Relief Funds. These funds are not required to be repaid
                    upon attestation and compliance with certain terms and conditions, which could change materially based on evolving grant compliance provisions and guidance provided by the U.S. Department of Health and Human Services. Currently, the
                    Company can attest and comply with the terms and conditions.&#160; We will continue to monitor the evolving guidelines and may record adjustments as additional information is released.</div>
                </td>

  </tr>


</table>
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">CRITICAL ACCOUNTING POLICIES</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Critical accounting policies are those that have a significant impact on our results of operations and financial position involving significant estimates requiring
          our judgment. Our critical accounting policies are:</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">23</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; text-indent: 18pt;">Revenue Recognition.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Revenues are recognized in the period in which services are rendered. Net patient revenue consists of revenues for physical therapy and occupational therapy
          clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenue (patient
          revenues less estimated contractual adjustments) is recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied.
          There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as we provide physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent
          on previously rendered services. We have agreements with third-party payors that provide for payments to us at amounts different from our established rates. The allowance for estimated contractual adjustments is based on terms of payor contracts
          and historical collection and write-off experience.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Management contract revenue, which is included in other revenue in the consolidated statements of net income, is derived from contractual arrangements whereby we
          manage a clinic owned by a third party. We do not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized at the point in time when services are
          performed. Costs, typically salaries for our employees, are recorded when incurred.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Revenues from the industrial injury prevention services business, which are also included in other revenues in the consolidated statements of net income, are
          derived from onsite services we provide to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the industrial injury prevention services business is recognized when
          obligations under the terms of the contract are satisfied. Revenues are recognized at an amount equal to the consideration we expect to receive in exchange for providing injury prevention services to our clients. The revenue is determined and
          recognized based on the number of hours and respective rate for services provided in a given period.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Additionally, other revenue includes services we provide on-site at locations such as schools and industrial worksites for physical or occupational therapy
          services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between us and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If
          the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time when the services are performed.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We implemented ASC 606 beginning January 1, 2018, using a modified retrospective transition method. The principal change relates to how the new standard requires
          healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a significant reversal will not occur. The most common forms of variable consideration we
          experience are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues upon implementation. Under the new standards, our estimate for unrealizable amounts will continue
          to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">For ASC 606, there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party
          payors (e.g. insurers, managed care programs, government programs, and workers' compensation programs which establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not
          considered contracts with the customer, they are used for determining the transaction price for services provided to the patients covered by the third-party payors. The payor contracts do not indicate performance obligations for us but indicate
          reimbursement rates for patients who are covered by those payors when the services are provided. At that time, we are obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone
          does not indicate a performance obligation. For self-paying customers, the performance obligation exists when we provide the services at established rates. The difference between our established rate and the anticipated reimbursement rate is
          accounted for as an offset to revenue&#8212;contractual allowance.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">We determine allowances for credit losses based on the specific agings of receivables and payor classifications at each clinic. The provision for credit losses is
          included in clinic operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses, includes only those
          amounts we estimate to be collectible.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">The following table details the revenue related to the various categories (in thousands):</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: auto; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="10">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Year Ended</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2020</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2019</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Net patient revenue</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">438,330</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">373,340</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">433,345</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Other revenue</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2,939</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2,020</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2,486</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 54%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Physical therapy operations</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">441,269</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">375,360</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">435,831</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 54%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Management contract revenue</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">9,853</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">8,410</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">8,676</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 54%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Industrial injury prevention services revenue</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">43,900</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">39,199</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">37,462</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 54%; padding-bottom: 4px; text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">495,022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">422,969</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">481,969</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">24</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Contractual Allowances. </span>Contractual allowances result from the differences between the rates charged for services
          performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include
          multiple reimbursement mechanisms payable for the services provided in our clinics. We estimate contractual allowances based on our interpretation of the applicable regulations, payor contracts and historical calculations. Each month we estimate
          our contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and apply an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor
          of the clinic. Based on our historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow us to provide the necessary detail and accuracy with our collectability estimates. However, the
          services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from our estimates. Payor terms are periodically revised necessitating continual review and assessment of the
          estimates made by management. Our billing systems may not capture the exact change in our contractual allowance reserve estimate from period to period. Therefore, in order to assess the accuracy of our revenues and hence our contractual allowance
          reserves, our management regularly compares our cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, the historical difference between net revenues and corresponding cash
          collections in any given fiscal year has generally reflected a difference within approximately 1.0% to 1.5% of net revenues. Additionally, analysis of subsequent period&#8217;s contractual write-offs on a payor basis reflects a difference within
          approximately 1.0% to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, we believe that a reasonable
          likely change in the contractual allowance reserve estimate would not be more than 1% to 1.5% of gross billings in accounts receivable at December 31, 2021. For purposes of demonstrating the sensitivity of this estimate on our Company&#8217;s financial
          condition, a 1% to 1.5% increase or decrease in our aggregate contractual allowance reserve percentage would decrease or increase, respectively, net patient revenue by approximately $1.3 million to $1.9 million for the year ended December 31,
          2021. Management believes the changes in the estimate of the contractual allowance reserve for the periods ended December 31, 2021, 2020 and 2019 have not been material to the statement of income.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The following table sets forth information regarding our patient accounts receivable as of the dates indicated (in thousands):</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 70%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 46%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="6">
                  <div style="text-align: center; font-family: 'Times New Roman';">December 31,</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; padding-bottom: 2px; width: 46%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';"> 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Gross patient accounts receivable</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">129,524</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">119,180</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Less contractual allowances</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">80,484</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">75,266</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Subtotal - accounts receivable</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">49,040</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">43,914</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Less allowance for credit losses</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">2,768</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">2,008</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Net patient accounts receivable</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">46,272</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">41,906</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The following table presents our patient accounts receivable aging by payor class as of the dates indicated (in thousands):</div>

        <div><br />
        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 18%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                  <div style="text-align: center; font-family: 'Times New Roman';">December 31, 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                  <div style="text-align: center; font-family: 'Times New Roman';">December 31, 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 18%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;"><span style="text-decoration: underline;">Payor</span></div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">
                    <div>Current to</div>
                    120 Days</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">120+ Days</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">Total</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">
                    <div>Current to</div>
                    120 Days</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">120+ Days</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">Total</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 18%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Managed Care/ Commercial Plans</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">13,985</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">2,381</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">16,366</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">13,053</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">1,774</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">14,827</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 18%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Medicare/Medicaid</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">13,442</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">1,636</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">15,078</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">10,707</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">1,196</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">11,903</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 18%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Workers Compensation*</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">5,600</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">1,312</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">6,912</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">6,576</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">926</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">7,502</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 18%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Self-pay</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">4,371</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">3,316</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">7,687</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">4,086</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">3,146</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">7,232</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 18%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Other**</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">1,168</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">1,829</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">2,997</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">1,108</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">1,342</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">2,450</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 18%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Totals</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">38,566</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">10,474</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">49,040</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">35,530</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">8,384</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">43,914</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">*</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Workers compensation is paid by state administrators or their designated agents.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">**</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Other includes primarily litigation claims and, to a lesser extent, vehicular insurance claims.</div>
              </td>

  </tr>


</table>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 18pt;"><br />
          Reimbursement for Medicare beneficiaries is based upon a fee schedule published by HHS. For a more complete description of our third-party revenue sources, see &#8220;Business&#8212;Sources of Revenue&#8221; in Item 1.</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Goodwill. </span>The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for
          impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair value if considered impaired. These events or conditions include but are not limited to: a significant adverse change in the
          business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a
          reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. We evaluate indefinite-lived tradenames in conjunction with our annual goodwill
          impairment test.<br />
          <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">25</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We operate a two segment business which is made up of various clinics within partnerships, and the other is an industrial injury prevention services business. The
          partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining our reporting units when performing our annual goodwill impairment test. In 2021, 2020 and 2019, there were six regions. In
          addition to the six regions, in 2021 and 2020, the impairment analysis included a separate analysis for the industrial injury prevention services business, as a separate reporting unit.</div>

        <div>&#160;</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">As part of the impairment analysis, we are first required to assess qualitatively if we can conclude whether goodwill is more likely than not impaired. If goodwill
          is more likely than not impaired, we are then required to complete a quantitative analysis of whether a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a
          reporting unit is less than its carrying amount, we consider relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. We consider both the income and market approach in determining the fair value of its
          reporting units when performing a quantitative analysis.</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable
          intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2021, 2020 and 2019 did not result in any goodwill amounts that were deemed impaired.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">For our annual assessment of goodwill, we evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting
          units were reduced below their carrying value as of December 31, 2021. As a result of the assessment, we determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2021.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Redeemable Non-Controlling Interest</span>&#8212;The non-controlling interests that are reflected as redeemable non-controlling
          interest in our consolidated financial statements consist of those owners, including us, that have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that we purchase or the owner sell
          the non-controlling interest held by the owner, if certain conditions are met and the owners request the purchase (&#8220;Put Right&#8221;). We also have a call right (&#8220;Call Right&#8221;). The Put Right or Call Right may be triggered by the owner or us,
          respectively, at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the
          transaction, typically three to five years, as defined in the limited partnership agreement. The Put Rights and Call Rights are not automatic (even upon death) and require either the owner or us to exercise our rights when the conditions
          triggering the Put or Call Rights have been satisfied. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; font-family: 'Times New Roman';"><span style="color: #000000;">On the date we acquire a controlling interest in a partnership and the limited partnership agreement for such partnerships contains redemption rights not
            under our control, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption&#8212;</span><span style="font-style: italic; color: #000000;">Redeemable non-controlling interest</span><span style="color: #000000;">. Then, in each reporting period thereafter until it is purchased by us, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial value, based on the
            predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial value. We record any adjustment in the redemption value, net of tax,
            directly to retained earnings and not in the consolidated statements of income. Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that we reflect the adjustments, net of tax,
            in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated </span>statement of income<span style="color: #000000;">. We believe the redemption value (i.e. the carrying amount) and fair value are the same.</span></div>

        <div style="text-indent: 20pt; font-family: 'Times New Roman';"><span style="color: #000000;"> <br />
          </span></div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Effective December 31, 2017, we entered into amendments to our limited partnership agreements for our acquired partnerships replacing the mandatory redemption
          feature. No monetary consideration was paid to the partners to amend the agreements. The amended limited partnership agreements provide that, upon the triggering events, we have a Call Right and the selling entity or individual has a Put Right
          for the purchase and sale of the limited partnership interest held by the partner. Once triggered, the Put Right and the Call Right do not expire, even upon an individual partner&#8217;s death, and contain no mandatory redemption feature. The purchase
          price of the partner&#8217;s limited partnership interest upon the exercise of either the Put Right or the Call Right is calculated per the terms of the respective agreements. We accounted for the amendment of the limited partnership agreements as an
          extinguishment of the outstanding mandatorily redeemable non-controlling interests, which were classified as liabilities, through the issuance of new redeemable non-controlling interests classified in temporary equity. Pursuant to Accounting
          Standards Codification (&#8220;ASC&#8221;) 470-50-40-2, we removed the outstanding liabilities at their carrying amounts, recognized the new temporary equities at their fair value, and recorded no gain or loss on extinguishment as management believes the
          redemption value (i.e. the carrying amount) and fair value are the same. In summary, the redemption values of the mandatorily redeemable non-controlling interest (previously classified as liabilities) were reclassified as redeemable
          non-controlling interest (temporary equity) at fair value on the December 31, 2017, consolidated balance sheet.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Non-Controlling Interest&#8212;</span>We recognize non-controlling interests, in which we have no obligation but the right to purchase
          the non-controlling interests, as equity in the consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face of
          the consolidated statements of income. Operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner. When we purchase a non-controlling interest and the
          purchase differs from the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">26</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">SELECTED OPERATING AND FINANCIAL DATA</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The following table and discussion relate to continuing operations unless otherwise noted. The defined terms with their respective description used in the
          following discussion are listed below:</div>

        <div><br />
        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 80%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;">


  <tr>

    <td style="width: 30%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">2021</div>
                </td>

    <td style="width: 50%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">Year ended December 31, 2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: bottom; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">2020</div>
                </td>

    <td style="width: 50%; vertical-align: bottom; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">Year ended December 31, 2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">2021 Additions</div>
                </td>

    <td style="width: 50%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">Clinics opened or acquired during the year ended December 31, 2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: bottom; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">2020 Additions</div>
                </td>

    <td style="width: 50%; vertical-align: bottom; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">Clinics opened or acquired during the year ended December 31, 2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">Clinics Additions</div>
                </td>

    <td style="width: 50%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">Clinics opened or acquired during the year ended December 31, 2021 and 2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: bottom; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">Mature Clinics</div>
                </td>

    <td style="width: 50%; vertical-align: bottom; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman';">Clinics opened or acquired prior to January 1, 2020 and are still operating</div>
                </td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The following table presents selected operating and financial data, used by management as key indicators of our operating performance:</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 70%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 46%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="6">
                  <div style="text-align: center; font-family: 'Times New Roman';">For the Years Ended December 31,</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 46%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';"> 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Number of clinics, at the end of period</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">591</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">554</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Working Days</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">254</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">256</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Average visits per day per clinic</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">29.1</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">24.6</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Total patient visits</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">4,219,576</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">3,533,371</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 46%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Net patient revenue per visit</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">103.88</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">105.66</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">RESULTS OF OPERATIONS</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">2021 COMPARED TO 2020</div>

        <div><br />
        </div>

        <div style="text-indent: 18pt; margin-right: 18pt; font-family: 'Times New Roman';">For 2021, the net income attributable to our shareholders was $40.8 million compared to $35.2 million for 2020 and $40.0 million for the year ended December 31,
          2019 (&#8220;2019&#8221;). Inclusive of the charge or credit for revaluation of non-controlling interest, net of taxes, used to compute earnings per diluted share in accordance with GAAP, the amount was $31.1 million, or $2.41 per diluted share, for 2021 as
          compared to $31.8 million, or $2.48 per diluted share, for 2020, and $31.3 million, or $2.45 per diluted share, for 2019.<span style="color: #000000;">&#160; For both 2021 and 2020, in accordance with current accounting guidance, the revaluation of
            redeemable non-controlling interest, net of tax, is not included in net income but rather charged directly to retained earnings; however, the charge for this change is included in the earnings per basic and diluted share calculation. See table
            below (in thousands, except per share data):</span></div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: auto; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 66%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="6">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">
                  <div style="color: #000000; font-weight: bold;">For the Year Ended&#160; December 31,<br />
                  </div>
                </div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 66%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> 2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">2020</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Computation of earnings per share - USPH shareholders:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Net income attributable to USPH shareholders</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">40,831</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">35,194</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">(Charges) credit to retained earnings:</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Revaluation of redeemable non-controlling interest</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(13,011</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(4,632</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Tax effect at statutory rate (federal and state) of 25.55% and 26.25%, respectively</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,324</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,216</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">31,144</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">31,778</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 66%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Earnings per share (basic and diluted)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2.41</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2.48</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">For 2021, our Operating Results, inclusive of Relief Funds, were $43.8 million, or $3.39 per diluted share, an increase of 13.8%, as compared to $38.4 million, or
          $2.99 per diluted share, for 2020.&#160; For 2021, our Operating Results, excluding Relief Funds (as defined below), were $40.9 million, or $3.17 per diluted share, an increase of 33.5%, as compared to $30.6 million, or $2.39 per diluted share, for
          2020.&#160; Operating Results, a non-Generally Accepted Accounting Principles (&#8220;non-GAAP&#8221;) measure, equals net income attributable to diluted shareholders per the consolidated statements of income less gain on sale of partnership interests and clinics
          plus charges incurred for clinic closure costs and expenses related to executive officer transitions and settlement of a legal matter, all net of taxes. Operating Results per diluted share also excludes the impact of the revaluation of redeemable
          non-controlling interest and the associated tax impact. See table below for a detailed computation (in thousands, except per share data):</div>

        <div>&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">27</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: auto; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; width: 66%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="6">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">For the Year Ended December 31,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; text-indent: -9pt; margin-left: 9pt; width: 66%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> 2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">2020</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Computation of earnings per share - USPH shareholders:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Net income attributable to USPH shareholders</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">40,831</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">35,194</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Credit (charges) to retained earnings:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Revaluation of redeemable non-controlling interest</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(13,011</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(4,632</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Tax effect at statutory rate (federal and state) of 25.55% and 26.25%, respectively</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,324</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,216</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">31,144</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">31,778</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Earnings per share (basic and diluted)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2.41</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2.48</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Adjustments:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Closure costs</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">30</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,931</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Expenses related to executive officers transition</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,301</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,331</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Gain on sale of partnership interest and clinics</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(1,091</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Relief Funds</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(4,597</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(13,500</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Settlement of a liability</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2,635</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Allocation to non-controlling interest</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">676</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,116</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Revaluation of redeemable non-controlling interest</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">13,011</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">4,632</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Tax effect at statutory rate (federal and state) of 25.55% and 26.25%, respectively</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(3,336</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">415</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Operating Results (excluding Relief Funds) (a non-GAAP measure)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">40,864</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">30,612</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Relief Funds</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">4,597</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">13,500</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Allocation to non-controlling interest</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(715</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(2,893</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Tax effect at statutory rate (federal and state) of 25.55% and 26.25%, respectively</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(992</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(2,784</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Operating Results (including Relief Funds) (a non-GAAP measure)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">43,754</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">38,435</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Basic and diluted Operating Results per share (excluding Relief Funds) (a non-GAAP measure)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3.17</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2.39</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Basic and diluted Operating Results per share (including Relief Funds) (a non-GAAP measure)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3.39</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2.99</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 66%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Shares used in computation - basic and diluted</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">12,898</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">12,835</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The above table reconciles net income attributable to our shareholders calculated in accordance with GAAP to Operating Results, a non-GAAP measure defined above.
          We believe that Operating Results, which eliminates certain items described above that can be subject to volatility and unusual costs, is one of the principal measures to evaluate and monitor financial performance period over period. We also
          believe that Operating Results is useful information for investors to use in comparing the Company's period-to-period results as well as for comparing with other similar businesses.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Operating Results is not a measure of financial performance under GAAP and, therefore, should not be considered in isolation or as an alternative to, or substitute
          for, net income attributable to our shareholders presented in the consolidated financial statements.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Reported total revenue</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 18pt; margin-right: 18pt; font-family: 'Times New Roman';">Reported total revenue for 2021 increased $72.1 million, or 17.0% to $495.0 million as compared to $423.0 million for 2020.&#160; See table below
          for a detail of reported total revenue (in thousands):</div>

        <div style="text-align: justify; text-indent: 18pt; margin-right: 18pt; font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">28</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> Year Ended</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Revenue related to Mature Clinics</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">402,744</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">358,103</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Revenue related to 2021 Clinic Additions</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">13,802</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Revenue related to 2020 Clinic Additions</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">21,283</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">9,664</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Revenue from clinics sold or closed in 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">455</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,242</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Revenue from clinics sold or closed in 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">46</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">4,331</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Net patient revenue from physical therapy operations</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">438,330</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">373,340</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Other revenue</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2,939</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2,020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Revenue from physical therapy operations</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">441,269</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">375,360</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Management contract revenue</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">9,853</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">8,410</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Industrial injury prevention services</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">43,900</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">39,199</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Net Revenue</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">495,022</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">422,969</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Net patient revenue from physical therapy operations</div>

        <div><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Net patient revenue from physical therapy operations increased $65.0 million, or 17.4%, to $438.3 million for 2021 from $373.3 million in 2020. Included in net
          patient revenue from physical therapy operations are revenues related to clinics sold or closed of $0.5 million for 2021 and $5.5 million for 2020.&#160; During 2021, the Company sold its interest in two clinics and closed three clinics. During 2020,
          the Company sold its interest in 14 clinics and closed 34 clinics. For comparison purposes, excluding revenue from the clinics sold or closed, net patient revenue from physical therapy operations was approximately $437.8 million for 2021 and
          $367.8 million for 2020, an increase of 19.1%. Revenue related to Mature Clinics increased $44.6 million, or 12.5%, for 2021 compared to 2020.</div>

        <div><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The average net patient revenue per visit was $103.88 for 2021 as compared to $105.66 for 2020, including all clinics operational during such periods. Total
          patient visits were 4,219,576 for 2021 and 3,533,371 for 2020, an increase of 19.4%.</div>

        <div>&#160;</div>

        <div style="text-indent: 18pt; font-family: 'Times New Roman';">Net patient revenues are based on established billing rates less allowances and discounts for patients covered by contractual programs and workers&#8217; compensation. Net patient revenues
          reflect contractual and other adjustments, which we evaluate monthly, relating to patient discounts from certain payors. Payments received under these contractual programs and workers&#8217; compensation are based on predetermined rates and are
          generally less than the established billing rates of the clinics.</div>

        <div>&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Other revenue from physical therapy operations, management contracts and industrial injury prevention services</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">
          <div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other revenue was $2.9&#160;million in 2021 and $2.0&#160;million in 2020.&#160; Revenues from management contracts were $9.9&#160;million in 2021
            as compared to $8.4&#160;million in 2020. Revenue from our industrial injury prevention services business increased 12.0% to $43.9&#160;million in 2021 compared to $39.2&#160;million in 2020, with $2.2 million of the increase related to the acquisition of an
            industrial injury prevention services business on November 30, 2021<span style="font-family: 'Times New Roman'; font-size: 10pt;">.</span></div>

        </div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Operating cost</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Total operating cost, excluding closure costs, a non-GAAP measure, was $377.8 million in 2021, as compared to $324.6 million in 2020. Total operating cost,
          excluding closure costs, was 76.3% as a percentage of net revenue in 2021 and 76.7% in 2020. On a cost per visit basis, total operating cost, excluding closure costs, was $79.70 per visit in 2021 as compared to $81.74 per visit in 2020, a
          decrease of 2.5%.&#160; Included in operating cost for 2021 was $30.6 million related to Clinic Additions, of which $19.6 million was associated with the 2020 Clinic Additions.&#160; Included in operating cost for 2020 was $8.4 million related to 2020
          Clinic Additions. Operating cost related to Mature Clinics increased by $31.7 million for 2021 compared to 2020.&#160; Operating cost related to management contracts increased by $1.7 million in 2021 compared to 2020. In addition, operating cost
          related to the industrial injury prevention services business increased by $4.1 million for the comparable periods.&#160; See table below for a detail of operating cost, excluding closure costs (a non-GAAP measure) (in thousands):</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">29</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Year Ended</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-indent: -9pt; margin-left: 9pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Operating cost related to Mature Clinics</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">305,148</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">273,476</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Operating cost related to 2021 Clinic Additions</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">11,080</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Operating cost related to 2020 Clinic Additions</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">19,561</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">8,416</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Operating cost related to clinics sold or closed in 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">484</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,345</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Operating cost related to clinics sold or closed in 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">25</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">5,583</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Closure costs</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">30</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,931</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Physical therapy operations</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">336,328</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">292,751</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Physical therapy management contracts</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">8,306</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">6,655</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Industrial injury prevention services</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">33,206</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">29,113</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Total operating cost</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">377,840</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">328,519</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">&#160;Less: Physical therapy operations - closure costs</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(30</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(3,931</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Total operating cost excluding closure costs (a non-GAAP measure)</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">377,810</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">324,588</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Closure costs in 2020 were $3.9 million, which includes estimates of remaining lease obligations, derecognition of goodwill and other costs related to closed and
          sold clinics. Each component of clinic operating costs is discussed below:</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Operating Cost&#8212;Salaries and Related Costs</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Salaries and related costs increased to $278.5 million for 2021 from $235.6 million in 2020, an increase of $42.8 million, or 18.2%. Included in salaries and
          related costs for 2021 was $7.3 million related to 2021 Clinic Additions. Salaries and related costs for clinics sold or closed in 2021 and 2020 were $0.3 million and $3.8 million in 2021 and 2020, respectively. Salaries and related costs for
          Mature Clinics increased $26.5 million in 2021 compared to 2020. Salaries and related costs for management contracts increased $1.4 million for 2021 compared to 2020. Salaries and related costs for the industrial injury prevention services
          business increased $2.8 million for the comparable periods. Salaries and related costs as a percentage of net revenues were 56.3% for 2021 and 55.7% for 2020. Salaries and related costs for physical therapy operations were $57.81 per visit in
          2021 as compared to $58.10 per visit in 2020, a decrease of 0.5%.&#160; See table below for a detail of salaries and related costs (in thousands):</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="width: 80%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: auto; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 56%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Year Ended</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-indent: -9pt; margin-left: 9pt; width: 56%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2020</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 56%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Physical therapy operations</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 56%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Salaries and related costs related to Mature Clinics</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">222,431</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">195,962</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 56%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Salaries and related costs related to 2021 Clinic Additions</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">7,258</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 56%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Salaries and related costs related to 2020 Clinic Additions</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">13,940</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">5,495</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 56%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Salaries and related costs related to clinics sold or closed in 2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">293</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">805</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 56%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Salaries and related costs related to clinics sold or closed in 2020</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">18</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,009</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 56%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Total Physical therapy operations</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">243,940</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">205,271</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 56%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Physical therapy management contracts</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">7,316</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">5,921</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 56%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Industrial injury prevention services</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">27,213</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">24,437</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 56%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Total salaries and related costs</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">278,469</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">235,629</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Operating Cost&#8212;Rent, Supplies, Contract Labor and Other</div>

        <div><br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Rent, supplies, contract labor and other costs increased to $94.0 million for 2021 from $84.3 million for 2020, an increase of $9.7 million, or 11.5%. Included in
          rent, supplies, contract labor and other costs for 2021 and 2020 related to Clinic Additions was $9.0 million. Rent, supplies, contract labor and other costs for clinics related to partnership interests closed or sold in 2021 and 2020 were $0.2
          million and $2.8 million in 2020, respectively. Rent, supplies, contract labor and other costs related to Mature Clinics increased $4.4 million. Rent, supplies, contract labor and other costs as a percent of net revenues was 19.0% for 2021 and
          19.9% for 2020. Rent, supplies, contract labor and other costs for physical therapy operations were $20.63 per visit in 2021 as compared to $22.37 per visit in 2020, a decrease of 7.8%. See table below for a detail of rent, supplies, contract
          labor and other costs (in thousands):</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">30</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Year Ended</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-indent: -9pt; margin-left: 9pt; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Physical therapy operations</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Rent, supplies, contract labor and other costs related to Mature Clinics</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">77,770</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">73,348</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Rent, supplies, contract labor and other costs related to 2021 Clinic Additions</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,653</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Rent, supplies, contract labor and other costs related to 2020 Clinic Additions</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">5,436</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2,846</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Rent, supplies, contract labor and other costs related to clinics sold or closed in 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">187</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">528</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Rent, supplies, contract labor and other costs related to clinics sold or closed in 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">8</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2,328</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Total Physical therapy operations</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">87,054</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">79,050</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Physical therapy management contracts</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">989</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">734</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Industrial injury prevention services</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">5,993</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">4,552</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Total rent, supplies, contract labor and other costs</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">94,036</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">84,336</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Operating Cost&#8212;Provision for Credit Losses</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The provision for credit losses for net patient receivables was $5.3 million for 2021 and $4.6 million for 2020. As a percentage of net patient revenues, the
          provision for credit losses was 1.1% for both 2021 and 2020. The provision for credit losses at the end of each period is based on a detailed, clinic-by-clinic review of overdue accounts and is regularly reviewed in the aggregate in light of
          historical experience.</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Our provision for credit losses as a percentage of total patient accounts receivable was 5.64% at December 31, 2021 and 4.57% at December 31, 2020.</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The average accounts receivable days outstanding were 32 days at December 31, 2021 and December 31, 2020. Net patient receivables in the amounts of $4.6 million
          and $4.5 million were written-off in 2021 and 2020, respectively.</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Gross Profit</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Gross profit, excluding closure costs, a non-GAAP measure, was $117.2 million for 2021, an increase of $18.8 million, or 19.1% as compared to $98.4 million for
          2020. The gross profit percentage, less closure costs, was 23.7% of total revenue for 2021, an increase of 40 basis points, as compared to 23.3% for 2020. The gross profit percentage for the Company&#8217;s physical therapy operations, excluding
          closure costs, was 23.8% for 2021, an increase of 70 basis points as compared to 23.1% for 2020. The gross profit percentage on management contracts revenue was 15.7% for 2021 as compared to 20.9% for 2020. The gross profit percentage for the
          industrial injury prevention services business was 24.4% for 2021 as compared to 25.7% for 2020. See table below for details on gross profit, excluding closure costs (a non-GAAP measure) (in thousands) and a reconciliation against Gross Profit
          (in thousands):</div>

        <div><br />
        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Year Ended</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-indent: -9pt; margin-left: 9pt; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 66%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Physical therapy operations</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">104,971</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">86,540</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Management contracts</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,547</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1,755</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Industrial injury prevention services</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">10,694</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">10,086</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Physical therapy operations - closure costs</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(30</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(3,931</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Gross profit</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">117,182</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">94,450</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Physical therapy operations - closure costs</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">30</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3,931</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Gross profit, excluding closure costs (a non-GAAP measure)</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">117,212</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">98,381</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Corporate Office Costs</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Corporate office costs were $46.5 million for 2021 compared to $42.0 million for 2020. Corporate office costs were 9.4% of total revenue for 2021 as compared to
          9.9% for 2020. For 2020, corporate offices costs included temporary salary reductions and furloughs related to the pandemic. Also, in both 2021 and 2020, corporate office costs included $1.3 million in equity compensation expense related to the
          accelerated vesting of restricted stock previously granted to two executive officers upon their retirement in July 2021 and November 2020. Excluding the equity compensation related to the accelerated vesting of restricted stock, corporate office
          costs was 9.1% of total revenue for 2021 and 9.6% for 2020.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">31</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Operating Income</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Operating income for 2021 was $70.6 million, an increase of $18.2 million, or 34.8%, as compared to $52.4 million for 2020. Operating income as a percentage of
          total revenue increased 190 basis points from 12.4% for 2020 to 14.3% for 2021.</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Other Income&#8212;Relief Funds</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Relief Funds recognized in other income were $4.6 million for 2021 and $13.5 million for 2020.&#160; See discussion related to Relief Funds for more information.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Other Income - Resolution of a Payor Matter and Other Expense &#8211; Settlement of a Legal Matter</div>

        <div>&#160;</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Other income for the 2021 Year includes $1.2 million of income related to the positive resolution of a payor matter and other expense includes a $2.6 million
          increase in a reserve related to a settlement of a legal matter.&#160; In January 2022, the Company paid $2.75 million related to this matter.</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Interest Expense&#8212;Debt and Other</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Interest expense&#8212;debt and other was $0.9 million for 2021 and $1.6 million for 2020. At December 31, 2021, $114.0 million was outstanding under our Amended Credit
          Agreement (as defined below under &#8220;&#8212;Liquidity and Capital Resources&#8221;). See &#8220;&#8212;Liquidity and Capital Resources&#8221; below for a discussion of the terms of our Amended Credit Agreement.</div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Provision for Income Taxes<br />
          <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The provision for income tax was $15.3 million for 2021 and $13.0 million for 2020. The provision for income tax as a percentage of income before taxes less net
          income attributable to non-controlling interest (effective tax rate) was 27.2% for 2021 and 27.0% for 2020. See table below ($ in thousands):<br />
          <br />
        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Year Ended</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-indent: -9pt; margin-left: 9pt; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2021</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">December 31, 2020</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 66%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Income before taxes</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">73,196</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">65,513</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Less: net income attributable to non-controlling interest:</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Redeemable non-controlling interest - temporary equity</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(11,358</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(11,175</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 18pt;">Non-controlling interest - permanent equity</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(5,735</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(6,122</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 66%; text-indent: -9pt; margin-left: 9pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(17,093</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(17,297</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Income before taxes less net income attributable to non-controlling interest</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">56,103</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">48,216</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Provision for income taxes</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">15,272</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">13,022</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 66%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Effective tax rate</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">27.2</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">%</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">27.0</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">%</div>
                </td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">Net Income Attributable to Non-controlling Interest</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;"> <br />
        </div>

        <div style="text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Net income attributable to redeemable non-controlling interest (temporary equity) was $11.4 million for 2021 and $11.2 million for 2020.&#160; Net income attributable
          to non-controlling interest (permanent equity) was $5.7 million for 2021 and $6.1 million for 2020.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">LIQUIDITY AND CAPITAL RESOURCES</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We believe that our business is generating sufficient cash flow from operating activities to allow us to meet our short-term and long-term cash requirements, other
          than those with respect to future significant acquisitions. At December 31, 2021, we had $28.5 million in cash and cash equivalents compared to $32.9 million at December 31, 2020. Although the start-up costs associated with opening new clinics
          and our planned capital expenditures are significant, we believe that our cash and cash equivalents and the availability under our Amended Credit Agreement are sufficient to fund the working capital needs of our operating subsidiaries, future
          clinic development and acquisitions and investments through at least December 2022. Significant acquisitions would likely require financing under our Amended Credit Agreement.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Effective December&#160;5, 2013, we entered into an Amended and Restated Credit Agreement with a commitment for a $125.0&#160;million revolving credit
            facility. This agreement was amended in August 2015, January 2016, March 2017, November 2017, January 2021, and November 2021 (hereafter is referred to as &#8220;Amended Credit Agreement&#8221;).&#160; In November 2021, we exercised the accordion feature in the
            Amended Credit Agreement to increase to limit on our facility from $125.0 million to $150.0 million, with an updated accordion feature providing for an additional capacity of $25.0 million, therefore increasing the availability up to $175.0
            million.</div>

        </div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">32</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The 2021 amendment to the Amended Credit Agreement allows for cash and noncash consideration for acquisitions permitted under the Amended Credit Agreement of up to
          $50,000,000 for any fiscal year, and allows for payments in cash dividends to&#160; shareholders in an aggregate amount not to exceed $50,000,000 in any fiscal year. The Amended Credit Agreement is unsecured and includes certain financial covenants
          which include a consolidated fixed charge coverage ratio and a consolidated leverage ratio, as defined in the agreement. The Amended Credit Agreement is unsecured and has loan covenants, including requirements that we comply with a consolidated
          fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of our common stock, dividend payments to our common stockholders, capital
          expenditures and other corporate purposes. The pricing grid is based on our consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.25% to 2.0% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees
          under the Amended Credit Agreement include an unused commitment fee ranging from 0.25% to 0.3% depending on our consolidated leverage ratio and the amount of funds outstanding under the Amended Credit Agreement.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">On December 31, 2021, $114.0 million was outstanding on the Amended Credit Agreement resulting in $61.0 million of availability. As of the date of this report, we
          were in compliance with all of the covenants thereunder.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cash provided by operations was $76.4 million and net proceeds from our Amended Credit Agreement amounted to $98.0 million. The major uses of cash for investing
          and financing activities included: purchase of interests in businesses ($86.8 million), purchases of redeemable non-controlling interest, temporary equity ($28.5 million), purchases of fixed assets ($8.2 million), proceeds on sale of partnership
          interest ($0.3 million), distributions to non-controlling interests ($16.9 million), payments of cash dividends to our shareholders ($18.8 million), and payments on notes payable ($4.9 million).</div>

        <div><br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">On December 31, 2021, we acquired a 75% interest in a three-clinic physical therapy practice with the practice founder retaining 25%. The purchase price for the
          75% interest was approximately $3.7 million, of which $3.5 million was paid in cash and $0.2 million in the form of a note payable.&#160; The note accrues interest at 3.25% per annum and the principal and interest is payable on December 31, 2023.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 20pt; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2021, we acquired an approximate 70% interest in a leading provider of industrial injury prevention services.
          The <span style="font-family: 'Times New Roman'; font-size: 10pt;">previous </span> owners retained the remaining interest. The initial purchase price for the 70% equity interest, not inclusive of the $2.0 million contingent payment in
          conjunction with the acquisition if specified future operational objectives are met, was approximately $63.2 million, of which $62.2 million was paid in cash, and $1.0 million is in the form of a note payable. The note accrues interest at 3.25%
          and the principal and interest is payable on November 30, 2023. <span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The business generates approximately $27.0 million in annual revenue at a margin of approximately
            20%. </span>As part of the transaction, we also agreed to the potential future purchase of a separate company under the same ownership that provides physical therapy and rehabilitation services to hospitals and other ancillary providers in a
          distinct market area.&#160; The current owners have the right to put this transaction to us in approximately five years, with such right having a $3.5 million <span style="font-family: 'Times New Roman'; font-size: 10pt;">fair </span>value at
          December 31, 2021, as reflected on the Company&#8217;s consolidated balance sheet in Other long-term liabilities.&#160; The value of this right will be adjusted in future periods, as appropriate, with any change in <span style="font-family: 'Times New Roman'; font-size: 10pt;">fair </span>value reflected in the Company&#8217;s consolidated statement of income.</div>

        <div><br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On September 30, 2021, we acquired a company that specializes in return-to-work and ergonomic services, among other offerings.
          The business generates more than $2.0 million in annual revenue. We acquired the company&#8217;s assets at a purchase price of approximately $3.3 million (which includes the obligation to pay an amount up to $0.6 million in contingent payment
          consideration in conjunction with the acquisition if specified future operational objectives are met) and contributed those assets to<span style="font-family: 'Times New Roman'; font-size: 10pt;"> o</span>ur industrial injury prevention services
          subsidiary. The initial purchase price, not inclusive of the $0.6 million contingent payment, was approximately $2.7 million, of which $2.4 million was paid in cash, and $0.3 million is in the form of a note payable. The note accrues interest at
          3.25% per annum and the principal and interest is payable on September 30, 2023.</div>

        <div><br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On June 30, 2021, we acquired a 65% interest in an eight-clinic physical therapy practice with the <span style="font-family: 'Times New Roman'; font-size: 10pt;">previous owners</span> retaining 35%. The purchase price was approximately $10.3 million, of which $9.0 million was paid in cash, $1.0 million is payable based on the achievement of certain business criteria
          and $0.3 million is in the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest is payable on June 30, 2023. Additionally, we have an obligation to pay an additional amount up to $0.8 million in
          contingent payment consideration in conjunction with the acquisition if specified future operational objectives are met. We recorded acquisition-date fair value of this contingent liability based on the likelihood of the contingent earn-out
          payment. The earn-out payment will subsequently be remeasured to fair value each reporting date.</div>

        <div><br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On March 31, 2021, we acquired a 70% interest in a five-clinic physical therapy practice with the <span style="font-family: 'Times New Roman'; font-size: 10pt;">previous owners</span> retaining 30%.&#160; When acquired, the practice was developing a sixth clinic which has been completed. The purchase price for the 70% interest was approximately $12.0 million, of which
          $11.7 million was paid in cash and $0.3 million in the form of a note payable.&#160; The note accrues interest at 3.25% per annum and the principal and interest is payable on March 31, 2023.</div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">33</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2020, we acquired a 75% interest in a three-clinic physical therapy practice<span style="font-family: 'Times New Roman'; font-size: 10pt;"> with the previous owners retaining 25%</span>. The purchase price for the 75% interest was $8.9 million (net of cash acquired), of which $8.6 million was paid in cash and $0.3 million in the form of a note payable
          that is payable in two principal installments totaling $162,500 each. The first principal payment plus accrued interest was paid in November 2021 with the second installment to be paid in November 2022. The note accrues interest at 3.25% per
          annum.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On September&#160;30, 2020, we acquired a 70% interest in an entity which holds six management contracts that have been in place for
          a number of years and had five years remaining on their term as of the acquisition date. <span style="font-family: 'Times New Roman'; font-size: 10pt;">The previous owners retained the remaining 30%. </span>The purchase price for the 70%
          interest was approximately $4.2&#160;million, with $3.7&#160;million payable in cash and $0.5&#160;million in notes payable. One of the notes payable of $0.2&#160;million was paid in September 2021 and the note of $0.3&#160;million was paid in November 2020.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On February&#160;27, 2020, we acquired interests in a four-clinic physical therapy practice. The four clinics are operated in four
          separate partnerships. The Company&#8217;s interests in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction. The aggregate purchase price was $11.9&#160;million, of which $11.6&#160;million was paid in
          cash and $0.3&#160;million in the form of a seller note. The note accrues interest at 4.75% per annum and the principal and interest was paid in February 2022.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On September&#160;30, 2019, we acquired a 67% interest in an eleven-clinic physical therapy practice<span style="font-family: 'Times New Roman'; font-size: 10pt;"> with the previous owners retaining 33%</span>. The purchase price for the 67% interest was $12.4&#160;million, of which $12.1&#160;million was paid in cash and $0.3&#160;million in the form of a seller note that is payable in
          two principal installments totaling $150,000 each. The first principal payment plus accrued interest was paid in September 2020 and the second installment was paid in September 2021. The note accrues interest at 5.0% per annum.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On April&#160;11, 2019, we acquired a company that is a provider of industrial injury prevention services. The acquired company
          specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network of 45 states including onsite at eleven client
          locations. The business was then combined with Briotix Health, the Company&#8217;s industrial injury prevention services operation, increasing the Company&#8217;s ownership position in the Briotix Health partnership to approximately 76.0%. The purchase price
          for the acquired company was $22.9&#160;million ($23.6&#160;million less cash acquired of $0.7&#160;million), which consisted of $18.9&#160;million in cash, (of which $0.5&#160;million will be paid to certain shareholders), and a $4.0&#160;million seller note. The note was
          paid in April 2021.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Historically, we have generated sufficient cash from operations to fund our development activities and to cover operational needs. We plan to continue developing
          new clinics and making additional acquisitions. We have from time to time purchased the non-controlling interests of limited partners in our Clinic Partnerships. We may purchase additional non-controlling interests in the future. Generally, any
          acquisition or purchase of non-controlling interests is expected to be accomplished using a combination of cash and financing. Any large acquisition would likely require financing.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We make reasonable and appropriate efforts to collect accounts receivable, including applicable deductible and co-payment amounts. Claims are submitted to payors
          daily, weekly or monthly in accordance with our policy or payor&#8217;s requirements. When possible, we submit our claims electronically. The collection process is time consuming and typically involves the submission of claims to multiple payors whose
          payment of claims may be dependent upon the payment of another payor. Claims under litigation and vehicular incidents can take a year or longer to collect. Medicare and other payor claims relating to new clinics awaiting CMS approval initially
          may not be submitted for six months or more. When all reasonable internal collection efforts have been exhausted, accounts are written off prior to sending them to outside collection firms. With managed care, commercial health plans and self-pay
          payor type receivables, the write-off generally occurs after the account receivable has been outstanding for 120 days or longer.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We have future obligations for debt repayments, employment agreements and future minimum rentals under operating leases. The obligations as of December 31, 2021
          are summarized as follows (in thousands):</div>

        <div><br />
        </div>

        <div style="margin-left: 18pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 95%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: 0px; margin-right: auto;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">Total</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">2022</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">2023</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">2024</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">2025</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">2026</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-family: 'Times New Roman';">Thereafter</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Credit Agreement</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">114,000</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">114,000</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Notes Payable</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">4,417</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">830</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">3,587</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Interest Payable</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">292</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">74</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">218</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Employee Agreements</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">61,278</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">52,837</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">8,321</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">120</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">-</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">Operating Leases</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">136,992</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">41,270</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">33,637</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">25,527</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">17,111</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">10,575</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">8,872</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">316,979</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">95,011</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">45,763</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">25,647</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">131,111</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">10,575</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="font-family: 'Times New Roman';">8,872</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="clear: both;"><br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We generally enter into various notes payable as a means of financing our acquisitions. Our present outstanding notes payable primarily relate to the acquisitions
          of a business or acquisitions of majority interests in businesses. At December 31, 2021, our remaining outstanding balance on these notes aggregated $4.4 million.</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">
          <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The notes payable for the acquisition of businesses of $4.4&#160;million are payable in 2022 and 2023. Notes are generally payable
            in equal annual installments of principal over two years plus any accrued and unpaid interest. See above table for a detail of future principal payments. Interest accrues at various interest rates ranging from 3.25% to 4.75% per annum.</div>

        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">34</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The limited partnership agreements, as amended, provide that, upon the triggering events, we have a Call Right and the selling
          entity or individual has a Put Right for the purchase and sale of the limited partnership interest held by the partner. Once triggered, the Put Right and the Call Right do not expire, even upon an individual partner&#8217;s death, and contain no
          mandatory redemption feature. The purchase price of the partner&#8217;s limited partnership interest upon the exercise of either the Put Right or the Call Right is calculated per the terms of the respective agreements and classified as redeemable
          non-controlling interest (temporary equity) in our consolidated balance sheets. The fair value of the redeemable non-controlling interest at December&#160;31, 2021 was $154.4&#160;million.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of December&#160;31, 2021, we have accrued $6.6&#160;million related to credit balances and overpayments due to patients and payors.
          This amount is expected to be paid in 2022.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">From September 2001 through December&#160;31, 2008, our Board of Directors (&#8220;Board&#8221;) authorized us to purchase, in the open market or
          in privately negotiated transactions, up to 2,250,000 shares of our common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of our common stock (&#8220;March 2009 Authorization&#8221;). Our Amended
          Credit Agreement permits share repurchases of up to $15,000,000 in the aggregate, subject to compliance with covenants. We are required to retire shares purchased under the March 2009 Authorization.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">There is no expiration date for the share repurchase program. As of December&#160;31, 2021, there are currently an additional
          estimated 156,986 shares (based on the closing price of $95.55 on December&#160;31, 2021) that may be purchased from time to time in the open market or private transactions depending on price, availability and our cash position. We did not purchase
          any shares of our common stock during the years ended December&#160;31, 2021 and 2020.</div>

        <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">W</span>e have an investment in a joint venture that is accounted
          for using the equity method of accounting.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">35</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">FACTORS AFFECTING FUTURE RESULTS</div>

        <div>&#160;</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">The risks related to our business and operations include:</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">the multiple effects of the impact of public health crises and epidemics/pandemics, such as the novel strain of COVID-19 and its variants, for which the total financial magnitude cannot be
                  currently estimated;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification and/or enrollment status&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">changes in reimbursement rates or payment methods from third party payors including government agencies, and changes in the deductibles and co-pays owed by patients&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible
                  write-down or write-off of goodwill and other intangible assets;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">the impact of COVID-19 related vaccination and/or testing mandates at the federal, state and/or local level, which could have an adverse impact on staffing, revenue, costs and the results of
                  operations:</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">changes as the result of government enacted national healthcare reform&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">business and regulatory conditions including federal and state regulations&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">governmental and other third party payor inspections, reviews, investigations and audits, which may result in sanctions or reputational harm and increased costs&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">revenue and earnings expectations&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">legal actions, which could subject us to increased operating costs and uninsured liabilities&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">general economic conditions&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">availability and cost of qualified physical therapists&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">personnel productivity and retaining key personnel&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">competitive environment in the industrial injury prevention services business, which could result in the termination or non-renewal of contractual service arrangements and other adverse financial
                  consequences for that service line;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">acquisitions, and the successful integration of the operations of the acquired businesses;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">impact on the business and cash reserves resulting from retirement or resignation of key partners and resulting purchase of their non-controlling interest (minority interests);</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">maintaining our information technology systems with adequate safeguards to protect against cyber-attacks&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">a security breach of our or our third party vendors&#8217; information technology systems may subject us to potential legal action and reputational harm and may result in a violation of the Health
                  Insurance Portability and Accountability Act of 1996 of the Health Information Technology for Economic and Clinical Health Act;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">maintaining clients for which we perform management and other services, as a breach or termination of those contractual arrangements by such clients could cause operating results to be less than
                  expected;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">maintaining adequate internal controls;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">maintaining necessary insurance coverage&#894;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">availability, terms, and use of capital&#894; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman';">weather and other seasonal factors.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">See also Risk Factors in Item 1A of this Annual Report on Form 10-K.</div>

        <div>
<div>&#160;
          </div>
<div>
            <a id="QUANTITATIVEANDQUALITATIV"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">ITEM 7A.</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><!--Anchor-->QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">We do not maintain any derivative instruments such as interest rate swap arrangements, hedging contracts, futures contracts or the like. Our only indebtedness as
          of December 31, 2021 was the outstanding balance of seller notes from our acquisitions of $4.4 million and an outstanding balance on our Amended Credit Agreement of $114.0 million. The outstanding balance under our Amended Credit Agreement is
          subject to fluctuating interest rates. A 1% change in the interest rate would yield an additional $1.1 million of interest expense. See Note 9 to our consolidated financial statements included in Item 8.</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">36</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);"> <div><br /></div>

    <div>
      <a id="FINANCIALSTATEMENTSANDSUP"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
              <div style="text-align: left;"><!--Anchor--><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 8.</span></div>
            </td>

    <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;"><!--Anchor--><!--Anchor--><span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">FINANCIAL STATEMENTS AND
                  SUPPLEMENTARY DATA.</span></div>
            </td>

  </tr>


</table>
    </div>

    <div><br />
    </div>

    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center; font-weight: bold;">
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND RELATED INFORMATION</div>

        <div><br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 93.38%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="#REPORTOFINDEPENDENTREGIST">Reports of Independent Registered Public Accounting Firm&#8212;Grant Thornton LLP</a> (PCAOB ID Number <span style="-sec-ix-hidden:Fact_e5031b4fde974c0ab8fd6effd4a5c369">248</span>)</div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">38</div>
            </td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Audited Financial Statements:</div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="#BALANCE">Consolidated Balance Sheets as of December 31, 2021 and 2020</a></div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">40</td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="#INCOME">Consolidated Statements of Income for the years ended December 31, 2021, 2020 and 2019</a></div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">41</td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="#EQUITY">Consolidated Statements of Changes in Equity for the years ended December 31, 2021, 2020 and 2019</a></div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">42</td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="#CASH">Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020 and 2021</a></div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">43</td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 93.38%; vertical-align: bottom; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a href="#NOTES">Notes to Consolidated Financial Statements</a></div>
            </td>

    <td style="width: 6.62%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">44</td>

  </tr>


</table>
      <div style="margin-bottom: 8pt;"><br />
      </div>

      <div><br class="Apple-interchange-newline" /></div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">37</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="REPORTOFINDEPENDENTREGIST"><!--Anchor--></a>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Board of Directors and Shareholders</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Opinion on the financial statements</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We have audited the accompanying consolidated balance sheets of U.S. Physical Therapy, Inc. (a Nevada corporation) and subsidiaries (the &#8220;Company&#8221;) as of December 31,
          2021 and 2020, the related consolidated statements of income, changes in equity, and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and financial statement schedule included under Item 15(a)
          (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations
          and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board
            (United States) (&#8220;PCAOB&#8221;), the Company&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in the 2013 </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Internal




            Control&#8212;Integrated Framework</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;), and our report dated March 1, 2022 expressed an
            unqualified opinion.</span></div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Basis for opinion</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based
          on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
          and Exchange Commission and the PCAOB.</div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about
          whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud,
          and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles
          used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Critical audit matters</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be
          communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit
          matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or
          disclosures to which they relate.</div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Measurement of Patient Revenue Net of Contractual Adjustments</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As discussed in Note 2 to the consolidated financial statements, revenues are recognized in the period in which services are rendered. Net patient revenues (patient
          revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied.
          The Company has agreements with third-party payors that provides for payments at amounts different from its established rates. Each month the Company estimates its contractual adjustment for each clinic based on the terms of third-party payor
          contracts and the historical collection and write-off experience of the clinic and applies a contractual adjustment reserve percentage to the gross accounts receivable balances. The Company then performs a comparison of cash collections to
          corresponding net revenues for the prior twelve months. We identified the measurement of contractual adjustments as a critical audit matter.</div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The principal consideration for our determination that the measurement of contractual adjustments is a critical audit matter is that the estimate requires a high degree
          of auditor subjectivity in evaluating management&#8217;s assumptions related to developing future collection patterns across the various clinic locations.</div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Our audit procedures related to the Company&#8217;s measurement of contractual adjustments included the following, among others.</div>

        <div><br />
        </div>

        <div>
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="width: 18pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-align: left; font-family: Symbol,serif; font-size: 10pt;">&#8226;</span></div>
                    </td>

    <td style="align: left; vertical-align: top; width: auto;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We tested the design and operating effectiveness of controls relating to billing and cash collection, net rate trend analysis by
                        clinic and cash collection versus net revenue trend analysis.</div>
                    </td>

  </tr>


</table>
            </div>

          </div>

        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: Symbol,serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For a sample of patient visits, we inspected and compared underlying documents for each transaction, which included gross billing rates
                    and cash collected (net revenue).</div>
                </td>

  </tr>


</table>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: Symbol,serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For a sample of patient visits, we traced gross billings and net revenue to net revenue recorded in the general ledger and to each report
                    used in determining and assessing the contractual adjustment calculation.</div>
                </td>

  </tr>


</table>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: Symbol,serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We compared cash collections to recorded net revenue over a twelve month period ending December 31, 2021 and again for the twelve month
                    period ending in the first month subsequent to period end, to identify whether there were unusual trends that would indicate that the usage of historical collection patterns would no longer be reasonable to predict future collection
                    patterns.</div>
                </td>

  </tr>


</table>
        </div>

        <div><br />
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ GRANT THORNTON LLP</div>

        <div>&#160;</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We have served as the Company&#8217;s auditor since 2004.</div>

        <div>&#160;</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Houston, Texas</div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2022</div>

      </div>

    </div>

    <div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <div>
          <div><br />
          </div>

        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">38</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>

    </div>

    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

      <div><br />
      </div>

    </div>

    <div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Board of Directors and Shareholders</div>

      <div><br />
      </div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>

      <div><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Opinion on internal control over financial reporting</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">We have audited the internal control over financial reporting of U.S. Physical Therapy, Inc. (a Nevada
          corporation) and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021, based on criteria established in the 2013 </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Internal Control&#8212;Integrated Framework</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). In our opinion, the Company maintained, in all material respects, effective internal control over
          financial reporting as of December 31, 2021, based on criteria established in the 2013 </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Internal Control&#8212;Integrated Framework</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> issued by COSO.</span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the consolidated financial statements
        of the Company as of and for the year ended December 31, 2021, and our report dated March 1, 2022 expressed an unqualified opinion on those financial statements.</div>

      <div><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Basis for opinion</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal
        control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our
        audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and
        Exchange Commission and the PCAOB.</div>

      <div><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about
        whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists,
        testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable
        basis for our opinion.</div>

      <div><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Our audit of, and opinion on, the Company&#8217;s internal control over financial reporting does not include the internal control over financial reporting of the acquisition
        made in November 2021 (&#8220;Acquired Entity&#8221;), whose financial statements reflect total assets and revenues constituting 13.3% and 0.4%, respectively, of the related consolidated financial statement amounts as of and for the year ended December 31,
        2021.&#160; As indicated in Management&#8217;s Report on Internal Control over Financial Reporting, the Acquired Entity was acquired on November 30, 2021.&#160; Management&#8217;s assertion of the effectiveness of the Company&#8217;s internal control over financial reporting
        excluded internal control over financial reporting of the Acquired Entity.</div>

      <div><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Definition and limitations of internal control over financial reporting</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the
        preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance
        of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
        statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
        assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</div>

      <div><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of
        effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div>

      <div><br />
      </div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">/s/ <ix:nonNumeric name="dei:AuditorName" id="Fact_4215a5369ab345179e60af1f9990d085" contextRef="c20210101to20211231">GRANT THORNTON LLP</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:AuditorLocation" id="Fact_c7b95ae6b1bd4efb8edf79999df50049" contextRef="c20210101to20211231">Houston, Texas</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2022</div>
          </td>

  </tr>


</table>
    <div style="margin-bottom: 8pt;"><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">39</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>CONSOLIDATED <a id="BALANCE"><!--Anchor--></a>BALANCE SHEETS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>(In thousands, except share data)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: center; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ASSETS</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center;" colspan="2">&#160;<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(audited)</span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center;" colspan="2">&#160;<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(audited)</span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Current assets:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_a535ef736e1a487380cec1ed89cd22f5" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">28,567</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_be9cfb14488f44f5ae61950ac34017f5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,918</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Patient accounts receivable, less allowance for credit losses of $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" id="Fact_e72303e0e1764b678c8a765c34ac7843" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,768</ix:nonFraction></span> and $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" id="Fact_43c922e483fc4473bf117994cde11764" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,008</ix:nonFraction></span>, respectively</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" id="Fact_76ecf9bdd9104d74ab0ccb2b6e4586f3" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46,272</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" id="Fact_d8c29be33f2d412283c065802dd7495d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">41,906</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Accounts receivable - other</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" id="Fact_1803d5b8e4d34c6ab952da610c91632f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,144</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" id="Fact_b60a785d75c5498f9f8c85b5963b45e1" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,039</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other current assets</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" id="Fact_7a1dc8b4e77d489e8d4801da06dc1d51" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,183</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" id="Fact_fb4a90e0f4fb40ab9583d5789bce0908" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,773</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_e8eedf6740184abb97fb8f06d9d9e72f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">95,166</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_181d032dd50d43e096704a99afcdc5c3" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">87,636</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Furniture and equipment</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" id="Fact_cbc5d6d16bec4d67aab83ce897c02828" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">58,743</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" id="Fact_03d18b74548b406bb41a92527d666d72" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">55,426</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Leasehold improvements</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" id="Fact_ec1cddb9504a41baaf51be15d8b20462" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">39,194</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" id="Fact_e13cdd10024648feae96cf7ecb37b41c" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,320</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets, gross</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_22214af7dffc4b88918393339547d34d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">97,937</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_4ae6d370b109429cb93c0541e67cdef1" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">90,746</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less accumulated depreciation and amortization</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_3086730850d74ade8797855a48924ee3" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">74,958</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_4dcda22fab13481481424a3e4ed92d5c" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">69,081</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets, net</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_cb45fc19b7f84e7e8e07ce186c74f506" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">22,979</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_d5eb708555d44300b413f17e4bd213ea" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,665</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_75a77e2966d7436a9df1684a4fa0642f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96,427</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_4dcaa2524c414fd0a543fe7fd31c63d3" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">81,595</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" rowspan="1">Investment in unconsolidated affiliate<br />
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" id="Fact_d6f3228bb15f4163bfc87dceeb3794bc" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,215</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" id="Fact_0e1d5b0f39644aa9b33d8cd942f501bd" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_6f92e980b420496683bbebdcfdfab404" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">434,679</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_9011cafb8ec941f38948a1a503f83288" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">345,646</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other identifiable intangible assets, net</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_7c184a117b3b44df9784196399c85d4a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,382</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_caeddf66f77746c194d65fb19932368e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">56,280</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other assets</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_2abf96646c8a4d9eaa4dd45e0a13b40a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,578</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_92a013d44ef74f1bac9a70311c6de12f" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,539</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total assets</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_71860dd8915e4aee9da560c0fdd5dbe2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">749,426</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_d29aa4d0b20c4153ba04b98ba98caf55" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">594,361</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: center; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH</div>
            <div style="text-align: center; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">SHAREHOLDERS&#8217; EQUITY AND NON-CONTROLLING INTEREST</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Current liabilities:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Accounts payable - trade</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" id="Fact_39cd985855e64dc2849a805e3fcef260" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,268</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" id="Fact_7b2aa506a6d5480a8de0b524d8cbda2e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,335</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" rowspan="1">
            <div style="margin-left: 9pt;">Accounts payable - due to seller of acquired business<br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="usph:AccountsPayableDueToSellerOfAcquiredBusiness" id="Fact_0a5a6154cfff4795b74d9935f31abc03" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,203</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="usph:AccountsPayableDueToSellerOfAcquiredBusiness" id="Fact_f256b437bea84123953ade840fd40419" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Accrued expenses</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_75e42cb1eac548ff92b25d4e3316f063" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">45,705</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_5cc11329e9614fbeab1ab488f369fad9" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">59,746</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Current portion of operating lease liabilities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_f1b27ba54dab47a5899787cbcb4741d5" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,475</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_b1ccd3fb1cfe49a4bd9b310f975be4ca" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">27,512</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Current portion of notes payable</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_8b4b09b7a12d45be8c319690b273b6c6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">830</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_6e5bf4cde38644dab6a00c2f6d0eb249" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,899</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current liabilities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_bb00b0a9397a493ca10dfb763916b7c4" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">83,481</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_d86db25023114b7bba8151c0559b263b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">93,492</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notes payable, net of current portion</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermNotesPayable" id="Fact_4f2bea893e4d45aaa65ffa0cc50f56bd" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,587</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermNotesPayable" id="Fact_eab516cc33c344cc9a60d64eab7a6a25" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">596</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revolving line of credit</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" id="Fact_ea49635133b14c36b4eb3b681360bbe3" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">114,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" id="Fact_f72b7a7afbfc40e98376849ab61fc5c7" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred taxes</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" id="Fact_2e591c1b081e41a9a37b9a3338b9d61c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,385</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" id="Fact_5ce10c7da9294f1ebc99b95be7588b60" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,779</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities, net of current portion</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_ad800241b89746bcb1cadd1f0aa0a21c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">74,185</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_f59d6c01a57442edb59924a1cbc3fda5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">61,985</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other long-term liabilities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_6addd01ebc994509b67af5d345eb381c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,345</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_0e9ff0b3483943029f9bd77f56b0f88a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,539</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_817007122e464b6892630a112b2d0eca" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">296,983</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_5d54e950c607429999675a876918fc3c" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">184,391</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_ec911c927a8a4658b6b7d143894eff72" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">155,262</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_326a987c204a438e984f1aecb8e1a346" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132,340</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Commitments and Contingencies</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_5910a85d80164a8c94ccc93ec7fe62ca" contextRef="c20211231" unitRef="U001" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_6555ceb72428412cac5d1355e6f0fd3d" contextRef="c20201231" unitRef="U001" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc. (&#8220;USPH&#8221;) shareholders&#8217; equity:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_32d7126da2a34e9f87c13c87392e0fc2" contextRef="c20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_13c581b90c7c4697be8f9f8405a148cd" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_abbefd204f944846b69b580e5cf37975" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_67b538724a4e4e9a9c7e374ee13694da" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">500,000</ix:nonFraction></ix:nonFraction></span> shares authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_fb6868cd0c484fe9ba4ab03851c157a3" contextRef="c20211231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_f43cea061a7d465489233d018a655e55" contextRef="c20201231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_7b82fae694654842b69783f0991d6c07" contextRef="c20211231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_5ce8b91973fe4168a7d03987ee0a378e" contextRef="c20201231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span> shares issued and outstanding</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_678722cd31f942c3ab82a910acf87873" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_bd15af50a941443fa04f37ed80164920" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_7578fe9d1428472bb04c65ec646e6609" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_6878e44345ff4e6d9db0c708a71ef2c9" contextRef="c20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_60037128a15a43a6a119db18505fc670" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_2c498357c9bd4bbeaad2a4388ada4245" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction></span> shares authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_bcb532b699f745d5a6d1b1e45aca3f6a" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">15,126,160</ix:nonFraction></span> and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_3c01722b97064a7e94efc2803983b64b" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">15,066,282</ix:nonFraction></span> shares issued, respectively</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_7e665364d7cd45e9932f55055ff8985a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_a05e645d1c434a57b3476dc7318f2cc0" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Additional paid-in capital</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_6e7f9341d85b48fc9f57b6a66ce336fc" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">102,688</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_a6bf1dbafdc74a7db98ccf18f022cbaa" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">95,622</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Retained earnings</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_62ffa77402df44f4b728d9a2e2913c1f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">224,395</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_ef73fc5fee014a439963f2743ac41d46" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">212,015</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Treasury stock at cost, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_6c30e1490a154eb9b7b61b16df8f1d41" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_12d4e0b5529247d8815e2a373b01a019" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,214,737</ix:nonFraction></ix:nonFraction></span> shares</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_647617b69a91413ea45866e937f1377c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_bbfa80d511344a26a4dbf71ab517c8dc" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total USPH shareholders&#8217; equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_cb793511837f479684d60e06bc107faf" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">295,606</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_e1f1b7f6274f4bf6ac8283c182c41475" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">276,160</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_d29af82b886c473ca26fb5e77d9d2dbf" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,575</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_e40f681f4fcd45a48b4abd8541149748" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,470</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total USPH shareholders' equity and non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_6a55b52b78ca4cdf8c0f25d326e2bdc7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">297,181</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_3360374067654ad49468bfc306d143ac" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">277,630</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and
              non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_65f3fab9f27f410b9768b3a85d71aa9e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">749,426</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_85311ecb8e2b4d2db5a31b844c2895a8" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">594,361</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">40</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>CONSOLIDATED STATEMENTS OF <a id="INCOME"><!--Anchor--></a>INCOME<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>(In thousands, except per share data)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="10">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenue</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_e1cb16a9a7334348a1106303e3af525d" contextRef="c20210101to20211231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">438,330</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_eb4e2cde723f4d859b9531be372816e7" contextRef="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">373,340</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_2f57d1f33cef424d8144ae847a2af67b" contextRef="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">433,345</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other revenue</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_99cf33b689df4309856b87c82848d17b" contextRef="c20210101to20211231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">56,692</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_26f8c780919f45ed94ab4ea50d7a4952" contextRef="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">49,629</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_eb7e08d7018c4eca843ca21f768a7613" contextRef="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">48,624</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net revenue</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_4de0d70f70fa44dca67c0ab89749b511" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">495,022</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_5bd8e260a034454fb1ecf6e5eb567be1" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">422,969</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_2448ceb9b60f484e8691c6e3f19e3c7b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">481,969</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating cost:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" id="Fact_f2dce5379cc94d33a4246b8516af4857" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">278,469</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" id="Fact_ac118e49d3df4b09b03c28394cc2427e" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">235,629</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" id="Fact_7739676c8c9742f8bb915047e85a4735" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">274,233</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Rent, supplies, contract labor and other</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RentSuppliesContractLaborAndOther" id="Fact_819566d9ffb84ce98ecec9cefbf378b6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">94,036</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RentSuppliesContractLaborAndOther" id="Fact_bd759e351de441ef863f34274ef98766" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">84,336</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RentSuppliesContractLaborAndOther" id="Fact_d38ed5ccb21a4036827265c60910b1b3" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">90,379</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Provision for credit losses</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_fa1d7a23cbe447fcbb6d39d64a3a60d6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,305</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_b0fca927939c4d33a0aa2797f7ffebf3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,623</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_d77e856c27f04d9480dfc39a6adac0a2" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,858</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Closure costs - lease and other</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_89db2acd89314d1bb0ec34cca19dae63" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_6ec25d8ef67b47429f04added077fab0" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,072</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_8b94654cb8ba4b05893337d6f72d88eb" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Closure costs - derecognition of goodwill</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_c89e2dfca74b48658f80a61777504948" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_ef8436762c4944d1a2d5d517b23f0097" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,859</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_d872deb8b2f44db5a1bc6207effe9afb" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total operating cost</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CostsAndExpenses" id="Fact_e849ad0f67d442caa78fc33146ede20e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">377,840</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CostsAndExpenses" id="Fact_b95c380a27154f5abc9cf61723cfd4cb" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">328,519</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CostsAndExpenses" id="Fact_f073ec28271845b2849ba9f45d4080b4" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">369,495</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_2230e8d51ede4d448373e5dbb638f972" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">117,182</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_28d515e87f0449aeac38a9c1782f001f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">94,450</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_69b07fefa0ff46de9c450452a5af4393" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112,474</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Corporate office costs</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_03fc1e8461f64735874f7e4bc37167d1" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46,533</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_83b4f09b36f041abb628653fa497b261" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">42,037</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_55ad1d0b62d04f2dbdbe640543a26e03" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">45,049</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating income</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_952bcbf7f0a14b259eb4396153f6501d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,649</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_6776c28acb604859a7eaa192e0ce6310" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,413</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_bbf768e27452478e85e58686cc591d1a" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">67,425</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other income and expense</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt; margin-left: 9pt;">Relief Funds</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ReliefFunds" id="Fact_728546326a3c42f1b440dbcc2c257d51" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,597</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ReliefFunds" id="Fact_8b0c1c78ceb946c4a637158c95be4e71" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,501</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ReliefFunds" id="Fact_85d89df0cb4349cfbe94c27bd499a633" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt; margin-left: 9pt;">Gain on sale of partnership interest and clinics</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInterestInProjects" id="Fact_29bb03f6a8914acb9020abc5d239e498" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInterestInProjects" id="Fact_6efb33dee66b41468bcbeddb9a4ca7bb" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,091</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInterestInProjects" id="Fact_6708f77dd5864d23b7043f8b871b1d94" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,514</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;" rowspan="1">
            <div style="text-indent: 0pt; margin-left: 9pt;">Settlement of a legal matter<br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:LitigationSettlementExpense" id="Fact_93ea064547ae405abb64ca970637316e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,635</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" id="Fact_1979805c2f844998906b73f4ca355218" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" id="Fact_afb4447734344fd18cf5aba59a71f68f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" rowspan="1">
            <div style="text-indent: 0pt; margin-left: 9pt;">Resolution of a payor matter<br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="usph:ResolutionOfPayorMatter" id="Fact_821a7be2798342d1b165216abbdc83b6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,216</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="usph:ResolutionOfPayorMatter" id="Fact_77bb66a2f8a64b3fb45d53e6982a5d9a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="usph:ResolutionOfPayorMatter" id="Fact_6ac2d0c3c3cc480eb74b18588d80a660" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt; margin-left: 9pt;">Equity in earnings of unconsolidated affiliate</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_166e8c28b7814f5e92af55445e54a6dd" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_8f6df4e7d5ab4d1596dafd7e30a6a7d7" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_88f2eebdb6104f06bd4d0b7b2e56dc27" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt; margin-left: 9pt;">Interest and other income, net</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" id="Fact_9fee0e0aa03c470181f7c7055ceca32b" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">199</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" id="Fact_2ed55a3e0e7c48b795c53e86984abcb0" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">142</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" id="Fact_2801f34e0b68466a9cddf9fbe9708d5f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt; margin-left: 9pt;">Interest expense - debt and other</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:InterestExpenseDebtAndOther" id="Fact_ca1eb9f41c4b4abca02d5fc75b0a9fd6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">942</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:InterestExpenseDebtAndOther" id="Fact_0d68368c452c4fa1801a32142bc164b0" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,634</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:InterestExpenseDebtAndOther" id="Fact_33aa6abc349e4ee3a127418e52658bcb" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,079</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total other income and expense</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_319bded2484846a7ae113bc9022473ee" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,547</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_a21a02c26c2a40fc817ce9704e1f71e3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,100</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_84c93afcc3444dd9b23f850ff4500933" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,481</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Income and equity in earnings of unconsolidated affiliates before taxes</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_168dad9a2d384e44b537dfb38d75a2d4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">73,196</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_d6f069bd58a5444a92384842e888b14a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">65,513</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_3965e80aabf7448795554f7ccc32b0e7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,906</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Provision for income taxes</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_e6780260503348ae95729d2e93ae06d1" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">15,272</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_b31decfc12cc462c836079d9e5f2c360" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,022</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_9720718997994bc6929a4d23de4625a7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,647</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_a0d5ad0a9bca4a2ea07ce389b7385683" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,924</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_8639b728d5944231bc3816efaf226615" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,491</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_70a3a83985d8478cb52c5d11fabfee3d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,259</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less: net income attributable to non-controlling interest:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_91185deae794443cae019ab7a71196e0" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,358</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_3d4a560266864bfa92a0d0e283d552c9" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,175</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_632ed812391540a79ba09142720058f9" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,659</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_2bc9ba4cafad45a09d0aabab1917ff75" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,735</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_fdd0996aa22a419baaa026a135e6163c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,122</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_115f3df3bddd43ae9981778d233517c0" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,561</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" id="Fact_81e4b14dc254429096f3dccefd48da95" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,093</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" id="Fact_7a0d883763904e6cb52daf1593a5082f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,297</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" id="Fact_e5b40fe8fb4447aba2190a53e0224408" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,220</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_b42c873889694c2abc599f5c7eb23ac1" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,831</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_9a34e610752944228b2aea1144ef0795" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_cc457f4209e24a6b88c8889ca65bca21" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_5a7d7c11c39243e6a4ea872da95e5b17" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.41</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_35784f67f4564a6d95c666aa8871debc" contextRef="c20200101to20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.48</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_ec606ecbfa5647b289fa7464dad9c7d5" contextRef="c20190101to20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.45</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation - basic and diluted</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_db77b7127bd346ca8bfed2ca603f05a7" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,898</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_f73218257879473d83230d0e8b136c9e" contextRef="c20200101to20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,835</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_4629f647bdad4b5386015849d1664364" contextRef="c20190101to20191231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,756</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Dividends declared per common share</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact_f0cce43faf144986ad991819bb444742" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.46</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact_82da76377a594a15a189331229ce0c16" contextRef="c20200101to20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.32</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact_83144a83093c42249559bdc91c056818" contextRef="c20190101to20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.14</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">41</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONSOLIDATED STATEMENTS OF CHANGES IN <a id="EQUITY"><!--Anchor--></a>EQUITY</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(In thousands)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="26" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. Physical Therapy, Inc.</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Paid-In Capital</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retained</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Earnings</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Treasury Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Shareholders&#8217;</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equity</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="text-align: left; vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-weight: bold;">Non-Controlling <br />
            </div>
            <div style="text-align: center;"><span style="font-weight: bold;">Interests</span><br />
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="text-align: center; vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><span style="font-weight: bold;">Total</span> <br />
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Balance January 1, <span style="text-indent: 0pt;">2019</span></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_f65a950d41ad49d8a56952b7b96a50a1" contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,899</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_c6cee96b93084403a2b464658770ef63" contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_104fc51c829841ea90f0ba005d9200bd" contextRef="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">80,028</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_61a7c83b7dd04987815f0235bd67af0c" contextRef="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">167,396</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_5c41ebe999384b718db8b093760f38cd" contextRef="c20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_66361c0ef4a3441182f81c7f565e5bed" contextRef="c20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_d65cc14e60cc4c36afeeed093f0117e1" contextRef="c20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">215,945</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_6d2bc0dea09341e5b526cadaab62ae4e" contextRef="c20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">930</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a84c139914ce463eb331b012593f506b" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">216,875</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Issuance of restricted stock, net of cancellations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_5af9bb97304144bdb88210c8e4149df9" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">90</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_87b8d2682cca46f3bd3fa279ce5b2d52" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_b995d1af5fa9403f9ec1471b989c39c8" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_ff67e8d631a24085a4fd2a0a5bfd31c5" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_578cd881faba47e79c8750d89b61da42" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_60c60798d7b8434e8ec4d2e8f14f320a" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_10b70886ac4c4a57a82a0845c07d818e" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_c1f1d838e81948e6aa95614ab6ba5ef5" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_86c2f6b2385e4873861735a1fffa01b9" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest, net of tax</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_555060c8d21846edac9b37121d732c12" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_16c3f35c5744424b8bbf4f0ebcd1d3f7" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_679b7f4c6dca4eaf9d16352008dfaa50" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_dca31aa3bb184e68a0aad1e65b3be7db" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,771</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_0c2cc057e1e74b1fb2757ff47acd9036" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_3d637b5715f5419586f903cb330d210c" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_37a54341c3984ac5b0d314e5aef05506" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,771</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_46594d29b9f04b669e31d5131d5db1f1" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_d0c26eb45caf4ecc8c05ed7a0e85fb35" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,771</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense - equity-based awards</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_ef7c001c18764c6ca33ce0cb8ebb5e3a" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_51ecfbdbe31e4a9780319b6dd18e81c4" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,985</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_9bc30bd812c84f45961d55c5763dc9d1" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_0333a898376d4d03b46ee7680c24e588" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_b59865a0690743618aa2e744b73ad0ff" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,985</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_9102bb76729a4de282c03bb5df727a69" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_c054447cf5644f9e8e8b773d48aa76fb" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,985</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_b1e66dc2be6a477899075ca3bf9f5f9d" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_3a075a966fc640aa9d122ed30b61d569" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">636</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_710389033a6a4d048511eca4c12e36db" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_9ccaf7dbd35d4d17b27901cb668cac31" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_169b4da7298e4680b0477ec9233239c9" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">636</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_119af8cfcecb4d7cabf9366a2fee67ec" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_ddcf0949b94543ae9175885c6706afab" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">636</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 10%; background-color: #CCEEFF;">
            <div style="margin-left: 9pt;">Purchase of partnership interests -&#160; non-controlling interest<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_b99189537a49420da988b3a40046ca01" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_df4f7f7a48b64275b2fbf70cb7c092b2" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">266</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_c8645efa72ab4e7e94fde75c365e52d0" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_5504c990b1df4f01b6193e5ac8578889" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_2c89bb06f9fd483fb2a7beca92eddb79" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">266</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_b4db139fd98c4cc489e4c3e7f7e551ce" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_5be009ab42ec41068ea665bf0511a8e6" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">292</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Sale of non-controlling interest, net of purchases and tax</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_6b9c920fd26342f6aaadc626fcddadab" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_eb30ef5795674c1d86ae33fe5f4d7151" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_923f708efe6b48d48863adb24cbca6bf" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">196</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_4a7b58fbf1244baa9c7adcf6a7ecd3fc" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_6610368e5b8c453981426f798a39624d" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">196</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_e0828cf664de4510abd2eeb9b4483b36" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_3b0cf04a8cf14521b5a611295ace5a92" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">196</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Dividends paid to USPT shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_c398970de53b44b39befbe8389835181" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_ffa1cf55f64b40bf8682f0007f624918" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_4f2d8cc6a79e454dbb3c80b3d2f71653" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,555</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_3bf39a0a65534c51999c78e2d46d336e" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_180713333e634843b6d3eea7a392c241" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,555</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_f9fbf0f7133046c680fc5ed2006a4b57" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_d0259b27cca84863b49e2aa9007f8b66" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,555</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest partners - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_1014efa84fa6401baf97f988feeeb984" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_f970d5e17e4645b99a6ad9df4225a267" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_7a39adb025584e66bc328cc0155291fb" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_439dab05d65142868dab667df44f738a" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_542e3eada5fb4492a25c91c3a575779e" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_4728bbed9d7943bb97012942155c4ef0" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,014</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_9266ea074f4a425da4e463493df63365" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,014</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_1b2601ca43c8415483e68093044b16c3" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_cd4866907f9f4c15a8603a090aea7e66" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_63c20b162eba446eb642b79806421a76" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">47</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_20af68715ab74315b1db0902793d79d7" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_06db0da12ff045fb9404fdc97c0f7a0b" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">47</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_eeac8ede38be411d85d59621a710d3a3" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">7</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_f68005520a534c698412b0470c925ed3" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_4bd5d442ed1843a6aff942f452c7da5f" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_6f7a985c2f04424ca5c4749cffa528e4" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_0628d91fda274b1fbf544cb5ca0da600" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_3728ff5e1d0f456cb6c0ef09b69b54b3" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_f1ea5d1da3a04d1abe3f12d7c5776532" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_2cabaa6b8706431586c7bcd5ac1e60d8" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,561</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; white-space: nowrap;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_c7d5a840e25a4ef7beb459c2086f3c15" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,561</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a72bf0fff1ac4414b4e2e7000b6a361d" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_7249bbb5d65841dba61fc28005038f2e" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_45821e7842e54f888c0a3351ad6f95c2" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_ee47f504d62640bf99c708fa5f10b677" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f4dd992903d2456095ffb2497b5ecf72" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_736cc1625b514b229e6f4223bdb4b235" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a20dc29a2c23420f81946f07cf977795" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Balance December 31, <span style="text-indent: 0pt;">2019</span></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_ad69747baa964ed28fdd01f69dfa6556" contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,989</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_b4a3b5acb12446afaf2c45c214a34844" contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">150</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_f03fd64292c94f6aa25c327ba136f17a" contextRef="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">87,383</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_fe3ea87714f7498d89b4c1b767d2357f" contextRef="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">184,352</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_59b01c70754840a8ac52c795cb526fca" contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_8bfcefdf830941c490a952050bdd3c36" contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_ebc2e49719cf4a028af04214f23104c2" contextRef="c20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">240,257</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_9d8425c86eca4122ba1ae2c854c16c71" contextRef="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,444</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_6a1c3f51b93343159b7bac6efb95bea3" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">241,701</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="26" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. Physical Therapy, Inc.</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Paid-In Capital</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retained</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Earnings</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Treasury Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Shareholders&#8217;</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equity</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-weight: bold;">Non-Controlling <br />
            </div>
            <div style="text-align: center;"><span style="font-weight: bold;">Interests</span><br />
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px; white-space: nowrap;"><span style="font-weight: bold;">Total</span><br />
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Issuance of restricted stock, net of cancellations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_4053310f060140fe8ea3daae23942a46" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">77</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_8f28287e5046473cae30088b5529be86" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_1695601984ff415e8066c7e23a8be7be" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_e28b964763dd40bcbf2d14ac1738bc02" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_ba56103ef81f49aab2d4bf49ace4731e" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_65947c8c7bb44ac1b5a744bb818ab0f1" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_7c20456871414947b57e0a07d5a5df54" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_7772c58cf84e4d619d6e3333f26fa9fc" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_5327af3b1ba34d71b4b3d0e010919722" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest, net of tax</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_07f8672fcddd44799a52ff91f81abf18" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_ff021b80569d4f2e8024e9470449f8fd" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_5646658adfc04525941291e242dc67a4" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_92ec4c4ae5364f268d5d401905fad796" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,415</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_1eacf60facef464e90a9fef4913be675" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_0f3edcfbde1f4957a8972d5da0347128" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_efad5fb4925b457a8bd0256be70704cb" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,415</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_a02438b4374c4306b4881f8d2d720263" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_eb8d0c8f37624a0fb122696e2f18b6ba" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,415</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense - equity-based awards</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_825856e9205b4a36974a58ce43613690" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_03f50db02887458ab6b67630e51598c6" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,917</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_134b01c0ec8b42af9a9e58d3069fa98e" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_f452b13455b54bc0acaf1d4a1765381d" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_20761336bfef42dfa8f3237b9fe31cf9" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,917</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_ad8379aee9ae42af83e919bec845a6ff" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_7b5a9138f30b4b628e48ef870a0e04d8" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,917</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_7ef94a7487384f7ca0acc08dd025cc00" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_83b40110b9ce40ba97669cd1e7016e55" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">486</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_6f8e73e7bc7b42ec8d072d828dc5beaf" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_dad2b0c9f09744cdaee507df3a4b322e" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_50bce6ccda504acfbb3b4ad90a15c44c" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">486</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_ce5b3bfaac814aa198a01c6ce40b134c" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_04adb77748204ec0af1eefb6b44f7749" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">486</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchase of partnership interests -&#160; non-controlling interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_ba69c822908d4fac9824b6afa21890ce" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_e9466cced8ce4764b4a462b73f1f8ddc" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_ffe5a42bf0d94891b48041cbf59cea72" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_7a0365a6e4df4c2da67f8ffdfdfbcbc1" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_c98c3c2211814863938603ac690a8994" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_1dccad6173564476a16129a0d517b1fa" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">168</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_30c184a21c424c95bff12009926d2184" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">168</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Sale of non-controlling interest, net of purchases and tax</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_d19ef9e79d47409183d027e56024f245" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_12c16500b2574740a01c55538f2bef20" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">164</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_eb32b2060c6b4714ad85504b65e33512" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_04195f36ec454c9dbd5eab1f6e6bf917" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_1350f4a10f204a228f1fcc0943eb69eb" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">164</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_eb3ba6e751134ce9847a03b361a80458" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_636ea4acf3b248a8908379e7eb6be596" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">164</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Dividends paid to USPT shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_c2cd644ba19a4d9494cc97a4c7d3a714" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_b4643b0b2651422e99d7012a4c3b7356" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_0538e32285e84e0ca6fa567a5123abec" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,110</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_725de49a678c4b0a80e91068d96fa286" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_d6558ea096094cd8b43465859630f981" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,110</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_0fc0fb7b326549bfbb3e075222231c94" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_0a30322975374c9cb09418ae7536f110" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,110</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest partners - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_efe0a93263784aa18727b24f46ae5657" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_194ab7d2d63a4095a31b63a7e31a14f1" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_b4fea8dc0ecd401280e90a3179b9e5b8" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_ec16dcb0c98448909f0c5ae8d6b9f333" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_c5fc98c97e804263bc1bd1e313d07147" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_870c17f5c0c64c18af964f417e92f5b6" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,928</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_869df43ac8eb4a94a5173fece4a98cf3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,928</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_0aa7195a452743d49f46cf852e1583b6" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_d689439de38f4da5914d6d6bf6e310e2" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_c64501ed764e4ad5beee7135ed678fe6" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_62cd125a80c54c3bae032ecd66085dda" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_118eb84613d746b9a60b9778063aeeb4" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_5ecc0461545f48ffa19bd04d194dfa14" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_9f46772ef7d648d8bf15f5a2d2d5decf" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_f1f57627c8314439a10d961c44c9c0b8" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_1d28a74e315843f5880b0657aa078505" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_331b3f8b806a4cc7a47701f3c75c3cef" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_ed3ebc955ca04178886175a50db9fb1b" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_43d1d18df56f4e94bb4472cab470a845" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_74ed3fcee5aa4794893156ae3800932a" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,122</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_0a619b7aa53549a597a334de87421d07" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,122</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_c6577dfd618643eb967dd96e3d648d0c" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_4f80cd3ee291408eb630809ffe352ebf" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_4017f2ac15954542826249b8eb8a33d8" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_638ce848c8304111be1f42bbf5f7ac5d" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_0f02a34292a94ee5989f9a853ec21171" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f4403508a3964623afe7810e2ce44520" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_febf90f710ae484c8f31f37ab247f40f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Balance December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_c71f907cb3fa46aa89f86711f64e52c7" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">15,066</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_d3fc114a25984473b546b3d702db134d" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_4a2ac7f79f6c42349a10c6597595651e" contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">95,622</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_84ecbcc58204472ebf1855edb61baa10" contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">212,015</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_c04a1614afd04cbe92de64a3156c7ef5" contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_fa745d27696d4b7a990563bd0a07ef0f" contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7a0f0229e2fa4d658941da25ac7a9ab4" contextRef="c20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">276,160</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_45b8ee601d4443399674992036dfa034" contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,470</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_4f7101c49fd249ed85b0143bb03fa5b7" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">277,630</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="26" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. Physical Therapy, Inc.</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Paid-In Capital</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retained</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Earnings</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Treasury Stock</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Shareholders&#8217;</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equity</div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-weight: bold;">Non-Controlling <br />
            </div>
            <div style="text-align: center;"><span style="font-weight: bold;">Interests</span><br />
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px; white-space: nowrap;"><span style="font-weight: bold;">Total</span> <br />
          </td>

    <td valign="bottom" colspan="1" rowspan="2" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Issuance of restricted stock, net of cancellations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_0c5ef694696b4160877c1a5999db218d" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">60</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_0633128d5254448b8768534ff359d4bb" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_5ece87b802284608b437f2a7c920a4aa" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_d51030e02e1e406584bda9775b9847c9" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_4a34b790dd0f408b978eb7f83d36b12d" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_75020d481b574cfd91d418504ac0a9a5" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_bb175e9d081e4ae298d2925854a396e1" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_3150a6a7c1de4314b2ea52fc5cd99852" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_5c79ec1e65ba418980e1abb722f56c9e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest, net of tax</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_becade5d0efd4b3db4d87224a4a0d44a" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_5be31be5329648a8b5496e6fd24420c9" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_69ed4b5775064088a46ca3a376fc7960" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_bc7b80e20f7e4a6487eab2aae1df2e27" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,686</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_5f887ba7d35949a0b3b9c6c9aba87fd6" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_c0a2bb97f0eb495a9cfd2f2f2ab44cb2" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_0f7123fe60994c79aaabf35d449e2859" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,686</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_6de3dfcb9bbe4b8c958221c650b92326" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_5d1db16e8f2b4830aad30d91c3960a06" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,686</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense - equity-based awards</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_7654289dac1d4439af456879a0e52e4d" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_e58827f7e7a44205a101c404f96bcea2" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,867</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_323ec51c9849407980ba21382db3e7fb" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_16aeabab537546bf838e06ac745259b7" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_c8eab06f645e4152901d848b5c5ca9cd" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,867</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_ff2891a8dc984d8094694e8d52519edd" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_5db1343d649c4f119914394ac1ae2d89" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,867</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchase of partnership interests -&#160; non-controlling interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_724b7965de994b9883e1d768f454579c" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_f298860424d7420da50914b3dc010bd6" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">918</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_1f141d87fb054b10b26e2262a1ffebbe" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_1a62881e94414e799c8adb2ee326f226" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_4c96544760504a70a5ee07216e560b28" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">918</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_f90f519bb62546358da4eade20ee2b95" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromRedemptions" id="Fact_b9a812b619ac40feb316b6e18facca1e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">978</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Sale of non-controlling interest, net of purchases and tax</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_26fc20af507648239abefb33b8d2949a" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_e2b5f36496454140a153df71b7aa6205" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_5287250b296b4c5e8ff9f9b294ca3473" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_6ce3f558d99b4923a64fd7b01f00d077" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_2b2768b8840646edaaedd8aac4eb2224" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_f4f2ea80264d42f3b92a2dd964750acb" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_3bf19cd79ca74c85bb3fd87a6cb5b64e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">98</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; white-space: nowrap;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Dividends paid to USPT shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_c6e2ae60e31d485cb2ee567e1ca00c59" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_78865d08518c4ec3a9724ee91fed432d" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_80eab7f4bf804b73931e960b482d1015" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,765</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_2278173ec8c64680a40f7b8ed0f80cc0" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_14eb957099ce424aad516041177ddbe7" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,765</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_a0824515a09c4aab977f0cd809e15d6e" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_12f6d44d6b83456f91b5cf42423ff91a" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,765</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest partners - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_823dc5902cad47fa9944474eea8dc5e3" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_37634107ba7c41e6b29c7ec0b6c5fa82" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_5784b63a2f1d4c2aab6011a2e2cdeed0" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_bf99aa2956474c019cc9c702e60c2b1b" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_22b846bf22144656a949eee7daabf95b" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_f5ad5c4ecf994e16b8bc781eed961161" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,572</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_902878980a2b47b4b26b60cc34de53d8" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,572</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 10%;">Short swing profit settlement<br />
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_23d0d1ca06f04488b7b9ee0b6f0eaa9a" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_4cd963c0b77940bca89177ce1dd066ae" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_61af570f402e44fe8bd2bbefcc97fdc5" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_090ae4c2fa7f40b481f8f4c2ed4b4d7d" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_dba67ed567764a369845132cbcf9af5e" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_bbf71a301987403e8764259376446345" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_06aca80a047a447f962ecee14a55aac5" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_f7ffd7b93e8349f4bfc2adf94a8af6e8" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_3f4f79e66e284505bb35a2bd7c3b9773" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_37f70da8931240898ff890c497c314de" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_f3ec5305658e4640b327137fbab1d4dd" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_fc06ea9719544bbaa784f85062e788ad" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_3374a56f2d2b4c0f873cbd05c7165937" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_67fdc0a8a8b244ad9f8ca00660f68760" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interest - permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_2e85c530ed23448da841ff4adedc916c" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_b419d606d74948c28b4b575a700c25e9" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_4de69e6cee714f449c6576b0b805451a" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_8a8366ab721643bfbfbcca64ce963500" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_fa69bf700ee84a7c876adb8116ba00ff" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_ecd024862cdf4df685fd26d36212f063" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,735</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_c91109f39ea94ae8a2ef6b4e8422ee79" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,735</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_6aea6ecf050340fdad5c20bab311cd36" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_ddef1ff20ed64a639ff92e92945e269c" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_fd7ab2fe970a4e5c879b04ffc6613e41" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,831</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_beffb9c4d31041fba982cdba226a350f" contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_c5b7a3181fb44d0095f5efbb3e022fe8" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,831</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_4f36b3fdc6804ed6b43bbb0221d13d75" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_2e3cc349835747d7879c9de6fa341538" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,831</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Balance December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_bf105e14393e436c82310bcd74e6d5a1" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">15,126</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_ede24158c0da451689da04c80bc0e04a" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_8d7662042c20475887069f145022d7ff" contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">102,688</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_9b5f263ceb8445ae8a1687a6107016c8" contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">224,395</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_a4d038c71f314f4bb40c55b1d7e0b856" contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_ca12bc19face4dd28ad0d1381ed931e5" contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_b42e53665a3e41febb63a602fd081ae0" contextRef="c20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">295,606</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7db499b30cd14e69820bb741730d8b46" contextRef="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,575</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$ <br />
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_c73bca7c2beb415698dbd291f1e0c599" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">297,181</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">42</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>CONSOLIDATED STATEMENTS OF <a id="CASH"><!--Anchor--></a>CASH FLOWS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>(In thousands)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OPERATING ACTIVITIES</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income including non-controlling interest and earnings from unconsolidated affiliates, net</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_aebe3da941e64ba396237ffdf4a3b95a" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,924</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_7e1c379e7403437c99a786ff0e73cb50" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,491</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_e651151376b145eda98c369729a2bc40" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,259</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Adjustments to reconcile net income including non-controlling interest to net cash provided by
              operating activities:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_bdb39987c56c4a76b9c4369692718364" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,591</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_2af09f393015451581f19c0fdb206116" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,533</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_8900b94d82144f76ab91c52126658c1a" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,095</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Provision for credit losses</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_a58a98f109da47aeb679c0997545edc5" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,305</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_bd0990a93c5f42679c601a713a6dad8b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,623</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_cdd8920cc868487ab7c22d5176b91347" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,858</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Equity-based awards compensation expense</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_9413ca5b64714d0a9788f6e6de837e77" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,867</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_f9b2a7f51e0e4fe182497e1fc152f44f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,917</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_94f3afab2a7443d5be6a15c325c0897d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,985</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred income taxes</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_cc82b6bbbcac47f0b4320436d54dc452" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,688</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_27979ee698c74a08abbbfc52904a0569" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">258</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_b72ca3ea6c4040c29a62639dba6b8ae3" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,651</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gain on sale of partnership interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:GainOnSaleOfPartnershipInterestNetOfTax" id="Fact_46320f60c5174cab9a50343c27ea9156" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:GainOnSaleOfPartnershipInterestNetOfTax" id="Fact_1291dc53a8fb430095e146b64ec3a5a7" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,091</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:GainOnSaleOfPartnershipInterestNetOfTax" id="Fact_c4b7acd52dcd4875ad69fc7ecce314bd" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,514</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Derecognition (write-off) of goodwill - closed clinics</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_c84c065ad6f14a4cbfef6fd92083c0d6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_0e7c036793ac4bd0b9eb5876dc071366" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,859</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_d0a42b7a1ccc4312aea451063dbc97eb" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="margin-left: 9pt;">
              <div style="margin-left: 9pt;">
                <div style="margin-left: 9pt;">Earnings in unconsolidated affiliate<br />
                </div>
              </div>
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_bebd92a8fe274d969ed96975fea8ca4f" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_1b2e0140ef3a4b33837c0279f4ed5100" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_f73e0b60d9a34000aa9e519d5fcf9a34" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" id="Fact_bbfb8e2a4cfe4f639ad972fc1a7e4333" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">134</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" id="Fact_9c20c79ed6a84ba69e3f26322679b50b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">281</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" id="Fact_aeaed84485bc4fc5864e4ea2bc9de08e" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Changes in operating assets and liabilities:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Increase) decrease in patient accounts receivable</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" id="Fact_977ef6d052af453abc8e7bf410ea7256" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,417</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" id="Fact_33c1ea507789402b9ea05876f7d5fb7b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">899</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" id="Fact_ca8f96edbf824c96a005295b36532e98" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,376</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Increase) decrease in accounts receivable - other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" id="Fact_7f72654063d4496d9aa0898b6476b8f4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,538</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" id="Fact_e3221e3a825d425eacf0da54c1aee456" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,661</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" id="Fact_33d9666db2a743ffa0152f435ff53697" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,499</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Increase) decrease in other assets</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_6354f5f011214e2aa40b78db5f3a4ab4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">633</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_e6bfc6dedd894c02910ff959356344b5" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,161</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_7c5e70a9c31e434ebc04b324fbe2559f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,878</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Increase (decrease) in accounts payable and accrued expenses</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_db4a41d3295b4f918942870ed577953a" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,657</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_a85933f4d1f9418fbb1dd69307b40227" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,427</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_24c18e186f6342e3bbd2cb9e770283d3" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,209</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Increase (decrease)&#160; in other long-term liabilities</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" id="Fact_874d157527804ddb963680bde3dddde7" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,792</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" id="Fact_b7ea7cbf9a4242a7a1923fa35d6e21ac" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,492</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" id="Fact_45761ab5379442d2b6e2f6e7a3809282" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,020</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net cash provided by operating activities</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_548076878f0e46509b4bc192257f0ae7" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">76,406</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_083e29002b454f37bbfacb2b025fefe2" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">99,995</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_43f2f870643c45a6bb4faab86d99ba28" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62,448</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" colspan="12" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INVESTING ACTIVITIES</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchase of fixed assets</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_b543eba572e9404a981dcb701b1e2247" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,201</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_e5ae60aacea44000af270a4f964872d8" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,639</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_0644431f6f1e460f899e30c54a3c2071" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,189</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchase of majority interest in businesses, net of cash acquired</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_a389dd9a787945a7b47d7965cae9f749" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,823</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_1562bbb7680a454d95c14e2755b68e10" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,907</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_56f62ee67f2743e88b5c483780879eed" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,597</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchase of redeemable non-controlling interest, temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PaymentsToAcquireRedeemableNonControllingInterest" id="Fact_992aa87502c540dba3b494eaec286b69" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">28,465</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PaymentsToAcquireRedeemableNonControllingInterest" id="Fact_dc662c6de3ad401a89d799753e47fa01" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,385</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PaymentsToAcquireRedeemableNonControllingInterest" id="Fact_9b2b78d71cf54e8391fb0cf63227c423" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,651</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchase of non-controlling interest, permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" id="Fact_986c7e387c424f97b61d82258fc32ec2" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,274</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" id="Fact_e933834e17464892bb4c50ecedd4ac3b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">238</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" id="Fact_34378ee085744a81b4137f558860fbaa" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">428</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Proceeds on sale of redeemable non-controlling interest, temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" id="Fact_997abf610bda427db40e96dc1675d4d9" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">69</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" id="Fact_203a0bea55b24de89d7e50ab3561a999" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">127</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" id="Fact_cc6af0bb274044b39b9439c5d24db305" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">207</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Proceeds on sales of partnership interest, clinics and fixed assets</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_bccb38feeb7443498232b40fcf454f9e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">275</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_189a247340a3417ca5efde89cd8d6ccf" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">839</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_0a4a7016a9d640638c1247b3d0eedd83" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,665</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 64%;">
            <div style="margin-left: 9pt;">Distributions from unconsolidated affiliate<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="usph:DistributionsFromUnconsolidatedAffiliate" id="Fact_e83fe6d322b44f108a1e6ae7841c0286" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">152</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="usph:DistributionsFromUnconsolidatedAffiliate" id="Fact_31234c4e21e7454aaa35f12b4b82af8b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="usph:DistributionsFromUnconsolidatedAffiliate" id="Fact_f59f73b06e614327a30cad63aeb11144" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="margin-left: 9pt;">Sales of non-controlling interest-permanent<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="usph:ProceedsFromSalesOfNonControllingInterestPermanent" id="Fact_e53b7324f2ba4e789fe73003a8802753" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">131</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="usph:ProceedsFromSalesOfNonControllingInterestPermanent" id="Fact_287b19816b3b43d0a4b03a5d1e787bea" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="usph:ProceedsFromSalesOfNonControllingInterestPermanent" id="Fact_9922d712b4a241d693fc102f3dda4372" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net cash used in investing activities</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_43c0698beb274196abe8e479647e727e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">124,136</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_9fa3e557b9d54da4b065ce35d62a62a7" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">51,203</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_f042b467f349438eb3d8f4f9a18fa3b5" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">37,993</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" colspan="12" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FINANCING ACTIVITIES</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest, permanent and temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" id="Fact_cdfb3d43a32b42ad84be52cc8b296fbb" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,931</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" id="Fact_f2167b68bd214158813dd5f1555dd4ab" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,331</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" id="Fact_820199e8c78945128c6e38f43192daf7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,235</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash dividends paid to shareholders</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" id="Fact_1be14e69d82d4f32a993b9b614821132" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,765</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" id="Fact_11225858b61b4e9a86e7e0da8a4ab7a3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,110</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" id="Fact_fa001a720800471ea899e1a89fe15e79" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,555</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Proceeds from revolving line of credit</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" id="Fact_b264d113953c4caeb8f7f432b3742fa3" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">316,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" id="Fact_d016fc260cc0468e8ae52fd4597a5db7" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">214,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" id="Fact_52028d41e40744dea85eb6031f0a7076" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">145,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Payments on revolving line of credit</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" id="Fact_d974f1c2f4ad49e8a0d63ec986b947c7" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">218,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" id="Fact_901cfe99d35b4b23b9172792bccad038" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">244,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" id="Fact_03dcc0cfb27b4e9ebf3c16da766a81ce" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Principal payments on notes payable</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_ee30fd68d7c640b898ab06ebd12a3e82" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,899</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_9bc711f916424acb9b783b5f7906d243" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,037</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_a7704a3035c04e0bbc398386a8654604" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,433</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Payment) receipt of Medicare Accelerated and Advance Funds</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentFunds" id="Fact_d61ac38e258d4d41b917fdb0eefd8ce4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">14,054</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentFunds" id="Fact_c39a622adc8f4329b60be01279adcf80" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,054</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentFunds" id="Fact_628c6953f207497690f7c211b73ed988" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" id="Fact_f594b6f2ca4749568ae358d903265b77" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">28</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" id="Fact_39aa2eba8f4c4733b7bf629e0439a9ca" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" id="Fact_2332bef3418840acb20c1eba04957952" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">52</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net cash provided by (used in) financing activities</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_7c61c19f104a46a1b6b93af9326250c3" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">43,379</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_262bad86795a4a9190dd33243aed00ff" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">39,422</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_6f897282c8ea49d9b9deeddf1adcf624" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">24,275</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net (decrease) increase in cash and cash equivalents</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_c8826012594c405c9614db698870b9f4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,351</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_eb7c273eab404d88ac5eabf5bed779a0" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,370</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_67ccd66d6564481a9424c7f9440272d2" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">180</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents - beginning of period</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_6c5e0210a0724dfb8c5ecbb5e4a6d34b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,918</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_9cea4105fce84c40bffe39380dd2f17e" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,548</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_bb322f8c206a4458946fd738871ed02d" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,368</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents - end of period</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_ea9542c3f2ed4433ab77371606f556ba" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">28,567</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_0cd23253fee84b96b44e0b80a588fbda" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,918</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_a6faf8d44a7441d682510c9d6b46533c" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,548</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid during the period for:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Income taxes</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_f82ad005e0df4693b3abffeef205610d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,214</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_5944c867b60340f9a07fc366e94655ee" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,677</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_78ef95b4c1c64ba4a09378722bd3d5c3" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,856</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_da3e5e3b5a324d7290c6c86e6aa749aa" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,352</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_bc7505c68f524ef0b9c758d5b98b92aa" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,202</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_e24bca8911674a50a82ccc7bb42a5b63" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,890</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-cash investing and financing transactions during the period:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchase of businesses - seller financing portion</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfBusinessSellerFinancingPortion" id="Fact_dc8a7e79e58b4affbb7cffb01e676dbd" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,050</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfBusinessSellerFinancingPortion" id="Fact_f2797fcac7af4638b214f5c72d7cd5e9" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,121</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfBusinessSellerFinancingPortion" id="Fact_e7516658d2884163ac9fb8e0e44dee48" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,300</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchase of business - payable to common shareholders of acquired business</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" id="Fact_6909b3c53f1b412b94898b0459e113bc" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" id="Fact_1ae60093f3e84a05bd81bfcdecdd2caf" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" id="Fact_a958e07fef054a4684a59305e67a758d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">502</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notes payable related to purchase of redeemable non-controlling interest, temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_a8ef4c3874654e1dae54528f94d006a2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,759</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_37f6634d2ca14d7583786d02ec6c88a9" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">136</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_4657db2bf24d437089d7c6ee488dd396" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">283</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notes payable due to purchase of non-controlling interest, permanent equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="Fact_76e8f571a44d49b78cbc403662d1d60d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="Fact_7e7af003731a4916aaf408509c4533d1" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">699</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="Fact_9498e41aa3554e38906009ed3c197c95" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sale of partnership interest - redeemable non-controlling interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" id="Fact_c8b7bfd8f5ff4cd9944217ac88dfb871" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">914</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" id="Fact_37607bd3293d46f49d60a246ef4565f7" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" id="Fact_a24f094016e4477d8bc82fecf9359a10" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,870</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Note receivables related to sale of partnership interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" id="Fact_1c978b3fd8b04b97b802058b8ff5f40c" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" id="Fact_f9466b66b50240c899a2095b15235406" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">994</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" id="Fact_8cda9b50f3104efaa33bd04ba3fc6349" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">43</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <!--PROfilePageNumberReset%Num%44%%%-->
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><!--Anchor-->U.S.
      <!--Anchor-->PHYSICAL THERAPY, INC. AND SUBSIDIARIES<a id="NOTES"><!--Anchor--></a><span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
        </span><!--Anchor-->NOTES TO CONSOLIDATED FINANCIAL <a id="STATEMENTS"><!--Anchor--></a>STATEMENTS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>YEARS ENDED DECEMBER 31, 2021, 2020 and 2019</div>

    <div><br />
    </div>


    <ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Text_0bcdd117a8324b4194c403f1cada0328" contextRef="c20210101to20211231" escape="true" continuedAt="Text_ab63f85a639e43c39de6654b1825698d1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1. Organization, Nature of Operations and Basis of Presentation</div>
</ix:nonNumeric>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d1" continuedAt="Text_ab63f85a639e43c39de6654b1825698d2">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d2" continuedAt="Text_ab63f85a639e43c39de6654b1825698d3">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#8220;Company&#8221;). All
      significant intercompany transactions and balances have been eliminated.</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d3" continuedAt="Text_ab63f85a639e43c39de6654b1825698d4">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d4" continuedAt="Text_ab63f85a639e43c39de6654b1825698d5">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company operates its business through <ix:nonFraction name="us-gaap:NumberOfReportableSegments" id="Fact_3bfe6525ba0d44a3beff2ae3e9148eef" contextRef="c20210101to20211231" unitRef="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> reportable business segments. The Company&#8217;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. The Company&#8217;s
      physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured
      workers and neurological injuries. Services provided by the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. Prior to the second quarter of 2020,
      the Company operated as a single segment. All prior year segment information has been reclassified to conform to the current segment presentation. See Note 12 - Segment Information.<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d5" continuedAt="Text_ab63f85a639e43c39de6654b1825698d6">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
      </span></div>
</ix:continuation>

    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d6" continuedAt="Text_ab63f85a639e43c39de6654b1825698d7"><ix:nonNumeric name="usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" id="Text_55972e31cc0a4cd7b99a6c52383b9823" contextRef="c20210101to20211231" escape="true" continuedAt="Text_d5a63345993245ddb971753537e8ee101">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">During the last three years we completed the acquisitions of <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_5c622a8f63514d6cad69a0244a10f55e" contextRef="c20210101to20211231_BusinessAcquisitionAxis_MultiClinicPracticesMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">seven</ix:nonFraction>
        multi-clinic practices and <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_6a6e956bbc604f3da31c9736c9a7c6d9" contextRef="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction> industrial injury prevention businesses as detailed below. </span></div>
</ix:nonNumeric></ix:continuation>
    <div style="text-align: left; text-indent: 27pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d7" continuedAt="Text_ab63f85a639e43c39de6654b1825698d8"><ix:continuation id="Text_d5a63345993245ddb971753537e8ee101" continuedAt="Text_d5a63345993245ddb971753537e8ee102">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d8" continuedAt="Text_ab63f85a639e43c39de6654b1825698d9"><ix:continuation id="Text_d5a63345993245ddb971753537e8ee102" continuedAt="Text_d5a63345993245ddb971753537e8ee103">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">% Interest</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Number of</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Clinics</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_effba6035d634988ac4a8d9c20ca6e1d" contextRef="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember" format="ixt:datemonthdayyearen">December 31, 2021</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_9a7522ec423a46409e1a2703179c67f4" contextRef="c20211231_BusinessAcquisitionAxis_December2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_8d39611bac3f46b1bf887b9e6dcaa42f" contextRef="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember" unitRef="U006" decimals="INF" scale="0" format="ixt:numdotdecimal">3</ix:nonFraction></div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_52bc541919a849eca4949c1a0e1e3c66" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember" format="ixt:datemonthdayyearen">November 30, 2021</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_d43fe56cbbdf43c7a4bea0f445af0520" contextRef="c20211231_BusinessAcquisitionAxis_November2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"> <span style="-sec-ix-hidden:Fact_fcd7d7afc36c4146ae8996c5533e716f">*</span><br />
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_12590ba149db42dd8433f68e08b053b4" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2021AcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2021</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_9916d80e1cd243f0b8f3bb18b023fba7" contextRef="c20211231_BusinessAcquisitionAxis_September2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;"> <span style="-sec-ix-hidden:Fact_9e406021f6644e219c3b143ef1491cbb">*</span><br />
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">June 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_c9a732880e5a4bcc83fc7744b3c0de9a" contextRef="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember" format="ixt:datemonthdayyearen">June 30, 2021</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_1b3082a8428c4db181324b41a7ebb792" contextRef="c20211231_BusinessAcquisitionAxis_June2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_e7e0e11d59fc4627afb96445699ffcec" contextRef="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember" unitRef="U006" decimals="INF" scale="0" format="ixt:numdotdecimal">8</ix:nonFraction></div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">March 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_a1f3a0ce19124aa3a54b21a01fcdcf66" contextRef="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember" format="ixt:datemonthdayyearen">March 31, 2021</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_50db100c27d74a549776db5dd5fa7faa" contextRef="c20211231_BusinessAcquisitionAxis_March2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_ee74dbcdd9214a2bb5efba772bf5f633" contextRef="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember" unitRef="U006" decimals="INF" scale="0" format="ixt:numdotdecimal">6</ix:nonFraction></div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_a80ccd569817402d86a24ce6d26c2606" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember" format="ixt:datemonthdayyearen">November 30, 2020</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_8aa92f67bb7244cfb205945dc3efdc3a" contextRef="c20211231_BusinessAcquisitionAxis_November2020AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_dbbc9ed2fc374dd695e2c15352500d05" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">3</ix:nonFraction></div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_92734568e7d642c5887b2fbf845e42ac" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2020</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_7e6fea3870294f9bbdf4fb3e9e0630f2" contextRef="c20211231_BusinessAcquisitionAxis_September2020AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f">**</span><br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_9309fc129819408f8304bbdf3fafc275" contextRef="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember" format="ixt:datemonthdayyearen">February 27, 2020</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_cccd0aebc3cd4a079b94f19491d12216" contextRef="c20211231_BusinessAcquisitionAxis_February2020AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>% ***</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_b5e08bf9b37648fab127ae7dfd4a668b" contextRef="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">4</ix:nonFraction></div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_19ebac35c770443eb34e72fe52e07178" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2019</ix:nonNumeric></div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_7919083f577a40f9941d7ee83e2b7dde" contextRef="c20211231_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_12b229a876aa42f9b92228d7ab14140b" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 47%; vertical-align: bottom; white-space: nowrap;">April 2019 Acquisition <br />
              </td>

    <td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 17.16%; vertical-align: bottom; text-align: center; white-space: nowrap;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_062e517f1223412cae7892d354bed64a" contextRef="c20210101to20211231_BusinessAcquisitionAxis_April2019AcquisitionMember" format="ixt:datemonthdayyearen">April 11, 2019</ix:nonNumeric><br />
              </td>

    <td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 14.71%; vertical-align: bottom; text-align: center; white-space: nowrap;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_63088025707d4e868c32ef23614a0fc8" contextRef="c20180831_BusinessAcquisitionAxis_April2019AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% <br />
              </td>

    <td rowspan="1" style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"><span style="-sec-ix-hidden:Fact_b50371aded1746619d40d044e9a29674">*</span><br />
              </td>

  </tr>


</table>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d9" continuedAt="Text_ab63f85a639e43c39de6654b1825698d10"><ix:continuation id="Text_d5a63345993245ddb971753537e8ee103" continuedAt="Text_d5a63345993245ddb971753537e8ee104">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d10" continuedAt="Text_ab63f85a639e43c39de6654b1825698d11"><ix:continuation id="Text_d5a63345993245ddb971753537e8ee104" continuedAt="Text_d5a63345993245ddb971753537e8ee105">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_b182115cb6ef4d009deff873b8909b51" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Industrial injury prevention
                  business</ix:footnote></div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation></ix:continuation>
      <div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d11" continuedAt="Text_ab63f85a639e43c39de6654b1825698d12"><ix:continuation id="Text_d5a63345993245ddb971753537e8ee105" continuedAt="Text_d5a63345993245ddb971753537e8ee106">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left;"> <ix:footnote id="Foot_089e16638e954876a030f33789a71503" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">The business includes <ix:nonFraction name="usph:NumberOfManagementContracts" id="Fact_e42a02e713b94fe8a4f13e0e328c9927" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction> management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of <ix:nonNumeric name="usph:RemainingContractTerm" id="Fact_9daf91c9ef3b49ea930918274781c30a" contextRef="c20210101to20211231_BusinessAcquisitionAxis_ManagementContractsMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.</ix:footnote></td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d12" continuedAt="Text_ab63f85a639e43c39de6654b1825698d13"><ix:continuation id="Text_d5a63345993245ddb971753537e8ee106">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</td>

    <td style="width: auto; vertical-align: top; text-align: left;"> <ix:footnote id="Foot_8632189867454c27a153d70883a46e78" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">The four clinics are in <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_809988f83eb14100afe6f91a35570e85" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> separate partnerships. The Company's interest in the <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_81bfda2ce0034f7bb93f1f5a6023c135" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction>
                partnerships range from <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_7e0b3061a9cd4338868a73ec1a2c9068" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">10.0</ix:nonFraction>% to <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_b963cbbcacdc496cb6a712c68faf4537" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">83.8</ix:nonFraction>%,
                with an overall <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_6ada95faac844989838162fdcc97b3af" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">65.0</ix:nonFraction>% based on the initial purchase transaction.</ix:footnote></td>

  </tr>


</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d13" continuedAt="Text_ab63f85a639e43c39de6654b1825698d14">
<div>
         <br /></div>
</ix:continuation>
      </div>

    </div>

    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d14" continuedAt="Text_ab63f85a639e43c39de6654b1825698d15">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Physical Therapy Operations</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d15" continuedAt="Text_ab63f85a639e43c39de6654b1825698d16">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d16" continuedAt="Text_ab63f85a639e43c39de6654b1825698d17">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The physical therapy operations segment primarily operates through subsidiary clinic partnerships, in which the Company generally
      owns a <ix:nonFraction name="usph:PercentageOfGeneralPartnershipInterestOwned" id="Fact_a4a526359a01462c9d76dfb79f2526f6" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% general partnership interest in all the Clinic Partnerships. Our limited partnership interests typically range from <ix:nonFraction name="usph:PercentageOfLimitedPartnershipInterestOwned" id="Fact_d4c2794cc0174ea89a26d1705e311e6f" contextRef="c20210101to20211231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% to <ix:nonFraction name="usph:PercentageOfLimitedPartnershipInterestOwned" id="Fact_a29fa724731c4ad5958a3dd83235a64a" contextRef="c20210101to20211231_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">99</ix:nonFraction>% in the Clinic Partnerships. The
      managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, the Company operates some clinics, through
      wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d17" continuedAt="Text_ab63f85a639e43c39de6654b1825698d18">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d18" continuedAt="Text_ab63f85a639e43c39de6654b1825698d19">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and
      other referral sources, by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior
      owners typically continue on as employees to manage the clinic operations, retain a non-controlling ownership interest in the clinics and receive a competitive salary for managing the clinic operations. In addition, the Company has developed
      satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than <ix:nonFraction name="usph:NumberOfOperatingClinicLocations" id="Fact_bc22911778194dabb60e90733d00e3c1" contextRef="c20211231_RangeAxis_MinimumMember" unitRef="U009" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> clinic location.</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d19" continuedAt="Text_ab63f85a639e43c39de6654b1825698d20">
<div><br /></div>
</ix:continuation>
    <div style="text-align: left; text-indent: 27pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d20" continuedAt="Text_ab63f85a639e43c39de6654b1825698d21">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Besides
        the multi-clinic acquisitions referenced in the table above, during 2021and 2020, we purchased the assets and business of <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_7d2f54e023504ec68d0395f939dbaabb" contextRef="c20210101to20211231" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction> and&#160; <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_d7c30f7fdc2b43f7a95ce6500c693aeb" contextRef="c20200101to20201231" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction> physical therapy clinics, respectively, in separate transactions.<br />
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d21" continuedAt="Text_ab63f85a639e43c39de6654b1825698d22">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">44</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d22" continuedAt="Text_ab63f85a639e43c39de6654b1825698d23">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During the year ended December 31, 2021, the Company sold <ix:nonFraction name="usph:NumberOfClosedClinicsSold" id="Fact_6c94a61301244cafa1c738e060ea253c" contextRef="c20211231" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> clinics. The aggregate sales price was $<ix:nonFraction name="usph:AggregateSalePriceOfCinics" id="Fact_bca129404f72455e8c0abc45427eb8fb" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million. During the
      year ended December 31, 2020, we sold <ix:nonFraction name="usph:NumberOfClosedClinicsSold" id="Fact_c374f3bdcae747cab366def74bcd56e0" contextRef="c20201231" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">14</ix:nonFraction> previously closed clinics. The aggregate sales price was $<ix:nonFraction name="usph:AggregateSalePriceOfCinics" id="Fact_e180d75660e64033b0ddd27d567b9ef9" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction> million, of which $<ix:nonFraction name="usph:CashReceivedRelatedToSaleOfClinics" id="Fact_5b73372cb4144087a46dc2e0d4a24a4e" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction> million was paid
      in cash and $<ix:nonFraction name="usph:NoteReceivableRelatedToSaleOfClinics" id="Fact_a1a4863e8d8f4e4d99705f313004616f" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction> million in a note receivable due in <ix:nonFraction name="usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration" id="Fact_900ca1e20fd04b56a0821a2dae5198a9" contextRef="c20200101to20201231" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> equal installments of principal and any accrued interest. The first payment was received in June 2021 and the next payment is due on June 15, 2022.</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d23" continuedAt="Text_ab63f85a639e43c39de6654b1825698d24">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d24" continuedAt="Text_ab63f85a639e43c39de6654b1825698d25">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; text-align: left; text-indent: 0px;">Clinic Partnerships</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d25" continuedAt="Text_ab63f85a639e43c39de6654b1825698d26">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d26" continuedAt="Text_ab63f85a639e43c39de6654b1825698d27">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by
      the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as <span style="font-style: italic;">non-controlling interest&#8212;permanent equity</span>. For acquired Clinic Partnerships with redeemable
      non-controlling interests, the earnings attributable to the redeemable non-controlling interests are recorded within the consolidated balance sheets and income statements as <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">redeemable non-controlling interest</span>&#8212;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">temporary equity</span>.</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d27" continuedAt="Text_ab63f85a639e43c39de6654b1825698d28">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d28" continuedAt="Text_ab63f85a639e43c39de6654b1825698d29">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; text-align: left; text-indent: 0px;">Wholly-Owned Facilities</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d29" continuedAt="Text_ab63f85a639e43c39de6654b1825698d30">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d30" continuedAt="Text_ab63f85a639e43c39de6654b1825698d31">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing
      due the clinic partners/directors. The amount is expensed as compensation and included in clinic operating costs&#8212;salaries and related costs. The respective liability is included in current liabilities&#8212;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">accrued expenses</span> on the consolidated balance sheets.</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d31" continuedAt="Text_ab63f85a639e43c39de6654b1825698d32">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d32" continuedAt="Text_ab63f85a639e43c39de6654b1825698d33">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Industrial Injury Prevention Services</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d33" continuedAt="Text_ab63f85a639e43c39de6654b1825698d34">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d34" continuedAt="Text_ab63f85a639e43c39de6654b1825698d35">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Services provided in the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post offer
        employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers
        and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).</span></div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d35" continuedAt="Text_ab63f85a639e43c39de6654b1825698d36">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d36" continuedAt="Text_ab63f85a639e43c39de6654b1825698d37">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">Impact of COVID-19</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d37" continuedAt="Text_ab63f85a639e43c39de6654b1825698d38">
<div><br />
    </div>
</ix:continuation>
    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d38" continuedAt="Text_ab63f85a639e43c39de6654b1825698d39">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">As previously disclosed in a series of filings with the SEC and further described in detail in the Company&#8217;s Quarterly Reports on
        Form 10-Q for the first three quarters of 2020 and our Annual Report on Form 10-K for the year ended December 31, 2020, the Company&#8217;s results were negatively impacted by the effects of the COVID-19 pandemic in 2020. For 2021 periods as compared to
        2020 periods, the increase in revenues and expenses are primarily due to the Company returning to and now exceeding pre-pandemic results.</div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d39" continuedAt="Text_ab63f85a639e43c39de6654b1825698d40">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d40" continuedAt="Text_ab63f85a639e43c39de6654b1825698d41">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company has put preparedness plans in place at our facilities to maintain continuity of operations, while also taking steps to
        keep employees and patients safe. In line with recommendations to reduce large gatherings and increase social distancing, the Company has continued to allow a large number of office-based employees to work remotely. The Company is continuing to
        monitor the situation and will adjust work environments accordingly.</div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d41" continuedAt="Text_ab63f85a639e43c39de6654b1825698d42">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d42" continuedAt="Text_ab63f85a639e43c39de6654b1825698d43">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In March 2020 in response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic
        Security Act (&#8220;CARES Act&#8221;). The CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future
        limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement
        property, and the creation of certain payroll tax credits associated with the retention of employees.</div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d43" continuedAt="Text_ab63f85a639e43c39de6654b1825698d44">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d44" continuedAt="Text_ab63f85a639e43c39de6654b1825698d45">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: left; text-indent: 0px;">Medicare Accelerated and Advance Payment Program (&#8220;MAAPP Funds&#8221;)</div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d45" continuedAt="Text_ab63f85a639e43c39de6654b1825698d46">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d46" continuedAt="Text_ab63f85a639e43c39de6654b1825698d47">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic Security Act
        (&#8220;CARES Act&#8221;). The CARES Act allowed for qualified healthcare providers to receive advanced payments under the MAAPP Funds during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future
        Medicare services provided. The Company applied for and received approval from Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. The Company recorded the $<ix:nonFraction name="us-gaap:GrantsReceivable" id="Fact_6eb29cf4934447319e4a729da63ab039" contextRef="c20200430_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction> million in advance payments received as a liability. During the first quarter of 2021, the Company repaid the MAAPP Funds of $<ix:nonFraction name="usph:RepaymentOfFunds" id="Fact_4a3345e6f056432bb93ff947a920e16d" contextRef="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction> million rather than applying them to future services performed.</div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d47" continuedAt="Text_ab63f85a639e43c39de6654b1825698d48">
<div><br /></div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d48" continuedAt="Text_ab63f85a639e43c39de6654b1825698d49">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Relief Funds</div>
</ix:continuation>
    <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d49" continuedAt="Text_ab63f85a639e43c39de6654b1825698d50">
<div><br />
    </div>
</ix:continuation>
    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d50" continuedAt="Text_ab63f85a639e43c39de6654b1825698d51">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On
        March 27, 2020, the CARES Act was enacted. The CARES Act provided additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $<ix:nonFraction name="usph:GrantsAndOtherFunds" id="Fact_c44ca1222eea48c19909f8eb1f23e145" contextRef="c20211231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember" unitRef="U001" decimals="-8" scale="9" format="ixt:numdotdecimal">100.0</ix:nonFraction> billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing,
        and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.</div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d51" continuedAt="Text_ab63f85a639e43c39de6654b1825698d52">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ab63f85a639e43c39de6654b1825698d52">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">For
        the years ended December 31, 2021 and December 31, 2020, the Company&#8217;s consolidated subsidiaries recorded income of approximately $<ix:nonFraction name="usph:ReliefFunds" id="Fact_1ee28e487b514566817134cd45a312e5" contextRef="c20210101to20211231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.6</ix:nonFraction>
        million and $<ix:nonFraction name="usph:ReliefFunds" id="Fact_824f66b7b8e6459caa75ad173bd8a012" contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">13.5</ix:nonFraction> million, respectively, from payments under the CARES Act (&#8220;Relief Funds&#8221;). Under the Company&#8217;s accounting policy, these
        payments were recorded as Other income &#8211; Relief Funds. These funds are not required to be repaid upon attestation and compliance with certain terms and conditions, which could change materially based on evolving grant compliance provisions and
        guidance provided by the U.S. Department of Health and Human Services. Currently, the Company can attest and comply with the terms and conditions.&#160; The Company will continue to monitor the evolving guidelines and may record adjustments as
        additional information is released.</div>
</ix:continuation>
    </div>


    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <!--PROfilePageNumberReset%Num%45%%%-->
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
      <ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" id="Text_79869cc327d943d19eacb4165990aa14" contextRef="c20210101to20211231" escape="true" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752591">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2. Significant Accounting Policies</div>
</ix:nonNumeric>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752591" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752592">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752592" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752593"><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="Text_eefc7967450b475a8ade6715fd4e10e5" contextRef="c20210101to20211231" escape="true" continuedAt="Text_577bd801df9a4a51ab6aa1b7716195421">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Cash Equivalents</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752593" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752594"><ix:continuation id="Text_577bd801df9a4a51ab6aa1b7716195421" continuedAt="Text_577bd801df9a4a51ab6aa1b7716195422">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752594" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752595"><ix:continuation id="Text_577bd801df9a4a51ab6aa1b7716195422">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments
        with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a
        concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752595" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752596">
<div><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">45</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>


      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752596" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752597"><ix:nonNumeric name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="Text_42c7b9ddce6f4ade83e6cba0c46adb66" contextRef="c20210101to20211231" escape="true" continuedAt="Text_ecb8125aff4243378f2557e944751d8d1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Long-Lived Assets</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752597" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752598"><ix:continuation id="Text_ecb8125aff4243378f2557e944751d8d1" continuedAt="Text_ecb8125aff4243378f2557e944751d8d2">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752598" continuedAt="Text_97ba1b944e93486e9e5c525bf9b752599"><ix:continuation id="Text_ecb8125aff4243378f2557e944751d8d2">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the
        related assets. Estimated useful lives for furniture and equipment range from <span style="-sec-ix-hidden:Fact_8dba1636fbb14fd492a5df628ebe9b1c">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_2325769c7c9f4b4b9a4ce64020c5e4ea" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">eight years</ix:nonNumeric> and for software purchased from <span style="-sec-ix-hidden:Fact_88c34f0df7f44d898218c12bf8c8a138">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_cb14591344b048ba82145d638c06a9cf" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">seven years</ix:nonNumeric>. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally
        <span style="-sec-ix-hidden:Fact_20d1e6de339f4109b6e30d66a9ab05cd">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_3a72583b8cd04becb9c5b0e5546bc8e1" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b752599" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525910">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525910" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525911"><ix:nonNumeric name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="Text_bfb3288357af41029ff059a0b1cfcfad" contextRef="c20210101to20211231" escape="true" continuedAt="Text_948a431701d048d38b1132a0201a9d781">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525911" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525912"><ix:continuation id="Text_948a431701d048d38b1132a0201a9d781" continuedAt="Text_948a431701d048d38b1132a0201a9d782">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525912" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525913"><ix:continuation id="Text_948a431701d048d38b1132a0201a9d782">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Company reviews property and equipment
        and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value
        less costs to sell.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525913" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525914">
<div><br />
      </div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525914" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525915"><ix:nonNumeric name="us-gaap:InvestmentPolicyTextBlock" id="Text_047f4fa0a6694b9da384168ded9a88d0" contextRef="c20210101to20211231" escape="true" continuedAt="Text_b5294797a6a04c2b929177f6451d27fa1">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;">Investment in unconsolidated affiliate</div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525915" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525916"><ix:continuation id="Text_b5294797a6a04c2b929177f6451d27fa1" continuedAt="Text_b5294797a6a04c2b929177f6451d27fa2">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
          </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525916" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525917"><ix:continuation id="Text_b5294797a6a04c2b929177f6451d27fa2">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;">Investments in unconsolidated joint ventures in which the Company has less than a controlling interest, are accounted for under the equity method of accounting
          and, accordingly, are adjusted for capital contributions, distributions and the Company&#8217;s equity in net earnings or loss of the respective joint venture.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525917" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525918">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span>
        <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525918" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525919">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525919" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525920">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525920" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525921"><ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="Text_8ed549a7adbb471ea29c5ae834094e87" contextRef="c20210101to20211231" escape="true" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Goodwill</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525921" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525922"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad1" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad2">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525922" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525923"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad2" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad3">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Goodwill represents the excess of the amount paid and fair value of
          the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional
          paid-in capital.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525923" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525924"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad3" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad4">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525924" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525925"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad4" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad5">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic impairment evaluations. The fair value of goodwill and
          other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair value if considered impaired. These events or
          conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of
          continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company
          evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525925" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525926"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad5" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad6">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525926" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525927"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad6" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad7">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Company operates a </span><ix:nonFraction name="us-gaap:NumberOfOperatingSegments" id="Fact_ad0eb764099c4e7ca0b92761607c1914" contextRef="c20210101to20211231" unitRef="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The
            partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test.</span> In 2021, 2020 and 2019</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> there were </span><ix:nonFraction name="usph:NumberOfRegions" id="Fact_c88d5a026ebb44478a4f4c201c7b4032" contextRef="c20200101to20201231" unitRef="U011" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="usph:NumberOfRegions" id="Fact_a45e092a76214ccaac88db2d1df7a7ef" contextRef="c20190101to20191231" unitRef="U011" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="usph:NumberOfRegions" id="Fact_234297b5cc1d49e1bd66fbeef7b72f65" contextRef="c20210101to20211231" unitRef="U011" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></ix:nonFraction></ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> regions. </span>In addition to the <ix:nonFraction name="usph:NumberOfRegions" id="Fact_f0b84e6e6bee437fa02bf8cc1256c8bb" contextRef="c20210101to20211231" unitRef="U011" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="usph:NumberOfRegions" id="Fact_8899ec852477412b9633c5c7298f1b0e" contextRef="c20190101to20191231" unitRef="U011" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="usph:NumberOfRegions" id="Fact_4b8959a095bf4d10bc1836e645be546b" contextRef="c20200101to20201231" unitRef="U011" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></ix:nonFraction></ix:nonFraction> regions, the impairment analysis
        included a separate analysis for the industrial injury prevention services business, as a separate reporting unit.<br class="Apple-interchange-newline" />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525927" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525928"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad7" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad8">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525928" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525929"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad8" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad9">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If
          goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair
          value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in
          determining the fair value of its reporting units when performing a quantitative analysis.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525929" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525930"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad9" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad10">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525930" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525931"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad10" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad11">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;">An impairment loss generally would be recognized when the carrying amount of the net
          assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2021, 2020 and 2019 did not result in any goodwill amounts that were
          deemed impaired.</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525931" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525932"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad11" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad12">
<div><br class="Apple-interchange-newline" /></div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525932" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525933"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad12" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad13">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below
          their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2021.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525933" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525934"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad13" continuedAt="Text_a6171130ed944aee99c6ff9fd2b3c2ad14">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 26.5333px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525934" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525935"><ix:continuation id="Text_a6171130ed944aee99c6ff9fd2b3c2ad14">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company will continue to monitor for any triggering events or other indicators of impairment. </span></div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525935" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525936">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525936" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525937"><ix:nonNumeric name="usph:RedeemableNonControllingInterestsPolicyTextBlock" id="Text_bd0febfaaa72460abc26d90bdff90565" contextRef="c20210101to20211231" escape="true" continuedAt="Text_1849fd2f89634c27bed947fccd4a40891">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Redeemable Non-Controlling Interest</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525937" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525938"><ix:continuation id="Text_1849fd2f89634c27bed947fccd4a40891" continuedAt="Text_1849fd2f89634c27bed947fccd4a40892">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525938" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525939"><ix:continuation id="Text_1849fd2f89634c27bed947fccd4a40892" continuedAt="Text_1849fd2f89634c27bed947fccd4a40893">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The non-controlling interest that is
        reflected as redeemable non-controlling interest in the consolidated financial statements consists of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the
        future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months
        earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s
        employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically <span style="-sec-ix-hidden:Fact_054bc4ad0f534600aebe5987db19283e">three</span>
        to <ix:nonNumeric name="usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="Fact_7ddf7906142b41dfbf0534e9dd4a64ce" contextRef="c20210101to20211231_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death)
        and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525939" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525940"><ix:continuation id="Text_1849fd2f89634c27bed947fccd4a40893" continuedAt="Text_1849fd2f89634c27bed947fccd4a40894">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525940" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525941"><ix:continuation id="Text_1849fd2f89634c27bed947fccd4a40894" continuedAt="Text_1849fd2f89634c27bed947fccd4a40895">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525941" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525942"><ix:continuation id="Text_1849fd2f89634c27bed947fccd4a40895" continuedAt="Text_1849fd2f89634c27bed947fccd4a40896">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">46</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525942" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525943"><ix:continuation id="Text_1849fd2f89634c27bed947fccd4a40896">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On the date the Company acquires a
        controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated
        balance sheet under the ca<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">ption&#8212;Redeemab</span>le non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of
        its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial
        carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated
        statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in
        consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525943" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525944">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
      <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525944" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525945">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525945" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525946"><ix:nonNumeric name="usph:NonControllingInterestsPolicyPolicyTextBlock" id="Text_97341a6eb3474169b82059ef26c4799d" contextRef="c20210101to20211231" escape="true" continuedAt="Text_13926e10b54f4bb2b40bdcf9f6f12e391">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Non-Controlling Interest</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525946" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525947"><ix:continuation id="Text_13926e10b54f4bb2b40bdcf9f6f12e391" continuedAt="Text_13926e10b54f4bb2b40bdcf9f6f12e392">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525947" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525948"><ix:continuation id="Text_13926e10b54f4bb2b40bdcf9f6f12e392" continuedAt="Text_13926e10b54f4bb2b40bdcf9f6f12e393">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the
        non-controlling interest, as permanent equity in the consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face
        of the statements of net income. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company
        recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525948" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525949"><ix:continuation id="Text_13926e10b54f4bb2b40bdcf9f6f12e393" continuedAt="Text_13926e10b54f4bb2b40bdcf9f6f12e394">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525949" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525950"><ix:continuation id="Text_13926e10b54f4bb2b40bdcf9f6f12e394">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or
        shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525950" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525951">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525951" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525952"><ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="Text_b554bea11a6848378c16f3b62a6a33d3" contextRef="c20210101to20211231" escape="true" continuedAt="Text_15c2186df9eb47bea4e1eac430d766051">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Revenue Recognition</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525952" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525953"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766051" continuedAt="Text_15c2186df9eb47bea4e1eac430d766052">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525953" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525954"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766052" continuedAt="Text_15c2186df9eb47bea4e1eac430d766053">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525954" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525955"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766053" continuedAt="Text_15c2186df9eb47bea4e1eac430d766054">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525955" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525956"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766054" continuedAt="Text_15c2186df9eb47bea4e1eac430d766055">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting
        Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with
        Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from
        Contracts with Customer (collectively the &#8220;standards&#8221;), respectively, which supersede most of the current revenue recognition requirements (&#8220;ASC 606&#8221;). The core principle of the new guidance is that an entity should recognize revenue to depict the
        transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525956" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525957"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766055" continuedAt="Text_15c2186df9eb47bea4e1eac430d766056">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525957" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525958"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766056" continuedAt="Text_15c2186df9eb47bea4e1eac430d766057">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525958" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525959"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766057" continuedAt="Text_15c2186df9eb47bea4e1eac430d766058">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525959" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525960"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766058" continuedAt="Text_15c2186df9eb47bea4e1eac430d766059">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">The Company implemented the new standards beginning January 1, 2018 using a modified
        retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a
        significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues
        upon implementation. Under the new standards, the Company&#8217;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525960" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525961"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d766059" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660510">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525961" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525962"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660510" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660511">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525962" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525963"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660511" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660512">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525963" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525964"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660512" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660513">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">For ASC 606,
          there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which
          establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided
          to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the
          Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists
          when we provide the services at established rates.</span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;"> The difference
          between the Company&#8217;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#8212;</span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;">contractual allowance.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525964" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525965"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660513" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660514">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525965" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525966"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660514" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660515">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525966" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525967"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660515" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660516">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">47</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>
<ix:nonNumeric name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="Text_18b8e34835614d9680410c91671d46c2" contextRef="c20210101to20211231" escape="true" continuedAt="Text_b9f0e126d5fd4f52b742504f57391efb1"><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525967" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525968"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660516" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660517">
<div>
      <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation></ix:nonNumeric>
      <ix:continuation id="Text_b9f0e126d5fd4f52b742504f57391efb1" continuedAt="Text_b9f0e126d5fd4f52b742504f57391efb2"><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525968" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525969"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660517" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660518">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">The following table details the revenue related to the various categories (in
        thousands).</div>
</ix:continuation></ix:continuation></ix:continuation>
      <ix:continuation id="Text_b9f0e126d5fd4f52b742504f57391efb2" continuedAt="Text_b9f0e126d5fd4f52b742504f57391efb3"><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525969" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525970"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660518" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660519">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation></ix:continuation>
      <ix:continuation id="Text_b9f0e126d5fd4f52b742504f57391efb3" continuedAt="Text_b9f0e126d5fd4f52b742504f57391efb4"><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525970" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525971"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660519" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660520">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation></ix:continuation>
      <ix:continuation id="Text_b9f0e126d5fd4f52b742504f57391efb4" continuedAt="Text_b9f0e126d5fd4f52b742504f57391efb5"><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525971" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525972"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660520" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660521">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation></ix:continuation>
      <ix:continuation id="Text_b9f0e126d5fd4f52b742504f57391efb5"><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525972" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525973"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660521" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660522">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> <br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="10">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">Year Ended</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2021</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2020</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2019</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Net patient revenue</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_84f59c475c6f408bbbb7fcab668e21e1" contextRef="c20210101to20211231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">438,330</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_6d084ef3b3c34026a17cce1230475ff3" contextRef="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">373,340</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_cb5e96e705e3486789e637a2539a6d92" contextRef="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">433,345</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> Other patient revenue </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_84fcfc72fb9c4c848274defa81c449b1" contextRef="c20210101to20211231_ProductOrServiceAxis_OtherRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,939</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_a0ed771469bb4d209c28f483531a95bb" contextRef="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,020</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_cbd91ee6603d4cdf95643aea6a8e6d61" contextRef="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,486</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Physical therapy operations</div>
              </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" colspan="1"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$ <br />
              </span> </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_3da6d1fc7ded4bb492455bed635d1220" contextRef="c20210101to20211231_ProductOrServiceAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">441,269</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" colspan="1"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$<br />
              </span> </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_e56a54c046ae47e4a71fdf85a25f6543" contextRef="c20200101to20201231_ProductOrServiceAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">375,360</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" colspan="1"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$ <br />
              </span> </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_18f2405c79ce46368f5f67cbb1dd940f" contextRef="c20190101to20191231_ProductOrServiceAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">435,831</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Physical therapy management contracts</div>
              </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
                </span> </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_eca56bb2c595462dbbcfcc6581ccf86b" contextRef="c20210101to20211231_ProductOrServiceAxis_ManagementContractRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,853</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
                </span> </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_8dc5bf3c0e1a436b9c55ddbcfe6e1388" contextRef="c20200101to20201231_ProductOrServiceAxis_ManagementContractRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,410</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
                </span> </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_b1adb356b0cb45d784aaf9c67d74910f" contextRef="c20190101to20191231_ProductOrServiceAxis_ManagementContractRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,676</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Industrial injury prevention services<br />
              </div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_36a665a0c125474c8468027e9f9ade6f" contextRef="c20210101to20211231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">43,900</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_a108043f96164c75a1797e61b187652a" contextRef="c20200101to20201231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">39,199</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_5ebaa7d5fc174703a37d961c5abfa18b" contextRef="c20190101to20191231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">37,462</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_dc53ac3c1c8f4866a23ddbfd62e22406" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">495,022</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_402f514952a340e1a0f43d880f3ca2de" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">422,969</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_a161480783454c848bec0ecf8193dfb6" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">481,969</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation></ix:continuation><ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525973" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525974"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660522" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660523">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span>
      <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525974" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525975"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660523" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660524">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525975" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525976"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660524" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660525">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525976" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525977"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660525" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660526">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Patient revenue </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525977" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525978"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660526" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660527">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525978" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525979"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660527" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660528">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525979" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525980"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660528" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660529">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525980" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525981"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660529" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660530">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">Revenues are recognized in the period in
        which services are rendered. Net patient revenue consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries,
        preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors,
        patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides
        physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the
        Company at amounts different from its established rates. </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525981" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525982"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660530" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660531">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525982" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525983"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660531" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660532">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525983" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525984"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660532" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660533">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525984" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525985"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660533" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660534">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);">Medicare Reimbursement</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525985" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525986"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660534" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660535">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525986" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525987"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660535" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660536">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525987" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525988"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660536" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660537">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525988" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525989"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660537" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660538">
<div style="display:none;"><br /></div>
<div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Medicare program reimburses outpatient rehabilitation
        providers based on the Medicare Physician Fee Schedule (&#8220;MPFS&#8221;). For services provided in 2017 through 2019, a <ix:nonFraction name="usph:PercentageOfMedicarePaymentIncrease" id="Fact_e156e93da6b34362ae6335c04376b0af" contextRef="c20210101to20211231_UnusualOrInfrequentItemAxis_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">0.5</ix:nonFraction>% increase was applied
        to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025 <ix:nonFraction name="usph:PercentageOfMedicarePaymentIncrease" id="Fact_08411dc3a6eb4cb2a61642f215f917cc" contextRef="c20210101to20211231_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" unitRef="U005" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>
        adjustment is expected to be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525989" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525990"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660538" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660539">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; font-style: normal;"> </span> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525990" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525991"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660539" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660540">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525991" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525992"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660540" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660541">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <div>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525992" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525993"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660541" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660542">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"> In the 2020 MPFS Final Rule, CMS revised coding, documentation guidelines, and
          increased the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office
          visit codes and cuts to other specialty codes to maintain budget neutrality. As a result, CMS projected a <ix:nonFraction name="usph:EstimatedPercentageOfDecreaseInPayment" id="Fact_a72438d521c147a6b2babb70e4585e1f" contextRef="c20210101to20211231_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">9</ix:nonFraction>% decrease in fee schedule
          payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the Consolidated Appropriations Act, 2021 and reimbursement for the codes applicable to physical/occupational therapy services provided by
          our clinics received an estimated <ix:nonFraction name="usph:EstimatedPercentageOfDecreaseInPayment" id="Fact_ad266e8000ec4e5da2ace6074f12a93f" contextRef="c20210101to20211231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.5</ix:nonFraction>% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020.</div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525993" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525994"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660542" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660543">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525994" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525995"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660543" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660544">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525995" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525996"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660544" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660545">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <div>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525996" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525997"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660545" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660546">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">In the 2022 MPFS Final Rule published on November 2, 2021, there was to be an
          approximately <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_a613e943e123410d9aa6ee3c43013ca7" contextRef="c20211102_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.75</ix:nonFraction>% reduction to Medicare payments for physical/occupational therapy services. This was due to the expiration of the
          additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021. However, this reduction was addressed in the Protecting Medicare and American Farmers from Sequester Cuts Act (&#8220;2021 Act&#8221;)
          signed into law on December 10, 2021. Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year of 2022 will be approximately <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_3b2be61484b148bcad6e3b581c127dc1" contextRef="c20221231_StatementScenarioAxis_ScenarioForecastMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">0.75</ix:nonFraction>%. The 2021 Act did not address the <ix:nonFraction name="usph:EstimatedPercentageOfDecreaseInPayment" id="Fact_77eb84a86ba945dfada89f9491f699a3" contextRef="c20220101to20221231_StatementScenarioAxis_ScenarioForecastMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">15</ix:nonFraction>% reduction in
          Medicare payments for services performed by a physical or occupational therapist assistant, which began on January 1, 2022.</div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525997" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525998"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660546" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660547">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525998" continuedAt="Text_97ba1b944e93486e9e5c525bf9b7525999"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660547" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660548">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b7525999" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259100"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660548" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660549">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <div>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259100" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259101"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660549" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660550">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">In addition, the Consolidated Appropriations Act, 2021 includes reductions in
          Medicare payment rates of approximately <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_e758262019a440da92357639e7c2d66b" contextRef="c20231231_StatementScenarioAxis_ScenarioForecastMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal"><ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_6658247e329f42fab7ae785c5a1be1ea" contextRef="c20241231_StatementScenarioAxis_ScenarioForecastMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction></ix:nonFraction>% in each of calendar years 2023 and 2024, unless regulatory or Congressional action
          results in modifications to such rates as has occurred in 2021 and 2022.</div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259101" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259102"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660550" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660551">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259102" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259103"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660551" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660552">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <div>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259103" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259104"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660552" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660553">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with
          deficit reductions over the next <ix:nonNumeric name="usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" id="Fact_787ca2d5df954b88b24e628c12e5c38b" contextRef="c20210101to20211231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> and requires automatic reductions in federal spending by approximately $<ix:nonFraction name="usph:AmountOfReductionsInFederalSpending" id="Fact_8910c460c9654802b55228e2525e85c6" contextRef="c20210101to20211231" unitRef="U001" decimals="-11" scale="12" format="ixt:numdotdecimal">1.2</ix:nonFraction> trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a <ix:nonFraction name="usph:ReductionInMedicareSpendingPercentage" id="Fact_3dc201e0ab884669ae10cf1ab7222941" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% cap. On April 1, 2013, a <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_0e09100472f74dd8af303564df6bde25" contextRef="c20130401" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%
          reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_dd8860411f1e44859be21621754e62fa" contextRef="c20151102" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%
          reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_1d22e32f418847cf9cabbc9c820b71c1" contextRef="c20180209" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%
          reductions to Medicare payments through fiscal year 2027. The CARES Act suspended the <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_90743b63514242eca6747c151ee8586d" contextRef="c20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% payment reduction to Medicare payments for
          dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_4b2e37bec6234760bd7f5a871d09cc99" contextRef="c20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%
          payment reduction until March 31, 2021. On April 14, 2021, additional legislation was enacted that waived the <ix:nonFraction name="usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation" id="Fact_7bab068beef245aeab7d01714b5624cd" contextRef="c20210401to20210414" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% payment reduction for
          the remainder of calendar 2021. The 2021 Act, which was signed into law on December 10, 2021, included a <ix:nonNumeric name="usph:PeriodOfExtension" id="Fact_43c7758c1db54819a7a0bb20eb81d818" contextRef="c20210101to20211231" format="ixt-sec:durwordsen">three-month</ix:nonNumeric> extension of the
          <ix:nonFraction name="usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation" id="Fact_5e05c31577214845a026b4785b431818" contextRef="c20210401to20210414" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% sequester relief applied to all Medicare payments through March 31, 2022, followed by three months of <ix:nonFraction name="usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" id="Fact_76b720de3dd04fdfab9815cbdfd2de00" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% sequester relief through June 30, 2022. Sequester relief is scheduled to then end on June 30, 2022.</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259104" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259105"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660553" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660554">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259105" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259106"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660554" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660555">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">48</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259106" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259107"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660555" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660556">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
      <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259107" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259108"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660556" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660557">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">Beginning in 2021, payments to individual therapists (Physical/Occupational
          Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and
          meaningful use of electronic health records. Therapists eligible to participate in MIPS include only those therapists who are enrolled with Medicare as private practice providers, and does not include therapists in facility-based providers, such
          as our clinics enrolled as certified rehabilitation agencies. Less than <ix:nonFraction name="usph:PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" id="Fact_dc0a2c627e274ddfabbd5c42e2329bcb" contextRef="c20210101to20211231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction>% of the Company&#8217;s therapist providers currently participate
          in MIPS. Under the MIPS requirements, a provider&#8217;s performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional&#8217;s payment for the
          corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine the payment adjustment in 2021. For those therapist providers who actually participated in MIPS during 2019, the resulting average payment adjustment was an
          increase of <ix:nonFraction name="usph:PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" id="Fact_fc26576336b44deda96a41894dcd17b1" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%.</div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259108" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259109"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660557" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660558">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259109" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259110"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660558" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660559">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259110" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259111"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660559" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660560">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259111" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259112"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660560" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660561">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Under the Middle-Class Tax Relief and Job Creation Act of 2012 (&#8220;MCTRA&#8221;), since
        October 1, 2012, patients who met or exceeded $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_5a0346d8d824462397d0f9ac788292b4" contextRef="c20210101to20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> in therapy expenditures during a calendar year have been subject to a manual medical
        review to determine whether applicable payment criteria are satisfied. The $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_3ba675a29df34aab8464b3530a2a13bb" contextRef="c20210101to20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold is applied to Physical Therapy and Speech
        Language Pathology Services; a separate $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_77c3ff9bb7ee4be08e8f13c2ce5593bb" contextRef="c20210101to20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the
        manual medical review process such that those reviews will no longer apply to all claims exceeding the $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_6cb6f50a518f4cc680a847c958c83c56" contextRef="c20210101to20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold and instead will
        be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to $<ix:nonFraction name="usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_a1c3055defb6464db378210f2beda0b1" contextRef="c20210101to20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,000</ix:nonFraction> through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for
        2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259112" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259113"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660561" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660562">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259113" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259114"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660562" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660563">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259114" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259115"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660563" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660564">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259115" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259116"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660564" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660565">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">CMS adopted a multiple
          procedure payment reduction (&#8220;MPPR&#8221;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and
          speech-language pathology. Under the policy, the Medicare program pays <ix:nonFraction name="usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit" id="Fact_7c71c49351b74fa4a787c218a5727483" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the practice expense component of the Relative Value
          Unit (&#8220;RVU&#8221;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the
          same patient, regardless of whether those therapy services are furnished in separate sessions. In 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by
          <ix:nonFraction name="usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" id="Fact_ce7bc07fac93452fbe56b74d6bd2a35c" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>%.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259116" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259117"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660565" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660566">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259117" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259118"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660566" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660567">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259118" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259119"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660567" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660568">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259119" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259120"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660568" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660569">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Medicare claims for outpatient therapy services furnished by therapist assistants on
        or after January 1, 2020 must include a modifier indicating the service was furnished by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022, in whole or part by a therapist assistant will be paid at an amount
        equal to <ix:nonFraction name="usph:PercentageOfPaymentForOutpatientTherapyServices" id="Fact_de85fb5c01e74b6ab1d9baa803f83ed6" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">85</ix:nonFraction>% of the payment amount otherwise applicable for the service.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259120" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259121"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660569" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660570">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259121" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259122"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660570" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660571">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259122" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259123"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660571" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660572">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259123" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259124"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660572" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660573">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to
        Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving
        allegations of potential wrongdoing that would have a material effect on our financial statements as of December 31, 2021. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as
        significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the years ended December 31, 2021, and 2020, respectively, net patient revenue from Medicare was approximately $<ix:nonFraction name="usph:NetRevenueFromMedicare" id="Fact_9ccb919162754f42b1537dbec9633424" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">134.4</ix:nonFraction> million and $<ix:nonFraction name="usph:NetRevenueFromMedicare" id="Fact_5c451e9ef70a45feaf338f7557150a88" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">101.6</ix:nonFraction> million,
        respectively.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259124" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259125"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660573" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660574">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259125" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259126"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660574" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660575">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259126" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259127"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660575" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660576">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259127" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259128"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660576" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660577">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;">Management Contract Revenue</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259128" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259129"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660577" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660578">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;"> <br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259129" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259130"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660578" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660579">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: 18pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Management contract revenue, which is included in other revenue, is derived from contractual arrangements whereby the Company manages a clinic for third party
          owners. The Company does not have any ownership interest in these clinics. Typically, revenue is determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically
          salaries for the Company&#8217;s employees, are recorded when incurred. </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259130" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259131"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660579" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660580">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259131" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259132"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660580" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660581">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
          </span> </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259132" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259133"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660581" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660582">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> Industrial Injury
          Prevention Services Revenue</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259133" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259134"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660582" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660583">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation></ix:continuation>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; text-indent: 18pt;">
          <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259134" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259135"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660583" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660584">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revenue from the industrial injury prevention services business, which is also included in other revenue in the consolidated
            statements of net income, is derived from onsite services the Company provides to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments<span style="font-family: 'Times New Roman'; font-size: 10pt;">, post-offer
              employment testing</span> and performance optimization. Revenue from the Company&#8217;s industrial injury prevention services business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an
            amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services
            provided in a given period.</div>
</ix:continuation></ix:continuation>
        </div>

      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259135" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259136"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660584" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660585">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; font-style: normal;"> </span><br />
      </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259136" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259137"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660585" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660586">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Other Revenue</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259137" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259138"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660586" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660587">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259138" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259139"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660587" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660588">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259139" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259140"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660588" continuedAt="Text_15c2186df9eb47bea4e1eac430d7660589">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259140" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259141"><ix:continuation id="Text_15c2186df9eb47bea4e1eac430d7660589">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Additionally, other revenue includes services the Company provides on-site at
        locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are
        typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time,
        when the services are performed.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259141" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259142">
<div><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">49</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>


      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259142" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259143"><ix:nonNumeric name="us-gaap:ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" id="Text_2fd8fb3bf1a7468f9e4c7354f30e6bc0" contextRef="c20210101to20211231" escape="true" continuedAt="Text_00cf49e56031499a8abdcf89172edb841">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Contractual Allowances</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259143" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259144"><ix:continuation id="Text_00cf49e56031499a8abdcf89172edb841" continuedAt="Text_00cf49e56031499a8abdcf89172edb842">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259144" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259145"><ix:continuation id="Text_00cf49e56031499a8abdcf89172edb842">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off
        experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare
        regulations and the various third-party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based
        on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the
        clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve
        percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation
        that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact
        change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net
        revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within
        approximately <ix:nonFraction name="usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="Fact_f7157d0deb714320b992d870b7b8fef5" contextRef="c20210101to20211231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% to <ix:nonFraction name="usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="Fact_c9aa7243ac7d404da55cda7f26844077" contextRef="c20210101to20211231_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>%
        of net revenues. Additionally, analysis of subsequent periods&#8217; contractual write-offs on a payor basis reflects a difference within approximately <ix:nonFraction name="usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="Fact_1df87cf7e1454e999ad86b532b650b18" contextRef="c20210101to20211231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%
        to <ix:nonFraction name="usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="Fact_4277182b3b524b539538885d6cfba4b4" contextRef="c20210101to20211231_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve
        percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than <ix:nonFraction name="usph:MaximumContractualAllowanceReserveEstimate" id="Fact_f2811f47235b4e9aa49adc3155886b7c" contextRef="c20210101to20211231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% to <ix:nonFraction name="usph:MaximumContractualAllowanceReserveEstimate" id="Fact_9c822c97684c472c878c6ba1501942ec" contextRef="c20210101to20211231_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>% of gross billings included in accounts receivable at
        December 31, 2021.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259145" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259146">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259146" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259147"><ix:nonNumeric name="us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" id="Text_855ce53bcf2d450bbc43898475aed397" contextRef="c20210101to20211231" escape="true" continuedAt="Text_5d9dc471ba42469fa850c52b5f47d0261">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Allowance for Credit Losses</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259147" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259148"><ix:continuation id="Text_5d9dc471ba42469fa850c52b5f47d0261" continuedAt="Text_5d9dc471ba42469fa850c52b5f47d0262">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259148" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259149"><ix:continuation id="Text_5d9dc471ba42469fa850c52b5f47d0262">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The
        provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses,
        includes only those amounts the Company estimates to be collectible.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259149" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259150">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259150" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259151"><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" id="Text_d6dbeb5136184bc2bb845429a9dace20" contextRef="c20210101to20211231" escape="true" continuedAt="Text_4767b8bae7c84cfc934d3b2a1bb02a9a1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Income Taxes</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259151" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259152"><ix:continuation id="Text_4767b8bae7c84cfc934d3b2a1bb02a9a1" continuedAt="Text_4767b8bae7c84cfc934d3b2a1bb02a9a2">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259152" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259153"><ix:continuation id="Text_4767b8bae7c84cfc934d3b2a1bb02a9a2" continuedAt="Text_4767b8bae7c84cfc934d3b2a1bb02a9a3">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the
        future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and
        liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax
        rates is recognized in income in the period that includes the enactment date.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259153" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259154"><ix:continuation id="Text_4767b8bae7c84cfc934d3b2a1bb02a9a3" continuedAt="Text_4767b8bae7c84cfc934d3b2a1bb02a9a4">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259154" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259155"><ix:continuation id="Text_4767b8bae7c84cfc934d3b2a1bb02a9a4" continuedAt="Text_4767b8bae7c84cfc934d3b2a1bb02a9a5">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority
        would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent
        likelihood of being realized upon ultimate settlement with the relevant tax authority.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259155" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259156"><ix:continuation id="Text_4767b8bae7c84cfc934d3b2a1bb02a9a5" continuedAt="Text_4767b8bae7c84cfc934d3b2a1bb02a9a6">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <div>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259156" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259157"><ix:continuation id="Text_4767b8bae7c84cfc934d3b2a1bb02a9a6" continuedAt="Text_4767b8bae7c84cfc934d3b2a1bb02a9a7">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of interest expense and depreciation. ASC
          740, Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. The legislation had no effect on the Company&#8217;s deferred income taxes and current
          income taxes payable during the year ended December 31, 2021.</div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259157" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259158"><ix:continuation id="Text_4767b8bae7c84cfc934d3b2a1bb02a9a7" continuedAt="Text_4767b8bae7c84cfc934d3b2a1bb02a9a8">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259158" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259159"><ix:continuation id="Text_4767b8bae7c84cfc934d3b2a1bb02a9a8">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company did <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_b7aa493b1e374351a7c2647dd09abff6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_6a439e12d556494793b4ad5359c62eba" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_0279d35b976f4ed29e3d271b32fc0820" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t
        have any accrued interest or penalties associated with any unrecognized tax benefits <ix:nonFraction name="us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" id="Fact_ee40c3e9bff54c14a70fa70014551a6f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" id="Fact_c80c90bc4b4941f7b2f84f5092b4d1ce" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" id="Fact_1675402b2a7e4fc6acfacf53c410265e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>r was any interest expense recognized during
        the twelve months ended December 31, 2021, 2020 and 2019. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259159" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259160">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259160" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259161"><ix:nonNumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Text_d0f8e68bab4d45f4b952ccbafb76ee10" contextRef="c20210101to20211231" escape="true" continuedAt="Text_ac68edabd44447a1a2652523e27319431">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Fair Values of Financial Instruments</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259161" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259162"><ix:continuation id="Text_ac68edabd44447a1a2652523e27319431" continuedAt="Text_ac68edabd44447a1a2652523e27319432">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259162" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259163"><ix:continuation id="Text_ac68edabd44447a1a2652523e27319432" continuedAt="Text_ac68edabd44447a1a2652523e27319433">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out payments, accounts
          receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates the fair value. The interest rate on
          the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#8220;LIBOR&#8221;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
          exist.</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259163" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259164"><ix:continuation id="Text_ac68edabd44447a1a2652523e27319433" continuedAt="Text_ac68edabd44447a1a2652523e27319434">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>
</ix:continuation></ix:continuation>
        <div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259164" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259165"><ix:continuation id="Text_ac68edabd44447a1a2652523e27319434">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Redeemable non-controlling interest included on the consolidated balance sheets and the put right associated with the
            potential future purchase of the separate company in the November 2021 acquisition are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of Redeemable non-controlling interests approximates the fair
            value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable inputs such as asset volatility and discount
            rates. The unobservable inputs in the valuation include asset volatility of <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" id="Fact_61a99f89e6a741ab9bddf40f35f53db7" contextRef="c20211231_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>% and a discount rate of <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" id="Fact_8290387510ae420eac5ceeb9d930d619" contextRef="c20211231_MeasurementInputTypeAxis_MeasurementInputDiscountRateMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">8.96</ix:nonFraction>%.&#160;See Note 5 for the changes in the fair value of Redeemable non-controlling interest.&#160; There were no changes in the fair value of put right
            associated with the potential future purchase of the separate company in the November 2021 acquisition for the year ended December 31, 2021.</div>
</ix:continuation></ix:continuation>
        </div>

      </div>


      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259165" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259166">
<div><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">50</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>


      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259166" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259167"><ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="Text_b745fc0c78914a5f834207a4392ccbde" contextRef="c20210101to20211231" escape="true" continuedAt="Text_436640ab29b345a38fd28d6b43e4c0eb1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Segment Reporting</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259167" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259168"><ix:continuation id="Text_436640ab29b345a38fd28d6b43e4c0eb1" continuedAt="Text_436640ab29b345a38fd28d6b43e4c0eb2">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259168" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259169"><ix:continuation id="Text_436640ab29b345a38fd28d6b43e4c0eb2">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Operating segments are components of an enterprise for which
          separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. </span>The Company currently operates through <ix:nonFraction name="us-gaap:NumberOfOperatingSegments" id="Fact_da9f79b50cd34131aba08e77ff538154" contextRef="c20210101to20211231" unitRef="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> segments: physical therapy operations and industrial injury prevention services.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259169" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259170">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259170" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259171"><ix:nonNumeric name="us-gaap:UseOfEstimates" id="Text_d30eea001f1c4f78b24f9149df7972b6" contextRef="c20210101to20211231" escape="true" continuedAt="Text_26bb9562e0e14368ae62c2e9be2ce3141">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259171" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259172"><ix:continuation id="Text_26bb9562e0e14368ae62c2e9be2ce3141" continuedAt="Text_26bb9562e0e14368ae62c2e9be2ce3142">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259172" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259173"><ix:continuation id="Text_26bb9562e0e14368ae62c2e9be2ce3142">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in
        relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and
        related disclosures. Actual results may differ from these estimates.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259173" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259174">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259174" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259175"><ix:nonNumeric name="usph:SelfInsuranceProgramPolicyPolicyTextBlock" id="Text_288fb46274b34b4d90c558a14917e75e" contextRef="c20210101to20211231" escape="true" continuedAt="Text_d5d5f98a8d7249618437915124e16d531">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Self-Insurance Program</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259175" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259176"><ix:continuation id="Text_d5d5f98a8d7249618437915124e16d531" continuedAt="Text_d5d5f98a8d7249618437915124e16d532">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259176" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259177"><ix:continuation id="Text_d5d5f98a8d7249618437915124e16d532">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third
        party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated
        future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2021.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259177" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259178">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259178" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259179"><ix:nonNumeric name="usph:RestrictedStockPolicyPolicyTextBlock" id="Text_df94358a3a5545228c0f8e9edb6b69d7" contextRef="c20210101to20211231" escape="true" continuedAt="Text_3f32c4965db04130abf0fd5b1863462c1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Restricted Stock</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259179" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259180"><ix:continuation id="Text_3f32c4965db04130abf0fd5b1863462c1" continuedAt="Text_3f32c4965db04130abf0fd5b1863462c2">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259180" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259181"><ix:continuation id="Text_3f32c4965db04130abf0fd5b1863462c2">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board,
        respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_61e076fe690248718f13697be1324500">four</span>
        anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_139391eb54254fc583112777fb6d273d">first</span>
        year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the <ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_c2f44ce44b9c416fa4faf70f291f23d9" contextRef="c20210101to20211231_TitleOfIndividualAxis_OfficerMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric>
        following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The
        restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259181" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259182">
<div><br />
      </div>
</ix:continuation>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259182" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259183"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Text_35df2706f95e4339a7c18e17deb81574" contextRef="c20210101to20211231" escape="true" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5971">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Adopted Accounting Pronouncements</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259183" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259184"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5971" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5972">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259184" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259185"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5972" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5973">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In June 2016, the FASB issued ASU 2016-13, <span style="font-style: italic;">Financial Instruments &#8211; Credit Losses</span>, which
        added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses.
        The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low
        risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259185" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259186"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5973" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5974">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259186" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259187"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5974" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5975">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company completed the adoption of the standard on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#8217;s accounts
        receivable derived from contracts with customers. A significant portion of the Company&#8217;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial
        insurers. The Company&#8217;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained
        earnings on the adoption date of the standard.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259187" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259188"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5975" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5976">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259188" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259189"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5976" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5977">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In January 2017, the FASB issued ASU 2017-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Simplifying the Test
          for Goodwill Impairment (Topic 350),</span> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods
        within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#8217;s adoption of this change.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259189" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259190"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5977" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5978">
<div><br /></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259190" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259191"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5978" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa5979">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">In December 2019, the FASB issued ASU 2019-12, </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Income Taxes (Topic 740)&#8211;Simplifying the Accounting for Income Taxes </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">(&#8220;ASU 2019-12&#8221;). The
          objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The
          amendments in this ASU are effective for fiscal years beginning after December&#160;15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259191" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259192"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa5979" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa59710">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259192" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259193"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa59710" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa59711">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In August 2020, the FASB issued ASU 2020-06&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Debt&#8212;Debt














          with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, </span>which simplifies the
        accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted
        earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings
        per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a
        stated policy.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259193" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259194"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa59711" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa59712">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">51</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>

      <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259194" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259195"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa59712" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa59713">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">This pronouncement was effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021.The Board
          specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition
          is permitted. The Company has determined that the adoption of ASU 2020-06 will not have a material impact on the Company&#8217;s financial statements.</div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259195" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259196"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa59713" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa59714">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259196" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259197"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa59714" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa59715">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-style: italic; font-weight: bold;">Recently Issued Accounting Guidance</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259197" continuedAt="Text_97ba1b944e93486e9e5c525bf9b75259198"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa59715" continuedAt="Text_f15a8f4b14324d76994d5f380bdfa59716">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_97ba1b944e93486e9e5c525bf9b75259198"><ix:continuation id="Text_f15a8f4b14324d76994d5f380bdfa59716">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In March 2020, the FASB issued ASU 2020-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Reference Rate Reform
          (Topic 848): Facilitation of the Effects of Reference</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Rate Reform on Financial Reporting</span>. This ASU provides temporary optional expedients and
        exceptions to the guidance on contract<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR
        and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit
        Agreement (as defined in Note 9) bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
        exist.</div>
</ix:continuation></ix:continuation>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">52</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:BusinessCombinationDisclosureTextBlock" id="Text_ab4577941af4444b8ff1efb979f8074b" contextRef="c20210101to20211231" escape="true" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3. Acquisitions of Businesses</div>
</ix:nonNumeric>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d1" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d2">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d2" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d3"><ix:nonNumeric name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="Text_223af21ec41f4fddae783f9ea292a114" contextRef="c20210101to20211231" escape="true" continuedAt="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a1">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the Company acquired a majority interest in the following businesses:</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d3" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d4"><ix:continuation id="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a1" continuedAt="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d4" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d5"><ix:continuation id="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a2" continuedAt="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a3">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>Acquired</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>Clinics</div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 2021 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_51909ede401341ca8aab09a0cc7d596b" contextRef="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember" format="ixt:datemonthdayyearen">December 31, 2021</ix:nonNumeric></div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_691c87e44bfb4aedad3d69ea7e814152" contextRef="c20211231_BusinessAcquisitionAxis_December2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_0b2a1be8955c4d23823a7373ef8d260b" contextRef="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">3</ix:nonFraction></div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom;" rowspan="1">November 2021 Acquisition<br />
          </td>

    <td style="width: 3.06%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 22.92%; vertical-align: top; text-align: center;" rowspan="1"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_16f35fa8dc06485d848a65a032dc46aa" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember" format="ixt:datemonthdayyearen">November 30, 2021</ix:nonNumeric></td>

    <td style="width: 2.78%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 14.72%; vertical-align: top; text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_fd6699083b5c4208a72273a1a8833a9f" contextRef="c20211231_BusinessAcquisitionAxis_November2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</td>

    <td style="width: 2.92%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 14.58%; vertical-align: top; text-align: right;" rowspan="1"><span style="-sec-ix-hidden:Fact_f2ab670c292849e0a6da2f6f425f8ab8">IIPS*</span></td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;" rowspan="1">September 2021 Acquisition<br />
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;" rowspan="1"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_94f520edfbcf4413a9974f22968e1163" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2021AcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2021</ix:nonNumeric></td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_f60c5ffa5760444b96acb7dd05ac8927" contextRef="c20211231_BusinessAcquisitionAxis_September2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" rowspan="1"><span style="-sec-ix-hidden:Fact_8fc8c722672b4497be0c04af98353c23">IIPS*</span></td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom;" rowspan="1">June 2021 Acquisition<br />
          </td>

    <td style="width: 3.06%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 22.92%; vertical-align: top; text-align: center;" rowspan="1"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_25edb2bd8b2d4fb995948b0d3daecdb7" contextRef="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember" format="ixt:datemonthdayyearen">June 30, 2021</ix:nonNumeric></td>

    <td style="width: 2.78%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 14.72%; vertical-align: top; text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_910a905d94df4fa3acafe4621dbf7ca1" contextRef="c20211231_BusinessAcquisitionAxis_June2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>%</td>

    <td style="width: 2.92%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 14.58%; vertical-align: top; text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_2daf28ef48444d92817a3ac5c4e3255b" contextRef="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">8</ix:nonFraction></td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;" rowspan="1">March 2021 Acquisition<br />
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;" rowspan="1"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_7cc5e9e048c249ea92af1bec5449c2fc" contextRef="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember" format="ixt:datemonthdayyearen">March 31, 2021</ix:nonNumeric></td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_19a760f54e4f4283b8c51ba8b0ea146e" contextRef="c20211231_BusinessAcquisitionAxis_March2021AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_822a78aa9cc7436c8f98a5334dc6b79f" contextRef="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">6</ix:nonFraction></td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom;" rowspan="1">November 2020 Acquisition</td>

    <td style="width: 3.06%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 22.92%; vertical-align: top; text-align: center;" rowspan="1"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_a62642426b404beda2dde6c3ff196c4a" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember" format="ixt:datemonthdayyearen">November 30, 2020</ix:nonNumeric></td>

    <td style="width: 2.78%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 14.72%; vertical-align: top; text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_424cb3bc67404ccebec35cce34e8eb50" contextRef="c20211231_BusinessAcquisitionAxis_November2020AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</td>

    <td style="width: 2.92%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 14.58%; vertical-align: top; text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_030e4c8bb3bb4a54af6f76045f75d225" contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">3</ix:nonFraction></td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_f5387b4a0bee4d53bc61e7ac94afb6d6" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2020</ix:nonNumeric></div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_acfb0a2ae1a44067b7296b1efb54cfa6" contextRef="c20211231_BusinessAcquisitionAxis_September2020AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_d7b298373dc646968960932c7a99c477">**</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_fd681e8d37954cf7978cda4333af4efc" contextRef="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember" format="ixt:datemonthdayyearen">February 27, 2020</ix:nonNumeric></div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_8ebe68ea117342b08f53feddf56f59df" contextRef="c20211231_BusinessAcquisitionAxis_February2020AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</div>
          </td>

    <td style="width: 14.58%; vertical-align: bottom;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_ac3a41188b4a493f902867ddf0c8eff9" contextRef="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">4</ix:nonFraction></div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_3b33a84861d54d04abd28de3c2c1ae64" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2019</ix:nonNumeric></div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_c4dd660a96654e5395c1c485be383e3f" contextRef="c20211231_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_bd06c8922b254344ba669beeaa1edf4e" contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom;" rowspan="1">April 2019 Acquisition <br />
          </td>

    <td style="width: 3.06%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; text-align: center;" rowspan="1"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_b5ee5dd710c74858909477d74dccaa60" contextRef="c20210101to20211231_BusinessAcquisitionAxis_April2019AcquisitionMember" format="ixt:datemonthdayyearen">April 11, 2019</ix:nonNumeric> <br />
          </td>

    <td style="width: 2.78%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; text-align: right;" rowspan="1"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_2c93b02e25af4f3884fb0f7d33ea050e" contextRef="c20211231_BusinessAcquisitionAxis_April2019AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% <br />
          </td>

    <td style="width: 2.92%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; text-align: right;" rowspan="1"><span style="-sec-ix-hidden:Fact_9ccb1564cfba40339b352148e6a9107a">*</span><br />
          </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d5" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d6"><ix:continuation id="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a3" continuedAt="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a4">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d6" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d7"><ix:continuation id="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a4" continuedAt="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a5">
<div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:footnote id="Foot_1489efe16e1f4150a98808b1fa3d39cc" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Industrial injury prevention business</ix:footnote><br />
              </span></td>

  </tr>


</table>
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d7" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d8"><ix:continuation id="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a5" continuedAt="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a6">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="c25a46c3472f4e9d89f721c383608370" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:footnote id="Foot_daa3f0e35dde4f99997e6a382a591d10" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="Foot_25ec908db3f34196baebd865f5787bc31">The business includes <ix:nonFraction name="usph:NumberOfManagementContracts" id="Fact_fafc19011a2f4879b6e6b3c72b82abb0" contextRef="c20210101to20211231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></ix:footnote><ix:continuation id="Foot_25ec908db3f34196baebd865f5787bc31" continuedAt="Foot_25ec908db3f34196baebd865f5787bc32"> management
              and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of <ix:nonNumeric name="usph:RemainingContractTerm" id="Fact_f69eb4a2c6eb4c1582c995cdf1902af6" contextRef="c20210101to20211231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric></ix:continuation></span><ix:continuation id="Foot_25ec908db3f34196baebd865f5787bc32">.</ix:continuation></td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d8" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d9"><ix:continuation id="Text_ae3ef7a75d0746dcb6795efbdbbb2c9a6">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z9554ae614f714132a1278bbaa794d16d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:footnote id="Foot_c17d1a5ce0344dbb9898dd830df565d6" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">The <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_4ef40850141c4b55826bbf823bd711fe" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> clinics are in <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_b91b1d5f6aa144a389414372099ff55a" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> separate partnerships. The Company's interest in the <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_a4ded9463916428d8bdc0cf7a4373ca3" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction>
                partnerships range from <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_32583d5f2c8045069fcf4b423b1ea908" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">10.0</ix:nonFraction>% to <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_44240ed4a91944909060a4d2a853b016" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">83.8</ix:nonFraction>%,
                with an overall <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_a63e4972b87e453f8be3cb9888772e54" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">65.0</ix:nonFraction>% based on the initial purchase transaction.</ix:footnote></span></div>
          </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d9" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d10">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d10" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d11">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On December 31, 2021, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_e003590e5f8840919eead4dff7fc8aaa" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>% in <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_847fdc8f431c40d9ba56d7a8606540f7" contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction>-clinic physical therapy practice with the practice founder retaining <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" id="Fact_a260b0ba83914d21b92f3cd00980418d" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>%. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_fe70cce6eca44fe293eaec88601ed661" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%
      interest was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_53367bfdf19241909e8fb118251f1c2b" contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_1b4431721bbf4a389dd3ac362890cb0e" contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_2aea88e409624722be50ad75357cc082" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million in the form of a note payable. The note accrues interest at
      <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_367fcf17fb924e3ba22a7ab8dad2711b" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the principal and interest is payable on December 31, 2023.</div>
</ix:continuation>
    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
      <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d11" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d12">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d12" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d13">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">On November 30, 2021, the Company acquired an approximate <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_fb00faf0c3fe47879651cd671f5e26b3" contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest in a leading provider of industrial injury prevention services. In each case, the previous owners retained the remaining interest. The
          purchase price for the approximate <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_0dfc7c1b36c443a385e0887f18d4e0a3" contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% equity interest, not inclusive of a $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_55d37c69b0d64977b1b84f3ae6c7192c" contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction> million contingent payment, was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_d1763181524d4f8199d0929836988bc2" contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">63.2</ix:nonFraction> million
          of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_8e4f879240754ee584395bb139ca4b72" contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">60.7</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_c417575de67c4c2bbbbf7624a738d3cd" contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million in the form of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_6edfd779015544e4a1a098f0c2970ea0" contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the
          principal and interest is payable on November 30, 2023. </span>As part of the transaction, the Company also agreed to the potential future purchase of a separate company under the same ownership that provides physical therapy and rehabilitation
        services to hospitals and other ancillary providers in a distinct market area. The current owners have the right to put this transaction to the Company in approximately <ix:nonNumeric name="usph:RemainingContractTerm" id="Fact_6ae61204009b4d0faa212cdea9c86e7a" contextRef="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>, with such right having a $<ix:nonFraction name="us-gaap:ContractWithCustomerAssetPurchase" id="Fact_7d3ff51e5dd248dd8083f8b1c8ad48de" contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction> million value at December 31, 2021, as reflected on the
        Company&#8217;s consolidated balance sheet in Other long-term liabilities. The value of this right will be adjusted in future periods, as appropriate, with any change in value reflected in the Company&#8217;s consolidated statement of income. The Company does
        not currently possess more than 50% of the controlling interests in this separate company, does not control this company through contract or governance rights and currently does not exercise significant influence over this separate company. Due to
        the aforementioned reasons, and based on current accounting guidance, the Company did not consolidate the separate company through the variable interest or voting interest model.</div>
</ix:continuation>
      <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d13" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d14">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br />
      </div>
</ix:continuation>
      <div style="margin: 0px 0px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <div>
          <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d14" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d15">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On September 30, 2021, the Company acquired a company that specializes in return-to-work and ergonomic services, among other
            offerings. The Company acquired the company&#8217;s assets at a purchase price of approximately $<ix:nonFraction name="usph:BusinessCombinationConsiderationTransferredIncludesContingentConsideration" id="Fact_4a668e47d40d45a0b8654f9e657784c3" contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction> million (which includes the obligation
            to pay an amount up to $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_67061870b3a74a439ff11fd1dbab96f8" contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million in contingent payment consideration in conjunction with the acquisition if specified future
            operational objectives are met), and contributed those assets to Briotix Health. The initial purchase price, not inclusive of the $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_67f741ee9de84cfcbe1a64162df07a0c" contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction>
            million contingent payment, was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_f5b5cbedac1044d4a6b62cc87bfd429c" contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_7fabaef8355948d08fc7f3f93c7e2632" contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction> million was paid in cash, and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_e8c859b8fd3248cfb2d95aa682f1b4dc" contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million is in the form
            of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_715a4af7886742ddae839207079b46d9" contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the principal and interest is payable on September 30, 2023.</div>
</ix:continuation>
          <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d15" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d16">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 13.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d16" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d17">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On June 30, 2021, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_bd741ed9668544e5abf223d3172356a7" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>% interest in an <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_0c24befd5d764fceb7f855ac306e64b6" contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">eight</ix:nonFraction>-clinic physical therapy with the previous owners retaining <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" id="Fact_79aaf342ccc045b3abb6aabe00e4a062" contextRef="c20210630_OwnershipAxis_PreviousOwnersMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>%. The purchase price was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_0d3ec5a582724f45a726f7a30ff4c442" contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">10.3</ix:nonFraction>
            million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_5d33a58dc780425db3556970c15dfcf7" contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction> million was paid in cash, $<ix:nonFraction name="usph:BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" id="Fact_ab8ecfaa9ec44b13a308bc2395e0b5d1" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million is payable based on the achievement of certain business criteria and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_f32a4ad530534e7197d3247145137e26" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million is in
            the form of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_7cc695c32e4f4dfab1894815a1b8aeca" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum and the principal and interest is payable on June 30, 2023.
            Additionally, the Company has an obligation to pay an additional amount up to $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_ac2e9db4c6714148b52b9b3b961a28b8" contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million in contingent payment consideration in
            conjunction with the acquisition if specified future operational objectives are met. The Company recorded acquisition-date fair value of this contingent liability based on the likelihood of the contingent earn-out payment. The earn-out payment
            will subsequently be remeasured to fair value each reporting date.</div>
</ix:continuation>
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d17" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d18">
<div><br /></div>
</ix:continuation>
            <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d18" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d19">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On March 31, 2021, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_9bccc79dfd0a44a1b3554472884dc2a9" contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest in a <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_15c3ec6cce7947e4828132e51a3ce4a0" contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction>-clinic physical therapy practice with the previous owners retaining <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" id="Fact_0bdbf1b49b8b4a239a3a1ba0d1603e67" contextRef="c20210331_OwnershipAxis_PreviousOwnersMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>%. When acquired, the practice was developing a sixth clinic which has been completed. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_45e88c305151481bb39cb373f1c7d48b" contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_7997ab5a9f6844cb89004565d9604cab" contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction>
              million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_1a3f7652a1544564af35f52903b5a057" contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">11.7</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_e3cf2f9fb6834cf387e402c3adaeafa5" contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in the form of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_f58a4e1484f14fbf8014c4fbde98d146" contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>%
              per annum and the principal and interest is payable on March 31, 2023.</div>
</ix:continuation>
            <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d19" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d20">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 13.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
</ix:continuation>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">53</span></div>

              <div style="page-break-after: always;" class="DSPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div style="width: 100%;" class="DSPFPageHeader">
                <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
                </div>

              </div>

            </div>

            <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
              <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d20" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d21"><ix:nonNumeric name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="Text_72c2c9d174bd47119b4b1f595426f5b4" contextRef="c20210101to20211231" escape="true" continuedAt="Text_b306249067884711afc9a6755db37f691">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2021 acquisitions has been preliminarily allocated as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
            </div>

            <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d21" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d22"><ix:continuation id="Text_b306249067884711afc9a6755db37f691" continuedAt="Text_b306249067884711afc9a6755db37f692">
<div><br /></div>
</ix:continuation></ix:continuation>
            <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d22" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d23"><ix:continuation id="Text_b306249067884711afc9a6755db37f692" continuedAt="Text_b306249067884711afc9a6755db37f693">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> IIPS*</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);">
                    <div style="margin-top: 0px; margin-bottom: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">Cash paid, net of cash acquired<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_63bd36af48894270815cc46c963ba2db" contextRef="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">63,193</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_c0e689ac1b0648fe8f7f376d9d17e13a" contextRef="c20210101to20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,630</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_ad579798c9f945b8a93beddfddd7dcec" contextRef="c20210101to20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,823</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller notes<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_aaf9411d8f9e4e009c9335f0ff382bdf" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,250</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_28cc4f3346484ec28711d37f2baf87d6" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">800</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_f0fd9390987747079bf0323b04920f0c" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,050</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" rowspan="1">Contingent payments</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_76c42aa88a124b4db6f0502587ec6f42" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,520</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_5d51ac831b2e44f59e989c9e45bddab2" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">837</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_28d337ba857044b5a33e2cffca374d57" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,357</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;" rowspan="1">Other payable<br />
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_27a094a9eace4a64be08154bf989f82e" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_6205fa6b4a6e4d379e90d1ad07fc6de8" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_7e05756573114a3fbc5386da591648bf" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller put right<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetPurchase" id="Fact_11d862d2defd4dca8c3f3c891cae62ca" contextRef="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,522</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"><br />
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1"> <br />
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetPurchase" id="Fact_1a7de6bad54641f7af5427b5065596f5" contextRef="c20210101to20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,522</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_01ef1578c3654cdb9d9b1052ecedc226" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,485</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_9e9d2c0466cb4bb88683d23202f6a380" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26,267</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_23d75c3658db427c81f734b6655588f3" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96,752</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_f75bbdaed45746e78fee56e41cedb979" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,589</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_6943e486c96e4874bc9505a208e66ff4" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,046</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_ad35b5cc0c634c2e91708f8366fcc49c" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,635</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_f80eff9fe13e4df08a15f7acb274fc5e" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,620</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_ee1b10ecf07b49bf8d2391c6ec76b4a2" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,462</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_de064a8a748a4105a4f77f07832675d5" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19,082</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_2c2db17745e24c4eb66135c92aad7b8a" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,842</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_dc4cb0d4efda4280bf2e5c4b2d81cbdd" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6,832</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_74a9191c50e1410d859aa8424d872773" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">11,674</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
                    <div style="text-align: left; text-indent: -15.85pt; margin-left: 60.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_1cdd8b720f4a44a082c6939bf4b22496" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,367</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_b06467cb6bd04db2ac41d1def8954a7a" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">676</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_43ebdb84850049b581945b1781448233" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,043</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_494bf47a05ff4579a733449bea643c70" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,126</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_2ee8cf3e0b6f481abec87a833f448835" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,729</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_4d49b65f36a543e2984cc8454568e4f3" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,855</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_46c4521940754dddb49b9e190cced525" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">500</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_213c3f5e07bd46218e80ecea04a812f0" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">574</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_19303b99b4b246e5963bd832cdfe681e" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,074</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_c24ffdcebb2d493696e3a422d9966828" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,141</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_92afb88ef1c241289b8bd9c80cd4348b" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,755</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_2f314db3fbb544ad8b71fe06c4cba0cb" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,896</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_9d4aac14de6549938264f58e705c3aa7" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">58,257</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_063ae95c5d0347d08e385bd9c5e13895" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,489</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_311fcc26364949fba739a931101b225f" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">89,746</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_9d349ef66f714b458c14a80861d985df" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">27,906</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_4425ed8180dd4538ba8b82beb85e71f1" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,956</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_59d97b0c34e74ae49827e8c469c13d86" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">39,862</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_71308383dd34492c907897ee2a3d7c84" contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,485</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_b6ea00c6db6d4e159171f27ca763fa08" contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26,267</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_3af0a2c38e024e0dbcd737bf0c8d2978" contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96,752</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
            <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d23" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d24"><ix:continuation id="Text_b306249067884711afc9a6755db37f693" continuedAt="Text_b306249067884711afc9a6755db37f694">
<div><br />
            </div>
</ix:continuation></ix:continuation>
            <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d24" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d25"><ix:continuation id="Text_b306249067884711afc9a6755db37f694" continuedAt="Text_b306249067884711afc9a6755db37f695">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 13.5pt; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">*<ix:footnote id="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="Foot_a1a5ec962e3648f5877c2724512de0f71">Industrial




























              injury prevention services </ix:footnote></div>
</ix:continuation></ix:continuation>
          </div>

        </div>

      </div>

    </div>

    <ix:continuation id="Text_b306249067884711afc9a6755db37f695" continuedAt="Text_b306249067884711afc9a6755db37f696"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d25" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d26">
<div><span style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab"><ix:continuation id="Foot_a1a5ec962e3648f5877c2724512de0f71">&#160;&#160;&#160;</ix:continuation></span> </div>
</ix:continuation></ix:continuation>
    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
      <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d26" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d27">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d27" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d28">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">On November 30, 2020, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_fb31bbf463bb47289730d583ccf6b4cd" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>% interest in a <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_5cb71b04d18947c78b9e1f232902406a" contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction>-clinic physical therapy practice with the previous owners retaining <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" id="Fact_a5ced06c3bf745a39898bcf186873ff8" contextRef="c20201130_OwnershipAxis_PreviousOwnersMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>%. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_5a2b05ef00924aba8085e80fb6947bfd" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%
        interest was $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_1185c4c2387f4afbb2c377389a74c433" contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.9</ix:nonFraction> million (net of cash acquired), of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_2c9fd829664d4dda8974841bfb3a38b2" contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_2a83c9539db34a44b199323fd3458a47" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in the form of a
        note payable that is payable in <ix:nonFraction name="usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" id="Fact_ebe135ea34b94bc59a47ef42aacc1f9a" contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> principal installments totaling $<ix:nonFraction name="us-gaap:DebtInstrumentAnnualPrincipalPayment" id="Fact_4d89927a1b3e4fd28fbce8906d7ee306" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">162,500</ix:nonFraction> each. The first principal payment plus accrued interest was paid in November 2021 with the second installment to be paid in November 2022 totaling $<ix:nonFraction name="us-gaap:DebtInstrumentAnnualPrincipalPayment" id="Fact_cc37ec5ff9d34e8982b0eb68f162cffc" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">162,500</ix:nonFraction>. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_949d01c325b242ff91419a5e4453e865" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>%
        per annum.</div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d28" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d29">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d29" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d30">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On September 30, 2020, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_5968a848b9594413ad4c3707c7f809d5" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest in an entity which holds <ix:nonFraction name="usph:NumberOfManagementContracts" id="Fact_5bf9ad61ce094386b45b774468a403a8" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction>-management contracts that have been in place for a number of
      years. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_7562c10c2b6b4bf58c299d30b2a3683c" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_7fe32f3008e3499f9a6ce98408312de0" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_bd5fefa6732b4d29b7d48c96b3299964" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_4e310f11b5774b62a4ce1354774531bb" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million in the form of two notes payable. One of the notes payable of $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_f57acd780b844dba8ff1b4cc2f55d7fc" contextRef="c20201130_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million was paid in November 2020. The remaining note payable of $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_1ebc11a42d424700882f5c399a56d166" contextRef="c20210930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableTwoMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million was paid on September
      30, 2021.</div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d30" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d31">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d31" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d32">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On February 27, 2020, the Company acquired interests in a <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_c46f303442954e1fa9c00df7603f9893" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction>-clinic physical therapy practice. The <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_8497635bd48a405ba840f67de7b81db1" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> clinics are in <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_ec41bd1e228b46a09b6430a89cf3895f" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> separate partnerships. The Company&#8217;s interests in the <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_e11e6e014d914714b5997a61cd94c2dc" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction>
      partnerships range from <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_7c444a08a02746a89979100445901ee1" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">10.0</ix:nonFraction>% to <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_f69de05990d8447ab118361b3fe91d35" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">83.8</ix:nonFraction>%,
      with an overall <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_37a150988cdd4586b9e8d7f8ae28db4e" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">65.0</ix:nonFraction>% based on the initial purchase transaction. The aggregate purchase price was $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_e79fb6d777b5404ebf032554275c06c5" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_7673530f60d147619d2f0bc0dc7bd650" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">11.6</ix:nonFraction> million was
      paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_59a3d71ea5334f56885360c3f35916e3" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in the form of a note payable. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_0c3bf3e3872941f49ab87c6676a38744" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">4.75</ix:nonFraction>% per annum and the principal and interest was paid on February 2022.</div>
</ix:continuation>

    <ix:continuation id="Text_b306249067884711afc9a6755db37f696" continuedAt="Text_b306249067884711afc9a6755db37f697"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d32" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d33">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f697" continuedAt="Text_b306249067884711afc9a6755db37f698"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d33" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d34">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2020 physical therapy operations acquisitions has been allocated as follows (in thousands):</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f698" continuedAt="Text_b306249067884711afc9a6755db37f699"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d34" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d35">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f699" continuedAt="Text_b306249067884711afc9a6755db37f6910"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d35" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d36">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired<br />
            </div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_65ea10e9ff21488daed0c8e1b250d88e" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,912</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_22055d23595d4a719dfafb660f8991ca" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,121</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_35acfeb8bda24d4c8ca2dbb75374b797" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25,033</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_1af412c31b3c43138849c4ec3b0140ca" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,049</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_f12ca0d540e14146bf216360cb674324" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">196</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_2964447e878946cb84412627e62e5323" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">562</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_abb92068cc184506ab4478a53b78af85" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">683</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_ce5fe8ca801c4d4d873ce65a8e646a86" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,520</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_9a772c5b865b405683726ef0b659f96c" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">500</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_7039d868aebf42e48c2ebd44f0892ebe" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,890</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_0ce74c29f8e04f58b43d1f75860b4de3" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">27,738</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_28dbe5bcfc1548f9a0112df85244754b" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,298</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_3456529d650e4626bc92ab4f726983b8" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25,033</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d36" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d37">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">54</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d37" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d38">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On September 30, 2019, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_0809f78b46094055b3e1b873f47f1fa5" contextRef="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>% interest in an <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_4f04251926c44e3bb754df356727fb42" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">eleven</ix:nonFraction>-clinic physical therapy practice. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_fc15e10d9f954952adbc4bbf8ba49415" contextRef="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>% interest was $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_27ff3a8732164b2ba0c1595d4bc10559" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction> million ($<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_686ae0b890a44e48babe15f81444788d" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.6</ix:nonFraction> million less cash acquired of $<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_0ffa2c91aea248ab970d584e84796e86" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction>
      million), of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_21f4975ed0e6454384404b57a88884db" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.3</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_418617e53e8f45c7b930242b984529a8" contextRef="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in a seller note payable in <ix:nonFraction name="usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" id="Fact_e64f4a38174a46e68485528eaf2eb2e4" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> principal installments totaling $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_ad91b351b8894e088f07d01862ec33c1" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">150</ix:nonFraction>,000 each, plus accrued interest. A payment of $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_c02b9991cffc4bd2a8e1b3f07d4d43f1" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">150</ix:nonFraction>,000



























      plus accrued interest was paid in September 2020 and a second payment of $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_6deb32a8af9646e18b2008d05b52d98f" contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyOneMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">150</ix:nonFraction>,000 was paid in September 2021. The note accrues interest at
      <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_06d6fb2bb06f4f6e9738270fe49683b8" contextRef="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">5.0</ix:nonFraction>% per annum.</div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d38" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d39">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d39" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d40">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On April 11, 2019, the Company acquired a company that is a provider of industrial injury prevention services. The acquired company
      specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network of <ix:nonFraction name="usph:NumberOfStatesOfNetworkServices" id="Fact_7055f832176345eeb7f381f37145f0f5" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U012" decimals="0" scale="0" format="ixt:numdotdecimal">45</ix:nonFraction> states including onsite at <ix:nonFraction name="usph:NumberOfOnsiteClientLocations" id="Fact_06e9fdc8768f4e58ac5656fd2ecc2827" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U009" decimals="INF" scale="0" format="ixt-sec:numwordsen">eleven</ix:nonFraction> client locations. The
      acquired business was then combined with Briotix Health, the Company&#8217;s industrial injury prevention services operation, increasing the Company&#8217;s ownership position in the Briotix Health partnership to approximately <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_e4fd5ef250f24c829f801bc200ef976f" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">76.0</ix:nonFraction>%. The purchase price for the acquired company was $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_0a3aa99ee4c9406ca3527a0990fa3046" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction>
      million ($<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_1bb89b2e94e94cf29b44368887e4bb68" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">23.6</ix:nonFraction> million less cash acquired of $<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_bd9522d1c8df49488a37f897a883b782" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction>
      million), which consisted of $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_08bd8aa6af6a4b62956204f2f2ed1ebb" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">18.9</ix:nonFraction> million in cash, (of which $<ix:nonFraction name="usph:BusinessAcquisitionPayableToShareholdersOfSeller" id="Fact_1b26b19cc3cd4cd8a77e08b359aece38" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million will be paid to certain shareholders), and a $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_3659249cd7674d909ffba26927075152" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction>
      million seller note. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_e4dbf83a147442a98fa288ca5f44df89" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">5.5</ix:nonFraction>% and the principal and accrued interest was paid on April 9, 2021.</div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d40" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d41">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d41" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d42">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the
      date of their respective acquisition. The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>
</ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f6910" continuedAt="Text_b306249067884711afc9a6755db37f6911"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d42" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d43">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f6911" continuedAt="Text_b306249067884711afc9a6755db37f6912"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d43" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d44">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2019 acquisitions was allocated as follows (in thousands):</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f6912" continuedAt="Text_b306249067884711afc9a6755db37f6913"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d44" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d45">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f6913" continuedAt="Text_b306249067884711afc9a6755db37f6914"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d45" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d46">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">IIPS*</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_0539e081efe84384b08a1850430433bf" contextRef="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">890</ix:nonFraction></span>)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_09256687656b4cb0829a3bba208bbd0b" contextRef="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,428</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_6ff2584eee614ff4b3d2643ff36542df" contextRef="c20190930to20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,170</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_775cb570a7c64ac99a7304b5be69fcc1" contextRef="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,598</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Payable to shareholders of seller</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPayableToShareholdersOfSeller" id="Fact_6ccec2bf85c84363a31b411049754947" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">485</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPayableToShareholdersOfSeller" id="Fact_f3624d1d7eb648589d35c8fd72de4004" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPayableToShareholdersOfSeller" id="Fact_55512b3d8f894ed988016170d58cd142" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">485</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_d5231447dfa54dcf8bc822f06da3d57d" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_5cd42f8e9b2a4b5bb7369d3a1b3fa7b1" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">300</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_274149558baf413893e4eefcfe4f12b0" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,300</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_2e55eaf9bd1a44fba6fdc7aa37f488f4" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">22,913</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_73608f8804ed4a269d268d53738cf5df" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,470</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_de19e0979d4a428698aaeab124f70381" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,383</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_f1dfaea40e90417ab9618457098915f7" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,641</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_915f365a88224a39a7a1c5f4abfd835b" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">650</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_5a19db7cdb274b94b558423d07af8e5e" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,291</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_bfb19040c12b4373b120a149674ff028" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">848</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_8dfa0a1cca5b4cbb87bdde8da117b7fc" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">394</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_6fe21dd8e03e4885ab5701f7f15788de" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,242</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_24336172ac1f4c7b87d22bacbbbd45fc" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,978</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_80e83efe85994d188f09da7da0c1619a" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">191</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_a789fcbb560142e7aa9b4633b158f0e8" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,169</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_e49d6261833247f2947adece9f7d5a9f" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">489</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_8128ae7fbef245f1add5497d788928cb" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">853</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_05c86f4c390f4c498e6d7616b6806fde" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">364</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_bd807fe1634b42079b82b93a313c6f0c" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,400</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_5dd40f1e219b46098514ee40fc7de3ab" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,600</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_b2bc6fa524214a109a0ce2f7352601cb" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_5537f26b563e45e3ba14cc86cb093d9e" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">250</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_4c37e528f4f54dff970f48ac121ba242" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">270</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_cb70a78d54c94dbc8d01adf4b2b11d56" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">520</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_55629db4c4fb4f3d94188cadc2e92208" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,300</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_43b13b34d81f4352888b7725458e3c98" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">740</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_cc4359b2e26240928f3ac4152d310b80" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,040</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_d9d8787977f14988ac98b2fccb95a943" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,452</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_697b476204a142f7aceb2df1a843b314" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,237</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_6b5e0518893e43a799774212c26674e1" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,689</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_e730f71471494b67be39a111ddb754e1" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_1b9ce831bebf41e182c0c311de2ee90a" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,230</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_938d5513a5c6491297274256b9dcf0b4" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,230</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_1dfbb6b5fc4b48afade4b5fb290ba8f7" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">22,913</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_0924885764744129957a199800958ef7" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,470</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_5221836f96a143029fdc48dbb920f6bf" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,383</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f6914" continuedAt="Text_b306249067884711afc9a6755db37f6915"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d46" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d47">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_b306249067884711afc9a6755db37f6915"><ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d47" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d48">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">* Industrial injury prevention services</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d48" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d49">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d49" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d50">
<div><br /></div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d50" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d51">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The finalized purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2020 and 2019 were
      allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the
      amount exceeding the fair values being recorded as goodwill. For some of the acquisitions in 2021, the Company is in the process of completing its formal valuation analysis to identify and determine the fair value of tangible and identifiable
      intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the preliminary estimates used at December 31, 2021 based on additional information obtained and completion of the valuation of
      the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded
      pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill. The Company does not expect the adjustments to be material.</div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d51" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d52">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d52" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d53">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the acquisitions in 2021, the values assigned to the customer and referral relationships and non-compete agreements are being
      amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period is <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_7ce6b9b95d694557815a78e1378d2d81" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerAndReferralRelationshipMember" format="ixt-sec:duryear">13.8</ix:nonNumeric>
      years. For non-compete agreements, the weighted-average amortization period is <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_80041e62f1ef4bab9a747c4902b75b66" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" format="ixt-sec:duryear">5.6</ix:nonNumeric> years. The values assigned to tradenames are tested
      annually for impairment.</div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d53" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d54">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d54" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d55">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the acquisitions in 2020 and 2019, the values assigned to the referral relationships and non-compete agreements are being
      amortized to expense equally over the respective estimated lives. For referral relationships, the weighted average amortization period was <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_0a1d555197a44dffa6fb4ec555b4e6fd" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" format="ixt-sec:duryear">10.54</ix:nonNumeric>
      and <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_b5d3478fcb6444ad8399c092ea4a0417" contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" format="ixt-sec:duryear">10.10</ix:nonNumeric> years at December 31, 2020 and December 31, 2019, respectively. For non-compete agreements, the weighted average amortization
      period was <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_ed36d375c56a419795dcceb66aac99ea" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" format="ixt-sec:duryear">6.00</ix:nonNumeric> years and <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_ccb91713c57c421ca0d3c6ca776b2264" contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" format="ixt-sec:duryear">5.16</ix:nonNumeric>
      years at December 31, 2020 and December 31, 2019, respectively. Generally, the values assigned to tradenames are tested annually for impairment.</div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d55" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d56">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d56" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d57">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the 2021, 2020 and 2019 acquisitions, total current assets primarily represent patient accounts receivable. Total non-current
      assets are fixed assets, primarily equipment, used in the practices.</div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d57" continuedAt="Text_39bd4070c50a4fcf86ffc3808841530d58">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_39bd4070c50a4fcf86ffc3808841530d58">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The consideration paid for each of the acquisitions was derived through arm&#8217;s length negotiations. Funding for the cash portions was
      derived from proceeds from the Company&#8217;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#8217;s consolidated financial statements since their respective date of acquisition. Unaudited proforma
      consolidated financial information for the acquisitions in 2021, 2020 and 2019, have not been included as the results are immaterial individually and in the aggregate.</div>
</ix:continuation>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">55</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:MinorityInterestDisclosureTextBlock" id="Text_b4e40e6a0bbd40a0ad44a3b2b7d3fde1" contextRef="c20210101to20211231" escape="true" continuedAt="Text_912fa11d1ff8477baf97ebd7956c9f971">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4. Acquisitions and Sale of Non-Controlling Interests</div>
</ix:nonNumeric>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"><ix:continuation id="Text_912fa11d1ff8477baf97ebd7956c9f971" continuedAt="Text_912fa11d1ff8477baf97ebd7956c9f972">
<div><br /></div>
</ix:continuation>
      <ix:continuation id="Text_912fa11d1ff8477baf97ebd7956c9f972" continuedAt="Text_912fa11d1ff8477baf97ebd7956c9f973">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">During
        2021, the Company acquired additional interests in <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_e3b6d4bd77f94e8b8b46b6a25521aeda" contextRef="c20210101to20211231" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction> partnerships which are included in non-controlling interest. The additional
        interests purchased in each of the partnerships ranged from <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_4e6fd6bc4c9c4cea8910a5224d1cf342" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">5</ix:nonFraction>% to <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_a6857d1bc4064ffe81661d8e2e012b61" contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>%. The aggregated purchase price for these acquired interests was $<ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" id="Fact_f943401e5c5247b1bf09162a940174c9" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction>
        million. The Company also sold an interest in a partnership for $<ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" id="Fact_0cc9448d33764678920a25d762388d36" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million.</div>
</ix:continuation>
      <ix:continuation id="Text_912fa11d1ff8477baf97ebd7956c9f973" continuedAt="Text_912fa11d1ff8477baf97ebd7956c9f974">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_912fa11d1ff8477baf97ebd7956c9f974" continuedAt="Text_912fa11d1ff8477baf97ebd7956c9f975">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">During </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the Company acquired additional interests in </span><ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_06adda1b4c1d474eb11f1c36f131b7a3" contextRef="c20200101to20201231" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from </span><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_2c12b97615b241ac989a111c23c0d0cc" contextRef="c20201231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> to </span><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_ec5e492686bf465ba822abf2969c6493" contextRef="c20201231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. The aggregated purchase price for these acquired interests was </span>$<ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" id="Fact_5feef8112d7f4adbac23a1c81cd8ea5e" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. The Company also sold an interest in a partnership for </span>$<ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" id="Fact_1279ae8b401546a4b87f06cceac19b7d" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. Also during </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the Company sold </span><ix:nonFraction name="usph:NumberOfClosedClinicsSold" id="Fact_0c786783cbff40db9ed459f7842f6699" contextRef="c20201231" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">14</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> previously closed clinics. The aggregate sales price was </span>$<ix:nonFraction name="usph:AggregateSalePriceOfCinics" id="Fact_ae8977d8e0bb468e81689b0adede2a0d" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, of which </span>$<ix:nonFraction name="usph:CashReceivedRelatedToSaleOfClinics" id="Fact_4a2f5d214b6a4840bd873f395d74814a" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> was paid in cash and </span>$<ix:nonFraction name="usph:NoteReceivableRelatedToSaleOfClinics" id="Fact_8d6b53b980f14a69940d72d67f23197a" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> in a note receivable payable in </span><ix:nonFraction name="usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration" id="Fact_5a5df302c59547179b097792df11b9e2" contextRef="c20200101to20201231" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> equal installments of principal and any accrued interest. The first payment was received in June 2021 and the next payment is due on June </span>15,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</span>2022<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</span><br />
      <span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span> </div>
</ix:continuation>
    <ix:continuation id="Text_912fa11d1ff8477baf97ebd7956c9f975" continuedAt="Text_912fa11d1ff8477baf97ebd7956c9f976">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_912fa11d1ff8477baf97ebd7956c9f976">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">During </span>2019,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the Company acquired additional interests in </span><ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_e67a8dc493bd47618e702da5102f52e9" contextRef="c20190101to20191231" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from </span><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_2d915209ca444f708fafdc5299c23277" contextRef="c20191231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> to <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_81279c5d086846759372924d7fce5fb4" contextRef="c20191231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>%. Also in </span>2019,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the Company sold a </span><ix:nonFraction name="usph:SaleOfNoncontrollingInterestPercentageInPartnershipOne" id="Fact_fbcf3fadf2bf4baabca4de7405f0c464" contextRef="c20190101to20191231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> interest in a partnership. The net after-tax difference between the payments and the
        portion of undistributed earnings of </span>$<ix:nonFraction name="usph:TaxEffectOnSaleOfNoncontrollingInterest" id="Fact_7f8292e6818f48839bcf4c22cc4b0ce4" contextRef="c20190101to20191231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">196,000</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">
        was credited to additional paid-in capital.</span></div>
</ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="usph:RedeemableNonControllingInterestTextBlock" id="Text_157d9fb6253d471bb38e8f324d462d63" contextRef="c20210101to20211231" escape="true" continuedAt="Text_26084fd1bb9a42908017fabd2dee72811">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5. Redeemable Non-Controlling Interest</div>
</ix:nonNumeric>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72811" continuedAt="Text_26084fd1bb9a42908017fabd2dee72812">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72812" continuedAt="Text_26084fd1bb9a42908017fabd2dee72813">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 18pt;"><span style="text-decoration: underline;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Therapy Practice Acquisitions</span></span><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72813" continuedAt="Text_26084fd1bb9a42908017fabd2dee72814">
<div style="text-align: left;"> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72814" continuedAt="Text_26084fd1bb9a42908017fabd2dee72815">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Since October 2017, when the Company acquires a majority interest (the &#8220;Acquisition&#8221;) in a physical therapy clinic Therapy Practice
      (referred to as &#8220;Therapy Practice&#8221;), these Therapy Practice transactions occur in a series of steps which are described below.</div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72815" continuedAt="Text_26084fd1bb9a42908017fabd2dee72816">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72816" continuedAt="Text_26084fd1bb9a42908017fabd2dee72817">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#8220;Seller Entity&#8221;). The Seller Entity is owned by one or more individuals
              (the &#8220;Selling Shareholders&#8221;) most of whom are physical therapists that work in the Acquired Therapy Practice and provide physical therapy services to patients.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72817" continuedAt="Text_26084fd1bb9a42908017fabd2dee72818">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72818" continuedAt="Text_26084fd1bb9a42908017fabd2dee72819">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the Acquisition, the Seller Entity contributes the Acquired Therapy Practice into a newly-formed limited partnership (&#8220;NewCo&#8221;), in exchange
              for one hundred percent (<ix:nonFraction name="usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="Fact_f050711b9b95401b9584fe5779190760" contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a
              wholly-owned subsidiary of the Seller Entity.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee72819" continuedAt="Text_26084fd1bb9a42908017fabd2dee728110">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728110" continuedAt="Text_26084fd1bb9a42908017fabd2dee728111">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company enters into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Seller Entity a majority (ranges from <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="Fact_f5dd41c7f47b4c6399b017db720ec54f" contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% to <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="Fact_2c731d08dd884ad4a380c619c58caa51" contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">90</ix:nonFraction>%) of the limited
              partnership interest and in <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">all</span></span> cases <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" id="Fact_2e52b1f3a05f471d9d54c911e1778f09" contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the
              general partnership interest in NewCo. The Company does not purchase <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="Fact_334b5f2954cc49c78204017403c0e2b3" contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the limited partnership interest because the Selling
              Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small <ix:nonNumeric name="usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="Fact_a8d379b21c35487abccff5bd2a9fdf7c" contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">two-year</ix:nonNumeric> note in lieu of an escrow (the &#8220;Purchase Price&#8221;). The Purchase Agreement usually does not contain any future earn-out or other contingent consideration that is
              payable to the Seller Entity or the Selling Shareholders.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728111" continuedAt="Text_26084fd1bb9a42908017fabd2dee728112">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728112" continuedAt="Text_26084fd1bb9a42908017fabd2dee728113">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Seller Entity also execute a partnership agreement (the &#8220;Partnership Agreement&#8221;) for NewCo that sets forth the rights and obligations of the
              limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728113" continuedAt="Text_26084fd1bb9a42908017fabd2dee728114">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728114" continuedAt="Text_26084fd1bb9a42908017fabd2dee728115">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited
              partnership interest in NewCo (&#8220;Seller Entity Interest&#8221;).</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728115" continuedAt="Text_26084fd1bb9a42908017fabd2dee728116">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728116" continuedAt="Text_26084fd1bb9a42908017fabd2dee728117">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#8220;Employment Agreement&#8221;) with NewCo with an initial term that
              ranges from <span style="-sec-ix-hidden:Fact_0d92bcc8360a42b4b9b9cf260432b9cf">three</span> to <ix:nonNumeric name="usph:TermOfEmploymentAgreement" id="Fact_e30139b98051459c9def5619b1e7f3e3" contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>
              (the &#8220;Employment Term&#8221;), with automatic <ix:nonNumeric name="usph:EmploymentAgreementRenewalTerm" id="Fact_e363ba866f044e879151cedc665a0f09" contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">one-year</ix:nonNumeric> renewals, unless employment is terminated prior to the end of the Employment
              Term. As a result, a Selling Shareholder becomes an employee (&#8220;Employed Selling Shareholder&#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause,
              at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller
              Entity as of the closing of the Acquisition.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728117" continuedAt="Text_26084fd1bb9a42908017fabd2dee728118">
<div><br /></div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728118" continuedAt="Text_26084fd1bb9a42908017fabd2dee728119">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities
              based on other employees in similar capacities within NewCo, the Company and the industry.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728119" continuedAt="Text_26084fd1bb9a42908017fabd2dee728120">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728120" continuedAt="Text_26084fd1bb9a42908017fabd2dee728121">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete
              agreement (the &#8220;Non-Compete Agreement&#8221;) which restricts the Selling Shareholder from engaging in competing Therapy Practice activities for a specified period of time (the &#8220;Non-Compete Term&#8221;). A Non-Compete Agreement is executed with the
              Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing Therapy Practice during the Non-Compete Term.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728121" continuedAt="Text_26084fd1bb9a42908017fabd2dee728122">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">56</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728122" continuedAt="Text_26084fd1bb9a42908017fabd2dee728123">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and expires on the <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">later</span></span>
              of:</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728123" continuedAt="Text_26084fd1bb9a42908017fabd2dee728124">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728124" continuedAt="Text_26084fd1bb9a42908017fabd2dee728125">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="usph:BusinessAcquisitionConsiderationPayableTermOfNote" id="Fact_e3acf3ef98dc425ea6c25a607bc5d37f" contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">Two years</ix:nonNumeric> after the date an Employed Selling
              Shareholders&#8217; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728125" continuedAt="Text_26084fd1bb9a42908017fabd2dee728126">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728126" continuedAt="Text_26084fd1bb9a42908017fabd2dee728127">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_0b4b01dde9444fa395f3ee7e597f70c6">Five</span> to <ix:nonNumeric name="usph:NonCompeteAgreementBasicTerm" id="Fact_cfa0aff43b8c4e7d864d1431b8618161" contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">six years</ix:nonNumeric> from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728127" continuedAt="Text_26084fd1bb9a42908017fabd2dee728128">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728128" continuedAt="Text_26084fd1bb9a42908017fabd2dee728129">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to a restricted region which is defined as a mileage radius from the Acquired Therapy Practice. That is, an Employed Selling
              Shareholder is permitted to engage in competing Therapy Practicees or activities outside the designated geography (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo
              immediately is permitted to engage in the competing Therapy Practice or activities outside the designated geography.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728129" continuedAt="Text_26084fd1bb9a42908017fabd2dee728130">
<div><br /></div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728130" continuedAt="Text_26084fd1bb9a42908017fabd2dee728131">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company
      (the &#8220;Call Right&#8221;) or at the option of the Seller Entity (the &#8220;Put Right&#8221;) as follows:</div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728131" continuedAt="Text_26084fd1bb9a42908017fabd2dee728132">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728132" continuedAt="Text_26084fd1bb9a42908017fabd2dee728133">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728133" continuedAt="Text_26084fd1bb9a42908017fabd2dee728134">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728134" continuedAt="Text_26084fd1bb9a42908017fabd2dee728135">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment is terminated under certain circumstances prior to the fifth anniversary of the Closing Date, the Seller
              Entity thereafter may have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div>
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728135" continuedAt="Text_26084fd1bb9a42908017fabd2dee728136">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call
              Right with respect to the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, Seller Entity thereafter has the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s
              Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div>
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
          </td>

  </tr>


</table>
</ix:continuation>
    <div>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728136" continuedAt="Text_26084fd1bb9a42908017fabd2dee728137">
<div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c.</div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the
                  Seller Entity has the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728137" continuedAt="Text_26084fd1bb9a42908017fabd2dee728138">
<div><br /></div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728138" continuedAt="Text_26084fd1bb9a42908017fabd2dee728139">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728139" continuedAt="Text_26084fd1bb9a42908017fabd2dee728140">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728140" continuedAt="Text_26084fd1bb9a42908017fabd2dee728141">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s employment by NewCo is terminated prior to the fifth anniversary of the Closing Date, the Company thereafter has an irrevocable
              right to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728141" continuedAt="Text_26084fd1bb9a42908017fabd2dee728142">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company
              has the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728142" continuedAt="Text_26084fd1bb9a42908017fabd2dee728143">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728143" continuedAt="Text_26084fd1bb9a42908017fabd2dee728144">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings
              before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on
              available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728144" continuedAt="Text_26084fd1bb9a42908017fabd2dee728145">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728145" continuedAt="Text_26084fd1bb9a42908017fabd2dee728146">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings
              that is used in the Put Right and the Call Right noted above.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728146" continuedAt="Text_26084fd1bb9a42908017fabd2dee728147">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728147" continuedAt="Text_26084fd1bb9a42908017fabd2dee728148">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.<br />
            </div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728148" continuedAt="Text_26084fd1bb9a42908017fabd2dee728149">
<div> <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728149" continuedAt="Text_26084fd1bb9a42908017fabd2dee728150">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling
              Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.</div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728150" continuedAt="Text_26084fd1bb9a42908017fabd2dee728151">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728151" continuedAt="Text_26084fd1bb9a42908017fabd2dee728152">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the
      Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder,
      nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not
      forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for
      breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a
      forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div>
</ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728152" continuedAt="Text_26084fd1bb9a42908017fabd2dee728153">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">57</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728153" continuedAt="Text_26084fd1bb9a42908017fabd2dee728154">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"><span style="text-decoration: underline;">ProgressiveHealth










          Acquisition</span></div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728154" continuedAt="Text_26084fd1bb9a42908017fabd2dee728155">
<div><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728155" continuedAt="Text_26084fd1bb9a42908017fabd2dee728156">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">On November 30, 2021, the Company acquired a majority interest in ProgressiveHealth Companies, LLC (&#8220;Progressive&#8221;), which owns a
        majority interest in certain subsidiaries (&#8220;Progressive Subsidiaries&#8221;) that operate in the industrial injury prevention and therapy services businesses.&#160; The Progressive transaction was completed in a series of steps which are described below.<br />
        <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728156" continuedAt="Text_26084fd1bb9a42908017fabd2dee728157">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Prior to the acquisition, the Progressive Subsidiaries were owned by a legal entity (&#8220;Progressive Parent&#8221;) controlled by its individual owners (the &#8220;Selling
                  Shareholders&#8221;), who work in and manage the Progressive business.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728157" continuedAt="Text_26084fd1bb9a42908017fabd2dee728158">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728158" continuedAt="Text_26084fd1bb9a42908017fabd2dee728159">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the acquisition, the Selling Shareholders caused the Progressive Parent to transfer its ownership of the Progressive Subsidiaries into a
                  newly-formed limited liability company (&#8220;NewCo&#8221;), in exchange for one hundred percent (<ix:nonFraction name="usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="Fact_727ec918566d4d078666533b965869cb" contextRef="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%) of the membership interests in
                  NewCo. Therefore, in this step, NewCo became wholly-owned by the Selling Shareholders.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728159" continuedAt="Text_26084fd1bb9a42908017fabd2dee728160">
<div><br /></div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728160" continuedAt="Text_26084fd1bb9a42908017fabd2dee728161">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company entered into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Selling Shareholders a majority of the membership interest in NewCo. The
                  consideration for the acquisition is primarily payable in the form of cash at closing, a relatively small portion paid in cash after the closing contingent on certain performance criteria, and a small note in lieu of an escrow (the
                  &#8220;Purchase Price&#8221;).</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728161" continuedAt="Text_26084fd1bb9a42908017fabd2dee728162">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728162" continuedAt="Text_26084fd1bb9a42908017fabd2dee728163">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholders also executed an operating agreement (the &#8220;Operating Agreement&#8221;) for NewCo that sets forth the rights and
                  obligations of the members of NewCo.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728163" continuedAt="Text_26084fd1bb9a42908017fabd2dee728164">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728164" continuedAt="Text_26084fd1bb9a42908017fabd2dee728165">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company did not purchase <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="Fact_0e7bdfddc03642dfaec76c6d1c1eb0fa" contextRef="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%
                  of the membership interests in NewCo and the Selling Shareholders retained a portion of the membership interest in NewCo (&#8220;Selling Shareholders&#8217; Interest&#8221;).</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728165" continuedAt="Text_26084fd1bb9a42908017fabd2dee728166">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728166" continuedAt="Text_26084fd1bb9a42908017fabd2dee728167">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholders executed a non-compete agreement (the &#8220;Non-Compete Agreement&#8221;) which restricts the Selling Shareholders from
                  competing for a specified period of time (the &#8220;Non-Compete Term&#8221;).</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728167" continuedAt="Text_26084fd1bb9a42908017fabd2dee728168">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728168" continuedAt="Text_26084fd1bb9a42908017fabd2dee728169">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and expires on the <span style="text-decoration: underline;"><span style="font-size: 10pt; font-family: 'Times New Roman';">later</span></span>
                  of:</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728169" continuedAt="Text_26084fd1bb9a42908017fabd2dee728170">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728170" continuedAt="Text_26084fd1bb9a42908017fabd2dee728171">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="Fact_9112d2f2ad5e48cbae551d5255b5efe0" contextRef="c20210101to20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">Two years</ix:nonNumeric> after the date a Selling Shareholder
                  no longer is involved in the management of NewCo or</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728171" continuedAt="Text_26084fd1bb9a42908017fabd2dee728172">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728172" continuedAt="Text_26084fd1bb9a42908017fabd2dee728173">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="usph:NonCompeteAgreementBasicTerm" id="Fact_3651b70a7d154799bf3d62c173787f93" contextRef="c20210101to20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">Seven years</ix:nonNumeric> from the date of the acquisition.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728173" continuedAt="Text_26084fd1bb9a42908017fabd2dee728174">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728174" continuedAt="Text_26084fd1bb9a42908017fabd2dee728175">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to the entire United States.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728175" continuedAt="Text_26084fd1bb9a42908017fabd2dee728176">
<div><br /></div>
</ix:continuation>
        <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728176" continuedAt="Text_26084fd1bb9a42908017fabd2dee728177">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.</div>
              </td>

  </tr>


</table>
</ix:continuation>
        <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728177" continuedAt="Text_26084fd1bb9a42908017fabd2dee728178">
<div><br /></div>
</ix:continuation>
      </div>

    </div>

    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728178" continuedAt="Text_26084fd1bb9a42908017fabd2dee728179">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">The Operating Agreement contains provisions for the redemption of the Selling Shareholder&#8217;s Interest, either at the option of the
        Company (the &#8220;Call Right&#8221;) or at the option of the Selling Shareholder (the &#8220;Put Right&#8221;) as follows:</div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728179" continuedAt="Text_26084fd1bb9a42908017fabd2dee728180">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728180" continuedAt="Text_26084fd1bb9a42908017fabd2dee728181">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728181" continuedAt="Text_26084fd1bb9a42908017fabd2dee728182">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728182" continuedAt="Text_26084fd1bb9a42908017fabd2dee728183">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each of the Selling Shareholders has the right to sell <ix:nonFraction name="usph:PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" id="Fact_6937b463ffef4a28a0ecb39ff02e50dc" contextRef="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>%
                  of their respective residual interests on each of the 4th and 5th anniversaries of the acquisition closing, and then <ix:nonFraction name="usph:PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" id="Fact_e71df80f688545928354fc3800d447eb" contextRef="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% on
                  each of the 6th and 7th anniversaries.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728183" continuedAt="Text_26084fd1bb9a42908017fabd2dee728184">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728184" continuedAt="Text_26084fd1bb9a42908017fabd2dee728185">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder terminates his management relationship with NewCo for any reason on or after the seventh anniversary of the Closing
                  Date, the Selling Shareholder has the Put Right, and upon the exercise of the Put Right, the Selling Shareholder&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728185" continuedAt="Text_26084fd1bb9a42908017fabd2dee728186">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728186" continuedAt="Text_26084fd1bb9a42908017fabd2dee728187">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728187" continuedAt="Text_26084fd1bb9a42908017fabd2dee728188">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728188" continuedAt="Text_26084fd1bb9a42908017fabd2dee728189">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s ceases to perform management services on behalf of NewCo, the Company thereafter shall have an irrevocable right to purchase
                  from such Selling Shareholder his Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728189" continuedAt="Text_26084fd1bb9a42908017fabd2dee728190">
<div><br /></div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728190" continuedAt="Text_26084fd1bb9a42908017fabd2dee728191">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of
                  earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed
                  monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728191" continuedAt="Text_26084fd1bb9a42908017fabd2dee728192">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">58</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728192" continuedAt="Text_26084fd1bb9a42908017fabd2dee728193">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month
                  earnings that is used in the Put Right and the Call Right noted above.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728193" continuedAt="Text_26084fd1bb9a42908017fabd2dee728194">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728194" continuedAt="Text_26084fd1bb9a42908017fabd2dee728195">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.</div>
              </td>

  </tr>


</table>
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728195" continuedAt="Text_26084fd1bb9a42908017fabd2dee728196">
<div><br /></div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728196" continuedAt="Text_26084fd1bb9a42908017fabd2dee728197">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">Neither the Operating Agreement nor the Non-Compete Agreement contain any provision to escrow or &#8220;claw back&#8221; the equity interest
        in NewCo held by the Selling Shareholders, in the event of a breach of the operating agreement or non-compete terms, or the management services agreement pursuant to which the Selling Shareholders perform services on behalf of NewCo. The Company&#8217;s
        only recourse against the Selling Shareholder for breach of any of these agreements is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with a Selling Shareholder that would result
        in a forfeiture of the equity interest in NewCo held by a Selling Shareholder.</div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728197" continuedAt="Text_26084fd1bb9a42908017fabd2dee728198">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728198" continuedAt="Text_26084fd1bb9a42908017fabd2dee728199">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the
        Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling
        Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder
        does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling
        Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that
        would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee728199" continuedAt="Text_26084fd1bb9a42908017fabd2dee7281100">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee7281100" continuedAt="Text_26084fd1bb9a42908017fabd2dee7281101"><ix:nonNumeric name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="Text_066936ff95a247458f1624b458cf60c7" contextRef="c20210101to20211231" escape="true" continuedAt="Text_12974105702c4a03a066a9ab72dd09601">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021, 2020 and 2019, the following table details the changes in the carrying amount (fair value) of
      the redeemable non-controlling interests (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee7281101" continuedAt="Text_26084fd1bb9a42908017fabd2dee7281102"><ix:continuation id="Text_12974105702c4a03a066a9ab72dd09601" continuedAt="Text_12974105702c4a03a066a9ab72dd09602">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee7281102" continuedAt="Text_26084fd1bb9a42908017fabd2dee7281103"><ix:continuation id="Text_12974105702c4a03a066a9ab72dd09602">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, <span style="text-indent: 0pt;">2019</span></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_e519461d1594453c82af9327dd95da2c" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132,340</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_5a515f7eaaad49808fa4b3463d33d03e" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,750</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_9d5df2714a3342ec926aabb9ab3433d3" contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">133,943</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_96e46e0f159e483381c5292562456968" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,358</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_96a5778ce002420b9e366725ebf8af8b" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,175</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_cc8b514da15c4858a5765b1e6c8590b0" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,659</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="Fact_32a79f64882049b8b4bd65b2f5bae218" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,359</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="Fact_4d58483eeb044bc9bd74f163500bc909" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,403</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="Fact_37f5628af60843ea94811b9f392a7c03" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,221</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestChangeInRedemptionValue" id="Fact_bf39b5754c1443ee9e361c4798bd02ea" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,011</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestChangeInRedemptionValue" id="Fact_79ce4d284f3d499889cfae0153d1c049" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,632</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestChangeInRedemptionValue" id="Fact_b3fb834200964fc7b4a19c6754e107da" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,893</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" id="Fact_ea1d0d7c62a746eab037585baa978b17" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">30,204</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" id="Fact_ee3471e034904d46bed650260c9af8fb" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">20,521</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" id="Fact_0372dbd1509a4f0ebc3a53bfab9c9298" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,934</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" id="Fact_709e87f326774ae5983dc641b9e00039" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">39,862</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" id="Fact_3348f6c84b9a4b12a0bae41e4b5c7d47" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,297</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" id="Fact_de7c4eec0eac4fc3950618484a8d574f" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,230</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reduction of non-controlling interest due to sale of USPH partnership interest</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" id="Fact_b34815854550435face1e523f9fdfba5" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" id="Fact_4601ff6857814984b70c9c77cab5ca7b" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,132</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_c7214ccd5365418facb3827e8ab63762" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">982</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_7491aef98ee843cea607d3f63ab6d385" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,133</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_f053667ad40945c2923ea95ee54866e5" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,120</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_3f613ec2d5f948f1a6a4486838cb87d3" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">914</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_4cb4fc05cc3945caad12fa1009a95c1e" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,006</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_a141164931ce455fa1dde312ec349a97" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,870</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest -
              temporary equity</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_66f8eefb546443149f973d70c91e0491" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">186</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_61e7812ef4c84ee9becfbeaa7b50a499" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">283</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_1d4e37f2e05e4d3d9318771b516cc070" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" id="Fact_0375a7f38141449f8149127003f4cd2c" contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" id="Fact_ac172e236f804da49c023e94ea4e1d66" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" id="Fact_367f0a3a666a48b9a332fff57955cbe8" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_fe6f6689c88243759f5541b4350da47b" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">155,262</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_0f994170ded74fc4b2dd8dbf8b90d414" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132,340</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_7c0d2dd457ea49029c5b1ee9a974d17f" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,750</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <div style="text-align: left;">
      <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee7281103" continuedAt="Text_26084fd1bb9a42908017fabd2dee7281104">
<div><br />
      </div>
</ix:continuation>
    </div>


    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee7281104" continuedAt="Text_26084fd1bb9a42908017fabd2dee7281105"><ix:nonNumeric name="usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" id="Text_b83f11c6501c465f814d328d96c3455d" contextRef="c20210101to20211231" escape="true" continuedAt="Text_e25515edabd248b5a1ca507cdd1302b81">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee7281105" continuedAt="Text_26084fd1bb9a42908017fabd2dee7281106"><ix:continuation id="Text_e25515edabd248b5a1ca507cdd1302b81" continuedAt="Text_e25515edabd248b5a1ca507cdd1302b82">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_26084fd1bb9a42908017fabd2dee7281106"><ix:continuation id="Text_e25515edabd248b5a1ca507cdd1302b82">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, <span style="text-indent: 0pt;">2019</span></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder's employment has not terminated</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="Fact_4cd04cafef8a48688b989b9c4e40ace4" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">80,781</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="Fact_28ff8ad94bf44a93a8cf5013f2c0f94a" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62,390</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="Fact_69ee4a96cf38419c83b182b8d673ce81" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">51,921</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder's employment has not terminated</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="Fact_cf8e592db4e24e2197bcd5158a84edd5" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">74,481</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="Fact_83f618a87a354824a9abf683f3fbbf7c" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">69,950</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="Fact_6fbe4772020f443fa1a46ef44856ff34" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,829</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has expired</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="Fact_51345c1fb9a04711b569beafb3d2db0c" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="Fact_d634f775ef554225abb491072b7b945a" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="Fact_21299d4934bf42799b558237962b3f24" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has not expired</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="Fact_43830159c4d34fa98c6a68fb9021297f" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="Fact_faa2d01a99124a3d85b7f8b8922f1d50" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="Fact_5768ac08e2db4a2988aa6103ac584e5b" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_fae8de90dc1e469ea1baf2422f5df539" contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">155,262</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_ecd6175e472343309565aee7733a4735" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132,340</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_2b7170e7b46242b2b812e63fe28f4e68" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,750</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">59</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:GoodwillDisclosureTextBlock" id="Text_0a042661c4824e7ebff351e883729394" contextRef="c20210101to20211231" escape="true" continuedAt="Text_81ff684334a84e89a0af1ee09c53b0f01">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6. Goodwill</div>
</ix:nonNumeric>
    <ix:continuation id="Text_81ff684334a84e89a0af1ee09c53b0f01" continuedAt="Text_81ff684334a84e89a0af1ee09c53b0f02">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_81ff684334a84e89a0af1ee09c53b0f02" continuedAt="Text_81ff684334a84e89a0af1ee09c53b0f03"><ix:nonNumeric name="us-gaap:ScheduleOfGoodwillTextBlock" id="Text_9f5e9a0ef6dc4693bc1d10c3c718ab84" contextRef="c20210101to20211231" escape="true" continuedAt="Text_88f9ea6ea5bf4ee48916ddab4d90037c1">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The changes in the carrying amount of goodwill as of December 31, 2021 and 2020 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_81ff684334a84e89a0af1ee09c53b0f03" continuedAt="Text_81ff684334a84e89a0af1ee09c53b0f04"><ix:continuation id="Text_88f9ea6ea5bf4ee48916ddab4d90037c1" continuedAt="Text_88f9ea6ea5bf4ee48916ddab4d90037c2">
<div style="text-align: left;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_81ff684334a84e89a0af1ee09c53b0f04" continuedAt="Text_81ff684334a84e89a0af1ee09c53b0f05"><ix:continuation id="Text_88f9ea6ea5bf4ee48916ddab4d90037c2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_e47c6d5df3cb48138fc8a9f449ee86bf" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">345,646</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_bd6f35f59f1a4ba8b4ae81dbe6c78809" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">317,676</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" id="Fact_1ffb8221c72542a483c26c9690720fc1" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">89,746</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" id="Fact_790e0f0358bb4fc8b85e475d44b9fbc3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">28,540</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill derecognition (write-off) related to closed clinics</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_797e8407e246469b89ea2aabb71d5206" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_d87a5233b3aa4b6fa946627f3952aefb" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,859</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:GoodwillPurchaseAccountingAdjustments" id="Fact_73af0364042c474cb87998b0ad11eb30" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">713</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillPurchaseAccountingAdjustments" id="Fact_d0e866e97e524ff1b1956f67976ad210" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,289</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_4c17c6a33889445aa5ba72ca20a67731" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">434,679</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_eabfde1effd34232a4b41915bb70cbd4" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">345,646</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div>
      <ix:continuation id="Text_81ff684334a84e89a0af1ee09c53b0f05">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt; margin-left: 18pt;"><br />
        During the year ended December 31, 2020, the Company derecognized (wrote off) goodwill in the amount of $<ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_ee7a2f5f46c14e2fb09ac941479d0384" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction> million related to closed
        clinics due to COVID-19.</div>
</ix:continuation>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt; margin-left: 18pt;"> <br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="Text_9c7a4877c13a4277b5aef171298422e6" contextRef="c20210101to20211231" escape="true" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab371">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7. Intangible Assets, net</div>
</ix:nonNumeric>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab371" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab372">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab372" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab373"><ix:nonNumeric name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="Text_5cb1fef2d96c43afa5056d7718b2eb91" contextRef="c20210101to20211231" escape="true" continuedAt="Text_21661c874dce49a8a7fe62f89558c6721">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Intangible assets, net as of December 31, 2021, and 2020 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab373" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab374"><ix:continuation id="Text_21661c874dce49a8a7fe62f89558c6721" continuedAt="Text_21661c874dce49a8a7fe62f89558c6722">
<div style="text-align: left;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab374" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab375"><ix:continuation id="Text_21661c874dce49a8a7fe62f89558c6722">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_c23009a079b94f28bd1d849179d8e8b6" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">38,790</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_e8540a7b9f6540b1a1c542b2cf0a9494" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,317</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships, net of accumulated amortization of $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_1897fd8807e8421f95d3ef7b3936e584" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,762</ix:nonFraction></span> and $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_7cb2a0c00fd24be2b3a79a43c705fbd0" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,522</ix:nonFraction></span>, respectively</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_5e9e0b0393fe438cb6f4cdec95784836" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">45,643</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_2558758d09bf42e1bff46df0a0260a25" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">22,119</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_d7fd42a679d94c2b9cda8bfbb35528c1" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,450</ix:nonFraction></span> and $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_4ee113c5146d42d394b7b229c85c2f70" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,993</ix:nonFraction></span>, respectively</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_31f0719955c14064bce3c53f75a577a2" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,949</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_5ba60ef150f74e1d85a76d1ccfaa9204" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,844</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_9a66f2141c1845faae4c74b8d87e47ac" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,382</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_f9b52e8e1ac64405b4284babf6723edd" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">56,280</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab375" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab376">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab376" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab377">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Tradenames, customer and referral relationships and non-compete agreements are related to the businesses acquired. The value
      assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&#8217;s annual goodwill impairment test. The value assigned to customer and referral
      relationships is being amortized over their respective estimated useful lives which range from <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_5d318f555da1466a97cccfc8301f03e4" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MinimumMember" format="ixt-sec:duryear">6</ix:nonNumeric> to <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_bed05098bcc14fc0b960a779f43267a4" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">16 years</ix:nonNumeric>. Non-compete agreements are amortized over the respective term of the agreements which range from <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_98be32acfaf04497bc167196dc002d9c" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember" format="ixt-sec:duryear">5</ix:nonNumeric> to <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_b0541cfea7b249d495f4dc02d1e06ace" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">6 years</ix:nonNumeric>.</div>
</ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab377" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab378">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab378" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab379"><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="Text_a115d96080de400f8f0366554314df45" contextRef="c20210101to20211231" escape="true" continuedAt="Text_6dd080ce9f0b4385b7daefa5c88718831">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2021, 2020 and 2019 (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab379" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab3710"><ix:continuation id="Text_6dd080ce9f0b4385b7daefa5c88718831" continuedAt="Text_6dd080ce9f0b4385b7daefa5c88718832">
<div><br /></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab3710" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab3711"><ix:continuation id="Text_6dd080ce9f0b4385b7daefa5c88718832">
<div style="text-align: left;">
      <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><br />
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_80b0f9d1f85d4ee89b3f33eb45b3b0d2" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,240</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_725bb3c760ab41f986346484ef49ea96" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,845</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_c8a7379a422841db80d7efa2e5a52ed0" contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,307</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_8deea87710124782be56f0b2375e2138" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">458</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_714b2663ef3a4a559d2bdd877ad27e60" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">569</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_008922325e104ce99ed52f07f6593617" contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">708</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_8e4eba3b5c70490aa45429ef805a5696" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,698</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_2ba02ac2573745a1821af20ed73700b3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,414</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_8e8d4f748cd742ad9405f2fcdd2293d4" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,015</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab3711" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab3712">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab3712" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab3713">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For <ix:nonFraction name="usph:NumberOfAcquiredOperations" id="Fact_3a78827f93814f87a945415abd1928fe" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U013" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> acquisition,
      the value assigned to tradename was being amortized over the term of the <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_d7ea720f42d74b8e847cdf39a4e3fe4e" contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" format="ixt-sec:durwordsen">six year</ix:nonNumeric> agreement in which the Company had acquired the right to
      use the specific tradename.</div>
</ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab3713" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab3714">
<div><br />
    </div>
</ix:continuation>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">
      <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab3714" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab3715"><ix:nonNumeric name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="Text_f6654359e7ea4b029d9a0b1cb1317571" contextRef="c20210101to20211231" escape="true" continuedAt="Text_7d08467b4fc54a51b2225320143aadba1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The remaining balances of the customer and referral relationships and non-compete agreements <span style="font-family: 'Times New Roman'; font-size: 10pt;">are</span> expected to be amortized as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    </div>

    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab3715" continuedAt="Text_f0b77302e7c040a7b64e50a8a781ab3716"><ix:continuation id="Text_7d08467b4fc54a51b2225320143aadba1" continuedAt="Text_7d08467b4fc54a51b2225320143aadba2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_f0b77302e7c040a7b64e50a8a781ab3716"><ix:continuation id="Text_7d08467b4fc54a51b2225320143aadba2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;" colspan="3">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Customer and Referral Relationships</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;" colspan="3">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" id="Fact_7a349fd4dd154c2a956149d7b0f71e49" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,798</ix:nonFraction></div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" id="Fact_8eb5d9222c3947b28434c6fef6873c59" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">512</ix:nonFraction></div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" id="Fact_03973a6595dc445eb393b2620139c343" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,691</ix:nonFraction></div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" id="Fact_936101413d1345abb87495550c220ee3" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">443</ix:nonFraction></div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" id="Fact_3f494e10bb5846ea8154019952c4ae4e" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,526</ix:nonFraction></div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" id="Fact_7376a63f68b14882a4a41e64761fd3e5" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">387</ix:nonFraction></div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" id="Fact_17a135f92dcf4866bfe4815177b495b4" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,382</ix:nonFraction></div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" id="Fact_10001c96df0142e592ba34c8dac49e2f" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">322</ix:nonFraction></div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" id="Fact_98e9d84b3d0e4e11b98dbf389721d1f3" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,914</ix:nonFraction></div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" id="Fact_04e6a2009bf7403d928696ebe3ec1b5d" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">236</ix:nonFraction></div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" id="Fact_7091b1aa551d466cab308e7982dbc627" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,332</ix:nonFraction></div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" id="Fact_7286d71f48e344f5808ff82bea71645f" contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">49</ix:nonFraction></div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">60</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_3aae6a8ce7d84f0c9cd6eddfbef36e4d" contextRef="c20210101to20211231" escape="true" continuedAt="Text_9a5b9f2a6c78473eaf26f4d5afa952fc1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8. Accrued Expenses</div>
</ix:nonNumeric>
    <ix:continuation id="Text_9a5b9f2a6c78473eaf26f4d5afa952fc1" continuedAt="Text_9a5b9f2a6c78473eaf26f4d5afa952fc2">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_9a5b9f2a6c78473eaf26f4d5afa952fc2" continuedAt="Text_9a5b9f2a6c78473eaf26f4d5afa952fc3"><ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_333f31417ac64f07989d8c121efd0bbd" contextRef="c20210101to20211231" escape="true" continuedAt="Text_7914369d91fc4b1996f0201cc6f12c581">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Accrued expenses as of December 31, 2021
      and 2020 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_9a5b9f2a6c78473eaf26f4d5afa952fc3" continuedAt="Text_9a5b9f2a6c78473eaf26f4d5afa952fc4"><ix:continuation id="Text_7914369d91fc4b1996f0201cc6f12c581" continuedAt="Text_7914369d91fc4b1996f0201cc6f12c582">
<div style="text-align: left;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9a5b9f2a6c78473eaf26f4d5afa952fc4" continuedAt="Text_9a5b9f2a6c78473eaf26f4d5afa952fc5"><ix:continuation id="Text_7914369d91fc4b1996f0201cc6f12c582">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_db242ccc2c9244cc84464d8287adfec9" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,569</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_20680758040e499e8828edae3c3c2936" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,646</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PatientsAndPayorsRelatedLiability" id="Fact_8f5b7c7e4dd0400dafd0613982372679" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,649</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PatientsAndPayorsRelatedLiability" id="Fact_d11fcb47847f4e93b13311af94b7227e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,756</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedInsuranceCurrent" id="Fact_ebd9ac765a9d49c2833342f1bcd1f2f1" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,984</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedInsuranceCurrent" id="Fact_6611277b24b84d38b3c61593a522e184" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,113</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" id="Fact_f4d1ebcdc71b4e8fb023f70a05515eb1" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">498</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" id="Fact_c053d55884a44258ba640f60f5dac42c" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,333</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal taxes payable</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" id="Fact_482263ed051945f3a6499c3a48fe465b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,716</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" id="Fact_fa7957fd3ccc4701894b882ebca8fb1c" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,885</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">MAAPP funds payable</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" id="Fact_afb7512ccc944dc3888beb58a12b750f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" id="Fact_dc1dd837ba8544a2b4da7ffb5b409a5f" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,054</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contingent payment related to acquisition</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent" id="Fact_aad6409c3cc24ef7900d79239b987a3e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent" id="Fact_08d2e8b37e654962a4221425c424a3e0" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%;">Settlement of a legal matter<br />
          </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:LitigationReserveCurrent" id="Fact_cdc024e6654a4f4f9fea96d4f49dd633" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,750</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:LitigationReserveCurrent" id="Fact_574875543e52405d9272a7ca24992c67" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_ae12d6d5a9ff45a1b4941ddcf0973703" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,539</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_b240ca9122d54ba493fe7c51bc849e6a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,959</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_9c711f761ec249ca8d037499687d6b14" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">45,705</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_3a53721905e240318b347fd51c275f73" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">59,746</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><ix:continuation id="Text_9a5b9f2a6c78473eaf26f4d5afa952fc5" continuedAt="Text_9a5b9f2a6c78473eaf26f4d5afa952fc6">
<div><br /></div>
</ix:continuation>
      <ix:continuation id="Text_9a5b9f2a6c78473eaf26f4d5afa952fc6">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-indent: 20pt;">Federal






















        taxes payable includes $<ix:nonFraction name="usph:DeferredEmployerPayrollTaxesCARESACT" id="Fact_4ff7861c2d93460994b8617c0539ec9b" contextRef="c20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction> million related to deferred employer payroll taxes pursuant to the CARES ACT offset by a federal income tax
        receivable of $<ix:nonFraction name="us-gaap:IncomeTaxesReceivable" id="Fact_0b64ae3000c14f2db58dba6076062386" contextRef="c20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction> million.</div>
</ix:continuation>
       </div>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" id="Text_55820ab9458146278380569ef8e35714" contextRef="c20210101to20211231" escape="true" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452631">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9. Notes Payable</div>
</ix:nonNumeric>
    <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452631" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452632">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452632" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452633"><ix:nonNumeric name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="Text_ac30634f26b4412783d5e15e452b5493" contextRef="c20210101to20211231" escape="true" continuedAt="Text_81c6e93642c94f15bb092ef78148f9fd1">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt; margin-left: 9pt;">Notes payable as of December 31, 2021, and 2020 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452633" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452634"><ix:continuation id="Text_81c6e93642c94f15bb092ef78148f9fd1" continuedAt="Text_81c6e93642c94f15bb092ef78148f9fd2">
<div style="text-align: left;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452634" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452635"><ix:continuation id="Text_81c6e93642c94f15bb092ef78148f9fd2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_d7d84d5e11bd437e8de14231d7963e47" contextRef="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_21b7bc5df79648ab867009d07068816d" contextRef="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.1</ix:nonFraction></ix:nonFraction></span>% for December 31, 2021 and December 31, 2020, (inclusive of unused fee)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_9f073b21e6ca4be7ad40b73d40069c0b" contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">114,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_b5fa905fd7f84b75b47bbe45754636f6" contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:DebtInstrumentAnnualPrincipalPayment" id="Fact_c072f8455e09497e997be85b87e7d096" contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">830</ix:nonFraction></span> plus accrued interest due in the next year, interest accrues in the range of <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_8aa95d218202449eba037982f4a2fce9" contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction></span>%
              through <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_0ec4783a01554daeaa8b0dfd9e9b6cc7" contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">4.75</ix:nonFraction></span>% per annum</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_55330831126f47f2b8e01b12d0972f05" contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,417</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_64316e3cc2f4486399915e905de96260" contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,495</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_a992874ecdc1415ca564e65469705c5d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">118,417</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_01eeb0810f334ace89eb0b5749879204" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,495</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_fef207e7ec214425868307f2bb6c8b36" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">830</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_7ccfc85e1cde4fdb8d561205ecd32a48" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,899</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" id="Fact_a7437ef82bf0438a9d23fa2a37385b7e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">117,587</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" id="Fact_f640ef1394ad4833a9af64667df8e03d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,596</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452635" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452636">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <div style="text-align: left; text-indent: 36pt;">
      <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452636" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452637">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Effective

        December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_9a1cd50b1a7a4cf4be506ef5d9a93d80" contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">125.0</ix:nonFraction> million revolving
        credit facility. This agreement was amended in August 2015, January 2016, March 2017, November 2017, January 2021, and November 2021 (hereafter is referred to as &#8220;Amended Credit Agreement&#8221;). In November 2021, the Company exercised the accordion
        feature in the Amended Credit Agreement to increase the limit on the facility from $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_87c21b0379134a5c8c20ff826134cbc6" contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">125.0</ix:nonFraction> million to $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_6fb6f1139c87478b96e3648b9a4ea7aa" contextRef="c20211130_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">150.0</ix:nonFraction> million, with an updated accordion feature providing for additional capacity of $<ix:nonFraction name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" id="Fact_9719444c8f004a13a38f5fe86bd2bd9e" contextRef="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">25.0</ix:nonFraction> million, therefore increasing the availability up to $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_350c861853fc4793923eec5964a1fa4d" contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">175.0</ix:nonFraction> million.<br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452637" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452638">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452638" continuedAt="Text_cff4e2f5560f479ea14bbe1cf44452639">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The
        Amended Credit Agreement is unsecured and has loan covenants, including requirements that we comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working
        capital, acquisitions, purchases of our common stock, dividend payments to our common stockholders, capital expenditures and other corporate purposes. The pricing grid is based on our consolidated leverage ratio with the applicable spread over
        LIBOR ranging from <ix:nonFraction name="usph:DebtInstrumentBasisSpreadOnLiborVariableRate" id="Fact_9df99134a3f644a1b01653459dcf9463" contextRef="c20211231_RangeAxis_MinimumMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">1.25</ix:nonFraction>% to <ix:nonFraction name="usph:DebtInstrumentBasisSpreadOnLiborVariableRate" id="Fact_7c938954848542afb0f968e417f41728" contextRef="c20211231_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.0</ix:nonFraction>%
        or the applicable spread over the Base Rate ranging from <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" id="Fact_b3b9fb97de3c432ba7b5d5c9fd3567fa" contextRef="c20210101to20211231_RangeAxis_MinimumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">0.1</ix:nonFraction>% to <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" id="Fact_73998fb5d05f46c98666913d6490810c" contextRef="c20210101to20211231_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%. Fees under the Amended Credit Agreement include an unused commitment fee of <ix:nonFraction name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" id="Fact_f31c971f94154d489f8178d06f49f5aa" contextRef="c20210101to20211231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">0.3</ix:nonFraction>%
        of the amount of funds outstanding under the Amended Credit Agreement.</div>
</ix:continuation>
      <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf44452639" continuedAt="Text_cff4e2f5560f479ea14bbe1cf444526310">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf444526310" continuedAt="Text_cff4e2f5560f479ea14bbe1cf444526311">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The 2021 amendment to the Amended Credit Agreement allows for cash and noncash consideration for acquisitions permitted under the Amended Credit Agreement of up to
          $<ix:nonFraction name="usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" id="Fact_f639cbae1baf44878ea0c1de720461fa" contextRef="c20210101to20211231_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">50,000,000</ix:nonFraction> for any fiscal year, and allows for payments in cash dividends to shareholders in an aggregate amount not to exceed $<ix:nonFraction name="usph:DividendsCashAfterAmendment" id="Fact_98d447c04ea24031aa392ee2b2ae5ce2" contextRef="c20210101to20211231_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">50,000,000</ix:nonFraction> in any fiscal year.&#160; The Amended Credit Agreement is unsecured and includes certain financial covenants which include a consolidated fixed
          charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.</span></div>
</ix:continuation>
      <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf444526311" continuedAt="Text_cff4e2f5560f479ea14bbe1cf444526312">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span></div>
</ix:continuation>
      <div style="text-align: left; text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf444526312" continuedAt="Text_cff4e2f5560f479ea14bbe1cf444526313">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20.15pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On
          December 31, 2021, $<ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_06c5f9366d724ffeb50ce9e3132578f2" contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">114.0</ix:nonFraction> million was outstanding on the Amended Credit Agreement resulting in $<ix:nonFraction name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" id="Fact_7c174ba799ae48c8affa9ea502c84e4d" contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">61.0</ix:nonFraction> million of availability. As of December 31, 2021, the Company was in compliance with all of the covenants thereunder.</div>
</ix:continuation>
        <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf444526313" continuedAt="Text_cff4e2f5560f479ea14bbe1cf444526314">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_cff4e2f5560f479ea14bbe1cf444526314">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20.15pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The

          Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchasing of non-controlling interests. In conjunction with these transactions in 2021, the Company entered into notes payable in the
          aggregate amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_d1c648acd5a94de79dfe0afc81400efa" contextRef="c20211231_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.4</ix:nonFraction> million of which an aggregate principal payment of $<ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" id="Fact_55757610dcb3458ebb31d564822b2cc6" contextRef="c20211231_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million was due in 2021 and $<ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" id="Fact_17189d2acf094363adca77e67bdc6d8d" contextRef="c20211231_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction> million is due in 2022. Interest accrues
          in the range of <ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_3d870d9e08a84390beff57bb229d9e57" contextRef="c20210101to20211231_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% to <ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_4bb0ce155b3c4f9ab351980c181e6b37" contextRef="c20210101to20211231_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">4.75</ix:nonFraction>%
          per annum and is payable with each principal installment. The balance of the various notes payable entered into prior to 2021 was $<ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" id="Fact_b66dfafef33248eba0a9c0a78d4d59a4" contextRef="c20211231_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction>
          million which will be paid in 2022 and 2023.</div>
</ix:continuation>

        <div style="text-align: left; text-indent: 20.15pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>

      </div>

    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">61</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_cdbb9734057d444aa98080f53fa7afef" contextRef="c20210101to20211231" escape="true" continuedAt="Text_9e79e38504784a72bda801aaad53db721">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">10. Leases</div>
</ix:nonNumeric>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db721" continuedAt="Text_9e79e38504784a72bda801aaad53db722">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db722" continuedAt="Text_9e79e38504784a72bda801aaad53db723">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a
      lease at the inception of a contract. Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#8217;s right to use an underlying asset during
      the lease term and operating lease liabilities represent net present value of the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the
      net present value of the fixed lease payments over the lease term. The Company&#8217;s operating lease terms are generally <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Fact_7fefe8b93693415e9fa87570d093816c" contextRef="c20211231_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> or less.
      The Company&#8217;s lease terms include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#8217;s operating leases do not provide an implicit rate, the Company uses its incremental
      borrowing rate based on the information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.</div>
</ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db723" continuedAt="Text_9e79e38504784a72bda801aaad53db724">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db724" continuedAt="Text_9e79e38504784a72bda801aaad53db725">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The
      Company has elected, in compliance with current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable
      lease components. The Company has elected the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included
      in the measurement of the right-of-use assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease
      classification. Variable lease payment amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease
      liabilities. These are expensed as incurred and recorded as variable lease expense.</div>
</ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db725" continuedAt="Text_9e79e38504784a72bda801aaad53db726">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db726" continuedAt="Text_9e79e38504784a72bda801aaad53db727"><ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" id="Text_e7c6545c972a48239cd66b21587489f9" contextRef="c20210101to20211231" escape="true" continuedAt="Text_25d6217e1c5f430aa4d29a9398271d411">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021
      and 2020, the components of lease expense were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db727" continuedAt="Text_9e79e38504784a72bda801aaad53db728"><ix:continuation id="Text_25d6217e1c5f430aa4d29a9398271d411" continuedAt="Text_25d6217e1c5f430aa4d29a9398271d412">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db728" continuedAt="Text_9e79e38504784a72bda801aaad53db729"><ix:continuation id="Text_25d6217e1c5f430aa4d29a9398271d412" continuedAt="Text_25d6217e1c5f430aa4d29a9398271d413">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_3a52a0fd562747aaba28db104b42204a" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,021</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_c2abb0f991ea43edb5e9389bf4c02d20" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,710</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" id="Fact_693b6ba2f8a14f59b60dbe2849d58a8e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,160</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" id="Fact_ef3e23ac818d4f6cb42c44e78eeaa900" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,454</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_45cfd55318e8430e8abd228664256dc4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,057</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_a4406ddea50443b5b81fb9580d8fdf10" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,752</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost<sup>*</sup></div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_37c9d93f7a2345308c093a2c7e4106c9" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,238</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_2d8530006ec74a9781d163ce2d72292d" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">37,916</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db729" continuedAt="Text_9e79e38504784a72bda801aaad53db7210"><ix:continuation id="Text_25d6217e1c5f430aa4d29a9398271d413" continuedAt="Text_25d6217e1c5f430aa4d29a9398271d414">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7210" continuedAt="Text_9e79e38504784a72bda801aaad53db7211"><ix:continuation id="Text_25d6217e1c5f430aa4d29a9398271d414">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"></td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_aeaed244265844d580a05be145ffd595" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Sublease income was immaterial</ix:footnote></div>
          </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7211" continuedAt="Text_9e79e38504784a72bda801aaad53db7212">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7212" continuedAt="Text_9e79e38504784a72bda801aaad53db7213">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Lease costs are reflected in the consolidated statements of net income in the line item&#8212;rent, supplies, contract labor and other.</div>
</ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7213" continuedAt="Text_9e79e38504784a72bda801aaad53db7214">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7214" continuedAt="Text_9e79e38504784a72bda801aaad53db7215"><ix:nonNumeric name="usph:OperatingLeaseSupplementalInformationTableTextBlock" id="Text_2247309c229e4ddabdd31813b2c5a7d0" contextRef="c20210101to20211231" escape="true" continuedAt="Text_c5249136f65d481ab23b5baa1603659d1">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021
      and 2020, supplemental cash flow information related to leases was as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7215" continuedAt="Text_9e79e38504784a72bda801aaad53db7216"><ix:continuation id="Text_c5249136f65d481ab23b5baa1603659d1" continuedAt="Text_c5249136f65d481ab23b5baa1603659d2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7216" continuedAt="Text_9e79e38504784a72bda801aaad53db7217"><ix:continuation id="Text_c5249136f65d481ab23b5baa1603659d2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeasePayments" id="Fact_915702139d34496ead17abd32c208d80" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">33,192</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeasePayments" id="Fact_a99caf854f304fe4aa1c8dbd80fb92fa" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,307</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" id="Fact_e052d37fb1d34b1a95b622952bb39436" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46,088</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" id="Fact_f0f7cb3b8b564e2eb2db89017fec57bb" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,710</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7217" continuedAt="Text_9e79e38504784a72bda801aaad53db7218">
<div> <br /></div>
</ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7218" continuedAt="Text_9e79e38504784a72bda801aaad53db7219">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7219" continuedAt="Text_9e79e38504784a72bda801aaad53db7220"><ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_052dc785c4dc44b6aa14a5450de192a7" contextRef="c20210101to20211231" escape="true" continuedAt="Text_9d31046915d74df1a2e9dc89c865b5141">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The aggregate future lease payments for operating leases as of December 31, 2021 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7220" continuedAt="Text_9e79e38504784a72bda801aaad53db7221"><ix:continuation id="Text_9d31046915d74df1a2e9dc89c865b5141" continuedAt="Text_9d31046915d74df1a2e9dc89c865b5142">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7221" continuedAt="Text_9e79e38504784a72bda801aaad53db7222"><ix:continuation id="Text_9d31046915d74df1a2e9dc89c865b5142">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Fiscal Year</span></div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_31887a6f4b924a64b7539e2b517efaf1" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,945</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_3dcdbf2cc29e4d7e8f0eb51b88bab6d1" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">27,467</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_6c9fb936a89549158ae09d506165e0a5" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,876</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" id="Fact_2b0015b5ea4d47829763994b80e71dfa" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">2026<br />
          </td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" id="Fact_b1719787b0df46deb6751c9ecbce1411" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,492</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2027 and therafter</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" id="Fact_4a4f75b0102b444580140cea26689283" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,055</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_b616dc0447fb4f5e9b1b9b220603e12a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">110,835</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed interest</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_94ebb1b48970459b81a38269913da18e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,175</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_f116813389474de8ab97a719322c075d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">104,660</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7222" continuedAt="Text_9e79e38504784a72bda801aaad53db7223">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">62</span></div>

      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>


    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7223" continuedAt="Text_9e79e38504784a72bda801aaad53db7224"><ix:nonNumeric name="usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" id="Text_8d47354d0a59407b8b3338b4e8039d19" contextRef="c20210101to20211231" escape="true" continuedAt="Text_734378a339464f67b8b19842bcfe1d561">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Average lease terms and discount rates were as follows:</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7224" continuedAt="Text_9e79e38504784a72bda801aaad53db7225"><ix:continuation id="Text_734378a339464f67b8b19842bcfe1d561" continuedAt="Text_734378a339464f67b8b19842bcfe1d562">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_9e79e38504784a72bda801aaad53db7225"><ix:continuation id="Text_734378a339464f67b8b19842bcfe1d562">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"> </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_64e7e79771ad4ababc643348f87de0ca" contextRef="c20211231" format="ixt-sec:duryear">4.17</ix:nonNumeric> Years</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"><span style="text-indent: 0pt;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_c67a6112f822431590579ef07d1f32ca" contextRef="c20201231" format="ixt-sec:duryear">4.05</ix:nonNumeric></span> Years</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_55f0f60fcc454c1990a86a011ce4f264" contextRef="c20211231" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">2.77</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_a34c4798313a4b228d31aae046ec30be" contextRef="c20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="Text_cb0dfa70c1104063bfc7e17519ae272f" contextRef="c20210101to20211231" escape="true" continuedAt="Text_ddad850311e741e8b1a0e109a75f40411">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11. Income Taxes</div>
</ix:nonNumeric>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40411" continuedAt="Text_ddad850311e741e8b1a0e109a75f40412">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40412" continuedAt="Text_ddad850311e741e8b1a0e109a75f40413"><ix:nonNumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="Text_3cf65d4846c84c9584293d577c037d64" contextRef="c20210101to20211231" escape="true" continuedAt="Text_c2c4d2ce6cdb44f8a07a5fa609333a221">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2021 and
      2020 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40413" continuedAt="Text_ddad850311e741e8b1a0e109a75f40414"><ix:continuation id="Text_c2c4d2ce6cdb44f8a07a5fa609333a221" continuedAt="Text_c2c4d2ce6cdb44f8a07a5fa609333a222">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40414" continuedAt="Text_ddad850311e741e8b1a0e109a75f40415"><ix:continuation id="Text_c2c4d2ce6cdb44f8a07a5fa609333a222">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets:</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Compensation</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" id="Fact_87574d133e53433fb5491d491cc0b4ad" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,817</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" id="Fact_cd2864cb95284f1cb681e6bbe03b7314" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,865</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" id="Fact_cd2b722e05cf42efad06cf05d355c91d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">573</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" id="Fact_f7e6f68a828d4387913c3854c3b64bf2" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">396</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired net operating losses</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" id="Fact_e71fdc809bb94df6b9d06a2a7abaabb9" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" id="Fact_4f939afffc2b400f8c94c9276af582bb" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">558</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Lease obligations - including closed clinics</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DeferredTaxAssetsLeaseObligations" id="Fact_0009c968794943d8a6bac7f255e0e52b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26,856</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DeferredTaxAssetsLeaseObligations" id="Fact_51c62008a57741f7a4a10955eab8f039" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,819</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_1b786c406213482d85406e0cd434a33c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,246</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_1c4113d9e12549e3a932104e66b1a6b7" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26,638</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" id="Fact_938551610d5b4547b0a6647b9d933ada" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19,607</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" id="Fact_05205e059b574f279e2fc2956c415ea7" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,650</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" id="Fact_093aa6b6e9934268a181ab9e3b210215" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,637</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" id="Fact_72492258a04948daaa5bc824e3ef8ad0" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,419</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" id="Fact_cedf88057b5847a4a341040a8873239d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">387</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" id="Fact_4005c6408fb94f5ea4e54c1587356d3e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">348</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_28ddff1cd1804f0f99a886e0e565ce89" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">44,631</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_37f3b7d41d30476a89d9b9c18dfa301a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,417</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax liability</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" id="Fact_4617ccacc21b43818ee184244ad91d8e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,385</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" id="Fact_98aa793e124f4c4398247d26a0e5cb97" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,779</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40415" continuedAt="Text_ddad850311e741e8b1a0e109a75f40416">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40416" continuedAt="Text_ddad850311e741e8b1a0e109a75f40417">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The deferred tax assets and liabilities related to purchased interests not yet finalized may result in an immaterial adjustment.</div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40417" continuedAt="Text_ddad850311e741e8b1a0e109a75f40418">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40418" continuedAt="Text_ddad850311e741e8b1a0e109a75f40419">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, the Company recorded net deferred tax assets of $<ix:nonFraction name="usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" id="Fact_6fb2adbab7f7478a888c22dd4777c2b1" contextRef="c20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million related to the revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests. In addition, during 2021, the Company recorded an
      adjustment to the deferred tax assets of $<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" id="Fact_8583d17313a34bc7b2fe28146115729a" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction> million as a result of a detailed reconciliation of its federal and state taxes payable and
      receivable accounts along with its federal and state deferred tax asset and liability accounts with its federal and state tax returns for 2020. The offset of this adjustment was a decrease to the previously reported state income tax receivable and a
      decrease to the federal income tax payable. As of December 31, 2021, the Company has a federal tax payable of $<ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" id="Fact_7c219709944f44e998c3aeaebc081531" contextRef="c20211231_IncomeTaxAuthorityAxis_ForeignCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction> million and state tax
      receivables of $<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherTaxReceivableCurrent" id="Fact_214ab719665b479189f25ae7383c4e8e" contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million. <span style="font-size: 10pt; font-family: 'Times New Roman';">The federal income tax payable is included in
      </span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">accrued liabilities</span><span style="font-size: 10pt; font-family: 'Times New Roman';"> and the tax receivable is</span> included in <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">other current assets</span> on the accompanying consolidated balance sheets.</div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f40419" continuedAt="Text_ddad850311e741e8b1a0e109a75f404110">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404110" continuedAt="Text_ddad850311e741e8b1a0e109a75f404111"><ix:nonNumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Text_f78cb5eab44f4a7f82b65ad62b7fdc18" contextRef="c20210101to20211231" escape="true" continuedAt="Text_36ad75dfc60e4fc8a7e5c509763df8591">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The differences between the federal tax rate and the Company&#8217;s effective tax rate for the years ended December 31, 2021, 2020 and
      2019 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404111" continuedAt="Text_ddad850311e741e8b1a0e109a75f404112"><ix:continuation id="Text_36ad75dfc60e4fc8a7e5c509763df8591" continuedAt="Text_36ad75dfc60e4fc8a7e5c509763df8592">
<div style="text-align: left;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404112" continuedAt="Text_ddad850311e741e8b1a0e109a75f404113"><ix:continuation id="Text_36ad75dfc60e4fc8a7e5c509763df8592">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">U. S. tax at statutory rate</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" id="Fact_9333dadbb89842ab939c3b351d92d492" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,782</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_fc7dc75e92ed455faf98a5670c4635d0" contextRef="c20210101to20211231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" id="Fact_3b7da54ea05f4bfc996203e5f7379370" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,125</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_6a30d1f0914e441191d8c08f2afa5221" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" id="Fact_5568d7fd8a64412fa2ed10c4e51f0f80" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,274</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_7c35bc4e2feb415ea8c42be0f1a66bf9" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap; width: 28%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income taxes, net of federal benefit</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" id="Fact_21b2465e3bf745eb846694a6afe436df" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,478</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_60d779d9a6824895a2d70ee8f6baf11c" contextRef="c20210101to20211231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">4.4</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" id="Fact_d248dbe56c934baba06b58d189ff9330" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,956</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_d5b20f7e3a5b46d3985a99b08dfcb2c6" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.9</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" id="Fact_9bab47651eea4444b13ca51c8b851358" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,059</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_b7e904305a774c31b6b02e11477a162b" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.8</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Excess equity compensation deduction</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationDeductions" id="Fact_5a69f284952d46418d777f879ed874ee" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">246</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductions" id="Fact_a66f2ff266ab43718c54e1ae2e8e87d2" contextRef="c20210101to20211231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">0.4</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationDeductions" id="Fact_666467fce52347b29ff20230b3e6d80b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">99</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductions" id="Fact_778a2d409e1845ca8f264db588bfcf26" contextRef="c20200101to20201231" unitRef="U005" decimals="3" sign="-" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction>.0%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationDeductions" id="Fact_38e182f8365345d2b5d8d26773b5c50d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">871</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductions" id="Fact_5be8a63a33e741cdb7f990a01595a7f4" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.6</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap; width: 28%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" id="Fact_05d9eccbf2a342e3ac1881635514802c" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,258</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_1c1e4e13eb4e4fbf9769bc4a734e830e" contextRef="c20210101to20211231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.2</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" id="Fact_f68339c2a4a44194a4d7d3762b8a4c03" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,040</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_72b10c55e8c24177949b1bbe3281ecd0" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.1</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" id="Fact_b361a8e469df4a599c426bf334be93e0" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,185</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_0700afa9225f453ebfb4d5c1ae6fb2dc" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.2</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_1555021278224f6aa8e8c4c6d21ab0c6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">15,272</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_91ebc05a6fa8455ba2619e39d0734808" contextRef="c20210101to20211231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">27.2</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_ec3741de8ce640d78ea1ce494f990987" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,022</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_80d432ab568648a3b1d899ab6a81ef91" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">27.0</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_2711b9d3ee3f41d6a54d57d5c18de386" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,647</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_735084fa1dc6462ba06ada330178700e" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">25.4</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404113" continuedAt="Text_ddad850311e741e8b1a0e109a75f404114">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404114" continuedAt="Text_ddad850311e741e8b1a0e109a75f404115"><ix:nonNumeric name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Text_1631118cbae147aba560298813819f37" contextRef="c20210101to20211231" escape="true" continuedAt="Text_5faa13de13b446caa7e08b3ca8c9368c1">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Significant components of the provision for income taxes for the years ended December 31, 2021, 2020 and 2019 were as follows (in
      thousands):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404115" continuedAt="Text_ddad850311e741e8b1a0e109a75f404116"><ix:continuation id="Text_5faa13de13b446caa7e08b3ca8c9368c1" continuedAt="Text_5faa13de13b446caa7e08b3ca8c9368c2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404116" continuedAt="Text_ddad850311e741e8b1a0e109a75f404117"><ix:continuation id="Text_5faa13de13b446caa7e08b3ca8c9368c2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2019</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Current:</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_c435fd1ea291455fb5c6a6a8859c71fd" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,477</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_ec5d4e6255914cd3886e5bffaa3f92e0" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,506</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_9bac9e5a3c1e4783810f1d7a959b7b9b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,523</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_c61f1bcf3f114612b5d1aff878c92001" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,107</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_b5b918fe8b814ef08e8a27e062909d73" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,774</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_93515880ca6142138553120ba39fce13" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,473</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_0dcd1a8d8f104696afa9645ba10b5882" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,584</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_83e04d6bfd064432b6674cdd3336dc37" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,280</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_0fcde56b61cc4306b72d46c3f4b35f9f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,996</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; white-space: nowrap;">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_9e6e7320ade94bcd95a0641ad0bfe738" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,866</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_ae9fa96d150540eb9a0c3c1b60e31e9b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">38</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_7808ed8624c647b0ad39c46d8f1b5635" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,730</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_749a26fbf43747dd96a8f3d40187a037" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">822</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_480174fd1e8a41eab3a4fc0b957acde8" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">220</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_d05103d47c8849398af51c5eeb85c27b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">921</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_d442b44bb59d429ab2a9d4bdd0cb70f4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,688</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_66c3d403d3de463e9d526790b0768795" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">258</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_2e2c9e384f9f41e4b0f6ef8adb4371ca" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,651</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total income tax provision</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_921de044b03c4609984ed5065ba6b907" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">15,272</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_b73985877e034c7aa2506893c86be3dd" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,022</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_05fe715e4901416e97771b5893defb6e" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,647</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404117" continuedAt="Text_ddad850311e741e8b1a0e109a75f404118">
<div><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">63</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404118" continuedAt="Text_ddad850311e741e8b1a0e109a75f404119">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For 2021, 2020 and 2019, the Company performed a detailed reconciliation of its federal and state taxes payable and receivable
      accounts along with its federal and state deferred tax asset and liability accounts. The adjustments were immaterial. The Company considers this reconciliation process to be an annual control.</div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404119" continuedAt="Text_ddad850311e741e8b1a0e109a75f404120">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404120" continuedAt="Text_ddad850311e741e8b1a0e109a75f404121">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company is required to establish a valuation allowance for deferred tax assets if, based on the weight of available evidence, it
      is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary
      differences become deductible. Management considers the projected future taxable income and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income in the periods
      which the deferred tax assets are deductible, management believes that a valuation allowance is not required, as it is more likely than not that the results of future operations will generate sufficient taxable income to realize the deferred tax
      assets.</div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404121" continuedAt="Text_ddad850311e741e8b1a0e109a75f404122">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404122" continuedAt="Text_ddad850311e741e8b1a0e109a75f404123">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company&#8217;s U.S. federal returns remain open to examination for <span style="-sec-ix-hidden:Fact_19a08fedb1b74db5a6b4b517c5b42088">2018 through 2020</span> and U.S. state jurisdictions are open for periods ranging from <span style="-sec-ix-hidden:Fact_b89ef7a81a69420b8fe8694136cd02d4">2017 through 2020</span>.</div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404123" continuedAt="Text_ddad850311e741e8b1a0e109a75f404124">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404124" continuedAt="Text_ddad850311e741e8b1a0e109a75f404125">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company does not believe that it has any significant uncertain tax positions at December 31, 2021 and December 31, 2020, nor is
      this expected to change within the next twelve months due to the settlement and expiration of statutes of limitation.</div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404125" continuedAt="Text_ddad850311e741e8b1a0e109a75f404126">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ddad850311e741e8b1a0e109a75f404126">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company did <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" id="Fact_f3b286cf1e1e4dfbbdbc69796bc746bf" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_be753e34b4b649ec93561ebcad6c4cfd" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" id="Fact_b57c26c889664a849f4401ad8baa8aca" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_646799d8c60a4b6fb4cf8afa606b4c6c" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" id="Fact_5be3ffa4479d41a1804680a0865834dc" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_2069a011427a4311a190e01db5911083" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t
      have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the years ended December 31, 2021, 2020 and 2019.</div>
</ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:SegmentReportingDisclosureTextBlock" id="Text_6f4683897ad44728b6e412d1c8ccd4cc" contextRef="c20210101to20211231" escape="true" continuedAt="Text_1598f0069a5f49d5ba9cc037c989912c1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12. Segment Information</div>
</ix:nonNumeric>
    <ix:continuation id="Text_1598f0069a5f49d5ba9cc037c989912c1" continuedAt="Text_1598f0069a5f49d5ba9cc037c989912c2">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_1598f0069a5f49d5ba9cc037c989912c2" continuedAt="Text_1598f0069a5f49d5ba9cc037c989912c3">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company&#8217;s reportable segments include the physical therapy
        operations segment and the industrial injury prevention services segment. Also included in the physical therapy operations segment are revenues from management contract services and other services which include services the Company provides
        on-site, such as schools for athletic trainers</span>.</div>
</ix:continuation>
    <ix:continuation id="Text_1598f0069a5f49d5ba9cc037c989912c3" continuedAt="Text_1598f0069a5f49d5ba9cc037c989912c4">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_1598f0069a5f49d5ba9cc037c989912c4" continuedAt="Text_1598f0069a5f49d5ba9cc037c989912c5">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company evaluates performance of the segments based on gross
        profit. The Company has provided additional information regarding its reportable segments which contributes to the understanding of the Company and provides useful information</span>.</div>
</ix:continuation>
    <ix:continuation id="Text_1598f0069a5f49d5ba9cc037c989912c5" continuedAt="Text_1598f0069a5f49d5ba9cc037c989912c6">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_1598f0069a5f49d5ba9cc037c989912c6" continuedAt="Text_1598f0069a5f49d5ba9cc037c989912c7"><ix:nonNumeric name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="Text_cd3f99d7b75b42b19a09c264e746e13a" contextRef="c20210101to20211231" escape="true" continuedAt="Text_8267e8e597b4460b94aa69d45ad68d691">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he following table summarizes selected financial data for the
        Company&#8217;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation</span>.</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_1598f0069a5f49d5ba9cc037c989912c7" continuedAt="Text_1598f0069a5f49d5ba9cc037c989912c8"><ix:continuation id="Text_8267e8e597b4460b94aa69d45ad68d691" continuedAt="Text_8267e8e597b4460b94aa69d45ad68d692">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_1598f0069a5f49d5ba9cc037c989912c8"><ix:continuation id="Text_8267e8e597b4460b94aa69d45ad68d692">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1">&#160;<span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Year Ended December 31,</span><br />
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2019</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;"> <br />
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;"> <br />
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenue:</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_08bbc0ae239e4fdcbbe658ff8fd1d20e" contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">451,122</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_46cb9ddf266c4ec3b7cfab81c1966ad6" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">383,770</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_f3dac2a50e9d44cfa906c85d8500ac9c" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">444,507</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_1d76abb000d1418088105c84c1c1c4f7" contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">43,900</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_d6c760bb16e444fdb69f4101fae0c83a" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">39,199</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_e949751c86c74d80aa32138d831fd36b" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">37,462</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_331d4f1d30ea4a24be31fac9fdcf3c38" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">495,022</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_7af1895063984a198bbecac9dda16a5a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">422,969</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_c99f8c477c6e4a0ea05b876a9dd62b75" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">481,969</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations (excluding closure costs) (a non-GAAP measure)<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_af85b664d61e4aa3b9d5c0cb873855b5" contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">106,518</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_15f94e91e0cd4ee498148fe1b920ef45" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">88,295</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_8fc54460aa144492b9582e4bc696d443" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">104,120</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_2c1ea5cbf8d84078ab403a147f6336e9" contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,694</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_8f59b1d6bf6f4b1baea5e2c34d98bc58" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,086</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_c765d9df7c184ef58a02fbda9b554475" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,379</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%;">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_d82933349890427a8e65dfb2ddd74d71" contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">117,212</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_a6f7fb79962747c9b54db1bd4727438e" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">98,381</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_90b9c038251f404fbce4c4f0ccfc5bb6" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112,499</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations - closure costs</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_c81d426883804918acfc01dbfff7779a" contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_29f92ce2b8894b8cb2d22dc8eebc8615" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,931</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_34aece889196491092208f245812ee80" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_7f48fe3866c6493d834d36f613825237" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">117,182</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_bf5d8b4aec4a48558ed76e3bd85867d3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">94,450</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_498e1c80994841c29815a2ea6474ee8f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112,474</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_571c23cf36354b17bfac107251f57699" contextRef="c20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">587,801</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_a6af9c9c506e486b8566ebeac361fdd1" contextRef="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">499,911</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_ddc70c3b8fe4484d800c0c747df4e3cf" contextRef="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">518,027</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_52c33044fbf1491aa1fc41a6ac7cc204" contextRef="c20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">161,625</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_8c4d454330464f4ebf86108e33e81ef7" contextRef="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">94,450</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_6d49b488712b4596a6db15bc4b19489d" contextRef="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112,474</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_f89adaaf0aa24933b7de79666d41f5d8" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">749,426</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_eaea358833d4408fbfbe8f719a61bd3a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">594,361</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_27806b7ce2f94498ba4e404f3f1268d1" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">630,501</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div>
      <div>
        <ix:nonNumeric name="us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" id="Text_31f4dd57d03840e2b92858543bbb8fa3" contextRef="c20210101to20211231" escape="true" continuedAt="Text_4435d57afc3e44cb88888e1b7ed5bc7c1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13. Investment in Unconsolidated Affiliate</div>
</ix:nonNumeric>
        <ix:continuation id="Text_4435d57afc3e44cb88888e1b7ed5bc7c1" continuedAt="Text_4435d57afc3e44cb88888e1b7ed5bc7c2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_4435d57afc3e44cb88888e1b7ed5bc7c2">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Through one of the subsidiaries, the Company has a <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_0dcbe31c658f4ff4a8f235873aa17b73" contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">49</ix:nonFraction>% joint venture interest in a company which provides physical therapy services for patients at hospitals. Since the Company is deemed to not have a controlling interest in
          the company, the Company&#8217;s investment is accounted for using the equity method of accounting. The investment balance of this joint venture as of December 31, 2021, is $<ix:nonFraction name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" id="Fact_945e4d32dbb74577b130af790a8103cd" contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.2</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:EquityMethodInvestmentQuotedMarketValue" id="Fact_7f116bafab0e43c0844cee9ed219b2e7" contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.3</ix:nonFraction> million related to the fair value on the date of acquisition. The $<ix:nonFraction name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" id="Fact_52c59c37774b44aa8400c66242872d43" contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.2</ix:nonFraction> million includes earnings of $<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" id="Fact_83f9bbce9bd8413bbf10c4f4e1600770" contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112</ix:nonFraction>
          thousand less a distribution received of $<ix:nonFraction name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" id="Fact_1f9da528faa948ed9389cebf39919461" contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">153</ix:nonFraction> thousand.</div>
</ix:continuation>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">64</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Text_07c6c5b8db9d462395607f5df3a870a5" contextRef="c20210101to20211231" escape="true" continuedAt="Text_d0aeafd686a049dabdce60197e3923881">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14. Equity Based Plans</div>
</ix:nonNumeric>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923881" continuedAt="Text_d0aeafd686a049dabdce60197e3923882">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923882" continuedAt="Text_d0aeafd686a049dabdce60197e3923883">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company has the following equity-based plans with outstanding equity grants:</div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923883" continuedAt="Text_d0aeafd686a049dabdce60197e3923884">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923884" continuedAt="Text_d0aeafd686a049dabdce60197e3923885">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Amended and Restated 1999 Employee Stock Option Plan (the &#8220;Amended 1999 Plan&#8221;) permits the Company to grant to non-employee
      directors and employees of the Company up to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_3220e015fa234b0bb44714a24ff4e7ba" contextRef="c20211231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">600,000</ix:nonFraction> non-qualified options to purchase shares of common stock and restricted stock
      (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The exercise prices of options granted under the Amended 1999 Plan are determined by the Compensation Committee. The period within
      which each option will be exercisable is determined by the Compensation Committee. The Amended 1999 Plan was approved by the shareholders of the Company at the 2008 Shareholders Meeting on May 20, 2008.</div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923885" continuedAt="Text_d0aeafd686a049dabdce60197e3923886">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923886" continuedAt="Text_d0aeafd686a049dabdce60197e3923887">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Amended and Restated 2003 Stock Option Plan (the &#8220;Amended 2003 Plan&#8221;) permits the Company to grant to key employees and outside
      directors of the Company incentive and non-qualified options and shares of restricted stock covering up to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_4504c6296d154e079cd650005a4b42b7" contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,100,000</ix:nonFraction> shares of common
      stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The material terms of the Amended 2003 Plan was reapproved by the shareholders of the Company at the 2015 Shareholders Meeting
      on May 19, 2015 and an increase in the number of shares authorized for issuance from <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_a507335d277e495185b4f4327874c96b" contextRef="c20160316_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,750,000</ix:nonFraction> to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_43cb9d8298944486beb7e0127c56e072" contextRef="c20160317_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,100,000</ix:nonFraction> was approved at the 2016 Shareholders Meeting on March 17, 2016.</div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923887" continuedAt="Text_d0aeafd686a049dabdce60197e3923888">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923888" continuedAt="Text_d0aeafd686a049dabdce60197e3923889"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="Text_f5321119c5a84a36ac486d95a4b05a8c" contextRef="c20210101to20211231" escape="true" continuedAt="Text_f7152155ce1c4311a2f9c863e0d4faba1">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">A cumulative summary of equity plans as of December 31, 2021 follows:</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e3923889" continuedAt="Text_d0aeafd686a049dabdce60197e39238810"><ix:continuation id="Text_f7152155ce1c4311a2f9c863e0d4faba1" continuedAt="Text_f7152155ce1c4311a2f9c863e0d4faba2">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238810" continuedAt="Text_d0aeafd686a049dabdce60197e39238811"><ix:continuation id="Text_f7152155ce1c4311a2f9c863e0d4faba2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"></td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Authorized</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>Stock Issued</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>Stock Options</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>Exercised</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>Exercisable</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>for Grant</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Equity Plans</span></div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amended 1999 Plan</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_c963404f30c6480288304ba47456aa80" contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">600,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" id="Fact_124b060cd3664fd28edab7d5df7f5120" contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">416,402</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_e38ee44592f34e3f93ad65125770b6b5" contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" id="Fact_b5821ca78b9c4f11b4d589342498c4e9" contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">139,791</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" id="Fact_fde7f5a226d64e5e889f87298d6aacc3" contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_8bd38b26d5494ddb81f686645f88f175" contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">7,775</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amended 2003 Plan</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_050eddc590d6480882f6009cbd66ff55" contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,100,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" id="Fact_b4f5d20e9b4042fb8f6957ddb020c788" contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,166,855</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_5ae0a70f021f467491b21b3d734ec647" contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" id="Fact_07840a8d2dcd497d8c138542260dacd7" contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">778,300</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" id="Fact_fc2d455ee1a44d389bc7c9900cb3a990" contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_cbd731943027471e86f8d6f586192145" contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">164,882</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_120cc3f60e184c7c804b2ce034bd25af" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,700,000</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" id="Fact_79d19bcf25804a64aafdce8d2db55d93" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,583,257</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_51cc6e4e98be40dbbba3342415547018" contextRef="c20211231" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" id="Fact_50b44f56b9ca42a8a2956b06d30126ea" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">918,091</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" id="Fact_2aba047d14e940c09110ccd0a9c5b1cb" contextRef="c20211231" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_f19d85838fc64b58a1a3019914f2ab42" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">172,657</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238811" continuedAt="Text_d0aeafd686a049dabdce60197e39238812">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238812" continuedAt="Text_d0aeafd686a049dabdce60197e39238813"><ix:nonNumeric name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="Text_a8b85f73f749486d9609c98f75b0bcbf" contextRef="c20210101to20211231" escape="true" continuedAt="Text_59cbd6cf3c6f41ffb084d32abcc4000f1">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the Company granted the following shares of restricted stock to directors, officers and employees
      pursuant to its equity plans as follows:</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238813" continuedAt="Text_d0aeafd686a049dabdce60197e39238814"><ix:continuation id="Text_59cbd6cf3c6f41ffb084d32abcc4000f1" continuedAt="Text_59cbd6cf3c6f41ffb084d32abcc4000f2">
<div style="text-align: left;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238814" continuedAt="Text_d0aeafd686a049dabdce60197e39238815"><ix:continuation id="Text_59cbd6cf3c6f41ffb084d32abcc4000f2" continuedAt="Text_59cbd6cf3c6f41ffb084d32abcc4000f3">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Granted</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>Value Per Share</div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2021</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_af1d2d465aff4ed8b09cb0e433b177f8" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">60,317</ix:nonFraction></div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_98df55e3b54b461faf4f8139b3b0e91a" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">131.29</ix:nonFraction></div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 33.07%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2020</div>
          </td>

    <td style="vertical-align: bottom; width: 0.97%;">&#160;</td>

    <td style="vertical-align: bottom; width: 33.21%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_53f83548d71a4e4e9819cbceb4682407" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">86,982</ix:nonFraction></div>
          </td>

    <td style="vertical-align: bottom; width: 1.11%;">&#160;</td>

    <td style="vertical-align: bottom; width: 2.36%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="vertical-align: bottom; width: 28.07%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_accca307d58f4387b2f35ea529d2f33f" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">104.69</ix:nonFraction></div>
          </td>

    <td style="vertical-align: bottom; width: 1.21%;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2019</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_ee45d14a33c3475196096c431971855c" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">91,682</ix:nonFraction></div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_b170dce4303247a395a68f7f4d3f55d0" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">104.85</ix:nonFraction></div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238815" continuedAt="Text_d0aeafd686a049dabdce60197e39238816"><ix:continuation id="Text_59cbd6cf3c6f41ffb084d32abcc4000f3" continuedAt="Text_59cbd6cf3c6f41ffb084d32abcc4000f4">
<div style="text-align: left;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238816" continuedAt="Text_d0aeafd686a049dabdce60197e39238817"><ix:continuation id="Text_59cbd6cf3c6f41ffb084d32abcc4000f4" continuedAt="Text_59cbd6cf3c6f41ffb084d32abcc4000f5">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the following shares were cancelled due to employee terminations prior to restrictions lapsing:</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238817" continuedAt="Text_d0aeafd686a049dabdce60197e39238818"><ix:continuation id="Text_59cbd6cf3c6f41ffb084d32abcc4000f5" continuedAt="Text_59cbd6cf3c6f41ffb084d32abcc4000f6">
<div style="text-align: left;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238818" continuedAt="Text_d0aeafd686a049dabdce60197e39238819"><ix:continuation id="Text_59cbd6cf3c6f41ffb084d32abcc4000f6">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Cancelled</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
              </span>Value Per Share</div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2021</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_891fa0a315b14b80bf9362cad48aa4e3" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">439</ix:nonFraction></div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_d1997abdf5104e8c9922bf77f2bf255c" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">113.80</ix:nonFraction></div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 33.06%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2020</div>
          </td>

    <td style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td style="vertical-align: bottom; width: 33.04%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_cc956308c2854f5cbf8af555c8681b60" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">10,037</ix:nonFraction></div>
          </td>

    <td style="vertical-align: bottom; width: 1.32%;">&#160;</td>

    <td style="vertical-align: bottom; width: 2.23%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="vertical-align: bottom; width: 28.13%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_9c6ec859b6104877b36d384c6c00962b" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">102.52</ix:nonFraction></div>
          </td>

    <td style="vertical-align: bottom; width: 1.22%;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2019</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_4cc23c8e9129405782c55ede87b1ad55" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,578</ix:nonFraction></div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_482ef6de74734abbb4ce542b6f50fc24" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">87.88</ix:nonFraction></div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238819" continuedAt="Text_d0aeafd686a049dabdce60197e39238820">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238820" continuedAt="Text_d0aeafd686a049dabdce60197e39238821">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_bc274c91f2484d4a9acb65f2349c1f1a">four</span> anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the
      first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the <ix:nonNumeric name="usph:RestrictedPeriodToEmployeesOnTheStockGranted" id="Fact_4572149d854e43fc92adac9533876684" contextRef="c20210101to20211231_TitleOfIndividualAxis_ExecutiveOfficerMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric>
      following the date of grant.</div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238821" continuedAt="Text_d0aeafd686a049dabdce60197e39238822">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238822" continuedAt="Text_d0aeafd686a049dabdce60197e39238823">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">There were <ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" id="Fact_c8817494c98e48c0825146a80652f58a" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">102,682</ix:nonFraction>
      and <ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" id="Fact_5b221a9311d44dc592bc8541093dd118" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">127,562</ix:nonFraction> shares outstanding as of December 31, 2021 and December 31, 2020, respectively, for which restrictions had not lapsed. The
      restrictions will lapse in <ix:nonNumeric name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" id="Fact_aa58963dd6a04298a290253276476d72" contextRef="c20210101to20211231_RangeAxis_MinimumMember">2022</ix:nonNumeric> through <ix:nonNumeric name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" id="Fact_a779e6f309fd4b8194c5d227da1ac0b4" contextRef="c20210101to20211231_RangeAxis_MaximumMember">2025</ix:nonNumeric>.</div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238823" continuedAt="Text_d0aeafd686a049dabdce60197e39238824">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_d0aeafd686a049dabdce60197e39238824">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Compensation expense for grants of restricted stock is recognized based on the fair value on the date of grant. Compensation expense
      for restricted stock grants was $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_9ada25ff9cf942bb85ffd0aa1ee8f836" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">7.8</ix:nonFraction> million, $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_10b626ab34eb404a87e865ef6f000c5e" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">7.9</ix:nonFraction>
      million, and $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_43809269e58a412dbe1688431ed7bb79" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">7.0</ix:nonFraction> million, respectively, for 2021, 2020 and 2019. As of December 31, 2021, the remaining $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" id="Fact_3c4fc1918945431bbfe64757558308b2" contextRef="c20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.9</ix:nonFraction> million of compensation expense will be recognized from 2022 through 2025.</div>
</ix:continuation>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">65</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:PreferredStockTextBlock" id="Text_583508f2c96e4d68a93bb1e48bae5ef5" contextRef="c20210101to20211231" escape="true" continuedAt="Text_7ace7cbd5826413e9de2529ca85e7e9c1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15. Preferred Stock</div>
</ix:nonNumeric>
    <ix:continuation id="Text_7ace7cbd5826413e9de2529ca85e7e9c1" continuedAt="Text_7ace7cbd5826413e9de2529ca85e7e9c2">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_7ace7cbd5826413e9de2529ca85e7e9c2" continuedAt="Text_7ace7cbd5826413e9de2529ca85e7e9c3">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Board is empowered, without approval of the shareholders, to cause shares of preferred stock to be issued in one or more series
      and to establish the number of shares to be included in each such series and the rights, powers, preferences and limitations of each series. There are no provisions in the Company&#8217;s Articles of Incorporation specifying the vote required by the
      holders of preferred stock to take action. All such provisions would be set out in the designation of any series of preferred stock established by the Board. The bylaws of the Company specify that, when a quorum is present at any meeting, the vote of
      the holders of at least a majority of the outstanding shares entitled to vote who are present, in person or by proxy, shall decide any question brought before the meeting, unless a different vote is required by law or the Company&#8217;s Articles of
      Incorporation.</div>
</ix:continuation>
    <ix:continuation id="Text_7ace7cbd5826413e9de2529ca85e7e9c3" continuedAt="Text_7ace7cbd5826413e9de2529ca85e7e9c4">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_7ace7cbd5826413e9de2529ca85e7e9c4">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Because the Board has the power to establish the preferences and rights of each series, it may afford the holders of any series of
      preferred stock, preferences, powers, and rights, voting or otherwise, senior to the right of holders of common stock. The issuance of the preferred stock could have the effect of delaying or preventing a change in control of the Company.</div>
</ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_9ce10d54805f430799ac3747b58f7c0b" contextRef="c20210101to20211231" escape="true" continuedAt="Text_3f8d310bd12f463fa08bd8399d89f90e1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">16. Common Stock</div>
</ix:nonNumeric>
    <ix:continuation id="Text_3f8d310bd12f463fa08bd8399d89f90e1" continuedAt="Text_3f8d310bd12f463fa08bd8399d89f90e2">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_3f8d310bd12f463fa08bd8399d89f90e2" continuedAt="Text_3f8d310bd12f463fa08bd8399d89f90e3">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately
      negotiated transactions, up to <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_1c5a7dbc41064675a93fb56b3fc2870c" contextRef="c20081231_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,250,000</ix:nonFraction> shares of the Company&#8217;s common stock. In March 2009, the Board authorized the repurchase of up to
      <ix:nonFraction name="usph:PercentageOfRepurchaseOfCommonStock" id="Fact_50c45510ad434de4af4e36eeb9629383" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% or approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_f0cfc560d36e4b86bdf2c7981b1d6cdd" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,200,000</ix:nonFraction>
      shares of its common stock (&#8220;March 2009 Authorization&#8221;). The Amended Credit Agreement permits share repurchases of up to $<ix:nonFraction name="usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock" id="Fact_08009d570cc54eba83557727002b14bb" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">15,000,000</ix:nonFraction>,
      subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.</div>
</ix:continuation>
    <ix:continuation id="Text_3f8d310bd12f463fa08bd8399d89f90e3" continuedAt="Text_3f8d310bd12f463fa08bd8399d89f90e4">
<div style="text-align: left;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_3f8d310bd12f463fa08bd8399d89f90e4">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Under the March 2009 Authorization, the Company has purchased a total of <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact_98418bc5c839418db8cacdbef142b684" contextRef="c20090301to20090331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">859,499</ix:nonFraction> shares. There is no expiration date for the share repurchase program. There are currently an additional estimated <ix:nonFraction name="usph:AdditionalEstimatedRepurchaseOfCommonStock" id="Fact_8239aa6b843a45119d2dc3beb929f1fb" contextRef="c20210101to20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">156,986</ix:nonFraction> shares (based on the closing price of $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" id="Fact_8e21ed249cb7480fa4970a6b331e6a8b" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">95.55</ix:nonFraction> on December 31, 2021, the
      last business day in 2021) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&#8217;s cash position. The Company did <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact_509a7e83d0104f87b4bd26c54c256b84" contextRef="c20200101to20201231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact_76b5c4a978464958a310dd55788d8d4e" contextRef="c20210101to20211231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t purchase any shares of its common stock during 2021 or 2020.</div>
</ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="Text_ebb40e5913474ba7a3ba448849cc2fda" contextRef="c20210101to20211231" escape="true" continuedAt="Text_6a0ae62d8c8641f69e3f108ec680364f1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">17. Defined Contribution Plan</div>
</ix:nonNumeric>
    <ix:continuation id="Text_6a0ae62d8c8641f69e3f108ec680364f1" continuedAt="Text_6a0ae62d8c8641f69e3f108ec680364f2">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_6a0ae62d8c8641f69e3f108ec680364f2">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company has several 401(k) profit sharing plans covering all employees with <ix:nonNumeric name="usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" id="Fact_13d12c8b0511407baa5e20303ea38412" contextRef="c20210101to20211231" format="ixt-sec:durwordsen">three months</ix:nonNumeric> of service. For certain plans, the Company makes matching contributions. The Company may also make discretionary contributions of up to <ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" id="Fact_4e01278b0f864cb297b01cbd28692d91" contextRef="c20210101to20211231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% of employee contributions. The Company did <ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" id="Fact_8faafc070f9d463caf6a86305e80f2f2" contextRef="c20210101to20211231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" id="Fact_2ea44ff5753645aaaea539f291c3aed4" contextRef="c20190101to20191231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" id="Fact_0103112abec44aae9fa11f1539c77cd3" contextRef="c20200101to20201231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t
      make any discretionary contributions for the years ended December 31, 2021, 2020 and 2019. The Company matching contributions totaled $<ix:nonFraction name="usph:DefinedContributionPlanEmployerMatchingContributionAmount" id="Fact_0a15245c97744903a17baf4cc7dd14fc" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction>
      million, $<ix:nonFraction name="usph:DefinedContributionPlanEmployerMatchingContributionAmount" id="Fact_37ae56f540964b85b5d246acf6d3f0f4" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction> million and $<ix:nonFraction name="usph:DefinedContributionPlanEmployerMatchingContributionAmount" id="Fact_852e23f4bda2460d8ee2cdc8df92e340" contextRef="c20190101to20191231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction>
      million, respectively, for the years ended December 31, 2021, 2020 and 2019.</div>
</ix:continuation>

    <div><br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Text_ef6eb7a58e894815a7f840e9ce3563e2" contextRef="c20210101to20211231" escape="true" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a31">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18. Commitments and Contingencies</div>
</ix:nonNumeric>
    <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a31" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a32">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>
</ix:continuation>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a32" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a33">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-variant: normal; text-transform: none;">Employment Agreements</div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a33" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a34">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 20pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a34" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a35">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">At December 31, 2021, the
        Company had outstanding employment agreements with <ix:nonFraction name="usph:NumberOfEmployeesCoveredUnderEmployeeAgreement" id="Fact_4ff576c5ffb34c968f777f52b7f67094" contextRef="c20210101to20211231_TitleOfIndividualAxis_ExecutiveOfficerMember" unitRef="U014" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> of its executive officers. The agreements have terms that expire <ix:nonNumeric name="usph:EmploymentAgreementsExpirationDate" id="Fact_f0b9f09d480e4693b40863e9e8c59d24" contextRef="c20210101to20211231" format="ixt:datemonthdayyearen">November 8, 2022</ix:nonNumeric>, <ix:nonNumeric name="usph:EmploymentAgreementsExpirationDateTwo" id="Fact_527a10dc7cfc42dbbf6249b71d169b62" contextRef="c20210101to20211231" format="ixt:datemonthdayyearen">July 1, 2023</ix:nonNumeric>, <ix:nonNumeric name="usph:EmploymentAgreementsExpirationDateThree" id="Fact_041cd29574b444f0aa5dd41122014bd0" contextRef="c20210101to20211231" format="ixt:datemonthdayyearen">December 31, 2023</ix:nonNumeric>, and <ix:nonNumeric name="usph:EmploymentAgreementsExpirationDateFour" id="Fact_9607d9b9c5e64f448525c30422e7fe4a" contextRef="c20210101to20211231" format="ixt:datemonthdayyearen">February 28, 2024</ix:nonNumeric>;
        however, each of these agreements provide for an automatic <ix:nonNumeric name="usph:RenewalPeriodForEmploymentAgreement" id="Fact_edb1999e81e94293a07d5d35297cdcb3" contextRef="c20210101to20211231" format="ixt-sec:durwordsen">two-year</ix:nonNumeric> renewal at the conclusion of the expiring term or renewal term.<br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a35" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a36">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a36" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a37">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">In addition, the Company
        has outstanding employment agreements with most of the managing physical therapist partners of the Company&#8217;s physical therapy clinics and with certain other clinic employees which obligate subsidiaries of the Company to pay compensation of $<ix:nonFraction name="usph:EmployeeCompensationFuturePaymentDueNextFiscalYear" id="Fact_7ea88b22d0604f66a75ba0134390c424" contextRef="c20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">52.8</ix:nonFraction> million in 2022 and $<ix:nonFraction name="usph:EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" id="Fact_8b9fe3dcb4374b7f8fd8b4b2ca76dc34" contextRef="c20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.4</ix:nonFraction> million in
        the aggregate from 2023 through 2024. In addition, many of the employment agreements with the managing physical therapists provide for monthly bonus payments calculated as a percentage of each clinic&#8217;s net revenues (not in excess of operating
        profits) or operating profits.</div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a37" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a38">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a38" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a39">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-variant: normal; text-transform: none;">Litigation</div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a39" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a310">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
      </div>
</ix:continuation>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a310" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a311">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Settlement of&#160; a Legal Matter</div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a311" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a312">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a312" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a313">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On August 19, 2019, we
        received notice of a qui tam lawsuit (&#8220;the Complaint&#8221;) filed by a relator on behalf of the United States, titled U.S. ex rel. Bonnie Elsdon, v. U.S. Physical Therapy, Inc., U.S. Physical Therapy, Ltd., Rehab Partners #2, Inc., The Hale Hand Center,
        Limited Partnership (the &#8220;Hale Partnership&#8221;), and Suzanne Hale.&#160;&#160; This whistleblower lawsuit was filed in the U.S. District Court for the Southern District of Texas, seeking damages and civil penalties under the federal False Claim Act.&#160; This
        lawsuit was originally filed under seal by a former employee of The Hale Hand Center, Limited Partnership (&#8220;Hale Partnership&#8221;), a majority-owned subsidiary of the Company, on May 25, 2018.&#160; The U.S Government declined to intervene in the case and
        unsealed the Complaint on July 17, 2019.</div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a313" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a314">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">66</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a314" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a315">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Complaint alleged that
        the Hale Partnership engaged in conduct to purposely &#8220;upcode&#8221; its billings for services provided to Medicare patients. The plaintiff - relator also claimed that similar false claims occurred on other days and at other Company-owned partnerships.</div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a315" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a316">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a316" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a317">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On October 3, 2019, we
        filed Motions to Dismiss based on numerous grounds on behalf of each of the named defendants. On October 29, 2019, the plaintiff-relator dismissed <ix:nonFraction name="us-gaap:LossContingencyNumberOfDefendants" id="Fact_a156b14aab0d4dafb95ea9436a38bd3c" contextRef="c20191029to20191029" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction>
        of the named defendants, Rehab Partners #2, Inc., U.S. Physical Therapy, Ltd., and Suzanne Hale. The Motions to Dismiss were denied on November 30, 2020.</div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a317" continuedAt="Text_cac35fdcb81e4eef9abd589519ef49a318">
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_cac35fdcb81e4eef9abd589519ef49a318">
<div style="display:none;"><br /></div>
<div style="background-color: #FFFFFF; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; text-indent: 18pt; text-transform: none;"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In January 2022,</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;to avoid the legal fees and discovery costs in defending this matter and the uncertainty of protracted litigation, </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">the Company entered into a settlement agreement with the plaintiff-relator. In the settlement agreement, the plaintiff-relator released all defendants from liability
          for all conduct alleged in the Complaint, and the Company admitted no liability or wrongdoing.&#160; In connection with the settlement, the Office of the United States Attorney for the Southern District of Texas agreed to a dismissal of the claims
          against the Hale Partnership and the Company. Under the terms of the settlement, the Company agreed to make payments to the government, the plaintiff-relator and her counsel. Such payments, in the aggregate, amounted to</span> $<ix:nonFraction name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" id="Fact_b5dda6daf3714487be1dda1ac4d11b54" contextRef="c20220101to20220131_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-4" scale="6" format="ixt:numdotdecimal">2.75</ix:nonFraction> million<span style="font-family: 'Times New Roman'; font-size: 10pt;"> of which $<ix:nonFraction name="us-gaap:LossContingencyLossInPeriod" id="Fact_2c1088f3a8824a3e8b83de551fb32f10" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction> million was recorded as an expense in 2021</span>.&#160;  </div>
</ix:continuation>
      <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;"> <br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_fc8200a4203f4fd2bdc1f600f1982114" contextRef="c20210101to20211231" escape="true" continuedAt="Text_72ed8783e22c4c87aae0d2d821f431ab1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19. Earnings Per Share</div>
</ix:nonNumeric>
    <ix:continuation id="Text_72ed8783e22c4c87aae0d2d821f431ab1" continuedAt="Text_72ed8783e22c4c87aae0d2d821f431ab2">
<div><br />
    </div>
</ix:continuation>

    <ix:continuation id="Text_72ed8783e22c4c87aae0d2d821f431ab2" continuedAt="Text_72ed8783e22c4c87aae0d2d821f431ab3"><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="Text_67d65149f3da4caca8b810d743d38904" contextRef="c20210101to20211231" escape="true" continuedAt="Text_8047ab108ad441f1b1203406c3bc83e41">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The computations of basic and diluted earnings per share for the years ended December 31, 2021, 2020 and 2019 are as follows (in
      thousands, except per share data):</div>
</ix:nonNumeric></ix:continuation>
    <ix:continuation id="Text_72ed8783e22c4c87aae0d2d821f431ab3" continuedAt="Text_72ed8783e22c4c87aae0d2d821f431ab4"><ix:continuation id="Text_8047ab108ad441f1b1203406c3bc83e41" continuedAt="Text_8047ab108ad441f1b1203406c3bc83e42">
<div><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_72ed8783e22c4c87aae0d2d821f431ab4"><ix:continuation id="Text_8047ab108ad441f1b1203406c3bc83e42">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="10">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_9fd1cb79184349b0bc6d05da3dbaa7a9" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,831</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_b4a5685075864607a3a0c243a1d77ba1" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_fcd1740cfd3f45dfb4a64786ec9781bb" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Charges) credit to retained earnings:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="Fact_b8243cdefeea4903bbc4750ce7f648ff" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">13,011</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="Fact_898ef67026e8488eb6309b159c458f29" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,632</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="Fact_f62a843ce710444eaff31352c79fbf1c" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">11,893</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of <span style="text-indent: 0pt;"><ix:nonFraction name="usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_5008bcbab612438b9efb1e24d394f57f" contextRef="c20210101to20211231" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">25.55</ix:nonFraction></span>% and <span style="text-indent: 0pt;"><ix:nonFraction name="usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_ce16f12188d74c24adf50f9afcc0c095" contextRef="c20200101to20201231" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">26.25</ix:nonFraction></span>%, respectively<br />
            </div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_a4e9dcdff2404af6b243256ee56d5826" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,324</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_0ab858a0266c4cc1976836aed6310326" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,216</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_abc83c2c53dd43009247d0ec7c0526da" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,121</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="Fact_ab507a1588eb48fe9f7ceb1f48f35d23" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,144</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="Fact_034ba7dcd58348e7aaf2caa2da68fa08" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,778</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="Fact_83b649350a314014ac19d196d96f3ab3" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,267</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_bab9e6cb1592469d89d2a442dc93f40e" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_0a44547067ad40a4b7f98ec7b4a809d0" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.41</ix:nonFraction></ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_febfcb465b91466aba62462d09d4b478" contextRef="c20200101to20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_f63fd6cb88414576928f74d9382699fb" contextRef="c20200101to20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.48</ix:nonFraction></ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_9162db6486144061bb7df1092d2600e4" contextRef="c20190101to20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_05650d94eeb4458f82abb296f1e415bf" contextRef="c20190101to20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.45</ix:nonFraction></ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div>
          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_fb73c7ea3c21491785e4d3c4b95bb5ef" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_24f90dc0d5a845099e8bb0234c219038" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,898</ix:nonFraction></ix:nonFraction><br />
            </div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_666636c9fbba4022bb0684094ae1af06" contextRef="c20200101to20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_2af4961613544ce0acf6d884d1d3fe99" contextRef="c20200101to20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,835</ix:nonFraction></ix:nonFraction><br />
            </div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_d1e38dd1e68041e39f9533121f594d28" contextRef="c20190101to20191231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_73328d6e5f40472181dbfcb00680c73f" contextRef="c20190101to20191231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,756</ix:nonFraction></ix:nonFraction><br />
            </div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div>
      <div>&#160;</div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="Text_8999209758944c7d89b7d4b67ff0f159" contextRef="c20210101to20211231" escape="true" continuedAt="Text_24df997faf6f40af9f0c6ab8efa98cb01">
<div style="font-weight: bold;"><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">20. Related
        Party Transactions</span><br />
    </div>
</ix:nonNumeric>
    <ix:continuation id="Text_24df997faf6f40af9f0c6ab8efa98cb01" continuedAt="Text_24df997faf6f40af9f0c6ab8efa98cb02">
<div style="font-weight: bold;"> <br />
    </div>
</ix:continuation>
    <div style="font-weight: bold;">
      <ix:continuation id="Text_24df997faf6f40af9f0c6ab8efa98cb02" continuedAt="Text_24df997faf6f40af9f0c6ab8efa98cb03">
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: left; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Settlement of Short Swing
        Profit Claim</div>
</ix:continuation>
      <ix:continuation id="Text_24df997faf6f40af9f0c6ab8efa98cb03" continuedAt="Text_24df997faf6f40af9f0c6ab8efa98cb04">
<div>&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_24df997faf6f40af9f0c6ab8efa98cb04">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; text-align: left; text-indent: 18pt;">For the year ended December 31, 2021, the Company recorded approximately $<ix:nonFraction name="usph:ShortSwingProfitSettlement" id="Fact_119cdcafd48d421893cff5e9f8f07f7e" contextRef="c20210101to20211231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">20,000</ix:nonFraction> related to the short swing profit settlement remitted by a shareholder of our company under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Company
        recognized the proceeds as an increase to additional paid-in capital in the consolidated balance sheets as of December 31, 2021 and consolidated statements of stockholders&#8217; equity, as well as in cash provided by financing activities included in
        Other, in the consolidated statements of cash flows, for the year ended December 31, 2021.</div>
</ix:continuation>

      <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; text-align: left; text-indent: 18pt;"> <br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <ix:nonNumeric name="us-gaap:ErrorCorrectionTextBlock" id="Text_288d80cc8045454c9d93cdc8354fdcb5" contextRef="c20210101to20211231" escape="true" continuedAt="Text_0e803ca660f747ac896e08f93a34e9a11">
<div style="font-weight: bold;"><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">21.
        Reclassification of Prior Period Presentation</span><br />
    </div>
</ix:nonNumeric>
    <ix:continuation id="Text_0e803ca660f747ac896e08f93a34e9a11" continuedAt="Text_0e803ca660f747ac896e08f93a34e9a12">
<div style="font-weight: bold;"> <br />
    </div>
</ix:continuation>
    <div style="font-weight: bold;">
      <ix:continuation id="Text_0e803ca660f747ac896e08f93a34e9a12">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; text-align: left; text-indent: 18pt;">Certain prior year amounts have been reclassified for consistency with the current year
        presentation. These reclassifications had no effect on the reported results of operations.</div>
</ix:continuation>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div>
      <div>
<div><br /></div>

        <div style="color: rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0);">
            <div>
              <a id="CHANGESINANDDISAGREEMENTS"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                      <div style="text-align: left; font-weight: bold;">ITEM 9.</div>
                    </td>

    <td style="align: left; vertical-align: top; width: auto;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
                        AND FINANCIAL DISCLOSURE.</div>
                    </td>

  </tr>


</table>
            </div>

          </div>

          <div style="color: rgb(0, 0, 0);">&#160;</div>

        </div>

        <div style="color: rgb(0, 0, 0);">Not applicable.</div>

        <div style="color: rgb(0, 0, 0);"> <br />
        </div>

        <div style="color: rgb(0, 0, 0);">
          <div>
            <a id="CONTROLSANDPROCEDURES."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 54pt;">
                    <div style="text-align: left; font-weight: bold;">ITEM 9A.</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; font-weight: bold;">CONTROLS AND PROCEDURES.</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div><br /></div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Evaluation of Disclosure Controls and Procedures</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Our management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of our disclosure controls and
          procedures (as defined in Rule 13a-15(e) promulgated under the Exchange Act) as of the end of the fiscal period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our
          disclosure controls and procedures are effective in ensuring that the information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified
          in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Management&#8217;s Report on Internal Control over Financial Reporting</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the
          Exchange Act. U.S. Physical Therapy, Inc. and subsidiaries&#8217; (the &#8220;Company&#8221;) internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
          statements for external purposes in accordance with generally accepted accounting principles.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Internal control over financial reporting includes those policies and procedures that:</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">67</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting
                  principles, and that our receipts and expenditures are being made only in accordance with authorizations of the Company&#8217;s management and directors&#894; and</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material
                  effect on the financial statements.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations.
          Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting can also be
          circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. Also, projections
          of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. However, these
          inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, the risk.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 18pt;">Management conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2021. In making this assessment,
          management used the criteria described in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In accordance with guidance issued by the SEC, recently acquired businesses
          may be excluded from management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting in the year of acquisition.&#160; Accordingly, management excluded the November 2021 Acquisition from management&#8217;s assessment
          of the effectiveness of the Company&#8217;s internal control over financial reporting from the November 30, 2021, acquisition date, which excluded total assets and total net revenues representing approximately 13.3% and 0.4%, respectively, of the
          Company&#8217;s related consolidated financial statement amounts as of and for the year ended December 31, 2021.</div>

        <div><br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Based on this assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2021.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);">The Company&#8217;s internal control over financial reporting has been audited by Grant Thornton LLP, an independent registered
          public accounting firm, as stated in their report included on page 39.</div>

        <div><br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Changes in Internal Control over Financial Reporting</div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">In November 2021, we completed an acquisition of a leading provider of industrial injury prevention services. As part of our ongoing integration activities, we are
          currently in the process of implementing internal controls and procedures at the newly acquired entity.</div>

        <div>&#160;</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Except for the integration of the newly acquired entity noted above, there were no changes in our internal control over financial reporting during the quarter
          ended December 31, 2021 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</div>

        <div>&#160;</div>

        <a id="OTHERINFORMATION."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 9B.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">OTHER INFORMATION.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Not applicable.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">PART III</div>

        <div>&#160;</div>

        <a id="DIRECTORSEXECUTIVEOFFICER"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 10.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The information required in response to this Item 10 is incorporated herein by reference to our definitive proxy statement relating to our 2022 Annual Meeting of
          Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>

        <div>&#160;</div>

        <a id="EXECUTIVECOMPENSATION."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 11.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">EXECUTIVE COMPENSATION.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The information required in response to this Item 11 is incorporated herein by reference to our definitive proxy statement relating to our 2022 Annual Meeting of
          Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>

        <div>&#160;</div>

        <a id="SECURITYOWNERSHIPOFCERTAI"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 12.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
                  STOCKHOLDER MATTERS.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div>
          <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The information required in response to this Item 12 is incorporated herein by reference to our definitive proxy statement relating to our 2022 Annual Meeting of
            Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>

          <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
          </div>

        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">68</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <a id="CERTAINRELATIONSHIPSANDRE"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 13.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The information required in response to this Item 13 is incorporated herein by reference to our definitive proxy statement relating to our 2022 Annual Meeting of
          Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>

        <div><br />
        </div>

        <a id="PRINCIPALACCOUNTANTFEESAN"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">ITEM 14.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">PRINCIPAL ACCOUNTANT FEES AND SERVICES.</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">The information required in response to this Item 14 is incorporated herein by reference to our definitive proxy statement relating to our 2022 Annual Meeting of
          Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">PART IV</div>

        <div>&#160;</div>

        <a id="EXHIBITSANDFINANCIALSTATE"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 15.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 18pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                  <div style="text-align: left;"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</span></div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left;"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Documents filed as a part of this report:</span></div>
                </td>

  </tr>


</table>
        </div>

        <div>&#160;</div>

        <div>
          <div>
            <div>
              <div>
                <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="color: rgb(0, 0, 0);">1.</span></div>
                      </td>

    <td style="align: left; vertical-align: top; width: auto;">
                        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Financial Statements. </span>Reference is made to the Index to Financial Statements and Related Information under Item 8 in Part II<span style="font-style: italic;">&#160;</span>hereof, where these documents are listed.</div>
                      </td>

  </tr>


</table>
              </div>

            </div>

          </div>

        </div>

        <div>&#160;</div>

        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">2.</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Financial Statement Schedules. </span>See page 85 for Schedule II<span style="font-style: italic;">&#160;</span>&#8212;<span style="font-style: italic;">&#160;</span>Valuation and Qualifying Accounts. All other schedules are<span style="font-style: italic;">&#160;</span>omitted because of the absence of conditions under which they are required or because the required information is
                      shown in the financial statements or notes thereto.</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div>&#160;</div>

        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">3.</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-style: italic;">Exhibits. </span>The exhibits listed in List of Exhibits on the next page are filed or incorporated by reference as part of this
                      report.</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div>&#160;</div>

        <a id="Form10-KSummary"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">ITEM 16.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Form 10-K Summary</div>
              </td>

  </tr>


</table>
        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">None.</div>

        <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">69</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">EXHIBIT INDEX</div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">LIST OF EXHIBITS</div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Number</div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; padding-bottom: 2px;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000095012901502598/h89745ex3-1.txt">3.1</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Articles of Incorporation of the Company [filed as an exhibit to the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2001 and incorporated herein by reference].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000095012901502598/h89745ex3-2.txt">3.2</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Amendment to the Articles of Incorporation of the Company [filed as an exhibit to the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2001 and incorporated herein
                  by reference].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">3.3</div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Bylaws of the Company, as amended [filed as an exhibit to the Company&#8217;s Form 10-KSB for the year ended December 31, 1993 and incorporated herein by reference&#8212;Commission File
                  Number&#8212;1-11151].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="brhc10034321_ex4-1.htm">4.1*</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Description of Company Securities [filed herewith the Company&#8217;s Form 10-K for the year ended December 31, 2019 filed with the SEC on February 28, 2020.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000095012908002272/h55685def14a.htm">10.1+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">1999 Employee Stock Option Plan (as amended and restated May 20, 2008) [incorporated by reference to Appendix A to the Company&#8217;s Definitive Proxy Statement on Schedule 14A,
                  filed with the SEC on April 17, 2008].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000156761916002163/h10035537x1_def14a.htm">10.2+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U.S. Physical Therapy, Inc. 2003 Stock Incentive Plan, (as amended and restated effective March 26, 2016) [incorporated herein by reference to Appendix A to the Company's
                  Definitive Proxy Statement on Schedule 14A filed with the SEC on April 7, 2016.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312513136397/d514665dex991.htm">10.3+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Long-Term Incentive Plan for Senior Management for 2013, effective March 27, 2013 [incorporated by reference to Exhibit 99.1 to the Company
                  Current Report on Form 8-K filed with the SEC on April 1, 2013].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312513136397/d514665dex992.htm">10.4+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for 2013, effective March 27, 2013 [incorporated by reference to Exhibit 99.2 to the Company Current Report on Form 8-K
                  filed with the SEC on April 1, 2013].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312513136397/d514665dex993.htm">10.5+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for 2013, effective March 27, 2013 [incorporated by reference to Exhibit 99.3 to the Company Current Report on Form
                  8-K filed with the SEC on April 1, 2013].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312514117900/d699247dex991.htm">10.6+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Long-Term Incentive Plan for Senior Management for 2014, effective March 21, 2014 [incorporated by reference to Exhibit 99.1 to the Company
                  Current Report on Form 8-K filed with the SEC on March 27, 2014].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312514117900/d699247dex992.htm">10.7+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2014, effective March 21, 2014 [incorporated by reference to Exhibit 99.2 to the
                  Company Current Report on Form 8-K filed with the SEC on March 27, 2014].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312514117900/d699247dex993.htm">10.8+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2014, effective March 21, 2014 [incorporated by reference to Exhibit 99.3 to the Company
                  Current Report on Form 8-K filed with the SEC on March 27, 2014].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312514117900/d699247dex994.htm">10.9+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2014, effective March 21, 2014 [incorporated by reference to Exhibit 99.4 to the Company
                  Current Report on Form 8-K filed with the SEC on March 27, 2014].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036115013296/ex99_1.htm">10.10+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Long Term Incentive Plan for Senior Management for 2015, effective March 23, 2015 [incorporated by reference to Exhibit 99.1 to the Company&#8217;s
                  Current Report on Form 8-K filed with the SEC on March 27, 2015.]</div>
              </td>

  </tr>


</table>
        <div><br /></div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">70</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Number</div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036115013296/ex99_2.htm">10.11+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U.S. Physical Therapy, Inc. Discretionary Long Term Incentive Plan for Senior Management for 2015, effective March 23, 2015 [incorporated by reference to Exhibit 99.2 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on March 27, 2015.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036115013296/ex99_3.htm">10.12+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2015, effective March 23, 2015 [incorporated by reference to Exhibit 99.3 to the Company&#8217;s
                  Current Report on Form 8-K filed with the SEC on March 27, 2015.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036115013296/ex99_4.htm">10.13+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2015, effective March 23, 2015 [incorporated by reference to Exhibit 99.4 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on March 27, 2015.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-1.htm">10.14+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Long Term Incentive Plan for Senior Management for 2016, effective March 10, 2016 [incorporated by reference to Exhibit 10.1 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-2.htm">10.15+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Long Term Incentive Plan for Senior Management for 2016, effective March 10, 2016 [incorporated by reference to Exhibit 10.2 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-3.htm">10.16+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2016, effective March 10, 2016 [incorporated by reference to Exhibit 10.3 to the Company&#8217;s
                  Current Report on Form 8-K filed with the SEC on March 16, 2016].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-4.htm">10.17+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2016, effective March 10, 2016 [incorporated by reference to Exhibit 10.4 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-5.htm">10.18+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Form of Restricted Stock Agreement [incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000004/exhibit99-1.htm">10.19+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Long-Term Incentive Plan for Senior Management for 2017, effective March 24, 2017 [incorporated by reference to Exhibit 99.1 to the Company&#8217;s
                  Current Report on Form 8-K/A filed with the SEC on February 9, 2018.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597817000011/exhibit99-2.htm">10.20+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Long &#8211;Term Incentive Plan for Senior Management for 2017, effective March 24, 2017 [incorporated by reference to Exhibit 99.2 to
                  the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 30, 2017.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597817000011/exhibit99-3.htm">10.21+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2017, effective March 24, 2017 [incorporated by reference to Exhibit 99.3 to the Company&#8217;s
                  Current Report on Form 8-K filed with the SEC on March 30, 2017.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597817000011/exhibit99-4.htm">10.22+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2017, effective March 24, 2017 [incorporated by reference to Exhibit 99.4 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on March 30, 2017.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000018/exhibit99-1.htm">10.23+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2018, effective April 9, 2018 [incorporated by reference to Exhibit 99.1 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on April 12, 2018.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000018/exhibit99-2.htm">10.24+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2018, effective April 9, 2018 [incorporated by reference to Exhibit 99.2 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on April 12, 2018.]</div>
              </td>

  </tr>


</table>
        <div><br /></div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">71</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Number</div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000018/exhibit99-3.htm">10.25+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Cash/RSA Bonus Plan for Senior Management for 2018, effective April 9, 2018 [incorporated by reference to Exhibit 99.3 to the Company&#8217;s
                  Current Report on Form 8-K filed with the SEC on April 12, 2018.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000018/exhibit99-4.htm">10.26+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Cash/RSA Bonus Plan for Senior Management for 2018, effective April 9, 2018 [incorporated by reference to Exhibit 99.4 to the
                  Company&#8217;s Current Report on Form 8-K filed with the SEC on April 12, 2018.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036117042646/ex99_2.htm">10.27+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Second Amended and Restated Credit Agreement dated as of November 10, 2017 among the Company, as Borrower, Bank of America, N.A. as Administrative Agent and the Lenders Patty
                  (incorporated by reference to Exhibit 99.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 14, 2017).</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000017/exhibit10-1.htm">10.28+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Second Amended and Restated Employment Agreement by and between the Company and Christopher J. Reading dated effective February 9, 2016 [incorporated by reference to Exhibit
                  10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on February 12, 2016].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000017/exhibit10-2.htm">10.29+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Second Amended and Restated Employment Agreement by and between the Company and Lawrance W. McAfee dated effective February 9, 2016 [incorporated by reference to Exhibit 10.2
                  to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on February 12, 2016].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000017/exhibit10-3.htm">10.30+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Amended and Restated Employment Agreement by and between the Company and Glenn D. McDowell dated effective February 9, 2016 [incorporated by reference to Exhibit 10.3 to the
                  Company&#8217;s Current Report on Form 8-K, filed with the SEC on February 12, 2016].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000006/exhibit10-1.htm">10.31+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Employment Agreement commencing on March 1, 2018 by and between the Company and Graham Reeve [incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on
                  Form 8-K filed with the SEC on March 7, 2018].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119004598/ex99_1.htm">10.32+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Objective Long-Term Incentive Plan for Senior Management [incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 8,
                  2019.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119004598/ex99_2.htm">10.33+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Discretionary Long-Term Incentive Plan for Senior Management [incorporated by reference to Exhibit 99.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on
                  March 8, 2019.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119004598/ex99_3.htm">10.34+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Objective Cash/RSA Bonus Plan for Senior Management [incorporated by reference to Exhibit 99.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 8,
                  2019.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119004598/ex99_4.htm">10.35+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Discretionary Cash/RSA Bonus Plan for Senior Management [incorporated by reference to Exhibit 99.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 8,
                  2019.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_1.htm">10.36+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Third Amended and Restated Employment Agreement by and between the Company and Christopher J. Reading dated effective May 21, 2019 [incorporated by reference to Exhibit 10.1
                  to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 22, 2019]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_2.htm">10.37+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Third Amended and Restated Employment Agreement by and between the Company and Lawrance W. McAfee dated effective May 21, 2019 [incorporated by reference to Exhibit 10.2 to
                  the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 22, 2019]</div>
              </td>

  </tr>


</table>
        <div><br /></div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">72</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Number</div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_3.htm">10.38+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Second Amended and Restated Employment Agreement by and between the Company and Glenn D. McDowell dated effective May 21, 2019 [incorporated by reference to Exhibit 10.3 to
                  the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 22, 2019]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_4.htm">10.39+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Amended &amp; Restated Employment Agreement commencing by and between the Company and Graham Reeve dated effective May 21, 2019 [incorporated by reference to Exhibit 10.4 to
                  the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 22, 2019]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_5.htm">10.40+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Restricted Stock Agreement [incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 22, 2019]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_1.htm">10.41+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.1 to the
                  Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120007017/ex10_1.htm">10.42+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Amendment to Employment Agreement entered into as of March 26, 2020 by and between the Company and Christopher Reading [incorporated by reference to Exhibit 10.3 to the
                  Company Current Report on Form 8-K filed with the SEC on March 26, 2020].</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 9%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 1.23%; vertical-align: middle;">&#160;</td>

    <td rowspan="1" style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120007017/ex10_2.htm">10.43+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Amendment to Employment Agreement entered into as of March 26, 2020 by and between the Company and Lawrance McAfee [incorporated by reference to Exhibit 10.3 to the Company
                  Current Report on Form 8-K filed with the SEC on March 26, 2020].</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 9%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 1.23%; vertical-align: middle;">&#160;</td>

    <td rowspan="1" style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120007017/ex10_3.htm">10.44+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Amendment to Employment Agreement entered into as of March 26, 2020 by and between the Company and Glenn McDowell [incorporated by reference to Exhibit 10.3 to the Company
                  Current Report on Form 8-K filed with the SEC on March 26, 2020].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120007017/ex10_4.htm">10.45+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Amendment to Employment Agreement entered into as of March 26, 2020 by and between the Company and Graham Reeve [incorporated by reference to Exhibit 10.4 to the Company
                  Current Report on Form 8-K filed with the SEC on March 26, 2020].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_1.htm">10.46+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.1 to the
                  Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_2.htm">10.47+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.2 to the
                  Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_3.htm">10.48+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Objective Cash/RSA Bonus Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.3 to the Company
                  Current Report on Form 8-K filed with the SEC on March 6, 2020].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_4.htm">10.49+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">U. S. Physical Therapy, Inc. Discretionary Cash/RSA Bonus Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.4 to the
                  Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597820000037/ex10-1.htm">10.50+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Employment Agreement entered into as of November 9, 2020 by and between U.S. Physical Therapy and Carey Hendrickson [incorporated by reference to Exhibit 10.1 to the Company
                  Current Report on Form 8-K filed with the SEC on September 23, 2020.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597820000037/ex10-2.htm">10.51+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Consulting Agreement entered into as of September 22, 2020 by and between U.S. Physical Therapy and Lawrence McAfee [incorporated by reference to Exhibit 10.1 to the Company
                  Current Report on Form 8-K filed with the SEC on September 23, 2020.]</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 9%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 1.23%; vertical-align: middle;">&#160;</td>

    <td rowspan="1" style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center; background-color: rgb(204, 238, 255);"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597820000054/ex10-1.htm">10.52+</a></td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Employment Agreement by and between the Company and Eric Williams entered into on December 3, 2020 and commencing as of July 1, 2021 [filed by reference to Exhibit 10.1 to
                  the Company Current Report on Form 8-K filed with the SEC on December 7, 2020.]</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td rowspan="1" style="width: 1.23%; vertical-align: middle;">&#160;</td>

    <td rowspan="1" style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036121003360/brhc10019729_ex10-1.htm">10.53+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">First Amendment to Second Amended and Restated Credit Agreement [filed by reference to Exhibit 10.1 to the Company Current Report on Form 8-K filed with the SEC on February
                  4, 2021.]</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; text-align: center;">&#160;</td>

    <td style="width: 1.23%; vertical-align: middle;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="brhc10034321_ex10-54.htm">10.54+</a></div>
              </td>

    <td style="width: 1.23%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#8203;</div>
              </td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;Second Amendment to Second Amended and Restated Credit Agreement. *</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">73</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Number</div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="brhc10034321_ex21-1.htm">21.1*</a></div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Subsidiaries of the Registrant</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="brhc10034321_ex23-1.htm">23.1*</a></div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Consent of Independent Registered Public Accounting Firm&#8212;Grant Thornton LLP</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="brhc10034321_ex31-1.htm">31.1*</a></div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="brhc10034321_ex31-2.htm">31.2*</a></div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="brhc10034321_ex31-3.htm">31.3*</a></div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Certification of Controller pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="brhc10034321_ex32-1.htm">32.1*</a></div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Certification of Periodic Report of the Chief Executive Officer, Chief Financial Officer and Controller pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as
                  amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">101.INS*</div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">XBRL Instance Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">101.SCH*</div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">XBRL Taxonomy Extension Schema Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">101.CAL*</div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">XBRL Taxonomy Extension Calculation Linkbase Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">101.DEF*</div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">XBRL Taxonomy Extension Definition Linkbase Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">101.LAB*</div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">XBRL Taxonomy Extension Label Linkbase Document</div>
              </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top;">&#160;</td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">101.PRE*</div>
              </td>

    <td colspan="1" style="width: 1.23%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">XBRL Taxonomy Extension Presentation Linkbase Document</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">*</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Filed herewith</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div><br />
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                  <div>+</div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div>Management contract or compensatory plan or arrangement.</div>
                </td>

  </tr>


</table>
          <div> <br />
          </div>

        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">74</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div><br />
    </div>


    <ix:nonNumeric name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="Text_ed4d2d6d59cb44fd8590582c0bbac61c" contextRef="c20210101to20211231" escape="true" continuedAt="Text_ca4e1350b10647d8842795051b21dab01">
<div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FINANCIAL STATEMENT SCHEDULE*<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
      </span>U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>
</ix:nonNumeric>
    <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab01" continuedAt="Text_ca4e1350b10647d8842795051b21dab02">
<div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(In Thousands)</div>
</ix:continuation>
    <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab02" continuedAt="Text_ca4e1350b10647d8842795051b21dab03">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab03" continuedAt="Text_ca4e1350b10647d8842795051b21dab04">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balance at</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Beginning of Period</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additions Charged</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">to Costs and Expenses</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additions Charged</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">to Other Accounts</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Deductions</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balance at</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">End of Period</div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, <span style="text-indent: 0pt;">2021</span>:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses<sup>(1)</sup></div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_c01876b255b44fc4addc1ae57a419973" contextRef="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,008</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" id="Fact_8de08e8ccc1c42ecaf1889065dc51e35" contextRef="c20210101to20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,305</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" id="Fact_e8f8cd6e34b64aacafe0bf288bec27e7" contextRef="c20210101to20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" id="Fact_bc6028d882ea464b935160a3eb31031e" contextRef="c20210101to20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,545</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_f380bf553cd346c2a31ac62f1d843646" contextRef="c20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,768</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, <span style="text-indent: 0pt;">2020</span>:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_e313c40db53241b49b00979ec95e5131" contextRef="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,698</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" id="Fact_4bb44463732242d7819623b6d011af8b" contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,623</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" id="Fact_dfa002bdb3ce4d798b1df8c05aff1aaf" contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" id="Fact_dc991caa78a94c51a59fc0fa43e35e3d" contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,313</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_aefbb5579ec74ddd88e80782a748d3fa" contextRef="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,008</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, <span style="text-indent: 0pt;">2019</span>:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_4dcaca7942714fe2b80416f647772054" contextRef="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,672</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" id="Fact_7907a7e78c0b4602816a43afc63edd09" contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,858</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" id="Fact_9b1d4af990444450b191c74057568949" contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" id="Fact_0ce3ac6e75f540dab212aacd9f1cb8fb" contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,832</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_803154198e1f41399684f978343a471a" contextRef="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,698</ix:nonFraction></div>
          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab04" continuedAt="Text_ca4e1350b10647d8842795051b21dab05">
<div><br />
    </div>
</ix:continuation>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab05" continuedAt="Text_ca4e1350b10647d8842795051b21dab06"><hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: left; border: none; margin-left: 0px; margin-right: auto;" /></ix:continuation></div>

    <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab06" continuedAt="Text_ca4e1350b10647d8842795051b21dab07">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_c1daa8198f5247f8b265a5b321d9c423" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Related to patient accounts receivable and accounts
              receivable-other.</ix:footnote></div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab07" continuedAt="Text_ca4e1350b10647d8842795051b21dab08">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_48f584180c61464eac6330240454329a" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Uncollectible accounts written off, net of
              recoveries.</ix:footnote></div>
          </td>

  </tr>


</table>
</ix:continuation>
    <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab08" continuedAt="Text_ca4e1350b10647d8842795051b21dab09">
<div><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_ca4e1350b10647d8842795051b21dab09">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">All other schedules are omitted because of the absence of conditions under which they are required or because the required information is shown in the financial
              statements or notes thereto.</div>
          </td>

  </tr>


</table>
</ix:continuation>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">75</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><a id="SIGNATURES"><!--Anchor--></a>SIGNATURES</div>

    <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
    </div>

    <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
      the undersigned, thereunto duly authorized.</div>

    <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">U.S. PHYSICAL THERAPY, INC.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Registrant)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
          </td>

    <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Carey Hendrickson</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Carey Hendrickson</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Chief Financial Officer</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 45%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Principal Financial Officer and Principal Accounting Officer)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom; text-align: center;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
          </td>

    <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Jon C. Bates</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Jon C. Bates</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 45%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Vice President/Controller</div>
          </td>

  </tr>


</table>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);"> <br />
    </div>

    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);">Date: March 1, 2022</div>

    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);"> <br />
    </div>

    <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the
      capacities indicated as of the date indicated above.</div>

    <div style="text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Chris J. Reading</div>
          </td>

    <td rowspan="2" style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Chief Executive Officer, President and Director</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Principal Executive Officer)</div>
          </td>

    <td rowspan="2" style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Chris J. Reading</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Edward L. Kuntz</div>
          </td>

    <td rowspan="2" style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Chairman of the Board</div>
          </td>

    <td rowspan="2" style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Edward L. Kuntz</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Mark J. Brookner</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Director</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Mark J. Brookner</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: middle;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Harry S. Chapman</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Director</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Harry S. Chapman</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Bernard A. Harris</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Director</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Dr. Bernard A. Harris, Jr.</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">76</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div><span style="font-size: 8pt; font-style: italic;"><a href="#TableofContents">Table of Contents</a></span><br />
        </div>

      </div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Kathleen A. Gilmartin</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Director</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Kathleen A. Gilmartin</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Anne Motsenbocker</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Director</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Anne Motsenbocker</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Reginald E. Swanson</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Director</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Reginald E. Swanson</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Clayton K. Trier</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Director</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">March 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Clayton K. Trier</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
          </td>

    <td style="width: 20%; vertical-align: top;">
            <div>&#160;</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div><br />
    </div>

    <div style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);" class="DSPFPageNumber">77</span> </div>

    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  </div>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>brhc10034321_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">EXHIBIT 4.1</div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The Company&#8217;s authorized capital stock consists of 500,000 shares of preferred stock, par value $0.01 per share (the &#8220;Preferred
        Stock&#8221;), and 20,000,000 Common Stock.</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The following is a summary of the material provisions of the Company&#8217;s Certificate of Incorporation, as amended (the
        &#8220;Certificate of Incorporation&#8221;) and Amended and Restated By-laws (the &#8220;By-laws&#8221;), insofar as they relate to the material terms of the Common</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Stock. This description summarizes the material terms and provisions of the Common Stock, but it is not complete. This summary
        is qualified in its entirety by reference to the Certificate of Incorporation and By-laws, which are incorporated herein by reference.</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Each holder of the Common Stock is entitled to one vote for each share on all matters to be voted upon by the stockholders and
        there are no cumulative voting rights. In the event of a liquidation, dissolution or winding up of the Company, holders of the Common</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Stock would be entitled to share in the Company&#8217;s assets remaining after the payment of the Company&#8217;s debts and liabilities.
        Holders of the Common Stock have no preemptive or conversion rights or other subscription rights and there are no redemption or sinking fund provisions applicable to the Common Stock. The rights, preferences and privileges of the holders of the
        Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of Preferred Stock that we may designate in the future.</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The Common Stock is not convertible into, or exchangeable for, any other class or series of the Company&#8217;s capital stock.
        Holders of the Common Stock do not have preemptive or other rights to subscribe for or purchase additional securities of the Company. Certain provisions of the Company&#8217;s articles of incorporation and bylaws may delay, discourage, prevent or render
        more difficult an attempt to obtain control of the Company, whether through a tender offer, business combination, proxy contest or otherwise. These provisions include the charter authorization of &#8220;blank check&#8221; preferred stock (as described above)
        and a restriction on the ability of stockholders to call a special meeting.</div>
      <div>&#160;</div>
      <div> <br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.54
<SEQUENCE>3
<FILENAME>brhc10034321_ex10-54.htm
<DESCRIPTION>EXHIBIT 10.54
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;">EXHIBIT 10.54</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SECOND AMENDMENT AND CONSENT</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">THIS SECOND AMENDMENT AND CONSENT TO SECOND AMENDED AND<font style="font-weight: bold;"> RESTATED CREDIT AGREEMENT </font>(this &#8220;Amendment&#8221;), dated as of November 30, 2021, is by and among <font style="font-weight: bold;">U.S. PHYSICAL THERAPY, INC.</font>, a Nevada corporation (the &#8220;Borrower&#8221;), the Lenders party hereto, and <font style="font-weight: bold;">BANK OF AMERICA, N.A.</font>, as administrative agent (in such capacity, the
          &#8220;Administrative Agent&#8221;). Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Credit Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">W I T N E S S E T H</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">WHEREAS</font>, the Borrower, certain banks and financial institutions from time to time party thereto (the &#8220;Lenders&#8221;), and the Administrative Agent are parties to that certain
          Second Amended and Restated Credit Agreement, dated as of November 10, 2017 (as amended, modified, extended, restated, replaced, or supplemented from time to time, the &#8220;Credit Agreement&#8221;);</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">WHEREAS</font>, pursuant to Section 7.03(f) of the Credit Agreement, the Borrower is permitted to make certain acquisitions upon and subject to certain terms and conditions,
          provided, among other restrictions, that the total cash and noncash consideration paid by or on behalf of the Borrower and its Subsidiaries for any such acquisition shall not exceed (a) $25,000,000 for any single acquisition, and (b) when
          aggregated with all other acquisitions made by the Borrower and its Subsidiaries in such fiscal year, $50,000,000 in any fiscal year (such restriction, the &#8220;Consideration Cap&#8221;);</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">WHEREAS</font>, it is now proposed that a Subsidiary of the Borrower, U.S. Physical Therapy, Ltd., a Texas limited partnership (&#8220;USPT&#8221;) acquire (a) 70% of the issued and outstanding
          capital stock of ProgressiveHealth Companies, LLC, a Delaware limited liability company, (b) 70% of the issued and outstanding capital stock of ProgressiveHealth Aviation Services, LLC, an Indiana limited liability company, and (c) 51% of the
          issued and outstanding capital stock of ProgressiveHealth HealthSpot, LLC, an Indiana limited liability company, for the aggregate purchase price of $63,161.800.00 at closing, with an additional $2,000,000.00 payable after closing only upon the
          satisfaction of certain terms and conditions (collectively, the &#8220;Progressive Acquisition&#8221;); and</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">WHEREAS</font>, the Borrower has requested (a) that the Administrative Agent and the Lenders consent to the Progressive Acquisition, (b) an Incremental Facility, in accordance with
          the terms of Section 2.16 of the Credit Agreement, in the amount of $25,000,000.00, and (c) that the Lenders amend certain provisions of the Credit Agreement, and the Lenders are willing to consent to all of the foregoing, in accordance with and
          subject to the terms and conditions set forth herein.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">NOW, THEREFORE</font>, in consideration of the agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby
          acknowledged, the parties hereto agree as follows:</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ARTICLE I</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">AMENDMENTS TO CREDIT AGREEMENT</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">1.1. Amendments to Section 1.1. </font>Section 1.1 of the Credit Agreement is hereby amended as follows:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(a) The following definitions are hereby deleted from Section 1.1 of the Credit Agreement: &#8220;LIBOR Replacement Date&#8221;; &#8220;LIBOR Successor Rate&#8221;; &#8220;LIBOR Successor Rate Conforming Changes&#8221;; &#8220;Pre-Adjustment Successor
          Rate&#8221;; &#8220;Related Adjustment&#8221;; and &#8220;SOFR&#8221;.</div>
        <div style="margin-left: 4.5pt; color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);">(b) The following definitions are hereby added to Section 1.1 of the Credit Agreement in the appropriate alphabetical order:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Available Tenor&#8221;</u> means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if the then-current Benchmark is a term rate, any tenor for such Benchmark that is
          or may be used for determining the length of an Interest Period or (y) otherwise, any payment period for interest calculated with reference to such Benchmark, as applicable, pursuant to this Agreement as of such date.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Benchmark&#8221;</u> means, initially, LIBOR; provided that if a replacement of the Benchmark has occurred pursuant to Section 3.03(c) then &#8220;Benchmark&#8221; means the applicable Benchmark Replacement to the extent that
          such Benchmark Replacement has replaced such prior benchmark rate. Any reference to &#8220;Benchmark&#8221; shall include, as applicable, the published component used in the calculation thereof.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Benchmark Replacement&#8221;</u> means:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(1) For purposes of Section 3.03(c)(i), the first alternative set forth below that can be determined by the Administrative Agent:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(a) the sum of: (i) Term SOFR and (ii) 0.11448% (11.448 basis points) for an Available Tenor of one-month&#8217;s duration, 0.26161% (26.161 basis points) for an Available Tenor of three-months&#8217; duration, and 0.42826%
          (42.826 basis points) for an Available Tenor of six-months&#8217; duration, or</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(b) the sum of: (i) Daily Simple SOFR and (ii) 0.26161% (26.161 basis points);</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>provided</u> that, if initially LIBOR is replaced with the rate contained in clause (b) above (Daily Simple SOFR plus the applicable spread adjustment) and subsequent to such replacement, the Administrative
          Agent determines that Term SOFR has become available and is administratively feasible for the Administrative Agent in its sole discretion, and the Administrative Agent notifies the Borrower and each Lender of such availability, then from and
          after the beginning of the Interest Period, relevant interest payment date or payment period for interest calculated, in each case, commencing no less than thirty (30) days after the date of such notice, the Benchmark Replacement shall be as set
          forth in clause (a) above; and</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(2) For purposes of Section 3.03(c)(ii), the sum of (a) the alternate benchmark rate and</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(b) an adjustment (which may be a positive or negative value or zero), in each case, that has been selected by the Administrative Agent and the Borrower as the replacement Benchmark giving due consideration to any
          evolving or then prevailing market convention, including any applicable recommendations made by a Relevant Governmental Body, for U.S. dollar-denominated syndicated credit facilities at such time; provided that, if the Benchmark Replacement as
          determined pursuant to clause (1) or 0 above would be less than 0.25%, the Benchmark Replacement will be deemed to be 0.25% for the purposes of this Agreement and the other Loan Documents.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">Any Benchmark Replacement shall be applied in a manner consistent with market practice; provided that to the extent such market practice is not administratively feasible for the Administrative Agent, such Benchmark
          Replacement shall be applied in a manner as otherwise reasonably determined by the Administrative Agent.</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Benchmark Replacement Conforming Changes&#8221; </u>means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;Base Rate,&#8221; the
          definition of &#8220;Business Day,&#8221; the definition of &#8220;Interest Period,&#8221; timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and
          length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent decides may be appropriate to reflect the adoption and implementation of such
          Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is
          not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Administrative Agent decides is reasonably
          necessary in connection with the administration of this Agreement and the other Loan Documents).</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Benchmark Transition Event&#8221;</u> means, with respect to any then-current Benchmark other than LIBOR, the occurrence of a public statement or publication of information by or on behalf of the administrator of the
          then-current Benchmark or a Governmental Authority with jurisdiction over such administrator announcing or stating that all Available Tenors are or will no longer be representative, or made available, or used for determining the interest rate of
          loans, or shall or will otherwise cease, provided that, at the time of such statement or publication, there is no successor administrator that is satisfactory to the Administrative Agent, that will continue to provide any representative tenors of
          such Benchmark after such specific date.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Daily Simple SOFR&#8221;</u> with respect to any applicable determination date means the secured overnight financing rate (&#8220;SOFR&#8221;) published on such date by the Federal Reserve Bank of New York, as the administrator
          of the benchmark (or a successor administrator) on the Federal Reserve Bank of New York&#8217;s website (or any successor source).</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Early Opt-in Effective Date&#8221;</u> means, with respect to any Early Opt-in Election, the sixth (6th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, so long as the
          Administrative Agent has not received, by 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, written notice of objection to such Early Opt-in Election
          from Lenders comprising the Required Lenders.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Early Opt-in Election&#8221;</u> means the occurrence of:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(1) a determination by the Administrative Agent, or a notification by the Borrower to the Administrative Agent that the Borrower has made a determination, that U.S. dollar-denominated syndicated credit facilities
          currently being executed, or that include language similar to that contained in Section 3.03(c), are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace LIBOR, and</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(2) the joint election by the Administrative Agent and the Borrower to replace LIBOR with a Benchmark Replacement and the provision by the Administrative Agent of written notice of such election to the Lenders.</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Other Rate Early Opt-in&#8221;</u> means the Administrative Agent and the Borrower have elected to replace LIBOR with a Benchmark Replacement other than a SOFR-based rate pursuant to (1) an Early Opt-in Election and
          (2) Section 3.03(c)(ii) and paragraph (2) of the definition of &#8220;Benchmark Replacement&#8221;.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Rescindable Amount&#8221;</u> has the meaning as defined in Section 2.12(b)(i).</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Second Amendment Effective Date&#8221;</u> means November 30, 2021.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;SOFR Early Opt-in&#8221;</u> means the Administrative Agent and the Borrower have elected to replace LIBOR pursuant to (1) an Early Opt-in Election and (2) Section 3.03(c)(i) and paragraph (1) of the definition of
          &#8220;Benchmark Replacement&#8221;.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(c) The following definitions set forth in Section 1.1 of the Credit Agreement are hereby amended and restated in their entirety to read as follows:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Relevant Governmental Body&#8221;</u> means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of
          the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><u>&#8220;Term SOFR&#8221;</u> means, for the applicable corresponding tenor (or if any Available Tenor of a Benchmark does not correspond to an Available Tenor for the applicable Benchmark Replacement, the closest
          corresponding Available Tenor and if such Available Tenor corresponds equally to two Available Tenors of the applicable Benchmark Replacement, the corresponding tenor of the shorter duration shall be applied), the forward looking term rate based
          on SOFR that has been selected or recommended by the Relevant Governmental Body.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(d) The last sentence of the definition of &#8220;Commitment&#8221; set forth in Section 1.1 of the Credit Agreement is hereby amended and restated to read in its entirety as follows: &#8220;As of the Second Amendment Effective
          Date, the Commitment of all of the Lenders shall be $150,000,000.00.&#8221;</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(e) The definition of &#8220;Interest Period&#8221; set forth in Section 1.1 of the Credit Agreement is hereby amended to delete the reference to &#8220;two (2),&#8221; set forth therein.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">1.2. </font>Amendment to Section 2.12(b)(i). Section 2.12(b)(i) of the Credit Agreement is hereby amended and restated to read in its entirety as follows:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(i) <u>Payments by Borrower; Presumptions by Administrative Agent</u>.&#160; Unless the Administrative Agent shall have received notice from the Borrower prior to the date on which any payment is due to the
          Administrative Agent for the account of the Lenders or the L/C Issuer hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may,
          in reliance upon such assumption, distribute to the Appropriate Lenders or the L/C Issuer, as the case may be, the amount due. With respect to any payment that the Administrative Agent makes for the account of the Lenders or the L/C Issuer
          hereunder as to which the Administrative Agent determines (which determination shall be conclusive absent manifest error) that any of the following applies (such payment referred to as the <u>&#8220;Rescindable Amount&#8221;)</u> : (1) the Borrower has not
          in fact made such payment; (2) the Administrative Agent has made a payment in excess of the amount so paid by the Borrower (whether or not then owed); or (3) the Administrative agent has for any reason otherwise erroneously made such payment;
          then each of the Lenders or the L/C Issuer, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount so distributed to such Lender or the L/C Issuer, in immediately available funds with
          interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Rate and a rate determined by the Administrative
          Agent in accordance with banking industry rules on interbank compensation.<br>
          <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">1.3. </font>Amendment to Section 2.16(a). Section 2.16(a) of the Credit Agreement is hereby amended and restated to read in its entirety as follows:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(a) Request for Increase. Provided there exists no Default, upon notice to the Administrative Agent (which shall promptly notify the Lenders), the Borrower may from time to time after the Second Amendment Effective
          Date request an increase in the Revolving Facility by an amount (for all such requests) not exceeding $25,000,000 (an &#8220;Incremental Facility&#8221;); provided that (i) any such request for an Incremental Facility shall be in a minimum amount of
          $5,000,000 or any whole multiple of $500,000 in excess thereof, and (ii) the Borrower may make a maximum of four (4) such requests. At the time of sending such notice, the Borrower (in consultation with the Administrative Agent) shall specify the
          time period within which each Lender is requested to respond (which shall in no event be less than ten (10) Business Days from the date of delivery of such notice to the Lenders).</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">1.4. </font>Amendments to Section 3.03. Sections 3.03(d) and 3.03(e) of the Credit Agreement are hereby deleted, and Section 3.03(c) of the Credit Agreement is hereby amended and
          restated to read in its entirety as follows:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(c) Notwithstanding anything to the contrary herein or in any other Loan Document:</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(i) On March 5, 2021 the Financial Conduct Authority (&#8220;FCA&#8221;), the regulatory supervisor of LIBOR&#8217;s administrator (&#8220;IBA&#8221;), announced in a public statement the future cessation or loss of representativeness of
          overnight/Spot Next, 1-week, 1-month, 2-month, 3-month, 6-month and 12- month U.S. dollar LIBOR tenor settings. On the earliest of (A) the date that all Available Tenors of U.S dollar LIBOR have permanently or indefinitely ceased to be provided
          by IBA or have been announced by the FCA pursuant to public statement or publication of information to be no longer representative, (B) June 30, 2023 and (C) the Early Opt-in Effective Date in respect of a SOFR Early Opt-in, if the then-current
          Benchmark is LIBOR, the Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any setting of such Benchmark on such day and all subsequent settings without any amendment to, or
          further action or consent of any other party to this Agreement or any other Loan Document. If the Benchmark Replacement is Daily Simple SOFR, all interest payments will be payable on a quarterly basis.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(ii) (x) Upon (A) the occurrence of a Benchmark Transition Event or (B) a determination by the Administrative Agent that neither of the alternatives under clause (1) of the&#160; definition of Benchmark Replacement are
          available, the Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder&#160; and under any Loan Document in respect of any Benchmark setting at or after 5:00 p.m. on the fifth (5th) Business Day after the date notice
          of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time,
          written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders (and any such objection shall be conclusive and binding absent manifest error); provided that solely in the event that the then-current
          Benchmark at the time of such Benchmark Transition Event is not a SOFR-based rate, the Benchmark Replacement therefor shall be determined in accordance with clause (1) of the definition of Benchmark Replacement unless the Administrative Agent
          determines that neither of such alternative rates is available.</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);">(y) On the Early Opt-in Effective Date in respect of an Other Rate Early Opt-in, the Benchmark Replacement will replace LIBOR for all purposes hereunder and under any Loan Document in respect of any setting of such
          Benchmark on such day and all subsequent settings without any amendment to, or further action or consent of any other party to this Agreement or any other Loan Document.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(iii) At any time that the administrator of the then-current Benchmark has permanently or indefinitely ceased to provide such Benchmark or such Benchmark has been announced by the regulatory supervisor for the
          administrator of such Benchmark pursuant to public statement or publication of information to be no longer representative of the underlying market and economic reality that such Benchmark is intended to measure and that representativeness will
          not be restored, the Borrower may revoke any request for a borrowing of, conversion to or continuation of Loans to be made, converted or continued that would bear interest by reference to such Benchmark until the Borrower&#8217;s receipt of notice from
          the Administrative Agent that a Benchmark Replacement has replaced such Benchmark, and, failing that, the Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to Base Rate Loans. During the
          period referenced in the foregoing sentence, the component of Base Rate based upon the Benchmark will not be used in any determination of Base Rate.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(iv) In connection with the implementation and administration of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and,
          notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this
          Agreement.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(v) The Administrative Agent will promptly notify the Borrower and the Lenders of</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(A) the implementation of any Benchmark Replacement and (B) the effectiveness of any Benchmark Replacement Conforming Changes. Any determination, decision or election that may be made by the Administrative Agent
          pursuant to this Section 3.03(c), including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action, will be
          conclusive and binding absent manifest error and may be made in its sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section 3.03(c). At any time (including in
          connection with the implementation of a Benchmark Replacement),</div>
        <div><br>
        </div>
        <div>
          <div style="color: rgb(0, 0, 0); text-indent: 18pt;">(A)&#160;&#160; if the then-current Benchmark is a term rate (including Term SOFR or LIBOR), then the Administrative Agent may remove any tenor of such Benchmark that is unavailable or nonrepresentative</div>
        </div>
        <div style="color: rgb(0, 0, 0);">for Benchmark (including Benchmark Replacement) settings and</div>
        <div><br>
        </div>
        <div>
          <div style="text-indent: 18pt;">(B) &#160; theAdministrative Agent may reinstate any such previously removed tenor for Benchmark (including Benchmark Replacement) settings.</div>
        </div>
        <div>&#160;</div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">1.5. </font>Addition of New Section 9.13. A new Section 9.13 is hereby added to the Credit Agreement, immediately following Section 9.12 thereof, to read in its entirety as
          follows:</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">9.13 Recovery of Erroneous Payments.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">Without limitation of any other provision in this Agreement, if at any time the Administrative Agent makes a payment hereunder in error to any Lender or the L/C Issuer (the &#8220;Credit Party&#8221;), whether or not in
          respect of an Obligation due and owing by the Borrower at such time, where such payment is a Rescindable Amount, then in any such event, each Credit Party receiving a Rescindable Amount severally agrees to repay to the Administrative Agent
          forthwith on demand the Rescindable Amount received by such Credit Party in immediately available funds in the currency so received, with interest thereon, for each day from and including the date such Rescindable Amount is received by it to but
          excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation. Each Credit Party
          irrevocably waives any and all defenses, including any &#8220;discharge for value&#8221; (under which a creditor might otherwise claim a right to retain funds mistakenly paid by a third party in respect of a debt owed by another) or similar defense to its
          obligation to return any Rescindable Amount. The Administrative Agent shall inform each Credit Party promptly upon determining that any payment made to such Credit Party comprised, in whole or in part, a Rescindable Amount.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">1.6. </font>Amendment to Schedule 1.01(a). Schedule 1.01(a) to the Credit Agreement is hereby replaced with the Schedule 1.01(a) attached hereto for all purposes under the Credit
          Agreement, and any reference to Schedule 1.01(a) in any Loan Document shall refer to the Schedule 1.01(a) attached hereto.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">1.7. </font>Amendment to Schedule 1.01(b). Schedule 1.01(b) to the Credit Agreement is hereby replaced with the Schedule 1.01(b) attached hereto for all purposes under the Credit
          Agreement, and any reference to Schedule 1.01(b) in any Loan Document shall refer to the Schedule 1.01(b) attached hereto.</div>
        <div><br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ARTICLE II</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">CONSENT</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">2.1. Consent</font>. Notwithstanding anything in the Credit Agreement to the contrary (including, without limitation, the Consideration Cap), and subject to the effectiveness of
          this Amendment, the Administrative Agent and each Lender hereby consent to the Progressive Acquisition. Other than as expressly set forth herein, nothing contained herein shall be construed as a consent to or waiver of any other term, covenant or
          provision of the Credit Agreement or any other Loan Document. Nothing contained herein shall affect or diminish the right of the Administrative Agent and the Lenders to require strict performance by the Borrower of each provision of each Loan
          Document to which the Borrower is a party, except as expressly provided herein. All terms and provisions and all rights and remedies of the Administrative Agent and the Lenders under the Loan Documents shall continue in full force and effect and
          are hereby confirmed and ratified in all respects, except as expressly provided herein. </div>
        <div><br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ARTICLE III</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">CONDITIONS TO EFFECTIVENESS</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">3.1. Closing Conditions</font>. This Amendment shall become effective as of the day and year set forth above (the &#8220;Amendment Effective Date&#8221;) upon satisfaction of the following
          conditions (in each case, in form and substance reasonably acceptable to the Administrative Agent):</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(a) Executed Amendment. The Administrative Agent shall have received a copy of this Amendment duly executed by the Borrower, the Lenders, and the Administrative Agent.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(b) Progressive Acquisition Deliverables. The Administrative Agent shall have received such certificates, documents, and other deliverables as required under Section 7.03(f) of the Credit Agreement with respect to
          the Progressive Acquisition.</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);">(c) Incremental Facility Deliverables. The Administrative Agent shall have received such certificates, documents, and other deliverables as required under Section 2.16 of the Credit Agreement with respect to the
          Incremental Facility.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(d) Miscellaneous. All other documents and legal matters in connection with the transactions contemplated by this Amendment shall be reasonably satisfactory in form and substance to the Administrative Agent and its
          counsel.</div>
        <div><br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ARTICLE IV</div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">MISCELLANEOUS</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.1. Amended Terms. </font>On and after the Amendment Effective Date, all references to the Credit Agreement in each of the Loan Documents shall hereafter mean the Credit Agreement
          as amended by this Amendment. Except as specifically amended hereby or otherwise agreed, the Credit Agreement is hereby ratified and confirmed and shall remain in full force and effect according to its terms.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.2. Representations and Warranties of the Borrower. </font>The Borrower represents and warrants as follows: </div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(a) It has taken all necessary action to authorize the execution, delivery and performance of this Amendment.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(b) This Amendment has been duly executed and delivered by the Borrower and constitutes the Borrower&#8217;s legal, valid and binding obligation, enforceable in accordance with its terms.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(c) No approval, consent, exemption, authorization, or other action by, or notice to, or filing with, any Governmental Authority or any other Person is required in connection with the execution, delivery or
          performance by, or enforcement against, the Borrower of this Amendment.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(d) The representations and warranties set forth in Article V of the Credit Agreement</div>
        <div style="color: rgb(0, 0, 0);">are true and correct as of the date hereof (except for those which expressly relate to an earlier date).</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(e) No Default exists or would result from giving effect to this Amendment and the transactions contemplated hereby.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(f) Except as specifically provided in this Amendment, the Obligations are not reduced or modified by this Amendment and are not subject to any offsets, defenses or counterclaims.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.3. Reaffirmation of Obligations. </font>The Borrower hereby ratifies the Credit Agreement and acknowledges and reaffirms</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(a) that it is bound by all terms of the Credit Agreement applicable to it and</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">(b) that it is responsible for the observance and full performance of its respective Obligations.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.4. Loan Document. </font>This Amendment shall constitute a Loan Document under the terms of the Credit Agreement.</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.5. Expenses. </font>The Borrower agrees to pay all costs and expenses of the Administrative Agent in connection with the preparation, execution and delivery of this Amendment,
          including without limitation the fees and expenses of the Administrative Agent&#8217;s legal counsel, in accordance with Section 11.04(a) of the Credit Agreement.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.6. Further Assurances. </font>The Borrower agrees to promptly take such action, upon the request of the Administrative Agent, as is necessary to carry out the intent of this
          Amendment.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.7. Counterparts. </font>This Amendment may be executed in any number of counterparts, each of which when so executed and delivered shall be an original, but all of which shall
          constitute one and the same instrument. Delivery of an executed counterpart of a signature page of this Amendment or any other document required to be delivered hereunder, by fax transmission or e-mail transmission (e.g. &#8220;pdf&#8221; or &#8220;tif&#8221;) shall be
          effective as delivery of a manually executed counterpart of this Agreement. Without limiting the foregoing, upon the request of any party, such fax transmission or e-mail transmission shall be promptly followed by such manually executed
          counterpart.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.8. No Actions, Claims, Etc. </font>As of the date hereof, the Borrower hereby acknowledges and confirms that it has no knowledge of any actions, causes of action, claims,
          demands, damages and liabilities of whatever kind or nature, in law or in equity, against the Administrative Agent, the Lenders, or the Administrative Agent&#8217;s or the Lenders&#8217; respective officers, employees, representatives, agents, counsel or
          directors arising from any action by such Persons, or failure of such Persons to act under the Credit Agreement on or prior to the date hereof.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">4.9. GOVERNING LAW. THIS AMENDMENT SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF, THE STATE OF TEXAS.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.10. Successors and Assigns. </font>This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.11. Consent to Jurisdiction; Service of Process; Waiver of Jury Trial. </font>The jurisdiction, service of process and waiver of jury trial provisions set forth in Sections 11.14
          and 11.15 of the Credit Agreement are hereby incorporated by reference, <font style="font-style: italic;">mutatis mutandis</font>.</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">4.12. ENTIRE AGREEMENT</font>.</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL AGREEMENT AMONG THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE
          PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS AMONG THE PARTIES.</div>
        <div><br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0);">[Remainder of Page Intentionally Left Blank. Signature Pages Follow.]</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);">ADMINISTRATIVE AGENT: BANK OF AMERICA, N.A.,</div>
        <div style="color: rgb(0, 0, 0);">as Administrative Agent</div>
        <div style="color: rgb(0, 0, 0);">By:</div>
        <div style="color: rgb(0, 0, 0);">Alexander L. Rody</div>
        <div style="color: rgb(0, 0, 0);">Senior Vice President</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">Second Amendment and Consent to Second Amended and Restated Credit Agreement &#8211; Signature Page</div>
        <div style="color: rgb(0, 0, 0);">LENDERS: BANK OF AMERICA, N.A.,</div>
        <div style="color: rgb(0, 0, 0);">as a Lender, L/C Issuer and Swingline Lender</div>
        <div style="color: rgb(0, 0, 0);">By:</div>
        <div style="color: rgb(0, 0, 0);">Alexander L. Rody</div>
        <div style="color: rgb(0, 0, 0);">Senior Vice President</div>
        <div style="color: rgb(0, 0, 0);">Schedule 1.01(a)</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">SCHEDULE 1.01(a)</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">Certain Addresses for Notices</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">Borrower:</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">U.S. PHYSICAL THERAPY, INC.:</div>
        <div style="color: rgb(0, 0, 0);">1300 Sam Houston Parkway, Suite 300</div>
        <div style="color: rgb(0, 0, 0);">Houston, Texas 77042</div>
        <div style="color: rgb(0, 0, 0);">Attention: Larry McAfee</div>
        <div style="color: rgb(0, 0, 0);">Telephone: (713) 297-7021</div>
        <div style="color: rgb(0, 0, 0);">Telecopier: (713) 266-0558</div>
        <div style="color: rgb(0, 0, 0);">Electronic Mail: lmcafee@usph.com</div>
        <div style="color: rgb(0, 0, 0);">Website Address: www.usph.com</div>
        <div style="color: rgb(0, 0, 0);">U.S. Taxpayer Identification Number: 76.0364866</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">Administrative Agent:</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">For payments and Requests for Credit</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">Extensions</div>
        <div style="color: rgb(0, 0, 0);">Bank of America</div>
        <div style="color: rgb(0, 0, 0);">Gateway Village-900 Building</div>
        <div style="color: rgb(0, 0, 0);">NC1-026-06-09 (MacLegal)</div>
        <div style="color: rgb(0, 0, 0);">900 W Trade St</div>
        <div style="color: rgb(0, 0, 0);">Charlotte, NC 28255</div>
        <div style="color: rgb(0, 0, 0);">Account No.: 1366211001000</div>
        <div style="color: rgb(0, 0, 0);">Ref: U.S. Physical Therapy, Inc.</div>
        <div style="color: rgb(0, 0, 0);">ABA# 026009593</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">Other Notices for Administrative Agent</div>
        <div style="color: rgb(0, 0, 0);">Bank of America</div>
        <div style="color: rgb(0, 0, 0);">Gateway Village-900 Building</div>
        <div style="color: rgb(0, 0, 0);">NC1-026-06-09 (MacLegal)</div>
        <div style="color: rgb(0, 0, 0);">900 W Trade St</div>
        <div style="color: rgb(0, 0, 0);">Charlotte, NC 28255</div>
        <div style="color: rgb(0, 0, 0);">With a copy to:</div>
        <div style="color: rgb(0, 0, 0);">Bank of America</div>
        <div style="color: rgb(0, 0, 0);">TN9-120-24-03</div>
        <div style="color: rgb(0, 0, 0);">222 2nd Ave S, Suite 2440</div>
        <div style="color: rgb(0, 0, 0);">Nashville, TN 37201</div>
        <div style="color: rgb(0, 0, 0);">Attn: Alex Rody</div>
        <div style="color: rgb(0, 0, 0);">Phone: 615.749.3483</div>
        <div style="color: rgb(0, 0, 0);">Email: alex.rody@bofa.com</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">L/C Issuer:</div>
        <div style="color: rgb(0, 0, 0);">Bank of America</div>
        <div style="color: rgb(0, 0, 0);">Gateway Village-900 Building</div>
        <div style="color: rgb(0, 0, 0);">NC1-026-06-09 (MacLegal)</div>
        <div style="color: rgb(0, 0, 0);">900 W Trade St</div>
        <div style="color: rgb(0, 0, 0);">Charlotte, NC 28255</div>
        <div style="color: rgb(0, 0, 0); font-weight: bold;">Swingline Lender:</div>
        <div style="color: rgb(0, 0, 0);">Bank of America</div>
        <div style="color: rgb(0, 0, 0);">Gateway Village-900 Building</div>
        <div style="color: rgb(0, 0, 0);">NC1-026-06-09 (MacLegal)</div>
        <div style="color: rgb(0, 0, 0);">900 W Trade St</div>
        <div style="color: rgb(0, 0, 0);"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">

          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>

        </div>
        <div style="color: rgb(0, 0, 0);">Charlotte, NC 28255</div>
        <div style="color: rgb(0, 0, 0);">Schedule 1.01(b)</div>
        <div style="font-weight: bold; color: rgb(0, 0, 0);">SCHEDULE 1.01(b)</div>
        <div style="font-weight: bold; color: rgb(0, 0, 0);">Commitments and Applicable Percentages</div>
        <div style="font-weight: bold; color: rgb(0, 0, 0);">Lender Commitment Applicable Percentage</div>
        <div style="font-weight: bold; color: rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0); font-weight: bold;">(Loans)</div>
        </div>
        <div style="color: rgb(0, 0, 0);">Bank of America, N.A. $150,000,000.00 100.000000000%</div>
        <div style="font-weight: bold; color: rgb(0, 0, 0);">Total: $150,000,000.00 100.000000000%</div>
        <div style="color: rgb(0, 0, 0);"><br>
        </div>
        <div style="color: rgb(0, 0, 0);"><br>
        </div>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>brhc10034321_ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 21.1</font><br>
      </div>
      <div><br>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb9638b0610af4451bb765bf477d433ad">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Notes</div>
                  </div>
                </td>
                <td nowrap="nowrap" style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Name</div>
                  </div>
                </td>
                <td nowrap="nowrap" style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">DBA</div>
                  </div>
                </td>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Entity</div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Type</div>
                </td>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">State of</div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Formation</div>
                </td>
                <td nowrap="nowrap" style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Date of</div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Formation</div>
                  </div>
                </td>
                <td nowrap="nowrap" style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Foreign</div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Qualification</div>
                  </div>
                </td>
                <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">General Partner (LP)</div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">/BOD (corp)/Manging</div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Member or</div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Board of Managers (LLC)</div>
                  </div>
                </td>
                <td nowrap="nowrap" style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Tax ID</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">2037953 Ontario, Inc.</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Canada</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Briotix Health, LP</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Ability Health PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">FL</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">81-4216526</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Ability Health Services and Rehabilitation, L.P.</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Ability Rehabilitation</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Ability Health PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">38-4017532</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Achieve Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-3291851</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Achieve Physical Therapy and Performance, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Achieve Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-3283941</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Action Therapy Centers, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Action Physical Therapy</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Houston Hand Therapy&#160; &#160; PT Professionals</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0389610</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Adams County Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">PA</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0483100</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Advance Rehabilitation &amp; Consulting, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AL, FL &amp; GA</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Advance Rehabilitation Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-4414647</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Advance Rehabilitation Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-4414443</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Agape Physical Therapy &amp; Sports Rehabilitation, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MD</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Agape Physical Therapy Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">32-0378859</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Agape Physical Therapy Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">45-5378415</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Agility Spine &amp; Sports PT Management GP LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-10244870</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Agility Spine &amp; Sports Physical Therapy and Rehabilitation, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AZ</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Agility Spine &amp; Sports PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-0901134</div>
                  </div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div id="DSPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ARC Iowa PT Plus, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IA</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ARC PT Management GP, LLC (note:&#160; owned 100% by ARC Physical Therapy Plus, LP)</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-5241308</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ARC Physical Therapy Plus, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IA, KS, MO</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ARC PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">80-0955852</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ARC PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MO</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-3942987</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ARCH Physical Therapy and Sports Medicine, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-5086288</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Arrow Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Broken Arrow Physical Therapy</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OK</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0631992</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Arrowhead Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Elite Sports Medicine &amp; Physical Therapy</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MS</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-0176798</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Ashland Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OR</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">75-3054977</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Audubon Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LA</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0622471</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Barren Ridge Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">VA</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-3594831</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Bayside Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-4348787</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Bayside Physical Therapy &amp; Sports Rehabilitation, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MD</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Bayside Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-4348871</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Beaufort Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NC</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0639928</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Bow Physical Therapy &amp; Spine Center, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NH</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0623486</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Brazos Valley Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0407118</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Brick Hand &amp; Rehabilitative Services, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0420711</div>
                  </div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div id="DSPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Briotix Health, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">InSite Health (6/25/2020 - Per Cyndi M. and Leon P. this dba is no longer used).</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AL, AZ, CA, CO, CT, FL, GA, HI, IL, IA, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NV, NJ, NY, NC, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Briotix Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">81-1190407</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Briotix Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL, MA, OH, UT</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">81-1200727</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">BTE Workforce Solutions, LLC (formerly BTE Technoligies, Inc.)</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AK, AL,CO, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MD, ME, MI, MN, MO,MS, MT, NC, ND, NE, NH, NJ, NM, NV, OK, PA, RI, SC, SD, TX, UT, VT, WI,
                      WV, WY</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Briotix Health, LP</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">52-1165956</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">C. Foster Physical Therapists, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">C. Foster PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">36-4965660</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">C. Foster PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">35-2689219</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Cape Cod Hand Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Cape Cod Hand &amp; Upper Extremity Therapy</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MA</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-0058293</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Carbon County Therapy, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WY</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Fremont Therapy Group, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">85-2336515</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Carolina Physical Therapy and Sports Medicine, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">SC</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Carolina PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-1408170</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Carolina PT Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-1453799</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Center for Physical Rehabilitation and Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">CPR Management GP, LLC</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-4006118</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Cleveland Physical Therapy, Ltd.</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0410649</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Clinical Partnership Solutions, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProgressiveHealth Clinical Partnership Solutions</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-3006735</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Clinical Management Solutions, LLC</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProgressiveHealth Clinical Management Solutions</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">38-3975536</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Comprehensive Hand &amp; Physical Therapy, Limited Partnership</div>
                  </div>
                </td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                  </div>
                </td>
                <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                  </div>
                </td>
                <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                </td>
                <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL</div>
                  </div>
                </td>
                <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                  </div>
                </td>
                <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0452158</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7e312ab21625468ea5eb172eed0baa1e">

            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Coppell Spine &amp; Sports Rehab, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">North Davis/Keller Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy of Colleyville</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy of North Texas</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy of Corinth</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Trinity Sports &amp; Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy of Flower Mound</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Southlake Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy of Trophy Club</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Heritage Trace Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Therapy Partners of Frisco/Little Elm</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Therapy Partners of North Texas</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0513962</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">CPR Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-3434985</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Cross Creek Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MS</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">35-2185612</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Crossroads Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Green Oaks Physical Therapy - Fort Worth</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Green Oaks Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0551398</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Crossroads Rehabilitation, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Crossroads Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-1658419</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Custom Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NV</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">04-3708931</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Cutting Edge Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-4069256</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Dearborn Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Advanced Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0376595</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Decatur Hand and Physical Therapy Specialists, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">GA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3319149</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Dekalb Comprehensive Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">GA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3631634</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Denali Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AK</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-8666329</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">DHT Hand Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Arizona Desert Hand Therapy Services</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Desert Hand and Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AZ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">DHT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-5881475</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">DHT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AZ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-5881418</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Dynamic Hand Therapy &amp; Rehabilitation, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IL</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-8847486</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Eastgate Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Summit Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OH</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0637484</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Edge Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">River's Edge Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MT</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0473771</div>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Enhance Physiotherapy and Performance, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">1/25/2022</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">STAR Physical Therapy, LP</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">87-4738491</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Enid Therapy Center, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Enid Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OK</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0384228</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Everett Management, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WA</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">37-1776322</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Evergreen Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-8613843</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Excel Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AK</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Excel PT Texas GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3951569</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Excel PT Texas GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3951532</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Fit2WRK, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-1647054</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Five Rivers Therapy Services, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Peak Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AR</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3785604</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Flannery Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy Plus</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0580514</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Fredericksburg Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3589445</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Fremont PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">85-4237359</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Fremont Therapy Group, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">UT, WY</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Fremont PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">86-1249211</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Frisco Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">PT of Prosper</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0625171</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Gahanna Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Cornerstone Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OH</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-0643842</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Genesee Valley Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-2299603</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Green Oaks Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">72-1531238</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Hamilton Physical Therapy Services, LP</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">HPTS Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">74-3145890</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Hands-On Sports Medicine, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Metro Spine and Sports Rehabilitation</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IL</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3300800</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Hanoun Medical, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">BTE Workforce Solutions</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Briotix Health</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td colspan="2" style="vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Ontario, Canada</div>
                </div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">British Columbia</div>
                </div>
              </td>
              <td colspan="2" style="vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">2037053 Ontario, Inc. (owned by Briotix Health, LP)</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Harbor Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MD</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3303737</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">HH Rehab Associates, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Genesee Valley Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Theramax Physical Therapy</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT - Michigan, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">38-2427228</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">High Plains Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WY</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">41-2060941</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Highlands Physical Therapy &amp; Sports Medicine, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-3126287</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Horizon Rehabilitation PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">USPT, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">87-3158670</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Horizon Rehabilitation and Sports Medicine, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Horizon Rehabilitation PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">87-3221050</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Houston On Demand Physical Therapy, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Kingwood Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">85-3267403</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">HPTS Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">74-3145888</div>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3ddf047ee88947899a1442ba494495c3">

            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Indy ProCare Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">45-4419567</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Integrius, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">GA</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-4689092</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; background-color: rgb(255, 255, 0); border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="background-color: #FFFFFF;">
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">To be dissolved</div>
                </div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">InSite Health Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">IH GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-4365153</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Intermountain Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">ID</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0532873</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jackson Clinics PT Management GP , LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-4470249</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jackson Clinics, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MD, VA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jackson Clinics PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">61-1729833</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Rehab Honolulu Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-3191941</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Kapolei Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-3152468</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Mililani Management GP LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-3167120</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Waikele Management GP LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-3176419</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Rehab Honolulu, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">HI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Rehab Honolulu Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-3255422</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Rehab Kapolei, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">HI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Kapolei Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-3236943</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Rehab Mililani, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Mililani Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-3206751</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Rehab Waikele, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">HI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Jaco Waikele Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-3226914</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Joan Ostermeier Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Clinic of Wittenberg</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0556793</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Julie Emond Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Maple Valley Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">VT</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0544267</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Kelly Lynch Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Clinic of Watertown</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0559026</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Kennebec Physical Therapy, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">ME</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-4456545</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Kingwood Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Spring-Klein Physical Therapy&#160;</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">West Woodlands Physical Therapy</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Lake Conroe Sports Medicine and Rehabilitation Cypress Oaks Physical Therapy</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Services of Fairfield;&#160;</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Grand Oaks Sports Medicine and Rehabilitation</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Services of Lakewood</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0384227</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Lake Houston Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Northern Oaks Orthopedic &amp; Sports PT</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">75-3050296</div>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Leader Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Memphis Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0539465</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Withdraw PA</div>
                </div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Life Fitness Physical Therapy, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">In Balance Physical Therapy &#160;&#160;</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Herbst Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MD</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">PA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-1193079</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Life Strides Physical Therapy and Rehabilitation, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">SC</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-5120914</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">LiveWell Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-3700763</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Madden and Gilbert PT GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">1/7/2022</div>
                </div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">OPTN, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">87-4640726</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Madden and Gilbert Physical Therapy, LP&#160;</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">1/20/2022</div>
                </div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Madden and Gilbert PT GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">87-4672389</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Madison Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">MSPT Management GP, LLC&#160;</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-2047964</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Madison Spine, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">MSPT Management GP, LLC&#160;</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">90-0813058</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Max Motion Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AZ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-3988733</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Merrill Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0512097</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mishock Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Xcelerate Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">PA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mishock PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">30-0783139</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mishock PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-2793533</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mission Rehabilitation and Sports Medicine, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">RYKE Rehabilitation</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">RYKE Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-3747839</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mobile Spine and Rehabilitation, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AL</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0600186</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Momentum Physical &amp; Sports Rehabilitation, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Momentum Physical Therapy &amp; Sports Rehab;&#160; Momentum On Demand;</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Momentum Mobile PT</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL, CO, AZ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #10, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-2388509</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mountain View Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mountain View Physical and Hand Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OR</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0528482</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">MSPT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-2047906</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">National Rehab Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MO</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">National Rehab GP, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">74-2899827</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; background-color: rgb(255, 255, 0); border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="background-color: #FFFFFF;">
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">shows tax clearance</div>
                </div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">National Rehab GP, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL,MO</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT - Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0345539</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">National Rehab Management GP, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IL, OH</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT - Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0345543</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">New Horizons Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-2729857</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Norman Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OK</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0420713</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">North Jersey Game On Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Madison Spine &amp; Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-3885529</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">North Lake Physical Therapy and Rehab, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OR</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">North Lake PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">90-0964749</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">North Lake PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-2599705</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Northern Lights Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">ND</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-0342077</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Northwest PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-2410286</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Northwoods Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-1258418</div>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze797ecd143e148ec92eb650eac2dbd64">

            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">OPR Management Services, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AK, AL, AZ, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, OH, OK, OR, PA, SC, SD, TN, VA,
                    VT, WI, WY</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">81-3815218</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">OSR Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">OSR Physical Therapy Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">83-0657305</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">OSR Physical Therapy Management GP LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">83-0649952</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">One to One PT Management GP LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-4060850</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">One to One Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">One to One PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">84-4074270</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Oregon Spine &amp; Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Peak State Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OR</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0613909</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Peak Performance PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Peak Performance Physical Therapy and Fitness, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">85-3948317</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Peak Performance Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Peak Performance PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">85-4174416</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Pelican State Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Audubon Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0433513</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Penns Wood Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">PA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0430771</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">PerformancePro Sports Medicine and Rehabilitation, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-1539873</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Phoenix Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OH</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-0932165</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; background-color: rgb(255, 255, 0); border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="background-color: #FFFFFF;">
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Check with Peter if to be dissolved</div>
                </div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Restoration and Sports Medicine, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">VA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-0878621</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy Northwest, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OR</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Northwest PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-2397360</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy and Spine Institute, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IL</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0438263</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy Solutions, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">VA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">PTS GP Management, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-3075583</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Pinnacle Therapy Services, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MO</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-3247784</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Pioneer Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NE</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-3530492</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Plymouth Physical Therapy Specialists, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0424739</div>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Port City Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">ME</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0585914</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Precision Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">PA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0438265</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Premier Physical Therapy and Sports Performance, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Premier Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-5385666</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Premier Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-5403407</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProActive Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">SD</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0600187</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProCare Physical Therapy Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-2044643</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProCare PT, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">PA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProCare Physical Therapy Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">90-0941849</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProgressiveHealth Companies, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">87-4264322</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProgressiveHealth Occ Health, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI, TN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-8266936</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProgressiveHealth HealthSpot, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">85-3187128</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProgressiveHealth, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">68-0666444</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ProgressiveHealth Rehabilitation Solutions,Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">GA</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">58-1888359</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Progressive Physical Therapy Clinic, Ltd.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Progressive Hand and Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0387638</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">PTS GP Management, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-3239903</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Quad City Physical Therapy &amp; Spine, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">14-1921829</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">RACVA GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">VA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">37-1838302</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">R. Clair Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Clair Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0478967</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Radtke Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0574455</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Reaction Physical Therapy, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OK</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">47-1586428</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rebound Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OR</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rebound PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">81-1026078</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rebound PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">81-1045143</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Red River Valley Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-4489003</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Redmond Ridge Management, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WA</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">61-1754288</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Regional Physical Therapy Center, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0429008</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL, MA, &amp; WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0345544</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0379584</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Withdraw, NJ</div>
                </div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MO, MT, NJ, ND, &amp; SD</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0394604</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; background-color: rgb(255, 255, 0); border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="background-color: #FFFFFF;">
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Withdraw UT</div>
                </div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OH, &amp; UT</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0418425</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0427607</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OR</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0433511</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners Acquisition #1, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0377650</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehabilitation Associates of Central Virginia, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Associates of Central Virginia (Campbell County)</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">VA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">RACVA GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">81-3831622</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rice Rehabilitation Associates, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">GA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0430769</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Riverview Physical Therapy, Limited Partnership (formerly Yarmouth Physical Therapy)</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">ME</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">27-0001262</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Roepke Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Elite Hand&#160;&amp; Upper Extremity Clinic</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0483099</div>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0e17ec8b07be4b07902876abd0ac8d22">

            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">RYKE Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-3747599</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Saginaw Valley Sport and Spine, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Physical Therapy and Rehab; Evergreen PT</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0403520</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Saline Physical Therapy of Michigan, Ltd.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy in Motion</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0376594</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">San Antonio On Demand Physical Therapy, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">86-1384984</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Seacoast Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">ME</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #3, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">45-2498148</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Signature Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OK</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-5992649</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Snohomish Management, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WA</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">38-3953679</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Snohomish Physical Therapy, PLLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">PLLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WA</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Snohomish Management, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">South Tulsa Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy of Jenks</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">OK</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0566430</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Spectrum Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Southshore Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">CT</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0393448</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Clinic of Fort Atkinson, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Clinic of Sauk City</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Clinic of Madison&#160;</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Clinic of Jefferson</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Edgerton</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0694802</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Clinic, L.P.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Clinic of Edgar</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine Minocqua</div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Sport &amp; Spine - Rib Mountain</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners Acquisition #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0376131</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Spracklen Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NE</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0580510</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">STAR PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-1107563</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">STAR Physical Therapy, LP</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AR, TN, IN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">STAR PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">62-1707893</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Centers, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Services of Copperfield</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Services of Cy-Fair</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Services of Fulshear</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Services of Katy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Services of Magnolia</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Star Therapy Services of Spring Cypress&#160; &#160; &#160; &#160;&#160; Star Therapy Services of Cinco Ranch</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0389608</div>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4a36ed62ba68492782de0733ec935258">

            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Texstar Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0669263</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">The Hale Hand Center, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0601187</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">The U.S. Physical Therapy Foundation</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Qualified to fund raise in CA, FL, KS, MD, MI, TN, TX, VA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">81-1071364</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Therapyworks Physical Therapy, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Therapyworks</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">46-4446075</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Thibodeau Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-1147899</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Thunder Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">WA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-3806761</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NV</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">AZ; HI; MI; NJ</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">N/A</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0364866</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
                <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NC</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">National Rehab GP, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0388092</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT - Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">FL, IL, MN, MO</div>
                <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">NM,</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">51-0343523</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Alliance Rehabilitation Services, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Alliance Rehabilitation Services</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">PA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-2377769</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Management, Ltd.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">CA, ID, OH, WA, WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">National Rehab Management GP, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0388500</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Michigan #1, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Genesee Valley Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #1, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0570431</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Michigan #2, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy Solutions</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #2, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0579492</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Solutions, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Physical Therapy Solutions</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">VA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">26-0609553</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Texas, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Kinetix Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">MS</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-5125415</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">To be dissolved</div>
                </div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Therapy Services, Inc. (formerly U.S. Surgical Partners, Inc.)</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Capstone Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Carolina Hand and Wellness Center</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Hand Therapy of North Texas - Frisco</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Hand Therapy of North Texas - Coppell</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Innovative Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Lake City Hand Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Life Sport Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Life Sport Physical Therapy - Glen Ellyn</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Metro Hand Rehabilitation</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Missouri City Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mountain View Physical Therapy of Medford</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Mountain View Physical Therapy of Talent</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Northern Illinois Therapy Services</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Propel Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">ReAction Physical Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Therapeutic Concepts</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Tulsa Hand Therapy</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Waco Sports Medicine and Rehabilitation</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">DE</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">CA, FL, IA, IL, IN, KS, ME, MS, MO, NC, OH, OK, OR, PA, TX VA, &amp; WI</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0613914</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT Turnkey Services, Inc.</div>
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">(formerly Surgical Management GP, Inc.</div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">The Hand &amp; Orthopedic Rehab Clinic</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-2803028</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. Therapy, Inc.</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">First Choice Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">Corp</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IN</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">U.S. PT - Delaware, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0637511</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">The Facilities Group, Inc.</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">University Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">VA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #6, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">76-0613913</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">USPT Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Body Basics Physical Therapy</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">IA</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-5441273</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Victory Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-4406904</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">West Texas Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #5, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">20-5834588</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Wright PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LLC</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Rehab Partners #4, Inc.</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-3239740</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Wright Physical Therapy, Limited Partnership</div>
                </div>
              </td>
              <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">LP</div>
                </div>
              </td>
              <td style="width: 5%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">TX</div>
                </div>
              </td>
              <td style="width: 4.55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">ID</div>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">Wright PT Management GP, LLC</div>
                </div>
              </td>
              <td style="width: 7.45%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div>
                  <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt;">82-3255983</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <br>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>brhc10034321_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: right;">EXHIBIT 23.1</div>
      <div>&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
        <div style="text-align: left; color: rgb(0, 0, 0);">We have issued our reports dated March 1, 2022, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report of U.S. Physical
          Therapy, Inc. on Form 10-K for the year ended December 31, 2021. We consent to the incorporation by reference of said reports in the Registration Statements of U.S. Physical Therapy, Inc. on Forms S-8 (File Nos. 333-30071 effective June 26, 1997,
          333-64159 effective September 24, 1998, 333-67678 effective August 16, 2001, 333-67680 effective August 16, 2001, 333-82932 effective February 15, 2002, 333-103057 effective February 10, 2003, 333-113592 effective March 15, 2004, 333-116230
          effective June 4, 2004, 333-153051 effective August 15, 2008, 333-185381 effective December 11, 2012, 333-200832 effective December 10, 2014, and 333-230368 effective March 18, 2019).</div>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">/s/ GRANT THORNTON LLP</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Houston, Texas</div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255);">March 1, 2022</div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255);"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255);"> <br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>brhc10034321_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">EXHIBIT 31.1</div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CERTIFICATION</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">I, Christopher J. Reading, certify that:</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;">&#160;</td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">I have reviewed this annual report on Form 10-K of U.S. Physical Therapy, Inc.;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
                statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
                financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">4.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
                Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
                that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
                supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the
                effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent
                fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">5.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
                to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
                likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#894; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over
                financial reporting.</div>
            </td>
          </tr>

      </table>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Date: March 1, 2022</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">/s/ Christopher J. Reading</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Christopher J. Reading</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;" rowspan="1">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">President and Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;" rowspan="1">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(Principal Executive Officer)</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>brhc10034321_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">EXHIBIT 31.2</div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CERTIFICATION</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">I, Carey Hendrickson, certify that:</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;">&#160;</td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">I have reviewed this annual report on Form 10-K of U.S. Physical Therapy, Inc.;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
                light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
                condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">4.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
                Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
                information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
                reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
                disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the
                registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#894; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">5.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
                registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
                affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial
                reporting.</div>
            </td>
          </tr>

      </table>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Date: March 1, 2022</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">/s/ Carey Hendrickson</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Carey Hendrickson</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: bottom;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: bottom;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(Principal Financial and Accounting Officer)</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>8
<FILENAME>brhc10034321_ex31-3.htm
<DESCRIPTION>EXHIBIT 31.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">EXHIBIT 31.3</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CERTIFICATION</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">I, Jon C. Bates, certify that:</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">I have reviewed this annual report on Form 10-K of U.S. Physical Therapy, Inc.;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
                light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
                condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">4.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
                Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
                information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
                reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(c)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
                disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(d)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the
                registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#894; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 16pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">5.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
                registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(a)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
                affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 20.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(b)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial
                reporting.</div>
            </td>
          </tr>

      </table>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Date: March 1, 2022</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">/s/ Jon C. Bates</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Jon C. Bates</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: bottom;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Vice President and Corporate Controller</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div> <br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>brhc10034321_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">EXHIBIT 32.1</div>
      <div style="text-align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">18 U.S.C. SECTION 1350,</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
      </div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">In connection with the Annual Report of U.S. Physical Therapy, Inc. (the &#8220;registrant&#8221;) on Form 10-K for the year ending December 31, 2021 as filed with the Securities and
        Exchange Commission on the date hereof (the &#8220;report&#8221;), we, Christopher J. Reading, Carey Hendrickson and Jon C. Bates, Chief Executive Officer, Chief Financial Officer and Controller, respectively, of the registrant, certify, pursuant to 18 U.S.C.
        &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge:</div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr style="vertical-align: top;">
                <td style="width: 18pt;">&#160;</td>
                <td style="vertical-align: top; width: 18pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(1)</div>
                </td>
                <td style="align: left; vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr style="vertical-align: top;">
                <td style="width: 18pt;">&#160;</td>
                <td style="vertical-align: top; width: 18pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(2)</div>
                </td>
                <td style="align: left; vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">March 1, 2022</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">/s/ Christopher J. Reading</div>
            </td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Christopher J. Reading</div>
            </td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Principal Executive Officer</div>
            </td>
            <td rowspan="1" style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">/s/ Carey Hendrickson</div>
            </td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Carey Hendrickson</div>
            </td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Principal Financial and Accounting Officer</div>
            </td>
            <td rowspan="1" style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">/s/ Jon C. Bates</div>
            </td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Jon C. Bates</div>
            </td>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Vice President and Corporate Controller</div>
            </td>
            <td rowspan="1" style="width: 50%; vertical-align: bottom;">&#160;</td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">A signed original of this written statement required by Section 906 has been provided to U. S. Physical Therapy, Inc. and will be retained by U. S. Physical Therapy, Inc. and
        furnished to the Securities and Exchange Commission or its staff upon request.</div>
      <div>&#160;</div>
      <div> <br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>usph-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://usph.com/20211231" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:usph="http://usph.com/20211231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://usph.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>010000 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <!--Parent Role: CONSOLIDATED BALANCE SHEETS-->
        <link:definition>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
        <link:definition>020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" id="ConsolidatedStatementsOfChangesInEquity">
        <link:definition>030000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation" id="OrganizationNatureOfOperationsAndBasisOfPresentation">
        <link:definition>060100 - Disclosure - Organization, Nature of Operations and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>060200 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinesses" id="AcquisitionsOfBusinesses">
        <link:definition>060300 - Disclosure - Acquisitions of Businesses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests" id="AcquisitionsAndSaleOfNoncontrollingInterests">
        <link:definition>060400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" id="RedeemableNoncontrollingInterest">
        <link:definition>060500 - Disclosure - Redeemable Non-Controlling Interest</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/Goodwill" id="Goodwill">
        <link:definition>060600 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
        <link:definition>060700 - Disclosure - Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>060800 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayable" id="NotesPayable">
        <link:definition>060900 - Disclosure - Notes Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/Leases" id="Leases">
        <link:definition>061000 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>061100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformation" id="SegmentInformation">
        <link:definition>061200 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliate" id="InvestmentInUnconsolidatedAffiliate">
        <link:definition>061300 - Disclosure - Investment in Unconsolidated Affiliate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlans" id="EquityBasedPlans">
        <link:definition>061400 - Disclosure - Equity Based Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/PreferredStock" id="PreferredStock">
        <link:definition>061500 - Disclosure - Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommonStock" id="CommonStock">
        <link:definition>061600 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/DefinedContributionPlan" id="DefinedContributionPlan">
        <link:definition>061700 - Disclosure - Defined Contribution Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>061800 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShare" id="EarningsPerShare">
        <link:definition>061900 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>062000 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ReclassificationOfPriorPeriodPresentation" id="ReclassificationOfPriorPeriodPresentation">
        <link:definition>062100 - Disclosure - Reclassification of Prior Period Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts" id="ScheduleIiValuationAndQualifyingAccounts">
        <link:definition>062200 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>070200 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables" id="OrganizationNatureOfOperationsAndBasisOfPresentationTables">
        <!--Parent Role: Organization, Nature of Operations and Basis of Presentation-->
        <link:definition>080100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>080200 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" id="AcquisitionsOfBusinessesTables">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>080300 - Disclosure - Acquisitions of Businesses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" id="RedeemableNoncontrollingInterestTables">
        <!--Parent Role: Redeemable Non-Controlling Interest-->
        <link:definition>080500 - Disclosure - Redeemable Non-Controlling Interest (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/GoodwillTables" id="GoodwillTables">
        <!--Parent Role: Goodwill-->
        <link:definition>080600 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
        <!--Parent Role: Intangible Assets, net-->
        <link:definition>080700 - Disclosure - Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>080800 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableTables" id="NotesPayableTables">
        <!--Parent Role: Notes Payable-->
        <link:definition>080900 - Disclosure - Notes Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesTables" id="LeasesTables">
        <!--Parent Role: Leases-->
        <link:definition>081000 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <!--Parent Role: Income Taxes-->
        <link:definition>081100 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformationTables" id="SegmentInformationTables">
        <!--Parent Role: Segment Information-->
        <link:definition>081200 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansTables" id="EquityBasedPlansTables">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>081400 - Disclosure - Equity Based Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShareTables" id="EarningsPerShareTables">
        <!--Parent Role: Earnings Per Share-->
        <link:definition>081900 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" id="OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails">
        <!--Parent Role: Organization, Nature of Operations and Basis of Presentation-->
        <link:definition>090100 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails" id="OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails">
        <!--Parent Role: Organization, Nature of Operations and Basis of Presentation-->
        <link:definition>090102 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails" id="SignificantAccountingPoliciesLonglivedAssetsDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090200 - Disclosure - Significant Accounting Policies, Long-Lived Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails" id="SignificantAccountingPoliciesGoodwillDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090202 - Disclosure - Significant Accounting Policies, Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails" id="SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090204 - Disclosure - Significant Accounting Policies, Redeemable Non-Controlling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails" id="SignificantAccountingPoliciesRevenueRecognitionDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090206 - Disclosure - Significant Accounting Policies, Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails" id="SignificantAccountingPoliciesContractualAllowancesDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090208 - Disclosure - Significant Accounting Policies, Contractual Allowances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails" id="SignificantAccountingPoliciesIncomeTaxesDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090210 - Disclosure - Significant Accounting Policies, Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails" id="SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090212 - Disclosure - Significant Accounting Policies, Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails" id="SignificantAccountingPoliciesSegmentReportingDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090214 - Disclosure - Significant Accounting Policies, Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails" id="SignificantAccountingPoliciesRestrictedStockDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090216 - Disclosure - Significant Accounting Policies, Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails" id="AcquisitionsOfBusinessesAcquiredMajorityInterestDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090300 - Disclosure - Acquisitions of Businesses, Acquired Majority Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails" id="AcquisitionsOfBusinesses2021AcquisitionDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090302 - Disclosure - Acquisitions of Businesses, 2021 Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails" id="AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090304 - Disclosure - Acquisition of Business, 2021 Preliminary Purchase Prices Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails" id="AcquisitionsOfBusinesses2020AcquisitionDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090306 - Disclosure - Acquisitions of Businesses, 2020 Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails" id="AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090308 - Disclosure - Acquisition of Business, 2020 Preliminary Purchase Prices Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails" id="AcquisitionsOfBusinesses2019AcquisitionDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090310 - Disclosure - Acquisitions of Businesses, 2019 Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails" id="AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090312 - Disclosure - Acquisition of Business, 2019 Preliminary Purchase Prices Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails" id="AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090314 - Disclosure - Acquisition of Business, Weighted Average Amortization Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails" id="AcquisitionsAndSaleOfNoncontrollingInterestsDetails">
        <!--Parent Role: Acquisitions and Sale of Non-Controlling Interests-->
        <link:definition>090400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" id="RedeemableNoncontrollingInterestDetails">
        <!--Parent Role: Redeemable Non-Controlling Interest-->
        <link:definition>090500 - Disclosure - Redeemable Non-Controlling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/GoodwillDetails" id="GoodwillDetails">
        <!--Parent Role: Goodwill-->
        <link:definition>090600 - Disclosure - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" id="IntangibleAssetsNetIntangibleAssetsNetDetails">
        <!--Parent Role: Intangible Assets, net-->
        <link:definition>090700 - Disclosure - Intangible Assets, net - Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" id="IntangibleAssetsNetAmortizationExpensesDetails">
        <!--Parent Role: Intangible Assets, net-->
        <link:definition>090702 - Disclosure - Intangible Assets, net - Amortization Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" id="IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
        <!--Parent Role: Intangible Assets, net-->
        <link:definition>090704 - Disclosure - Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>090800 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails" id="NotesPayableSummaryOfNotesPayableDetails">
        <!--Parent Role: Notes Payable-->
        <link:definition>090900 - Disclosure - Notes Payable - Summary of Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAmendedCreditAgreementDetails" id="NotesPayableAmendedCreditAgreementDetails">
        <!--Parent Role: Notes Payable-->
        <link:definition>090902 - Disclosure - Notes Payable - Amended Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesDetails" id="LeasesDetails">
        <!--Parent Role: Leases-->
        <link:definition>091000 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesDetailsCalc01" id="LeasesDetailsCalc01">
        <!--Parent Role: Leases (Details)-->
        <link:definition>091002 - Disclosure - Leases (Details) CALC 01</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" id="IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091100 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesSummaryDetails" id="IncomeTaxesSummaryDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091102 - Disclosure - Income Taxes - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" id="IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091104 - Disclosure - Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" id="IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091106 - Disclosure - Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformationDetails" id="SegmentInformationDetails">
        <!--Parent Role: Segment Information-->
        <link:definition>091200 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails" id="InvestmentInUnconsolidatedAffiliateDetails">
        <!--Parent Role: Investment in Unconsolidated Affiliate-->
        <link:definition>091300 - Disclosure - Investment in Unconsolidated Affiliate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" id="EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091400 - Disclosure - Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" id="EquityBasedPlansCumulativeSummaryOfEquityPlansDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091402 - Disclosure - Equity Based Plans - Cumulative Summary of Equity Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" id="EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091404 - Disclosure - Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" id="EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091406 - Disclosure - Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansSummaryDetails" id="EquityBasedPlansSummaryDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091408 - Disclosure - Equity Based Plans - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommonStockDetails" id="CommonStockDetails">
        <!--Parent Role: Common Stock-->
        <link:definition>091600 - Disclosure - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/DefinedContributionPlanDetails" id="DefinedContributionPlanDetails">
        <!--Parent Role: Defined Contribution Plan-->
        <link:definition>091700 - Disclosure - Defined Contribution Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091800 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShareDetails" id="EarningsPerShareDetails">
        <!--Parent Role: Earnings Per Share-->
        <link:definition>091900 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
        <!--Parent Role: Related Party Transactions-->
        <link:definition>092000 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" id="ScheduleIiValuationAndQualifyingAccountsDetails">
        <!--Parent Role: SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS-->
        <link:definition>092200 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="REDEEMABLENONCONTROLLINGINTERESTAbstract" id="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestTextBlock" id="usph_RedeemableNonControllingInterestTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EmploymentAgreementRenewalTerm" id="usph_EmploymentAgreementRenewalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TermOfEmploymentAgreement" id="usph_TermOfEmploymentAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NonCompeteAgreementBasicTerm" id="usph_NonCompeteAgreementBasicTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="TherapyPracticeMember" id="usph_TherapyPracticeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProgressiveHealthCompaniesLLCMember" id="usph_ProgressiveHealthCompaniesLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionConsiderationPayableTermOfNote" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CarryingAmountOfRedeemableNonControllingInterestAbstract" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RedeemableNonControllingInterestMember" id="usph_RedeemableNonControllingInterestMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ShortSwingProfitSettlement" id="usph_ShortSwingProfitSettlement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="SaleOfNonControllingInterestNetOfTaxAndPurchases" id="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="RevaluationOfRedeemableNonControllingInterestNetOfTax" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AccountsPayableDueToSellerOfAcquiredBusiness" id="usph_AccountsPayableDueToSellerOfAcquiredBusiness" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PromissoryNotesMember" id="usph_PromissoryNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DividendsCashAfterAmendment" id="usph_DividendsCashAfterAmendment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DebtInstrumentBasisSpreadOnLiborVariableRate" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CreditAgreementMember" id="usph_CreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NotesPayableMember" id="usph_NotesPayableMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NoteReceivableRelatedToSaleOfClinics" id="usph_NoteReceivableRelatedToSaleOfClinics" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NumberOfInstallmentsForNoteReceivableInSaleConsideration" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfGeneralPartnershipInterestOwned" id="usph_PercentageOfGeneralPartnershipInterestOwned" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfOperatingClinicLocations" id="usph_NumberOfOperatingClinicLocations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="MedicareAcceleratedAndAdvancePaymentsProgramMember" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfLimitedPartnershipInterestOwned" id="usph_PercentageOfLimitedPartnershipInterestOwned" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CashReceivedRelatedToSaleOfClinics" id="usph_CashReceivedRelatedToSaleOfClinics" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AggregateSalePriceOfCinics" id="usph_AggregateSalePriceOfCinics" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NumberOfClosedClinicsSold" id="usph_NumberOfClosedClinicsSold" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="RepaymentOfFunds" id="usph_RepaymentOfFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="GrantsAndOtherFunds" id="usph_GrantsAndOtherFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PublicHealthAndSocialServicesEmergencyFundMember" id="usph_PublicHealthAndSocialServicesEmergencyFundMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ReliefFunds" id="usph_ReliefFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ResolutionOfPayorMatter" id="usph_ResolutionOfPayorMatter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="RentSuppliesContractLaborAndOther" id="usph_RentSuppliesContractLaborAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InterestExpenseDebtAndOther" id="usph_InterestExpenseDebtAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NetPatientRevenuesMember" id="usph_NetPatientRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DistributionsFromUnconsolidatedAffiliate" id="usph_DistributionsFromUnconsolidatedAffiliate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="CashPaidDuringPeriodForAbstract" id="usph_CashPaidDuringPeriodForAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromSalesOfNonControllingInterestPermanent" id="usph_ProceedsFromSalesOfNonControllingInterestPermanent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="GainOnSaleOfPartnershipInterestNetOfTax" id="usph_GainOnSaleOfPartnershipInterestNetOfTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PaymentsToAcquireRedeemableNonControllingInterest" id="usph_PaymentsToAcquireRedeemableNonControllingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PurchaseOfBusinessSellerFinancingPortion" id="usph_PurchaseOfBusinessSellerFinancingPortion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="MedicareAcceleratedAndAdvancePaymentFunds" id="usph_MedicareAcceleratedAndAdvancePaymentFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="EmployeeMember" id="usph_EmployeeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NonControllingInterestsPolicyPolicyTextBlock" id="usph_NonControllingInterestsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SelfInsuranceProgramPolicyPolicyTextBlock" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestsPolicyTextBlock" id="usph_RedeemableNonControllingInterestsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RestrictedStockPolicyPolicyTextBlock" id="usph_RestrictedStockPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="IndustrialInjuryPreventionServicesRevenuesMember" id="usph_IndustrialInjuryPreventionServicesRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ManagementContractRevenuesMember" id="usph_ManagementContractRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PhysicalTherapyOperationsMember" id="usph_PhysicalTherapyOperationsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OtherRevenuesMember" id="usph_OtherRevenuesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CentersForMedicareAndMedicaidServicesMember" id="usph_CentersForMedicareAndMedicaidServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MedicareReimbursementAbstract" id="usph_MedicareReimbursementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPaymentForOutpatientTherapyServices" id="usph_PercentageOfPaymentForOutpatientTherapyServices" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfMedicarePaymentIncrease" id="usph_PercentageOfMedicarePaymentIncrease" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AmountOfReductionsInFederalSpending" id="usph_AmountOfReductionsInFederalSpending" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="EstimatedPercentageOfDecreaseInPayment" id="usph_EstimatedPercentageOfDecreaseInPayment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NetRevenueFromMedicare" id="usph_NetRevenueFromMedicare" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ReductionInMedicareSpendingPercentage" id="usph_ReductionInMedicareSpendingPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ExpectedReductionInMedicareSpendingPercentage" id="usph_ExpectedReductionInMedicareSpendingPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PeriodOfExtension" id="usph_PeriodOfExtension" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" id="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" id="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" id="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CreditChargesToRetainedEarningsAbstract" id="usph_CreditChargesToRetainedEarningsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" id="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfRegions" id="usph_NumberOfRegions" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MultiClinicPracticesMember" id="usph_MultiClinicPracticesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LeadingProviderOfIndustrialInjuryPreventionMember" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ManagementContractsMember" id="usph_ManagementContractsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="September2020AcquisitionMember" id="usph_September2020AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="September2019AcquisitionMember" id="usph_September2019AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="September2021AcquisitionMember" id="usph_September2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="November2020AcquisitionMember" id="usph_November2020AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="March2021AcquisitionMember" id="usph_March2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfPartnershipInWhichInterestAcquired" id="usph_NumberOfPartnershipInWhichInterestAcquired" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfManagementContracts" id="usph_NumberOfManagementContracts" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="February2020AcquisitionMember" id="usph_February2020AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="December2021AcquisitionMember" id="usph_December2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RemainingContractTerm" id="usph_RemainingContractTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="June2021AcquisitionMember" id="usph_June2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClinicPracticeMember" id="usph_ClinicPracticeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="November2021AcquisitionMember" id="usph_November2021AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="April2019AcquisitionMember" id="usph_April2019AcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JointVentureInterestMember" id="usph_JointVentureInterestMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsAbstract" id="usph_EmploymentAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsExpirationDateThree" id="usph_EmploymentAgreementsExpirationDateThree" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RenewalPeriodForEmploymentAgreement" id="usph_RenewalPeriodForEmploymentAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmployeeCompensationFuturePaymentDueNextFiscalYear" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="EmploymentAgreementsExpirationDateTwo" id="usph_EmploymentAgreementsExpirationDateTwo" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsExpirationDate" id="usph_EmploymentAgreementsExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfEmployeesCoveredUnderEmployeeAgreement" id="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsExpirationDateFour" id="usph_EmploymentAgreementsExpirationDateFour" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="SaleOfNoncontrollingInterestPercentageInPartnershipOne" id="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TaxEffectOnSaleOfNoncontrollingInterest" id="usph_TaxEffectOnSaleOfNoncontrollingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PreferredStockAbstract" id="usph_PreferredStockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AdditionalEstimatedRepurchaseOfCommonStock" id="usph_AdditionalEstimatedRepurchaseOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfRepurchaseOfCommonStock" id="usph_PercentageOfRepurchaseOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DeferredTaxAssetsLeaseObligations" id="usph_DeferredTaxAssetsLeaseObligations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" id="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DeferredEmployerPayrollTaxesCARESACT" id="usph_DeferredEmployerPayrollTaxesCARESACT" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PatientsAndPayorsRelatedLiability" id="usph_PatientsAndPayorsRelatedLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="IncomeTaxExaminationAbstract" id="usph_IncomeTaxExaminationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" id="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="EmployeesMember" id="usph_EmployeesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="RestrictedPeriodToEmployeesOnTheStockGranted" id="usph_RestrictedPeriodToEmployeesOnTheStockGranted" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" id="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AmendedTwoThousandThreePlanMember" id="usph_AmendedTwoThousandThreePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NonQualifiedStockOptionsMember" id="usph_NonQualifiedStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="OperatingLeaseSupplementalInformationTableTextBlock" id="usph_OperatingLeaseSupplementalInformationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AverageLeaseTermsAndDiscountRatesAbstract" id="usph_AverageLeaseTermsAndDiscountRatesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SupplementalInformationRelatedToOperatingLeasesAbstract" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployerMatchingContributionAmount" id="usph_DefinedContributionPlanEmployerMatchingContributionAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" id="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfAcquiredOperations" id="usph_NumberOfAcquiredOperations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AmendedNineteenNinetyNinePlanMember" id="usph_AmendedNineteenNinetyNinePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NonControllingInterestRedeemableAbstract" id="usph_NonControllingInterestRedeemableAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ContractualAllowancesAbstract" id="usph_ContractualAllowancesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MaximumContractualAllowanceReserveEstimate" id="usph_MaximumContractualAllowanceReserveEstimate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionPayableToShareholdersOfSeller" id="usph_BusinessAcquisitionPayableToShareholdersOfSeller" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PaymentsToAcquireBusinessesConsideration" id="usph_PaymentsToAcquireBusinessesConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PreviousOwnersMember" id="usph_PreviousOwnersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" id="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" id="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" id="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ReturnToWorkAndErgonomicServicesMember" id="usph_ReturnToWorkAndErgonomicServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ManagementAndServicesContractsMember" id="usph_ManagementAndServicesContractsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" id="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NotesPayableTwoMember" id="usph_NotesPayableTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NotesPayableOneMember" id="usph_NotesPayableOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeptemberTwoThousandTwentyMember" id="usph_SeptemberTwoThousandTwentyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeptemberTwoThousandTwentyOneMember" id="usph_SeptemberTwoThousandTwentyOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AprilTwoThousandNineteenAcquisitionMember" id="usph_AprilTwoThousandNineteenAcquisitionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfStatesOfNetworkServices" id="usph_NumberOfStatesOfNetworkServices" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfOnsiteClientLocations" id="usph_NumberOfOnsiteClientLocations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ReferralRelationshipMember" id="usph_ReferralRelationshipMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CustomerAndReferralRelationshipMember" id="usph_CustomerAndReferralRelationshipMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SettlementOfShortSwingProfitClaimAbstract" id="usph_SettlementOfShortSwingProfitClaimAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>usph-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc01" xlink:type="simple" xlink:href="usph-20211231.xsd#LeasesDetailsCalc01" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayableSummaryOfNotesPayableDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedBalanceSheets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="LeaseholdImprovementsGross" xlink:title="calculation: PropertyPlantAndEquipmentGross to LeaseholdImprovementsGross" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="FurnitureAndFixturesGross" xlink:title="calculation: PropertyPlantAndEquipmentGross to FurnitureAndFixturesGross" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="calculation: PropertyPlantAndEquipmentNet to PropertyPlantAndEquipmentGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: PropertyPlantAndEquipmentNet to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="calculation: Assets to IntangibleAssetsNetExcludingGoodwill" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: Assets to OtherAssetsNoncurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="calculation: Assets to OperatingLeaseRightOfUseAsset" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="calculation: Assets to InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsAndOtherReceivablesNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsAndOtherReceivablesNetCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsReceivableNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsReceivableNetCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to OtherAssetsCurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="calculation: AssetsCurrent to CashAndCashEquivalentsAtCarryingValue" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermNotesPayable" xlink:title="calculation: Liabilities to LongTermNotesPayable" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DeferredIncomeTaxLiabilitiesNet" xlink:title="calculation: Liabilities to DeferredIncomeTaxLiabilitiesNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: Liabilities to OperatingLeaseLiabilityNoncurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermLineOfCredit" xlink:title="calculation: Liabilities to LongTermLineOfCredit" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableTradeCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableTradeCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="LongTermDebtCurrent" xlink:title="calculation: LiabilitiesCurrent to LongTermDebtCurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AccountsPayableDueToSellerOfAcquiredBusiness" xlink:label="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="AccountsPayableDueToSellerOfAcquiredBusiness" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableDueToSellerOfAcquiredBusiness" order="5.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="5.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="MinorityInterest" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to MinorityInterest" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="PreferredStockValue" xlink:title="calculation: StockholdersEquity to PreferredStockValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="TreasuryStockValue" xlink:title="calculation: StockholdersEquity to TreasuryStockValue" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="StockholdersEquity" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to StockholdersEquity" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="calculation: LiabilitiesAndStockholdersEquity to RedeemableNoncontrollingInterestEquityCarryingAmount" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="CommitmentsAndContingencies" xlink:title="calculation: LiabilitiesAndStockholdersEquity to CommitmentsAndContingencies" order="4.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="calculation: NetIncomeLossAttributableToNoncontrollingInterest to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="calculation: NetIncomeLossAttributableToNoncontrollingInterest to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to NetIncomeLossAttributableToNoncontrollingInterest" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="calculation: NonoperatingIncomeExpense to IncomeLossFromEquityMethodInvestments" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ResolutionOfPayorMatter" xlink:label="ResolutionOfPayorMatter" xlink:title="ResolutionOfPayorMatter" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="ResolutionOfPayorMatter" xlink:title="calculation: NonoperatingIncomeExpense to ResolutionOfPayorMatter" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InterestAndOtherIncome" xlink:title="calculation: NonoperatingIncomeExpense to InterestAndOtherIncome" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InterestExpenseDebtAndOther" xlink:title="calculation: NonoperatingIncomeExpense to InterestExpenseDebtAndOther" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="ReliefFunds" xlink:title="calculation: NonoperatingIncomeExpense to ReliefFunds" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInterestInProjects" xlink:label="GainLossOnSaleOfInterestInProjects" xlink:title="GainLossOnSaleOfInterestInProjects" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="GainLossOnSaleOfInterestInProjects" xlink:title="calculation: NonoperatingIncomeExpense to GainLossOnSaleOfInterestInProjects" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="LitigationSettlementExpense" xlink:title="LitigationSettlementExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="LitigationSettlementExpense" xlink:title="calculation: NonoperatingIncomeExpense to LitigationSettlementExpense" order="5.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="NonoperatingIncomeExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to NonoperatingIncomeExpense" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="calculation: OperatingIncomeLoss to SellingGeneralAndAdministrativeExpense" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="calculation: GrossProfit to RevenueFromContractWithCustomerExcludingAssessedTax" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="calculation: CostsAndExpenses to RentSuppliesContractLaborAndOther" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="GoodwillImpairmentLoss" xlink:title="calculation: CostsAndExpenses to GoodwillImpairmentLoss" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="RestructuringCharges" xlink:title="calculation: CostsAndExpenses to RestructuringCharges" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="LaborAndRelatedExpense" xlink:title="calculation: CostsAndExpenses to LaborAndRelatedExpense" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="calculation: CostsAndExpenses to ProvisionForDoubtfulAccounts" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="CostsAndExpenses" xlink:title="calculation: GrossProfit to CostsAndExpenses" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="GrossProfit" xlink:title="calculation: OperatingIncomeLoss to GrossProfit" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: ProfitLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: ProfitLoss to IncomeTaxExpenseBenefit" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="ProfitLoss" xlink:title="calculation: NetIncomeLoss to ProfitLoss" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromDivestitureOfBusinesses" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireBusinessesNetOfCashAcquired" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireRedeemableNonControllingInterest" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:label="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireProductiveAssets" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireInterestInSubsidiariesAndAffiliates" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DistributionsFromUnconsolidatedAffiliate" xlink:label="DistributionsFromUnconsolidatedAffiliate" xlink:title="DistributionsFromUnconsolidatedAffiliate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="DistributionsFromUnconsolidatedAffiliate" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to DistributionsFromUnconsolidatedAffiliate" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProceedsFromSalesOfNonControllingInterestPermanent" xlink:label="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="ProceedsFromSalesOfNonControllingInterestPermanent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSalesOfNonControllingInterestPermanent" order="8.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfLinesOfCredit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfLinesOfCredit" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromLinesOfCredit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromLinesOfCredit" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentFunds" xlink:label="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="MedicareAcceleratedAndAdvancePaymentFunds" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to MedicareAcceleratedAndAdvancePaymentFunds" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromPaymentsForOtherFinancingActivities" order="11.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfNotesPayable" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfNotesPayable" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsMinorityInterest" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsMinorityInterest" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsCommonStock" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProfitLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProfitLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherNoncurrentLiabilities" order="21.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationDepletionAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationDepletionAndAmortization" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DeferredIncomeTaxExpenseBenefit" order="14.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProvisionForDoubtfulAccounts" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GoodwillImpairmentLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GoodwillImpairmentLoss" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OtherOperatingActivitiesCashFlowStatement" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OtherOperatingActivitiesCashFlowStatement" order="12.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingAssets" order="19.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_GainOnSaleOfPartnershipInterestNetOfTax" xlink:label="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="GainOnSaleOfPartnershipInterestNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainOnSaleOfPartnershipInterestNetOfTax" order="10.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivable" order="17.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="20.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" order="18.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncomeLossFromEquityMethodInvestments" order="9.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="AssetAcquisitionContingentConsiderationLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AssetAcquisitionContingentConsiderationLiabilityCurrent" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="TaxesPayableCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to TaxesPayableCurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="calculation: AccruedLiabilitiesCurrent to MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to OtherAccruedLiabilitiesCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedInsuranceCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedInsuranceCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent" xlink:label="LitigationReserveCurrent" xlink:title="LitigationReserveCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="LitigationReserveCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to LitigationReserveCurrent" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="PatientsAndPayorsRelatedLiability" xlink:title="calculation: AccruedLiabilitiesCurrent to PatientsAndPayorsRelatedLiability" order="4.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtNoncurrent" xlink:title="calculation: LongTermDebt to LongTermDebtNoncurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtCurrent" xlink:title="calculation: LongTermDebt to LongTermDebtCurrent" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="OperatingLeaseCost" xlink:title="calculation: LeaseCost to OperatingLeaseCost" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="VariableLeaseCost" xlink:title="calculation: LeaseCost to VariableLeaseCost" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="ShortTermLeaseCost" xlink:title="calculation: LeaseCost to ShortTermLeaseCost" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc01">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsOperatingLossCarryforwards" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxAssetsLeaseObligations" xlink:label="DeferredTaxAssetsLeaseObligations" xlink:title="DeferredTaxAssetsLeaseObligations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsLeaseObligations" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsLeaseObligations" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="DeferredTaxAssetsGross" xlink:title="calculation: DeferredTaxLiabilities to DeferredTaxAssetsGross" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="DeferredTaxLiabilitiesOther" xlink:title="DeferredTaxLiabilitiesOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesOther" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesOther" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="calculation: DeferredTaxLiabilities to DeferredIncomeTaxLiabilities" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: IncomeTaxExpenseBenefit to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="IncomeTaxReconciliationDeductions" xlink:title="IncomeTaxReconciliationDeductions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationDeductions" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationDeductions" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationNondeductibleExpense" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationNondeductibleExpense" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:label="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="EffectiveIncomeTaxRateReconciliationDeductions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationDeductions" order="5.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredFederalIncomeTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: IncomeTaxExpenseBenefit to DeferredIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentFederalTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentStateAndLocalTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="calculation: IncomeTaxExpenseBenefit to CurrentIncomeTaxExpenseBenefit" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to ChargesToRetainedEarningsRevaluationOfNonControllingInterests" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="NetIncomeLoss" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to NetIncomeLoss" order="0.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>usph-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" />
  <link:roleRef roleURI="http://usph.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#RelatedPartyTransactionsDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#CommitmentsAndContingenciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/DefinedContributionPlanDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#DefinedContributionPlanDetails" />
  <link:roleRef roleURI="http://usph.com/role/CommonStockDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#CommonStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansSummaryDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansSummaryDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#InvestmentInUnconsolidatedAffiliateDetails" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SegmentInformationDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesSummaryDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesSummaryDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc01" xlink:type="simple" xlink:href="usph-20211231.xsd#LeasesDetailsCalc01" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAmendedCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayableAmendedCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayableSummaryOfNotesPayableDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNetAmortizationExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNetIntangibleAssetsNetDetails" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#GoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsAndSaleOfNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinesses2019AcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinesses2020AcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinesses2021AcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinessesAcquiredMajorityInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesRestrictedStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesSegmentReportingDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesIncomeTaxesDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesContractualAllowancesDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesRevenueRecognitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesGoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesLonglivedAssetsDetails" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="usph-20211231.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansTables" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansTables" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="usph-20211231.xsd#SegmentInformationTables" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesTables" />
  <link:roleRef roleURI="http://usph.com/role/LeasesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#LeasesTables" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableTables" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayableTables" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNetTables" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillTables" xlink:type="simple" xlink:href="usph-20211231.xsd#GoodwillTables" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" xlink:type="simple" xlink:href="usph-20211231.xsd#RedeemableNoncontrollingInterestTables" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinessesTables" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables" xlink:type="simple" xlink:href="usph-20211231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationTables" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" xlink:href="usph-20211231.xsd#ScheduleIiValuationAndQualifyingAccounts" />
  <link:roleRef roleURI="http://usph.com/role/ReclassificationOfPriorPeriodPresentation" xlink:type="simple" xlink:href="usph-20211231.xsd#ReclassificationOfPriorPeriodPresentation" />
  <link:roleRef roleURI="http://usph.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="usph-20211231.xsd#RelatedPartyTransactions" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShare" xlink:type="simple" xlink:href="usph-20211231.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://usph.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="usph-20211231.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://usph.com/role/DefinedContributionPlan" xlink:type="simple" xlink:href="usph-20211231.xsd#DefinedContributionPlan" />
  <link:roleRef roleURI="http://usph.com/role/CommonStock" xlink:type="simple" xlink:href="usph-20211231.xsd#CommonStock" />
  <link:roleRef roleURI="http://usph.com/role/PreferredStock" xlink:type="simple" xlink:href="usph-20211231.xsd#PreferredStock" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlans" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlans" />
  <link:roleRef roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliate" xlink:type="simple" xlink:href="usph-20211231.xsd#InvestmentInUnconsolidatedAffiliate" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformation" xlink:type="simple" xlink:href="usph-20211231.xsd#SegmentInformation" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxes" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://usph.com/role/Leases" xlink:type="simple" xlink:href="usph-20211231.xsd#Leases" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayable" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayable" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpenses" xlink:type="simple" xlink:href="usph-20211231.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNet" />
  <link:roleRef roleURI="http://usph.com/role/Goodwill" xlink:type="simple" xlink:href="usph-20211231.xsd#Goodwill" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" xlink:type="simple" xlink:href="usph-20211231.xsd#RedeemableNoncontrollingInterest" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsAndSaleOfNoncontrollingInterests" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinesses" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPolicies" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation" xlink:type="simple" xlink:href="usph-20211231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentation" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedStatementsOfChangesInEquity" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20211231.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevenuesAbstract" xlink:title="definition: StatementLineItems to RevenuesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CostsAndExpensesAbstract" xlink:title="definition: StatementLineItems to CostsAndExpensesAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GrossProfit" xlink:title="definition: StatementLineItems to GrossProfit" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="definition: StatementLineItems to SellingGeneralAndAdministrativeExpense" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingIncomeLoss" xlink:title="definition: StatementLineItems to OperatingIncomeLoss" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherNonoperatingIncomeExpenseAbstract" xlink:title="definition: StatementLineItems to OtherNonoperatingIncomeExpenseAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="definition: StatementLineItems to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncomeTaxExpenseBenefit" xlink:title="definition: StatementLineItems to IncomeTaxExpenseBenefit" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="definition: StatementLineItems to ProfitLoss" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="definition: StatementLineItems to MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EarningsPerShareBasicAndDiluted" xlink:title="definition: StatementLineItems to EarningsPerShareBasicAndDiluted" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="definition: StatementLineItems to WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockDividendsPerShareDeclared" xlink:title="definition: StatementLineItems to CommonStockDividendsPerShareDeclared" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterest" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ReliefFunds" xlink:title="definition: StatementLineItems to ReliefFunds" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInterestInProjects" xlink:label="GainLossOnSaleOfInterestInProjects" xlink:title="GainLossOnSaleOfInterestInProjects" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GainLossOnSaleOfInterestInProjects" xlink:title="definition: StatementLineItems to GainLossOnSaleOfInterestInProjects" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="LitigationSettlementExpense" xlink:title="LitigationSettlementExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LitigationSettlementExpense" xlink:title="definition: StatementLineItems to LitigationSettlementExpense" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ResolutionOfPayorMatter" xlink:label="ResolutionOfPayorMatter" xlink:title="ResolutionOfPayorMatter" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ResolutionOfPayorMatter" xlink:title="definition: StatementLineItems to ResolutionOfPayorMatter" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="definition: StatementLineItems to IncomeLossFromEquityMethodInvestments" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="InterestAndOtherIncome" xlink:title="definition: StatementLineItems to InterestAndOtherIncome" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="InterestExpenseDebtAndOther" xlink:title="definition: StatementLineItems to InterestExpenseDebtAndOther" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NonoperatingIncomeExpense" xlink:title="definition: StatementLineItems to NonoperatingIncomeExpense" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LaborAndRelatedExpense" xlink:title="definition: StatementLineItems to LaborAndRelatedExpense" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="definition: StatementLineItems to RentSuppliesContractLaborAndOther" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="definition: StatementLineItems to ProvisionForDoubtfulAccounts" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RestructuringCharges" xlink:title="definition: StatementLineItems to RestructuringCharges" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GoodwillImpairmentLoss" xlink:title="definition: StatementLineItems to GoodwillImpairmentLoss" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CostsAndExpenses" xlink:title="definition: StatementLineItems to CostsAndExpenses" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="definition: StatementLineItems to RevenueFromContractWithCustomerExcludingAssessedTax" order="32.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="33.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="ProductOrServiceAxis" xlink:title="definition: StatementTable to ProductOrServiceAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_2" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_2" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to NetPatientRevenuesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="definition: StatementLineItems to RevaluationOfRedeemableNonControllingInterestNetOfTax" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="definition: StatementLineItems to RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="definition: StatementLineItems to TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="MinorityInterestDecreaseFromRedemptions" xlink:title="MinorityInterestDecreaseFromRedemptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestDecreaseFromRedemptions" xlink:title="definition: StatementLineItems to MinorityInterestDecreaseFromRedemptions" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:label="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="SaleOfNonControllingInterestNetOfTaxAndPurchases" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="definition: StatementLineItems to SaleOfNonControllingInterestNetOfTaxAndPurchases" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DividendsCommonStockCash" xlink:title="definition: StatementLineItems to DividendsCommonStockCash" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="definition: StatementLineItems to MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShortSwingProfitSettlement" xlink:label="ShortSwingProfitSettlement" xlink:title="ShortSwingProfitSettlement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ShortSwingProfitSettlement" xlink:title="definition: StatementLineItems to ShortSwingProfitSettlement" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityOther" xlink:title="definition: StatementLineItems to StockholdersEquityOther" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="18.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="TreasuryStockMember" xlink:title="definition: EquityComponentDomain to TreasuryStockMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="ParentMember" xlink:title="definition: EquityComponentDomain to ParentMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="NoncontrollingInterestMember" xlink:title="definition: EquityComponentDomain to NoncontrollingInterestMember" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterest" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/Goodwill" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNet" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayable" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/Leases" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxes" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/InvestmentInUnconsolidatedAffiliate" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlans" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/PreferredStock" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStock" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/DefinedContributionPlan" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommitmentsAndContingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RelatedPartyTransactions" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ReclassificationOfPriorPeriodPresentation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfManagementContracts" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfManagementContracts" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="RemainingContractTerm" xlink:title="definition: BusinessAcquisitionLineItems to RemainingContractTerm" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfReportableSegments" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfReportableSegments" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionDateOfAcquisitionAgreement1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MultiClinicPracticesMember" xlink:label="MultiClinicPracticesMember" xlink:title="MultiClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MultiClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to MultiClinicPracticesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_December2021AcquisitionMember" xlink:label="December2021AcquisitionMember" xlink:title="December2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="December2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to December2021AcquisitionMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2021AcquisitionMember" xlink:label="November2021AcquisitionMember" xlink:title="November2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to November2021AcquisitionMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2021AcquisitionMember" xlink:label="September2021AcquisitionMember" xlink:title="September2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to September2021AcquisitionMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_June2021AcquisitionMember" xlink:label="June2021AcquisitionMember" xlink:title="June2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="June2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to June2021AcquisitionMember" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_March2021AcquisitionMember" xlink:label="March2021AcquisitionMember" xlink:title="March2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="March2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to March2021AcquisitionMember" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2020AcquisitionMember" xlink:label="November2020AcquisitionMember" xlink:title="November2020AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2020AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to November2020AcquisitionMember" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2020AcquisitionMember" xlink:label="September2020AcquisitionMember" xlink:title="September2020AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2020AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to September2020AcquisitionMember" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_February2020AcquisitionMember" xlink:label="February2020AcquisitionMember" xlink:title="February2020AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="February2020AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to February2020AcquisitionMember" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2019AcquisitionMember" xlink:label="September2019AcquisitionMember" xlink:title="September2019AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2019AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to September2019AcquisitionMember" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_April2019AcquisitionMember" xlink:label="April2019AcquisitionMember" xlink:title="April2019AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="April2019AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to April2019AcquisitionMember" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="PercentageOfGeneralPartnershipInterestOwned" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to PercentageOfGeneralPartnershipInterestOwned" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="PercentageOfLimitedPartnershipInterestOwned" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to PercentageOfLimitedPartnershipInterestOwned" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfOperatingClinicLocations" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfOperatingClinicLocations" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfBusinessesAcquired" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfClosedClinicsSold" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfClosedClinicsSold" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="AggregateSalePriceOfCinics" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to AggregateSalePriceOfCinics" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="CashReceivedRelatedToSaleOfClinics" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to CashReceivedRelatedToSaleOfClinics" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NoteReceivableRelatedToSaleOfClinics" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NoteReceivableRelatedToSaleOfClinics" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfInstallmentsForNoteReceivableInSaleConsideration" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="GrantsReceivable" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to GrantsReceivable" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RepaymentOfFunds" xlink:label="RepaymentOfFunds" xlink:title="RepaymentOfFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="RepaymentOfFunds" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to RepaymentOfFunds" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="GrantsAndOtherFunds" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to GrantsAndOtherFunds" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="ReliefFunds" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to ReliefFunds" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="15.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="RangeAxis" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to UnusualOrInfrequentItemAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain_2" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain_2" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="definition: UnusualOrInfrequentItemDomain to MedicareAcceleratedAndAdvancePaymentsProgramMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="definition: UnusualOrInfrequentItemDomain to PublicHealthAndSocialServicesEmergencyFundMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentAbstract" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ScheduleOfPropertyPlantAndEquipmentTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerSoftwareIntangibleAssetMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerSoftwareIntangibleAssetMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NonControllingInterestRedeemableAbstract" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NonControllingInterestRedeemableAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestByLegalEntityTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="RangeAxis" xlink:title="definition: RedeemableNoncontrollingInterestByLegalEntityTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="MedicareReimbursementAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to MedicareReimbursementAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfMedicarePaymentIncrease" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfMedicarePaymentIncrease" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="EstimatedPercentageOfDecreaseInPayment" xlink:title="definition: DisaggregationOfRevenueLineItems to EstimatedPercentageOfDecreaseInPayment" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ExpectedReductionInMedicareSpendingPercentage" xlink:title="definition: DisaggregationOfRevenueLineItems to ExpectedReductionInMedicareSpendingPercentage" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="definition: DisaggregationOfRevenueLineItems to PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="AmountOfReductionsInFederalSpending" xlink:title="definition: DisaggregationOfRevenueLineItems to AmountOfReductionsInFederalSpending" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ReductionInMedicareSpendingPercentage" xlink:title="definition: DisaggregationOfRevenueLineItems to ReductionInMedicareSpendingPercentage" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfPaymentReductionWaivedThroughEnactedLegislation" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PeriodOfExtension" xlink:label="PeriodOfExtension" xlink:title="PeriodOfExtension" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PeriodOfExtension" xlink:title="definition: DisaggregationOfRevenueLineItems to PeriodOfExtension" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="definition: DisaggregationOfRevenueLineItems to CombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="definition: DisaggregationOfRevenueLineItems to ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfPracticeExpenseComponentOfRelativeValueUnit" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="definition: DisaggregationOfRevenueLineItems to PercentageOfPaymentForOutpatientTherapyServices" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="NetRevenueFromMedicare" xlink:title="definition: DisaggregationOfRevenueLineItems to NetRevenueFromMedicare" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="definition: DisaggregationOfRevenueLineItems to RevenueFromContractWithCustomerExcludingAssessedTax" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueTable" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueTable" order="21.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="ProductOrServiceAxis" xlink:title="definition: DisaggregationOfRevenueTable to ProductOrServiceAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_2" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_2" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to NetPatientRevenuesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to OtherRevenuesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: ProductsAndServicesDomain to PhysicalTherapyOperationsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="ManagementContractRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to ManagementContractRevenuesMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="definition: DisaggregationOfRevenueTable to UnusualOrInfrequentItemAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain_2" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain_2" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:label="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="definition: UnusualOrInfrequentItemDomain to FromTwoThousandSeventeenThroughTwoThousandNineteenMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="definition: UnusualOrInfrequentItemDomain to FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="StatementScenarioAxis" xlink:title="definition: DisaggregationOfRevenueTable to StatementScenarioAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain_2" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain_2" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="definition: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="definition: DisaggregationOfRevenueTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: DisaggregationOfRevenueTable to RelatedPartyTransactionsByRelatedPartyAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CentersForMedicareAndMedicaidServicesMember" xlink:label="CentersForMedicareAndMedicaidServicesMember" xlink:title="CentersForMedicareAndMedicaidServicesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="CentersForMedicareAndMedicaidServicesMember" xlink:title="definition: RelatedPartyDomain to CentersForMedicareAndMedicaidServicesMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualAllowancesAbstract" xlink:label="ContractualAllowancesAbstract" xlink:title="ContractualAllowancesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractualAllowancesAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractualAllowancesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="definition: DisaggregationOfRevenueLineItems to DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="definition: DisaggregationOfRevenueLineItems to DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="MaximumContractualAllowanceReserveEstimate" xlink:title="definition: DisaggregationOfRevenueLineItems to MaximumContractualAllowanceReserveEstimate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueTable" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="definition: DisaggregationOfRevenueTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="FairValueDisclosuresAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems to FairValueDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="DebtInstrumentMeasurementInput" xlink:title="DebtInstrumentMeasurementInput" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="DebtInstrumentMeasurementInput" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems to DebtInstrumentMeasurementInput" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="MeasurementInputTypeAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable to MeasurementInputTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain_2" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain_2" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="MeasurementInputDiscountRateMember" xlink:title="MeasurementInputDiscountRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputDiscountRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputDiscountRateMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementsAbstract" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="DirectorMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to DirectorMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="OfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to OfficerMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionDateOfAcquisitionAgreement1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfManagementContracts" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfManagementContracts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="RemainingContractTerm" xlink:title="definition: BusinessAcquisitionLineItems to RemainingContractTerm" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_December2021AcquisitionMember" xlink:label="December2021AcquisitionMember" xlink:title="December2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="December2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to December2021AcquisitionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2021AcquisitionMember" xlink:label="November2021AcquisitionMember" xlink:title="November2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to November2021AcquisitionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2021AcquisitionMember" xlink:label="September2021AcquisitionMember" xlink:title="September2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to September2021AcquisitionMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_June2021AcquisitionMember" xlink:label="June2021AcquisitionMember" xlink:title="June2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="June2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to June2021AcquisitionMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_March2021AcquisitionMember" xlink:label="March2021AcquisitionMember" xlink:title="March2021AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="March2021AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to March2021AcquisitionMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2020AcquisitionMember" xlink:label="November2020AcquisitionMember" xlink:title="November2020AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2020AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to November2020AcquisitionMember" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2020AcquisitionMember" xlink:label="September2020AcquisitionMember" xlink:title="September2020AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2020AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to September2020AcquisitionMember" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_February2020AcquisitionMember" xlink:label="February2020AcquisitionMember" xlink:title="February2020AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="February2020AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to February2020AcquisitionMember" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2019AcquisitionMember" xlink:label="September2019AcquisitionMember" xlink:title="September2019AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2019AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to September2019AcquisitionMember" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_April2019AcquisitionMember" xlink:label="April2019AcquisitionMember" xlink:title="April2019AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="April2019AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to April2019AcquisitionMember" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementAndServicesContractsMember" xlink:label="ManagementAndServicesContractsMember" xlink:title="ManagementAndServicesContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementAndServicesContractsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ManagementAndServicesContractsMember" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="definition: BusinessAcquisitionLineItems to MinorityInterestOwnershipPercentageByNoncontrollingOwners" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:label="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferred1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationContingentConsiderationLiability" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationContingentConsiderationLiability" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:label="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferredIncludesContingentConsideration" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesGross" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:label="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: BusinessAcquisitionLineItems to DebtInstrumentInterestRateStatedPercentage" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="RemainingContractTerm" xlink:title="definition: BusinessAcquisitionLineItems to RemainingContractTerm" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase" xlink:label="ContractWithCustomerAssetPurchase" xlink:title="ContractWithCustomerAssetPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ContractWithCustomerAssetPurchase" xlink:title="definition: BusinessAcquisitionLineItems to ContractWithCustomerAssetPurchase" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="15.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReturnToWorkAndErgonomicServicesMember" xlink:label="ReturnToWorkAndErgonomicServicesMember" xlink:title="ReturnToWorkAndErgonomicServicesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ReturnToWorkAndErgonomicServicesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ReturnToWorkAndErgonomicServicesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PreviousOwnersMember" xlink:label="PreviousOwnersMember" xlink:title="PreviousOwnersMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="PreviousOwnersMember" xlink:title="definition: OwnershipDomain to PreviousOwnersMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesNetOfCashAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationContingentConsiderationLiability" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationContingentConsiderationLiability" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase" xlink:label="ContractWithCustomerAssetPurchase" xlink:title="ContractWithCustomerAssetPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ContractWithCustomerAssetPurchase" xlink:title="definition: BusinessAcquisitionLineItems to ContractWithCustomerAssetPurchase" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesConsideration" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="definition: BusinessAcquisitionLineItems to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="18.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementBusinessSegmentsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain_2" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain_2" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="definition: BusinessAcquisitionLineItems to MinorityInterestOwnershipPercentageByNoncontrollingOwners" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfManagementContracts" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfManagementContracts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferred1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesGross" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="definition: BusinessAcquisitionLineItems to DebtInstrumentAnnualPrincipalPayment" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: BusinessAcquisitionLineItems to DebtInstrumentInterestRateStatedPercentage" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="13.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PreviousOwnersMember" xlink:label="PreviousOwnersMember" xlink:title="PreviousOwnersMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="PreviousOwnersMember" xlink:title="definition: OwnershipDomain to PreviousOwnersMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ShortTermDebtTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain_2" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain_2" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableOneMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableTwoMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableTwoMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesNetOfCashAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesConsideration" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="definition: BusinessAcquisitionLineItems to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="15.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfStatesOfNetworkServices" xlink:label="NumberOfStatesOfNetworkServices" xlink:title="NumberOfStatesOfNetworkServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfStatesOfNetworkServices" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfStatesOfNetworkServices" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfOnsiteClientLocations" xlink:label="NumberOfOnsiteClientLocations" xlink:title="NumberOfOnsiteClientLocations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfOnsiteClientLocations" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfOnsiteClientLocations" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesNetOfCashAcquired" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferred1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CashAcquiredFromAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to CashAcquiredFromAcquisition" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesGross" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPayableToShareholdersOfSeller" xlink:label="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="BusinessAcquisitionPayableToShareholdersOfSeller" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPayableToShareholdersOfSeller" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: BusinessAcquisitionLineItems to DebtInstrumentInterestRateStatedPercentage" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2019AcquisitionMember" xlink:label="September2019AcquisitionMember" xlink:title="September2019AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2019AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to September2019AcquisitionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AprilTwoThousandNineteenAcquisitionMember" xlink:label="AprilTwoThousandNineteenAcquisitionMember" xlink:title="AprilTwoThousandNineteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AprilTwoThousandNineteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AprilTwoThousandNineteenAcquisitionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementScenarioAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementScenarioAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain_2" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain_2" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SeptemberTwoThousandTwentyMember" xlink:label="SeptemberTwoThousandTwentyMember" xlink:title="SeptemberTwoThousandTwentyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="SeptemberTwoThousandTwentyMember" xlink:title="definition: ScenarioUnspecifiedDomain to SeptemberTwoThousandTwentyMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SeptemberTwoThousandTwentyOneMember" xlink:label="SeptemberTwoThousandTwentyOneMember" xlink:title="SeptemberTwoThousandTwentyOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="SeptemberTwoThousandTwentyOneMember" xlink:title="definition: ScenarioUnspecifiedDomain to SeptemberTwoThousandTwentyOneMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesNetOfCashAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPayableToShareholdersOfSeller" xlink:label="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="BusinessAcquisitionPayableToShareholdersOfSeller" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPayableToShareholdersOfSeller" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesConsideration" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="definition: BusinessAcquisitionLineItems to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CashAcquiredFromAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to CashAcquiredFromAcquisition" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="17.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementBusinessSegmentsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain_2" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain_2" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CustomerAndReferralRelationshipMember" xlink:label="CustomerAndReferralRelationshipMember" xlink:title="CustomerAndReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerAndReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerAndReferralRelationshipMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="definition: BusinessAcquisitionLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="definition: BusinessAcquisitionLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfClosedClinicsSold" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfClosedClinicsSold" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AggregateSalePriceOfCinics" xlink:title="definition: BusinessAcquisitionLineItems to AggregateSalePriceOfCinics" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CashReceivedRelatedToSaleOfClinics" xlink:title="definition: BusinessAcquisitionLineItems to CashReceivedRelatedToSaleOfClinics" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NoteReceivableRelatedToSaleOfClinics" xlink:title="definition: BusinessAcquisitionLineItems to NoteReceivableRelatedToSaleOfClinics" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfInstallmentsForNoteReceivableInSaleConsideration" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:label="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="SaleOfNoncontrollingInterestPercentageInPartnershipOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="definition: BusinessAcquisitionLineItems to SaleOfNoncontrollingInterestPercentageInPartnershipOne" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TaxEffectOnSaleOfNoncontrollingInterest" xlink:label="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="TaxEffectOnSaleOfNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="definition: BusinessAcquisitionLineItems to TaxEffectOnSaleOfNoncontrollingInterest" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="13.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to CarryingAmountOfRedeemableNonControllingInterestAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmount" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="MinorityInterestChangeInRedemptionValue" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to MinorityInterestChangeInRedemptionValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ProceedsFromPaymentsToMinorityShareholders" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ProceedsFromPaymentsToMinorityShareholders" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="PaymentsToMinorityShareholders" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to PaymentsToMinorityShareholders" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:label="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="NoncontrollingInterestDecreaseFromDeconsolidation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NoncontrollingInterestDecreaseFromDeconsolidation" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestByLegalEntityTable" order="18.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="OwnershipAxis" xlink:title="definition: RedeemableNoncontrollingInterestByLegalEntityTable to OwnershipAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="RedeemableNonControllingInterestMember" xlink:title="definition: OwnershipDomain to RedeemableNonControllingInterestMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionConsiderationPayableTermOfNote" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="TermOfEmploymentAgreement" xlink:title="definition: BusinessAcquisitionLineItems to TermOfEmploymentAgreement" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EmploymentAgreementRenewalTerm" xlink:title="definition: BusinessAcquisitionLineItems to EmploymentAgreementRenewalTerm" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="definition: BusinessAcquisitionLineItems to NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementBasicTerm" xlink:title="definition: BusinessAcquisitionLineItems to NonCompeteAgreementBasicTerm" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TherapyPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to TherapyPracticeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProgressiveHealthCompaniesLLCMember" xlink:label="ProgressiveHealthCompaniesLLCMember" xlink:title="ProgressiveHealthCompaniesLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ProgressiveHealthCompaniesLLCMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ProgressiveHealthCompaniesLLCMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ConsolidatedEntitiesAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ConsolidatedEntitiesAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain" xlink:title="definition: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain_2" xlink:title="ConsolidatedEntitiesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain_2" xlink:title="definition: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidatedEntitiesDomain" xlink:to="SubsidiariesMember" xlink:title="definition: ConsolidatedEntitiesDomain to SubsidiariesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to IntangibleAssetsNetExcludingGoodwill" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetUsefulLife" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfDeferredChargesAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to AmortizationOfDeferredChargesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfIntangibleAssets" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to AmortizationOfIntangibleAssets" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfAcquiredOperations" xlink:label="NumberOfAcquiredOperations" xlink:title="NumberOfAcquiredOperations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="NumberOfAcquiredOperations" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to NumberOfAcquiredOperations" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetUsefulLife" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtCurrent" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtCurrent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtNoncurrent" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtNoncurrent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentAnnualPrincipalPayment" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentInterestRateStatedPercentage" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="PromissoryNotesMember" xlink:title="definition: DebtInstrumentNameDomain to PromissoryNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAmendedCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityMaximumBorrowingCapacity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityIncreaseDecreaseForPeriodNet" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentBasisSpreadOnLiborVariableRate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentBasisSpreadOnVariableRate1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="definition: DebtInstrumentLineItems to CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DividendsCashAfterAmendment" xlink:title="definition: DebtInstrumentLineItems to DividendsCashAfterAmendment" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityRemainingBorrowingCapacity" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentFaceAmount" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="15.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="CreditAgreementMember" xlink:title="definition: DebtInstrumentNameDomain to CreditAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="definition: DebtInstrumentTable to ShortTermDebtTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain_2" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain_2" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCostAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseCostAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to SupplementalInformationRelatedToOperatingLeasesAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to AverageLeaseTermsAndDiscountRatesAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseWeightedAverageDiscountRatePercent" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDue" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiability" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeasePayments" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeasePayments" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseCost" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="ShortTermLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to ShortTermLeaseCost" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="VariableLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to VariableLeaseCost" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseCost" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseTermOfContract" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeLeaseDescriptionTable" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeLeaseDescriptionTable" order="24.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="definition: LesseeLeaseDescriptionTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc01" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesSummaryDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="IncomeTaxExaminationLineItems" xlink:title="IncomeTaxExaminationLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeTaxExaminationAbstract" xlink:label="IncomeTaxExaminationAbstract" xlink:title="IncomeTaxExaminationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExaminationAbstract" xlink:title="definition: IncomeTaxExaminationLineItems to IncomeTaxExaminationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:label="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="definition: IncomeTaxExaminationLineItems to DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="definition: IncomeTaxExaminationLineItems to IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="AccruedIncomeTaxesCurrent" xlink:title="AccruedIncomeTaxesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="AccruedIncomeTaxesCurrent" xlink:title="definition: IncomeTaxExaminationLineItems to AccruedIncomeTaxesCurrent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:label="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="definition: IncomeTaxExaminationLineItems to DeferredIncomeTaxesAndOtherTaxReceivableCurrent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="definition: IncomeTaxExaminationLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:label="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="definition: IncomeTaxExaminationLineItems to UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:label="IncomeTaxExaminationYearUnderExamination" xlink:title="IncomeTaxExaminationYearUnderExamination" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExaminationYearUnderExamination" xlink:title="definition: IncomeTaxExaminationLineItems to IncomeTaxExaminationYearUnderExamination" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="IncomeTaxExaminationTable" xlink:title="IncomeTaxExaminationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExaminationTable" xlink:title="definition: IncomeTaxExaminationLineItems to IncomeTaxExaminationTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeTaxExaminationTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="definition: IncomeTaxExaminationTable to IncomeTaxAuthorityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain_2" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain_2" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="ForeignCountryMember" xlink:title="definition: IncomeTaxAuthorityDomain to ForeignCountryMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="definition: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeTaxExaminationTable" xlink:to="RangeAxis" xlink:title="definition: IncomeTaxExaminationTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="definition: SegmentReportingInformationLineItems to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="Revenues" xlink:title="definition: SegmentReportingInformationLineItems to Revenues" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="GrossProfit" xlink:title="definition: SegmentReportingInformationLineItems to GrossProfit" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="RestructuringCharges" xlink:title="definition: SegmentReportingInformationLineItems to RestructuringCharges" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="Assets" xlink:title="definition: SegmentReportingInformationLineItems to Assets" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SegmentReportingInformationLineItems" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="definition: SegmentReportingInformationLineItems to ScheduleOfSegmentReportingInformationBySegmentTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="ConsolidationItemsAxis" xlink:title="definition: ScheduleOfSegmentReportingInformationBySegmentTable to ConsolidationItemsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain" xlink:title="definition: ConsolidationItemsAxis to ConsolidationItemsDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain_2" xlink:title="ConsolidationItemsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain_2" xlink:title="definition: ConsolidationItemsAxis to ConsolidationItemsDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationItemsDomain" xlink:to="OperatingSegmentsMember" xlink:title="definition: ConsolidationItemsDomain to OperatingSegmentsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="definition: ScheduleOfSegmentReportingInformationBySegmentTable to StatementBusinessSegmentsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain_2" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain_2" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: SegmentDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:label="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:title="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="ScheduleOfEquityMethodInvestmentsLineItems" xlink:title="ScheduleOfEquityMethodInvestmentsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentQuotedMarketValue" xlink:label="EquityMethodInvestmentQuotedMarketValue" xlink:title="EquityMethodInvestmentQuotedMarketValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="EquityMethodInvestmentQuotedMarketValue" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to EquityMethodInvestmentQuotedMarketValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to IncomeLossFromEquityMethodInvestments" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:label="EquityMethodInvestmentDividendsOrDistributions" xlink:title="EquityMethodInvestmentDividendsOrDistributions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="EquityMethodInvestmentDividendsOrDistributions" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to EquityMethodInvestmentDividendsOrDistributions" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="ScheduleOfEquityMethodInvestmentsTable" xlink:title="ScheduleOfEquityMethodInvestmentsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="ScheduleOfEquityMethodInvestmentsTable" xlink:title="definition: ScheduleOfEquityMethodInvestmentsLineItems to ScheduleOfEquityMethodInvestmentsTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfEquityMethodInvestmentsTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfEquityMethodInvestmentsTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_JointVentureInterestMember" xlink:label="JointVentureInterestMember" xlink:title="JointVentureInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="JointVentureInterestMember" xlink:title="definition: EquityMethodInvesteeNameDomain to JointVentureInterestMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="definition: PlanNameAxis to PlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="AmendedTwoThousandThreePlanMember" xlink:title="definition: PlanNameDomain to AmendedTwoThousandThreePlanMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonQualifiedStockOptionsMember" xlink:label="NonQualifiedStockOptionsMember" xlink:title="NonQualifiedStockOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="NonQualifiedStockOptionsMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to NonQualifiedStockOptionsMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="definition: PlanNameAxis to PlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmendedNineteenNinetyNinePlanMember" xlink:label="AmendedNineteenNinetyNinePlanMember" xlink:title="AmendedNineteenNinetyNinePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="AmendedNineteenNinetyNinePlanMember" xlink:title="definition: PlanNameDomain to AmendedNineteenNinetyNinePlanMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="AmendedTwoThousandThreePlanMember" xlink:title="definition: PlanNameDomain to AmendedTwoThousandThreePlanMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansSummaryDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RestrictedPeriodToEmployeesOnTheStockGranted" xlink:label="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="RestrictedPeriodToEmployeesOnTheStockGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to RestrictedPeriodToEmployeesOnTheStockGranted" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeesMember" xlink:label="EmployeesMember" xlink:title="EmployeesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeesMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to EmployeesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ExecutiveOfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ExecutiveOfficerMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfStockDisclosuresAbstract" xlink:title="definition: EquityClassOfTreasuryStockLineItems to ClassOfStockDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: EquityClassOfTreasuryStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="PercentageOfRepurchaseOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to PercentageOfRepurchaseOfCommonStock" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to BankCreditAgreementToPermitShareRepurchasesOfCommonStock" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchasedDuringPeriodShares" xlink:title="definition: EquityClassOfTreasuryStockLineItems to StockRepurchasedDuringPeriodShares" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to AdditionalEstimatedRepurchaseOfCommonStock" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="SharesIssuedPricePerShare" xlink:title="definition: EquityClassOfTreasuryStockLineItems to SharesIssuedPricePerShare" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfTreasuryStockTable" xlink:title="definition: EquityClassOfTreasuryStockLineItems to ClassOfTreasuryStockTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfTreasuryStockTable" xlink:to="RangeAxis" xlink:title="definition: ClassOfTreasuryStockTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/DefinedContributionPlanDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommitmentsAndContingenciesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsAbstract" xlink:label="EmploymentAgreementsAbstract" xlink:title="EmploymentAgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsAbstract" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlementAbstract" xlink:label="GainLossRelatedToLitigationSettlementAbstract" xlink:title="GainLossRelatedToLitigationSettlementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="GainLossRelatedToLitigationSettlementAbstract" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to GainLossRelatedToLitigationSettlementAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="LossContingencyNumberOfDefendants" xlink:title="LossContingencyNumberOfDefendants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="LossContingencyNumberOfDefendants" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to LossContingencyNumberOfDefendants" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="LitigationSettlementAmountAwardedToOtherParty" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to LitigationSettlementAmountAwardedToOtherParty" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="LossContingencyLossInPeriod" xlink:title="LossContingencyLossInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="LossContingencyLossInPeriod" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to LossContingencyLossInPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:label="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="NumberOfEmployeesCoveredUnderEmployeeAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to NumberOfEmployeesCoveredUnderEmployeeAgreement" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDate" xlink:label="EmploymentAgreementsExpirationDate" xlink:title="EmploymentAgreementsExpirationDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsExpirationDate" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsExpirationDate" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateTwo" xlink:label="EmploymentAgreementsExpirationDateTwo" xlink:title="EmploymentAgreementsExpirationDateTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsExpirationDateTwo" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsExpirationDateTwo" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateThree" xlink:label="EmploymentAgreementsExpirationDateThree" xlink:title="EmploymentAgreementsExpirationDateThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsExpirationDateThree" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsExpirationDateThree" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateFour" xlink:label="EmploymentAgreementsExpirationDateFour" xlink:title="EmploymentAgreementsExpirationDateFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsExpirationDateFour" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsExpirationDateFour" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RenewalPeriodForEmploymentAgreement" xlink:label="RenewalPeriodForEmploymentAgreement" xlink:title="RenewalPeriodForEmploymentAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="RenewalPeriodForEmploymentAgreement" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to RenewalPeriodForEmploymentAgreement" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmployeeCompensationFuturePaymentDueNextFiscalYear" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ExecutiveOfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ExecutiveOfficerMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to SubsequentEventTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RelatedPartyTransactionsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:title="ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="MovementInValuationAllowancesAndReservesRollForward" xlink:title="MovementInValuationAllowancesAndReservesRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="MovementInValuationAllowancesAndReservesRollForward" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to MovementInValuationAllowancesAndReservesRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="ValuationAllowancesAndReservesBalance" xlink:title="ValuationAllowancesAndReservesBalance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAllowancesAndReservesBalance" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAllowancesAndReservesBalance" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="ValuationAllowancesAndReservesChargedToCostAndExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAllowancesAndReservesChargedToCostAndExpense" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="ValuationAllowancesAndReservesChargedToOtherAccounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAllowancesAndReservesChargedToOtherAccounts" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="ValuationAllowancesAndReservesDeductions" xlink:title="ValuationAllowancesAndReservesDeductions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAllowancesAndReservesDeductions" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAllowancesAndReservesDeductions" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="ValuationAndQualifyingAccountsDisclosureTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAndQualifyingAccountsDisclosureTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="ValuationAllowancesAndReservesTypeAxis" xlink:title="ValuationAllowancesAndReservesTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ValuationAndQualifyingAccountsDisclosureTable" xlink:to="ValuationAllowancesAndReservesTypeAxis" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureTable to ValuationAllowancesAndReservesTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="ValuationAllowancesAndReservesDomain" xlink:title="definition: ValuationAllowancesAndReservesTypeAxis to ValuationAllowancesAndReservesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain_2" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="ValuationAllowancesAndReservesDomain_2" xlink:title="definition: ValuationAllowancesAndReservesTypeAxis to ValuationAllowancesAndReservesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="AllowanceForCreditLossMember" xlink:title="AllowanceForCreditLossMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAllowancesAndReservesDomain" xlink:to="AllowanceForCreditLossMember" xlink:title="definition: ValuationAllowancesAndReservesDomain to AllowanceForCreditLossMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>usph-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AwardTypeAxis_lbl1" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl1">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl1" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountingPoliciesAbstract_lbl">Significant Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:title="label: AccountingPoliciesAbstract to us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableTradeCurrent_lbl">Accounts payable - trade</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:title="label: AccountsPayableTradeCurrent to us-gaap_AccountsPayableTradeCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableTradeCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableTradeCurrent_lbl1">Accounts Payable, Trade, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl1" xlink:title="label: AccountsPayableTradeCurrent to us-gaap_AccountsPayableTradeCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl">Payables and Accruals [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl">Accounts receivable - other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1">Accounts and Other Receivables, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsReceivableNetCurrent_lbl">Patient accounts receivable, less allowance for credit losses of $2,768 and $2,008, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:title="label: AccountsReceivableNetCurrent to us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsReceivableNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsReceivableNetCurrent_lbl1">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl1" xlink:title="label: AccountsReceivableNetCurrent to us-gaap_AccountsReceivableNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedInsuranceCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AccruedInsuranceCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedInsuranceCurrent_lbl">Group health insurance claims</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedInsuranceCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent_lbl" xlink:title="label: AccruedInsuranceCurrent to us-gaap_AccruedInsuranceCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedInsuranceCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedInsuranceCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedInsuranceCurrent_lbl1">Accrued Insurance, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedInsuranceCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent_lbl1" xlink:title="label: AccruedInsuranceCurrent to us-gaap_AccruedInsuranceCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="AccruedIncomeTaxesCurrent" xlink:title="AccruedIncomeTaxesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedIncomeTaxesCurrent_lbl">Tax payable included in accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:title="label: AccruedIncomeTaxesCurrent to us-gaap_AccruedIncomeTaxesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl">Less accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl1">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid-In Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl">Compensation expense - equity-based awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl">Compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl1">Share-based Payment Arrangement, Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl">Allowance for credit losses, patient accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:title="label: AllowanceForDoubtfulAccountsReceivableCurrent to us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xlink:title="label: AllowanceForDoubtfulAccountsReceivableCurrent to us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="AllowanceForCreditLossMember" xlink:title="AllowanceForCreditLossMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForCreditLossMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForCreditLossMember_lbl" xml:lang="en-US" id="us-gaap_AllowanceForCreditLossMember_lbl">Allowance for Credit Losses [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForCreditLossMember" xlink:to="us-gaap_AllowanceForCreditLossMember_lbl" xlink:title="label: AllowanceForCreditLossMember to us-gaap_AllowanceForCreditLossMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl">Total amortization expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl1">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfDeferredChargesAbstract_lbl">Amortization of Deferred Charges [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xlink:title="label: AmortizationOfDeferredChargesAbstract to us-gaap_AmortizationOfDeferredChargesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="AssetAcquisitionContingentConsiderationLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl">Contingent payment related to acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" xlink:title="label: AssetAcquisitionContingentConsiderationLiabilityCurrent to us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl">Other payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl">Total non-current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl">Acquisition date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:title="label: BusinessAcquisitionDateOfAcquisitionAgreement1 to us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1">Business Acquisition, Date of Acquisition Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xlink:title="label: BusinessAcquisitionDateOfAcquisitionAgreement1 to us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl">Contingent payment consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:title="label: BusinessCombinationContingentConsiderationLiability to us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1">Contingent payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1" xlink:title="label: BusinessCombinationContingentConsiderationLiability to us-gaap_BusinessCombinationContingentConsiderationLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl2" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl2">Business Combination, Contingent Consideration, Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl2" xlink:title="label: BusinessCombinationContingentConsiderationLiability to us-gaap_BusinessCombinationContingentConsiderationLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationConsiderationTransferred1_lbl">Aggregate purchase price for the acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:title="label: BusinessCombinationConsiderationTransferred1 to us-gaap_BusinessCombinationConsiderationTransferred1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1">Business Combination, Consideration Transferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xlink:title="label: BusinessCombinationConsiderationTransferred1 to us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract" xlink:label="BusinessCombinationGoodwillAbstract" xlink:title="BusinessCombinationGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationGoodwillAbstract_lbl">Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xlink:title="label: BusinessCombinationGoodwillAbstract to us-gaap_BusinessCombinationGoodwillAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationGoodwillAbstract_lbl1">Business Combination, Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xlink:title="label: BusinessCombinationGoodwillAbstract to us-gaap_BusinessCombinationGoodwillAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl">Percentage of interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationsAbstract_lbl">Acquisitions of Businesses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:title="label: BusinessCombinationsAbstract to us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionLineItems_lbl">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:title="label: BusinessAcquisitionLineItems to us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount to us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount to us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl">Business Combination, Description [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="BusinessCombinationDisclosureTextBlock" xlink:title="BusinessCombinationDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDisclosureTextBlock_lbl">Acquisitions of Businesses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:title="label: BusinessCombinationDisclosureTextBlock to us-gaap_BusinessCombinationDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationDisclosureTextBlock_lbl1">Business Combination Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl1" xlink:title="label: BusinessCombinationDisclosureTextBlock to us-gaap_BusinessCombinationDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl">Cash and cash equivalents - end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1">Cash and cash equivalents - beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl">Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl">Cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl1" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl1">Net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl1" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl">Non-cash investing and financing transactions during the period:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfTreasuryStockTable_lbl" xml:lang="en-US" id="us-gaap_ClassOfTreasuryStockTable_lbl">Class of Treasury Stock [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfTreasuryStockTable" xlink:to="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:title="label: ClassOfTreasuryStockTable to us-gaap_ClassOfTreasuryStockTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDisclosuresAbstract_lbl">Class of Stock Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xlink:title="label: ClassOfStockDisclosuresAbstract to us-gaap_ClassOfStockDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl">Commitments and Contingencies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingencies_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl1">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl1" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US" id="us-gaap_CommonStockDividendsPerShareDeclared_lbl">Dividends declared per common share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:title="label: CommonStockDividendsPerShareDeclared to us-gaap_CommonStockDividendsPerShareDeclared_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xml:lang="en-US" id="us-gaap_CommonStockDividendsPerShareDeclared_lbl1">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xlink:title="label: CommonStockDividendsPerShareDeclared to us-gaap_CommonStockDividendsPerShareDeclared_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl1">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl1">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $.01 par value, 20,000,000 shares authorized, 15,126,160 and 15,066,282 shares issued, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl1" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl1">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl1" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl1">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl">Defined Contribution Plan [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:title="label: CompensationAndRetirementDisclosureAbstract to us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="CompensationAndEmployeeBenefitPlansTextBlock" xlink:title="CompensationAndEmployeeBenefitPlansTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US" id="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl">Defined Contribution Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:title="label: CompensationAndEmployeeBenefitPlansTextBlock to us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1" xlink:title="label: CompensationAndEmployeeBenefitPlansTextBlock to us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl">Deferred tax assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:title="label: ComponentsOfDeferredTaxAssetsAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1" xlink:title="label: ComponentsOfDeferredTaxAssetsAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl">Deferred tax liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:title="label: ComponentsOfDeferredTaxLiabilitiesAbstract to us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1" xlink:title="label: ComponentsOfDeferredTaxLiabilitiesAbstract to us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US" id="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl">Software [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:title="label: ComputerSoftwareIntangibleAssetMember to us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xml:lang="en-US" id="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1">Computer Software, Intangible Asset [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xlink:title="label: ComputerSoftwareIntangibleAssetMember to us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl">Cash proceeds from sale of non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Sale of Interest by Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl">Purchase price for additional non controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase" xlink:label="ContractWithCustomerAssetPurchase" xlink:title="ContractWithCustomerAssetPurchase" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ContractWithCustomerAssetPurchase_lbl" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetPurchase_lbl">Ownership rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetPurchase" xlink:to="us-gaap_ContractWithCustomerAssetPurchase_lbl" xlink:title="label: ContractWithCustomerAssetPurchase to us-gaap_ContractWithCustomerAssetPurchase_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetPurchase_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ContractWithCustomerAssetPurchase_lbl1" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetPurchase_lbl1">Seller put right</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetPurchase" xlink:to="us-gaap_ContractWithCustomerAssetPurchase_lbl1" xlink:title="label: ContractWithCustomerAssetPurchase to us-gaap_ContractWithCustomerAssetPurchase_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetPurchase_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerAssetPurchase_lbl2" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetPurchase_lbl2">Contract with Customer, Asset, Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetPurchase" xlink:to="us-gaap_ContractWithCustomerAssetPurchase_lbl2" xlink:title="label: ContractWithCustomerAssetPurchase to us-gaap_ContractWithCustomerAssetPurchase_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:label="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl">Contractual Allowances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:to="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xlink:title="label: ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock to us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1">Contractual Adjustments and Third Party Settlements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:to="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xlink:title="label: ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock to us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl">Total operating cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpenses_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl1">Costs and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl1" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpensesAbstract_lbl">Operating cost:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:title="label: CostsAndExpensesAbstract to us-gaap_CostsAndExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpensesAbstract_lbl1">Costs and Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl1" xlink:title="label: CostsAndExpensesAbstract to us-gaap_CostsAndExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityAxis_lbl">Credit Facility [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:title="label: CreditFacilityAxis to us-gaap_CreditFacilityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityDomain_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityDomain_lbl">Credit Facility [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl" xlink:title="label: CreditFacilityDomain to us-gaap_CreditFacilityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:title="label: CurrentStateAndLocalTaxExpenseBenefit to us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1">Current State and Local Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xlink:title="label: CurrentStateAndLocalTaxExpenseBenefit to us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1">Current Federal Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl">Total current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1">Current Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl">Customer and Referral Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CustomerRelationshipsMember_lbl1" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl1">Customer Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl1" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueLineItems_lbl">Disaggregation of Revenue [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:title="label: DisaggregationOfRevenueLineItems to us-gaap_DisaggregationOfRevenueLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTable_lbl">Disaggregation of Revenue [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:title="label: DisaggregationOfRevenueTable to us-gaap_DisaggregationOfRevenueTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="DisaggregationOfRevenueTableTextBlock" xlink:title="DisaggregationOfRevenueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl">Disaggregation of Revenue, Categories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:title="label: DisaggregationOfRevenueTableTextBlock to us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisaggregationOfRevenueAbstract_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueAbstract_lbl">Revenue Recognition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueAbstract" xlink:to="us-gaap_DisaggregationOfRevenueAbstract_lbl" xlink:title="label: DisaggregationOfRevenueAbstract to us-gaap_DisaggregationOfRevenueAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueAbstract_lbl1" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueAbstract_lbl1">Disaggregation of Revenue [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueAbstract" xlink:to="us-gaap_DisaggregationOfRevenueAbstract_lbl1" xlink:title="label: DisaggregationOfRevenueAbstract to us-gaap_DisaggregationOfRevenueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl">Spread on variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="DebtInstrumentMeasurementInput" xlink:title="DebtInstrumentMeasurementInput" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentMeasurementInput_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentMeasurementInput_lbl">Debt instrument, measurement input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:title="label: DebtInstrumentMeasurementInput to us-gaap_DebtInstrumentMeasurementInput_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureAbstract_lbl">Notes Payable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:title="label: DebtDisclosureAbstract to us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl">Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl1">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAxis_lbl">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:title="label: DebtInstrumentAxis to us-gaap_DebtInstrumentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl">Annual installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:title="label: DebtInstrumentAnnualPrincipalPayment to us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1">Principal installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xlink:title="label: DebtInstrumentAnnualPrincipalPayment to us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl">Aggregate amount of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl1">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentTable_lbl">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:title="label: DebtInstrumentTable to us-gaap_DebtInstrumentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentLineItems_lbl">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:title="label: DebtInstrumentLineItems to us-gaap_DebtInstrumentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentsAbstract_lbl">Debt Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentsAbstract_lbl" xlink:title="label: DebtInstrumentsAbstract to us-gaap_DebtInstrumentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl">Percentage of interest accrued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentNameDomain_lbl">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xlink:title="label: DebtInstrumentNameDomain to us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl">Deferred taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:title="label: DeferredIncomeTaxLiabilitiesNet to us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl">Period in which restrictions lapse on stock granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xlink:title="label: DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1 to us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:title="label: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:label="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl">Tax receivable included in other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl" xlink:title="label: DeferredIncomeTaxesAndOtherTaxReceivableCurrent to us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1">Deferred Income Taxes and Other Tax Receivable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1" xlink:title="label: DeferredIncomeTaxesAndOtherTaxReceivableCurrent to us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementsAbstract_lbl">Restricted Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementsAbstract" xlink:to="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xlink:title="label: DeferredCompensationArrangementsAbstract to us-gaap_DeferredCompensationArrangementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl">Deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl1">Deferred Tax Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Deferred [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl">Deferred income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1">Total deferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2">Deferred Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl">Acquired net operating losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwards to us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl">Deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl1">Deferred Tax Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl">Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilities_lbl">Net deferred tax liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:title="label: DeferredTaxLiabilities to us-gaap_DeferredTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilities_lbl1">Deferred Tax Liabilities, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl1" xlink:title="label: DeferredTaxLiabilities to us-gaap_DeferredTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl">Allowance for credit losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts to us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts to us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="DeferredTaxLiabilitiesOther" xlink:title="DeferredTaxLiabilitiesOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesOther_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:title="label: DeferredTaxLiabilitiesOther to us-gaap_DeferredTaxLiabilitiesOther_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesOther_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesOther_lbl1">Deferred Tax Liabilities, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl1" xlink:title="label: DeferredTaxLiabilitiesOther to us-gaap_DeferredTaxLiabilitiesOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:title="label: DeferredTaxLiabilitiesPropertyPlantAndEquipment to us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xlink:title="label: DeferredTaxLiabilitiesPropertyPlantAndEquipment to us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl">Maximum employer contribution as a percentage of employee contribution</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatch to us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatch to us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl">Contribution expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:title="label: DefinedContributionPlanEmployerDiscretionaryContributionAmount to us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1" xlink:title="label: DefinedContributionPlanEmployerDiscretionaryContributionAmount to us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl1">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl">Equity Based Plans [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl">Equity Based Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1">Share-based Payment Arrangement [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsCommonStockCash_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DividendsCommonStockCash_lbl" xml:lang="en-US" id="us-gaap_DividendsCommonStockCash_lbl">Dividends paid to USPT shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl" xlink:title="label: DividendsCommonStockCash to us-gaap_DividendsCommonStockCash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsCommonStockCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsCommonStockCash_lbl1" xml:lang="en-US" id="us-gaap_DividendsCommonStockCash_lbl1">Dividends, Common Stock, Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl1" xlink:title="label: DividendsCommonStockCash to us-gaap_DividendsCommonStockCash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl">Earnings Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl1">Earnings Per Share [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl">Earnings per share basic (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDiluted_lbl">Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:title="label: EarningsPerShareBasicAndDiluted to us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract_lbl">Earnings Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl">Earnings per share diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:label="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="EffectiveIncomeTaxRateReconciliationDeductions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl">Excess equity compensation deduction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDeductions" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationDeductions to us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1">Effective Income Tax Rate Reconciliation, Deduction, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDeductions" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationDeductions to us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl">Nondeductible expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationNondeductibleExpense to us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationNondeductibleExpense to us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl">U.S. tax at statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:title="label: EffectiveIncomeTaxRateContinuingOperations to us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xlink:title="label: EffectiveIncomeTaxRateContinuingOperations to us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl">State income taxes, net of federal benefit and tax reform</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes to us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes to us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl">Compensation not yet recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Salaries and related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1">Employee-related Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl">Common Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentQuotedMarketValue" xlink:label="EquityMethodInvestmentQuotedMarketValue" xlink:title="EquityMethodInvestmentQuotedMarketValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl">Fair value of investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentQuotedMarketValue" xlink:to="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl" xlink:title="label: EquityMethodInvestmentQuotedMarketValue to us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1">Equity Method Investment, Quoted Market Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentQuotedMarketValue" xlink:to="us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1" xlink:title="label: EquityMethodInvestmentQuotedMarketValue to us-gaap_EquityMethodInvestmentQuotedMarketValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:label="EquityMethodInvestmentDividendsOrDistributions" xlink:title="EquityMethodInvestmentDividendsOrDistributions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl">Distribution received from investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentDividendsOrDistributions" xlink:to="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl" xlink:title="label: EquityMethodInvestmentDividendsOrDistributions to us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentDividendsOrDistributions" xlink:to="us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1" xlink:title="label: EquityMethodInvestmentDividendsOrDistributions to us-gaap_EquityMethodInvestmentDividendsOrDistributions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl">Percentage of ownership in joint venture interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1">Equity Method Investment, Ownership Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xml:lang="en-US" id="us-gaap_EquityClassOfTreasuryStockLineItems_lbl">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:title="label: EquityClassOfTreasuryStockLineItems to us-gaap_EquityClassOfTreasuryStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="ErrorCorrectionTextBlock" xlink:title="ErrorCorrectionTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ErrorCorrectionTextBlock_lbl" xml:lang="en-US" id="us-gaap_ErrorCorrectionTextBlock_lbl">Reclassification of Prior Period Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl" xlink:title="label: ErrorCorrectionTextBlock to us-gaap_ErrorCorrectionTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ErrorCorrectionTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ErrorCorrectionTextBlock_lbl1">Error Correction [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl1" xlink:title="label: ErrorCorrectionTextBlock to us-gaap_ErrorCorrectionTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract_lbl">Fair Values of Financial Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl">Fair Values of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:label="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:title="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl" xml:lang="en-US" id="us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl">Allowance for Credit Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl" xlink:title="label: FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts to us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xlink:title="label: FiniteLivedIntangibleAssetsNetAbstract to us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl">Estimated useful life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl">Accumulated amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:title="label: FiniteLivedIntangibleAssetsLineItems to us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl">Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xlink:title="label: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:label="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl">Preliminary Purchase Prices Allocation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock to us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock to us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl">Amortization Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US" id="us-gaap_ForeignCountryMember_lbl">Federal [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:title="label: ForeignCountryMember to us-gaap_ForeignCountryMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl">Furniture and Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl1">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesGross_lbl">Furniture and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" xlink:title="label: FurnitureAndFixturesGross to us-gaap_FurnitureAndFixturesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesGross_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesGross_lbl1">Furniture and Fixtures, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl1" xlink:title="label: FurnitureAndFixturesGross to us-gaap_FurnitureAndFixturesGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInterestInProjects" xlink:label="GainLossOnSaleOfInterestInProjects" xlink:title="GainLossOnSaleOfInterestInProjects" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfInterestInProjects_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GainLossOnSaleOfInterestInProjects_lbl" xml:lang="en-US" id="us-gaap_GainLossOnSaleOfInterestInProjects_lbl">Gain on sale of partnership interest and clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnSaleOfInterestInProjects" xlink:to="us-gaap_GainLossOnSaleOfInterestInProjects_lbl" xlink:title="label: GainLossOnSaleOfInterestInProjects to us-gaap_GainLossOnSaleOfInterestInProjects_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfInterestInProjects_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainLossOnSaleOfInterestInProjects_lbl1" xml:lang="en-US" id="us-gaap_GainLossOnSaleOfInterestInProjects_lbl1">Gain (Loss) on Sale of Interest in Projects</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnSaleOfInterestInProjects" xlink:to="us-gaap_GainLossOnSaleOfInterestInProjects_lbl1" xlink:title="label: GainLossOnSaleOfInterestInProjects to us-gaap_GainLossOnSaleOfInterestInProjects_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlementAbstract" xlink:label="GainLossRelatedToLitigationSettlementAbstract" xlink:title="GainLossRelatedToLitigationSettlementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossRelatedToLitigationSettlementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainLossRelatedToLitigationSettlementAbstract_lbl" xml:lang="en-US" id="us-gaap_GainLossRelatedToLitigationSettlementAbstract_lbl">Litigation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossRelatedToLitigationSettlementAbstract" xlink:to="us-gaap_GainLossRelatedToLitigationSettlementAbstract_lbl" xlink:title="label: GainLossRelatedToLitigationSettlementAbstract to us-gaap_GainLossRelatedToLitigationSettlementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:title="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" xml:lang="en-US" id="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl">Goodwill related to partnership interest sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" xlink:title="label: GoodwillWrittenOffRelatedToSaleOfBusinessUnit to us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1" xml:lang="en-US" id="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1" xlink:title="label: GoodwillWrittenOffRelatedToSaleOfBusinessUnit to us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Goodwill_lbl" xml:lang="en-US" id="us-gaap_Goodwill_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_Goodwill_lbl1" xml:lang="en-US" id="us-gaap_Goodwill_lbl1">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl1" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_Goodwill_lbl2" xml:lang="en-US" id="us-gaap_Goodwill_lbl2">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl2" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Goodwill_lbl3" xml:lang="en-US" id="us-gaap_Goodwill_lbl3">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl3" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="GoodwillPurchaseAccountingAdjustments" xlink:title="GoodwillPurchaseAccountingAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xml:lang="en-US" id="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillPurchaseAccountingAdjustments" xlink:to="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:title="label: GoodwillPurchaseAccountingAdjustments to us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1" xml:lang="en-US" id="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillPurchaseAccountingAdjustments" xlink:to="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1" xlink:title="label: GoodwillPurchaseAccountingAdjustments to us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="GoodwillDisclosureTextBlock" xlink:title="GoodwillDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillDisclosureTextBlock_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:title="label: GoodwillDisclosureTextBlock to us-gaap_GoodwillDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillDisclosureTextBlock_lbl1">Goodwill Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl1" xlink:title="label: GoodwillDisclosureTextBlock to us-gaap_GoodwillDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl">Closure costs - derecognition of goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl1" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl1">Derecognition (write-off) of goodwill - closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl1" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl2" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl2">Goodwill derecognition (write-off) related to closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl2" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:title="label: GoodwillAndIntangibleAssetsPolicyTextBlock to us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsPolicyTextBlock to us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="GoodwillRollForward" xlink:title="GoodwillRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillRollForward_lbl" xml:lang="en-US" id="us-gaap_GoodwillRollForward_lbl">Goodwill [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl" xlink:title="label: GoodwillRollForward to us-gaap_GoodwillRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillRollForward_lbl1" xml:lang="en-US" id="us-gaap_GoodwillRollForward_lbl1">Goodwill [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl1" xlink:title="label: GoodwillRollForward to us-gaap_GoodwillRollForward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl">Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="GoodwillAcquiredDuringPeriod" xlink:title="GoodwillAcquiredDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US" id="us-gaap_GoodwillAcquiredDuringPeriod_lbl">Goodwill acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:title="label: GoodwillAcquiredDuringPeriod to us-gaap_GoodwillAcquiredDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAcquiredDuringPeriod_lbl1">Goodwill, Acquired During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xlink:title="label: GoodwillAcquiredDuringPeriod to us-gaap_GoodwillAcquiredDuringPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrantsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrantsReceivable_lbl" xml:lang="en-US" id="us-gaap_GrantsReceivable_lbl">Advance payment received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl" xlink:title="label: GrantsReceivable to us-gaap_GrantsReceivable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_GrossProfit_lbl" xml:lang="en-US" id="us-gaap_GrossProfit_lbl">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrossProfit_lbl1" xml:lang="en-US" id="us-gaap_GrossProfit_lbl1">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl1" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl">Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl">Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed of</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl">Income and equity in earnings of unconsolidated affiliates before taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:label="IncomeTaxExaminationYearUnderExamination" xlink:title="IncomeTaxExaminationYearUnderExamination" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl">Periods open for examination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationYearUnderExamination" xlink:to="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" xlink:title="label: IncomeTaxExaminationYearUnderExamination to us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1">Income Tax Examination, Year under Examination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationYearUnderExamination" xlink:to="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1" xlink:title="label: IncomeTaxExaminationYearUnderExamination to us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl">Adjustment to deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl1">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityAxis_lbl">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:title="label: IncomeTaxAuthorityAxis to us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromEquityMethodInvestments_lbl">Earnings in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:title="label: IncomeLossFromEquityMethodInvestments to us-gaap_IncomeLossFromEquityMethodInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeLossFromEquityMethodInvestments_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromEquityMethodInvestments_lbl1">Earnings from investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl1" xlink:title="label: IncomeLossFromEquityMethodInvestments to us-gaap_IncomeLossFromEquityMethodInvestments_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromEquityMethodInvestments_lbl2" xml:lang="en-US" id="us-gaap_IncomeLossFromEquityMethodInvestments_lbl2">Equity in earnings of unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl2" xlink:title="label: IncomeLossFromEquityMethodInvestments to us-gaap_IncomeLossFromEquityMethodInvestments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">CONSOLIDATED STATEMENTS OF INCOME [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="IncomeTaxExaminationTable" xlink:title="IncomeTaxExaminationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExaminationTable_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExaminationTable_lbl">Income Tax Examination [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationTable" xlink:to="us-gaap_IncomeTaxExaminationTable_lbl" xlink:title="label: IncomeTaxExaminationTable to us-gaap_IncomeTaxExaminationTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityDomain_lbl">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:title="label: IncomeTaxAuthorityDomain to us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="IncomeTaxExaminationLineItems" xlink:title="IncomeTaxExaminationLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExaminationLineItems_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExaminationLineItems_lbl">Income Tax Examination [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationLineItems" xlink:to="us-gaap_IncomeTaxExaminationLineItems_lbl" xlink:title="label: IncomeTaxExaminationLineItems to us-gaap_IncomeTaxExaminationLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl1">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="IncomeTaxReconciliationDeductions" xlink:title="IncomeTaxReconciliationDeductions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationDeductions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncomeTaxReconciliationDeductions_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationDeductions_lbl">Excess equity compensation deduction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationDeductions" xlink:to="us-gaap_IncomeTaxReconciliationDeductions_lbl" xlink:title="label: IncomeTaxReconciliationDeductions to us-gaap_IncomeTaxReconciliationDeductions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationDeductions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationDeductions_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationDeductions_lbl1">Effective Income Tax Rate Reconciliation, Deduction, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationDeductions" xlink:to="us-gaap_IncomeTaxReconciliationDeductions_lbl1" xlink:title="label: IncomeTaxReconciliationDeductions to us-gaap_IncomeTaxReconciliationDeductions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl">U.S. tax at statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl">Provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl1">Total income tax provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl2" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl2">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl">State income taxes, net of federal benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:title="label: IncomeTaxReconciliationStateAndLocalIncomeTaxes to us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" xlink:title="label: IncomeTaxReconciliationStateAndLocalIncomeTaxes to us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl">Non-deductible expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:title="label: IncomeTaxReconciliationNondeductibleExpense to us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xlink:title="label: IncomeTaxReconciliationNondeductibleExpense to us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl1">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl1">Income Taxes Paid, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="IncomeTaxesReceivable" xlink:title="IncomeTaxesReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesReceivable_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesReceivable_lbl">Federal income tax receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable_lbl" xlink:title="label: IncomeTaxesReceivable to us-gaap_IncomeTaxesReceivable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl">Increase (decrease) in other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOtherNoncurrentLiabilities to us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl">(Increase) decrease in patient accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:title="label: IncreaseDecreaseInAccountsReceivable to us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1">Increase (Decrease) in Accounts Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xlink:title="label: IncreaseDecreaseInAccountsReceivable to us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl">(Increase) decrease in accounts receivable - other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets to us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1">Increase (Decrease) in Accounts Receivable and Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets to us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl">Increase (decrease) in accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl">(Increase) decrease in other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1">Increase (Decrease) in Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl">Intangible Assets, net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:title="label: IntangibleAssetsNetExcludingGoodwillAbstract to us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl">Other identifiable intangible assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="IntangibleAssetsDisclosureTextBlock" xlink:title="IntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl">Intangible Assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:title="label: IntangibleAssetsDisclosureTextBlock to us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1">Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xlink:title="label: IntangibleAssetsDisclosureTextBlock to us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US" id="us-gaap_InterestAndOtherIncome_lbl">Interest and other income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:title="label: InterestAndOtherIncome to us-gaap_InterestAndOtherIncome_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestAndOtherIncome_lbl1" xml:lang="en-US" id="us-gaap_InterestAndOtherIncome_lbl1">Interest and Other Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl1" xlink:title="label: InterestAndOtherIncome to us-gaap_InterestAndOtherIncome_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xml:lang="en-US" id="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl">Interest expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:to="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xlink:title="label: InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations to us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xml:lang="en-US" id="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1">Interest Expense on Prepetition Liabilities Recognized in Statement of Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:to="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xlink:title="label: InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations to us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="InvestmentPolicyTextBlock" xlink:title="InvestmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_InvestmentPolicyTextBlock_lbl">Investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:title="label: InvestmentPolicyTextBlock to us-gaap_InvestmentPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl">Investments in Unconsolidated Affiliate [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl" xlink:title="label: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xml:lang="en-US" id="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl">Investment in unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xlink:title="label: InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures to us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" xml:lang="en-US" id="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" xlink:title="label: InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures to us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl" xml:lang="en-US" id="us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl">Investment in Unconsolidated Affiliate [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl" xlink:title="label: InvestmentsInAndAdvancesToAffiliatesAbstract to us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl">Investment in Unconsolidated Affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl" xlink:title="label: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock to us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1">Investments in and Advances to Affiliates, Schedule of Investments [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1" xlink:title="label: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock to us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl">2027 and therafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl">Total lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl">Less: imputed interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseTermOfContract_lbl">Lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:title="label: LesseeOperatingLeaseTermOfContract to us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl">Future Lease Payments for Operating Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionTable_lbl">Lessee, Lease, Description [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:title="label: LesseeLeaseDescriptionTable to us-gaap_LesseeLeaseDescriptionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionLineItems_lbl">Lessee, Lease, Description [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:title="label: LesseeLeaseDescriptionLineItems to us-gaap_LesseeLeaseDescriptionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl">Operating Lease [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xlink:title="label: LesseeOperatingLeaseDescriptionAbstract to us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US" id="us-gaap_LaborAndRelatedExpense_lbl">Salaries and related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:title="label: LaborAndRelatedExpense to us-gaap_LaborAndRelatedExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LaborAndRelatedExpense_lbl1" xml:lang="en-US" id="us-gaap_LaborAndRelatedExpense_lbl1">Labor and Related Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl1" xlink:title="label: LaborAndRelatedExpense to us-gaap_LaborAndRelatedExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US" id="us-gaap_LeaseCostAbstract_lbl">Components of Lease Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:title="label: LeaseCostAbstract to us-gaap_LeaseCostAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LeaseCost_lbl" xml:lang="en-US" id="us-gaap_LeaseCost_lbl">Total lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCost_lbl1" xml:lang="en-US" id="us-gaap_LeaseCost_lbl1">Lease, Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl1" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LeaseCostTableTextBlock_lbl">Components of Lease Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:title="label: LeaseCostTableTextBlock to us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl1">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl">Leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl1">Leasehold Improvements, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" id="us-gaap_LeasesAbstract_lbl">Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTEREST</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl">Closure costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:title="label: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent to us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl1">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl">Percentage of unused commitment fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:title="label: LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage to us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xlink:title="label: LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage to us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl">Revolving credit facility commitment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl">Increase on limit of credit facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:title="label: LineOfCreditFacilityIncreaseDecreaseForPeriodNet to us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl">Remaining revolving credit outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityRemainingBorrowingCapacity to us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xlink:title="label: LineOfCreditFacilityRemainingBorrowingCapacity to us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl">Average effective interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent" xlink:label="LitigationReserveCurrent" xlink:title="LitigationReserveCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationReserveCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LitigationReserveCurrent_lbl" xml:lang="en-US" id="us-gaap_LitigationReserveCurrent_lbl">Settlement of a legal matter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationReserveCurrent" xlink:to="us-gaap_LitigationReserveCurrent_lbl" xlink:title="label: LitigationReserveCurrent to us-gaap_LitigationReserveCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationReserveCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LitigationReserveCurrent_lbl1" xml:lang="en-US" id="us-gaap_LitigationReserveCurrent_lbl1">Estimated Litigation Liability, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationReserveCurrent" xlink:to="us-gaap_LitigationReserveCurrent_lbl1" xlink:title="label: LitigationReserveCurrent to us-gaap_LitigationReserveCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="LitigationSettlementExpense" xlink:title="LitigationSettlementExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LitigationSettlementExpense_lbl" xml:lang="en-US" id="us-gaap_LitigationSettlementExpense_lbl">Settlement of a legal matter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl" xlink:title="label: LitigationSettlementExpense to us-gaap_LitigationSettlementExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationSettlementExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LitigationSettlementExpense_lbl1" xml:lang="en-US" id="us-gaap_LitigationSettlementExpense_lbl1">Litigation Settlement, Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl1" xlink:title="label: LitigationSettlementExpense to us-gaap_LitigationSettlementExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xml:lang="en-US" id="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl">Payment of settlement amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountAwardedToOtherParty" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:title="label: LitigationSettlementAmountAwardedToOtherParty to us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LongTermDebt_lbl" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl">Payments/Long term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebt_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl1">Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl">Aggregate principal payment due in 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl">Less current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtCurrent_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl1">Current portion of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl1" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtCurrent_lbl2" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl2">Long-term Debt, Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl2" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl">Aggregate principal payment due in 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1">Long-Term Debt, Maturity, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US" id="us-gaap_LongTermLineOfCredit_lbl">Revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:title="label: LongTermLineOfCredit to us-gaap_LongTermLineOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermLineOfCredit_lbl1" xml:lang="en-US" id="us-gaap_LongTermLineOfCredit_lbl1">Long-term Line of Credit, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl1" xlink:title="label: LongTermLineOfCredit to us-gaap_LongTermLineOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl">Long term portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:title="label: LongTermDebtNoncurrent to us-gaap_LongTermDebtNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl1">Long-term Debt, Excluding Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl1" xlink:title="label: LongTermDebtNoncurrent to us-gaap_LongTermDebtNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US" id="us-gaap_LongTermNotesPayable_lbl">Notes payable, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:title="label: LongTermNotesPayable to us-gaap_LongTermNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_LongTermNotesPayable_lbl1">Notes Payable, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl1" xlink:title="label: LongTermNotesPayable to us-gaap_LongTermNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl">Aggregate principal payment due in 2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1">Long-Term Debt, Maturity, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="LossContingencyNumberOfDefendants" xlink:title="LossContingencyNumberOfDefendants" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyNumberOfDefendants_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyNumberOfDefendants_lbl" xml:lang="en-US" id="us-gaap_LossContingencyNumberOfDefendants_lbl">Number of defendants dismissed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNumberOfDefendants" xlink:to="us-gaap_LossContingencyNumberOfDefendants_lbl" xlink:title="label: LossContingencyNumberOfDefendants to us-gaap_LossContingencyNumberOfDefendants_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="LossContingencyLossInPeriod" xlink:title="LossContingencyLossInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyLossInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyLossInPeriod_lbl" xml:lang="en-US" id="us-gaap_LossContingencyLossInPeriod_lbl">Amount of payments recorded as expense during the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyLossInPeriod" xlink:to="us-gaap_LossContingencyLossInPeriod_lbl" xlink:title="label: LossContingencyLossInPeriod to us-gaap_LossContingencyLossInPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US" id="us-gaap_MeasurementInputTypeAxis_lbl">Measurement Input Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:title="label: MeasurementInputTypeAxis to us-gaap_MeasurementInputTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputTypeDomain_lbl" xml:lang="en-US" id="us-gaap_MeasurementInputTypeDomain_lbl">Measurement Input Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" xlink:title="label: MeasurementInputTypeDomain to us-gaap_MeasurementInputTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US" id="us-gaap_MeasurementInputPriceVolatilityMember_lbl">Volatility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:title="label: MeasurementInputPriceVolatilityMember to us-gaap_MeasurementInputPriceVolatilityMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="MeasurementInputDiscountRateMember" xlink:title="MeasurementInputDiscountRateMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US" id="us-gaap_MeasurementInputDiscountRateMember_lbl">Discount Rate [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:title="label: MeasurementInputDiscountRateMember to us-gaap_MeasurementInputDiscountRateMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl">Distributions to non-controlling interest partners - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:title="label: MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders to us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xlink:title="label: MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders to us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl">Less: net income attributable to non-controlling interest:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xlink:title="label: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="MinorityInterestDecreaseFromRedemptions" xlink:title="MinorityInterestDecreaseFromRedemptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl">Purchase of partnership interests - non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromRedemptions" xlink:to="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" xlink:title="label: MinorityInterestDecreaseFromRedemptions to us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromRedemptions" xlink:to="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1" xlink:title="label: MinorityInterestDecreaseFromRedemptions to us-gaap_MinorityInterestDecreaseFromRedemptions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestChangeInRedemptionValue_lbl">Changes in the fair value of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestChangeInRedemptionValue" xlink:to="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xlink:title="label: MinorityInterestChangeInRedemptionValue to us-gaap_MinorityInterestChangeInRedemptionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestChangeInRedemptionValue" xlink:to="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xlink:title="label: MinorityInterestChangeInRedemptionValue to us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="MinorityInterestDisclosureTextBlock" xlink:title="MinorityInterestDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDisclosureTextBlock_lbl">Acquisitions and Sale of Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:title="label: MinorityInterestDisclosureTextBlock to us-gaap_MinorityInterestDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MinorityInterest_lbl" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl">Non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl1">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl1" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl">Percentage of retained interest by previous owners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:title="label: MinorityInterestOwnershipPercentageByNoncontrollingOwners to us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="MovementInValuationAllowancesAndReservesRollForward" xlink:title="MovementInValuationAllowancesAndReservesRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xml:lang="en-US" id="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl">Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xlink:title="label: MovementInValuationAllowancesAndReservesRollForward to us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash provided by (used in) financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">FINANCING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash provided by operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">INVESTING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">OPERATING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl2">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl">Computation of earnings per share - USPH shareholders [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl">Net income attributable to non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">Recently Issued Accounting Pronouncement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:title="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xml:lang="en-US" id="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl">Note receivables related to sale of partnership interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xlink:title="label: NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 to us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:label="NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:title="NoncashOrPartNoncashAcquisitionPayablesAssumed1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl" xml:lang="en-US" id="us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl">Purchase of business - payable to common shareholders of acquired business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl" xlink:title="label: NoncashOrPartNoncashAcquisitionPayablesAssumed1 to us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US" id="us-gaap_NoncompeteAgreementsMember_lbl">Non-compete Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:title="label: NoncompeteAgreementsMember to us-gaap_NoncompeteAgreementsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncompeteAgreementsMember_lbl1" xml:lang="en-US" id="us-gaap_NoncompeteAgreementsMember_lbl1">Non-compete Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl1" xlink:title="label: NoncompeteAgreementsMember to us-gaap_NoncompeteAgreementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl">Total other income and expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl1">Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US" id="us-gaap_NumberOfReportableSegments_lbl">Number of reportable segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" xlink:title="label: NumberOfReportableSegments to us-gaap_NumberOfReportableSegments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfReportableSegments_lbl1" xml:lang="en-US" id="us-gaap_NumberOfReportableSegments_lbl1">Number of Reportable Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl1" xlink:title="label: NumberOfReportableSegments to us-gaap_NumberOfReportableSegments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments_lbl">Number of business segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xlink:title="label: NumberOfOperatingSegments to us-gaap_NumberOfOperatingSegments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfOperatingSegments_lbl1" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments_lbl1">Number of Operating Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl1" xlink:title="label: NumberOfOperatingSegments to us-gaap_NumberOfOperatingSegments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl">Number of businesses acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl1" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl1">Number of clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl1" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="NoncontrollingInterestAbstract" xlink:title="NoncontrollingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestAbstract_lbl">Acquisitions and Sale of Non-Controlling Interests [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:title="label: NoncontrollingInterestAbstract to us-gaap_NoncontrollingInterestAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:label="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="NoncontrollingInterestDecreaseFromDeconsolidation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl">Reduction of non-controlling interest due to sale of USPH partnership interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:to="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl" xlink:title="label: NoncontrollingInterestDecreaseFromDeconsolidation to us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1">Noncontrolling Interest, Decrease from Deconsolidation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:to="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1" xlink:title="label: NoncontrollingInterestDecreaseFromDeconsolidation to us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xlink:title="label: NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable to us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1">Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xlink:title="label: NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable to us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl">Non-Controlling Interests [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestMember_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl1">Noncontrolling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl1" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl">Current portion of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl">Weighted-average discount rate - Operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl">Operating lease liabilities, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl">Future Lease Payments for Operating Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US" id="us-gaap_OperatingLeasePayments_lbl">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:title="label: OperatingLeasePayments to us-gaap_OperatingLeasePayments_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl">Operating lease right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseCost_lbl">Operating lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:title="label: OperatingLeaseCost to us-gaap_OperatingLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl">Weighted-average remaining lease term - Operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl1">Operating Lease, Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingSegmentsMember_lbl" xml:lang="en-US" id="us-gaap_OperatingSegmentsMember_lbl">Reportable Segments [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl" xlink:title="label: OperatingSegmentsMember to us-gaap_OperatingSegmentsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Operating income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl">Organization, Nature of Operations and Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl">Organization, Nature of Operations and Basis of Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xml:lang="en-US" id="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherOperatingActivitiesCashFlowStatement" xlink:to="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:title="label: OtherOperatingActivitiesCashFlowStatement to us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsCurrent_lbl">Other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:title="label: OtherAssetsCurrent to us-gaap_OtherAssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsCurrent_lbl1">Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl1" xlink:title="label: OtherAssetsCurrent to us-gaap_OtherAssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl1">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl">Other income and expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:title="label: OtherNonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xlink:title="label: OtherNonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1">Other Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ParentMember_lbl" xml:lang="en-US" id="us-gaap_ParentMember_lbl">Total Shareholders' Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ParentMember_lbl1" xml:lang="en-US" id="us-gaap_ParentMember_lbl1">Parent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl1" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract_lbl">Accrued Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsMinorityInterest_lbl">Distributions to non-controlling interest, permanent and temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:title="label: PaymentsOfDividendsMinorityInterest to us-gaap_PaymentsOfDividendsMinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xlink:title="label: PaymentsOfDividendsMinorityInterest to us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsCommonStock_lbl">Cash dividends paid to shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:title="label: PaymentsOfDividendsCommonStock to us-gaap_PaymentsOfDividendsCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsCommonStock_lbl1">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xlink:title="label: PaymentsOfDividendsCommonStock to us-gaap_PaymentsOfDividendsCommonStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl">Purchase of non-controlling interest, permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xlink:title="label: PaymentsToAcquireInterestInSubsidiariesAndAffiliates to us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xlink:title="label: PaymentsToAcquireInterestInSubsidiariesAndAffiliates to us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesGross_lbl">Cash paid for acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:title="label: PaymentsToAcquireBusinessesGross to us-gaap_PaymentsToAcquireBusinessesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesGross_lbl1">Payments to Acquire Businesses, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xlink:title="label: PaymentsToAcquireBusinessesGross to us-gaap_PaymentsToAcquireBusinessesGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl">Purchase of majority interest in businesses, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1">Cash paid, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_PaymentsToMinorityShareholders_lbl">Acquired interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:title="label: PaymentsToMinorityShareholders to us-gaap_PaymentsToMinorityShareholders_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl">Purchase of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl1">Payments to Acquire Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_PlanNameDomain_lbl">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" xlink:title="label: PlanNameDomain to us-gaap_PlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="us-gaap_PlanNameAxis_lbl">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:title="label: PlanNameAxis to us-gaap_PlanNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="PreferredStockTextBlock" xlink:title="PreferredStockTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US" id="us-gaap_PreferredStockTextBlock_lbl">Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:title="label: PreferredStockTextBlock to us-gaap_PreferredStockTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockTextBlock_lbl1">Preferred Stock [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl1" xlink:title="label: PreferredStockTextBlock to us-gaap_PreferredStockTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl1">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl1" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl">Preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl">Preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl">Preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract" xlink:label="PriorPeriodAdjustmentAbstract" xlink:title="PriorPeriodAdjustmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PriorPeriodAdjustmentAbstract_lbl" xml:lang="en-US" id="us-gaap_PriorPeriodAdjustmentAbstract_lbl">Reclassification of Prior Period Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_PriorPeriodAdjustmentAbstract_lbl" xlink:title="label: PriorPeriodAdjustmentAbstract to us-gaap_PriorPeriodAdjustmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:title="label: ProceedsFromPaymentsForOtherFinancingActivities to us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xlink:title="label: ProceedsFromPaymentsForOtherFinancingActivities to us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl">Purchases of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsToMinorityShareholders" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:title="label: ProceedsFromPaymentsToMinorityShareholders to us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:label="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl">Proceeds on sale of redeemable non-controlling interest, temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl" xlink:title="label: ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates to us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1">Proceeds from Divestiture of Interest in Subsidiaries and Affiliates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1" xlink:title="label: ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates to us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl">Proceeds on sales of partnership interest, clinics and fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:title="label: ProceedsFromDivestitureOfBusinesses to us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromLinesOfCredit_lbl">Proceeds from revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:title="label: ProceedsFromLinesOfCredit to us-gaap_ProceedsFromLinesOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromLinesOfCredit_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromLinesOfCredit_lbl1">Proceeds from Lines of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl1" xlink:title="label: ProceedsFromLinesOfCredit to us-gaap_ProceedsFromLinesOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="ProceedsFromMinorityShareholders" xlink:title="ProceedsFromMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromMinorityShareholders_lbl">Notes receivable related to sale of partnership interest - redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromMinorityShareholders" xlink:to="us-gaap_ProceedsFromMinorityShareholders_lbl" xlink:title="label: ProceedsFromMinorityShareholders to us-gaap_ProceedsFromMinorityShareholders_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromMinorityShareholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromMinorityShareholders_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromMinorityShareholders_lbl1">Proceeds from Noncontrolling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromMinorityShareholders" xlink:to="us-gaap_ProceedsFromMinorityShareholders_lbl1" xlink:title="label: ProceedsFromMinorityShareholders to us-gaap_ProceedsFromMinorityShareholders_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_ProfitLoss_lbl" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl">Net income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProfitLoss_lbl1" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl1">Net income including non-controlling interest and earnings from unconsolidated affiliates, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl1" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProfitLoss_lbl2" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl2">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl2" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentLineItems_lbl">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:title="label: PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl">Estimated useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentAbstract_lbl">Long-Lived Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl">Long-Lived Tangible Asset [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1">Long-Lived Tangible Asset [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl">Long-Lived Tangible Asset [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1">Long-Lived Tangible Asset [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Fixed assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl1">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl">Fixed assets, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl1">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl">Fixed assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl">Provision for credit losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl1">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:title="label: RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability to us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl">Redeemable Noncontrolling Interest, by Legal Entity [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xlink:title="label: RedeemableNoncontrollingInterestByLegalEntityTable to us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl">Redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3">Fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="RedeemableNoncontrollingInterestTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl">Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:title="label: RedeemableNoncontrollingInterestTableTextBlock to us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xlink:title="label: RedeemableNoncontrollingInterestTableTextBlock to us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl">Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xlink:title="label: RedeemableNoncontrollingInterestLineItems to us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl">Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interests [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsAbstract_lbl">Related Party Transactions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:title="label: RelatedPartyTransactionsAbstract to us-gaap_RelatedPartyTransactionsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:title="label: RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl">Related Party Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:title="label: RelatedPartyTransactionsDisclosureTextBlock to us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyDomain_lbl">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xlink:title="label: RelatedPartyDomain to us-gaap_RelatedPartyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl">Principal payments on notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl1">Repayments of Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfLinesOfCredit_lbl">Payments on revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:title="label: RepaymentsOfLinesOfCredit to us-gaap_RepaymentsOfLinesOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfLinesOfCredit_lbl1">Repayments of Lines of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xlink:title="label: RepaymentsOfLinesOfCredit to us-gaap_RepaymentsOfLinesOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockMember_lbl1" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl1">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl1" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestructuringCharges_lbl" xml:lang="en-US" id="us-gaap_RestructuringCharges_lbl">Closure costs - lease and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl" xlink:title="label: RestructuringCharges to us-gaap_RestructuringCharges_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCharges_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RestructuringCharges_lbl1" xml:lang="en-US" id="us-gaap_RestructuringCharges_lbl1">Closure costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl1" xlink:title="label: RestructuringCharges to us-gaap_RestructuringCharges_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCharges_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestructuringCharges_lbl2" xml:lang="en-US" id="us-gaap_RestructuringCharges_lbl2">Restructuring Charges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl2" xlink:title="label: RestructuringCharges to us-gaap_RestructuringCharges_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Retained earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:title="label: RevenueFromContractWithCustomerPolicyTextBlock to us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xlink:title="label: RevenueFromContractWithCustomerPolicyTextBlock to us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl">Net revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1">Revenue related to the various categories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US" id="us-gaap_RevenuesAbstract_lbl">Revenues [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:title="label: RevenuesAbstract to us-gaap_RevenuesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Revenues_lbl" xml:lang="en-US" id="us-gaap_Revenues_lbl">Net operating revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:title="label: Revenues to us-gaap_Revenues_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US" id="us-gaap_RevolvingCreditFacilityMember_lbl">Credit Facility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:title="label: RevolvingCreditFacilityMember to us-gaap_RevolvingCreditFacilityMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevolvingCreditFacilityMember_lbl1" xml:lang="en-US" id="us-gaap_RevolvingCreditFacilityMember_lbl1">Revolving Credit Facility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl1" xlink:title="label: RevolvingCreditFacilityMember to us-gaap_RevolvingCreditFacilityMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl">Amortization of Customer and Referral Relationships and Non Competition Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:title="label: ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock to us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xlink:title="label: ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock to us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl">Cumulative Summary of Equity Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedCompensationActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl">Restricted Stock Granted and Cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1" xlink:title="label: ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl">Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl">Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl">Significant Components of Provision for Income Taxes for Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl">Intangible Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl">Schedule of Finite Lived Intangible Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTable to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl">Computations of Basic and Diluted Earnings Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl">Clinic Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="ScheduleOfDebtInstrumentsTextBlock" xlink:title="ScheduleOfDebtInstrumentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl">Credit Agreement and Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:title="label: ScheduleOfDebtInstrumentsTextBlock to us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xlink:title="label: ScheduleOfDebtInstrumentsTextBlock to us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:title="label: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="ScheduleOfEquityMethodInvestmentsLineItems" xlink:title="ScheduleOfEquityMethodInvestmentsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentsLineItems to us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="ScheduleOfEquityMethodInvestmentsTable" xlink:title="ScheduleOfEquityMethodInvestmentsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl">Schedule of Equity Method Investments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentsTable to us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="ScheduleOfGoodwillTextBlock" xlink:title="ScheduleOfGoodwillTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfGoodwillTextBlock_lbl">Changes in Carrying Amount of Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:title="label: ScheduleOfGoodwillTextBlock to us-gaap_ScheduleOfGoodwillTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfGoodwillTextBlock_lbl1">Schedule of Goodwill [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xlink:title="label: ScheduleOfGoodwillTextBlock to us-gaap_ScheduleOfGoodwillTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:title="label: ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:title="label: ScheduleOfSegmentReportingInformationBySegmentTable to us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl">Selected Financial Data for Reportable Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:title="label: ScheduleOfSegmentReportingInformationBySegmentTextBlock to us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentDomain_lbl" xml:lang="en-US" id="us-gaap_SegmentDomain_lbl">Segments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl" xlink:title="label: SegmentDomain to us-gaap_SegmentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingInformationLineItems_lbl">Segment Reporting Information [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:title="label: SegmentReportingInformationLineItems to us-gaap_SegmentReportingInformationLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingAbstract_lbl">Segment Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:title="label: SegmentReportingAbstract to us-gaap_SegmentReportingAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="SegmentReportingDisclosureTextBlock" xlink:title="SegmentReportingDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureTextBlock_lbl">Segment Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:title="label: SegmentReportingDisclosureTextBlock to us-gaap_SegmentReportingDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl">Segment Reporting [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xlink:title="label: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1">Segment Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xlink:title="label: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl">Segment Reporting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl">Corporate office costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1">Selling, General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US" id="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl">Acquisitions [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xlink:title="label: SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember to us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAbstract_lbl">Share-based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationAbstract_lbl" xlink:title="label: ShareBasedCompensationAbstract to us-gaap_ShareBasedCompensationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl">Equity-based awards compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl1">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl">Weighted average fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl">Number of shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Weighted average fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl">Number of shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl">Number of shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1">Authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl">Number of common shares available for grant (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1">Shares available for grant (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl">Stock options exercisable (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl">Outstanding stock options (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US" id="us-gaap_SharesIssuedPricePerShare_lbl">Closing price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:title="label: SharesIssuedPricePerShare to us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeAxis_lbl">Short-term Debt, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:title="label: ShortTermDebtTypeAxis to us-gaap_ShortTermDebtTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US" id="us-gaap_ShortTermLeaseCost_lbl">Short-term lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:title="label: ShortTermLeaseCost to us-gaap_ShortTermLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeDomain_lbl" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeDomain_lbl">Short-term Debt, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:title="label: ShortTermDebtTypeDomain to us-gaap_ShortTermDebtTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl">Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:title="label: SignificantAccountingPoliciesTextBlock to us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1">Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xlink:title="label: SignificantAccountingPoliciesTextBlock to us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl">State [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl1" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl1">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementBusinessSegmentsAxis_lbl">Segments [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:title="label: StatementBusinessSegmentsAxis to us-gaap_StatementBusinessSegmentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl">Common stock authorized by the Board of Directors (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl">Issuance of restricted stock, net of cancellations (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl">Issuance of restricted stock, net of cancellations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US" id="us-gaap_StockRepurchasedDuringPeriodShares_lbl">Total purchased shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:title="label: StockRepurchasedDuringPeriodShares to us-gaap_StockRepurchasedDuringPeriodShares_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchasedDuringPeriodShares_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchasedDuringPeriodShares_lbl1">Stock Repurchased During Period, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl1" xlink:title="label: StockRepurchasedDuringPeriodShares to us-gaap_StockRepurchasedDuringPeriodShares_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total USPH shareholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl">Equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2">Total USPH shareholders' equity and non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityOther_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityOther_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl" xlink:title="label: StockholdersEquityOther to us-gaap_StockholdersEquityOther_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityOther_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityOther_lbl1">Stockholders' Equity, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl1" xlink:title="label: StockholdersEquityOther to us-gaap_StockholdersEquityOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl">U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl1">U. S. Physical Therapy, Inc. shareholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl1" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventMember_lbl">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain_lbl">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis_lbl">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_TaxesPayableCurrent_lbl">Federal taxes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:title="label: TaxesPayableCurrent to us-gaap_TaxesPayableCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TrademarksMember_lbl" xml:lang="en-US" id="us-gaap_TrademarksMember_lbl">Tradenames [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:title="label: TrademarksMember to us-gaap_TrademarksMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TrademarksMember_lbl1" xml:lang="en-US" id="us-gaap_TrademarksMember_lbl1">Trademarks [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl1" xlink:title="label: TrademarksMember to us-gaap_TrademarksMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl">Treasury stock at cost, 2,214,737 shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockValue_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl1">Treasury Stock, Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl1" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl">Treasury stock, shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockShares_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl1">Treasury Stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl1" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockMember_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl1">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl1" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl">Accrued interest and penalties associated with any unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:label="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl">Interest expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl" xlink:title="label: UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense to us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1">Unrecognized Tax Benefits, Interest on Income Taxes Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1" xlink:title="label: UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense to us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemDomain_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemDomain_lbl">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:title="label: UnusualOrInfrequentItemDomain to us-gaap_UnusualOrInfrequentItemDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemAxis_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemAxis_lbl">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:title="label: UnusualOrInfrequentItemAxis to us-gaap_UnusualOrInfrequentItemAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UseOfEstimates_lbl1" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl1">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl1" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="ValuationAllowancesAndReservesTypeAxis" xlink:title="ValuationAllowancesAndReservesTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl">Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xlink:title="label: ValuationAllowancesAndReservesTypeAxis to us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesDomain_lbl">Valuation Allowances and Reserves [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xlink:title="label: ValuationAllowancesAndReservesDomain to us-gaap_ValuationAllowancesAndReservesDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="ValuationAllowancesAndReservesDeductions" xlink:title="ValuationAllowancesAndReservesDeductions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesDeductions_lbl">Deductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesDeductions" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xlink:title="label: ValuationAllowancesAndReservesDeductions to us-gaap_ValuationAllowancesAndReservesDeductions_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="ValuationAllowancesAndReservesBalance" xlink:title="ValuationAllowancesAndReservesBalance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesBalance_lbl">Ending Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:title="label: ValuationAllowancesAndReservesBalance to us-gaap_ValuationAllowancesAndReservesBalance_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ValuationAllowancesAndReservesBalance_lbl1" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesBalance_lbl1">Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl1" xlink:title="label: ValuationAllowancesAndReservesBalance to us-gaap_ValuationAllowancesAndReservesBalance_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesBalance_lbl2" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesBalance_lbl2">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl2" xlink:title="label: ValuationAllowancesAndReservesBalance to us-gaap_ValuationAllowancesAndReservesBalance_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="ValuationAllowancesAndReservesChargedToCostAndExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl">Additions Charged to Cost and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xlink:title="label: ValuationAllowancesAndReservesChargedToCostAndExpense to us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1" xlink:title="label: ValuationAllowancesAndReservesChargedToCostAndExpense to us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="ValuationAllowancesAndReservesChargedToOtherAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl">Additions Charged to Other Accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" xlink:title="label: ValuationAllowancesAndReservesChargedToOtherAccounts to us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US" id="us-gaap_VariableLeaseCost_lbl">Variable lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:title="label: VariableLeaseCost to us-gaap_VariableLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl">Shares used in computation - basic and diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl">Diluted earnings per share - weighted-average shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl">Basic earnings per share - weighted-average shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl">Shares used in computation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US" id="srt_ConsolidatedEntitiesDomain_lbl">Consolidated Entities [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl" xlink:title="label: ConsolidatedEntitiesDomain to srt_ConsolidatedEntitiesDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US" id="srt_ConsolidatedEntitiesAxis_lbl">Consolidated Entities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:title="label: ConsolidatedEntitiesAxis to srt_ConsolidatedEntitiesAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidationItemsDomain_lbl" xml:lang="en-US" id="srt_ConsolidationItemsDomain_lbl">Consolidation Items [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl" xlink:title="label: ConsolidationItemsDomain to srt_ConsolidationItemsDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidationItemsAxis_lbl" xml:lang="en-US" id="srt_ConsolidationItemsAxis_lbl">Consolidation Items [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl" xlink:title="label: ConsolidationItemsAxis to srt_ConsolidationItemsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:label xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_DirectorMember_lbl" xml:lang="en-US" id="srt_DirectorMember_lbl">Directors [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:title="label: DirectorMember to srt_DirectorMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:label xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US" id="srt_EquityMethodInvesteeNameDomain_lbl">Investment, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl" xlink:title="label: EquityMethodInvesteeNameDomain to srt_EquityMethodInvesteeNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="srt_ExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ExecutiveOfficerMember_lbl" xml:lang="en-US" id="srt_ExecutiveOfficerMember_lbl">Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExecutiveOfficerMember" xlink:to="srt_ExecutiveOfficerMember_lbl" xlink:title="label: ExecutiveOfficerMember to srt_ExecutiveOfficerMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ExecutiveOfficerMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ExecutiveOfficerMember_lbl1" xml:lang="en-US" id="srt_ExecutiveOfficerMember_lbl1">Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExecutiveOfficerMember" xlink:to="srt_ExecutiveOfficerMember_lbl1" xlink:title="label: ExecutiveOfficerMember to srt_ExecutiveOfficerMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_MaximumMember_lbl" xml:lang="en-US" id="srt_MaximumMember_lbl">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:title="label: MaximumMember to srt_MaximumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember_lbl1" xml:lang="en-US" id="srt_MaximumMember_lbl1">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl1" xlink:title="label: MaximumMember to srt_MaximumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_MinimumMember_lbl" xml:lang="en-US" id="srt_MinimumMember_lbl">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:title="label: MinimumMember to srt_MinimumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember_lbl1" xml:lang="en-US" id="srt_MinimumMember_lbl1">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl1" xlink:title="label: MinimumMember to srt_MinimumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipDomain_lbl" xml:lang="en-US" id="srt_OwnershipDomain_lbl">Ownership [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl" xlink:title="label: OwnershipDomain to srt_OwnershipDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipAxis_lbl" xml:lang="en-US" id="srt_OwnershipAxis_lbl">Ownership [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:title="label: OwnershipAxis to srt_OwnershipAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:label xlink:type="resource" xlink:label="srt_OfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OfficerMember_lbl" xml:lang="en-US" id="srt_OfficerMember_lbl">Officers [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OfficerMember" xlink:to="srt_OfficerMember_lbl" xlink:title="label: OfficerMember to srt_OfficerMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US" id="srt_ProductsAndServicesDomain_lbl">Products and Services [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" xlink:title="label: ProductsAndServicesDomain to srt_ProductsAndServicesDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ProductsAndServicesDomain_lbl1" xml:lang="en-US" id="srt_ProductsAndServicesDomain_lbl1">Product and Service [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl1" xlink:title="label: ProductsAndServicesDomain to srt_ProductsAndServicesDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ProductOrServiceAxis_lbl" xml:lang="en-US" id="srt_ProductOrServiceAxis_lbl">Products and Services [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:title="label: ProductOrServiceAxis to srt_ProductOrServiceAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ProductOrServiceAxis_lbl1" xml:lang="en-US" id="srt_ProductOrServiceAxis_lbl1">Product and Service [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl1" xlink:title="label: ProductOrServiceAxis to srt_ProductOrServiceAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember_lbl" xml:lang="en-US" id="srt_RangeMember_lbl">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl" xlink:title="label: RangeMember to srt_RangeMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis_lbl" xml:lang="en-US" id="srt_RangeAxis_lbl">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:title="label: RangeAxis to srt_RangeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioForecastMember_lbl" xml:lang="en-US" id="srt_ScenarioForecastMember_lbl">Forecast [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:title="label: ScenarioForecastMember to srt_ScenarioForecastMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" id="srt_ScenarioUnspecifiedDomain_lbl">Scenario [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xlink:title="label: ScenarioUnspecifiedDomain to srt_ScenarioUnspecifiedDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US" id="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl">Investment, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:title="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US" id="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:title="label: ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock to srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1" xml:lang="en-US" id="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1" xlink:title="label: ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock to srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:label xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_StatementScenarioAxis_lbl" xml:lang="en-US" id="srt_StatementScenarioAxis_lbl">Scenario [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:title="label: StatementScenarioAxis to srt_StatementScenarioAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:label xlink:type="resource" xlink:label="srt_SubsidiariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_SubsidiariesMember_lbl" xml:lang="en-US" id="srt_SubsidiariesMember_lbl">NewCo. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiariesMember" xlink:to="srt_SubsidiariesMember_lbl" xlink:title="label: SubsidiariesMember to srt_SubsidiariesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl">Relationship to Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:title="label: TitleOfIndividualWithRelationshipToEntityDomain to srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1" xml:lang="en-US" id="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1">Relationship to Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1" xlink:title="label: TitleOfIndividualWithRelationshipToEntityDomain to srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="srt_TitleOfIndividualAxis_lbl">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:title="label: TitleOfIndividualAxis to srt_TitleOfIndividualAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_TitleOfIndividualAxis_lbl1" xml:lang="en-US" id="srt_TitleOfIndividualAxis_lbl1">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl1" xlink:title="label: TitleOfIndividualAxis to srt_TitleOfIndividualAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="ValuationAndQualifyingAccountsAbstract" xlink:title="ValuationAndQualifyingAccountsAbstract" />
    <link:label xlink:type="resource" xlink:label="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US" id="srt_ValuationAndQualifyingAccountsAbstract_lbl">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:title="label: ValuationAndQualifyingAccountsAbstract to srt_ValuationAndQualifyingAccountsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:title="ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:label xlink:type="resource" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xml:lang="en-US" id="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl">Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xlink:title="label: ValuationAndQualifyingAccountsDisclosureLineItems to srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="ValuationAndQualifyingAccountsDisclosureTable" />
    <link:label xlink:type="resource" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xml:lang="en-US" id="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl">Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAndQualifyingAccountsDisclosureTable" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xlink:title="label: ValuationAndQualifyingAccountsDisclosureTable to srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="DocumentAnnualReport" xlink:title="DocumentAnnualReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentAnnualReport_lbl" xml:lang="en-US" id="dei_DocumentAnnualReport_lbl">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:title="label: DocumentAnnualReport to dei_DocumentAnnualReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentTransitionReport_lbl" xml:lang="en-US" id="dei_DocumentTransitionReport_lbl">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:title="label: DocumentTransitionReport to dei_DocumentTransitionReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" id="dei_EntityInteractiveDataCurrent_lbl">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:title="label: EntityInteractiveDataCurrent to dei_EntityInteractiveDataCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="IcfrAuditorAttestationFlag" xlink:title="IcfrAuditorAttestationFlag" />
    <link:label xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US" id="dei_IcfrAuditorAttestationFlag_lbl">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:title="label: IcfrAuditorAttestationFlag to dei_IcfrAuditorAttestationFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" id="dei_EntityWellKnownSeasonedIssuer_lbl">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:title="label: EntityWellKnownSeasonedIssuer to dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" id="dei_EntityVoluntaryFilers_lbl">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:title="label: EntityVoluntaryFilers to dei_EntityVoluntaryFilers_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityShellCompany_lbl" xml:lang="en-US" id="dei_EntityShellCompany_lbl">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:title="label: EntityShellCompany to dei_EntityShellCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="dei_EntitySmallBusiness_lbl">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityPublicFloat_lbl" xml:lang="en-US" id="dei_EntityPublicFloat_lbl">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:title="label: EntityPublicFloat to dei_EntityPublicFloat_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="AuditorName" xlink:title="AuditorName" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorName_lbl" xml:lang="en-US" id="dei_AuditorName_lbl">Auditor Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorName" xlink:to="dei_AuditorName_lbl" xlink:title="label: AuditorName to dei_AuditorName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="AuditorLocation" xlink:title="AuditorLocation" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorLocation_lbl" xml:lang="en-US" id="dei_AuditorLocation_lbl">Auditor Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:title="label: AuditorLocation to dei_AuditorLocation_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="AuditorFirmId" xlink:title="AuditorFirmId" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorFirmId_lbl" xml:lang="en-US" id="dei_AuditorFirmId_lbl">Auditor Firm ID</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:title="label: AuditorFirmId to dei_AuditorFirmId_lbl" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1" xml:lang="en-US" id="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1">REDEEMABLE NON-CONTROLLING INTEREST [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1" xlink:title="label: REDEEMABLENONCONTROLLINGINTERESTAbstract to usph_REDEEMABLENONCONTROLLINGINTERESTAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestTextBlock" xlink:label="RedeemableNonControllingInterestTextBlock" xlink:title="RedeemableNonControllingInterestTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl">The entire disclosure for a redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl1">Redeemable Non-Controlling Interest [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl1" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl2">Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl2" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:label="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl">Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1">Carrying Amount of Redeemable Non-Controlling Interest [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2">Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl">The percentage of right to sell equity interest on each of the 4th and 5th anniversaries by shareholders.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1">Percentage of Right to Sell Equity Interest on Each of the 4th and 5th Anniversaries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2">Percentage of right to sell equity interest on each of the 4th and 5th anniversaries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl">The renewal term of the employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl1">Employment Agreement Renewal Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl1" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl2">Employment agreement renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl2" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TermOfEmploymentAgreement_lbl" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl">The term of employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TermOfEmploymentAgreement_lbl1" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl1">Term of Employment Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl1" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TermOfEmploymentAgreement_lbl2" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl2">Employment agreement term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl2" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl">Refers to the percentage of general partnership interest acquired in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1">Business Acquisition, Percentage of General Partnership Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2">Business acquisition, percentage of general partnership interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl">The percentage of right to sell equity interest on each of the 6th and 7th anniversaries by shareholders.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1">Percentage of Right to Sell Equity Interest on Each of the 6th and 7th Anniversaries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2" xml:lang="en-US" id="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2">Percentage of right to sell equity interest on each of the 6th and 7th anniversaries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:to="usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2" xlink:title="label: PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries to usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl">The term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl1" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl1">Non-Compete Agreement Term under Condition Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl1" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl2" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl2">Non-Compete agreement term regardless of whether the selling shareholder is employed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl2" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl">Refers to the percentage of limited partnership interest acquired in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1">Business Acquisition, Percentage of Limited Partnership Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2">Business acquisition, percentage of limited partnership acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl">Refers to the percentage of equity interest in subsidiary contributed for acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1">Business Acquisition Percentage Of Equity Interest In Subsidiary Contributed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2">Percentage of equity interest of subsidiary contributed for acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TherapyPracticeMember_lbl" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl">Refers to the acquiree entity Therapy Practice.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TherapyPracticeMember_lbl1" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl1">Therapy Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl1" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TherapyPracticeMember_lbl2" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl2">Therapy Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl2" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProgressiveHealthCompaniesLLCMember" xlink:label="ProgressiveHealthCompaniesLLCMember" xlink:title="ProgressiveHealthCompaniesLLCMember" />
    <link:label xlink:type="resource" xlink:label="usph_ProgressiveHealthCompaniesLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ProgressiveHealthCompaniesLLCMember_lbl" xml:lang="en-US" id="usph_ProgressiveHealthCompaniesLLCMember_lbl">Refers to the acquiree entity Therapy Practice.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressiveHealthCompaniesLLCMember" xlink:to="usph_ProgressiveHealthCompaniesLLCMember_lbl" xlink:title="label: ProgressiveHealthCompaniesLLCMember to usph_ProgressiveHealthCompaniesLLCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ProgressiveHealthCompaniesLLCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ProgressiveHealthCompaniesLLCMember_lbl1" xml:lang="en-US" id="usph_ProgressiveHealthCompaniesLLCMember_lbl1">ProgressiveHealth Companies, LLC [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressiveHealthCompaniesLLCMember" xlink:to="usph_ProgressiveHealthCompaniesLLCMember_lbl1" xlink:title="label: ProgressiveHealthCompaniesLLCMember to usph_ProgressiveHealthCompaniesLLCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ProgressiveHealthCompaniesLLCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ProgressiveHealthCompaniesLLCMember_lbl2" xml:lang="en-US" id="usph_ProgressiveHealthCompaniesLLCMember_lbl2">ProgressiveHealth [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressiveHealthCompaniesLLCMember" xlink:to="usph_ProgressiveHealthCompaniesLLCMember_lbl2" xlink:title="label: ProgressiveHealthCompaniesLLCMember to usph_ProgressiveHealthCompaniesLLCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl">The term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1">Non-Compete Agreement Term under Condition of Termination of Employment of Employed Selling Shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl">The term of the note issued for consideration payable for the acquisition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1">Business Acquisition Consideration Payable, Term of Note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2">Business acquisition, consideration payable, term of note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1">Carrying Amount of Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestAbstract to usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2">Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestAbstract to usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl">Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1">Contractual Time Period Has Not Lapsed And Holders Employment Has Not Been Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2">Contractual time period has not lapsed and holder's employment has not terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl">Refers to holder's employment has terminated and contractual time period has not expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1">Holders Employment Has Terminated and Contractual Time Period Has Not Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2">Holder's employment has terminated and contractual time period has not expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl">The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Proceeds from Sale of Redeemable Non-controlling Interest Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl">Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1">Net Income Loss Attributable To Redeemable Noncontrolling Interest temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2">Operating results allocated to redeemable non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3">Redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl">Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1">Contractual Time Period Has Lapsed But Holders Employment Has Not Been Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2">Contractual time period has lapsed but holder's employment has not terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Decrease in Note Receivable form sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl">The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1">Distributions to Limited Partners and Redeemable Noncontrolling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2">Distributions to redeemable non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Notes Receivable Related to Sale of Redeemable Non-controlling Interest Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestMember_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestMember_lbl">Represents the upper bound of a range for the estimate of fair value as of the reporting date of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestMember" xlink:to="usph_RedeemableNonControllingInterestMember_lbl" xlink:title="label: RedeemableNonControllingInterestMember to usph_RedeemableNonControllingInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestMember_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestMember_lbl1">Redeemable Non-Controlling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestMember" xlink:to="usph_RedeemableNonControllingInterestMember_lbl1" xlink:title="label: RedeemableNonControllingInterestMember to usph_RedeemableNonControllingInterestMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestMember_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestMember_lbl2">Redeemable Non-Controlling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestMember" xlink:to="usph_RedeemableNonControllingInterestMember_lbl2" xlink:title="label: RedeemableNonControllingInterestMember to usph_RedeemableNonControllingInterestMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl">Refers to holder's employment has terminated and contractual time period has expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1">Holders Employment Has Terminated and Contractual Time Period Has Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2">Holder's employment has terminated and contractual time period has expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl">Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1">Transfer of Compensation Liability for Certain Stock Issued Pursuant to Incentive Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShortSwingProfitSettlement" xlink:label="ShortSwingProfitSettlement" xlink:title="ShortSwingProfitSettlement" />
    <link:label xlink:type="resource" xlink:label="usph_ShortSwingProfitSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShortSwingProfitSettlement_lbl" xml:lang="en-US" id="usph_ShortSwingProfitSettlement_lbl">Amount of short swing profit settlement from any purchase or sale (or sale and purchase) of the company's equity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortSwingProfitSettlement" xlink:to="usph_ShortSwingProfitSettlement_lbl" xlink:title="label: ShortSwingProfitSettlement to usph_ShortSwingProfitSettlement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShortSwingProfitSettlement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShortSwingProfitSettlement_lbl1" xml:lang="en-US" id="usph_ShortSwingProfitSettlement_lbl1">Short Swing Profit Settlement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortSwingProfitSettlement" xlink:to="usph_ShortSwingProfitSettlement_lbl1" xlink:title="label: ShortSwingProfitSettlement to usph_ShortSwingProfitSettlement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShortSwingProfitSettlement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ShortSwingProfitSettlement_lbl2" xml:lang="en-US" id="usph_ShortSwingProfitSettlement_lbl2">Short swing profit settlement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortSwingProfitSettlement" xlink:to="usph_ShortSwingProfitSettlement_lbl2" xlink:title="label: ShortSwingProfitSettlement to usph_ShortSwingProfitSettlement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:label="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="SaleOfNonControllingInterestNetOfTaxAndPurchases" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl">Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:to="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl" xlink:title="label: SaleOfNonControllingInterestNetOfTaxAndPurchases to usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1">Sale of non-controlling interest, net of tax and purchases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:to="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1" xlink:title="label: SaleOfNonControllingInterestNetOfTaxAndPurchases to usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2">Sale of non-controlling interest, net of purchases and tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:to="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2" xlink:title="label: SaleOfNonControllingInterestNetOfTaxAndPurchases to usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl">Amount of distributions during the period on mandatorily redeemable securities net of tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1">Revaluation of Redeemable Non-controlling Interest Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2">Revaluation of redeemable non-controlling interest, net of tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl">Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1">Net Income Loss Attributable To Noncontrolling Interest, Permanent Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2">Net income attributable to non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3">Non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl">Number of shares issued during the period related to redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1">Revaluation of Redeemable Non-controlling Interest Net of Tax, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2">Revaluation of redeemable non-controlling interest, net of tax (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AccountsPayableDueToSellerOfAcquiredBusiness" xlink:label="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="AccountsPayableDueToSellerOfAcquiredBusiness" />
    <link:label xlink:type="resource" xlink:label="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl" xml:lang="en-US" id="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl">Carrying value as of the balance sheet date of obligations incurred related to accounts payable due to seller of acquired business.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:to="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl" xlink:title="label: AccountsPayableDueToSellerOfAcquiredBusiness to usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1" xml:lang="en-US" id="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1">Accounts Payable Due to Seller of Acquired Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:to="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1" xlink:title="label: AccountsPayableDueToSellerOfAcquiredBusiness to usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2" xml:lang="en-US" id="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2">Accounts payable - due to seller of acquired business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:to="usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2" xlink:title="label: AccountsPayableDueToSellerOfAcquiredBusiness to usph_AccountsPayableDueToSellerOfAcquiredBusiness_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PromissoryNotesMember_lbl" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PromissoryNotesMember_lbl1" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl1">Promissory Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl1" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PromissoryNotesMember_lbl2" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl2">3.25% through 4.75% Notes Payable due in Next Year [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl2" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DividendsCashAfterAmendment_lbl" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl">Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DividendsCashAfterAmendment_lbl1" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl1">Dividends Cash After Amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl1" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DividendsCashAfterAmendment_lbl2" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl2">Cash dividends after amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl2" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl">The percentage points added to the reference rate to compute the variable rate on the debt instrument.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1">Debt Instrument Basis Spread On Libor Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2">Spread on Libor variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl">Amount of cash and noncash consideration that could pay with respect to acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1">Cash And Noncash Consideration With Respect To Acquisition After Amendement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2">Cash and noncash consideration with respect to acquisition after amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:label xlink:type="resource" xlink:label="usph_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CreditAgreementMember_lbl" xml:lang="en-US" id="usph_CreditAgreementMember_lbl">A credit agreement is a legal contract in which a bank arranges to loan a customer a certain amount of money for a specified amount of time.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditAgreementMember" xlink:to="usph_CreditAgreementMember_lbl" xlink:title="label: CreditAgreementMember to usph_CreditAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CreditAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CreditAgreementMember_lbl1" xml:lang="en-US" id="usph_CreditAgreementMember_lbl1">Credit Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditAgreementMember" xlink:to="usph_CreditAgreementMember_lbl1" xlink:title="label: CreditAgreementMember to usph_CreditAgreementMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableMember_lbl" xml:lang="en-US" id="usph_NotesPayableMember_lbl">A written promise to pay a note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableMember" xlink:to="usph_NotesPayableMember_lbl" xlink:title="label: NotesPayableMember to usph_NotesPayableMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableMember_lbl1" xml:lang="en-US" id="usph_NotesPayableMember_lbl1">Notes Payable [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableMember" xlink:to="usph_NotesPayableMember_lbl1" xlink:title="label: NotesPayableMember to usph_NotesPayableMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:label xlink:type="resource" xlink:label="usph_NoteReceivableRelatedToSaleOfClinics_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NoteReceivableRelatedToSaleOfClinics_lbl" xml:lang="en-US" id="usph_NoteReceivableRelatedToSaleOfClinics_lbl">Note receivable related to sale of discontinued clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoteReceivableRelatedToSaleOfClinics" xlink:to="usph_NoteReceivableRelatedToSaleOfClinics_lbl" xlink:title="label: NoteReceivableRelatedToSaleOfClinics to usph_NoteReceivableRelatedToSaleOfClinics_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NoteReceivableRelatedToSaleOfClinics_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NoteReceivableRelatedToSaleOfClinics_lbl1" xml:lang="en-US" id="usph_NoteReceivableRelatedToSaleOfClinics_lbl1">Note Receivable Related to Sale of Clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoteReceivableRelatedToSaleOfClinics" xlink:to="usph_NoteReceivableRelatedToSaleOfClinics_lbl1" xlink:title="label: NoteReceivableRelatedToSaleOfClinics to usph_NoteReceivableRelatedToSaleOfClinics_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NoteReceivableRelatedToSaleOfClinics_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NoteReceivableRelatedToSaleOfClinics_lbl2" xml:lang="en-US" id="usph_NoteReceivableRelatedToSaleOfClinics_lbl2">Note receivable related to sale of closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoteReceivableRelatedToSaleOfClinics" xlink:to="usph_NoteReceivableRelatedToSaleOfClinics_lbl2" xlink:title="label: NoteReceivableRelatedToSaleOfClinics to usph_NoteReceivableRelatedToSaleOfClinics_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl" xml:lang="en-US" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl">The number of installments for note receivable in sale consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:to="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl" xlink:title="label: NumberOfInstallmentsForNoteReceivableInSaleConsideration to usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1" xml:lang="en-US" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1">Number of Installments for Note Receivable in Sale Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:to="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1" xlink:title="label: NumberOfInstallmentsForNoteReceivableInSaleConsideration to usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2" xml:lang="en-US" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2">Number of installments for note receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:to="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2" xlink:title="label: NumberOfInstallmentsForNoteReceivableInSaleConsideration to usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3" xml:lang="en-US" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3">Number of installments for note receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:to="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3" xlink:title="label: NumberOfInstallmentsForNoteReceivableInSaleConsideration to usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl">Percentage of general partnership interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1">Percentage Of General Partnership Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2">Percentage of general partnership interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfOperatingClinicLocations_lbl" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl">Number of operating clinic locations during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfOperatingClinicLocations_lbl1" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl1">Number of Operating Clinic Locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl1" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfOperatingClinicLocations_lbl2" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl2">Number of operating clinic locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl2" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl">Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1">Medicare Accelerated and Advance Payments Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2">Medicare Accelerated and Advance Payments Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl">Percentage of limited partnership interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1">Percentage Of Limited Partnership Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2">Percentage of limited partnership interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:label xlink:type="resource" xlink:label="usph_CashReceivedRelatedToSaleOfClinics_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CashReceivedRelatedToSaleOfClinics_lbl" xml:lang="en-US" id="usph_CashReceivedRelatedToSaleOfClinics_lbl">Cash received related to sale of discontinued clinics.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashReceivedRelatedToSaleOfClinics" xlink:to="usph_CashReceivedRelatedToSaleOfClinics_lbl" xlink:title="label: CashReceivedRelatedToSaleOfClinics to usph_CashReceivedRelatedToSaleOfClinics_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CashReceivedRelatedToSaleOfClinics_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashReceivedRelatedToSaleOfClinics_lbl1" xml:lang="en-US" id="usph_CashReceivedRelatedToSaleOfClinics_lbl1">Cash Received Related to Sale of Clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashReceivedRelatedToSaleOfClinics" xlink:to="usph_CashReceivedRelatedToSaleOfClinics_lbl1" xlink:title="label: CashReceivedRelatedToSaleOfClinics to usph_CashReceivedRelatedToSaleOfClinics_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashReceivedRelatedToSaleOfClinics_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashReceivedRelatedToSaleOfClinics_lbl2" xml:lang="en-US" id="usph_CashReceivedRelatedToSaleOfClinics_lbl2">Cash received related to sale of closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashReceivedRelatedToSaleOfClinics" xlink:to="usph_CashReceivedRelatedToSaleOfClinics_lbl2" xlink:title="label: CashReceivedRelatedToSaleOfClinics to usph_CashReceivedRelatedToSaleOfClinics_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:label xlink:type="resource" xlink:label="usph_AggregateSalePriceOfCinics_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AggregateSalePriceOfCinics_lbl" xml:lang="en-US" id="usph_AggregateSalePriceOfCinics_lbl">Sale price of the clinics sold which were discontinued.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateSalePriceOfCinics" xlink:to="usph_AggregateSalePriceOfCinics_lbl" xlink:title="label: AggregateSalePriceOfCinics to usph_AggregateSalePriceOfCinics_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AggregateSalePriceOfCinics_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AggregateSalePriceOfCinics_lbl1" xml:lang="en-US" id="usph_AggregateSalePriceOfCinics_lbl1">Aggregate Sale Price of Clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateSalePriceOfCinics" xlink:to="usph_AggregateSalePriceOfCinics_lbl1" xlink:title="label: AggregateSalePriceOfCinics to usph_AggregateSalePriceOfCinics_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AggregateSalePriceOfCinics_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AggregateSalePriceOfCinics_lbl2" xml:lang="en-US" id="usph_AggregateSalePriceOfCinics_lbl2">Aggregate sale price of clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateSalePriceOfCinics" xlink:to="usph_AggregateSalePriceOfCinics_lbl2" xlink:title="label: AggregateSalePriceOfCinics to usph_AggregateSalePriceOfCinics_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClosedClinicsSold_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfClosedClinicsSold_lbl" xml:lang="en-US" id="usph_NumberOfClosedClinicsSold_lbl">Number of closed clinics sold during the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClosedClinicsSold" xlink:to="usph_NumberOfClosedClinicsSold_lbl" xlink:title="label: NumberOfClosedClinicsSold to usph_NumberOfClosedClinicsSold_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClosedClinicsSold_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfClosedClinicsSold_lbl1" xml:lang="en-US" id="usph_NumberOfClosedClinicsSold_lbl1">Number of Closed Clinics Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClosedClinicsSold" xlink:to="usph_NumberOfClosedClinicsSold_lbl1" xlink:title="label: NumberOfClosedClinicsSold to usph_NumberOfClosedClinicsSold_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClosedClinicsSold_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfClosedClinicsSold_lbl2" xml:lang="en-US" id="usph_NumberOfClosedClinicsSold_lbl2">Number of closed clinics sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClosedClinicsSold" xlink:to="usph_NumberOfClosedClinicsSold_lbl2" xlink:title="label: NumberOfClosedClinicsSold to usph_NumberOfClosedClinicsSold_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RepaymentOfFunds" xlink:label="RepaymentOfFunds" xlink:title="RepaymentOfFunds" />
    <link:label xlink:type="resource" xlink:label="usph_RepaymentOfFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RepaymentOfFunds_lbl" xml:lang="en-US" id="usph_RepaymentOfFunds_lbl">The amount of repayment to Medicare Accelerated and Advance Payment Program ("MAAPP Funds") rather than applying them to future services performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentOfFunds" xlink:to="usph_RepaymentOfFunds_lbl" xlink:title="label: RepaymentOfFunds to usph_RepaymentOfFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RepaymentOfFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RepaymentOfFunds_lbl1" xml:lang="en-US" id="usph_RepaymentOfFunds_lbl1">Repayment of Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentOfFunds" xlink:to="usph_RepaymentOfFunds_lbl1" xlink:title="label: RepaymentOfFunds to usph_RepaymentOfFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RepaymentOfFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RepaymentOfFunds_lbl2" xml:lang="en-US" id="usph_RepaymentOfFunds_lbl2">Repayment of funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentOfFunds" xlink:to="usph_RepaymentOfFunds_lbl2" xlink:title="label: RepaymentOfFunds to usph_RepaymentOfFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_GrantsAndOtherFunds_lbl" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl">Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_GrantsAndOtherFunds_lbl1" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl1">Grants and Other Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl1" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_GrantsAndOtherFunds_lbl2" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl2">Grants and other funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl2" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl">Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1">Public Health and Social Services Emergency Fund [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2">Public Health and Social Services Emergency Fund [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:label xlink:type="resource" xlink:label="usph_ReliefFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReliefFunds_lbl" xml:lang="en-US" id="usph_ReliefFunds_lbl">Relief funds relates to social welfare, a fund of money set up to provide aid for people in need, especially in disaster areas.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReliefFunds" xlink:to="usph_ReliefFunds_lbl" xlink:title="label: ReliefFunds to usph_ReliefFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReliefFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReliefFunds_lbl1" xml:lang="en-US" id="usph_ReliefFunds_lbl1">Relief Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReliefFunds" xlink:to="usph_ReliefFunds_lbl1" xlink:title="label: ReliefFunds to usph_ReliefFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReliefFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReliefFunds_lbl2" xml:lang="en-US" id="usph_ReliefFunds_lbl2">Relief funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReliefFunds" xlink:to="usph_ReliefFunds_lbl2" xlink:title="label: ReliefFunds to usph_ReliefFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ResolutionOfPayorMatter" xlink:label="ResolutionOfPayorMatter" xlink:title="ResolutionOfPayorMatter" />
    <link:label xlink:type="resource" xlink:label="usph_ResolutionOfPayorMatter_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ResolutionOfPayorMatter_lbl" xml:lang="en-US" id="usph_ResolutionOfPayorMatter_lbl">Income received on resolution related to a payor matter.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResolutionOfPayorMatter" xlink:to="usph_ResolutionOfPayorMatter_lbl" xlink:title="label: ResolutionOfPayorMatter to usph_ResolutionOfPayorMatter_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ResolutionOfPayorMatter_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ResolutionOfPayorMatter_lbl1" xml:lang="en-US" id="usph_ResolutionOfPayorMatter_lbl1">Resolution of Payor Matter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResolutionOfPayorMatter" xlink:to="usph_ResolutionOfPayorMatter_lbl1" xlink:title="label: ResolutionOfPayorMatter to usph_ResolutionOfPayorMatter_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ResolutionOfPayorMatter_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ResolutionOfPayorMatter_lbl2" xml:lang="en-US" id="usph_ResolutionOfPayorMatter_lbl2">Resolution of a payor matter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResolutionOfPayorMatter" xlink:to="usph_ResolutionOfPayorMatter_lbl2" xlink:title="label: ResolutionOfPayorMatter to usph_ResolutionOfPayorMatter_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl">Amount of expense related to rent, supplies, contract labor and other.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl1" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl1">Rent Supplies Contract Labor And Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl1" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl2" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl2">Rent, supplies, contract labor and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl2" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_InterestExpenseDebtAndOther_lbl" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl">Debt related expenses and other expenses associated with nonoperating financing activities of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_InterestExpenseDebtAndOther_lbl1" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl1">Interest Expense, Debt and Other Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl1" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_InterestExpenseDebtAndOther_lbl2" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl2">Interest expense - debt and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl2" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetPatientRevenuesMember_lbl" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl">Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetPatientRevenuesMember_lbl1" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl1">Net Patient Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl1" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NetPatientRevenuesMember_lbl2" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl2">Net Patient Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl2" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetPatientRevenuesMember_lbl3" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl3">Net Patient Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl3" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl">Other revenues includes management contract revenues, industrial injury prevention services revenues and services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1">Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2">Other Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DistributionsFromUnconsolidatedAffiliate" xlink:label="DistributionsFromUnconsolidatedAffiliate" xlink:title="DistributionsFromUnconsolidatedAffiliate" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsFromUnconsolidatedAffiliate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DistributionsFromUnconsolidatedAffiliate_lbl" xml:lang="en-US" id="usph_DistributionsFromUnconsolidatedAffiliate_lbl">The cash inflow associated with the distributions from unconsolidated affiliate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsFromUnconsolidatedAffiliate" xlink:to="usph_DistributionsFromUnconsolidatedAffiliate_lbl" xlink:title="label: DistributionsFromUnconsolidatedAffiliate to usph_DistributionsFromUnconsolidatedAffiliate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsFromUnconsolidatedAffiliate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DistributionsFromUnconsolidatedAffiliate_lbl1" xml:lang="en-US" id="usph_DistributionsFromUnconsolidatedAffiliate_lbl1">Distributions from Unconsolidated Affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsFromUnconsolidatedAffiliate" xlink:to="usph_DistributionsFromUnconsolidatedAffiliate_lbl1" xlink:title="label: DistributionsFromUnconsolidatedAffiliate to usph_DistributionsFromUnconsolidatedAffiliate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsFromUnconsolidatedAffiliate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DistributionsFromUnconsolidatedAffiliate_lbl2" xml:lang="en-US" id="usph_DistributionsFromUnconsolidatedAffiliate_lbl2">Distributions from unconsolidated affiliate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsFromUnconsolidatedAffiliate" xlink:to="usph_DistributionsFromUnconsolidatedAffiliate_lbl2" xlink:title="label: DistributionsFromUnconsolidatedAffiliate to usph_DistributionsFromUnconsolidatedAffiliate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashPaidDuringPeriodForAbstract" xlink:label="CashPaidDuringPeriodForAbstract" xlink:title="CashPaidDuringPeriodForAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CashPaidDuringPeriodForAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashPaidDuringPeriodForAbstract_lbl1" xml:lang="en-US" id="usph_CashPaidDuringPeriodForAbstract_lbl1">Cash Paid During Period For [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="usph_CashPaidDuringPeriodForAbstract_lbl1" xlink:title="label: CashPaidDuringPeriodForAbstract to usph_CashPaidDuringPeriodForAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashPaidDuringPeriodForAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashPaidDuringPeriodForAbstract_lbl2" xml:lang="en-US" id="usph_CashPaidDuringPeriodForAbstract_lbl2">Cash paid during the period for:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="usph_CashPaidDuringPeriodForAbstract_lbl2" xlink:title="label: CashPaidDuringPeriodForAbstract to usph_CashPaidDuringPeriodForAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProceedsFromSalesOfNonControllingInterestPermanent" xlink:label="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="ProceedsFromSalesOfNonControllingInterestPermanent" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl" xml:lang="en-US" id="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl">The cash inflow associated with the sales of non-controlling interest-permanent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:to="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl" xlink:title="label: ProceedsFromSalesOfNonControllingInterestPermanent to usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1" xml:lang="en-US" id="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1">Proceeds from Sales of Non-controlling Interest Permanent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:to="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1" xlink:title="label: ProceedsFromSalesOfNonControllingInterestPermanent to usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2" xml:lang="en-US" id="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2">Sales of non-controlling interest-permanent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:to="usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2" xlink:title="label: ProceedsFromSalesOfNonControllingInterestPermanent to usph_ProceedsFromSalesOfNonControllingInterestPermanent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_GainOnSaleOfPartnershipInterestNetOfTax" xlink:label="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="GainOnSaleOfPartnershipInterestNetOfTax" />
    <link:label xlink:type="resource" xlink:label="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl" xml:lang="en-US" id="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl">After tax amount of gain on sale or disposal of partnership interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnSaleOfPartnershipInterestNetOfTax" xlink:to="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl" xlink:title="label: GainOnSaleOfPartnershipInterestNetOfTax to usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1" xml:lang="en-US" id="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1">Gain on Sale of Partnership Interest, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnSaleOfPartnershipInterestNetOfTax" xlink:to="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1" xlink:title="label: GainOnSaleOfPartnershipInterestNetOfTax to usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2" xml:lang="en-US" id="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2">Gain on sale of partnership interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnSaleOfPartnershipInterestNetOfTax" xlink:to="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2" xlink:title="label: GainOnSaleOfPartnershipInterestNetOfTax to usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:label="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl">The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1">Notes Payable Related to Purchase of Non-Controlling Interest, Permanent Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2">Notes payable due to purchase of non-controlling interest, permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Notes Payable Related to Purchase of Redeemable Non-controlling Interest, Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Notes payable related to purchase of redeemable non-controlling interest, temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl">The cash outflow associated with the acquisition of a redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1">Payments to Acquire Redeemable Non-controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2">Purchase of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PurchaseOfBusinessSellerFinancingPortion" xlink:label="PurchaseOfBusinessSellerFinancingPortion" xlink:title="PurchaseOfBusinessSellerFinancingPortion" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl">Purchase of business - seller financing portion in noncash investing or financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1">Purchase of Business Seller Financing Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2">Purchase of businesses - seller financing portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentFunds" xlink:label="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="MedicareAcceleratedAndAdvancePaymentFunds" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl">Amount of medicare accelerated and advance payment funds.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentFunds" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl" xlink:title="label: MedicareAcceleratedAndAdvancePaymentFunds to usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1">Medicare Accelerated and Advance Payment Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentFunds" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1" xlink:title="label: MedicareAcceleratedAndAdvancePaymentFunds to usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2">(Payment) receipt of Medicare Accelerated and Advance Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentFunds" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2" xlink:title="label: MedicareAcceleratedAndAdvancePaymentFunds to usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeeMember_lbl" xml:lang="en-US" id="usph_EmployeeMember_lbl">Person who is employed by the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="usph_EmployeeMember_lbl" xlink:title="label: EmployeeMember to usph_EmployeeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeeMember_lbl1" xml:lang="en-US" id="usph_EmployeeMember_lbl1">Employee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="usph_EmployeeMember_lbl1" xlink:title="label: EmployeeMember to usph_EmployeeMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmployeeMember_lbl2" xml:lang="en-US" id="usph_EmployeeMember_lbl2">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="usph_EmployeeMember_lbl2" xlink:title="label: EmployeeMember to usph_EmployeeMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonControllingInterestsPolicyPolicyTextBlock" xlink:label="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="NonControllingInterestsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1">Non controlling Interests Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2">Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SelfInsuranceProgramPolicyPolicyTextBlock" xlink:label="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="SelfInsuranceProgramPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for self-insurance program.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1">Self Insurance Program Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2">Self-Insurance Program</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestsPolicyTextBlock" xlink:label="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="RedeemableNonControllingInterestsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl">Disclosure of accounting policy for redeemable non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1">Redeemable Non Controlling Interests [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2">Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RestrictedStockPolicyPolicyTextBlock" xlink:label="RestrictedStockPolicyPolicyTextBlock" xlink:title="RestrictedStockPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for restricted stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl1">Restricted Stock Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl2">Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl">Revenues from the industrial injury prevention business are derived from onsite services provided to clients' employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenues are determined based on the number of hours and respective rate for services provided. The Company has agreements with third-party payers that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payer contracts and historical collection and write-off experience.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1">Industrial Injury Prevention Services Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2">Industrial Injury Prevention Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3">Industrial Injury Prevention Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ManagementContractRevenuesMember_lbl" xml:lang="en-US" id="usph_ManagementContractRevenuesMember_lbl">Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. Revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractRevenuesMember" xlink:to="usph_ManagementContractRevenuesMember_lbl" xlink:title="label: ManagementContractRevenuesMember to usph_ManagementContractRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ManagementContractRevenuesMember_lbl1" xml:lang="en-US" id="usph_ManagementContractRevenuesMember_lbl1">Management Contract Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractRevenuesMember" xlink:to="usph_ManagementContractRevenuesMember_lbl1" xlink:title="label: ManagementContractRevenuesMember to usph_ManagementContractRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ManagementContractRevenuesMember_lbl2" xml:lang="en-US" id="usph_ManagementContractRevenuesMember_lbl2">Physical Therapy Management Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractRevenuesMember" xlink:to="usph_ManagementContractRevenuesMember_lbl2" xlink:title="label: ManagementContractRevenuesMember to usph_ManagementContractRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PhysicalTherapyOperationsMember_lbl" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl">Physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PhysicalTherapyOperationsMember_lbl1" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl1">Physical Therapy Operations [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl1" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PhysicalTherapyOperationsMember_lbl2" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl2">Physical Therapy Operations [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl2" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OtherRevenuesMember_lbl" xml:lang="en-US" id="usph_OtherRevenuesMember_lbl">Other revenues include services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesMember" xlink:to="usph_OtherRevenuesMember_lbl" xlink:title="label: OtherRevenuesMember to usph_OtherRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OtherRevenuesMember_lbl1" xml:lang="en-US" id="usph_OtherRevenuesMember_lbl1">Other Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesMember" xlink:to="usph_OtherRevenuesMember_lbl1" xlink:title="label: OtherRevenuesMember to usph_OtherRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_OtherRevenuesMember_lbl2" xml:lang="en-US" id="usph_OtherRevenuesMember_lbl2">Other Patient Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesMember" xlink:to="usph_OtherRevenuesMember_lbl2" xlink:title="label: OtherRevenuesMember to usph_OtherRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl">Insurance products service years.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1">From Two Thousand Twenty Through Two Thousand Twenty Five [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2">From 2020 through 2025 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CentersForMedicareAndMedicaidServicesMember" xlink:label="CentersForMedicareAndMedicaidServicesMember" xlink:title="CentersForMedicareAndMedicaidServicesMember" />
    <link:label xlink:type="resource" xlink:label="usph_CentersForMedicareAndMedicaidServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CentersForMedicareAndMedicaidServicesMember_lbl" xml:lang="en-US" id="usph_CentersForMedicareAndMedicaidServicesMember_lbl">An approval authority for Medicare services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CentersForMedicareAndMedicaidServicesMember" xlink:to="usph_CentersForMedicareAndMedicaidServicesMember_lbl" xlink:title="label: CentersForMedicareAndMedicaidServicesMember to usph_CentersForMedicareAndMedicaidServicesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CentersForMedicareAndMedicaidServicesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CentersForMedicareAndMedicaidServicesMember_lbl1" xml:lang="en-US" id="usph_CentersForMedicareAndMedicaidServicesMember_lbl1">Centers for Medicare and Medicaid Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CentersForMedicareAndMedicaidServicesMember" xlink:to="usph_CentersForMedicareAndMedicaidServicesMember_lbl1" xlink:title="label: CentersForMedicareAndMedicaidServicesMember to usph_CentersForMedicareAndMedicaidServicesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CentersForMedicareAndMedicaidServicesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CentersForMedicareAndMedicaidServicesMember_lbl2" xml:lang="en-US" id="usph_CentersForMedicareAndMedicaidServicesMember_lbl2">CMS [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CentersForMedicareAndMedicaidServicesMember" xlink:to="usph_CentersForMedicareAndMedicaidServicesMember_lbl2" xlink:title="label: CentersForMedicareAndMedicaidServicesMember to usph_CentersForMedicareAndMedicaidServicesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareReimbursementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareReimbursementAbstract_lbl1" xml:lang="en-US" id="usph_MedicareReimbursementAbstract_lbl1">Medicare Reimbursement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareReimbursementAbstract" xlink:to="usph_MedicareReimbursementAbstract_lbl1" xlink:title="label: MedicareReimbursementAbstract to usph_MedicareReimbursementAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareReimbursementAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareReimbursementAbstract_lbl2" xml:lang="en-US" id="usph_MedicareReimbursementAbstract_lbl2">Medicare Reimbursement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareReimbursementAbstract" xlink:to="usph_MedicareReimbursementAbstract_lbl2" xlink:title="label: MedicareReimbursementAbstract to usph_MedicareReimbursementAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl">Refers to the percentage of payment for outpatient therapy services to the therapy assistant.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1">Percentage of Payment for Outpatient Therapy Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2">Percentage of payment for outpatient therapy services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl">Percentage of Medicare payment increase during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl1" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl1">Percentage Of Medicare Payment increase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl1" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl2" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl2">Percentage of increase in Medicare payment rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl2" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl">Amount of reductions in federal spending during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl1" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl1">Amount Of Reductions In Federal Spending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl1" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl2" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl2">Reductions in federal spending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl2" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl">Estimated percentage of decrease in payment during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl1">Estimated Percentage of Decrease in Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl2">Estimated percentage of decrease in payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetRevenueFromMedicare_lbl" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl">Net revenue from Medicare.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetRevenueFromMedicare_lbl1" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl1">Net revenue from Medicare</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl1" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetRevenueFromMedicare_lbl2" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl2">Net patient revenue from Medicare accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl2" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl">Percentage of payment reduction waived through enacted additional legislation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislation to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1">Percentage of Payment Reduction Waived Through Enacted Legislation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislation to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2">Percentage of payment reduction waived through enacted legislation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislation to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl">Combined physical therapy/speech language pathology expenses during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1">Combined Physical Therapy Speech Language Pathology Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2">Combined physical therapy/speech language pathology expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl">Reduction in Medicare spending percentage during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl1" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl1">Reduction In Medicare Spending Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl1" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl2" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl2">Medicare spending cut percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl2" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl">Reduction in Combined physical therapy/speech language pathology expenses during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1">Reduction In Combined Physical Therapy Speech Language Pathology Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2">Reduction in combined physical therapy/speech language pathology expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl">Expected reduction in Medicare spending percentage during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1">Expected Reduction In Medicare Spending Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2">Expected reduction in Medicare spending percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl">Percentage reduction for service in office or other non institutional settings during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1">Percentage Reduction For Service In Office Or Other Non Institutional Settings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2">Percentage reduction for service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl">Percentage of payment reduction waived through enacted additional legislation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl1" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl1">Percentage of Payment Reduction Waived Through Enacted Legislation Period Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl1" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl2" xml:lang="en-US" id="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl2">Percentage of payment reduction waived through enacted legislation, after March 31, 2022 through June 30, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:to="usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl2" xlink:title="label: PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo to usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl">This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1">Period Of Federal Debt Ceiling In Connection With Deficit Reductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2">Federal debt ceiling in connection with deficit reductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PeriodOfExtension" xlink:label="PeriodOfExtension" xlink:title="PeriodOfExtension" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfExtension_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PeriodOfExtension_lbl" xml:lang="en-US" id="usph_PeriodOfExtension_lbl">Extension period of 2021 Act, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfExtension" xlink:to="usph_PeriodOfExtension_lbl" xlink:title="label: PeriodOfExtension to usph_PeriodOfExtension_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfExtension_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PeriodOfExtension_lbl1" xml:lang="en-US" id="usph_PeriodOfExtension_lbl1">Period of Extension</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfExtension" xlink:to="usph_PeriodOfExtension_lbl1" xlink:title="label: PeriodOfExtension to usph_PeriodOfExtension_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfExtension_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PeriodOfExtension_lbl2" xml:lang="en-US" id="usph_PeriodOfExtension_lbl2">Period of extension</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfExtension" xlink:to="usph_PeriodOfExtension_lbl2" xlink:title="label: PeriodOfExtension to usph_PeriodOfExtension_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl" xml:lang="en-US" id="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl">Percentage of increase in payment adjustment for therapists participating in Merit Based Incentive Payment System (MIPS).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl" xlink:title="label: PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xml:lang="en-US" id="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1">Percentage of Increase in Payment Adjustment for Therapists Participating in Merit Based Incentive Payment System</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xlink:title="label: PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xml:lang="en-US" id="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2">Percentage of increase in payment adjustment for therapists participating in MIPS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xlink:title="label: PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:label="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl" xml:lang="en-US" id="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl">Insurance products service years.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:to="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl" xlink:title="label: FromTwoThousandSeventeenThroughTwoThousandNineteenMember to usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1" xml:lang="en-US" id="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1">From Two Thousand Seventeen Through Two Thousand Nineteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:to="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1" xlink:title="label: FromTwoThousandSeventeenThroughTwoThousandNineteenMember to usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2" xml:lang="en-US" id="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2">Year 2017 through 2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:to="usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2" xlink:title="label: FromTwoThousandSeventeenThroughTwoThousandNineteenMember to usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl" xml:lang="en-US" id="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl">Percentage of therapist providers participating in Merit Based Incentive Payment System (MIPS).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl" xlink:title="label: PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xml:lang="en-US" id="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1">Percentage of Therapist Providers Participating in Merit Based Incentive Payment System</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1" xlink:title="label: PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xml:lang="en-US" id="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2">Percentage of therapist providers participating in MIPS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:to="usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2" xlink:title="label: PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem to usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl">Percentage of practice expense component of relative value unit during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1">Percentage Of Practice Expense Component Of Relative Value Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2">Percentage of practice expense component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CreditChargesToRetainedEarningsAbstract" xlink:label="CreditChargesToRetainedEarningsAbstract" xlink:title="CreditChargesToRetainedEarningsAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CreditChargesToRetainedEarningsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CreditChargesToRetainedEarningsAbstract_lbl1" xml:lang="en-US" id="usph_CreditChargesToRetainedEarningsAbstract_lbl1">Credit Charges To Retained Earnings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="usph_CreditChargesToRetainedEarningsAbstract_lbl1" xlink:title="label: CreditChargesToRetainedEarningsAbstract to usph_CreditChargesToRetainedEarningsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CreditChargesToRetainedEarningsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CreditChargesToRetainedEarningsAbstract_lbl2" xml:lang="en-US" id="usph_CreditChargesToRetainedEarningsAbstract_lbl2">(Charges) credit to retained earnings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="usph_CreditChargesToRetainedEarningsAbstract_lbl2" xlink:title="label: CreditChargesToRetainedEarningsAbstract to usph_CreditChargesToRetainedEarningsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl">The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1">Income Tax Reconciliation Income Tax Expense Benefit At Federal and State Statutory Income Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2">Tax effect at statutory rate (federal and state) of 25.55% and 26.25%, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl">The amount of income (loss) from revaluation of redeemable noncontrolling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1">Charges To Retained Earnings Revaluation Of Non Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2">Revaluation of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl">The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1">Income Loss From Operations After Revaluation Of NonControlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2">Net income attributable to common shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl">Percentage of domestic federal and state statutory tax rate applicable to pretax income (loss).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate to usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1">Effective Income Tax Rate Reconciliation At Federal and State Statutory Income Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate to usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xml:lang="en-US" id="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2">Federal and state statutory income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate to usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfRegions_lbl" xml:lang="en-US" id="usph_NumberOfRegions_lbl">Number of regions of the entity operates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfRegions_lbl1" xml:lang="en-US" id="usph_NumberOfRegions_lbl1">Number of regions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl1" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfRegions_lbl2" xml:lang="en-US" id="usph_NumberOfRegions_lbl2">Number of regions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl2" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MultiClinicPracticesMember" xlink:label="MultiClinicPracticesMember" xlink:title="MultiClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_MultiClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MultiClinicPracticesMember_lbl" xml:lang="en-US" id="usph_MultiClinicPracticesMember_lbl">Acquisition of part of a company which provides multi-clinic practice services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MultiClinicPracticesMember" xlink:to="usph_MultiClinicPracticesMember_lbl" xlink:title="label: MultiClinicPracticesMember to usph_MultiClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MultiClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MultiClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_MultiClinicPracticesMember_lbl1">Multi-Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MultiClinicPracticesMember" xlink:to="usph_MultiClinicPracticesMember_lbl1" xlink:title="label: MultiClinicPracticesMember to usph_MultiClinicPracticesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MultiClinicPracticesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MultiClinicPracticesMember_lbl2" xml:lang="en-US" id="usph_MultiClinicPracticesMember_lbl2">Multi-Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MultiClinicPracticesMember" xlink:to="usph_MultiClinicPracticesMember_lbl2" xlink:title="label: MultiClinicPracticesMember to usph_MultiClinicPracticesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl">Acquisition of part of a company which provides services include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1">Leading Provider of Industrial Injury Prevention [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2">IIPS [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl3" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl3">IIPS [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl3" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ManagementContractsMember_lbl" xml:lang="en-US" id="usph_ManagementContractsMember_lbl">Acquisition of part of a company which holds management contracts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractsMember" xlink:to="usph_ManagementContractsMember_lbl" xlink:title="label: ManagementContractsMember to usph_ManagementContractsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ManagementContractsMember_lbl1" xml:lang="en-US" id="usph_ManagementContractsMember_lbl1">Management Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractsMember" xlink:to="usph_ManagementContractsMember_lbl1" xlink:title="label: ManagementContractsMember to usph_ManagementContractsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ManagementContractsMember_lbl2" xml:lang="en-US" id="usph_ManagementContractsMember_lbl2">Management Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractsMember" xlink:to="usph_ManagementContractsMember_lbl2" xlink:title="label: ManagementContractsMember to usph_ManagementContractsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2020AcquisitionMember" xlink:label="September2020AcquisitionMember" xlink:title="September2020AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_September2020AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_September2020AcquisitionMember_lbl" xml:lang="en-US" id="usph_September2020AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2020AcquisitionMember" xlink:to="usph_September2020AcquisitionMember_lbl" xlink:title="label: September2020AcquisitionMember to usph_September2020AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_September2020AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_September2020AcquisitionMember_lbl1" xml:lang="en-US" id="usph_September2020AcquisitionMember_lbl1">September 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2020AcquisitionMember" xlink:to="usph_September2020AcquisitionMember_lbl1" xlink:title="label: September2020AcquisitionMember to usph_September2020AcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_September2020AcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_September2020AcquisitionMember_lbl2" xml:lang="en-US" id="usph_September2020AcquisitionMember_lbl2">September 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2020AcquisitionMember" xlink:to="usph_September2020AcquisitionMember_lbl2" xlink:title="label: September2020AcquisitionMember to usph_September2020AcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2019AcquisitionMember" xlink:label="September2019AcquisitionMember" xlink:title="September2019AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_September2019AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_September2019AcquisitionMember_lbl" xml:lang="en-US" id="usph_September2019AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2019AcquisitionMember" xlink:to="usph_September2019AcquisitionMember_lbl" xlink:title="label: September2019AcquisitionMember to usph_September2019AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_September2019AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_September2019AcquisitionMember_lbl1" xml:lang="en-US" id="usph_September2019AcquisitionMember_lbl1">September 2019 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2019AcquisitionMember" xlink:to="usph_September2019AcquisitionMember_lbl1" xlink:title="label: September2019AcquisitionMember to usph_September2019AcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_September2019AcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_September2019AcquisitionMember_lbl2" xml:lang="en-US" id="usph_September2019AcquisitionMember_lbl2">September 2019 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2019AcquisitionMember" xlink:to="usph_September2019AcquisitionMember_lbl2" xlink:title="label: September2019AcquisitionMember to usph_September2019AcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2021AcquisitionMember" xlink:label="September2021AcquisitionMember" xlink:title="September2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_September2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_September2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_September2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2021AcquisitionMember" xlink:to="usph_September2021AcquisitionMember_lbl" xlink:title="label: September2021AcquisitionMember to usph_September2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_September2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_September2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_September2021AcquisitionMember_lbl1">September 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="September2021AcquisitionMember" xlink:to="usph_September2021AcquisitionMember_lbl1" xlink:title="label: September2021AcquisitionMember to usph_September2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2020AcquisitionMember" xlink:label="November2020AcquisitionMember" xlink:title="November2020AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_November2020AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_November2020AcquisitionMember_lbl" xml:lang="en-US" id="usph_November2020AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2020AcquisitionMember" xlink:to="usph_November2020AcquisitionMember_lbl" xlink:title="label: November2020AcquisitionMember to usph_November2020AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_November2020AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_November2020AcquisitionMember_lbl1" xml:lang="en-US" id="usph_November2020AcquisitionMember_lbl1">November 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2020AcquisitionMember" xlink:to="usph_November2020AcquisitionMember_lbl1" xlink:title="label: November2020AcquisitionMember to usph_November2020AcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_November2020AcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_November2020AcquisitionMember_lbl2" xml:lang="en-US" id="usph_November2020AcquisitionMember_lbl2">November 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2020AcquisitionMember" xlink:to="usph_November2020AcquisitionMember_lbl2" xlink:title="label: November2020AcquisitionMember to usph_November2020AcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_March2021AcquisitionMember" xlink:label="March2021AcquisitionMember" xlink:title="March2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_March2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_March2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_March2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="March2021AcquisitionMember" xlink:to="usph_March2021AcquisitionMember_lbl" xlink:title="label: March2021AcquisitionMember to usph_March2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_March2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_March2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_March2021AcquisitionMember_lbl1">March 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="March2021AcquisitionMember" xlink:to="usph_March2021AcquisitionMember_lbl1" xlink:title="label: March2021AcquisitionMember to usph_March2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfPartnershipInWhichInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfPartnershipInWhichInterestAcquired_lbl" xml:lang="en-US" id="usph_NumberOfPartnershipInWhichInterestAcquired_lbl">Number of partnership in which interest acquired during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPartnershipInWhichInterestAcquired" xlink:to="usph_NumberOfPartnershipInWhichInterestAcquired_lbl" xlink:title="label: NumberOfPartnershipInWhichInterestAcquired to usph_NumberOfPartnershipInWhichInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfPartnershipInWhichInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfPartnershipInWhichInterestAcquired_lbl1" xml:lang="en-US" id="usph_NumberOfPartnershipInWhichInterestAcquired_lbl1">Number Of Partnership In Which Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPartnershipInWhichInterestAcquired" xlink:to="usph_NumberOfPartnershipInWhichInterestAcquired_lbl1" xlink:title="label: NumberOfPartnershipInWhichInterestAcquired to usph_NumberOfPartnershipInWhichInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfPartnershipInWhichInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfPartnershipInWhichInterestAcquired_lbl2" xml:lang="en-US" id="usph_NumberOfPartnershipInWhichInterestAcquired_lbl2">Number of partnerships in which interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPartnershipInWhichInterestAcquired" xlink:to="usph_NumberOfPartnershipInWhichInterestAcquired_lbl2" xlink:title="label: NumberOfPartnershipInWhichInterestAcquired to usph_NumberOfPartnershipInWhichInterestAcquired_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfPartnershipInWhichInterestAcquired_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NumberOfPartnershipInWhichInterestAcquired_lbl3" xml:lang="en-US" id="usph_NumberOfPartnershipInWhichInterestAcquired_lbl3">Number of partnerships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPartnershipInWhichInterestAcquired" xlink:to="usph_NumberOfPartnershipInWhichInterestAcquired_lbl3" xlink:title="label: NumberOfPartnershipInWhichInterestAcquired to usph_NumberOfPartnershipInWhichInterestAcquired_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfManagementContracts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfManagementContracts_lbl" xml:lang="en-US" id="usph_NumberOfManagementContracts_lbl">The number of management contracts during period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfManagementContracts" xlink:to="usph_NumberOfManagementContracts_lbl" xlink:title="label: NumberOfManagementContracts to usph_NumberOfManagementContracts_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfManagementContracts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfManagementContracts_lbl1" xml:lang="en-US" id="usph_NumberOfManagementContracts_lbl1">Number of Management Contracts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfManagementContracts" xlink:to="usph_NumberOfManagementContracts_lbl1" xlink:title="label: NumberOfManagementContracts to usph_NumberOfManagementContracts_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfManagementContracts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfManagementContracts_lbl2" xml:lang="en-US" id="usph_NumberOfManagementContracts_lbl2">Number of management contracts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfManagementContracts" xlink:to="usph_NumberOfManagementContracts_lbl2" xlink:title="label: NumberOfManagementContracts to usph_NumberOfManagementContracts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_February2020AcquisitionMember" xlink:label="February2020AcquisitionMember" xlink:title="February2020AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_February2020AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_February2020AcquisitionMember_lbl" xml:lang="en-US" id="usph_February2020AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="February2020AcquisitionMember" xlink:to="usph_February2020AcquisitionMember_lbl" xlink:title="label: February2020AcquisitionMember to usph_February2020AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_February2020AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_February2020AcquisitionMember_lbl1" xml:lang="en-US" id="usph_February2020AcquisitionMember_lbl1">February 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="February2020AcquisitionMember" xlink:to="usph_February2020AcquisitionMember_lbl1" xlink:title="label: February2020AcquisitionMember to usph_February2020AcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_February2020AcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_February2020AcquisitionMember_lbl2" xml:lang="en-US" id="usph_February2020AcquisitionMember_lbl2">February 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="February2020AcquisitionMember" xlink:to="usph_February2020AcquisitionMember_lbl2" xlink:title="label: February2020AcquisitionMember to usph_February2020AcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_December2021AcquisitionMember" xlink:label="December2021AcquisitionMember" xlink:title="December2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_December2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_December2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_December2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2021AcquisitionMember" xlink:to="usph_December2021AcquisitionMember_lbl" xlink:title="label: December2021AcquisitionMember to usph_December2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_December2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_December2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_December2021AcquisitionMember_lbl1">December 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2021AcquisitionMember" xlink:to="usph_December2021AcquisitionMember_lbl1" xlink:title="label: December2021AcquisitionMember to usph_December2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RemainingContractTerm_lbl" xml:lang="en-US" id="usph_RemainingContractTerm_lbl">Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RemainingContractTerm_lbl1" xml:lang="en-US" id="usph_RemainingContractTerm_lbl1">Remaining Contract Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl1" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RemainingContractTerm_lbl2" xml:lang="en-US" id="usph_RemainingContractTerm_lbl2">Remaining contract term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl2" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_June2021AcquisitionMember" xlink:label="June2021AcquisitionMember" xlink:title="June2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_June2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_June2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_June2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="June2021AcquisitionMember" xlink:to="usph_June2021AcquisitionMember_lbl" xlink:title="label: June2021AcquisitionMember to usph_June2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_June2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_June2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_June2021AcquisitionMember_lbl1">June 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="June2021AcquisitionMember" xlink:to="usph_June2021AcquisitionMember_lbl1" xlink:title="label: June2021AcquisitionMember to usph_June2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:label xlink:type="resource" xlink:label="usph_ClinicPracticeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ClinicPracticeMember_lbl" xml:lang="en-US" id="usph_ClinicPracticeMember_lbl">Acquisition of part of a company which provides clinic practice services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClinicPracticeMember" xlink:to="usph_ClinicPracticeMember_lbl" xlink:title="label: ClinicPracticeMember to usph_ClinicPracticeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ClinicPracticeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ClinicPracticeMember_lbl1" xml:lang="en-US" id="usph_ClinicPracticeMember_lbl1">Clinic Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClinicPracticeMember" xlink:to="usph_ClinicPracticeMember_lbl1" xlink:title="label: ClinicPracticeMember to usph_ClinicPracticeMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ClinicPracticeMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ClinicPracticeMember_lbl2" xml:lang="en-US" id="usph_ClinicPracticeMember_lbl2">Clinic Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClinicPracticeMember" xlink:to="usph_ClinicPracticeMember_lbl2" xlink:title="label: ClinicPracticeMember to usph_ClinicPracticeMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2021AcquisitionMember" xlink:label="November2021AcquisitionMember" xlink:title="November2021AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_November2021AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_November2021AcquisitionMember_lbl" xml:lang="en-US" id="usph_November2021AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2021AcquisitionMember" xlink:to="usph_November2021AcquisitionMember_lbl" xlink:title="label: November2021AcquisitionMember to usph_November2021AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_November2021AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_November2021AcquisitionMember_lbl1" xml:lang="en-US" id="usph_November2021AcquisitionMember_lbl1">November 2021 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="November2021AcquisitionMember" xlink:to="usph_November2021AcquisitionMember_lbl1" xlink:title="label: November2021AcquisitionMember to usph_November2021AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_April2019AcquisitionMember" xlink:label="April2019AcquisitionMember" xlink:title="April2019AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_April2019AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_April2019AcquisitionMember_lbl" xml:lang="en-US" id="usph_April2019AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="April2019AcquisitionMember" xlink:to="usph_April2019AcquisitionMember_lbl" xlink:title="label: April2019AcquisitionMember to usph_April2019AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_April2019AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_April2019AcquisitionMember_lbl1" xml:lang="en-US" id="usph_April2019AcquisitionMember_lbl1">April 2019 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="April2019AcquisitionMember" xlink:to="usph_April2019AcquisitionMember_lbl1" xlink:title="label: April2019AcquisitionMember to usph_April2019AcquisitionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_JointVentureInterestMember" xlink:label="JointVentureInterestMember" xlink:title="JointVentureInterestMember" />
    <link:label xlink:type="resource" xlink:label="usph_JointVentureInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_JointVentureInterestMember_lbl" xml:lang="en-US" id="usph_JointVentureInterestMember_lbl">The joint venture interest in entity which provides physical therapy services for patients at hospitals</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JointVentureInterestMember" xlink:to="usph_JointVentureInterestMember_lbl" xlink:title="label: JointVentureInterestMember to usph_JointVentureInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_JointVentureInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_JointVentureInterestMember_lbl1" xml:lang="en-US" id="usph_JointVentureInterestMember_lbl1">Joint Venture Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JointVentureInterestMember" xlink:to="usph_JointVentureInterestMember_lbl1" xlink:title="label: JointVentureInterestMember to usph_JointVentureInterestMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_JointVentureInterestMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_JointVentureInterestMember_lbl2" xml:lang="en-US" id="usph_JointVentureInterestMember_lbl2">Joint Venture Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JointVentureInterestMember" xlink:to="usph_JointVentureInterestMember_lbl2" xlink:title="label: JointVentureInterestMember to usph_JointVentureInterestMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsAbstract" xlink:label="EmploymentAgreementsAbstract" xlink:title="EmploymentAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsAbstract_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsAbstract_lbl1">Employment Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsAbstract" xlink:to="usph_EmploymentAgreementsAbstract_lbl1" xlink:title="label: EmploymentAgreementsAbstract to usph_EmploymentAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsAbstract_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsAbstract_lbl2">Employee Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsAbstract" xlink:to="usph_EmploymentAgreementsAbstract_lbl2" xlink:title="label: EmploymentAgreementsAbstract to usph_EmploymentAgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateThree" xlink:label="EmploymentAgreementsExpirationDateThree" xlink:title="EmploymentAgreementsExpirationDateThree" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateThree_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementsExpirationDateThree_lbl" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateThree_lbl">Expiration date of the employment agreements three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateThree" xlink:to="usph_EmploymentAgreementsExpirationDateThree_lbl" xlink:title="label: EmploymentAgreementsExpirationDateThree to usph_EmploymentAgreementsExpirationDateThree_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsExpirationDateThree_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateThree_lbl1">Employment Agreements Expiration Date Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateThree" xlink:to="usph_EmploymentAgreementsExpirationDateThree_lbl1" xlink:title="label: EmploymentAgreementsExpirationDateThree to usph_EmploymentAgreementsExpirationDateThree_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateThree_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsExpirationDateThree_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateThree_lbl2">Expiration date of employment agreement, three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateThree" xlink:to="usph_EmploymentAgreementsExpirationDateThree_lbl2" xlink:title="label: EmploymentAgreementsExpirationDateThree to usph_EmploymentAgreementsExpirationDateThree_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RenewalPeriodForEmploymentAgreement" xlink:label="RenewalPeriodForEmploymentAgreement" xlink:title="RenewalPeriodForEmploymentAgreement" />
    <link:label xlink:type="resource" xlink:label="usph_RenewalPeriodForEmploymentAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RenewalPeriodForEmploymentAgreement_lbl" xml:lang="en-US" id="usph_RenewalPeriodForEmploymentAgreement_lbl">Employment agreement renewal period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RenewalPeriodForEmploymentAgreement" xlink:to="usph_RenewalPeriodForEmploymentAgreement_lbl" xlink:title="label: RenewalPeriodForEmploymentAgreement to usph_RenewalPeriodForEmploymentAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RenewalPeriodForEmploymentAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RenewalPeriodForEmploymentAgreement_lbl1" xml:lang="en-US" id="usph_RenewalPeriodForEmploymentAgreement_lbl1">Renewal Period For Employment Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RenewalPeriodForEmploymentAgreement" xlink:to="usph_RenewalPeriodForEmploymentAgreement_lbl1" xlink:title="label: RenewalPeriodForEmploymentAgreement to usph_RenewalPeriodForEmploymentAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RenewalPeriodForEmploymentAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RenewalPeriodForEmploymentAgreement_lbl2" xml:lang="en-US" id="usph_RenewalPeriodForEmploymentAgreement_lbl2">Renewal period of employment agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RenewalPeriodForEmploymentAgreement" xlink:to="usph_RenewalPeriodForEmploymentAgreement_lbl2" xlink:title="label: RenewalPeriodForEmploymentAgreement to usph_RenewalPeriodForEmploymentAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYear" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl">Amount of required minimum payments for employee agreements in excess of one year due in the next fiscal year following the latest fiscal year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYear to usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1">Employee Compensation Future Payment Due Next Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYear to usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2">Future compensation - 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYear to usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateTwo" xlink:label="EmploymentAgreementsExpirationDateTwo" xlink:title="EmploymentAgreementsExpirationDateTwo" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementsExpirationDateTwo_lbl" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateTwo_lbl">Expiration date of the employment agreements two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateTwo" xlink:to="usph_EmploymentAgreementsExpirationDateTwo_lbl" xlink:title="label: EmploymentAgreementsExpirationDateTwo to usph_EmploymentAgreementsExpirationDateTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsExpirationDateTwo_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateTwo_lbl1">Employment Agreements Expiration Date Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateTwo" xlink:to="usph_EmploymentAgreementsExpirationDateTwo_lbl1" xlink:title="label: EmploymentAgreementsExpirationDateTwo to usph_EmploymentAgreementsExpirationDateTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsExpirationDateTwo_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateTwo_lbl2">Expiration date of employment agreement, two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateTwo" xlink:to="usph_EmploymentAgreementsExpirationDateTwo_lbl2" xlink:title="label: EmploymentAgreementsExpirationDateTwo to usph_EmploymentAgreementsExpirationDateTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDate" xlink:label="EmploymentAgreementsExpirationDate" xlink:title="EmploymentAgreementsExpirationDate" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementsExpirationDate_lbl" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDate_lbl">Expiration date of the employment agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDate" xlink:to="usph_EmploymentAgreementsExpirationDate_lbl" xlink:title="label: EmploymentAgreementsExpirationDate to usph_EmploymentAgreementsExpirationDate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsExpirationDate_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDate_lbl1">Employment Agreements Expiration Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDate" xlink:to="usph_EmploymentAgreementsExpirationDate_lbl1" xlink:title="label: EmploymentAgreementsExpirationDate to usph_EmploymentAgreementsExpirationDate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsExpirationDate_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDate_lbl2">Expiration date of employment agreement, one</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDate" xlink:to="usph_EmploymentAgreementsExpirationDate_lbl2" xlink:title="label: EmploymentAgreementsExpirationDate to usph_EmploymentAgreementsExpirationDate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:label="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="NumberOfEmployeesCoveredUnderEmployeeAgreement" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl" xml:lang="en-US" id="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl">Number of employees covered under employee agreement during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:to="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl" xlink:title="label: NumberOfEmployeesCoveredUnderEmployeeAgreement to usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1" xml:lang="en-US" id="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1">Number Of Employees Covered Under Employee Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:to="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1" xlink:title="label: NumberOfEmployeesCoveredUnderEmployeeAgreement to usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2" xml:lang="en-US" id="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2">Number of officers with the company had employee agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:to="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2" xlink:title="label: NumberOfEmployeesCoveredUnderEmployeeAgreement to usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateFour" xlink:label="EmploymentAgreementsExpirationDateFour" xlink:title="EmploymentAgreementsExpirationDateFour" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementsExpirationDateFour_lbl" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateFour_lbl">Expiration date of the employment agreements four.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateFour" xlink:to="usph_EmploymentAgreementsExpirationDateFour_lbl" xlink:title="label: EmploymentAgreementsExpirationDateFour to usph_EmploymentAgreementsExpirationDateFour_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsExpirationDateFour_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateFour_lbl1">Employment Agreements Expiration Date Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateFour" xlink:to="usph_EmploymentAgreementsExpirationDateFour_lbl1" xlink:title="label: EmploymentAgreementsExpirationDateFour to usph_EmploymentAgreementsExpirationDateFour_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateFour_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsExpirationDateFour_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateFour_lbl2">Expiration date of employment agreement, four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateFour" xlink:to="usph_EmploymentAgreementsExpirationDateFour_lbl2" xlink:title="label: EmploymentAgreementsExpirationDateFour to usph_EmploymentAgreementsExpirationDateFour_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl">Amount of required minimum payments for employee agreements in excess of one year due after next fiscal year following the latest fiscal year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter to usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1">Employee Compensation Future Payment Due Next Fiscal Year Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter to usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2">Future compensation - 2023 through 2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter to usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:label="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="SaleOfNoncontrollingInterestPercentageInPartnershipOne" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl">Refers to noncontrolling percentage sold by an entity during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:to="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl" xlink:title="label: SaleOfNoncontrollingInterestPercentageInPartnershipOne to usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1">Sale of Noncontrolling Interest Percentage in Partnership One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:to="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1" xlink:title="label: SaleOfNoncontrollingInterestPercentageInPartnershipOne to usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2">Sale of non-controlling interest percentage in partnership one</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:to="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2" xlink:title="label: SaleOfNoncontrollingInterestPercentageInPartnershipOne to usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TaxEffectOnSaleOfNoncontrollingInterest" xlink:label="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="TaxEffectOnSaleOfNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl" xml:lang="en-US" id="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl">Refers to amount of tax effected on noncontrolling interest sale price during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxEffectOnSaleOfNoncontrollingInterest" xlink:to="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl" xlink:title="label: TaxEffectOnSaleOfNoncontrollingInterest to usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1" xml:lang="en-US" id="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1">Tax Effect on Sale of Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxEffectOnSaleOfNoncontrollingInterest" xlink:to="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1" xlink:title="label: TaxEffectOnSaleOfNoncontrollingInterest to usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2" xml:lang="en-US" id="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2">Tax effect on sale price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxEffectOnSaleOfNoncontrollingInterest" xlink:to="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2" xlink:title="label: TaxEffectOnSaleOfNoncontrollingInterest to usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PreferredStockAbstract" xlink:label="PreferredStockAbstract" xlink:title="PreferredStockAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_PreferredStockAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PreferredStockAbstract_lbl1" xml:lang="en-US" id="usph_PreferredStockAbstract_lbl1">Preferred Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockAbstract" xlink:to="usph_PreferredStockAbstract_lbl1" xlink:title="label: PreferredStockAbstract to usph_PreferredStockAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl">Bank credit agreement to permit share repurchases of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1">Bank Credit Agreement To Permit Share Repurchases Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2">Bank credit agreement to permit share repurchases of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl">Additional estimated repurchase of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1">Additional Estimated Repurchase Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2">Additional estimated shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl">Percentage of repurchase of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl1">Percentage Of Repurchase Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl2">Percentage of repurchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxAssetsLeaseObligations" xlink:label="DeferredTaxAssetsLeaseObligations" xlink:title="DeferredTaxAssetsLeaseObligations" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsLeaseObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DeferredTaxAssetsLeaseObligations_lbl" xml:lang="en-US" id="usph_DeferredTaxAssetsLeaseObligations_lbl">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the lease obligations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLeaseObligations" xlink:to="usph_DeferredTaxAssetsLeaseObligations_lbl" xlink:title="label: DeferredTaxAssetsLeaseObligations to usph_DeferredTaxAssetsLeaseObligations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsLeaseObligations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DeferredTaxAssetsLeaseObligations_lbl1" xml:lang="en-US" id="usph_DeferredTaxAssetsLeaseObligations_lbl1">Deferred Tax Assets Lease Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLeaseObligations" xlink:to="usph_DeferredTaxAssetsLeaseObligations_lbl1" xlink:title="label: DeferredTaxAssetsLeaseObligations to usph_DeferredTaxAssetsLeaseObligations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsLeaseObligations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DeferredTaxAssetsLeaseObligations_lbl2" xml:lang="en-US" id="usph_DeferredTaxAssetsLeaseObligations_lbl2">Lease obligations - including closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLeaseObligations" xlink:to="usph_DeferredTaxAssetsLeaseObligations_lbl2" xlink:title="label: DeferredTaxAssetsLeaseObligations to usph_DeferredTaxAssetsLeaseObligations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl" xml:lang="en-US" id="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl">Amount of deferred tax liability attributable to operating lease right-of-use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:to="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl" xlink:title="label: DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets to usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1" xml:lang="en-US" id="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1">Deferred Tax Liabilities Operating Lease Right-of-use Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:to="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1" xlink:title="label: DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets to usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2" xml:lang="en-US" id="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2">Operating lease right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:to="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2" xlink:title="label: DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets to usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredEmployerPayrollTaxesCARESACT" xlink:label="DeferredEmployerPayrollTaxesCARESACT" xlink:title="DeferredEmployerPayrollTaxesCARESACT" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredEmployerPayrollTaxesCARESACT_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DeferredEmployerPayrollTaxesCARESACT_lbl" xml:lang="en-US" id="usph_DeferredEmployerPayrollTaxesCARESACT_lbl">Amount of deferred employer payroll taxes - CARES ACT.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredEmployerPayrollTaxesCARESACT" xlink:to="usph_DeferredEmployerPayrollTaxesCARESACT_lbl" xlink:title="label: DeferredEmployerPayrollTaxesCARESACT to usph_DeferredEmployerPayrollTaxesCARESACT_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredEmployerPayrollTaxesCARESACT_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DeferredEmployerPayrollTaxesCARESACT_lbl1" xml:lang="en-US" id="usph_DeferredEmployerPayrollTaxesCARESACT_lbl1">Deferred employer payroll taxes - CARES ACT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredEmployerPayrollTaxesCARESACT" xlink:to="usph_DeferredEmployerPayrollTaxesCARESACT_lbl1" xlink:title="label: DeferredEmployerPayrollTaxesCARESACT to usph_DeferredEmployerPayrollTaxesCARESACT_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredEmployerPayrollTaxesCARESACT_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DeferredEmployerPayrollTaxesCARESACT_lbl2" xml:lang="en-US" id="usph_DeferredEmployerPayrollTaxesCARESACT_lbl2">Deferred employer payroll taxes - CARES ACT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredEmployerPayrollTaxesCARESACT" xlink:to="usph_DeferredEmployerPayrollTaxesCARESACT_lbl2" xlink:title="label: DeferredEmployerPayrollTaxesCARESACT to usph_DeferredEmployerPayrollTaxesCARESACT_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl">Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl1" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl1">Patients And Payors Related Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl1" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl2" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl2">Credit balances due to patients and payors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl2" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl">Amount of funds from the CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing Medicare Accelerated and Advance Payments Program ("MAAPP funds") during the COVID-19 pandemic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable to usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1">Medicare Accelerated and Advance Payments Program Funds Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable to usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2">MAAPP Funds Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable to usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeTaxExaminationAbstract" xlink:label="IncomeTaxExaminationAbstract" xlink:title="IncomeTaxExaminationAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxExaminationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncomeTaxExaminationAbstract_lbl1" xml:lang="en-US" id="usph_IncomeTaxExaminationAbstract_lbl1">Income Tax Examination [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationAbstract" xlink:to="usph_IncomeTaxExaminationAbstract_lbl1" xlink:title="label: IncomeTaxExaminationAbstract to usph_IncomeTaxExaminationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:label="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl" xml:lang="en-US" id="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl">Value of deferred tax assets related to revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:to="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl" xlink:title="label: DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests to usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1" xml:lang="en-US" id="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1">Deferred Tax Assets Related to Redeemable Non-controlling Interests and Acquisitions of Non-controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:to="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1" xlink:title="label: DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests to usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2" xml:lang="en-US" id="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2">Net deferred tax assets, related to revaluation and acquisition of redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:to="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2" xlink:title="label: DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests to usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeesMember" xlink:label="EmployeesMember" xlink:title="EmployeesMember" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeesMember_lbl" xml:lang="en-US" id="usph_EmployeesMember_lbl">An individual who works part-time or full-time under a contract of employment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeesMember" xlink:to="usph_EmployeesMember_lbl" xlink:title="label: EmployeesMember to usph_EmployeesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeesMember_lbl1" xml:lang="en-US" id="usph_EmployeesMember_lbl1">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeesMember" xlink:to="usph_EmployeesMember_lbl1" xlink:title="label: EmployeesMember to usph_EmployeesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmployeesMember_lbl2" xml:lang="en-US" id="usph_EmployeesMember_lbl2">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeesMember" xlink:to="usph_EmployeesMember_lbl2" xlink:title="label: EmployeesMember to usph_EmployeesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl">Description of restriction lapse grant to employees.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1">Share Based Compensation Arrangement By Share Based Payment Award Restriction Lapse Period Description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2">Restrictions will lapse in</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl">Number of shares outstanding for which restrictions had not lapsed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1">Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2">Shares outstanding for which restrictions had not lapsed (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RestrictedPeriodToEmployeesOnTheStockGranted" xlink:label="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="RestrictedPeriodToEmployeesOnTheStockGranted" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl" xml:lang="en-US" id="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl">Restricted period to employees on the stock granted during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:to="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl" xlink:title="label: RestrictedPeriodToEmployeesOnTheStockGranted to usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1" xml:lang="en-US" id="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1">Restricted period to employees on the stock granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:to="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1" xlink:title="label: RestrictedPeriodToEmployeesOnTheStockGranted to usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2" xml:lang="en-US" id="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2">Restricted period on the stock granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:to="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2" xlink:title="label: RestrictedPeriodToEmployeesOnTheStockGranted to usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:label="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:title="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl" xml:lang="en-US" id="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl">Physical therapy operations excluding closure cost a non-GAAP measure consist of net revenue from physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:to="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl" xlink:title="label: PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember to usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl1" xml:lang="en-US" id="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl1">Physical Therapy Operations Excluding Closure Costs a Non-GAAP Measure [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:to="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl1" xlink:title="label: PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember to usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl2" xml:lang="en-US" id="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl2">Physical Therapy Operations (Less Closure Costs) (a non-GAAP measure) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:to="usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl2" xlink:title="label: PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember to usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedTwoThousandThreePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AmendedTwoThousandThreePlanMember_lbl" xml:lang="en-US" id="usph_AmendedTwoThousandThreePlanMember_lbl">Name of the equity-based compensation arrangement plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedTwoThousandThreePlanMember" xlink:to="usph_AmendedTwoThousandThreePlanMember_lbl" xlink:title="label: AmendedTwoThousandThreePlanMember to usph_AmendedTwoThousandThreePlanMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedTwoThousandThreePlanMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AmendedTwoThousandThreePlanMember_lbl1" xml:lang="en-US" id="usph_AmendedTwoThousandThreePlanMember_lbl1">Amended Two Thousand Three Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedTwoThousandThreePlanMember" xlink:to="usph_AmendedTwoThousandThreePlanMember_lbl1" xlink:title="label: AmendedTwoThousandThreePlanMember to usph_AmendedTwoThousandThreePlanMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedTwoThousandThreePlanMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AmendedTwoThousandThreePlanMember_lbl2" xml:lang="en-US" id="usph_AmendedTwoThousandThreePlanMember_lbl2">Amended 2003 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedTwoThousandThreePlanMember" xlink:to="usph_AmendedTwoThousandThreePlanMember_lbl2" xlink:title="label: AmendedTwoThousandThreePlanMember to usph_AmendedTwoThousandThreePlanMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonQualifiedStockOptionsMember" xlink:label="NonQualifiedStockOptionsMember" xlink:title="NonQualifiedStockOptionsMember" />
    <link:label xlink:type="resource" xlink:label="usph_NonQualifiedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonQualifiedStockOptionsMember_lbl" xml:lang="en-US" id="usph_NonQualifiedStockOptionsMember_lbl">Non-qualified stock options are stock options which do not qualify for the special treatment accorded to incentive stock options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionsMember" xlink:to="usph_NonQualifiedStockOptionsMember_lbl" xlink:title="label: NonQualifiedStockOptionsMember to usph_NonQualifiedStockOptionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonQualifiedStockOptionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonQualifiedStockOptionsMember_lbl1" xml:lang="en-US" id="usph_NonQualifiedStockOptionsMember_lbl1">Non Qualified Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionsMember" xlink:to="usph_NonQualifiedStockOptionsMember_lbl1" xlink:title="label: NonQualifiedStockOptionsMember to usph_NonQualifiedStockOptionsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonQualifiedStockOptionsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonQualifiedStockOptionsMember_lbl2" xml:lang="en-US" id="usph_NonQualifiedStockOptionsMember_lbl2">Non Qualified Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionsMember" xlink:to="usph_NonQualifiedStockOptionsMember_lbl2" xlink:title="label: NonQualifiedStockOptionsMember to usph_NonQualifiedStockOptionsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl">Tabular disclosure of business combination completed within the physical therapy operations segment during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1">Schedule of Business Acquisitions Within Physical Therapy Operations Segment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2">Acquisitions Within Physical Therapy Operations Segment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:label="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl">Tabular disclosure of information related to weighted average lease terms and discount rates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1">Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2">Average Lease Terms and Discount Rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_OperatingLeaseSupplementalInformationTableTextBlock" xlink:label="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="OperatingLeaseSupplementalInformationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl">Tabular disclosure of supplemental information related to leases.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1">Operating Lease, Supplemental Information [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2">Supplemental Information Related to Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xml:lang="en-US" id="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1">Average Lease Terms and Discount Rates [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xlink:title="label: AverageLeaseTermsAndDiscountRatesAbstract to usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xml:lang="en-US" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1">Supplemental Information Related to Operating Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xlink:title="label: SupplementalInformationRelatedToOperatingLeasesAbstract to usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xml:lang="en-US" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2">Supplemental Information Related to Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xlink:title="label: SupplementalInformationRelatedToOperatingLeasesAbstract to usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:label="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:title="DefinedContributionPlanEmployerMatchingContributionAmount" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" xml:lang="en-US" id="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl">Amount of matching contributions made by an employer to a defined contribution plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:to="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionAmount to usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1" xml:lang="en-US" id="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1">Defined Contribution Plan, Employer Matching Contribution Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:to="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionAmount to usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2" xml:lang="en-US" id="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2">Employer matching contribution amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:to="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionAmount to usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:label="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:title="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl" xml:lang="en-US" id="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl">Period consider for new employees to cover under defined contribution plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:to="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl" xlink:title="label: DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan to usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1" xml:lang="en-US" id="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1">Defined Contribution Plan Period For New Employees Covered Under Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:to="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1" xlink:title="label: DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan to usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2" xml:lang="en-US" id="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2">Required time period for employees for profit sharing plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:to="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2" xlink:title="label: DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan to usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfAcquiredOperations" xlink:label="NumberOfAcquiredOperations" xlink:title="NumberOfAcquiredOperations" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfAcquiredOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfAcquiredOperations_lbl" xml:lang="en-US" id="usph_NumberOfAcquiredOperations_lbl">Refers to number of acquired operations during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAcquiredOperations" xlink:to="usph_NumberOfAcquiredOperations_lbl" xlink:title="label: NumberOfAcquiredOperations to usph_NumberOfAcquiredOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfAcquiredOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfAcquiredOperations_lbl1" xml:lang="en-US" id="usph_NumberOfAcquiredOperations_lbl1">Number of Acquired Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAcquiredOperations" xlink:to="usph_NumberOfAcquiredOperations_lbl1" xlink:title="label: NumberOfAcquiredOperations to usph_NumberOfAcquiredOperations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfAcquiredOperations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfAcquiredOperations_lbl2" xml:lang="en-US" id="usph_NumberOfAcquiredOperations_lbl2">Number of acquired operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAcquiredOperations" xlink:to="usph_NumberOfAcquiredOperations_lbl2" xlink:title="label: NumberOfAcquiredOperations to usph_NumberOfAcquiredOperations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmendedNineteenNinetyNinePlanMember" xlink:label="AmendedNineteenNinetyNinePlanMember" xlink:title="AmendedNineteenNinetyNinePlanMember" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedNineteenNinetyNinePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AmendedNineteenNinetyNinePlanMember_lbl" xml:lang="en-US" id="usph_AmendedNineteenNinetyNinePlanMember_lbl">Name of the equity-based compensation arrangement plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedNineteenNinetyNinePlanMember" xlink:to="usph_AmendedNineteenNinetyNinePlanMember_lbl" xlink:title="label: AmendedNineteenNinetyNinePlanMember to usph_AmendedNineteenNinetyNinePlanMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedNineteenNinetyNinePlanMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AmendedNineteenNinetyNinePlanMember_lbl1" xml:lang="en-US" id="usph_AmendedNineteenNinetyNinePlanMember_lbl1">Amended Nineteen Ninety Nine Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedNineteenNinetyNinePlanMember" xlink:to="usph_AmendedNineteenNinetyNinePlanMember_lbl1" xlink:title="label: AmendedNineteenNinetyNinePlanMember to usph_AmendedNineteenNinetyNinePlanMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedNineteenNinetyNinePlanMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AmendedNineteenNinetyNinePlanMember_lbl2" xml:lang="en-US" id="usph_AmendedNineteenNinetyNinePlanMember_lbl2">Amended 1999 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedNineteenNinetyNinePlanMember" xlink:to="usph_AmendedNineteenNinetyNinePlanMember_lbl2" xlink:title="label: AmendedNineteenNinetyNinePlanMember to usph_AmendedNineteenNinetyNinePlanMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl">Number of share options (or share units) exercised for the cumulative period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises For the Cumulative Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2">Stock options exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl">The number of grants made for the cumulative period on restricted stock units plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award Restricted Stock Grants For The Cumulative Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2">Restricted stock issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestRedeemableAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonControllingInterestRedeemableAbstract_lbl1" xml:lang="en-US" id="usph_NonControllingInterestRedeemableAbstract_lbl1">Non-Controlling Interest, Redeemable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="usph_NonControllingInterestRedeemableAbstract_lbl1" xlink:title="label: NonControllingInterestRedeemableAbstract to usph_NonControllingInterestRedeemableAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestRedeemableAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NonControllingInterestRedeemableAbstract_lbl2" xml:lang="en-US" id="usph_NonControllingInterestRedeemableAbstract_lbl2">Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="usph_NonControllingInterestRedeemableAbstract_lbl2" xlink:title="label: NonControllingInterestRedeemableAbstract to usph_NonControllingInterestRedeemableAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl">The commencement period of redemption rights for redeemable non controlling interest, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1">Redeemable Non-controlling Interest, Redemption Rights, Commencement Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2">Redeemable non-controlling interest, redemption rights, commencement period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualAllowancesAbstract" xlink:label="ContractualAllowancesAbstract" xlink:title="ContractualAllowancesAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualAllowancesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualAllowancesAbstract_lbl1" xml:lang="en-US" id="usph_ContractualAllowancesAbstract_lbl1">Contractual Allowances [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualAllowancesAbstract" xlink:to="usph_ContractualAllowancesAbstract_lbl1" xlink:title="label: ContractualAllowancesAbstract to usph_ContractualAllowancesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl">Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1">Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl">Difference between net revenues and corresponding cash collections reflected percentage of net revenues.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1">Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2">Difference between net revenues and corresponding cash collections, approximately of net revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl">Maximum contractual allowance reserve estimate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl1">Maximum Contractual Allowance Reserve Estimate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl2">Maximum contractual allowance reserve estimate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl">This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1">Business Combination Acquisition Fair Value of Redeemable Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl">The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1">Business Acquisition Cost Of Acquired Entity Debt Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2">Notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3">Seller notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPayableToShareholdersOfSeller" xlink:label="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="BusinessAcquisitionPayableToShareholdersOfSeller" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl">The amount payable to shareholders of seller in business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:to="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl" xlink:title="label: BusinessAcquisitionPayableToShareholdersOfSeller to usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1">Business Acquisition,Payable to Shareholders of Seller</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:to="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1" xlink:title="label: BusinessAcquisitionPayableToShareholdersOfSeller to usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2">Payable to shareholders of seller</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:to="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2" xlink:title="label: BusinessAcquisitionPayableToShareholdersOfSeller to usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xml:lang="en-US" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1">Estimated Fair Value Of Net Tangible Assets Acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xlink:title="label: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xml:lang="en-US" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2">Estimated fair value of net tangible assets acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xlink:title="label: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl">The amount of non-competition agreements recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2">Non-compete agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl3" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl3">Non-compete</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl3" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl">The amount of tradename recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2">Tradenames</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl3" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl3">Tradename</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl3" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl">Amount of net tangible asset acquired at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1">Business Acquisition Purchase Price Allocation Net Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2">Net tangible assets acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl">Payments to acquire businesses total consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl1">Payments To Acquire Businesses Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl2">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl3">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl">Amount of referral relationships at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2">Customer and referral relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl3" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl3">Referral relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl3" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PreviousOwnersMember" xlink:label="PreviousOwnersMember" xlink:title="PreviousOwnersMember" />
    <link:label xlink:type="resource" xlink:label="usph_PreviousOwnersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PreviousOwnersMember_lbl" xml:lang="en-US" id="usph_PreviousOwnersMember_lbl">Refers to the previous owners who maintain a minority interest after acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreviousOwnersMember" xlink:to="usph_PreviousOwnersMember_lbl" xlink:title="label: PreviousOwnersMember to usph_PreviousOwnersMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PreviousOwnersMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PreviousOwnersMember_lbl1" xml:lang="en-US" id="usph_PreviousOwnersMember_lbl1">Previous Owners [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreviousOwnersMember" xlink:to="usph_PreviousOwnersMember_lbl1" xlink:title="label: PreviousOwnersMember to usph_PreviousOwnersMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:label="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl" xml:lang="en-US" id="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl">Amount of liability recognized arising from contingent consideration upon on achievement of certain business criteria in a business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:to="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl" xlink:title="label: BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria to usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1" xml:lang="en-US" id="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1">Business Combination, Contingent Consideration, Payable on Achievement of Certain Business Criteria</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:to="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1" xlink:title="label: BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria to usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2" xml:lang="en-US" id="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2">Amount payable upon achievement of certain business criteria</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:to="usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2" xlink:title="label: BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria to usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:label="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl">Percentage of voting equity interests retained by practice founder at the acquisition date in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:to="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl" xlink:title="label: BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder to usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1">Business Acquisition, Percentage of Interest Retained by Practice Founder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:to="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder to usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2">Percentage of interest retained by practice founder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:to="usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder to usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:label="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl" xml:lang="en-US" id="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl">Amount of consideration transferred including contingent consideration, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:to="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl" xlink:title="label: BusinessCombinationConsiderationTransferredIncludesContingentConsideration to usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1" xml:lang="en-US" id="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1">Business Combination, Consideration Transferred, Includes Contingent Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:to="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1" xlink:title="label: BusinessCombinationConsiderationTransferredIncludesContingentConsideration to usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2" xml:lang="en-US" id="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2">Aggregate purchase price for the acquisition including contingent consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:to="usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2" xlink:title="label: BusinessCombinationConsiderationTransferredIncludesContingentConsideration to usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReturnToWorkAndErgonomicServicesMember" xlink:label="ReturnToWorkAndErgonomicServicesMember" xlink:title="ReturnToWorkAndErgonomicServicesMember" />
    <link:label xlink:type="resource" xlink:label="usph_ReturnToWorkAndErgonomicServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReturnToWorkAndErgonomicServicesMember_lbl" xml:lang="en-US" id="usph_ReturnToWorkAndErgonomicServicesMember_lbl">Acquisition of a company which has return-to-work and ergonomic services among other offerings.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReturnToWorkAndErgonomicServicesMember" xlink:to="usph_ReturnToWorkAndErgonomicServicesMember_lbl" xlink:title="label: ReturnToWorkAndErgonomicServicesMember to usph_ReturnToWorkAndErgonomicServicesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReturnToWorkAndErgonomicServicesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReturnToWorkAndErgonomicServicesMember_lbl1" xml:lang="en-US" id="usph_ReturnToWorkAndErgonomicServicesMember_lbl1">Return to Work and Ergonomic Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReturnToWorkAndErgonomicServicesMember" xlink:to="usph_ReturnToWorkAndErgonomicServicesMember_lbl1" xlink:title="label: ReturnToWorkAndErgonomicServicesMember to usph_ReturnToWorkAndErgonomicServicesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReturnToWorkAndErgonomicServicesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReturnToWorkAndErgonomicServicesMember_lbl2" xml:lang="en-US" id="usph_ReturnToWorkAndErgonomicServicesMember_lbl2">Return-to-work and Ergonomic Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReturnToWorkAndErgonomicServicesMember" xlink:to="usph_ReturnToWorkAndErgonomicServicesMember_lbl2" xlink:title="label: ReturnToWorkAndErgonomicServicesMember to usph_ReturnToWorkAndErgonomicServicesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementAndServicesContractsMember" xlink:label="ManagementAndServicesContractsMember" xlink:title="ManagementAndServicesContractsMember" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementAndServicesContractsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ManagementAndServicesContractsMember_lbl" xml:lang="en-US" id="usph_ManagementAndServicesContractsMember_lbl">Acquisition of part of a company which holds management and service contracts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementAndServicesContractsMember" xlink:to="usph_ManagementAndServicesContractsMember_lbl" xlink:title="label: ManagementAndServicesContractsMember to usph_ManagementAndServicesContractsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementAndServicesContractsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ManagementAndServicesContractsMember_lbl1" xml:lang="en-US" id="usph_ManagementAndServicesContractsMember_lbl1">Management and Services Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementAndServicesContractsMember" xlink:to="usph_ManagementAndServicesContractsMember_lbl1" xlink:title="label: ManagementAndServicesContractsMember to usph_ManagementAndServicesContractsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementAndServicesContractsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ManagementAndServicesContractsMember_lbl2" xml:lang="en-US" id="usph_ManagementAndServicesContractsMember_lbl2">Management and Services Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementAndServicesContractsMember" xlink:to="usph_ManagementAndServicesContractsMember_lbl2" xlink:title="label: ManagementAndServicesContractsMember to usph_ManagementAndServicesContractsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl">Business acquisition number of installments for payment of purchase consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1">Business Acquisition Number Of Installments For Payment Of Purchase Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2">Number of installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableTwoMember_lbl" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableTwoMember_lbl1" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl1">Notes Payable Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl1" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableTwoMember_lbl2" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl2">Notes Payable Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl2" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableOneMember_lbl" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableOneMember_lbl1" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl1">Notes Payable One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl1" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableOneMember_lbl2" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl2">Notes Payable One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl2" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SeptemberTwoThousandTwentyMember" xlink:label="SeptemberTwoThousandTwentyMember" xlink:title="SeptemberTwoThousandTwentyMember" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SeptemberTwoThousandTwentyMember_lbl" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyMember" xlink:to="usph_SeptemberTwoThousandTwentyMember_lbl" xlink:title="label: SeptemberTwoThousandTwentyMember to usph_SeptemberTwoThousandTwentyMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SeptemberTwoThousandTwentyMember_lbl1" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyMember_lbl1">September Two Thousand Twenty [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyMember" xlink:to="usph_SeptemberTwoThousandTwentyMember_lbl1" xlink:title="label: SeptemberTwoThousandTwentyMember to usph_SeptemberTwoThousandTwentyMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SeptemberTwoThousandTwentyMember_lbl2" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyMember_lbl2">September 2020 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyMember" xlink:to="usph_SeptemberTwoThousandTwentyMember_lbl2" xlink:title="label: SeptemberTwoThousandTwentyMember to usph_SeptemberTwoThousandTwentyMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SeptemberTwoThousandTwentyOneMember" xlink:label="SeptemberTwoThousandTwentyOneMember" xlink:title="SeptemberTwoThousandTwentyOneMember" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SeptemberTwoThousandTwentyOneMember_lbl" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyOneMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyOneMember" xlink:to="usph_SeptemberTwoThousandTwentyOneMember_lbl" xlink:title="label: SeptemberTwoThousandTwentyOneMember to usph_SeptemberTwoThousandTwentyOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SeptemberTwoThousandTwentyOneMember_lbl1" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyOneMember_lbl1">September Two Thousand Twenty One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyOneMember" xlink:to="usph_SeptemberTwoThousandTwentyOneMember_lbl1" xlink:title="label: SeptemberTwoThousandTwentyOneMember to usph_SeptemberTwoThousandTwentyOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyOneMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SeptemberTwoThousandTwentyOneMember_lbl2" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyOneMember_lbl2">September 2021 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyOneMember" xlink:to="usph_SeptemberTwoThousandTwentyOneMember_lbl2" xlink:title="label: SeptemberTwoThousandTwentyOneMember to usph_SeptemberTwoThousandTwentyOneMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AprilTwoThousandNineteenAcquisitionMember" xlink:label="AprilTwoThousandNineteenAcquisitionMember" xlink:title="AprilTwoThousandNineteenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_AprilTwoThousandNineteenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AprilTwoThousandNineteenAcquisitionMember_lbl" xml:lang="en-US" id="usph_AprilTwoThousandNineteenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AprilTwoThousandNineteenAcquisitionMember" xlink:to="usph_AprilTwoThousandNineteenAcquisitionMember_lbl" xlink:title="label: AprilTwoThousandNineteenAcquisitionMember to usph_AprilTwoThousandNineteenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AprilTwoThousandNineteenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AprilTwoThousandNineteenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_AprilTwoThousandNineteenAcquisitionMember_lbl1">April Two Thousand Nineteen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AprilTwoThousandNineteenAcquisitionMember" xlink:to="usph_AprilTwoThousandNineteenAcquisitionMember_lbl1" xlink:title="label: AprilTwoThousandNineteenAcquisitionMember to usph_AprilTwoThousandNineteenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AprilTwoThousandNineteenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_AprilTwoThousandNineteenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_AprilTwoThousandNineteenAcquisitionMember_lbl2">April 2019 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AprilTwoThousandNineteenAcquisitionMember" xlink:to="usph_AprilTwoThousandNineteenAcquisitionMember_lbl2" xlink:title="label: AprilTwoThousandNineteenAcquisitionMember to usph_AprilTwoThousandNineteenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfStatesOfNetworkServices" xlink:label="NumberOfStatesOfNetworkServices" xlink:title="NumberOfStatesOfNetworkServices" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfStatesOfNetworkServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfStatesOfNetworkServices_lbl" xml:lang="en-US" id="usph_NumberOfStatesOfNetworkServices_lbl">This element represents number of states of network services provided by the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesOfNetworkServices" xlink:to="usph_NumberOfStatesOfNetworkServices_lbl" xlink:title="label: NumberOfStatesOfNetworkServices to usph_NumberOfStatesOfNetworkServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfStatesOfNetworkServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfStatesOfNetworkServices_lbl1" xml:lang="en-US" id="usph_NumberOfStatesOfNetworkServices_lbl1">Number of States of Network Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesOfNetworkServices" xlink:to="usph_NumberOfStatesOfNetworkServices_lbl1" xlink:title="label: NumberOfStatesOfNetworkServices to usph_NumberOfStatesOfNetworkServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfStatesOfNetworkServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfStatesOfNetworkServices_lbl2" xml:lang="en-US" id="usph_NumberOfStatesOfNetworkServices_lbl2">Number of states of network services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesOfNetworkServices" xlink:to="usph_NumberOfStatesOfNetworkServices_lbl2" xlink:title="label: NumberOfStatesOfNetworkServices to usph_NumberOfStatesOfNetworkServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfOnsiteClientLocations" xlink:label="NumberOfOnsiteClientLocations" xlink:title="NumberOfOnsiteClientLocations" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOnsiteClientLocations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfOnsiteClientLocations_lbl" xml:lang="en-US" id="usph_NumberOfOnsiteClientLocations_lbl">Number of client locations that included in total operated states that are providing industrial injury prevention services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOnsiteClientLocations" xlink:to="usph_NumberOfOnsiteClientLocations_lbl" xlink:title="label: NumberOfOnsiteClientLocations to usph_NumberOfOnsiteClientLocations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOnsiteClientLocations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfOnsiteClientLocations_lbl1" xml:lang="en-US" id="usph_NumberOfOnsiteClientLocations_lbl1">Number of Onsite Client Locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOnsiteClientLocations" xlink:to="usph_NumberOfOnsiteClientLocations_lbl1" xlink:title="label: NumberOfOnsiteClientLocations to usph_NumberOfOnsiteClientLocations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOnsiteClientLocations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfOnsiteClientLocations_lbl2" xml:lang="en-US" id="usph_NumberOfOnsiteClientLocations_lbl2">Number of onsite client locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOnsiteClientLocations" xlink:to="usph_NumberOfOnsiteClientLocations_lbl2" xlink:title="label: NumberOfOnsiteClientLocations to usph_NumberOfOnsiteClientLocations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReferralRelationshipMember_lbl" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl">Referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReferralRelationshipMember_lbl1" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl1">Referral Relationship [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl1" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ReferralRelationshipMember_lbl2" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl2">Referral Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl2" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CustomerAndReferralRelationshipMember" xlink:label="CustomerAndReferralRelationshipMember" xlink:title="CustomerAndReferralRelationshipMember" />
    <link:label xlink:type="resource" xlink:label="usph_CustomerAndReferralRelationshipMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CustomerAndReferralRelationshipMember_lbl" xml:lang="en-US" id="usph_CustomerAndReferralRelationshipMember_lbl">Entity's established relationships with its customers through contracts and also includes referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerAndReferralRelationshipMember" xlink:to="usph_CustomerAndReferralRelationshipMember_lbl" xlink:title="label: CustomerAndReferralRelationshipMember to usph_CustomerAndReferralRelationshipMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CustomerAndReferralRelationshipMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CustomerAndReferralRelationshipMember_lbl1" xml:lang="en-US" id="usph_CustomerAndReferralRelationshipMember_lbl1">Customer and Referral Relationship [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerAndReferralRelationshipMember" xlink:to="usph_CustomerAndReferralRelationshipMember_lbl1" xlink:title="label: CustomerAndReferralRelationshipMember to usph_CustomerAndReferralRelationshipMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CustomerAndReferralRelationshipMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CustomerAndReferralRelationshipMember_lbl2" xml:lang="en-US" id="usph_CustomerAndReferralRelationshipMember_lbl2">Customer and Referral Relationship [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerAndReferralRelationshipMember" xlink:to="usph_CustomerAndReferralRelationshipMember_lbl2" xlink:title="label: CustomerAndReferralRelationshipMember to usph_CustomerAndReferralRelationshipMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl">Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1">Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2">Estimated useful lives of acquired intangibles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SettlementOfShortSwingProfitClaimAbstract" xlink:label="SettlementOfShortSwingProfitClaimAbstract" xlink:title="SettlementOfShortSwingProfitClaimAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_SettlementOfShortSwingProfitClaimAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SettlementOfShortSwingProfitClaimAbstract_lbl1" xml:lang="en-US" id="usph_SettlementOfShortSwingProfitClaimAbstract_lbl1">Settlement of Short Swing Profit Claim [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SettlementOfShortSwingProfitClaimAbstract" xlink:to="usph_SettlementOfShortSwingProfitClaimAbstract_lbl1" xlink:title="label: SettlementOfShortSwingProfitClaimAbstract to usph_SettlementOfShortSwingProfitClaimAbstract_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>usph-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" />
  <link:roleRef roleURI="http://usph.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#RelatedPartyTransactionsDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#CommitmentsAndContingenciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/DefinedContributionPlanDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#DefinedContributionPlanDetails" />
  <link:roleRef roleURI="http://usph.com/role/CommonStockDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#CommonStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansSummaryDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansSummaryDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#InvestmentInUnconsolidatedAffiliateDetails" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SegmentInformationDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesSummaryDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesSummaryDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc01" xlink:type="simple" xlink:href="usph-20211231.xsd#LeasesDetailsCalc01" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAmendedCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayableAmendedCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayableSummaryOfNotesPayableDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNetAmortizationExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNetIntangibleAssetsNetDetails" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#GoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsAndSaleOfNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinesses2019AcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinesses2020AcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinesses2021AcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinessesAcquiredMajorityInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesRestrictedStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesSegmentReportingDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesIncomeTaxesDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesContractualAllowancesDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesRevenueRecognitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesGoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesLonglivedAssetsDetails" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" xlink:type="simple" xlink:href="usph-20211231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="usph-20211231.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansTables" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlansTables" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="usph-20211231.xsd#SegmentInformationTables" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxesTables" />
  <link:roleRef roleURI="http://usph.com/role/LeasesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#LeasesTables" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableTables" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayableTables" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNetTables" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillTables" xlink:type="simple" xlink:href="usph-20211231.xsd#GoodwillTables" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" xlink:type="simple" xlink:href="usph-20211231.xsd#RedeemableNoncontrollingInterestTables" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinessesTables" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables" xlink:type="simple" xlink:href="usph-20211231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationTables" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" xlink:href="usph-20211231.xsd#ScheduleIiValuationAndQualifyingAccounts" />
  <link:roleRef roleURI="http://usph.com/role/ReclassificationOfPriorPeriodPresentation" xlink:type="simple" xlink:href="usph-20211231.xsd#ReclassificationOfPriorPeriodPresentation" />
  <link:roleRef roleURI="http://usph.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="usph-20211231.xsd#RelatedPartyTransactions" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShare" xlink:type="simple" xlink:href="usph-20211231.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://usph.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="usph-20211231.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://usph.com/role/DefinedContributionPlan" xlink:type="simple" xlink:href="usph-20211231.xsd#DefinedContributionPlan" />
  <link:roleRef roleURI="http://usph.com/role/CommonStock" xlink:type="simple" xlink:href="usph-20211231.xsd#CommonStock" />
  <link:roleRef roleURI="http://usph.com/role/PreferredStock" xlink:type="simple" xlink:href="usph-20211231.xsd#PreferredStock" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlans" xlink:type="simple" xlink:href="usph-20211231.xsd#EquityBasedPlans" />
  <link:roleRef roleURI="http://usph.com/role/InvestmentInUnconsolidatedAffiliate" xlink:type="simple" xlink:href="usph-20211231.xsd#InvestmentInUnconsolidatedAffiliate" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformation" xlink:type="simple" xlink:href="usph-20211231.xsd#SegmentInformation" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxes" xlink:type="simple" xlink:href="usph-20211231.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://usph.com/role/Leases" xlink:type="simple" xlink:href="usph-20211231.xsd#Leases" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayable" xlink:type="simple" xlink:href="usph-20211231.xsd#NotesPayable" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpenses" xlink:type="simple" xlink:href="usph-20211231.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="usph-20211231.xsd#IntangibleAssetsNet" />
  <link:roleRef roleURI="http://usph.com/role/Goodwill" xlink:type="simple" xlink:href="usph-20211231.xsd#Goodwill" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" xlink:type="simple" xlink:href="usph-20211231.xsd#RedeemableNoncontrollingInterest" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsAndSaleOfNoncontrollingInterests" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses" xlink:type="simple" xlink:href="usph-20211231.xsd#AcquisitionsOfBusinesses" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="usph-20211231.xsd#SignificantAccountingPolicies" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation" xlink:type="simple" xlink:href="usph-20211231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentation" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedStatementsOfChangesInEquity" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20211231.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20211231.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="DocumentAnnualReport" xlink:title="DocumentAnnualReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentAnnualReport" xlink:title="presentation: CoverAbstract to DocumentAnnualReport" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentTransitionReport" xlink:title="presentation: CoverAbstract to DocumentTransitionReport" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityWellKnownSeasonedIssuer" xlink:title="presentation: CoverAbstract to EntityWellKnownSeasonedIssuer" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityVoluntaryFilers" xlink:title="presentation: CoverAbstract to EntityVoluntaryFilers" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: CoverAbstract to EntityCurrentReportingStatus" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityInteractiveDataCurrent" xlink:title="presentation: CoverAbstract to EntityInteractiveDataCurrent" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="IcfrAuditorAttestationFlag" xlink:title="IcfrAuditorAttestationFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="IcfrAuditorAttestationFlag" xlink:title="presentation: CoverAbstract to IcfrAuditorAttestationFlag" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityShellCompany" xlink:title="presentation: CoverAbstract to EntityShellCompany" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityPublicFloat" xlink:title="presentation: CoverAbstract to EntityPublicFloat" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: CoverAbstract to EntityCommonStockSharesOutstanding" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="AuditorFirmId" xlink:title="AuditorFirmId" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorFirmId" xlink:title="presentation: CoverAbstract to AuditorFirmId" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="AuditorName" xlink:title="AuditorName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorName" xlink:title="presentation: CoverAbstract to AuditorName" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="AuditorLocation" xlink:title="AuditorLocation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorLocation" xlink:title="presentation: CoverAbstract to AuditorLocation" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: AssetsCurrentAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsReceivableNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsReceivableNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsAndOtherReceivablesNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsAndOtherReceivablesNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="FurnitureAndFixturesGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to FurnitureAndFixturesGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="LeaseholdImprovementsGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to LeaseholdImprovementsGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNetAbstract" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNetAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: AssetsAbstract to OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="presentation: AssetsAbstract to InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsAbstract to Goodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: AssetsAbstract to IntangibleAssetsNetExcludingGoodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableTradeCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AccountsPayableDueToSellerOfAcquiredBusiness" xlink:label="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="AccountsPayableDueToSellerOfAcquiredBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableDueToSellerOfAcquiredBusiness" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableDueToSellerOfAcquiredBusiness" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LongTermDebtCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LongTermDebtCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermNotesPayable" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermNotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermLineOfCredit" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermLineOfCredit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DeferredIncomeTaxLiabilitiesNet" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DeferredIncomeTaxLiabilitiesNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OperatingLeaseLiabilityNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockValue" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockValue" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="MinorityInterest" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to MinorityInterest" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="presentation: AssetsCurrentAbstract to AllowanceForDoubtfulAccountsReceivableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockShares" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to StockholdersEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to NetPatientRevenuesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="presentation: ProductOrServiceAxis to ProductsAndServicesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="ProductOrServiceAxis" xlink:title="presentation: StatementTable to ProductOrServiceAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: RevenuesAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="RevenuesAbstract" xlink:title="presentation: StatementLineItems to RevenuesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="LaborAndRelatedExpense" xlink:title="presentation: CostsAndExpensesAbstract to LaborAndRelatedExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="presentation: CostsAndExpensesAbstract to RentSuppliesContractLaborAndOther" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: CostsAndExpensesAbstract to ProvisionForDoubtfulAccounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="RestructuringCharges" xlink:title="presentation: CostsAndExpensesAbstract to RestructuringCharges" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: CostsAndExpensesAbstract to GoodwillImpairmentLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="CostsAndExpenses" xlink:title="presentation: CostsAndExpensesAbstract to CostsAndExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="CostsAndExpensesAbstract" xlink:title="presentation: StatementLineItems to CostsAndExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="GrossProfit" xlink:title="presentation: StatementLineItems to GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="presentation: StatementLineItems to SellingGeneralAndAdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="OperatingIncomeLoss" xlink:title="presentation: StatementLineItems to OperatingIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="ReliefFunds" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to ReliefFunds" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInterestInProjects" xlink:label="GainLossOnSaleOfInterestInProjects" xlink:title="GainLossOnSaleOfInterestInProjects" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="GainLossOnSaleOfInterestInProjects" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to GainLossOnSaleOfInterestInProjects" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="LitigationSettlementExpense" xlink:title="LitigationSettlementExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="LitigationSettlementExpense" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to LitigationSettlementExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ResolutionOfPayorMatter" xlink:label="ResolutionOfPayorMatter" xlink:title="ResolutionOfPayorMatter" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="ResolutionOfPayorMatter" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to ResolutionOfPayorMatter" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to IncomeLossFromEquityMethodInvestments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="InterestAndOtherIncome" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to InterestAndOtherIncome" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="InterestExpenseDebtAndOther" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to InterestExpenseDebtAndOther" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to NonoperatingIncomeExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="OtherNonoperatingIncomeExpenseAbstract" xlink:title="presentation: StatementLineItems to OtherNonoperatingIncomeExpenseAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: StatementLineItems to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: StatementLineItems to IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="presentation: StatementLineItems to ProfitLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="presentation: StatementLineItems to MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="presentation: StatementLineItems to NetIncomeLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="EarningsPerShareBasicAndDiluted" xlink:title="presentation: StatementLineItems to EarningsPerShareBasicAndDiluted" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="presentation: StatementLineItems to WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="CommonStockDividendsPerShareDeclared" xlink:title="presentation: StatementLineItems to CommonStockDividendsPerShareDeclared" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="StatementTable" xlink:title="presentation: IncomeStatementAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="TreasuryStockMember" xlink:title="presentation: StatementEquityComponentsAxis to TreasuryStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="ParentMember" xlink:title="presentation: StatementEquityComponentsAxis to ParentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="NoncontrollingInterestMember" xlink:title="presentation: StatementEquityComponentsAxis to NoncontrollingInterestMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to RevaluationOfRedeemableNonControllingInterestNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="MinorityInterestDecreaseFromRedemptions" xlink:title="MinorityInterestDecreaseFromRedemptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="MinorityInterestDecreaseFromRedemptions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to MinorityInterestDecreaseFromRedemptions" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:label="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="SaleOfNonControllingInterestNetOfTaxAndPurchases" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SaleOfNonControllingInterestNetOfTaxAndPurchases" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="DividendsCommonStockCash" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to DividendsCommonStockCash" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShortSwingProfitSettlement" xlink:label="ShortSwingProfitSettlement" xlink:title="ShortSwingProfitSettlement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="ShortSwingProfitSettlement" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to ShortSwingProfitSettlement" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityOther" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityOther" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLoss" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProfitLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationDepletionAndAmortization" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ProvisionForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DeferredIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_GainOnSaleOfPartnershipInterestNetOfTax" xlink:label="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="GainOnSaleOfPartnershipInterestNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainOnSaleOfPartnershipInterestNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GoodwillImpairmentLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncomeLossFromEquityMethodInvestments" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OtherOperatingActivitiesCashFlowStatement" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OtherOperatingActivitiesCashFlowStatement" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherNoncurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireProductiveAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireRedeemableNonControllingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireInterestInSubsidiariesAndAffiliates" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:label="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromDivestitureOfBusinesses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DistributionsFromUnconsolidatedAffiliate" xlink:label="DistributionsFromUnconsolidatedAffiliate" xlink:title="DistributionsFromUnconsolidatedAffiliate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="DistributionsFromUnconsolidatedAffiliate" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to DistributionsFromUnconsolidatedAffiliate" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProceedsFromSalesOfNonControllingInterestPermanent" xlink:label="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="ProceedsFromSalesOfNonControllingInterestPermanent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSalesOfNonControllingInterestPermanent" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSalesOfNonControllingInterestPermanent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsMinorityInterest" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsMinorityInterest" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromLinesOfCredit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromLinesOfCredit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfLinesOfCredit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfLinesOfCredit" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfNotesPayable" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfNotesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentFunds" xlink:label="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="MedicareAcceleratedAndAdvancePaymentFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to MedicareAcceleratedAndAdvancePaymentFunds" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromPaymentsForOtherFinancingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashPaidDuringPeriodForAbstract" xlink:label="CashPaidDuringPeriodForAbstract" xlink:title="CashPaidDuringPeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="IncomeTaxesPaidNet" xlink:title="presentation: CashPaidDuringPeriodForAbstract to IncomeTaxesPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: CashPaidDuringPeriodForAbstract to InterestPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashPaidDuringPeriodForAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashPaidDuringPeriodForAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PurchaseOfBusinessSellerFinancingPortion" xlink:label="PurchaseOfBusinessSellerFinancingPortion" xlink:title="PurchaseOfBusinessSellerFinancingPortion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="PurchaseOfBusinessSellerFinancingPortion" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PurchaseOfBusinessSellerFinancingPortion" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:label="NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:title="NoncashOrPartNoncashAcquisitionPayablesAssumed1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NoncashOrPartNoncashAcquisitionPayablesAssumed1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:label="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="ProceedsFromMinorityShareholders" xlink:title="ProceedsFromMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ProceedsFromMinorityShareholders" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to ProceedsFromMinorityShareholders" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:title="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="BusinessCombinationDisclosureTextBlock" xlink:title="BusinessCombinationDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="BusinessCombinationDisclosureTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to BusinessCombinationDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="NoncontrollingInterestAbstract" xlink:title="NoncontrollingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="MinorityInterestDisclosureTextBlock" xlink:title="MinorityInterestDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NoncontrollingInterestAbstract" xlink:to="MinorityInterestDisclosureTextBlock" xlink:title="presentation: NoncontrollingInterestAbstract to MinorityInterestDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterest">
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestTextBlock" xlink:label="RedeemableNonControllingInterestTextBlock" xlink:title="RedeemableNonControllingInterestTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="RedeemableNonControllingInterestTextBlock" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to RedeemableNonControllingInterestTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/Goodwill">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="GoodwillDisclosureTextBlock" xlink:title="GoodwillDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNet">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="IntangibleAssetsDisclosureTextBlock" xlink:title="IntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="IntangibleAssetsDisclosureTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to IntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayable">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtDisclosureTextBlock" xlink:title="presentation: DebtDisclosureAbstract to DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/Leases">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxes">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxDisclosureTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="SegmentReportingDisclosureTextBlock" xlink:title="SegmentReportingDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="SegmentReportingDisclosureTextBlock" xlink:title="presentation: SegmentReportingAbstract to SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/InvestmentInUnconsolidatedAffiliate">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:to="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesAbstract to InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlans">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/PreferredStock">
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PreferredStockAbstract" xlink:label="PreferredStockAbstract" xlink:title="PreferredStockAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="PreferredStockTextBlock" xlink:title="PreferredStockTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PreferredStockAbstract" xlink:to="PreferredStockTextBlock" xlink:title="presentation: PreferredStockAbstract to PreferredStockTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStock">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: EquityAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DefinedContributionPlan">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="CompensationAndEmployeeBenefitPlansTextBlock" xlink:title="CompensationAndEmployeeBenefitPlansTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="CompensationAndEmployeeBenefitPlansTextBlock" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to CompensationAndEmployeeBenefitPlansTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShare">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RelatedPartyTransactions">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="presentation: RelatedPartyTransactionsAbstract to RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ReclassificationOfPriorPeriodPresentation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract" xlink:label="PriorPeriodAdjustmentAbstract" xlink:title="PriorPeriodAdjustmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="ErrorCorrectionTextBlock" xlink:title="ErrorCorrectionTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PriorPeriodAdjustmentAbstract" xlink:to="ErrorCorrectionTextBlock" xlink:title="presentation: PriorPeriodAdjustmentAbstract to ErrorCorrectionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="ValuationAndQualifyingAccountsAbstract" xlink:title="ValuationAndQualifyingAccountsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:title="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsAbstract" xlink:to="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:title="presentation: ValuationAndQualifyingAccountsAbstract to ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="InvestmentPolicyTextBlock" xlink:title="InvestmentPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="InvestmentPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to InvestmentPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to GoodwillAndIntangibleAssetsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestsPolicyTextBlock" xlink:label="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="RedeemableNonControllingInterestsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RedeemableNonControllingInterestsPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonControllingInterestsPolicyPolicyTextBlock" xlink:label="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="NonControllingInterestsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NonControllingInterestsPolicyPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RevenueFromContractWithCustomerPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:label="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:label="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:title="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:title="presentation: AccountingPoliciesAbstract to FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="IncomeTaxPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to IncomeTaxPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FairValueOfFinancialInstrumentsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to FairValueOfFinancialInstrumentsPolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingPolicyPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SelfInsuranceProgramPolicyPolicyTextBlock" xlink:label="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="SelfInsuranceProgramPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SelfInsuranceProgramPolicyPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RestrictedStockPolicyPolicyTextBlock" xlink:label="RestrictedStockPolicyPolicyTextBlock" xlink:title="RestrictedStockPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RestrictedStockPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RestrictedStockPolicyPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="DisaggregationOfRevenueTableTextBlock" xlink:title="DisaggregationOfRevenueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DisaggregationOfRevenueTableTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to DisaggregationOfRevenueTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:label="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestTables">
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="RedeemableNoncontrollingInterestTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to RedeemableNoncontrollingInterestTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:label="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="ScheduleOfGoodwillTextBlock" xlink:title="ScheduleOfGoodwillTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ScheduleOfGoodwillTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ScheduleOfGoodwillTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="ScheduleOfDebtInstrumentsTextBlock" xlink:title="ScheduleOfDebtInstrumentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfDebtInstrumentsTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfDebtInstrumentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostTableTextBlock" xlink:title="presentation: LeasesAbstract to LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_OperatingLeaseSupplementalInformationTableTextBlock" xlink:label="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="OperatingLeaseSupplementalInformationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="presentation: LeasesAbstract to OperatingLeaseSupplementalInformationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:label="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="presentation: LeasesAbstract to WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="presentation: SegmentReportingAbstract to ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MultiClinicPracticesMember" xlink:label="MultiClinicPracticesMember" xlink:title="MultiClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MultiClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to MultiClinicPracticesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_December2021AcquisitionMember" xlink:label="December2021AcquisitionMember" xlink:title="December2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="December2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to December2021AcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2021AcquisitionMember" xlink:label="November2021AcquisitionMember" xlink:title="November2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to November2021AcquisitionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2021AcquisitionMember" xlink:label="September2021AcquisitionMember" xlink:title="September2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to September2021AcquisitionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_June2021AcquisitionMember" xlink:label="June2021AcquisitionMember" xlink:title="June2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="June2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to June2021AcquisitionMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_March2021AcquisitionMember" xlink:label="March2021AcquisitionMember" xlink:title="March2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="March2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to March2021AcquisitionMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2020AcquisitionMember" xlink:label="November2020AcquisitionMember" xlink:title="November2020AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2020AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to November2020AcquisitionMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2020AcquisitionMember" xlink:label="September2020AcquisitionMember" xlink:title="September2020AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2020AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to September2020AcquisitionMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_February2020AcquisitionMember" xlink:label="February2020AcquisitionMember" xlink:title="February2020AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="February2020AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to February2020AcquisitionMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2019AcquisitionMember" xlink:label="September2019AcquisitionMember" xlink:title="September2019AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2019AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to September2019AcquisitionMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_April2019AcquisitionMember" xlink:label="April2019AcquisitionMember" xlink:title="April2019AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="April2019AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to April2019AcquisitionMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfReportableSegments" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfReportableSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionDateOfAcquisitionAgreement1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesAcquired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfManagementContracts" xlink:title="presentation: BusinessAcquisitionLineItems to NumberOfManagementContracts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="RemainingContractTerm" xlink:title="presentation: BusinessAcquisitionLineItems to RemainingContractTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="presentation: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="RangeAxis" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to MedicareAcceleratedAndAdvancePaymentsProgramMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to PublicHealthAndSocialServicesEmergencyFundMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="presentation: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to UnusualOrInfrequentItemAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="PercentageOfGeneralPartnershipInterestOwned" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to PercentageOfGeneralPartnershipInterestOwned" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="PercentageOfLimitedPartnershipInterestOwned" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to PercentageOfLimitedPartnershipInterestOwned" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfOperatingClinicLocations" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfOperatingClinicLocations" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfBusinessesAcquired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfClosedClinicsSold" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfClosedClinicsSold" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="AggregateSalePriceOfCinics" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to AggregateSalePriceOfCinics" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="CashReceivedRelatedToSaleOfClinics" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to CashReceivedRelatedToSaleOfClinics" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NoteReceivableRelatedToSaleOfClinics" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NoteReceivableRelatedToSaleOfClinics" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfInstallmentsForNoteReceivableInSaleConsideration" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="GrantsReceivable" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to GrantsReceivable" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RepaymentOfFunds" xlink:label="RepaymentOfFunds" xlink:title="RepaymentOfFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="RepaymentOfFunds" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to RepaymentOfFunds" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="GrantsAndOtherFunds" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to GrantsAndOtherFunds" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="ReliefFunds" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to ReliefFunds" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerSoftwareIntangibleAssetMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerSoftwareIntangibleAssetMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentAbstract" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentLineItems" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfPropertyPlantAndEquipmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract" xlink:label="BusinessCombinationGoodwillAbstract" xlink:title="BusinessCombinationGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="NumberOfOperatingSegments" xlink:title="presentation: BusinessCombinationGoodwillAbstract to NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="NumberOfRegions" xlink:title="presentation: BusinessCombinationGoodwillAbstract to NumberOfRegions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="BusinessCombinationGoodwillAbstract" xlink:title="presentation: AccountingPoliciesAbstract to BusinessCombinationGoodwillAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="RangeAxis" xlink:title="presentation: RedeemableNoncontrollingInterestByLegalEntityTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="presentation: NonControllingInterestRedeemableAbstract to RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NonControllingInterestRedeemableAbstract" xlink:title="presentation: RedeemableNoncontrollingInterestLineItems to NonControllingInterestRedeemableAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="RedeemableNoncontrollingInterestLineItems" xlink:title="presentation: RedeemableNoncontrollingInterestByLegalEntityTable to RedeemableNoncontrollingInterestLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="presentation: AccountingPoliciesAbstract to RedeemableNoncontrollingInterestByLegalEntityTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to NetPatientRevenuesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to OtherRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: ProductsAndServicesDomain to PhysicalTherapyOperationsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="ManagementContractRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to ManagementContractRevenuesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="presentation: ProductOrServiceAxis to ProductsAndServicesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="ProductOrServiceAxis" xlink:title="presentation: DisaggregationOfRevenueTable to ProductOrServiceAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:label="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandSeventeenThroughTwoThousandNineteenMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to FromTwoThousandSeventeenThroughTwoThousandNineteenMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="presentation: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="presentation: DisaggregationOfRevenueTable to UnusualOrInfrequentItemAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="presentation: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="presentation: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="StatementScenarioAxis" xlink:title="presentation: DisaggregationOfRevenueTable to StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="presentation: DisaggregationOfRevenueTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CentersForMedicareAndMedicaidServicesMember" xlink:label="CentersForMedicareAndMedicaidServicesMember" xlink:title="CentersForMedicareAndMedicaidServicesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="CentersForMedicareAndMedicaidServicesMember" xlink:title="presentation: RelatedPartyDomain to CentersForMedicareAndMedicaidServicesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: DisaggregationOfRevenueTable to RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract" xlink:label="DisaggregationOfRevenueAbstract" xlink:title="DisaggregationOfRevenueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: DisaggregationOfRevenueAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfMedicarePaymentIncrease" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfMedicarePaymentIncrease" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="EstimatedPercentageOfDecreaseInPayment" xlink:title="presentation: MedicareReimbursementAbstract to EstimatedPercentageOfDecreaseInPayment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ExpectedReductionInMedicareSpendingPercentage" xlink:title="presentation: MedicareReimbursementAbstract to ExpectedReductionInMedicareSpendingPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="presentation: MedicareReimbursementAbstract to PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="AmountOfReductionsInFederalSpending" xlink:title="presentation: MedicareReimbursementAbstract to AmountOfReductionsInFederalSpending" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ReductionInMedicareSpendingPercentage" xlink:title="presentation: MedicareReimbursementAbstract to ReductionInMedicareSpendingPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPaymentReductionWaivedThroughEnactedLegislation" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPaymentReductionWaivedThroughEnactedLegislation" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PeriodOfExtension" xlink:label="PeriodOfExtension" xlink:title="PeriodOfExtension" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PeriodOfExtension" xlink:title="presentation: MedicareReimbursementAbstract to PeriodOfExtension" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:label="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:title="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:label="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="presentation: MedicareReimbursementAbstract to CombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="presentation: MedicareReimbursementAbstract to ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPracticeExpenseComponentOfRelativeValueUnit" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="presentation: MedicareReimbursementAbstract to PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPaymentForOutpatientTherapyServices" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="NetRevenueFromMedicare" xlink:title="presentation: MedicareReimbursementAbstract to NetRevenueFromMedicare" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="MedicareReimbursementAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to MedicareReimbursementAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="DisaggregationOfRevenueLineItems" xlink:title="presentation: DisaggregationOfRevenueTable to DisaggregationOfRevenueLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DisaggregationOfRevenueTable" xlink:title="presentation: AccountingPoliciesAbstract to DisaggregationOfRevenueTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="RangeAxis" xlink:title="presentation: DisaggregationOfRevenueTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualAllowancesAbstract" xlink:label="ContractualAllowancesAbstract" xlink:title="ContractualAllowancesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractualAllowancesAbstract" xlink:to="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="presentation: ContractualAllowancesAbstract to DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractualAllowancesAbstract" xlink:to="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="presentation: ContractualAllowancesAbstract to DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractualAllowancesAbstract" xlink:to="MaximumContractualAllowanceReserveEstimate" xlink:title="presentation: ContractualAllowancesAbstract to MaximumContractualAllowanceReserveEstimate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractualAllowancesAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to ContractualAllowancesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="DisaggregationOfRevenueLineItems" xlink:title="presentation: DisaggregationOfRevenueTable to DisaggregationOfRevenueLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DisaggregationOfRevenueTable" xlink:title="presentation: AccountingPoliciesAbstract to DisaggregationOfRevenueTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="presentation: IncomeTaxDisclosureAbstract to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="presentation: IncomeTaxDisclosureAbstract to InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="IncomeTaxDisclosureAbstract" xlink:title="presentation: AccountingPoliciesAbstract to IncomeTaxDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="MeasurementInputDiscountRateMember" xlink:title="MeasurementInputDiscountRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputDiscountRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputDiscountRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="presentation: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="MeasurementInputTypeAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable to MeasurementInputTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="DebtInstrumentMeasurementInput" xlink:title="DebtInstrumentMeasurementInput" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="DebtInstrumentMeasurementInput" xlink:title="presentation: FairValueDisclosuresAbstract to DebtInstrumentMeasurementInput" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="FairValueDisclosuresAbstract" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems to FairValueDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:title="presentation: AccountingPoliciesAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="NumberOfOperatingSegments" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="DirectorMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to DirectorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="OfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to OfficerMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementsAbstract" xlink:to="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="presentation: DeferredCompensationArrangementsAbstract to DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementsAbstract" xlink:title="presentation: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_December2021AcquisitionMember" xlink:label="December2021AcquisitionMember" xlink:title="December2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="December2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to December2021AcquisitionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2021AcquisitionMember" xlink:label="November2021AcquisitionMember" xlink:title="November2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to November2021AcquisitionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2021AcquisitionMember" xlink:label="September2021AcquisitionMember" xlink:title="September2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to September2021AcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_June2021AcquisitionMember" xlink:label="June2021AcquisitionMember" xlink:title="June2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="June2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to June2021AcquisitionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_March2021AcquisitionMember" xlink:label="March2021AcquisitionMember" xlink:title="March2021AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="March2021AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to March2021AcquisitionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_November2020AcquisitionMember" xlink:label="November2020AcquisitionMember" xlink:title="November2020AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="November2020AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to November2020AcquisitionMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2020AcquisitionMember" xlink:label="September2020AcquisitionMember" xlink:title="September2020AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2020AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to September2020AcquisitionMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_February2020AcquisitionMember" xlink:label="February2020AcquisitionMember" xlink:title="February2020AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="February2020AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to February2020AcquisitionMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2019AcquisitionMember" xlink:label="September2019AcquisitionMember" xlink:title="September2019AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2019AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to September2019AcquisitionMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_April2019AcquisitionMember" xlink:label="April2019AcquisitionMember" xlink:title="April2019AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="April2019AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to April2019AcquisitionMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementAndServicesContractsMember" xlink:label="ManagementAndServicesContractsMember" xlink:title="ManagementAndServicesContractsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementAndServicesContractsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ManagementAndServicesContractsMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionDateOfAcquisitionAgreement1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfManagementContracts" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfManagementContracts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="RemainingContractTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to RemainingContractTerm" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfPartnershipInWhichInterestAcquired" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReturnToWorkAndErgonomicServicesMember" xlink:label="ReturnToWorkAndErgonomicServicesMember" xlink:title="ReturnToWorkAndErgonomicServicesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ReturnToWorkAndErgonomicServicesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ReturnToWorkAndErgonomicServicesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PreviousOwnersMember" xlink:label="PreviousOwnersMember" xlink:title="PreviousOwnersMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="PreviousOwnersMember" xlink:title="presentation: OwnershipDomain to PreviousOwnersMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="presentation: BusinessCombinationDescriptionAbstract to MinorityInterestOwnershipPercentageByNoncontrollingOwners" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:label="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationConsiderationTransferred1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationContingentConsiderationLiability" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationContingentConsiderationLiability" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:label="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationConsiderationTransferredIncludesContingentConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationConsiderationTransferredIncludesContingentConsideration" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesGross" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:label="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to DebtInstrumentInterestRateStatedPercentage" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="RemainingContractTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to RemainingContractTerm" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase" xlink:label="ContractWithCustomerAssetPurchase" xlink:title="ContractWithCustomerAssetPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ContractWithCustomerAssetPurchase" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ContractWithCustomerAssetPurchase" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="presentation: StatementBusinessSegmentsAxis to SegmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementBusinessSegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationContingentConsiderationLiability" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationContingentConsiderationLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase" xlink:label="ContractWithCustomerAssetPurchase" xlink:title="ContractWithCustomerAssetPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ContractWithCustomerAssetPurchase" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ContractWithCustomerAssetPurchase" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesConsideration" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to PaymentsToAcquireBusinessesConsideration" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PreviousOwnersMember" xlink:label="PreviousOwnersMember" xlink:title="PreviousOwnersMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="PreviousOwnersMember" xlink:title="presentation: OwnershipDomain to PreviousOwnersMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableOneMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableTwoMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="presentation: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ShortTermDebtTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:title="presentation: BusinessCombinationDescriptionAbstract to MinorityInterestOwnershipPercentageByNoncontrollingOwners" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfManagementContracts" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfManagementContracts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfPartnershipInWhichInterestAcquired" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationConsiderationTransferred1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesGross" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="presentation: BusinessCombinationDescriptionAbstract to DebtInstrumentAnnualPrincipalPayment" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to DebtInstrumentInterestRateStatedPercentage" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesConsideration" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to PaymentsToAcquireBusinessesConsideration" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_September2019AcquisitionMember" xlink:label="September2019AcquisitionMember" xlink:title="September2019AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="September2019AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to September2019AcquisitionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AprilTwoThousandNineteenAcquisitionMember" xlink:label="AprilTwoThousandNineteenAcquisitionMember" xlink:title="AprilTwoThousandNineteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AprilTwoThousandNineteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AprilTwoThousandNineteenAcquisitionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SeptemberTwoThousandTwentyMember" xlink:label="SeptemberTwoThousandTwentyMember" xlink:title="SeptemberTwoThousandTwentyMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="SeptemberTwoThousandTwentyMember" xlink:title="presentation: ScenarioUnspecifiedDomain to SeptemberTwoThousandTwentyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SeptemberTwoThousandTwentyOneMember" xlink:label="SeptemberTwoThousandTwentyOneMember" xlink:title="SeptemberTwoThousandTwentyOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="SeptemberTwoThousandTwentyOneMember" xlink:title="presentation: ScenarioUnspecifiedDomain to SeptemberTwoThousandTwentyOneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="presentation: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementScenarioAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementScenarioAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfStatesOfNetworkServices" xlink:label="NumberOfStatesOfNetworkServices" xlink:title="NumberOfStatesOfNetworkServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfStatesOfNetworkServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfStatesOfNetworkServices" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfOnsiteClientLocations" xlink:label="NumberOfOnsiteClientLocations" xlink:title="NumberOfOnsiteClientLocations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfOnsiteClientLocations" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfOnsiteClientLocations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesAcquired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationConsiderationTransferred1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CashAcquiredFromAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CashAcquiredFromAcquisition" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesGross" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPayableToShareholdersOfSeller" xlink:label="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="BusinessAcquisitionPayableToShareholdersOfSeller" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPayableToShareholdersOfSeller" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to DebtInstrumentInterestRateStatedPercentage" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="presentation: StatementBusinessSegmentsAxis to SegmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementBusinessSegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPayableToShareholdersOfSeller" xlink:label="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="BusinessAcquisitionPayableToShareholdersOfSeller" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPayableToShareholdersOfSeller" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesConsideration" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to PaymentsToAcquireBusinessesConsideration" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CashAcquiredFromAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CashAcquiredFromAcquisition" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CustomerAndReferralRelationshipMember" xlink:label="CustomerAndReferralRelationshipMember" xlink:title="CustomerAndReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerAndReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerAndReferralRelationshipMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="NoncontrollingInterestAbstract" xlink:title="NoncontrollingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfPartnershipInWhichInterestAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfClosedClinicsSold" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfClosedClinicsSold" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AggregateSalePriceOfCinics" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AggregateSalePriceOfCinics" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CashReceivedRelatedToSaleOfClinics" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CashReceivedRelatedToSaleOfClinics" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NoteReceivableRelatedToSaleOfClinics" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NoteReceivableRelatedToSaleOfClinics" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfInstallmentsForNoteReceivableInSaleConsideration" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:label="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="SaleOfNoncontrollingInterestPercentageInPartnershipOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="presentation: BusinessCombinationDescriptionAbstract to SaleOfNoncontrollingInterestPercentageInPartnershipOne" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TaxEffectOnSaleOfNoncontrollingInterest" xlink:label="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="TaxEffectOnSaleOfNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="presentation: BusinessCombinationDescriptionAbstract to TaxEffectOnSaleOfNoncontrollingInterest" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NoncontrollingInterestAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: NoncontrollingInterestAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TherapyPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to TherapyPracticeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProgressiveHealthCompaniesLLCMember" xlink:label="ProgressiveHealthCompaniesLLCMember" xlink:title="ProgressiveHealthCompaniesLLCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ProgressiveHealthCompaniesLLCMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ProgressiveHealthCompaniesLLCMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedEntitiesDomain" xlink:to="SubsidiariesMember" xlink:title="presentation: ConsolidatedEntitiesDomain to SubsidiariesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain" xlink:title="presentation: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ConsolidatedEntitiesAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionConsiderationPayableTermOfNote" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="TermOfEmploymentAgreement" xlink:title="presentation: BusinessCombinationDescriptionAbstract to TermOfEmploymentAgreement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EmploymentAgreementRenewalTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EmploymentAgreementRenewalTerm" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NonCompeteAgreementBasicTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NonCompeteAgreementBasicTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:label="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="RedeemableNonControllingInterestMember" xlink:title="presentation: OwnershipDomain to RedeemableNonControllingInterestMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="OwnershipAxis" xlink:title="presentation: RedeemableNoncontrollingInterestByLegalEntityTable to OwnershipAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="MinorityInterestChangeInRedemptionValue" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to MinorityInterestChangeInRedemptionValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="ProceedsFromPaymentsToMinorityShareholders" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to ProceedsFromPaymentsToMinorityShareholders" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="PaymentsToMinorityShareholders" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to PaymentsToMinorityShareholders" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:label="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="NoncontrollingInterestDecreaseFromDeconsolidation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NoncontrollingInterestDecreaseFromDeconsolidation" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount_2" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount_2" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="presentation: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="presentation: RedeemableNoncontrollingInterestLineItems to CarryingAmountOfRedeemableNonControllingInterestAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="RedeemableNoncontrollingInterestLineItems" xlink:title="presentation: RedeemableNoncontrollingInterestByLegalEntityTable to RedeemableNoncontrollingInterestLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTAbstract" xlink:to="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTAbstract to RedeemableNoncontrollingInterestByLegalEntityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="GoodwillRollForward" xlink:title="GoodwillRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="Goodwill" xlink:title="presentation: GoodwillRollForward to Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="GoodwillAcquiredDuringPeriod" xlink:title="GoodwillAcquiredDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillAcquiredDuringPeriod" xlink:title="presentation: GoodwillRollForward to GoodwillAcquiredDuringPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:title="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:title="presentation: GoodwillRollForward to GoodwillWrittenOffRelatedToSaleOfBusinessUnit" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: GoodwillRollForward to GoodwillImpairmentLoss" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="GoodwillPurchaseAccountingAdjustments" xlink:title="GoodwillPurchaseAccountingAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillPurchaseAccountingAdjustments" xlink:title="presentation: GoodwillRollForward to GoodwillPurchaseAccountingAdjustments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill_2" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="Goodwill_2" xlink:title="presentation: GoodwillRollForward to Goodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillRollForward" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to IntangibleAssetsNetExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="AmortizationOfIntangibleAssets" xlink:title="presentation: AmortizationOfDeferredChargesAbstract to AmortizationOfIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfAcquiredOperations" xlink:label="NumberOfAcquiredOperations" xlink:title="NumberOfAcquiredOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="NumberOfAcquiredOperations" xlink:title="presentation: AmortizationOfDeferredChargesAbstract to NumberOfAcquiredOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: AmortizationOfDeferredChargesAbstract to FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfDeferredChargesAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to AmortizationOfDeferredChargesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="PatientsAndPayorsRelatedLiability" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to PatientsAndPayorsRelatedLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AccruedInsuranceCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AccruedInsuranceCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="TaxesPayableCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to TaxesPayableCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:label="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="AssetAcquisitionContingentConsiderationLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AssetAcquisitionContingentConsiderationLiabilityCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AssetAcquisitionContingentConsiderationLiabilityCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent" xlink:label="LitigationReserveCurrent" xlink:title="LitigationReserveCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="LitigationReserveCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to LitigationReserveCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to OtherAccruedLiabilitiesCurrent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredEmployerPayrollTaxesCARESACT" xlink:label="DeferredEmployerPayrollTaxesCARESACT" xlink:title="DeferredEmployerPayrollTaxesCARESACT" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="DeferredEmployerPayrollTaxesCARESACT" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to DeferredEmployerPayrollTaxesCARESACT" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="IncomeTaxesReceivable" xlink:title="IncomeTaxesReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="IncomeTaxesReceivable" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to IncomeTaxesReceivable" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="PromissoryNotesMember" xlink:title="presentation: DebtInstrumentNameDomain to PromissoryNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebt" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtCurrent" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtNoncurrent" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityInterestRateDuringPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentAnnualPrincipalPayment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentInterestRateStatedPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAmendedCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="CreditAgreementMember" xlink:title="presentation: DebtInstrumentNameDomain to CreditAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="presentation: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="presentation: DebtInstrumentTable to ShortTermDebtTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityMaximumBorrowingCapacity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityIncreaseDecreaseForPeriodNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentBasisSpreadOnLiborVariableRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentBasisSpreadOnVariableRate1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="presentation: DebtInstrumentsAbstract to CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DividendsCashAfterAmendment" xlink:title="presentation: DebtInstrumentsAbstract to DividendsCashAfterAmendment" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityRemainingBorrowingCapacity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentFaceAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityInterestRateDuringPeriod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeOperatingLeaseTermOfContract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseCost" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="ShortTermLeaseCost" xlink:title="presentation: LeaseCostAbstract to ShortTermLeaseCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="VariableLeaseCost" xlink:title="presentation: LeaseCostAbstract to VariableLeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="LeaseCost" xlink:title="presentation: LeaseCostAbstract to LeaseCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCostAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LeaseCostAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="OperatingLeasePayments" xlink:title="presentation: SupplementalInformationRelatedToOperatingLeasesAbstract to OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="presentation: SupplementalInformationRelatedToOperatingLeasesAbstract to RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to SupplementalInformationRelatedToOperatingLeasesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: AverageLeaseTermsAndDiscountRatesAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: AverageLeaseTermsAndDiscountRatesAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to AverageLeaseTermsAndDiscountRatesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="LesseeLeaseDescriptionLineItems" xlink:title="presentation: LesseeLeaseDescriptionTable to LesseeLeaseDescriptionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeLeaseDescriptionTable" xlink:title="presentation: LeasesAbstract to LesseeLeaseDescriptionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc01" />
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsOperatingLossCarryforwards" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxAssetsLeaseObligations" xlink:label="DeferredTaxAssetsLeaseObligations" xlink:title="DeferredTaxAssetsLeaseObligations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsLeaseObligations" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsLeaseObligations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsGross" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfDeferredTaxAssetsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfDeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="presentation: ComponentsOfDeferredTaxLiabilitiesAbstract to DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="presentation: ComponentsOfDeferredTaxLiabilitiesAbstract to DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="DeferredTaxLiabilitiesOther" xlink:title="DeferredTaxLiabilitiesOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesOther" xlink:title="presentation: ComponentsOfDeferredTaxLiabilitiesAbstract to DeferredTaxLiabilitiesOther" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="presentation: ComponentsOfDeferredTaxLiabilitiesAbstract to DeferredIncomeTaxLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfDeferredTaxLiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="DeferredTaxLiabilities" xlink:title="presentation: IncomeTaxDisclosureAbstract to DeferredTaxLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesSummaryDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="IncomeTaxExaminationTable" xlink:title="IncomeTaxExaminationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="ForeignCountryMember" xlink:title="presentation: IncomeTaxAuthorityDomain to ForeignCountryMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="presentation: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="presentation: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="presentation: IncomeTaxExaminationTable to IncomeTaxAuthorityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationTable" xlink:to="RangeAxis" xlink:title="presentation: IncomeTaxExaminationTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="IncomeTaxExaminationLineItems" xlink:title="IncomeTaxExaminationLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeTaxExaminationAbstract" xlink:label="IncomeTaxExaminationAbstract" xlink:title="IncomeTaxExaminationAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:label="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="presentation: IncomeTaxExaminationAbstract to DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="presentation: IncomeTaxExaminationAbstract to IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="AccruedIncomeTaxesCurrent" xlink:title="AccruedIncomeTaxesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="AccruedIncomeTaxesCurrent" xlink:title="presentation: IncomeTaxExaminationAbstract to AccruedIncomeTaxesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:label="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="presentation: IncomeTaxExaminationAbstract to DeferredIncomeTaxesAndOtherTaxReceivableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="presentation: IncomeTaxExaminationAbstract to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:label="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="presentation: IncomeTaxExaminationAbstract to UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:label="IncomeTaxExaminationYearUnderExamination" xlink:title="IncomeTaxExaminationYearUnderExamination" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="IncomeTaxExaminationYearUnderExamination" xlink:title="presentation: IncomeTaxExaminationAbstract to IncomeTaxExaminationYearUnderExamination" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExaminationAbstract" xlink:title="presentation: IncomeTaxExaminationLineItems to IncomeTaxExaminationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationTable" xlink:to="IncomeTaxExaminationLineItems" xlink:title="presentation: IncomeTaxExaminationTable to IncomeTaxExaminationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExaminationTable" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExaminationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="IncomeTaxReconciliationDeductions" xlink:title="IncomeTaxReconciliationDeductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationDeductions" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxReconciliationDeductions" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationNondeductibleExpense" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxReconciliationNondeductibleExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:label="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="EffectiveIncomeTaxRateReconciliationDeductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationDeductions" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateContinuingOperations" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateContinuingOperations" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredFederalIncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationItemsDomain" xlink:to="OperatingSegmentsMember" xlink:title="presentation: ConsolidationItemsDomain to OperatingSegmentsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain" xlink:title="presentation: ConsolidationItemsAxis to ConsolidationItemsDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="ConsolidationItemsAxis" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to ConsolidationItemsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: SegmentDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:label="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:title="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="presentation: StatementBusinessSegmentsAxis to SegmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to StatementBusinessSegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="Revenues" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="GrossProfit" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to GrossProfit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="RestructuringCharges" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to RestructuringCharges" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="Assets" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to Assets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingInformationLineItems" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="presentation: SegmentReportingInformationLineItems to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="SegmentReportingInformationLineItems" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to SegmentReportingInformationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="presentation: SegmentReportingAbstract to ScheduleOfSegmentReportingInformationBySegmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="ScheduleOfEquityMethodInvestmentsTable" xlink:title="ScheduleOfEquityMethodInvestmentsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_JointVentureInterestMember" xlink:label="JointVentureInterestMember" xlink:title="JointVentureInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="JointVentureInterestMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to JointVentureInterestMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentsTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfEquityMethodInvestmentsTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="ScheduleOfEquityMethodInvestmentsLineItems" xlink:title="ScheduleOfEquityMethodInvestmentsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:label="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentQuotedMarketValue" xlink:label="EquityMethodInvestmentQuotedMarketValue" xlink:title="EquityMethodInvestmentQuotedMarketValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="EquityMethodInvestmentQuotedMarketValue" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to EquityMethodInvestmentQuotedMarketValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromEquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="IncomeLossFromEquityMethodInvestments" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to IncomeLossFromEquityMethodInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:label="EquityMethodInvestmentDividendsOrDistributions" xlink:title="EquityMethodInvestmentDividendsOrDistributions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:to="EquityMethodInvestmentDividendsOrDistributions" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract to EquityMethodInvestmentDividendsOrDistributions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" xlink:title="presentation: ScheduleOfEquityMethodInvestmentsLineItems to InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentsTable" xlink:to="ScheduleOfEquityMethodInvestmentsLineItems" xlink:title="presentation: ScheduleOfEquityMethodInvestmentsTable to ScheduleOfEquityMethodInvestmentsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsInAndAdvancesToAffiliatesAbstract" xlink:to="ScheduleOfEquityMethodInvestmentsTable" xlink:title="presentation: InvestmentsInAndAdvancesToAffiliatesAbstract to ScheduleOfEquityMethodInvestmentsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="AmendedTwoThousandThreePlanMember" xlink:title="presentation: PlanNameDomain to AmendedTwoThousandThreePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="presentation: PlanNameAxis to PlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NonQualifiedStockOptionsMember" xlink:label="NonQualifiedStockOptionsMember" xlink:title="NonQualifiedStockOptionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="NonQualifiedStockOptionsMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to NonQualifiedStockOptionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmendedNineteenNinetyNinePlanMember" xlink:label="AmendedNineteenNinetyNinePlanMember" xlink:title="AmendedNineteenNinetyNinePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="AmendedNineteenNinetyNinePlanMember" xlink:title="presentation: PlanNameDomain to AmendedNineteenNinetyNinePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="AmendedTwoThousandThreePlanMember" xlink:title="presentation: PlanNameDomain to AmendedTwoThousandThreePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="presentation: PlanNameAxis to PlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansSummaryDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeesMember" xlink:label="EmployeesMember" xlink:title="EmployeesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeesMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to EmployeesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ExecutiveOfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ExecutiveOfficerMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RestrictedPeriodToEmployeesOnTheStockGranted" xlink:label="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="RestrictedPeriodToEmployeesOnTheStockGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="presentation: ShareBasedCompensationAbstract to RestrictedPeriodToEmployeesOnTheStockGranted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationAbstract to AllocatedShareBasedCompensationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="presentation: ShareBasedCompensationAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfTreasuryStockTable" xlink:to="RangeAxis" xlink:title="presentation: ClassOfTreasuryStockTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: ClassOfStockDisclosuresAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="PercentageOfRepurchaseOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to PercentageOfRepurchaseOfCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to BankCreditAgreementToPermitShareRepurchasesOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="StockRepurchasedDuringPeriodShares" xlink:title="presentation: ClassOfStockDisclosuresAbstract to StockRepurchasedDuringPeriodShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to AdditionalEstimatedRepurchaseOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="SharesIssuedPricePerShare" xlink:title="presentation: ClassOfStockDisclosuresAbstract to SharesIssuedPricePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfStockDisclosuresAbstract" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to ClassOfStockDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfTreasuryStockTable" xlink:to="EquityClassOfTreasuryStockLineItems" xlink:title="presentation: ClassOfTreasuryStockTable to EquityClassOfTreasuryStockLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ClassOfTreasuryStockTable" xlink:title="presentation: EquityAbstract to ClassOfTreasuryStockTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DefinedContributionPlanDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:label="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:title="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:label="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:title="DefinedContributionPlanEmployerMatchingContributionAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to DefinedContributionPlanEmployerMatchingContributionAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommitmentsAndContingenciesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ExecutiveOfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ExecutiveOfficerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to SubsequentEventTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsAbstract" xlink:label="EmploymentAgreementsAbstract" xlink:title="EmploymentAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:label="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="NumberOfEmployeesCoveredUnderEmployeeAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="presentation: EmploymentAgreementsAbstract to NumberOfEmployeesCoveredUnderEmployeeAgreement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDate" xlink:label="EmploymentAgreementsExpirationDate" xlink:title="EmploymentAgreementsExpirationDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmploymentAgreementsExpirationDate" xlink:title="presentation: EmploymentAgreementsAbstract to EmploymentAgreementsExpirationDate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateTwo" xlink:label="EmploymentAgreementsExpirationDateTwo" xlink:title="EmploymentAgreementsExpirationDateTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmploymentAgreementsExpirationDateTwo" xlink:title="presentation: EmploymentAgreementsAbstract to EmploymentAgreementsExpirationDateTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateThree" xlink:label="EmploymentAgreementsExpirationDateThree" xlink:title="EmploymentAgreementsExpirationDateThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmploymentAgreementsExpirationDateThree" xlink:title="presentation: EmploymentAgreementsAbstract to EmploymentAgreementsExpirationDateThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmploymentAgreementsExpirationDateFour" xlink:label="EmploymentAgreementsExpirationDateFour" xlink:title="EmploymentAgreementsExpirationDateFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmploymentAgreementsExpirationDateFour" xlink:title="presentation: EmploymentAgreementsAbstract to EmploymentAgreementsExpirationDateFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_RenewalPeriodForEmploymentAgreement" xlink:label="RenewalPeriodForEmploymentAgreement" xlink:title="RenewalPeriodForEmploymentAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="RenewalPeriodForEmploymentAgreement" xlink:title="presentation: EmploymentAgreementsAbstract to RenewalPeriodForEmploymentAgreement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="presentation: EmploymentAgreementsAbstract to EmployeeCompensationFuturePaymentDueNextFiscalYear" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="presentation: EmploymentAgreementsAbstract to EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsAbstract" xlink:title="presentation: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlementAbstract" xlink:label="GainLossRelatedToLitigationSettlementAbstract" xlink:title="GainLossRelatedToLitigationSettlementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants" xlink:label="LossContingencyNumberOfDefendants" xlink:title="LossContingencyNumberOfDefendants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GainLossRelatedToLitigationSettlementAbstract" xlink:to="LossContingencyNumberOfDefendants" xlink:title="presentation: GainLossRelatedToLitigationSettlementAbstract to LossContingencyNumberOfDefendants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GainLossRelatedToLitigationSettlementAbstract" xlink:to="LitigationSettlementAmountAwardedToOtherParty" xlink:title="presentation: GainLossRelatedToLitigationSettlementAbstract to LitigationSettlementAmountAwardedToOtherParty" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="LossContingencyLossInPeriod" xlink:title="LossContingencyLossInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GainLossRelatedToLitigationSettlementAbstract" xlink:to="LossContingencyLossInPeriod" xlink:title="presentation: GainLossRelatedToLitigationSettlementAbstract to LossContingencyLossInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="GainLossRelatedToLitigationSettlementAbstract" xlink:title="presentation: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to GainLossRelatedToLitigationSettlementAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_CreditChargesToRetainedEarningsAbstract" xlink:label="CreditChargesToRetainedEarningsAbstract" xlink:title="CreditChargesToRetainedEarningsAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="presentation: CreditChargesToRetainedEarningsAbstract to ChargesToRetainedEarningsRevaluationOfNonControllingInterests" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="presentation: CreditChargesToRetainedEarningsAbstract to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="presentation: CreditChargesToRetainedEarningsAbstract to IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="CreditChargesToRetainedEarningsAbstract" xlink:title="presentation: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to CreditChargesToRetainedEarningsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="presentation: EarningsPerShareAbstract to NetIncomeLossAvailableToCommonStockholdersBasicAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareDiluted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="presentation: EarningsPerShareAbstract to WeightedAverageNumberOfSharesOutstandingAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="presentation: EarningsPerShareAbstract to EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_SettlementOfShortSwingProfitClaimAbstract" xlink:label="SettlementOfShortSwingProfitClaimAbstract" xlink:title="SettlementOfShortSwingProfitClaimAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20211231.xsd#usph_ShortSwingProfitSettlement" xlink:label="ShortSwingProfitSettlement" xlink:title="ShortSwingProfitSettlement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SettlementOfShortSwingProfitClaimAbstract" xlink:to="ShortSwingProfitSettlement" xlink:title="presentation: SettlementOfShortSwingProfitClaimAbstract to ShortSwingProfitSettlement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="SettlementOfShortSwingProfitClaimAbstract" xlink:title="presentation: RelatedPartyTransactionsAbstract to SettlementOfShortSwingProfitClaimAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="ValuationAndQualifyingAccountsAbstract" xlink:title="ValuationAndQualifyingAccountsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="ValuationAndQualifyingAccountsDisclosureTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="ValuationAllowancesAndReservesTypeAxis" xlink:title="ValuationAllowancesAndReservesTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="AllowanceForCreditLossMember" xlink:title="AllowanceForCreditLossMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAllowancesAndReservesDomain" xlink:to="AllowanceForCreditLossMember" xlink:title="presentation: ValuationAllowancesAndReservesDomain to AllowanceForCreditLossMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="ValuationAllowancesAndReservesDomain" xlink:title="presentation: ValuationAllowancesAndReservesTypeAxis to ValuationAllowancesAndReservesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsDisclosureTable" xlink:to="ValuationAllowancesAndReservesTypeAxis" xlink:title="presentation: ValuationAndQualifyingAccountsDisclosureTable to ValuationAllowancesAndReservesTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:title="ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="MovementInValuationAllowancesAndReservesRollForward" xlink:title="MovementInValuationAllowancesAndReservesRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="ValuationAllowancesAndReservesBalance" xlink:title="ValuationAllowancesAndReservesBalance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesBalance" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesBalance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="ValuationAllowancesAndReservesChargedToCostAndExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesChargedToCostAndExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="ValuationAllowancesAndReservesChargedToOtherAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesChargedToOtherAccounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="ValuationAllowancesAndReservesDeductions" xlink:title="ValuationAllowancesAndReservesDeductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesDeductions" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesDeductions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="ValuationAllowancesAndReservesBalance_2" xlink:title="ValuationAllowancesAndReservesBalance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesBalance_2" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesBalance" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="MovementInValuationAllowancesAndReservesRollForward" xlink:title="presentation: ValuationAndQualifyingAccountsDisclosureLineItems to MovementInValuationAllowancesAndReservesRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsDisclosureTable" xlink:to="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:title="presentation: ValuationAndQualifyingAccountsDisclosureTable to ValuationAndQualifyingAccountsDisclosureLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsAbstract" xlink:to="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="presentation: ValuationAndQualifyingAccountsAbstract to ValuationAndQualifyingAccountsDisclosureTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +H _ # 2(  A$! Q$!_\0
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M ,31X$_Y)YX9_P"P5:_^BEKH* .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
MT*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@
MNA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH*
M* .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$
M$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J
M:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_
M (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/
M!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA
M_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^
M)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?
M_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_
M /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X
M+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC
M_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
MT*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@
MNA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH*
M* .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$
M$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J
M:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_
M (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/
M!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA
M_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^
M)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?
M_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_
M /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X
M+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC
M_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
MT*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@
MNA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH*
M* .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$
M$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J
M:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_
M (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/
M!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA
M_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^
M)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?
M_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_
M /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X
M+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC
M_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
MT*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@
MNA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH*
M* .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$
M$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J
M:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_
M (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/
M!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA
M_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^
M)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?
M_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_
M /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X
M+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC
M_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/^._\ DGGB;_L%77_H
MIJZ"N?\ '?\ R3SQ-_V"KK_T4U !X$_Y)YX9_P"P5:_^BEKH*Y_P)_R3SPS_
M -@JU_\ 12UT% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <_X
M>_Y#GBS_ +"J?^D5K705S_A[_D.>+/\ L*I_Z16M=!0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<_X[_Y)YXF_P"P5=?^BFKH*Y_QW_R3SQ-_V"KK
M_P!%-0 >!/\ DGGAG_L%6O\ Z*6N@KG_  )_R3SPS_V"K7_T4M=!0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% '/\ A[_D.>+/^PJG_I%:UT%<
M_P"'O^0YXL_["J?^D5K704 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7/^._\ DGGB;_L%77_HIJZ"N?\ '?\ R3SQ-_V"KK_T4U !X$_Y)YX9_P"P
M5:_^BEKH*Y_P)_R3SPS_ -@JU_\ 12UT% !1110 4444 %%%% !1110 45YI
M;#XC^*DNM5M-8C\-6ZS.EGIMSI@=Y44X#2L_S)NQV'2EA^)5Z?A2WB*2QB.M
M"8V"VR$['N=^P8[X_BQGU&>] 'I5%>77M]XZ\#'3]8U_7[/6-+GN8X+^W2S2
M V@<X#1N.6 ) ^;\NXW/&>NZT-:TCPOX;FAMM2U(232WLL?F"U@0<L%/!))P
M,\?GD ':T5P&@ZMXDT/QM'X6\3ZE!JJ7ULUQ8:@ENL#LR'YXV1>. <C'Z]N_
MH **** .?\/?\ASQ9_V%4_\ 2*UKH*Y_P]_R'/%G_853_P!(K6N@H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***YOQ-XVTGPS$RSR^?>;<K:Q'+>V[^Z/<_AFIE.,%>3-J&'JX
MB:ITHW;[&1XH^(,>@>+M/TM=C6XP;YB,E WW<>F!\Q]B*[H$$ @Y!Z$5\K:A
M?3ZGJ-Q?7+;IIY#(Y]SZ>U>Y_##Q%_;7AE;29\W=AB)LGED_@/Y#'X5Q8;%.
MI4<7UV/I\[R*.#P=.K3WCI+Y]?OT^X[>BBBN\^2"BBB@ KG_ !W_ ,D\\3?]
M@JZ_]%-705S_ ([_ .2>>)O^P5=?^BFH / G_)//#/\ V"K7_P!%+705S_@3
M_DGGAG_L%6O_ **6N@H **** "BBB@ HHHH ***1@64@,5)&,CJ* .(\0>)M
M0U;5)_"OA$!]14!;_4F&8=.4]_\ ;DQT4=^O0U@>.O#MGX2^'7AZTM"WV#2=
M7M9[AY.2Z[SN=OJS9J_9_!RRT])$L?&/C"U260RR+!J:QAG/5B @R3ZUT]EX
M/LH?#%SH&H7NHZS:7.[S7U2X\Z4@XXW8& ,9&.AH P/C*RO\.+BU5\3WEU;P
M0 'EG,JD >^ 3^%,OU^R?'70YIVPEWHLUM#N[R(^]@/?;_*K6C_"O1=*U2TO
MI=0UG4OL)S90:A>&6*U/;8N!C';.>@[UM^*?".F>+K.&#4//BEMY/-MKJUD\
MN:!_[R-V_'(X'I0!SGB0_:?C-X,@A?,EM;7EQ,H/1&0*"?8M_*O0:YGPQX&T
MSPO=W-]%<W^H:C<J$EOM1N/.F9!T7=@8'T'8>E=-0 5D7]OXBDNV;3]5TNWM
MB!MCN--DF<<<Y99T!Y_V:UZ* .#T*U\5'6/$XBUG1E<:F@E+:3*P9OLEORH^
MTC:-NT8)/()SS@;GV/QA_P!!W0__  33?_)5'A[_ )#GBS_L*I_Z16M=!0!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/
MQA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!-
M-_\ )5=!10!S_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S
M_P!C\8?]!W0__!--_P#)5'V/QA_T'=#_ /!--_\ )5=!10!S_P!C\8?]!W0_
M_!--_P#)5'V/QA_T'=#_ /!--_\ )5=!2,P52S$!0,DD\"@# ^Q^,/\ H.Z'
M_P"":;_Y*JGJ=UXAT:S:[U#Q-X?MX5_B?1YN3Z ?:LD^PIMWXOFU&Y?3_"EH
M-1N%.V2[<XMH3[M_$?85-IG@Z);Q=3UVY;5M3'*O,/W4/M&G0?7^59>T<M(:
M^?0[U@XTES8I\O\ =7Q/_)>;^29A6%QXZ\503(MY::;IS_ZN_6P>&9Q_LQM*
M_'OD>QIT7PXOH]+DL'O]#F25@TTLFE3^;*P.<LXN@>O;I[5Z'10J2WEJQ3Q]
M1+EH>Y%=%OZM[M_ET2//]-^%FF13.=4ATZZB*X5;6&Y@8-ZDM</D>V!]:Z;1
M?">B>'IY)]+LOL\DJ[';S7?(SG'S$UM44U2IIW45]Q%3'XNI%PJ59-/HY-K\
MPHHHK0Y HHHH *Y_QW_R3SQ-_P!@JZ_]%-705S_CO_DGGB;_ +!5U_Z*:@ \
M"?\ )//#/_8*M?\ T4M=!7/^!/\ DGGAG_L%6O\ Z*6N@H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#G_  ]_R'/%G_853_TBM:Z"N?\ #W_(
M<\6?]A5/_2*UKH* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVM@ZQ[V!.68X   ))R>PJ#Q#XETCPKIHU'6KO[+:&01^9Y;O\QS@84$]CVH
MUJ*X ?&SX>$X'B'_ ,DKC_XW73>(O%6B^%-.CU#6[T6MK)((D?RG?+$$@84$
M] >U &S17+^'/B+X5\6ZB]AH>J_:[I(C*R?9Y4P@(!.64#J1744 %%%% '/^
M'O\ D.>+/^PJG_I%:UT%<_X>_P"0YXL_["J?^D5K704 %%%% !1110 4444
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M_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\
MSZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\
MXS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?
M_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;
MW_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <
M_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\
MSZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\
MXS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?
M_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;
MW_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <
M_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\
MSZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\
MXS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?
M_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;
MW_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <
M_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\
MSZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\
MXS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?
M_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;
MW_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <
M_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\
MSZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\
MXS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?
M_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;
MW_XS7044 <__ ,)EI?\ SZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <
M_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;W_XS7044 <__ ,)EI?\
MSZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS7044 <_P#\)EI?_/KKG_@AO?\
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MT5^LK?DR@?'D%X=FA:3J.K,>!)%"8XOQ=NGY4;?'.J_>?3=$A/\ ='VB9?\
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M_(<\6?\ 853_ -(K6N@K@]"T+47UCQ.J^+-9C,>IHK,L5GF0_9+<[FS 1G!
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M/^ASUS_OS9?_ "/0!T%%<_\ \(]JG_0YZY_WYLO_ )'H_P"$>U3_ *'/7/\
MOS9?_(] '045S_\ PCVJ?]#GKG_?FR_^1Z/^$>U3_H<]<_[\V7_R/0!T%%<_
M_P (]JG_ $.>N?\ ?FR_^1Z/^$>U3_H<]<_[\V7_ ,CT =!17/\ _"/:I_T.
M>N?]^;+_ .1Z/^$>U3_H<]<_[\V7_P CT =!17/_ /"/:I_T.>N?]^;+_P"1
MZ/\ A'M4_P"ASUS_ +\V7_R/0!T%%<__ ,(]JG_0YZY_WYLO_D>C_A'M4_Z'
M/7/^_-E_\CT =!17/_\ "/:I_P!#GKG_ 'YLO_D>C_A'M4_Z'/7/^_-E_P#(
M] '045S_ /PCVJ?]#GKG_?FR_P#D>C_A'M4_Z'/7/^_-E_\ (] '045S_P#P
MCVJ?]#GKG_?FR_\ D>C_ (1[5/\ H<]<_P"_-E_\CT =!17/_P#"/:I_T.>N
M?]^;+_Y'H_X1[5/^ASUS_OS9?_(] '045S__  CVJ?\ 0YZY_P!^;+_Y'H_X
M1[5/^ASUS_OS9?\ R/0!T%%<_P#\(]JG_0YZY_WYLO\ Y'H_X1[5/^ASUS_O
MS9?_ "/0!T%%<E;6S7>I76G6_P 0-5EO;4 SP(EB7CSTR/L]7?\ A'M4_P"A
MSUS_ +\V7_R/3::W Z"BN:N-'O+2!I[GQSK$,2_>DD2Q51]2;>N/OO&FDVTY
MMK+QYXCU>[[6^EV=G.S?0BWVG\ZJ%*<_A5Q72/5:*\A7_A:>M,ITF?4=*MR>
M)]::S)(_ZY1V^X'ZUM'X=Z]K-ML\3>/-6N-RX,6G*EHGT. =WX@5K[!1^.27
MX_E_F%^QU.L^+_#OAX'^U=9L[9Q_RS:0&3_O@98_E7-_\++GU4[?"OA75]7S
M]VXD06UN?^!O_@*CTCX/Z1H3B33]6U&.4'(EDM[*5P?9GMR1^=='_P (]JG_
M $.>N?\ ?FR_^1Z7-1CLF_73\%_F&I@?V=\2=</^FZQIGAZW;_EG80FXFQZ%
MGX!]UJ6W^%'A]IUN=;FU'7KH<^9J5TS@'V48&/8YK:_X1[5/^ASUS_OS9?\
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MUUI2M!?W5;\=_O9KV>GV6G1>596D%M'_ '88PH_2K-<__P (]JG_ $.>N?\
M?FR_^1Z/^$>U3_H<]<_[\V7_ ,CUJE;8XI2<G>3NSH**Y_\ X1[5/^ASUS_O
MS9?_ "/1_P (]JG_ $.>N?\ ?FR_^1Z!'045S_\ PCVJ?]#GKG_?FR_^1Z/^
M$>U3_H<]<_[\V7_R/0!T%%<__P (]JG_ $.>N?\ ?FR_^1Z/^$>U3_H<]<_[
M\V7_ ,CT =!17/\ _"/:I_T.>N?]^;+_ .1Z/^$>U3_H<]<_[\V7_P CT =!
M17/_ /"/:I_T.>N?]^;+_P"1Z/\ A'M4_P"ASUS_ +\V7_R/0!T%%<__ ,(]
MJG_0YZY_WYLO_D>C_A'M4_Z'/7/^_-E_\CT =!17/_\ "/:I_P!#GKG_ 'YL
MO_D>C_A'M4_Z'/7/^_-E_P#(] '045S_ /PCVJ?]#GKG_?FR_P#D>C_A'M4_
MZ'/7/^_-E_\ (] '045S_P#PCVJ?]#GKG_?FR_\ D>C_ (1[5/\ H<]<_P"_
M-E_\CT =!17/_P#"/:I_T.>N?]^;+_Y'H_X1[5/^ASUS_OS9?_(] '045S__
M  CVJ?\ 0YZY_P!^;+_Y'H_X1[5/^ASUS_OS9?\ R/0!T%%<_P#\(]JG_0YZ
MY_WYLO\ Y'H_X1[5/^ASUS_OS9?_ "/0!!XE\":3XCF2^_>V&KQ<PZE9MY<R
M'MDC[P]C^&*P5\4^)/!+"#QE:G4-+!PNN6,1.T>LT8Y7ZCCZUTO_  CVJ?\
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MUN-!^PZ-!;6T_FJYEE)RP&<@M@GO6C_PCVJ?]#GKG_?FR_\ D>C_ (1[5/\
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MQ%XFTKPMIIOM6NA#&3MC0<O*W]U%ZD_Y-<3-X=UOXFA9O$Z2Z/X?5M]OI<9
MN)3@X>5L?+U^Z/Q]3U8:,8R52JO=7X^G?^KDOLCYOT?Q!JFA:Y'K%A=R)?(Y
M<R,<[\]0W]X'OFOH?PWJ'C[XB:.FIC5K+P]ITC%5%M9M)-(!U(,AP 3T(-<W
MX?\ @%+!XNF;6KA)]$MV#0[#A[KT5A_"!W]>WJ/=XHHX(4AAC6.*-0J(@P%
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M5IZ+XRTG7IYH;4S(T4?F,9E"C;D#.<^XKPFNM^'VD66LZY/#?1&6&. R!-Q
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MKKG_ ((;W_XS0!T%%<__ ,)EI?\ SZZY_P""&]_^,T?\)EI?_/KKG_@AO?\
MXS0!T%%<_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/KKG_ ((;W_XS0!T%%<__
M ,)EI?\ SZZY_P""&]_^,T?\)EI?_/KKG_@AO?\ XS0!T%%<_P#\)EI?_/KK
MG_@AO?\ XS1_PF6E_P#/KKG_ ((;W_XS0!T%%<__ ,)EI?\ SZZY_P""&]_^
M,T?\)EI?_/KKG_@AO?\ XS0!T%%<_P#\)EI?_/KKG_@AO?\ XS1_PF6E_P#/
MKKG_ ((;W_XS0!T%%<__ ,)EI?\ SZZY_P""&]_^,T?\)EI?_/KKG_@AO?\
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MELO9%,7S-_M'T]LUO&DDN>IHOQ?]=Q7[&CY?B'XEG,PN=!\*-TC^[=WZ^_\
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MUT'A&[N;/4YGMKNYMF:$J7M].DO6QD?P1J2/J>.W>OH,9E.$IT)2BK-=;O\
MX)]1C\DP-+#3G!<K2W;>GY_D>[45YU_:,TO_ !\^(/%#>OD^&KJ+^4-&=(?_
M (^-2\;S^H;3;X+^0AKYKV-%;U/N3_6Q\C["@MZJ^2?ZI'HI( R> *J2ZGI\
M'^NOK:/']^91_,UPPMO!C',^F>(KAASF;2M1/_M.K44G@N'&SP]J1Q_?\/7K
M_P XC1RX9?:;^2_S#DPB^W)_]NI?^W/\CH9?%GA^'[VKVAQ_<D#?RS50^._#
MV[;%>23L/X8K>1OZ57BUSPS;X\G1=2CQTV>&[L?RAJV/&&E* %M-< '0#0;W
M_P",T<V&7V9/YI?HPYL(OLR?_;R7_MK(_P#A,H9/^/?1M:N/0QV9Q^9(H_X2
M/5Y?^/;PK?-Z>=*D7\ZE_P"$RTO_ )]=<_\ !#>__&:/^$RTO_GUUS_P0WO_
M ,9H]K16U/[V_P!+![>@MJ7WM_I8B_M'Q9-]S0+2WS_SVO ^/^^11M\:2]9-
M$MU/]U9'8?GQ4O\ PF6E_P#/KKG_ ((;W_XS1_PF6E_\^NN?^"&]_P#C-'UA
M+X817WO\VP^MI?#3BODW^;9%_97BF7_6>)8H1W$-BI_5C1_PC&H2_P#'SXHU
M1O7R2L7\A4O_  F6E_\ /KKG_@AO?_C-'_"9:7_SZZY_X(;W_P",T?6ZG2R_
M[=7^0?7JO2R](Q_R(O\ A"K)_P#CYU'5KGU\Z\8Y_+%/3P+X<1MQTX2-W:25
MVS^9IW_"9:7_ ,^NN?\ @AO?_C-'_"9:7_SZZY_X(;W_ .,T?7,1_._OL)X_
M%=*C7H[?D6XO#&A08V:199'0M"K']15Z*RM+?'DVL,>.FR,#^58W_"9:7_SZ
MZY_X(;W_ .,T?\)EI?\ SZZY_P""&]_^,UE*K4E\4FS&=:K/XI-_,Z"N+^(6
M@:EKMM8+IUN)FB=RXWJN 0,?>(]*U/\ A,M+_P"?77/_  0WO_QFC_A,M+_Y
M]=<_\$-[_P#&:K#UY8>JJL-T7A,3/"UHUH;KO]QY=_PK_P 4?] S_P F(O\
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ME_X_GU"_]?M5X[9_(C_(KK**GV,.JO\ B']I8I?#/E_PI1_)(P;;P5X9M?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *Y_QW_P D\\3?]@JZ_P#135T%<_X[_P"2>>)O^P5=?^BFH /
MG_)//#/_ &"K7_T4M=!7/^!/^2>>&?\ L%6O_HI:Z"@ HHHH **** "BBB@
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M_44U@JV\E9=^G_!,ZF$KTUS2@[=^GW[&SKWCIUU-_#_A6T&KZZ.) #^XM/\
M:E<=,?W1SVXJ7PWX%33]0.N:[=MK'B&0<W<H^2 ?W84Z(/?KUZ9Q6YH'AW2_
M#.F)I^DVB00CEB.6D;^\S=2?<UJ5G*JHKEIZ+OU?]=OS.:W<****P&%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%0W-W;64)FNIXX(AU
M>1@H_6N?;Q<+UC%H.FW.I../- \N$'W=JUIT*E17BM._3[]C>EAJM57@M.^R
M^]Z'35E:GXCTG2#LN[Q!*>D*?/(?^ CFLW^QM>U;G5]7^RPGK:Z<-O'H9#S]
M:U-,\/Z5HX_T*SCCD[RD;G/U8\UK[.C3^.7,^R_S?Z)FOLL/3_B2YGVCM][_
M $3]3+_M7Q#JW&EZ4MA >ESJ!PV/:,<_GQ3D\'Q74BS:Y?W.J2@Y"2-LB4^R
M+Q72T4OK4HZ4DH^F_P!^_P!P?7)1THI0]-_O>OW61%;VT%I"L-M#'#$O1(U"
M@?@*EHHKG;;=V<C;;NPHHHI""BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N?\=_\ )//$W_8*NO\ T4U=!7/^
M._\ DGGB;_L%77_HIJ #P)_R3SPS_P!@JU_]%+705S_@3_DGGAG_ +!5K_Z*
M6N@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G_#W_(<\6?\
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M@ # %+16-2M4J/WW<PJUZM9WJ2O_ %T[!11169D%%%% !1110 4444 %%%%
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MS7 A;^":46\6/0QI\Q_$UM:7\.?L@'F:C]G'=;"(1-CT\PY8CZUI2?$GP7$
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M "O!OBE)Y?C&[0,<R+&3D]!L'^?SKWFN2U[X=:+XAU634KR2[6>155A%( O
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MK7/_  ?7O_QZN@HH Y__ (0W2_\ GZUS_P 'U[_\>H_X0W2_^?K7/_!]>_\
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M<\6?]A5/_2*UKH*Y_P /?\ASQ9_V%4_](K6N@H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N?\=_\ )//$W_8*NO\ T4U=!7/^._\ DGGB;_L%77_H
MIJ #P)_R3SPS_P!@JU_]%+705S_@3_DGGAG_ +!5K_Z*6N@H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#G_#W_(<\6?\ 853_ -(K6N@KG_#W
M_(<\6?\ 853_ -(K6N@H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\M$QR2P(YR?3IWH ["BN?\,ZOXBU0W/]O>%_[#\O;Y/_ !,([GS<YS]P#;C
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M,V$A6Z8[RQ 8KA!G'()/&.];7P_\-W/A3P=::5?20RWJO))<2PL65W=RV<D
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M*3E5%O#%@^^8F/T(K3H Y_\ X2'5/^A,US_O]9?_ "11_P )#JG_ $)FN?\
M?ZR_^2*Z"B@#G_\ A(=4_P"A,US_ +_67_R11_PD.J?]"9KG_?ZR_P#DBN@H
MH Y__A(=4_Z$S7/^_P!9?_)%'_"0ZI_T)FN?]_K+_P"2*Z"B@#G_ /A(=4_Z
M$S7/^_UE_P#)%'_"0ZI_T)FN?]_K+_Y(KH** .?_ .$AU3_H3-<_[_67_P D
M4?\ "0ZI_P!"9KG_ '^LO_DBN@HH Y__ (2'5/\ H3-<_P"_UE_\D4?\)#JG
M_0F:Y_W^LO\ Y(KH** .?_X2'5/^A,US_O\ 67_R11_PD.J?]"9KG_?ZR_\
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M5/\ H3-<_P"_UE_\D4?\)#JG_0F:Y_W^LO\ Y(KH** .?_X2'5/^A,US_O\
M67_R11_PD.J?]"9KG_?ZR_\ DBN@HH Y_P#X2'5/^A,US_O]9?\ R11_PD.J
M?]"9KG_?ZR_^2*Z"B@#G_P#A(=4_Z$S7/^_UE_\ )%'_  D.J?\ 0F:Y_P!_
MK+_Y(KH** .7?Q?=QZC#8-X1UP74T4DT:>99_,B% QS]HQP9$_/V-6/^$AU3
M_H3-<_[_ %E_\D5=GTV67Q38:H'00VUE<V[*2=Q:1X&!'; $39^HK3H Y_\
MX2'5/^A,US_O]9?_ "11_P )#JG_ $)FN?\ ?ZR_^2*Z"B@#G_\ A(=4_P"A
M,US_ +_67_R11_PD.J?]"9KG_?ZR_P#DBN@HH Y__A(=4_Z$S7/^_P!9?_)%
M'_"0ZI_T)FN?]_K+_P"2*Z"B@#G_ /A(=4_Z$S7/^_UE_P#)%'_"0ZI_T)FN
M?]_K+_Y(KH** .?_ .$AU3_H3-<_[_67_P D4?\ "0ZI_P!"9KG_ '^LO_DB
MN@HH Y__ (2'5/\ H3-<_P"_UE_\D4?\)#JG_0F:Y_W^LO\ Y(KH** .?_X2
M'5/^A,US_O\ 67_R11_PD.J?]"9KG_?ZR_\ DBN@HH Y_P#X2'5/^A,US_O]
M9?\ R11_PD.J?]"9KG_?ZR_^2*Z"B@#G_P#A(=4_Z$S7/^_UE_\ )%'_  D.
MJ?\ 0F:Y_P!_K+_Y(KH** ,2P\1276L1Z9=Z)J.G3RV\EQ$;IH&5U1D5L&*5
M\$&5.N.M;=9D^FRR^*;#5 Z"&VLKFW923N+2/ P([8 B;/U%:= !1110 444
M4 %<_P"._P#DGGB;_L%77_HIJZ"N?\=_\D\\3?\ 8*NO_134 '@3_DGGAG_L
M%6O_ **6N@KG_ G_ "3SPS_V"K7_ -%+704 %%%% !1110 4444 %%%% !11
M10 4444 %%5=1O#I^FW%XMK<71AC+B"W3=))@?=4=R:\\\(ZSXGU#XJ:E#KZ
M?8HFTE)[?34F+K IDP"_8R<')'J![4 >FT5PVMZ%XF\4>*[BUEU34=$\-VT"
M>3+IMPD<UW,>6)89957I@@9JOX&N]6T[QCX@\)7^JSZO:Z?'#/;7=R=TR!QR
MDC?Q'N">?Y  ]!HKD);ZXO\ XF?98+B<6>C:>9KF&*0@2S3'"*R@X;"HQ&>[
M"N9M/$?BC4OBMX?&H6DVD:/=6]TUOI[R?O9 JCYYE' /(PO..?Q /5:*XCQ_
MK&JQ7.B^'-$O%L;[6)G5[TJ&-O!&NZ1@#QNQC!/OT/(S?#6E7-IXBMY?#OC]
M_$.GKE=4M-0U%;IT&/E:,J#M(/8X^M 'I-%%% !1110 4444 %%%% !1110
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M+8K9:?#Y-NKL^W<6)9F+,26)))))Y-,U+1=/U::QFOK?S9+&X%S;'>R[) "
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M K@OC%_R3R;_ *_+7_T<E=[5#6-%T_7].:PU.W\^U9U<IO9?F5@RG*D'@@4
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M$S7/^_UE_P#)% '045S_ /PD.J?]"9KG_?ZR_P#DBC_A(=4_Z$S7/^_UE_\
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M0ZI_T)FN?]_K+_Y(H_X2'5/^A,US_O\ 67_R10!T%%<__P )#JG_ $)FN?\
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M^\_Y*'HW_8*O_P#T;:5T%<_>?\E#T;_L%7__ *-M* .@HHHH **** "BBB@
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MUI:06[7$AEF,,83S'/5FP.6/J>:L4 <#\,/];XS_ .QEN_Y)4/BX _%_P!D
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M\>E:99V*2'<ZVL"Q!CZD*!FN/UK2O$'BWQ?I]EJ&CPV7AS2KT7HNC=+(]ZZ
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M\2/#&@_#'31>7R+?6%NMM-IJ$?:C*ORE1&2"23WZ>]>F16%G!>SWL-I!'=7
M433I& \H487<V,G Z9Z56.@:,=4&J'2+ Z@#D79MD\W_ +[QG]: )&U6SA2R
M^V3QV<UYA88+F14D9R,[ ,\L/09J[5:YT^RO9K>:ZL[>>6V?S('EB5C$W]Y2
M1\I]Q5F@ HHHH **** "BBB@ HHHH **** "BBB@ KG[/_DH>L_]@JP_]&W=
M=!7/V?\ R4/6?^P58?\ HV[H Z"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "N?\=_\D\\3?\ 8*NO_135T%<_X[_Y)YXF_P"P5=?^BFH
M/ G_ "3SPS_V"K7_ -%+705S_@3_ ))YX9_[!5K_ .BEKH* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N?O/^2AZ-_V"K__ -&VE=!7/WG_ "4/1O\ L%7_ /Z-M* .@HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "N?L_^2AZS_V"K#_T;=UT%<_9_P#)0]9_[!5A_P"C;N@#H**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y_QW_R3SQ-_P!@JZ_]%-70
M5S_CO_DGGB;_ +!5U_Z*:@ \"?\ )//#/_8*M?\ T4M=!7/^!/\ DGGAG_L%
M6O\ Z*6N@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *Y^\_Y*'HW_8*O_\ T;:5T%<_>?\
M)0]&_P"P5?\ _HVTH Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *Y^S_Y*'K/_8*L/_1MW705S]G_ ,E#UG_L
M%6'_ *-NZ .@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKG_'?_)//$W_ &"KK_T4U=!7/^._^2>>)O\ L%77_HIJ #P)_P D\\,_]@JU
M_P#12UT%<_X$_P"2>>&?^P5:_P#HI:Z"@ HHHH **** "BBB@ HHHH ****
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MAZS_ -@JP_\ 1MW705S]G_R4/6?^P58?^C;N@#H**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *Y_QW_P D\\3?]@JZ_P#135T%<_X[_P"2
M>>)O^P5=?^BFH / G_)//#/_ &"K7_T4M=!7/^!/^2>>&?\ L%6O_HI:Z"@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KG[S_DH>C?\ 8*O_ /T;:5T%<_>?\E#T;_L%7_\
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M1BW += 3Z4 8:ZMXX\0_$+Q1X>TG6(=.T^PDA*WLEHDS0 H#L12 &+'))8G
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M_L%6'_HV[H Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N?\=_\ )//$W_8*NO\ T4U=!7/^._\ DGGB;_L%77_HIJ #P)_R3SPS_P!@
MJU_]%+705S_@3_DGGAG_ +!5K_Z*6N@H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y^\_Y*
M'HW_ &"K_P#]&VE=!7/WG_)0]&_[!5__ .C;2@#H**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\_Y*'HW_ &"K_P#]&VE=!7/WG_)0]&_[!5__ .C;2@#H**** "BBB@ HHHH
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MB@ KG[/_ )*'K/\ V"K#_P!&W==!7/V?_)0]9_[!5A_Z-NZ .@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_'?_ "3SQ-_V"KK_ -%-
M705S_CO_ ))YXF_[!5U_Z*:@ \"?\D\\,_\ 8*M?_12UT%<_X$_Y)YX9_P"P
M5:_^BEKH* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "N?O/^2AZ-_P!@J_\ _1MI705S]Y_R
M4/1O^P5?_P#HVTH Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MXGX@^%=:\5QV=MI]S:16L)+R).[*6?H#PIZ#/YUQ$/PA\2V\\<T5_IB21L'1
MA+)E2#D'[E>VT5S5,+3J2YI;GM83/L7A:*H4K<J\NY' )1;Q"<H9@@\PI]TM
MCG'MFI***Z3QF[NYQOQ T+4M;;PT=.MO.^Q:W;W=Q\ZKLB7.YOF(SC/09-3^
M/O"3>*]!"V<GV?6+)Q<Z=<@X,<J\@9]#T/X'M75T4".,^%>AZGX=^']CINL6
M_P!GOHY)6DCWJ^-TC$<J2.A]:77-#U&\^)WA;6(+;?86,-TMS+O4;"Z@+P3D
MY/H#7944 9'BC0+?Q3X:O]%N7:..[CV>8HR48'*MCO@@'\*XZRU3XFZ'9Q:9
M<>$[+7'A41IJ-OJ:0*X P"R.-V>YQCVKTBB@#SO3O!NM6WA/QA-J$D%QKWB"
M.9VAMCMBC)C*QQJ6QG&>IQ^F33T'6?B'HGA[3=*_X5MYWV*VCM_-_MVW7?L4
M+G&#C..F37J%% &%X9U77]4BN&U[PW_8CQLHB3[='<^:#G)R@&W''7UK,^*&
MB:CXB^'^H:7I5O\ :+R9HBD>]4SB12>6('0'O7844 -C!$:@]0 #7#>$_"M[
M!;^-+/5[8PV^L:I<R1$.K%X9%P&X)QWX//M7=T4 >6Z2/B5X5T:/PU:>'K#5
M([9?)L]6-\L2)'_"9(C\Q('7'Z]3+XN\)>)K_2O#$\R6?B>[TJ5I;^RN=D$=
MZS#&1P$&WG&1[G/(/IM% 'DDWAWQ=JOB/PMJTGAO3](T_3;X%M-M9XW>-6&&
ME=QM4@8&%4$\FNHFT+4G^,-OKPMO^)8NBM:M/O7B4REMNW.[IWQBNSHH \GT
M+P[XJT_P+XF\(W.B)M:&Z-E?1WD96Z:0G"[#@IUZMC\*ZF+1-07X0KH1M\:D
M-#^R>3O7_6^3MV[L[>O&<XKKZ* /,;GP;KR>#?!MSI\4*>(?#L:,+6>0;)04
M"R1[AD G'!SC^=;F@3^.-6U\7NM6,&@Z3#"4&G+/'<R3RGH[.H^50.P(YZYK
MLJ* /'/#OAKQ?X::YTZ'P=HE[>R7$DB^))[E/FWL2&=,&0D9Z# _4F-/ ?B6
M+X.ZAX;-CYNI?VKYL>)8U$T?G*WF#YL+D G!.:]GHH Y?QWX8N/%/AM;6RN4
MMM1M9X[NSED&566,Y&?8\C\>_2L-+_XG:RUMI[Z)9>'@LBFZU07<=SO0'YA%
M%@X+?[6<#WKT2B@ KC1H6I?\+C.O?9O^)9_8GV3S]Z_ZWS0VW;G=TYSC%=E1
M0!QOAO0M2L/B+XPU6YMO+LM1^R?99=ZGS-D9#< Y&">X%94_@:\UCQ1X\6_A
M,.FZW:6T-M<!U;+)'@G:#D;6QU S7H]% 'EK?\+.G\.2>&)-"L$D%JULVMB^
M5DD4+C*PX#;R/7 SR<"E;P1KZ^"/!\U@(+?Q)X>0,MO<,&CDRNUXRRD]1W!_
MQ'J-% '"Z?>?$+7-9L?MNDV_AK3;=]]U_I4=W)=CLBX&$7U/7T-96H> ;_QO
M>:[J?B&-[&X*_9=$C\Q7-HBD,)LH2-S, 3SD#BO3Z* ,3PE/K<_AJS/B*R^R
M:LB^7.@D5PY'&\%21\PYQVR:VZ** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *Y^S_P"2AZS_ -@JP_\ 1MW705S]G_R4/6?^P58?^C;N@#H*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y_QW_P D\\3?
M]@JZ_P#135T%<_X[_P"2>>)O^P5=?^BFH / G_)//#/_ &"K7_T4M=!7/^!/
M^2>>&?\ L%6O_HI:Z"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG[S_DH>C?\ 8*O_ /T;
M:5T%<_>?\E#T;_L%7_\ Z-M* .@HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "N?L_\ DH>L_P#8*L/_ $;=UT%<
M_9_\E#UG_L%6'_HV[H Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N?\=_\ )//$W_8*NO\ T4U=!7/^._\ DGGB;_L%77_HIJ #P)_R
M3SPS_P!@JU_]%+705S_@3_DGGAG_ +!5K_Z*6N@H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *R]5\/Z?K-Q;W%W]J6>W1TBEM;R:W8*Y4L,Q,I()13@^@K4HH Y_P#X0W2_
M^?K7/_!]>_\ QZC_ (0W2_\ GZUS_P 'U[_\>KH** .?_P"$-TO_ )^M<_\
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MK7/_  ?7O_QZN@HH Y__ (0W2_\ GZUS_P 'U[_\>H_X0W2_^?K7/_!]>_\
MQZN@HH Y_P#X0W2_^?K7/_!]>_\ QZC_ (0W2_\ GZUS_P 'U[_\>KH** .?
M_P"$-TO_ )^M<_\ !]>__'J/^$-TO_GZUS_P?7O_ ,>KH** .?\ ^$-TO_GZ
MUS_P?7O_ ,>H_P"$-TO_ )^M<_\ !]>__'JZ"B@#G_\ A#=+_P"?K7/_  ?7
MO_QZC_A#=+_Y^M<_\'U[_P#'JZ"B@#G_ /A#=+_Y^M<_\'U[_P#'J/\ A#=+
M_P"?K7/_  ?7O_QZN@HH Y__ (0W2_\ GZUS_P 'U[_\>H_X0W2_^?K7/_!]
M>_\ QZN@HH Y_P#X0W2_^?K7/_!]>_\ QZC_ (0W2_\ GZUS_P 'U[_\>KH*
M* .?_P"$-TO_ )^M<_\ !]>__'J/^$-TO_GZUS_P?7O_ ,>KH** .?\ ^$-T
MO_GZUS_P?7O_ ,>H_P"$-TO_ )^M<_\ !]>__'JZ"B@#G_\ A#=+_P"?K7/_
M  ?7O_QZC_A#=+_Y^M<_\'U[_P#'JZ"B@#G_ /A#=+_Y^M<_\'U[_P#'J/\
MA#=+_P"?K7/_  ?7O_QZN@HH Y__ (0W2_\ GZUS_P 'U[_\>JYI7A_3]&N+
MBXM/M33W"(DLMU>37#%4+%1F5F( +L<#U-:E% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7/^._^2>>)O\ L%77_HIJZ"N?\=_\D\\3
M?]@JZ_\ 134 '@3_ ))YX9_[!5K_ .BEKH*Y_P "?\D\\,_]@JU_]%+704 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\
MX,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@
M_P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T
M->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\
MBJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\
MT->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?
M_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$
M[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_
M^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^
M$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A
M_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ*
M* #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_
M /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'
M_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'
M_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@
MQA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_
M (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0U
MZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*
MH_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0
MUZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^
M*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3O
MP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X
M,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3
MOP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_
M .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH
M /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\
M]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_
M (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_
M -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&
M'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\
MA._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H
M?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC
M_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7
MH?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJ
MBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!
M_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@Q
MA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._
M!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\
MX,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@
M_P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T
M->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\
MBJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\
MT->A_P#@QA_^*HHH /\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?
M_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJBB@ _P"$
M[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*HHH /\ A._!_P#T->A_
M^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJ** #_ (3OP?\ ]#7H?_@QA_\ BJQ/
G&?C/PM=^!?$%M;>)=&FGFTVYCCBCOXF9V,3 * &R23Q@444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663011634296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 01, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">U S PHYSICAL THERAPY INC /NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0364866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1300 WEST SAM HOUSTON PARKWAY SOUTH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">SUITE 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">HOUSTON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">297-7000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">USPH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,950,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">GRANT THORNTON LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Houston, Texas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663008265256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 28,567<span></span>
</td>
<td class="nump">$ 32,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Patient accounts receivable, less allowance for credit losses of $2,768 and $2,008, respectively</a></td>
<td class="nump">46,272<span></span>
</td>
<td class="nump">41,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts receivable - other</a></td>
<td class="nump">16,144<span></span>
</td>
<td class="nump">9,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">4,183<span></span>
</td>
<td class="nump">3,773<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">95,166<span></span>
</td>
<td class="nump">87,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Fixed assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and equipment</a></td>
<td class="nump">58,743<span></span>
</td>
<td class="nump">55,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">39,194<span></span>
</td>
<td class="nump">35,320<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Fixed assets, gross</a></td>
<td class="nump">97,937<span></span>
</td>
<td class="nump">90,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">74,958<span></span>
</td>
<td class="nump">69,081<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">22,979<span></span>
</td>
<td class="nump">21,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">96,427<span></span>
</td>
<td class="nump">81,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in unconsolidated affiliate</a></td>
<td class="nump">12,215<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">434,679<span></span>
</td>
<td class="nump">345,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other identifiable intangible assets, net</a></td>
<td class="nump">86,382<span></span>
</td>
<td class="nump">56,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,578<span></span>
</td>
<td class="nump">1,539<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">749,426<span></span>
</td>
<td class="nump">594,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">3,268<span></span>
</td>
<td class="nump">1,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AccountsPayableDueToSellerOfAcquiredBusiness', window );">Accounts payable - due to seller of acquired business</a></td>
<td class="nump">3,203<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">45,705<span></span>
</td>
<td class="nump">59,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">30,475<span></span>
</td>
<td class="nump">27,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">830<span></span>
</td>
<td class="nump">4,899<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">83,481<span></span>
</td>
<td class="nump">93,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">3,587<span></span>
</td>
<td class="nump">596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Revolving line of credit</a></td>
<td class="nump">114,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred taxes</a></td>
<td class="nump">14,385<span></span>
</td>
<td class="nump">7,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">74,185<span></span>
</td>
<td class="nump">61,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">7,345<span></span>
</td>
<td class="nump">4,539<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">296,983<span></span>
</td>
<td class="nump">184,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable non-controlling interest - temporary equity</a></td>
<td class="nump">155,262<span></span>
</td>
<td class="nump">132,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value, 20,000,000 shares authorized, 15,126,160 and 15,066,282 shares issued, respectively</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">102,688<span></span>
</td>
<td class="nump">95,622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">224,395<span></span>
</td>
<td class="nump">212,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost, 2,214,737 shares</a></td>
<td class="num">(31,628)<span></span>
</td>
<td class="num">(31,628)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total USPH shareholders' equity</a></td>
<td class="nump">295,606<span></span>
</td>
<td class="nump">276,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest - permanent equity</a></td>
<td class="nump">1,575<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total USPH shareholders' equity and non-controlling interest - permanent equity</a></td>
<td class="nump">297,181<span></span>
</td>
<td class="nump">277,630<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity</a></td>
<td class="nump">$ 749,426<span></span>
</td>
<td class="nump">$ 594,361<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AccountsPayableDueToSellerOfAcquiredBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred related to accounts payable due to seller of acquired business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AccountsPayableDueToSellerOfAcquiredBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663008227912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses, patient accounts receivable</a></td>
<td class="nump">$ 2,768<span></span>
</td>
<td class="nump">$ 2,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>U. S. Physical Therapy, Inc. shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">15,126,160<span></span>
</td>
<td class="nump">15,066,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">2,214,737<span></span>
</td>
<td class="nump">2,214,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663011745016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 495,022<span></span>
</td>
<td class="nump">$ 422,969<span></span>
</td>
<td class="nump">$ 481,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and related costs</a></td>
<td class="nump">278,469<span></span>
</td>
<td class="nump">235,629<span></span>
</td>
<td class="nump">274,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RentSuppliesContractLaborAndOther', window );">Rent, supplies, contract labor and other</a></td>
<td class="nump">94,036<span></span>
</td>
<td class="nump">84,336<span></span>
</td>
<td class="nump">90,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">5,305<span></span>
</td>
<td class="nump">4,623<span></span>
</td>
<td class="nump">4,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Closure costs - lease and other</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">2,072<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Closure costs - derecognition of goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating cost</a></td>
<td class="nump">377,840<span></span>
</td>
<td class="nump">328,519<span></span>
</td>
<td class="nump">369,495<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">117,182<span></span>
</td>
<td class="nump">94,450<span></span>
</td>
<td class="nump">112,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Corporate office costs</a></td>
<td class="nump">46,533<span></span>
</td>
<td class="nump">42,037<span></span>
</td>
<td class="nump">45,049<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">70,649<span></span>
</td>
<td class="nump">52,413<span></span>
</td>
<td class="nump">67,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income and expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReliefFunds', window );">Relief funds</a></td>
<td class="nump">4,597<span></span>
</td>
<td class="nump">13,501<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInterestInProjects', window );">Gain on sale of partnership interest and clinics</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="nump">5,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Settlement of a legal matter</a></td>
<td class="num">(2,635)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ResolutionOfPayorMatter', window );">Resolution of a payor matter</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of unconsolidated affiliate</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_InterestExpenseDebtAndOther', window );">Interest expense - debt and other</a></td>
<td class="num">(942)<span></span>
</td>
<td class="num">(1,634)<span></span>
</td>
<td class="num">(2,079)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income and expense</a></td>
<td class="nump">2,547<span></span>
</td>
<td class="nump">13,100<span></span>
</td>
<td class="nump">3,481<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income and equity in earnings of unconsolidated affiliates before taxes</a></td>
<td class="nump">73,196<span></span>
</td>
<td class="nump">65,513<span></span>
</td>
<td class="nump">70,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">15,272<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="nump">13,647<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">57,924<span></span>
</td>
<td class="nump">52,491<span></span>
</td>
<td class="nump">57,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract', window );"><strong>Less: net income attributable to non-controlling interest:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Redeemable non-controlling interest - temporary equity</a></td>
<td class="num">(11,358)<span></span>
</td>
<td class="num">(11,175)<span></span>
</td>
<td class="num">(10,659)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Non-controlling interest - permanent equity</a></td>
<td class="num">(5,735)<span></span>
</td>
<td class="num">(6,122)<span></span>
</td>
<td class="num">(6,561)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to non-controlling interest</a></td>
<td class="num">(17,093)<span></span>
</td>
<td class="num">(17,297)<span></span>
</td>
<td class="num">(17,220)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">$ 40,831<span></span>
</td>
<td class="nump">$ 35,194<span></span>
</td>
<td class="nump">$ 40,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)</a></td>
<td class="nump">$ 2.41<span></span>
</td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="nump">$ 2.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in computation - basic and diluted (in shares)</a></td>
<td class="nump">12,898<span></span>
</td>
<td class="nump">12,835<span></span>
</td>
<td class="nump">12,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 1.46<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember', window );">Net Patient Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 438,330<span></span>
</td>
<td class="nump">$ 373,340<span></span>
</td>
<td class="nump">$ 433,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember', window );">Other Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 56,692<span></span>
</td>
<td class="nump">$ 49,629<span></span>
</td>
<td class="nump">$ 48,624<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInterestInProjects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) included in earnings resulting from the sale of interest in projects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInterestInProjects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_InterestExpenseDebtAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt related expenses and other expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_InterestExpenseDebtAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReliefFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Relief funds relates to social welfare, a fund of money set up to provide aid for people in need, especially in disaster areas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReliefFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RentSuppliesContractLaborAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to rent, supplies, contract labor and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RentSuppliesContractLaborAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ResolutionOfPayorMatter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income received on resolution related to a payor matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ResolutionOfPayorMatter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663004893624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Total Shareholders' Equity [Member]</div></th>
<th class="th"><div>Non-Controlling Interests [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="nump">$ 149,000<span></span>
</td>
<td class="nump">$ 80,028,000<span></span>
</td>
<td class="nump">$ 167,396,000<span></span>
</td>
<td class="num">$ (31,628,000)<span></span>
</td>
<td class="nump">$ 215,945,000<span></span>
</td>
<td class="nump">$ 930,000<span></span>
</td>
<td class="nump">$ 216,875,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="nump">14,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax', window );">Revaluation of redeemable non-controlling interest, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,771,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(8,771,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,771,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares', window );">Revaluation of redeemable non-controlling interest, net of tax (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">6,985,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">6,985,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,985,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans', window );">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">636,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">636,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">636,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of partnership interests - non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(266,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(266,000)<span></span>
</td>
<td class="num">(26,000)<span></span>
</td>
<td class="num">(292,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNonControllingInterestNetOfTaxAndPurchases', window );">Sale of non-controlling interest, net of purchases and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">196,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">196,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">196,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends paid to USPT shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,555,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,555,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,555,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest partners - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,014,000)<span></span>
</td>
<td class="num">(6,014,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="num">(7,000)<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Net income attributable to non-controlling interest - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,561,000<span></span>
</td>
<td class="nump">6,561,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,039,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,039,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,039,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">87,383,000<span></span>
</td>
<td class="nump">184,352,000<span></span>
</td>
<td class="num">$ (31,628,000)<span></span>
</td>
<td class="nump">240,257,000<span></span>
</td>
<td class="nump">1,444,000<span></span>
</td>
<td class="nump">241,701,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">14,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax', window );">Revaluation of redeemable non-controlling interest, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,415,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(3,415,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,415,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares', window );">Revaluation of redeemable non-controlling interest, net of tax (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,917,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,917,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,917,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans', window );">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">486,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">486,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">486,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of partnership interests - non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(168,000)<span></span>
</td>
<td class="num">(168,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNonControllingInterestNetOfTaxAndPurchases', window );">Sale of non-controlling interest, net of purchases and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(164,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(164,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(164,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends paid to USPT shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,110,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,110,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,110,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest partners - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,928,000)<span></span>
</td>
<td class="num">(5,928,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Net income attributable to non-controlling interest - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,122,000<span></span>
</td>
<td class="nump">6,122,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,194,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,194,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,194,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 151,000<span></span>
</td>
<td class="nump">95,622,000<span></span>
</td>
<td class="nump">212,015,000<span></span>
</td>
<td class="num">$ (31,628,000)<span></span>
</td>
<td class="nump">276,160,000<span></span>
</td>
<td class="nump">1,470,000<span></span>
</td>
<td class="nump">277,630,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">15,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax', window );">Revaluation of redeemable non-controlling interest, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,686,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(9,686,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,686,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares', window );">Revaluation of redeemable non-controlling interest, net of tax (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,867,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,867,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,867,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of partnership interests - non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(918,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(918,000)<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
<td class="num">(978,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNonControllingInterestNetOfTaxAndPurchases', window );">Sale of non-controlling interest, net of purchases and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">96,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">96,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">98,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends paid to USPT shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,765,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,765,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,765,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest partners - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,572,000)<span></span>
</td>
<td class="num">(5,572,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShortSwingProfitSettlement', window );">Short swing profit settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Net income attributable to non-controlling interest - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,735,000<span></span>
</td>
<td class="nump">5,735,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,831,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,831,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,831,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 151,000<span></span>
</td>
<td class="nump">$ 102,688,000<span></span>
</td>
<td class="nump">$ 224,395,000<span></span>
</td>
<td class="num">$ (31,628,000)<span></span>
</td>
<td class="nump">$ 295,606,000<span></span>
</td>
<td class="nump">$ 1,575,000<span></span>
</td>
<td class="nump">$ 297,181,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">15,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distributions during the period on mandatorily redeemable securities net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RevaluationOfRedeemableNonControllingInterestNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SaleOfNonControllingInterestNetOfTaxAndPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SaleOfNonControllingInterestNetOfTaxAndPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShortSwingProfitSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short swing profit settlement from any purchase or sale (or sale and purchase) of the company's equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShortSwingProfitSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663011864584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income including non-controlling interest and earnings from unconsolidated affiliates, net</a></td>
<td class="nump">$ 57,924<span></span>
</td>
<td class="nump">$ 52,491<span></span>
</td>
<td class="nump">$ 57,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">11,591<span></span>
</td>
<td class="nump">10,533<span></span>
</td>
<td class="nump">10,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">5,305<span></span>
</td>
<td class="nump">4,623<span></span>
</td>
<td class="nump">4,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based awards compensation expense</a></td>
<td class="nump">7,867<span></span>
</td>
<td class="nump">7,917<span></span>
</td>
<td class="nump">6,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">5,688<span></span>
</td>
<td class="num">(258)<span></span>
</td>
<td class="nump">4,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_GainOnSaleOfPartnershipInterestNetOfTax', window );">Gain on sale of partnership interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,091)<span></span>
</td>
<td class="num">(5,514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Derecognition (write-off) of goodwill - closed clinics</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings in unconsolidated affiliate</a></td>
<td class="num">(112)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="num">(134)<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) decrease in patient accounts receivable</a></td>
<td class="num">(9,417)<span></span>
</td>
<td class="nump">899<span></span>
</td>
<td class="num">(6,376)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets', window );">(Increase) decrease in accounts receivable - other</a></td>
<td class="num">(1,538)<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
<td class="num">(2,499)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">(Increase) decrease in other assets</a></td>
<td class="num">(633)<span></span>
</td>
<td class="nump">4,161<span></span>
</td>
<td class="num">(1,878)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in accounts payable and accrued expenses</a></td>
<td class="nump">4,657<span></span>
</td>
<td class="nump">12,427<span></span>
</td>
<td class="num">(4,209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Increase (decrease) in other long-term liabilities</a></td>
<td class="num">(4,792)<span></span>
</td>
<td class="nump">4,492<span></span>
</td>
<td class="num">(1,020)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">76,406<span></span>
</td>
<td class="nump">99,995<span></span>
</td>
<td class="nump">62,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase of fixed assets</a></td>
<td class="num">(8,201)<span></span>
</td>
<td class="num">(7,639)<span></span>
</td>
<td class="num">(10,189)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchase of majority interest in businesses, net of cash acquired</a></td>
<td class="num">(86,823)<span></span>
</td>
<td class="num">(23,907)<span></span>
</td>
<td class="num">(30,597)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireRedeemableNonControllingInterest', window );">Purchase of redeemable non-controlling interest - temporary equity</a></td>
<td class="num">(28,465)<span></span>
</td>
<td class="num">(20,385)<span></span>
</td>
<td class="num">(8,651)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase of non-controlling interest, permanent equity</a></td>
<td class="num">(1,274)<span></span>
</td>
<td class="num">(238)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates', window );">Proceeds on sale of redeemable non-controlling interest, temporary equity</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds on sales of partnership interest, clinics and fixed assets</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">839<span></span>
</td>
<td class="nump">11,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DistributionsFromUnconsolidatedAffiliate', window );">Distributions from unconsolidated affiliate</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ProceedsFromSalesOfNonControllingInterestPermanent', window );">Sales of non-controlling interest-permanent</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(124,136)<span></span>
</td>
<td class="num">(51,203)<span></span>
</td>
<td class="num">(37,993)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to non-controlling interest, permanent and temporary equity</a></td>
<td class="num">(16,931)<span></span>
</td>
<td class="num">(18,331)<span></span>
</td>
<td class="num">(16,235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid to shareholders</a></td>
<td class="num">(18,765)<span></span>
</td>
<td class="num">(4,110)<span></span>
</td>
<td class="num">(14,555)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving line of credit</a></td>
<td class="nump">316,000<span></span>
</td>
<td class="nump">214,000<span></span>
</td>
<td class="nump">145,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving line of credit</a></td>
<td class="num">(218,000)<span></span>
</td>
<td class="num">(244,000)<span></span>
</td>
<td class="num">(137,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on notes payable</a></td>
<td class="num">(4,899)<span></span>
</td>
<td class="num">(1,037)<span></span>
</td>
<td class="num">(1,433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareAcceleratedAndAdvancePaymentFunds', window );">(Payment) receipt of Medicare Accelerated and Advance Funds</a></td>
<td class="num">(14,054)<span></span>
</td>
<td class="nump">14,054<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">43,379<span></span>
</td>
<td class="num">(39,422)<span></span>
</td>
<td class="num">(24,275)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(4,351)<span></span>
</td>
<td class="nump">9,370<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of period</a></td>
<td class="nump">32,918<span></span>
</td>
<td class="nump">23,548<span></span>
</td>
<td class="nump">23,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">28,567<span></span>
</td>
<td class="nump">32,918<span></span>
</td>
<td class="nump">23,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">12,214<span></span>
</td>
<td class="nump">7,677<span></span>
</td>
<td class="nump">9,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">1,352<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">1,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing transactions during the period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PurchaseOfBusinessSellerFinancingPortion', window );">Purchase of businesses - seller financing portion</a></td>
<td class="nump">3,050<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1', window );">Purchase of business - payable to common shareholders of acquired business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity', window );">Notes payable related to purchase of redeemable non-controlling interest, temporary equity</a></td>
<td class="nump">1,759<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity', window );">Notes payable due to purchase of non-controlling interest, permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">699<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Notes receivable related to sale of partnership interest - redeemable non-controlling interest</a></td>
<td class="nump">914<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Note receivables related to sale of partnership interest</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 994<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables, and operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DistributionsFromUnconsolidatedAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the distributions from unconsolidated affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DistributionsFromUnconsolidatedAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_GainOnSaleOfPartnershipInterestNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>After tax amount of gain on sale or disposal of partnership interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_GainOnSaleOfPartnershipInterestNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MedicareAcceleratedAndAdvancePaymentFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of medicare accelerated and advance payment funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MedicareAcceleratedAndAdvancePaymentFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireRedeemableNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireRedeemableNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ProceedsFromSalesOfNonControllingInterestPermanent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sales of non-controlling interest-permanent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ProceedsFromSalesOfNonControllingInterestPermanent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PurchaseOfBusinessSellerFinancingPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of business - seller financing portion in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PurchaseOfBusinessSellerFinancingPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663102659192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Operations and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Nature of Operations and Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Nature of Operations and Basis of Presentation</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1. Organization, Nature of Operations and Basis of Presentation</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#8220;Company&#8221;). All
      significant intercompany transactions and balances have been eliminated.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company operates its business through two reportable business segments. The Company&#8217;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. The Company&#8217;s
      physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured
      workers and neurological injuries. Services provided by the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. Prior to the second quarter of 2020,
      the Company operated as a single segment. All prior year segment information has been reclassified to conform to the current segment presentation. See Note 12 - Segment Information.<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
      </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">During the last three years we completed the acquisitions of seven
        multi-clinic practices and three industrial injury prevention businesses as detailed below. </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table border="0" cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">% Interest</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Number of</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Clinics</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"> <span style="-sec-ix-hidden:Fact_fcd7d7afc36c4146ae8996c5533e716f">*</span><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">100%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;"> <span style="-sec-ix-hidden:Fact_9e406021f6644e219c3b143ef1491cbb">*</span><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">June 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">June 30, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">March 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">March 31, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f">**</span><br/>
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65% ***</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">67%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 47%; vertical-align: bottom; white-space: nowrap;">April 2019 Acquisition <br/>
              </td>

    <td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 17.16%; vertical-align: bottom; text-align: center; white-space: nowrap;">April 11, 2019<br/>
              </td>

    <td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 14.71%; vertical-align: bottom; text-align: center; white-space: nowrap;">100% <br/>
              </td>

    <td rowspan="1" style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"><span style="-sec-ix-hidden:Fact_b50371aded1746619d40d044e9a29674">*</span><br/>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention
                  business</div>
              </td>

  </tr>


</table>
      </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left;"> The business includes six management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.</td>

  </tr>


</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</td>

    <td style="width: auto; vertical-align: top; text-align: left;"> The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.</td>

  </tr>


</table>

<div>
         <br/></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Physical Therapy Operations</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The physical therapy operations segment primarily operates through subsidiary clinic partnerships, in which the Company generally
      owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests typically range from 10% to 99% in the Clinic Partnerships. The
      managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, the Company operates some clinics, through
      wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and
      other referral sources, by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior
      owners typically continue on as employees to manage the clinic operations, retain a non-controlling ownership interest in the clinics and receive a competitive salary for managing the clinic operations. In addition, the Company has developed
      satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than one clinic location.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Besides
        the multi-clinic acquisitions referenced in the table above, during 2021and 2020, we purchased the assets and business of five and&#160; three physical therapy clinics, respectively, in separate transactions.<br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During the year ended December 31, 2021, the Company sold two clinics. The aggregate sales price was $0.1 million. During the
      year ended December 31, 2020, we sold 14 previously closed clinics. The aggregate sales price was $1.1 million, of which $0.7 million was paid
      in cash and $0.4 million in a note receivable due in two equal installments of principal and any accrued interest. The first payment was received in June 2021 and the next payment is due on June 15, 2022.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; text-align: left; text-indent: 0px;">Clinic Partnerships</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by
      the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as <span style="font-style: italic;">non-controlling interest&#8212;permanent equity</span>. For acquired Clinic Partnerships with redeemable
      non-controlling interests, the earnings attributable to the redeemable non-controlling interests are recorded within the consolidated balance sheets and income statements as <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">redeemable non-controlling interest</span>&#8212;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">temporary equity</span>.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; text-align: left; text-indent: 0px;">Wholly-Owned Facilities</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing
      due the clinic partners/directors. The amount is expensed as compensation and included in clinic operating costs&#8212;salaries and related costs. The respective liability is included in current liabilities&#8212;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">accrued expenses</span> on the consolidated balance sheets.</div>

<div><br/>
    </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Industrial Injury Prevention Services</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Services provided in the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post offer
        employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers
        and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">Impact of COVID-19</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">As previously disclosed in a series of filings with the SEC and further described in detail in the Company&#8217;s Quarterly Reports on
        Form 10-Q for the first three quarters of 2020 and our Annual Report on Form 10-K for the year ended December 31, 2020, the Company&#8217;s results were negatively impacted by the effects of the COVID-19 pandemic in 2020. For 2021 periods as compared to
        2020 periods, the increase in revenues and expenses are primarily due to the Company returning to and now exceeding pre-pandemic results.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company has put preparedness plans in place at our facilities to maintain continuity of operations, while also taking steps to
        keep employees and patients safe. In line with recommendations to reduce large gatherings and increase social distancing, the Company has continued to allow a large number of office-based employees to work remotely. The Company is continuing to
        monitor the situation and will adjust work environments accordingly.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In March 2020 in response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic
        Security Act (&#8220;CARES Act&#8221;). The CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future
        limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement
        property, and the creation of certain payroll tax credits associated with the retention of employees.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: left; text-indent: 0px;">Medicare Accelerated and Advance Payment Program (&#8220;MAAPP Funds&#8221;)</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic Security Act
        (&#8220;CARES Act&#8221;). The CARES Act allowed for qualified healthcare providers to receive advanced payments under the MAAPP Funds during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future
        Medicare services provided. The Company applied for and received approval from Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. The Company recorded the $14.1 million in advance payments received as a liability. During the first quarter of 2021, the Company repaid the MAAPP Funds of $14.1 million rather than applying them to future services performed.</div>

<div><br/></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Relief Funds</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On
        March 27, 2020, the CARES Act was enacted. The CARES Act provided additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0 billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing,
        and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.</div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">For
        the years ended December 31, 2021 and December 31, 2020, the Company&#8217;s consolidated subsidiaries recorded income of approximately $4.6
        million and $13.5 million, respectively, from payments under the CARES Act (&#8220;Relief Funds&#8221;). Under the Company&#8217;s accounting policy, these
        payments were recorded as Other income &#8211; Relief Funds. These funds are not required to be repaid upon attestation and compliance with certain terms and conditions, which could change materially based on evolving grant compliance provisions and
        guidance provided by the U.S. Department of Health and Human Services. Currently, the Company can attest and comply with the terms and conditions.&#160; The Company will continue to monitor the evolving guidelines and may record adjustments as
        additional information is released.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009797768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2. Significant Accounting Policies</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Cash Equivalents</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments
        with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a
        concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Long-Lived Assets</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the
        related assets. Estimated useful lives for furniture and equipment range from <span style="-sec-ix-hidden:Fact_8dba1636fbb14fd492a5df628ebe9b1c">three</span> to eight years and for software purchased from <span style="-sec-ix-hidden:Fact_88c34f0df7f44d898218c12bf8c8a138">three</span> to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally
        <span style="-sec-ix-hidden:Fact_20d1e6de339f4109b6e30d66a9ab05cd">three</span> to five years.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Company reviews property and equipment
        and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value
        less costs to sell.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;">Investment in unconsolidated affiliate</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;">Investments in unconsolidated joint ventures in which the Company has less than a controlling interest, are accounted for under the equity method of accounting
          and, accordingly, are adjusted for capital contributions, distributions and the Company&#8217;s equity in net earnings or loss of the respective joint venture.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span>
        <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Goodwill</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Goodwill represents the excess of the amount paid and fair value of
          the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional
          paid-in capital.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic impairment evaluations. The fair value of goodwill and
          other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair value if considered impaired. These events or
          conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of
          continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company
          evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Company operates a </span>two<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The
            partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test.</span> In 2021, 2020 and 2019</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> there were </span>six<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> regions. </span>In addition to the six regions, the impairment analysis
        included a separate analysis for the industrial injury prevention services business, as a separate reporting unit.<br class="Apple-interchange-newline"/>
      </div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If
          goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair
          value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in
          determining the fair value of its reporting units when performing a quantitative analysis.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;">An impairment loss generally would be recognized when the carrying amount of the net
          assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2021, 2020 and 2019 did not result in any goodwill amounts that were
          deemed impaired.</div>

<div><br class="Apple-interchange-newline"/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below
          their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2021.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 26.5333px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company will continue to monitor for any triggering events or other indicators of impairment. </span></div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Redeemable Non-Controlling Interest</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The non-controlling interest that is
        reflected as redeemable non-controlling interest in the consolidated financial statements consists of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the
        future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months
        earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s
        employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically <span style="-sec-ix-hidden:Fact_054bc4ad0f534600aebe5987db19283e">three</span>
        to five years, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death)
        and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On the date the Company acquires a
        controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated
        balance sheet under the ca<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">ption&#8212;Redeemab</span>le non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of
        its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial
        carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated
        statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in
        consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
      <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Non-Controlling Interest</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the
        non-controlling interest, as permanent equity in the consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face
        of the statements of net income. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company
        recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or
        shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Revenue Recognition</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting
        Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with
        Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from
        Contracts with Customer (collectively the &#8220;standards&#8221;), respectively, which supersede most of the current revenue recognition requirements (&#8220;ASC 606&#8221;). The core principle of the new guidance is that an entity should recognize revenue to depict the
        transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">The Company implemented the new standards beginning January 1, 2018 using a modified
        retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a
        significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues
        upon implementation. Under the new standards, the Company&#8217;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">For ASC 606,
          there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which
          establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided
          to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the
          Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists
          when we provide the services at established rates.</span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;"> The difference
          between the Company&#8217;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#8212;</span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;">contractual allowance.</span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div>
      <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">The following table details the revenue related to the various categories (in
        thousands).</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">Year Ended</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2020</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2019</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Net patient revenue</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">438,330</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">373,340</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">433,345</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"> Other patient revenue </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,939</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,020</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,486</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Physical therapy operations</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$ <br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">441,269</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$<br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">375,360</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$ <br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">435,831</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Physical therapy management contracts</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">9,853</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">8,410</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">8,676</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Industrial injury prevention services<br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">43,900</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">39,199</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">37,462</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">495,022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">422,969</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">481,969</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span>
      <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Patient revenue </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">Revenues are recognized in the period in
        which services are rendered. Net patient revenue consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries,
        preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors,
        patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides
        physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the
        Company at amounts different from its established rates. </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);">Medicare Reimbursement</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Medicare program reimburses outpatient rehabilitation
        providers based on the Medicare Physician Fee Schedule (&#8220;MPFS&#8221;). For services provided in 2017 through 2019, a 0.5% increase was applied
        to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025 no
        adjustment is expected to be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; font-style: normal;"> </span> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"> In the 2020 MPFS Final Rule, CMS revised coding, documentation guidelines, and
          increased the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office
          visit codes and cuts to other specialty codes to maintain budget neutrality. As a result, CMS projected a 9% decrease in fee schedule
          payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the Consolidated Appropriations Act, 2021 and reimbursement for the codes applicable to physical/occupational therapy services provided by
          our clinics received an estimated 3.5% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">In the 2022 MPFS Final Rule published on November 2, 2021, there was to be an
          approximately 3.75% reduction to Medicare payments for physical/occupational therapy services. This was due to the expiration of the
          additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021. However, this reduction was addressed in the Protecting Medicare and American Farmers from Sequester Cuts Act (&#8220;2021 Act&#8221;)
          signed into law on December 10, 2021. Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year of 2022 will be approximately 0.75%. The 2021 Act did not address the 15% reduction in
          Medicare payments for services performed by a physical or occupational therapist assistant, which began on January 1, 2022.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">In addition, the Consolidated Appropriations Act, 2021 includes reductions in
          Medicare payment rates of approximately 3% in each of calendar years 2023 and 2024, unless regulatory or Congressional action
          results in modifications to such rates as has occurred in 2021 and 2022.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with
          deficit reductions over the next ten years and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2%
          reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2%
          reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2%
          reductions to Medicare payments through fiscal year 2027. The CARES Act suspended the 2% payment reduction to Medicare payments for
          dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the 2%
          payment reduction until March 31, 2021. On April 14, 2021, additional legislation was enacted that waived the 2% payment reduction for
          the remainder of calendar 2021. The 2021 Act, which was signed into law on December 10, 2021, included a three-month extension of the
          2% sequester relief applied to all Medicare payments through March 31, 2022, followed by three months of 1% sequester relief through June 30, 2022. Sequester relief is scheduled to then end on June 30, 2022.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> <br/>
        </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">Beginning in 2021, payments to individual therapists (Physical/Occupational
          Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and
          meaningful use of electronic health records. Therapists eligible to participate in MIPS include only those therapists who are enrolled with Medicare as private practice providers, and does not include therapists in facility-based providers, such
          as our clinics enrolled as certified rehabilitation agencies. Less than 3% of the Company&#8217;s therapist providers currently participate
          in MIPS. Under the MIPS requirements, a provider&#8217;s performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional&#8217;s payment for the
          corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine the payment adjustment in 2021. For those therapist providers who actually participated in MIPS during 2019, the resulting average payment adjustment was an
          increase of 1%.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Under the Middle-Class Tax Relief and Job Creation Act of 2012 (&#8220;MCTRA&#8221;), since
        October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical
        review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech
        Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the
        manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will
        be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for
        2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">CMS adopted a multiple
          procedure payment reduction (&#8220;MPPR&#8221;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and
          speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value
          Unit (&#8220;RVU&#8221;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the
          same patient, regardless of whether those therapy services are furnished in separate sessions. In 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by
          50%.</span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Medicare claims for outpatient therapy services furnished by therapist assistants on
        or after January 1, 2020 must include a modifier indicating the service was furnished by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022, in whole or part by a therapist assistant will be paid at an amount
        equal to 85% of the payment amount otherwise applicable for the service.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to
        Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving
        allegations of potential wrongdoing that would have a material effect on our financial statements as of December 31, 2021. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as
        significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the years ended December 31, 2021, and 2020, respectively, net patient revenue from Medicare was approximately $134.4 million and $101.6 million,
        respectively.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;">Management Contract Revenue</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: 18pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Management contract revenue, which is included in other revenue, is derived from contractual arrangements whereby the Company manages a clinic for third party
          owners. The Company does not have any ownership interest in these clinics. Typically, revenue is determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically
          salaries for the Company&#8217;s employees, are recorded when incurred. </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> Industrial Injury
          Prevention Services Revenue</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revenue from the industrial injury prevention services business, which is also included in other revenue in the consolidated
            statements of net income, is derived from onsite services the Company provides to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments<span style="font-family: 'Times New Roman'; font-size: 10pt;">, post-offer
              employment testing</span> and performance optimization. Revenue from the Company&#8217;s industrial injury prevention services business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an
            amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services
            provided in a given period.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; font-style: normal;"> </span><br/>
      </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Other Revenue</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Additionally, other revenue includes services the Company provides on-site at
        locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are
        typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time,
        when the services are performed.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Contractual Allowances</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off
        experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare
        regulations and the various third-party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based
        on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the
        clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve
        percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation
        that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact
        change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net
        revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within
        approximately 1% to 1.5%
        of net revenues. Additionally, analysis of subsequent periods&#8217; contractual write-offs on a payor basis reflects a difference within approximately 1%
        to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve
        percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% to 1.5% of gross billings included in accounts receivable at
        December 31, 2021.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Allowance for Credit Losses</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The
        provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses,
        includes only those amounts the Company estimates to be collectible.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Income Taxes</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the
        future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and
        liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax
        rates is recognized in income in the period that includes the enactment date.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority
        would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent
        likelihood of being realized upon ultimate settlement with the relevant tax authority.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of interest expense and depreciation. ASC
          740, Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. The legislation had no effect on the Company&#8217;s deferred income taxes and current
          income taxes payable during the year ended December 31, 2021.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company did not
        have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during
        the twelve months ended December 31, 2021, 2020 and 2019. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Fair Values of Financial Instruments</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out payments, accounts
          receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates the fair value. The interest rate on
          the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#8220;LIBOR&#8221;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
          exist.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Redeemable non-controlling interest included on the consolidated balance sheets and the put right associated with the
            potential future purchase of the separate company in the November 2021 acquisition are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of Redeemable non-controlling interests approximates the fair
            value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable inputs such as asset volatility and discount
            rates. The unobservable inputs in the valuation include asset volatility of 25% and a discount rate of 8.96%.&#160;See Note 5 for the changes in the fair value of Redeemable non-controlling interest.&#160; There were no changes in the fair value of put right
            associated with the potential future purchase of the separate company in the November 2021 acquisition for the year ended December 31, 2021.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Segment Reporting</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Operating segments are components of an enterprise for which
          separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. </span>The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in
        relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and
        related disclosures. Actual results may differ from these estimates.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Self-Insurance Program</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third
        party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated
        future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2021.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Restricted Stock</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board,
        respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_61e076fe690248718f13697be1324500">four</span>
        anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_139391eb54254fc583112777fb6d273d">first</span>
        year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years
        following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The
        restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div>

<div><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Adopted Accounting Pronouncements</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In June 2016, the FASB issued ASU 2016-13, <span style="font-style: italic;">Financial Instruments &#8211; Credit Losses</span>, which
        added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses.
        The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low
        risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company completed the adoption of the standard on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#8217;s accounts
        receivable derived from contracts with customers. A significant portion of the Company&#8217;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial
        insurers. The Company&#8217;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained
        earnings on the adoption date of the standard.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In January 2017, the FASB issued ASU 2017-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Simplifying the Test
          for Goodwill Impairment (Topic 350),</span> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods
        within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#8217;s adoption of this change.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">In December 2019, the FASB issued ASU 2019-12, </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Income Taxes (Topic 740)&#8211;Simplifying the Accounting for Income Taxes </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">(&#8220;ASU 2019-12&#8221;). The
          objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The
          amendments in this ASU are effective for fiscal years beginning after December&#160;15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In August 2020, the FASB issued ASU 2020-06&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Debt&#8212;Debt














          with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, </span>which simplifies the
        accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted
        earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings
        per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a
        stated policy.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">This pronouncement was effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021.The Board
          specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition
          is permitted. The Company has determined that the adoption of ASU 2020-06 will not have a material impact on the Company&#8217;s financial statements.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-style: italic; font-weight: bold;">Recently Issued Accounting Guidance</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In March 2020, the FASB issued ASU 2020-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Reference Rate Reform
          (Topic 848): Facilitation of the Effects of Reference</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Rate Reform on Financial Reporting</span>. This ASU provides temporary optional expedients and
        exceptions to the guidance on contract<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR
        and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit
        Agreement (as defined in Note 9) bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
        exist.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663095443736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Acquisitions of Businesses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions of Businesses</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3. Acquisitions of Businesses</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the Company acquired a majority interest in the following businesses:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Acquired</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Clinics</div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 2021 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2021</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom;">November 2021 Acquisition<br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;">November 30, 2021</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;">70%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;"><span style="-sec-ix-hidden:Fact_f2ab670c292849e0a6da2f6f425f8ab8">IIPS*</span></td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">September 2021 Acquisition<br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;">September 30, 2021</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;">100%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"><span style="-sec-ix-hidden:Fact_8fc8c722672b4497be0c04af98353c23">IIPS*</span></td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom;">June 2021 Acquisition<br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;">June 30, 2021</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;">65%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;">8</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">March 2021 Acquisition<br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;">March 31, 2021</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;">70%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;">6</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom;">November 2020 Acquisition</td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;">November 30, 2020</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;">75%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;">3</td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_d7b298373dc646968960932c7a99c477">**</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</div>
          </td>

    <td style="width: 14.58%; vertical-align: bottom;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4</div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">67%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom;">April 2019 Acquisition <br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: bottom; text-align: center;">April 11, 2019 <br/>
          </td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: bottom; text-align: right;">100% <br/>
          </td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: bottom; text-align: right;"><span style="-sec-ix-hidden:Fact_9ccb1564cfba40339b352148e6a9107a">*</span><br/>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div>
      <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Industrial injury prevention business<br/>
              </span></td>

  </tr>


</table>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="c25a46c3472f4e9d89f721c383608370" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The business includes six management
              and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years</span>.</td>

  </tr>


</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z9554ae614f714132a1278bbaa794d16d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.</span></div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On December 31, 2021, the Company acquired a 75% in three-clinic physical therapy practice with the practice founder retaining 25%. The purchase price for the 75%
      interest was approximately $3.7 million, of which $3.5 million was paid in cash and $0.2 million in the form of a note payable. The note accrues interest at
      3.25% per annum and the principal and interest is payable on December 31, 2023.</div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">On November 30, 2021, the Company acquired an approximate 70% interest in a leading provider of industrial injury prevention services. In each case, the previous owners retained the remaining interest. The
          purchase price for the approximate 70% equity interest, not inclusive of a $2.0 million contingent payment, was approximately $63.2 million
          of which $60.7 million was paid in cash and $1.0 million in the form of a note payable. The note accrues interest at 3.25% per annum and the
          principal and interest is payable on November 30, 2023. </span>As part of the transaction, the Company also agreed to the potential future purchase of a separate company under the same ownership that provides physical therapy and rehabilitation
        services to hospitals and other ancillary providers in a distinct market area. The current owners have the right to put this transaction to the Company in approximately five years, with such right having a $3.5 million value at December 31, 2021, as reflected on the
        Company&#8217;s consolidated balance sheet in Other long-term liabilities. The value of this right will be adjusted in future periods, as appropriate, with any change in value reflected in the Company&#8217;s consolidated statement of income. The Company does
        not currently possess more than 50% of the controlling interests in this separate company, does not control this company through contract or governance rights and currently does not exercise significant influence over this separate company. Due to
        the aforementioned reasons, and based on current accounting guidance, the Company did not consolidate the separate company through the variable interest or voting interest model.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On September 30, 2021, the Company acquired a company that specializes in return-to-work and ergonomic services, among other
            offerings. The Company acquired the company&#8217;s assets at a purchase price of approximately $3.3 million (which includes the obligation
            to pay an amount up to $0.6 million in contingent payment consideration in conjunction with the acquisition if specified future
            operational objectives are met), and contributed those assets to Briotix Health. The initial purchase price, not inclusive of the $0.6
            million contingent payment, was approximately $2.7 million, of which $2.4 million was paid in cash, and $0.3 million is in the form
            of a note payable. The note accrues interest at 3.25% per annum and the principal and interest is payable on September 30, 2023.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 13.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On June 30, 2021, the Company acquired a 65% interest in an eight-clinic physical therapy with the previous owners retaining 35%. The purchase price was approximately $10.3
            million, of which $9.0 million was paid in cash, $1.0 million is payable based on the achievement of certain business criteria and $0.3 million is in
            the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest is payable on June 30, 2023.
            Additionally, the Company has an obligation to pay an additional amount up to $0.8 million in contingent payment consideration in
            conjunction with the acquisition if specified future operational objectives are met. The Company recorded acquisition-date fair value of this contingent liability based on the likelihood of the contingent earn-out payment. The earn-out payment
            will subsequently be remeasured to fair value each reporting date.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On March 31, 2021, the Company acquired a 70% interest in a five-clinic physical therapy practice with the previous owners retaining 30%. When acquired, the practice was developing a sixth clinic which has been completed. The purchase price for the 70% interest was approximately $12.0
              million, of which $11.7 million was paid in cash and $0.3 million in the form of a note payable. The note accrues interest at 3.25%
              per annum and the principal and interest is payable on March 31, 2023.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 13.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2021 acquisitions has been preliminarily allocated as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> IIPS*</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
                    <div style="margin-top: 0px; margin-bottom: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">Cash paid, net of cash acquired<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">63,193</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,630</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">86,823</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller notes<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">800</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,050</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">Contingent payments</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">2,520</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">837</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">3,357</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom">Other payable<br/>
                  </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">1,000</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">1,000</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller put right<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,522</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><br/>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <br/>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,522</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70,485</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,267</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">96,752</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,589</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,046</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,635</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,620</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,462</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">19,082</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(4,842</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6,832</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,674</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -15.85pt; margin-left: 60.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,367</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">676</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14,043</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21,126</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,729</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">24,855</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">500</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">574</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,074</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,141</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,755</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,896</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">58,257</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">31,489</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">89,746</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(27,906</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,956</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(39,862</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70,485</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,267</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">96,752</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 13.5pt; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">*Industrial




























              injury prevention services </div>

<div><span class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;&#160;&#160;</span> </div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">On November 30, 2020, the Company acquired a 75% interest in a three-clinic physical therapy practice with the previous owners retaining 25%. The purchase price for the 75%
        interest was $8.9 million (net of cash acquired), of which $8.6 million was paid in cash and $0.3 million in the form of a
        note payable that is payable in two principal installments totaling $162,500 each. The first principal payment plus accrued interest was paid in November 2021 with the second installment to be paid in November 2022 totaling $162,500. The note accrues interest at 3.25%
        per annum.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On September 30, 2020, the Company acquired a 70% interest in an entity which holds six-management contracts that have been in place for a number of
      years. The purchase price for the 70% interest was approximately $4.2 million, of which $3.7 million was paid in cash and $0.5 million in the form of two notes payable. One of the notes payable of $0.3 million was paid in November 2020. The remaining note payable of $0.2 million was paid on September
      30, 2021.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On February 27, 2020, the Company acquired interests in a four-clinic physical therapy practice. The four clinics are in four separate partnerships. The Company&#8217;s interests in the four
      partnerships range from 10.0% to 83.8%,
      with an overall 65.0% based on the initial purchase transaction. The aggregate purchase price was $11.9 million, of which $11.6 million was
      paid in cash and $0.3 million in the form of a note payable. The note accrues interest at 4.75% per annum and the principal and interest was paid on February 2022.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2020 physical therapy operations acquisitions has been allocated as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired<br/>
            </div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,912</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,121</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25,033</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,049</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">196</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(562</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">683</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,520</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">500</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,890</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,738</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,298</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25,033</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On September 30, 2019, the Company acquired a 67% interest in an eleven-clinic physical therapy practice. The purchase price for the 67% interest was $12.4 million ($12.6 million less cash acquired of $0.2
      million), of which $12.3 million was paid in cash and $0.3 million in a seller note payable in two principal installments totaling $150,000 each, plus accrued interest. A payment of $150,000



























      plus accrued interest was paid in September 2020 and a second payment of $150,000 was paid in September 2021. The note accrues interest at
      5.0% per annum.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">On April 11, 2019, the Company acquired a company that is a provider of industrial injury prevention services. The acquired company
      specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network of 45 states including onsite at eleven client locations. The
      acquired business was then combined with Briotix Health, the Company&#8217;s industrial injury prevention services operation, increasing the Company&#8217;s ownership position in the Briotix Health partnership to approximately 76.0%. The purchase price for the acquired company was $22.9
      million ($23.6 million less cash acquired of $0.7
      million), which consisted of $18.9 million in cash, (of which $0.5 million will be paid to certain shareholders), and a $4.0
      million seller note. The note accrues interest at 5.5% and the principal and accrued interest was paid on April 9, 2021.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the
      date of their respective acquisition. The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2019 acquisitions was allocated as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">IIPS*</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($<span style="text-indent: 0pt;">890</span>)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18,428</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,170</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30,598</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Payable to shareholders of seller</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">485</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">485</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">22,913</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,470</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">35,383</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,641</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">650</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,291</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">848</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">394</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,242</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,978</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(191</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(3,169</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(489</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">853</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">364</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,400</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,600</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">250</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">270</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">520</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">740</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,040</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18,452</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14,237</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,689</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6,230</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6,230</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">22,913</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,470</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">35,383</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">* Industrial injury prevention services</div>

<div><br/>
    </div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The finalized purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2020 and 2019 were
      allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the
      amount exceeding the fair values being recorded as goodwill. For some of the acquisitions in 2021, the Company is in the process of completing its formal valuation analysis to identify and determine the fair value of tangible and identifiable
      intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the preliminary estimates used at December 31, 2021 based on additional information obtained and completion of the valuation of
      the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded
      pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill. The Company does not expect the adjustments to be material.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the acquisitions in 2021, the values assigned to the customer and referral relationships and non-compete agreements are being
      amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period is 13.8
      years. For non-compete agreements, the weighted-average amortization period is 5.6 years. The values assigned to tradenames are tested
      annually for impairment.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the acquisitions in 2020 and 2019, the values assigned to the referral relationships and non-compete agreements are being
      amortized to expense equally over the respective estimated lives. For referral relationships, the weighted average amortization period was 10.54
      and 10.10 years at December 31, 2020 and December 31, 2019, respectively. For non-compete agreements, the weighted average amortization
      period was 6.00 years and 5.16
      years at December 31, 2020 and December 31, 2019, respectively. Generally, the values assigned to tradenames are tested annually for impairment.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the 2021, 2020 and 2019 acquisitions, total current assets primarily represent patient accounts receivable. Total non-current
      assets are fixed assets, primarily equipment, used in the practices.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The consideration paid for each of the acquisitions was derived through arm&#8217;s length negotiations. Funding for the cash portions was
      derived from proceeds from the Company&#8217;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#8217;s consolidated financial statements since their respective date of acquisition. Unaudited proforma
      consolidated financial information for the acquisitions in 2021, 2020 and 2019, have not been included as the results are immaterial individually and in the aggregate.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009762920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Sale of Non-Controlling Interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Acquisitions and Sale of Non-Controlling Interests [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Acquisitions and Sale of Non-Controlling Interests</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4. Acquisitions and Sale of Non-Controlling Interests</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">During
        2021, the Company acquired additional interests in five partnerships which are included in non-controlling interest. The additional
        interests purchased in each of the partnerships ranged from 5% to 35%. The aggregated purchase price for these acquired interests was $1.3
        million. The Company also sold an interest in a partnership for $0.1 million.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">During </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the Company acquired additional interests in </span>five<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from </span>20%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> to </span>35%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. The aggregated purchase price for these acquired interests was </span>$0.3 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. The Company also sold an interest in a partnership for </span>$0.1 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. Also during </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the Company sold </span>14<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> previously closed clinics. The aggregate sales price was </span>$1.1 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, of which </span>$0.7 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> was paid in cash and </span>$0.4 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> in a note receivable payable in </span>two<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> equal installments of principal and any accrued interest. The first payment was received in June 2021 and the next payment is due on June </span>15,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</span>2022<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</span><br/>
      <span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span> </div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">During </span>2019,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the Company acquired additional interests in </span>four<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from </span>1%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> to 20%. Also in </span>2019,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the Company sold a </span>1%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> interest in a partnership. The net after-tax difference between the payments and the
        portion of undistributed earnings of </span>$196,000<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">
        was credited to additional paid-in capital.</span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663102659192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interest<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_REDEEMABLENONCONTROLLINGINTERESTAbstract', window );"><strong>REDEEMABLE NON-CONTROLLING INTEREST [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestTextBlock', window );">Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5. Redeemable Non-Controlling Interest</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt;"><span style="text-decoration: underline;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Therapy Practice Acquisitions</span></span><br/>
    </div>

<div style="text-align: left;"> <br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Since October 2017, when the Company acquires a majority interest (the &#8220;Acquisition&#8221;) in a physical therapy clinic Therapy Practice
      (referred to as &#8220;Therapy Practice&#8221;), these Therapy Practice transactions occur in a series of steps which are described below.</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#8220;Seller Entity&#8221;). The Seller Entity is owned by one or more individuals
              (the &#8220;Selling Shareholders&#8221;) most of whom are physical therapists that work in the Acquired Therapy Practice and provide physical therapy services to patients.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the Acquisition, the Seller Entity contributes the Acquired Therapy Practice into a newly-formed limited partnership (&#8220;NewCo&#8221;), in exchange
              for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a
              wholly-owned subsidiary of the Seller Entity.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company enters into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited
              partnership interest and in <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">all</span></span> cases 100% of the
              general partnership interest in NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling
              Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small two-year note in lieu of an escrow (the &#8220;Purchase Price&#8221;). The Purchase Agreement usually does not contain any future earn-out or other contingent consideration that is
              payable to the Seller Entity or the Selling Shareholders.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Seller Entity also execute a partnership agreement (the &#8220;Partnership Agreement&#8221;) for NewCo that sets forth the rights and obligations of the
              limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited
              partnership interest in NewCo (&#8220;Seller Entity Interest&#8221;).</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#8220;Employment Agreement&#8221;) with NewCo with an initial term that
              ranges from <span style="-sec-ix-hidden:Fact_0d92bcc8360a42b4b9b9cf260432b9cf">three</span> to five years
              (the &#8220;Employment Term&#8221;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment
              Term. As a result, a Selling Shareholder becomes an employee (&#8220;Employed Selling Shareholder&#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause,
              at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller
              Entity as of the closing of the Acquisition.</div>
          </td>

  </tr>


</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities
              based on other employees in similar capacities within NewCo, the Company and the industry.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete
              agreement (the &#8220;Non-Compete Agreement&#8221;) which restricts the Selling Shareholder from engaging in competing Therapy Practice activities for a specified period of time (the &#8220;Non-Compete Term&#8221;). A Non-Compete Agreement is executed with the
              Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing Therapy Practice during the Non-Compete Term.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and expires on the <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">later</span></span>
              of:</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Two years after the date an Employed Selling
              Shareholders&#8217; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_0b4b01dde9444fa395f3ee7e597f70c6">Five</span> to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to a restricted region which is defined as a mileage radius from the Acquired Therapy Practice. That is, an Employed Selling
              Shareholder is permitted to engage in competing Therapy Practicees or activities outside the designated geography (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo
              immediately is permitted to engage in the competing Therapy Practice or activities outside the designated geography.</div>
          </td>

  </tr>


</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company
      (the &#8220;Call Right&#8221;) or at the option of the Seller Entity (the &#8220;Put Right&#8221;) as follows:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment is terminated under certain circumstances prior to the fifth anniversary of the Closing Date, the Seller
              Entity thereafter may have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div>
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>


</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call
              Right with respect to the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, Seller Entity thereafter has the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s
              Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div>
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>


</table>

<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c.</div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the
                  Seller Entity has the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
              </td>

  </tr>


</table>
      </div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s employment by NewCo is terminated prior to the fifth anniversary of the Closing Date, the Company thereafter has an irrevocable
              right to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>
          </td>

  </tr>


</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company
              has the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings
              before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on
              available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings
              that is used in the Put Right and the Call Right noted above.</div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.<br/>
            </div>
          </td>

  </tr>


</table>

<div> <br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling
              Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the
      Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder,
      nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not
      forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for
      breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a
      forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"><span style="text-decoration: underline;">ProgressiveHealth










          Acquisition</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">On November 30, 2021, the Company acquired a majority interest in ProgressiveHealth Companies, LLC (&#8220;Progressive&#8221;), which owns a
        majority interest in certain subsidiaries (&#8220;Progressive Subsidiaries&#8221;) that operate in the industrial injury prevention and therapy services businesses.&#160; The Progressive transaction was completed in a series of steps which are described below.<br/>
        <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Prior to the acquisition, the Progressive Subsidiaries were owned by a legal entity (&#8220;Progressive Parent&#8221;) controlled by its individual owners (the &#8220;Selling
                  Shareholders&#8221;), who work in and manage the Progressive business.</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the acquisition, the Selling Shareholders caused the Progressive Parent to transfer its ownership of the Progressive Subsidiaries into a
                  newly-formed limited liability company (&#8220;NewCo&#8221;), in exchange for one hundred percent (100%) of the membership interests in
                  NewCo. Therefore, in this step, NewCo became wholly-owned by the Selling Shareholders.</div>
              </td>

  </tr>


</table>
      </div>

<div><br/></div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company entered into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Selling Shareholders a majority of the membership interest in NewCo. The
                  consideration for the acquisition is primarily payable in the form of cash at closing, a relatively small portion paid in cash after the closing contingent on certain performance criteria, and a small note in lieu of an escrow (the
                  &#8220;Purchase Price&#8221;).</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholders also executed an operating agreement (the &#8220;Operating Agreement&#8221;) for NewCo that sets forth the rights and
                  obligations of the members of NewCo.</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company did not purchase 100%
                  of the membership interests in NewCo and the Selling Shareholders retained a portion of the membership interest in NewCo (&#8220;Selling Shareholders&#8217; Interest&#8221;).</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholders executed a non-compete agreement (the &#8220;Non-Compete Agreement&#8221;) which restricts the Selling Shareholders from
                  competing for a specified period of time (the &#8220;Non-Compete Term&#8221;).</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and expires on the <span style="text-decoration: underline;"><span style="font-size: 10pt; font-family: 'Times New Roman';">later</span></span>
                  of:</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Two years after the date a Selling Shareholder
                  no longer is involved in the management of NewCo or</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seven years from the date of the acquisition.</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to the entire United States.</div>
              </td>

  </tr>


</table>
      </div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.</div>
              </td>

  </tr>


</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">The Operating Agreement contains provisions for the redemption of the Selling Shareholder&#8217;s Interest, either at the option of the
        Company (the &#8220;Call Right&#8221;) or at the option of the Selling Shareholder (the &#8220;Put Right&#8221;) as follows:</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Each of the Selling Shareholders has the right to sell 30%
                  of their respective residual interests on each of the 4th and 5th anniversaries of the acquisition closing, and then 10% on
                  each of the 6th and 7th anniversaries.</div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder terminates his management relationship with NewCo for any reason on or after the seventh anniversary of the Closing
                  Date, the Selling Shareholder has the Put Right, and upon the exercise of the Put Right, the Selling Shareholder&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s ceases to perform management services on behalf of NewCo, the Company thereafter shall have an irrevocable right to purchase
                  from such Selling Shareholder his Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
              </td>

  </tr>


</table>
      </div>

<div><br/></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of
                  earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed
                  monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month
                  earnings that is used in the Put Right and the Call Right noted above.</div>
              </td>

  </tr>


</table>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date.</div>
              </td>

  </tr>


</table>
      </div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">Neither the Operating Agreement nor the Non-Compete Agreement contain any provision to escrow or &#8220;claw back&#8221; the equity interest
        in NewCo held by the Selling Shareholders, in the event of a breach of the operating agreement or non-compete terms, or the management services agreement pursuant to which the Selling Shareholders perform services on behalf of NewCo. The Company&#8217;s
        only recourse against the Selling Shareholder for breach of any of these agreements is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with a Selling Shareholder that would result
        in a forfeiture of the equity interest in NewCo held by a Selling Shareholder.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the
        Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling
        Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder
        does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling
        Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that
        would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021, 2020 and 2019, the following table details the changes in the carrying amount (fair value) of
      the redeemable non-controlling interests (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, <span style="text-indent: 0pt;">2019</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">132,340</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">137,750</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">133,943</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,358</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,175</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,659</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,359</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(12,403</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10,221</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,011</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,632</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,893</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(30,204</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(20,521</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(8,934</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">39,862</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,297</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,230</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reduction of non-controlling interest due to sale of USPH partnership interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6,132</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">982</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,133</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,120</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(914</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,006</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,870</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest -
              temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">186</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">283</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">62</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">155,262</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">132,340</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">137,750</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, <span style="text-indent: 0pt;">2019</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder's employment has not terminated</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">80,781</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">62,390</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">51,921</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder's employment has not terminated</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">74,481</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">69,950</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">85,829</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has expired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has not expired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">155,262</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">132,340</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">137,750</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_REDEEMABLENONCONTROLLINGINTERESTAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_REDEEMABLENONCONTROLLINGINTERESTAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009752104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6. Goodwill</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The changes in the carrying amount of goodwill as of December 31, 2021 and 2020 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">345,646</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">317,676</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">89,746</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">28,540</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill derecognition (write-off) related to closed clinics</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,859</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(713</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,289</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">434,679</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">345,646</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt; margin-left: 18pt;"><br/>
        During the year ended December 31, 2020, the Company derecognized (wrote off) goodwill in the amount of $1.9 million related to closed
        clinics due to COVID-19.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009761256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, net</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7. Intangible Assets, net</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Intangible assets, net as of December 31, 2021, and 2020 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">38,790</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,317</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships, net of accumulated amortization of $<span style="text-indent: 0pt;">17,762</span> and $<span style="text-indent: 0pt;">14,522</span>, respectively</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">45,643</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">22,119</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $<span style="text-indent: 0pt;">6,450</span> and $<span style="text-indent: 0pt;">5,993</span>, respectively</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,949</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,844</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">86,382</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">56,280</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Tradenames, customer and referral relationships and non-compete agreements are related to the businesses acquired. The value
      assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&#8217;s annual goodwill impairment test. The value assigned to customer and referral
      relationships is being amortized over their respective estimated useful lives which range from 6 to 16 years. Non-compete agreements are amortized over the respective term of the agreements which range from 5 to 6 years.</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2021, 2020 and 2019 (in thousands):</div>

<div><br/></div>

<div style="text-align: left;">
      <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,240</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,845</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,307</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">458</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">569</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">708</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,698</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,414</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,015</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
    </div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For one acquisition,
      the value assigned to tradename was being amortized over the term of the six year agreement in which the Company had acquired the right to
      use the specific tradename.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The remaining balances of the customer and referral relationships and non-compete agreements <span style="font-family: 'Times New Roman'; font-size: 10pt;">are</span> expected to be amortized as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Customer and Referral Relationships</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,798</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">512</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,691</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">443</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,526</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">387</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,382</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">322</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,914</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">236</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,332</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">49</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009762088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8. Accrued Expenses</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Accrued expenses as of December 31, 2021
      and 2020 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,569</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">24,646</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,649</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,756</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,984</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,113</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">498</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,333</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal taxes payable</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,716</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,885</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">MAAPP funds payable</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14,054</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contingent payment related to acquisition</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom">Settlement of a legal matter<br/>
          </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">2,750</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,539</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,959</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">45,705</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">59,746</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-indent: 20pt;">Federal






















        taxes payable includes $4.2 million related to deferred employer payroll taxes pursuant to the CARES ACT offset by a federal income tax
        receivable of $1.5 million.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663014653368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9. Notes Payable</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt; margin-left: 9pt;">Notes payable as of December 31, 2021, and 2020 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of <span style="text-indent: 0pt;">2.1</span>% for December 31, 2021 and December 31, 2020, (inclusive of unused fee)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">114,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $<span style="text-indent: 0pt;">830</span> plus accrued interest due in the next year, interest accrues in the range of <span style="text-indent: 0pt;">3.25</span>%
              through <span style="text-indent: 0pt;">4.75</span>% per annum</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,495</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">118,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21,495</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(830</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(4,899</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">117,587</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,596</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Effective

        December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving
        credit facility. This agreement was amended in August 2015, January 2016, March 2017, November 2017, January 2021, and November 2021 (hereafter is referred to as &#8220;Amended Credit Agreement&#8221;). In November 2021, the Company exercised the accordion
        feature in the Amended Credit Agreement to increase the limit on the facility from $125.0 million to $150.0 million, with an updated accordion feature providing for additional capacity of $25.0 million, therefore increasing the availability up to $175.0 million.<br/>
      </div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The
        Amended Credit Agreement is unsecured and has loan covenants, including requirements that we comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working
        capital, acquisitions, purchases of our common stock, dividend payments to our common stockholders, capital expenditures and other corporate purposes. The pricing grid is based on our consolidated leverage ratio with the applicable spread over
        LIBOR ranging from 1.25% to 2.0%
        or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee of 0.3%
        of the amount of funds outstanding under the Amended Credit Agreement.</div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The 2021 amendment to the Amended Credit Agreement allows for cash and noncash consideration for acquisitions permitted under the Amended Credit Agreement of up to
          $50,000,000 for any fiscal year, and allows for payments in cash dividends to shareholders in an aggregate amount not to exceed $50,000,000 in any fiscal year.&#160; The Amended Credit Agreement is unsecured and includes certain financial covenants which include a consolidated fixed
          charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20.15pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On
          December 31, 2021, $114.0 million was outstanding on the Amended Credit Agreement resulting in $61.0 million of availability. As of December 31, 2021, the Company was in compliance with all of the covenants thereunder.</div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20.15pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The

          Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchasing of non-controlling interests. In conjunction with these transactions in 2021, the Company entered into notes payable in the
          aggregate amount of $4.4 million of which an aggregate principal payment of $0.8 million was due in 2021 and $3.6 million is due in 2022. Interest accrues
          in the range of 3.25% to 4.75%
          per annum and is payable with each principal installment. The balance of the various notes payable entered into prior to 2021 was $3.6
          million which will be paid in 2022 and 2023.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009807272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">10. Leases</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a
      lease at the inception of a contract. Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#8217;s right to use an underlying asset during
      the lease term and operating lease liabilities represent net present value of the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the
      net present value of the fixed lease payments over the lease term. The Company&#8217;s operating lease terms are generally five years or less.
      The Company&#8217;s lease terms include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#8217;s operating leases do not provide an implicit rate, the Company uses its incremental
      borrowing rate based on the information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The
      Company has elected, in compliance with current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable
      lease components. The Company has elected the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included
      in the measurement of the right-of-use assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease
      classification. Variable lease payment amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease
      liabilities. These are expensed as incurred and recorded as variable lease expense.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021
      and 2020, the components of lease expense were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30,710</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,160</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,454</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7,057</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,752</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost<sup>*</sup></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">40,238</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">37,916</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Sublease income was immaterial</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Lease costs are reflected in the consolidated statements of net income in the line item&#8212;rent, supplies, contract labor and other.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021
      and 2020, supplemental cash flow information related to leases was as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">33,192</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30,307</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">46,088</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,710</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div> <br/></div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The aggregate future lease payments for operating leases as of December 31, 2021 were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Fiscal Year</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,945</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,467</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20,876</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">2026<br/>
          </td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">8,492</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2027 and therafter</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7,055</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">110,835</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed interest</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,175</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104,660</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Average lease terms and discount rates were as follows:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.17 Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"><span style="text-indent: 0pt;">4.05</span> Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.77</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.1</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009657496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11. Income Taxes</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2021 and
      2020 were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Compensation</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,817</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,865</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">573</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">396</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired net operating losses</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">558</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Lease obligations - including closed clinics</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,856</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,819</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30,246</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,638</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(19,607</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(12,650</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,637</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21,419</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(387</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(348</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(44,631</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(34,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax liability</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(14,385</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(7,779</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The deferred tax assets and liabilities related to purchased interests not yet finalized may result in an immaterial adjustment.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, the Company recorded net deferred tax assets of $0.8 million related to the revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests. In addition, during 2021, the Company recorded an
      adjustment to the deferred tax assets of $3.0 million as a result of a detailed reconciliation of its federal and state taxes payable and
      receivable accounts along with its federal and state deferred tax asset and liability accounts with its federal and state tax returns for 2020. The offset of this adjustment was a decrease to the previously reported state income tax receivable and a
      decrease to the federal income tax payable. As of December 31, 2021, the Company has a federal tax payable of $2.7 million and state tax
      receivables of $0.6 million. <span style="font-size: 10pt; font-family: 'Times New Roman';">The federal income tax payable is included in
      </span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">accrued liabilities</span><span style="font-size: 10pt; font-family: 'Times New Roman';"> and the tax receivable is</span> included in <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">other current assets</span> on the accompanying consolidated balance sheets.</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The differences between the federal tax rate and the Company&#8217;s effective tax rate for the years ended December 31, 2021, 2020 and
      2019 were as follows (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">U. S. tax at statutory rate</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,782</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,125</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,274</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap; width: 28%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income taxes, net of federal benefit</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,478</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.4</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,956</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.9</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,059</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.8</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Excess equity compensation deduction</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(246</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-0.4</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(99</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.0%</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(871</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-1.6</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap; width: 28%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,258</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.2</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,040</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.1</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,185</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.2</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">15,272</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27.2</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,647</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25.4</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Significant components of the provision for income taxes for the years ended December 31, 2021, 2020 and 2019 were as follows (in
      thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2019</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Current:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">7,477</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">10,506</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">6,523</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">2,107</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,774</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,473</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">9,584</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,280</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8,996</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,866</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(38</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,730</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">822</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(220</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">921</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,688</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(258</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,651</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total income tax provision</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">15,272</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">13,022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">13,647</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For 2021, 2020 and 2019, the Company performed a detailed reconciliation of its federal and state taxes payable and receivable
      accounts along with its federal and state deferred tax asset and liability accounts. The adjustments were immaterial. The Company considers this reconciliation process to be an annual control.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company is required to establish a valuation allowance for deferred tax assets if, based on the weight of available evidence, it
      is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary
      differences become deductible. Management considers the projected future taxable income and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income in the periods
      which the deferred tax assets are deductible, management believes that a valuation allowance is not required, as it is more likely than not that the results of future operations will generate sufficient taxable income to realize the deferred tax
      assets.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company&#8217;s U.S. federal returns remain open to examination for <span style="-sec-ix-hidden:Fact_19a08fedb1b74db5a6b4b517c5b42088">2018 through 2020</span> and U.S. state jurisdictions are open for periods ranging from <span style="-sec-ix-hidden:Fact_b89ef7a81a69420b8fe8694136cd02d4">2017 through 2020</span>.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company does not believe that it has any significant uncertain tax positions at December 31, 2021 and December 31, 2020, nor is
      this expected to change within the next twelve months due to the settlement and expiration of statutes of limitation.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company did not
      have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the years ended December 31, 2021, 2020 and 2019.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009656776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12. Segment Information</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company&#8217;s reportable segments include the physical therapy
        operations segment and the industrial injury prevention services segment. Also included in the physical therapy operations segment are revenues from management contract services and other services which include services the Company provides
        on-site, such as schools for athletic trainers</span>.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company evaluates performance of the segments based on gross
        profit. The Company has provided additional information regarding its reportable segments which contributes to the understanding of the Company and provides useful information</span>.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he following table summarizes selected financial data for the
        Company&#8217;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation</span>.</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;<span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Year Ended December 31,</span><br/>
          </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2019</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> <br/>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> <br/>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenue:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">451,122</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">383,770</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">444,507</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">43,900</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">39,199</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">37,462</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">495,022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">422,969</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">481,969</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations (excluding closure costs) (a non-GAAP measure)<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">106,518</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">88,295</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104,120</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,694</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,086</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8,379</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">117,212</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">98,381</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">112,499</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations - closure costs</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,931</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">117,182</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">94,450</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">112,474</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">587,801</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">499,911</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">518,027</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">161,625</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">94,450</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">112,474</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">749,426</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">594,361</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">630,501</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009821624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Unconsolidated Affiliate<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract', window );"><strong>Investment in Unconsolidated Affiliate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock', window );">Investment in Unconsolidated Affiliate</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13. Investment in Unconsolidated Affiliate</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Through one of the subsidiaries, the Company has a 49% joint venture interest in a company which provides physical therapy services for patients at hospitals. Since the Company is deemed to not have a controlling interest in
          the company, the Company&#8217;s investment is accounted for using the equity method of accounting. The investment balance of this joint venture as of December 31, 2021, is $12.2 million, of which $12.3 million related to the fair value on the date of acquisition. The $12.2 million includes earnings of $112
          thousand less a distribution received of $153 thousand.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009783256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Equity Based Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Based Plans</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14. Equity Based Plans</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company has the following equity-based plans with outstanding equity grants:</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Amended and Restated 1999 Employee Stock Option Plan (the &#8220;Amended 1999 Plan&#8221;) permits the Company to grant to non-employee
      directors and employees of the Company up to 600,000 non-qualified options to purchase shares of common stock and restricted stock
      (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The exercise prices of options granted under the Amended 1999 Plan are determined by the Compensation Committee. The period within
      which each option will be exercisable is determined by the Compensation Committee. The Amended 1999 Plan was approved by the shareholders of the Company at the 2008 Shareholders Meeting on May 20, 2008.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Amended and Restated 2003 Stock Option Plan (the &#8220;Amended 2003 Plan&#8221;) permits the Company to grant to key employees and outside
      directors of the Company incentive and non-qualified options and shares of restricted stock covering up to 2,100,000 shares of common
      stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The material terms of the Amended 2003 Plan was reapproved by the shareholders of the Company at the 2015 Shareholders Meeting
      on May 19, 2015 and an increase in the number of shares authorized for issuance from 1,750,000 to 2,100,000 was approved at the 2016 Shareholders Meeting on March 17, 2016.</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">A cumulative summary of equity plans as of December 31, 2021 follows:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Authorized</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Stock Issued</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Stock Options</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Exercised</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Exercisable</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>for Grant</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Equity Plans</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amended 1999 Plan</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">600,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">416,402</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">139,791</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7,775</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amended 2003 Plan</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,100,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,166,855</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">778,300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">164,882</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,700,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,583,257</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">918,091</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">172,657</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the Company granted the following shares of restricted stock to directors, officers and employees
      pursuant to its equity plans as follows:</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Granted</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Value Per Share</div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2021</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">60,317</div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">131.29</div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 33.07%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2020</div>
          </td>

    <td style="vertical-align: bottom; width: 0.97%;">&#160;</td>

    <td style="vertical-align: bottom; width: 33.21%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">86,982</div>
          </td>

    <td style="vertical-align: bottom; width: 1.11%;">&#160;</td>

    <td style="vertical-align: bottom; width: 2.36%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="vertical-align: bottom; width: 28.07%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104.69</div>
          </td>

    <td style="vertical-align: bottom; width: 1.21%;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2019</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">91,682</div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104.85</div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>


</table>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the following shares were cancelled due to employee terminations prior to restrictions lapsing:</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Cancelled</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Value Per Share</div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2021</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">439</div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">113.80</div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 33.06%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2020</div>
          </td>

    <td style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td style="vertical-align: bottom; width: 33.04%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,037</div>
          </td>

    <td style="vertical-align: bottom; width: 1.32%;">&#160;</td>

    <td style="vertical-align: bottom; width: 2.23%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="vertical-align: bottom; width: 28.13%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">102.52</div>
          </td>

    <td style="vertical-align: bottom; width: 1.22%;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2019</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,578</div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">87.88</div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_bc274c91f2484d4a9acb65f2349c1f1a">four</span> anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the
      first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years
      following the date of grant.</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">There were 102,682
      and 127,562 shares outstanding as of December 31, 2021 and December 31, 2020, respectively, for which restrictions had not lapsed. The
      restrictions will lapse in 2022 through 2025.</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Compensation expense for grants of restricted stock is recognized based on the fair value on the date of grant. Compensation expense
      for restricted stock grants was $7.8 million, $7.9
      million, and $7.0 million, respectively, for 2021, 2020 and 2019. As of December 31, 2021, the remaining $8.9 million of compensation expense will be recognized from 2022 through 2025.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009728552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PreferredStockAbstract', window );"><strong>Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Preferred Stock</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15. Preferred Stock</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Board is empowered, without approval of the shareholders, to cause shares of preferred stock to be issued in one or more series
      and to establish the number of shares to be included in each such series and the rights, powers, preferences and limitations of each series. There are no provisions in the Company&#8217;s Articles of Incorporation specifying the vote required by the
      holders of preferred stock to take action. All such provisions would be set out in the designation of any series of preferred stock established by the Board. The bylaws of the Company specify that, when a quorum is present at any meeting, the vote of
      the holders of at least a majority of the outstanding shares entitled to vote who are present, in person or by proxy, shall decide any question brought before the meeting, unless a different vote is required by law or the Company&#8217;s Articles of
      Incorporation.</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Because the Board has the power to establish the preferences and rights of each series, it may afford the holders of any series of
      preferred stock, preferences, powers, and rights, voting or otherwise, senior to the right of holders of common stock. The issuance of the preferred stock could have the effect of delaying or preventing a change in control of the Company.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PreferredStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PreferredStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009653176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Common Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">16. Common Stock</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately
      negotiated transactions, up to 2,250,000 shares of the Company&#8217;s common stock. In March 2009, the Board authorized the repurchase of up to
      10% or approximately 1,200,000
      shares of its common stock (&#8220;March 2009 Authorization&#8221;). The Amended Credit Agreement permits share repurchases of up to $15,000,000,
      subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.</div>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Under the March 2009 Authorization, the Company has purchased a total of 859,499 shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 156,986 shares (based on the closing price of $95.55 on December 31, 2021, the
      last business day in 2021) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&#8217;s cash position. The Company did not purchase any shares of its common stock during 2021 or 2020.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009658216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Defined Contribution Plan</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">17. Defined Contribution Plan</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company has several 401(k) profit sharing plans covering all employees with three months of service. For certain plans, the Company makes matching contributions. The Company may also make discretionary contributions of up to 50% of employee contributions. The Company did not
      make any discretionary contributions for the years ended December 31, 2021, 2020 and 2019. The Company matching contributions totaled $1.9
      million, $1.9 million and $2.0
      million, respectively, for the years ended December 31, 2021, 2020 and 2019.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663008792712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18. Commitments and Contingencies</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
    </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-variant: normal; text-transform: none;">Employment Agreements</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">At December 31, 2021, the
        Company had outstanding employment agreements with four of its executive officers. The agreements have terms that expire November 8, 2022, July 1, 2023, December 31, 2023, and February 28, 2024;
        however, each of these agreements provide for an automatic two-year renewal at the conclusion of the expiring term or renewal term.<br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">In addition, the Company
        has outstanding employment agreements with most of the managing physical therapist partners of the Company&#8217;s physical therapy clinics and with certain other clinic employees which obligate subsidiaries of the Company to pay compensation of $52.8 million in 2022 and $8.4 million in
        the aggregate from 2023 through 2024. In addition, many of the employment agreements with the managing physical therapists provide for monthly bonus payments calculated as a percentage of each clinic&#8217;s net revenues (not in excess of operating
        profits) or operating profits.</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-variant: normal; text-transform: none;">Litigation</div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Settlement of&#160; a Legal Matter</div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On August 19, 2019, we
        received notice of a qui tam lawsuit (&#8220;the Complaint&#8221;) filed by a relator on behalf of the United States, titled U.S. ex rel. Bonnie Elsdon, v. U.S. Physical Therapy, Inc., U.S. Physical Therapy, Ltd., Rehab Partners #2, Inc., The Hale Hand Center,
        Limited Partnership (the &#8220;Hale Partnership&#8221;), and Suzanne Hale.&#160;&#160; This whistleblower lawsuit was filed in the U.S. District Court for the Southern District of Texas, seeking damages and civil penalties under the federal False Claim Act.&#160; This
        lawsuit was originally filed under seal by a former employee of The Hale Hand Center, Limited Partnership (&#8220;Hale Partnership&#8221;), a majority-owned subsidiary of the Company, on May 25, 2018.&#160; The U.S Government declined to intervene in the case and
        unsealed the Complaint on July 17, 2019.</div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Complaint alleged that
        the Hale Partnership engaged in conduct to purposely &#8220;upcode&#8221; its billings for services provided to Medicare patients. The plaintiff - relator also claimed that similar false claims occurred on other days and at other Company-owned partnerships.</div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On October 3, 2019, we
        filed Motions to Dismiss based on numerous grounds on behalf of each of the named defendants. On October 29, 2019, the plaintiff-relator dismissed three
        of the named defendants, Rehab Partners #2, Inc., U.S. Physical Therapy, Ltd., and Suzanne Hale. The Motions to Dismiss were denied on November 30, 2020.</div>

<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: #FFFFFF; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; text-indent: 18pt; text-transform: none;"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In January 2022,</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;to avoid the legal fees and discovery costs in defending this matter and the uncertainty of protracted litigation, </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">the Company entered into a settlement agreement with the plaintiff-relator. In the settlement agreement, the plaintiff-relator released all defendants from liability
          for all conduct alleged in the Complaint, and the Company admitted no liability or wrongdoing.&#160; In connection with the settlement, the Office of the United States Attorney for the Southern District of Texas agreed to a dismissal of the claims
          against the Hale Partnership and the Company. Under the terms of the settlement, the Company agreed to make payments to the government, the plaintiff-relator and her counsel. Such payments, in the aggregate, amounted to</span> $2.75 million<span style="font-family: 'Times New Roman'; font-size: 10pt;"> of which $2.6 million was recorded as an expense in 2021</span>.&#160;  </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009744776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">19. Earnings Per Share</div>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The computations of basic and diluted earnings per share for the years ended December 31, 2021, 2020 and 2019 are as follows (in
      thousands, except per share data):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">40,831</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">35,194</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">40,039</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Charges) credit to retained earnings:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(13,011</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(4,632</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,893</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of <span style="text-indent: 0pt;">25.55</span>% and <span style="text-indent: 0pt;">26.25</span>%, respectively<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,324</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,216</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,121</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">31,144</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">31,778</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">31,267</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.41</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.48</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.45</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,898<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,835<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,756<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663010086056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">
<div style="font-weight: bold;"><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">20. Related
        Party Transactions</span><br/>
    </div>

<div style="font-weight: bold;"> <br/>
    </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: left; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Settlement of Short Swing
        Profit Claim</div>

<div>&#160;</div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; text-align: left; text-indent: 18pt;">For the year ended December 31, 2021, the Company recorded approximately $20,000 related to the short swing profit settlement remitted by a shareholder of our company under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Company
        recognized the proceeds as an increase to additional paid-in capital in the consolidated balance sheets as of December 31, 2021 and consolidated statements of stockholders&#8217; equity, as well as in cash provided by financing activities included in
        Other, in the consolidated statements of cash flows, for the year ended December 31, 2021.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009590024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reclassification of Prior Period Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodAdjustmentAbstract', window );"><strong>Reclassification of Prior Period Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionTextBlock', window );">Reclassification of Prior Period Presentation</a></td>
<td class="text">
<div style="font-weight: bold;"><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">21.
        Reclassification of Prior Period Presentation</span><br/>
    </div>

<div style="font-weight: bold;"> <br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; text-align: left; text-indent: 18pt;">Certain prior year amounts have been reclassified for consistency with the current year
        presentation. These reclassifications had no effect on the reported results of operations.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting error correction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009740248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text">
<div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FINANCIAL STATEMENT SCHEDULE*<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
      </span>SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
      </span>U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

<div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(In Thousands)</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balance at</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Beginning of Period</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additions Charged</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">to Costs and Expenses</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additions Charged</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">to Other Accounts</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Deductions</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balance at</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">End of Period</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, <span style="text-indent: 0pt;">2021</span>:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses<sup>(1)</sup></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,008</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,305</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,545</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,768</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, <span style="text-indent: 0pt;">2020</span>:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,698</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,623</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,313</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,008</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, <span style="text-indent: 0pt;">2019</span>:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,672</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,858</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,832</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,698</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>
<hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: left; border: none; margin-left: 0px; margin-right: auto;"/>
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Related to patient accounts receivable and accounts
              receivable-other.</div>
          </td>

  </tr>


</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2)</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Uncollectible accounts written off, net of
              recoveries.</div>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">All other schedules are omitted because of the absence of conditions under which they are required or because the required information is shown in the financial
              statements or notes thereto.</div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663011912696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Cash Equivalents</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments
        with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a
        concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Long-Lived Assets</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the
        related assets. Estimated useful lives for furniture and equipment range from <span style="-sec-ix-hidden:Fact_8dba1636fbb14fd492a5df628ebe9b1c">three</span> to eight years and for software purchased from <span style="-sec-ix-hidden:Fact_88c34f0df7f44d898218c12bf8c8a138">three</span> to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally
        <span style="-sec-ix-hidden:Fact_20d1e6de339f4109b6e30d66a9ab05cd">three</span> to five years.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed of</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Company reviews property and equipment
        and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value
        less costs to sell.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment in unconsolidated affiliate</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;">Investment in unconsolidated affiliate</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;">Investments in unconsolidated joint ventures in which the Company has less than a controlling interest, are accounted for under the equity method of accounting
          and, accordingly, are adjusted for capital contributions, distributions and the Company&#8217;s equity in net earnings or loss of the respective joint venture.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Goodwill</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Goodwill represents the excess of the amount paid and fair value of
          the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional
          paid-in capital.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic impairment evaluations. The fair value of goodwill and
          other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair value if considered impaired. These events or
          conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of
          continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company
          evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Company operates a </span>two<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The
            partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test.</span> In 2021, 2020 and 2019</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> there were </span>six<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> regions. </span>In addition to the six regions, the impairment analysis
        included a separate analysis for the industrial injury prevention services business, as a separate reporting unit.<br class="Apple-interchange-newline"/>
      </div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If
          goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair
          value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in
          determining the fair value of its reporting units when performing a quantitative analysis.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;">An impairment loss generally would be recognized when the carrying amount of the net
          assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2021, 2020 and 2019 did not result in any goodwill amounts that were
          deemed impaired.</div>

<div><br class="Apple-interchange-newline"/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below
          their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2021.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 26.5333px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company will continue to monitor for any triggering events or other indicators of impairment. </span></div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestsPolicyTextBlock', window );">Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Redeemable Non-Controlling Interest</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The non-controlling interest that is
        reflected as redeemable non-controlling interest in the consolidated financial statements consists of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the
        future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months
        earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s
        employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically <span style="-sec-ix-hidden:Fact_054bc4ad0f534600aebe5987db19283e">three</span>
        to five years, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death)
        and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">On the date the Company acquires a
        controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated
        balance sheet under the ca<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">ption&#8212;Redeemab</span>le non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of
        its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial
        carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated
        statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in
        consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestsPolicyPolicyTextBlock', window );">Non-Controlling Interest</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Non-Controlling Interest</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the
        non-controlling interest, as permanent equity in the consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face
        of the statements of net income. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company
        recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or
        shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Revenue Recognition</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting
        Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with
        Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from
        Contracts with Customer (collectively the &#8220;standards&#8221;), respectively, which supersede most of the current revenue recognition requirements (&#8220;ASC 606&#8221;). The core principle of the new guidance is that an entity should recognize revenue to depict the
        transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">The Company implemented the new standards beginning January 1, 2018 using a modified
        retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a
        significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues
        upon implementation. Under the new standards, the Company&#8217;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">For ASC 606,
          there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which
          establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided
          to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the
          Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists
          when we provide the services at established rates.</span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;"> The difference
          between the Company&#8217;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#8212;</span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;">contractual allowance.</span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div>
      <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">The following table details the revenue related to the various categories (in
        thousands).</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">Year Ended</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2020</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2019</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Net patient revenue</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">438,330</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">373,340</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">433,345</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"> Other patient revenue </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,939</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,020</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,486</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Physical therapy operations</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$ <br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">441,269</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$<br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">375,360</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$ <br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">435,831</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Physical therapy management contracts</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">9,853</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">8,410</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">8,676</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Industrial injury prevention services<br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">43,900</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">39,199</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">37,462</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">495,022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">422,969</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">481,969</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span>
      <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Patient revenue </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">Revenues are recognized in the period in
        which services are rendered. Net patient revenue consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries,
        preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors,
        patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides
        physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the
        Company at amounts different from its established rates. </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);">Medicare Reimbursement</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The Medicare program reimburses outpatient rehabilitation
        providers based on the Medicare Physician Fee Schedule (&#8220;MPFS&#8221;). For services provided in 2017 through 2019, a 0.5% increase was applied
        to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025 no
        adjustment is expected to be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; font-style: normal;"> </span> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"> In the 2020 MPFS Final Rule, CMS revised coding, documentation guidelines, and
          increased the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office
          visit codes and cuts to other specialty codes to maintain budget neutrality. As a result, CMS projected a 9% decrease in fee schedule
          payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the Consolidated Appropriations Act, 2021 and reimbursement for the codes applicable to physical/occupational therapy services provided by
          our clinics received an estimated 3.5% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">In the 2022 MPFS Final Rule published on November 2, 2021, there was to be an
          approximately 3.75% reduction to Medicare payments for physical/occupational therapy services. This was due to the expiration of the
          additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021. However, this reduction was addressed in the Protecting Medicare and American Farmers from Sequester Cuts Act (&#8220;2021 Act&#8221;)
          signed into law on December 10, 2021. Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year of 2022 will be approximately 0.75%. The 2021 Act did not address the 15% reduction in
          Medicare payments for services performed by a physical or occupational therapist assistant, which began on January 1, 2022.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">In addition, the Consolidated Appropriations Act, 2021 includes reductions in
          Medicare payment rates of approximately 3% in each of calendar years 2023 and 2024, unless regulatory or Congressional action
          results in modifications to such rates as has occurred in 2021 and 2022.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with
          deficit reductions over the next ten years and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2%
          reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2%
          reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2%
          reductions to Medicare payments through fiscal year 2027. The CARES Act suspended the 2% payment reduction to Medicare payments for
          dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the 2%
          payment reduction until March 31, 2021. On April 14, 2021, additional legislation was enacted that waived the 2% payment reduction for
          the remainder of calendar 2021. The 2021 Act, which was signed into law on December 10, 2021, included a three-month extension of the
          2% sequester relief applied to all Medicare payments through March 31, 2022, followed by three months of 1% sequester relief through June 30, 2022. Sequester relief is scheduled to then end on June 30, 2022.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> <br/>
        </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;">Beginning in 2021, payments to individual therapists (Physical/Occupational
          Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and
          meaningful use of electronic health records. Therapists eligible to participate in MIPS include only those therapists who are enrolled with Medicare as private practice providers, and does not include therapists in facility-based providers, such
          as our clinics enrolled as certified rehabilitation agencies. Less than 3% of the Company&#8217;s therapist providers currently participate
          in MIPS. Under the MIPS requirements, a provider&#8217;s performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional&#8217;s payment for the
          corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine the payment adjustment in 2021. For those therapist providers who actually participated in MIPS during 2019, the resulting average payment adjustment was an
          increase of 1%.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Under the Middle-Class Tax Relief and Job Creation Act of 2012 (&#8220;MCTRA&#8221;), since
        October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical
        review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech
        Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the
        manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will
        be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for
        2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">CMS adopted a multiple
          procedure payment reduction (&#8220;MPPR&#8221;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and
          speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value
          Unit (&#8220;RVU&#8221;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the
          same patient, regardless of whether those therapy services are furnished in separate sessions. In 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by
          50%.</span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Medicare claims for outpatient therapy services furnished by therapist assistants on
        or after January 1, 2020 must include a modifier indicating the service was furnished by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022, in whole or part by a therapist assistant will be paid at an amount
        equal to 85% of the payment amount otherwise applicable for the service.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to
        Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving
        allegations of potential wrongdoing that would have a material effect on our financial statements as of December 31, 2021. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as
        significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the years ended December 31, 2021, and 2020, respectively, net patient revenue from Medicare was approximately $134.4 million and $101.6 million,
        respectively.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;">Management Contract Revenue</div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: 18pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Management contract revenue, which is included in other revenue, is derived from contractual arrangements whereby the Company manages a clinic for third party
          owners. The Company does not have any ownership interest in these clinics. Typically, revenue is determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically
          salaries for the Company&#8217;s employees, are recorded when incurred. </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> Industrial Injury
          Prevention Services Revenue</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revenue from the industrial injury prevention services business, which is also included in other revenue in the consolidated
            statements of net income, is derived from onsite services the Company provides to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments<span style="font-family: 'Times New Roman'; font-size: 10pt;">, post-offer
              employment testing</span> and performance optimization. Revenue from the Company&#8217;s industrial injury prevention services business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an
            amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services
            provided in a given period.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; font-style: normal;"> </span><br/>
      </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Other Revenue</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">Additionally, other revenue includes services the Company provides on-site at
        locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are
        typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time,
        when the services are performed.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock', window );">Contractual Allowances</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Contractual Allowances</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off
        experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare
        regulations and the various third-party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based
        on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the
        clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve
        percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation
        that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact
        change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net
        revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within
        approximately 1% to 1.5%
        of net revenues. Additionally, analysis of subsequent periods&#8217; contractual write-offs on a payor basis reflects a difference within approximately 1%
        to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve
        percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% to 1.5% of gross billings included in accounts receivable at
        December 31, 2021.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts', window );">Allowance for Credit Losses</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Allowance for Credit Losses</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The
        provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses,
        includes only those amounts the Company estimates to be collectible.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Income Taxes</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the
        future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and
        liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax
        rates is recognized in income in the period that includes the enactment date.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority
        would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent
        likelihood of being realized upon ultimate settlement with the relevant tax authority.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of interest expense and depreciation. ASC
          740, Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. The legislation had no effect on the Company&#8217;s deferred income taxes and current
          income taxes payable during the year ended December 31, 2021.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company did not
        have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during
        the twelve months ended December 31, 2021, 2020 and 2019. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Values of Financial Instruments</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Fair Values of Financial Instruments</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out payments, accounts
          receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates the fair value. The interest rate on
          the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#8220;LIBOR&#8221;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
          exist.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Redeemable non-controlling interest included on the consolidated balance sheets and the put right associated with the
            potential future purchase of the separate company in the November 2021 acquisition are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of Redeemable non-controlling interests approximates the fair
            value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable inputs such as asset volatility and discount
            rates. The unobservable inputs in the valuation include asset volatility of 25% and a discount rate of 8.96%.&#160;See Note 5 for the changes in the fair value of Redeemable non-controlling interest.&#160; There were no changes in the fair value of put right
            associated with the potential future purchase of the separate company in the November 2021 acquisition for the year ended December 31, 2021.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Segment Reporting</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Operating segments are components of an enterprise for which
          separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. </span>The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in
        relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and
        related disclosures. Actual results may differ from these estimates.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SelfInsuranceProgramPolicyPolicyTextBlock', window );">Self-Insurance Program</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Self-Insurance Program</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third
        party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated
        future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2021.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RestrictedStockPolicyPolicyTextBlock', window );">Restricted Stock</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Restricted Stock</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board,
        respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_61e076fe690248718f13697be1324500">four</span>
        anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_139391eb54254fc583112777fb6d273d">first</span>
        year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years
        following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The
        restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncement</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Adopted Accounting Pronouncements</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In June 2016, the FASB issued ASU 2016-13, <span style="font-style: italic;">Financial Instruments &#8211; Credit Losses</span>, which
        added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses.
        The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low
        risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The Company completed the adoption of the standard on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#8217;s accounts
        receivable derived from contracts with customers. A significant portion of the Company&#8217;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial
        insurers. The Company&#8217;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained
        earnings on the adoption date of the standard.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In January 2017, the FASB issued ASU 2017-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Simplifying the Test
          for Goodwill Impairment (Topic 350),</span> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods
        within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#8217;s adoption of this change.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">In December 2019, the FASB issued ASU 2019-12, </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Income Taxes (Topic 740)&#8211;Simplifying the Accounting for Income Taxes </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">(&#8220;ASU 2019-12&#8221;). The
          objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The
          amendments in this ASU are effective for fiscal years beginning after December&#160;15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#8217;s financial statements.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In August 2020, the FASB issued ASU 2020-06&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Debt&#8212;Debt














          with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, </span>which simplifies the
        accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted
        earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings
        per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a
        stated policy.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">This pronouncement was effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021.The Board
          specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition
          is permitted. The Company has determined that the adoption of ASU 2020-06 will not have a material impact on the Company&#8217;s financial statements.</div>

<div><br/>
      </div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-style: italic; font-weight: bold;">Recently Issued Accounting Guidance</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">In March 2020, the FASB issued ASU 2020-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Reference Rate Reform
          (Topic 848): Facilitation of the Effects of Reference</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Rate Reform on Financial Reporting</span>. This ASU provides temporary optional expedients and
        exceptions to the guidance on contract<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR
        and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit
        Agreement (as defined in Note 9) bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
        exist.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contractual adjustments and third-party settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 405<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491204&amp;loc=d3e4869-115612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123364037&amp;loc=d3e3111-115594<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for charging off uncollectible financing receivables, including, but not limited to, factors and methodologies used in estimating the allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (a,b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonControllingInterestsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonControllingInterestsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RestrictedStockPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RestrictedStockPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SelfInsuranceProgramPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SelfInsuranceProgramPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009602696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Operations and Basis of Presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Nature of Operations and Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock', window );">Acquisitions Within Physical Therapy Operations Segment</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">During the last three years we completed the acquisitions of seven
        multi-clinic practices and three industrial injury prevention businesses as detailed below. </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
        <table border="0" cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">% Interest</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Number of</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Clinics</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"> <span style="-sec-ix-hidden:Fact_fcd7d7afc36c4146ae8996c5533e716f">*</span><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">100%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;"> <span style="-sec-ix-hidden:Fact_9e406021f6644e219c3b143ef1491cbb">*</span><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">June 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">June 30, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">March 2021 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">March 31, 2021</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f">**</span><br/>
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65% ***</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4</div>
              </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div>
              </td>

    <td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">67%</div>
              </td>

    <td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 47%; vertical-align: bottom; white-space: nowrap;">April 2019 Acquisition <br/>
              </td>

    <td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 17.16%; vertical-align: bottom; text-align: center; white-space: nowrap;">April 11, 2019<br/>
              </td>

    <td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 14.71%; vertical-align: bottom; text-align: center; white-space: nowrap;">100% <br/>
              </td>

    <td rowspan="1" style="width: 1.66%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td rowspan="1" style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"><span style="-sec-ix-hidden:Fact_b50371aded1746619d40d044e9a29674">*</span><br/>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention
                  business</div>
              </td>

  </tr>


</table>
      </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left;"> The business includes six management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.</td>

  </tr>


</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</td>

    <td style="width: auto; vertical-align: top; text-align: left;"> The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of business combination completed within the physical therapy operations segment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009808392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue, Categories</a></td>
<td class="text">
<div>
      <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;">The following table details the revenue related to the various categories (in
        thousands).</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">Year Ended</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2020</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;">December 31, 2019</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Net patient revenue</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">438,330</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">373,340</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">433,345</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"> Other patient revenue </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,939</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,020</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">2,486</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Physical therapy operations</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$ <br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">441,269</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$<br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">375,360</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$ <br/>
              </span> </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">435,831</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Physical therapy management contracts</div>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">9,853</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">8,410</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/>
                </span> </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">8,676</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Industrial injury prevention services<br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">43,900</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">39,199</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">37,462</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">495,022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">422,969</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">481,969</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009661416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Acquisitions of Businesses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Clinic Acquisition</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the Company acquired a majority interest in the following businesses:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Acquired</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Clinics</div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 2021 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2021</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">75%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom;">November 2021 Acquisition<br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;">November 30, 2021</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;">70%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;"><span style="-sec-ix-hidden:Fact_f2ab670c292849e0a6da2f6f425f8ab8">IIPS*</span></td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">September 2021 Acquisition<br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;">September 30, 2021</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;">100%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"><span style="-sec-ix-hidden:Fact_8fc8c722672b4497be0c04af98353c23">IIPS*</span></td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom;">June 2021 Acquisition<br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;">June 30, 2021</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;">65%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;">8</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">March 2021 Acquisition<br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;">March 31, 2021</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;">70%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;">6</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom;">November 2020 Acquisition</td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;">November 30, 2020</td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;">75%</td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;">3</td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_d7b298373dc646968960932c7a99c477">**</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</div>
          </td>

    <td style="width: 14.58%; vertical-align: bottom;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4</div>
          </td>

  </tr>

  <tr>

    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div>
          </td>

    <td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div>
          </td>

    <td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">67%</div>
          </td>

    <td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 39.03%; vertical-align: bottom;">April 2019 Acquisition <br/>
          </td>

    <td rowspan="1" style="width: 3.06%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22.92%; vertical-align: bottom; text-align: center;">April 11, 2019 <br/>
          </td>

    <td rowspan="1" style="width: 2.78%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.72%; vertical-align: bottom; text-align: right;">100% <br/>
          </td>

    <td rowspan="1" style="width: 2.92%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 14.58%; vertical-align: bottom; text-align: right;"><span style="-sec-ix-hidden:Fact_9ccb1564cfba40339b352148e6a9107a">*</span><br/>
          </td>

  </tr>


</table>

<div><br/>
    </div>

<div>
      <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: left;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Industrial injury prevention business<br/>
              </span></td>

  </tr>


</table>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="c25a46c3472f4e9d89f721c383608370" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">**</td>

    <td style="width: auto; vertical-align: top; text-align: left;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The business includes six management
              and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years</span>.</td>

  </tr>


</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z9554ae614f714132a1278bbaa794d16d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">***</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
            <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.</span></div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Preliminary Purchase Prices Allocation</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2021 acquisitions has been preliminarily allocated as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> IIPS*</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">
                    <div style="margin-top: 0px; margin-bottom: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">Cash paid, net of cash acquired<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">63,193</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,630</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">86,823</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller notes<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">800</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,050</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom">Contingent payments</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">2,520</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">837</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">3,357</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom">Other payable<br/>
                  </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">1,000</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">1,000</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller put right<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,522</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><br/>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <br/>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,522</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70,485</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,267</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">96,752</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,589</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,046</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,635</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,620</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,462</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">19,082</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(4,842</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6,832</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,674</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -15.85pt; margin-left: 60.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,367</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">676</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14,043</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21,126</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,729</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">24,855</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">500</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">574</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,074</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,141</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,755</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,896</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
                    <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">58,257</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">31,489</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">89,746</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(27,906</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,956</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(39,862</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">70,485</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,267</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">96,752</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 13.5pt; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">*Industrial




























              injury prevention services </div>

<div><span class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;&#160;&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2020 physical therapy operations acquisitions has been allocated as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired<br/>
            </div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,912</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,121</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25,033</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,049</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">196</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(562</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">683</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,520</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">500</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,890</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,738</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,298</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25,033</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The purchase price for the 2019 acquisitions was allocated as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">IIPS*</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($<span style="text-indent: 0pt;">890</span>)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18,428</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,170</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30,598</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Payable to shareholders of seller</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">485</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">485</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">22,913</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,470</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">35,383</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,641</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">650</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,291</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">848</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">394</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,242</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,978</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(191</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(3,169</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(489</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">853</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">364</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,400</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,600</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">250</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">270</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">520</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">740</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,040</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18,452</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14,237</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,689</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6,230</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6,230</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">22,913</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,470</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">35,383</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">* Industrial injury prevention services</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663005846264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interest (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_REDEEMABLENONCONTROLLINGINTERESTAbstract', window );"><strong>REDEEMABLE NON-CONTROLLING INTEREST [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021, 2020 and 2019, the following table details the changes in the carrying amount (fair value) of
      the redeemable non-controlling interests (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, <span style="text-indent: 0pt;">2019</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">132,340</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">137,750</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">133,943</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,358</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,175</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,659</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,359</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(12,403</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10,221</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,011</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,632</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,893</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(30,204</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(20,521</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(8,934</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">39,862</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,297</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,230</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reduction of non-controlling interest due to sale of USPH partnership interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6,132</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">982</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,133</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,120</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(914</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,006</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2,870</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest -
              temporary equity</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">186</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">283</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">62</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">155,262</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">132,340</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">137,750</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock', window );">Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, <span style="text-indent: 0pt;">2019</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder's employment has not terminated</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">80,781</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">62,390</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">51,921</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder's employment has not terminated</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">74,481</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">69,950</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">85,829</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has expired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has not expired</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">155,262</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">132,340</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">137,750</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_REDEEMABLENONCONTROLLINGINTERESTAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_REDEEMABLENONCONTROLLINGINTERESTAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663014664392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The changes in the carrying amount of goodwill as of December 31, 2021 and 2020 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">345,646</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">317,676</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">89,746</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">28,540</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill derecognition (write-off) related to closed clinics</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,859</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(713</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,289</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">434,679</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">345,646</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663015969080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Intangible assets, net as of December 31, 2021, and 2020 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">38,790</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,317</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships, net of accumulated amortization of $<span style="text-indent: 0pt;">17,762</span> and $<span style="text-indent: 0pt;">14,522</span>, respectively</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">45,643</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">22,119</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $<span style="text-indent: 0pt;">6,450</span> and $<span style="text-indent: 0pt;">5,993</span>, respectively</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,949</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,844</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">86,382</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">56,280</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Amortization Expenses</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2021, 2020 and 2019 (in thousands):</div>

<div><br/></div>

<div style="text-align: left;">
      <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Customer and referral relationships</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,240</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,845</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,307</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">458</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">569</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">708</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,698</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,414</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,015</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
    </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Amortization of Customer and Referral Relationships and Non Competition Agreements</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The remaining balances of the customer and referral relationships and non-compete agreements <span style="font-family: 'Times New Roman'; font-size: 10pt;">are</span> expected to be amortized as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Customer and Referral Relationships</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,798</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">512</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,691</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">443</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,526</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">387</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,382</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">322</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,914</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">236</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,332</div>
          </td>

    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>

    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
          </td>

    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">49</div>
          </td>

    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009831752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Accrued expenses as of December 31, 2021
      and 2020 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,569</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">24,646</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,649</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,756</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,984</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,113</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">498</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,333</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal taxes payable</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,716</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,885</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">MAAPP funds payable</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14,054</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Contingent payment related to acquisition</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom">Settlement of a legal matter<br/>
          </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">2,750</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,539</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,959</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">45,705</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">59,746</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009752104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Credit Agreement and Notes Payable</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt; margin-left: 9pt;">Notes payable as of December 31, 2021, and 2020 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of <span style="text-indent: 0pt;">2.1</span>% for December 31, 2021 and December 31, 2020, (inclusive of unused fee)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">114,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $<span style="text-indent: 0pt;">830</span> plus accrued interest due in the next year, interest accrues in the range of <span style="text-indent: 0pt;">3.25</span>%
              through <span style="text-indent: 0pt;">4.75</span>% per annum</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,495</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">118,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21,495</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(830</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(4,899</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">117,587</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,596</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663011929160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021
      and 2020, the components of lease expense were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30,710</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,160</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,454</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7,057</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,752</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost<sup>*</sup></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">40,238</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">37,916</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"/>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">*</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Sublease income was immaterial</div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_OperatingLeaseSupplementalInformationTableTextBlock', window );">Supplemental Information Related to Leases</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">For the years ended December 31, 2021
      and 2020, supplemental cash flow information related to leases was as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">33,192</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30,307</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">46,088</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,710</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Future Lease Payments for Operating Leases</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The aggregate future lease payments for operating leases as of December 31, 2021 were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Fiscal Year</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,945</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,467</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20,876</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">14,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">2026<br/>
          </td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">8,492</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2027 and therafter</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7,055</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">110,835</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed interest</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6,175</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104,660</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock', window );">Average Lease Terms and Discount Rates</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Average lease terms and discount rates were as follows:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"><span style="text-indent: 0pt;">2020</span></div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.17 Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"><span style="text-indent: 0pt;">4.05</span> Years</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.77</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.1</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_OperatingLeaseSupplementalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental information related to leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_OperatingLeaseSupplementalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to weighted average lease terms and discount rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663015974696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2021 and
      2020 were as follows (in thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Compensation</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,817</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,865</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">573</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">396</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Acquired net operating losses</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">558</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Lease obligations - including closed clinics</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,856</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,819</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30,246</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,638</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(19,607</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(12,650</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,637</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21,419</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(387</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(348</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(44,631</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(34,417</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax liability</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(14,385</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(7,779</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The differences between the federal tax rate and the Company&#8217;s effective tax rate for the years ended December 31, 2021, 2020 and
      2019 were as follows (in thousands):</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">U. S. tax at statutory rate</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,782</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,125</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,274</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap; width: 28%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income taxes, net of federal benefit</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,478</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.4</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,956</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.9</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,059</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.8</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Excess equity compensation deduction</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(246</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-0.4</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(99</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.0%</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(871</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-1.6</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap; width: 28%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,258</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.2</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,040</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.1</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,185</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.2</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">15,272</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27.2</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27.0</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,647</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25.4</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
          </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Significant Components of Provision for Income Taxes for Continuing Operations</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Significant components of the provision for income taxes for the years ended December 31, 2021, 2020 and 2019 were as follows (in
      thousands):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">December 31, </span>2019</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Current:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">7,477</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">10,506</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">6,523</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">2,107</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,774</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,473</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">9,584</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,280</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8,996</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Federal</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,866</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(38</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,730</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">822</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(220</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">921</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,688</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(258</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,651</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total income tax provision</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">15,272</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">13,022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">13,647</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663016118968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Selected Financial Data for Reportable Segments</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he following table summarizes selected financial data for the
        Company&#8217;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation</span>.</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;<span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Year Ended December 31,</span><br/>
          </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2019</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> <br/>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> <br/>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenue:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">451,122</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">383,770</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">444,507</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">43,900</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">39,199</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">37,462</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">495,022</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">422,969</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">481,969</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations (excluding closure costs) (a non-GAAP measure)<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">106,518</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">88,295</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104,120</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,694</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,086</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">8,379</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">117,212</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">98,381</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">112,499</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations - closure costs</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">30</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,931</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">117,182</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">94,450</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">112,474</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">587,801</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">499,911</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">518,027</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">161,625</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">94,450</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">112,474</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">749,426</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">594,361</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">630,501</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663013929832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Equity Based Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Cumulative Summary of Equity Plans</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">A cumulative summary of equity plans as of December 31, 2021 follows:</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Authorized</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Stock Issued</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Stock Options</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Exercised</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Exercisable</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>for Grant</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Equity Plans</span></div>
          </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amended 1999 Plan</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">600,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">416,402</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">139,791</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">7,775</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amended 2003 Plan</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,100,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,166,855</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">778,300</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">164,882</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,700,000</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,583,257</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">918,091</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">172,657</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Restricted Stock Granted and Cancelled</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the Company granted the following shares of restricted stock to directors, officers and employees
      pursuant to its equity plans as follows:</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Granted</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Value Per Share</div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2021</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">60,317</div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">131.29</div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 33.07%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2020</div>
          </td>

    <td style="vertical-align: bottom; width: 0.97%;">&#160;</td>

    <td style="vertical-align: bottom; width: 33.21%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">86,982</div>
          </td>

    <td style="vertical-align: bottom; width: 1.11%;">&#160;</td>

    <td style="vertical-align: bottom; width: 2.36%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="vertical-align: bottom; width: 28.07%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104.69</div>
          </td>

    <td style="vertical-align: bottom; width: 1.21%;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2019</div>
          </td>

    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">91,682</div>
          </td>

    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">104.85</div>
          </td>

    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>


</table>

<div style="text-align: left;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">During 2021, 2020 and 2019, the following shares were cancelled due to employee terminations prior to restrictions lapsing:</div>

<div style="text-align: left;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Cancelled</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
              </span>Value Per Share</div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2021</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">439</div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">113.80</div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 33.06%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2020</div>
          </td>

    <td style="vertical-align: bottom; width: 1%;">&#160;</td>

    <td style="vertical-align: bottom; width: 33.04%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,037</div>
          </td>

    <td style="vertical-align: bottom; width: 1.32%;">&#160;</td>

    <td style="vertical-align: bottom; width: 2.23%;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="vertical-align: bottom; width: 28.13%;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">102.52</div>
          </td>

    <td style="vertical-align: bottom; width: 1.22%;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2019</div>
          </td>

    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,578</div>
          </td>

    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">87.88</div>
          </td>

    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663014678200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computations of Basic and Diluted Earnings Per Share</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">The computations of basic and diluted earnings per share for the years ended December 31, 2021, 2020 and 2019 are as follows (in
      thousands, except per share data):</div>

<div><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2021</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div>
          </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">40,831</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">35,194</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">40,039</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Charges) credit to retained earnings:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(13,011</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(4,632</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,893</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of <span style="text-indent: 0pt;">25.55</span>% and <span style="text-indent: 0pt;">26.25</span>%, respectively<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,324</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,216</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,121</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">31,144</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">31,778</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">31,267</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.41</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.48</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.45</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">
            <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,898<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,835<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,756<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663001669368">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>Contract</div>
</th>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>Partnership </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Clinic </div>
<div>Segment </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Clinic </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Partnership</div>
</th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships | Partnership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_MultiClinicPracticesMember', window );">Multi-Clinic Practices [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember', window );">IIPS [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RemainingContractTerm', window );">Remaining contract term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember', window );">December 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember', window );">November 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember', window );">September 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember', window );">June 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember', window );">March 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_November2020AcquisitionMember', window );">November 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2020AcquisitionMember', window );">September 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_February2020AcquisitionMember', window );">February 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 27,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember', window );">September 2019 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_April2019AcquisitionMember', window );">April 2019 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 11,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfManagementContracts', window );">Number of management contracts | Contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RemainingContractTerm', window );">Remaining contract term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships | Partnership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Industrial injury prevention
                  business</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The business includes six management
              and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The business includes six management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfManagementContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of management contracts during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfManagementContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfPartnershipInWhichInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of partnership in which interest acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfPartnershipInWhichInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RemainingContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RemainingContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_MultiClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_MultiClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_November2020AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_November2020AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_September2020AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_September2020AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_February2020AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_February2020AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_April2019AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_April2019AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009887048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Operations and Basis of Presentation - Summary (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Location </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfGeneralPartnershipInterestOwned', window );">Percentage of general partnership interest owned</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Clinic</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfClosedClinicsSold', window );">Number of closed clinics sold | Clinic</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AggregateSalePriceOfCinics', window );">Aggregate sale price of clinics</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashReceivedRelatedToSaleOfClinics', window );">Cash received related to sale of closed clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NoteReceivableRelatedToSaleOfClinics', window );">Note receivable related to sale of closed clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration', window );">Number of installments for note receivable | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReliefFunds', window );">Relief funds</a></td>
<td class="nump">4,597<span></span>
</td>
<td class="nump">$ 13,501<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember', window );">Medicare Accelerated and Advance Payments Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Advance payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RepaymentOfFunds', window );">Repayment of funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember', window );">Public Health and Social Services Emergency Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_GrantsAndOtherFunds', window );">Grants and other funds</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReliefFunds', window );">Relief funds</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfLimitedPartnershipInterestOwned', window );">Percentage of limited partnership interest owned</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfOperatingClinicLocations', window );">Number of operating clinic locations | Location</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfLimitedPartnershipInterestOwned', window );">Percentage of limited partnership interest owned</a></td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AggregateSalePriceOfCinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale price of the clinics sold which were discontinued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AggregateSalePriceOfCinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashReceivedRelatedToSaleOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received related to sale of discontinued clinics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashReceivedRelatedToSaleOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_GrantsAndOtherFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_GrantsAndOtherFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NoteReceivableRelatedToSaleOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note receivable related to sale of discontinued clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NoteReceivableRelatedToSaleOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfClosedClinicsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of closed clinics sold during the period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfClosedClinicsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of installments for note receivable in sale consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfOperatingClinicLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating clinic locations during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfOperatingClinicLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfGeneralPartnershipInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of general partnership interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfGeneralPartnershipInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfLimitedPartnershipInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of limited partnership interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfLimitedPartnershipInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReliefFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Relief funds relates to social welfare, a fund of money set up to provide aid for people in need, especially in disaster areas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReliefFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RepaymentOfFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of repayment to Medicare Accelerated and Advance Payment Program ("MAAPP Funds") rather than applying them to future services performed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RepaymentOfFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663005233304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies, Long-Lived Assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663011834424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies, Goodwill (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Region </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Region</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Region</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationGoodwillAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments | Segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfRegions', window );">Number of regions | Region</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfRegions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of regions of the entity operates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfRegions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663004837384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies, Redeemable Non-Controlling Interest (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestRedeemableAbstract', window );"><strong>Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestRedeemableAbstract', window );"><strong>Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonControllingInterestRedeemableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonControllingInterestRedeemableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The commencement period of redemption rights for redeemable non controlling interest, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663003449592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies, Revenue Recognition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 14, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 02, 2021</div></th>
<th class="th"><div>Feb. 09, 2018</div></th>
<th class="th"><div>Nov. 02, 2015</div></th>
<th class="th"><div>Apr. 01, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495,022,000<span></span>
</td>
<td class="nump">$ 422,969,000<span></span>
</td>
<td class="nump">$ 481,969,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedPercentageOfDecreaseInPayment', window );">Estimated percentage of decrease in payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions', window );">Federal debt ceiling in connection with deficit reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AmountOfReductionsInFederalSpending', window );">Reductions in federal spending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReductionInMedicareSpendingPercentage', window );">Medicare spending cut percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation', window );">Percentage of payment reduction waived through enacted legislation</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PeriodOfExtension', window );">Period of extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo', window );">Percentage of payment reduction waived through enacted legislation, after March 31, 2022 through June 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem', window );">Percentage of increase in payment adjustment for therapists participating in MIPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses', window );">Combined physical therapy/speech language pathology expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses', window );">Reduction in combined physical therapy/speech language pathology expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit', window );">Percentage of practice expense component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings', window );">Percentage reduction for service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPaymentForOutpatientTherapyServices', window );">Percentage of payment for outpatient therapy services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetRevenueFromMedicare', window );">Net patient revenue from Medicare accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,400,000<span></span>
</td>
<td class="nump">101,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=usph_CentersForMedicareAndMedicaidServicesMember', window );">CMS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedPercentageOfDecreaseInPayment', window );">Estimated percentage of decrease in payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem', window );">Percentage of therapist providers participating in MIPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedPercentageOfDecreaseInPayment', window );">Estimated percentage of decrease in payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember', window );">Year 2017 through 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePaymentIncrease', window );">Percentage of increase in Medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember', window );">From 2020 through 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePaymentIncrease', window );">Percentage of increase in Medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember', window );">Net Patient Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 438,330,000<span></span>
</td>
<td class="nump">373,340,000<span></span>
</td>
<td class="nump">433,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_OtherRevenuesMember', window );">Other Patient Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,939,000<span></span>
</td>
<td class="nump">2,020,000<span></span>
</td>
<td class="nump">2,486,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember', window );">Physical Therapy Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">441,269,000<span></span>
</td>
<td class="nump">375,360,000<span></span>
</td>
<td class="nump">435,831,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember', window );">Physical Therapy Management Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,853,000<span></span>
</td>
<td class="nump">8,410,000<span></span>
</td>
<td class="nump">8,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember', window );">Industrial Injury Prevention Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,900,000<span></span>
</td>
<td class="nump">$ 39,199,000<span></span>
</td>
<td class="nump">$ 37,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AmountOfReductionsInFederalSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reductions in federal spending during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AmountOfReductionsInFederalSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Combined physical therapy/speech language pathology expenses during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedPercentageOfDecreaseInPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated percentage of decrease in payment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedPercentageOfDecreaseInPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ExpectedReductionInMedicareSpendingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected reduction in Medicare spending percentage during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ExpectedReductionInMedicareSpendingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MedicareReimbursementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MedicareReimbursementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetRevenueFromMedicare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net revenue from Medicare.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetRevenueFromMedicare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase in payment adjustment for therapists participating in Merit Based Incentive Payment System (MIPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfMedicarePaymentIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Medicare payment increase during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfMedicarePaymentIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPaymentForOutpatientTherapyServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of payment for outpatient therapy services to the therapy assistant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPaymentForOutpatientTherapyServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of payment reduction waived through enacted additional legislation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of payment reduction waived through enacted additional legislation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of practice expense component of relative value unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of therapist providers participating in Merit Based Incentive Payment System (MIPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage reduction for service in office or other non institutional settings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PeriodOfExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extension period of 2021 Act, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PeriodOfExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Combined physical therapy/speech language pathology expenses during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReductionInMedicareSpendingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Medicare spending percentage during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReductionInMedicareSpendingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=usph_CentersForMedicareAndMedicaidServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=usph_CentersForMedicareAndMedicaidServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_OtherRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_OtherRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663010441064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies, Contractual Allowances (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualAllowancesAbstract', window );"><strong>Contractual Allowances [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues', window );">Difference between net revenues and corresponding cash collections, approximately of net revenues</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage', window );">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MaximumContractualAllowanceReserveEstimate', window );">Maximum contractual allowance reserve estimate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualAllowancesAbstract', window );"><strong>Contractual Allowances [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues', window );">Difference between net revenues and corresponding cash collections, approximately of net revenues</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage', window );">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MaximumContractualAllowanceReserveEstimate', window );">Maximum contractual allowance reserve estimate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualAllowancesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualAllowancesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between net revenues and corresponding cash collections reflected percentage of net revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MaximumContractualAllowanceReserveEstimate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum contractual allowance reserve estimate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MaximumContractualAllowanceReserveEstimate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663005860808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies, Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties associated with any unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations', window );">Interest expense recognized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on prepetition obligations included in the statement of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124437977&amp;loc=d3e55733-112764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663003220216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies, Fair Value of Financial Instruments (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Values of Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Values of Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">0.0896<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009823464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies, Segment Reporting (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663013866872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies, Restricted Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=usph_EmployeeMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_OfficerMember', window );">Officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6409961&amp;loc=d3e20487-108367<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=usph_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=usph_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002761352">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses, Acquired Majority Interest (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>Partnership </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Clinic </div>
<div>Contract </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Clinic </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Partnership</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember', window );">December 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember', window );">November 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember', window );">September 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember', window );">June 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember', window );">March 2021 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_November2020AcquisitionMember', window );">November 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2020AcquisitionMember', window );">September 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_February2020AcquisitionMember', window );">February 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 27,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember', window );">September 2019 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_April2019AcquisitionMember', window );">April 2019 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 11,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementAndServicesContractsMember', window );">Management and Services Contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfManagementContracts', window );">Number of management contracts | Contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RemainingContractTerm', window );">Remaining contract term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Industrial injury prevention
                  business</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The business includes six management
              and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The business includes six management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfManagementContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of management contracts during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfManagementContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfPartnershipInWhichInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of partnership in which interest acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfPartnershipInWhichInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RemainingContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RemainingContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_December2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_November2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_September2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_June2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_March2021AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_November2020AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_November2020AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_September2020AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_September2020AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_February2020AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_February2020AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_April2019AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_April2019AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementAndServicesContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ManagementAndServicesContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663005613896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses, 2021 Acquisition (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th" colspan="2">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Apr. 11, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=usph_PreviousOwnersMember', window );">Previous Owners [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Percentage of retained interest by previous owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember', window );">IIPS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 63,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="nump">$ 2,520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">60,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Notes payable</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RemainingContractTerm', window );">Remaining contract term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetPurchase', window );">Ownership rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ReturnToWorkAndErgonomicServicesMember', window );">Return-to-work and Ergonomic Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration', window );">Aggregate purchase price for the acquisition including contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder', window );">Percentage of interest retained by practice founder</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,300<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">$ 8,900<span></span>
</td>
<td class="nump">$ 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payment consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">8,600<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria', window );">Amount payable upon achievement of certain business criteria</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Notes payable</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Industrial




























              injury prevention services &#160;&#160;&#160;</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase from purchase of right to consideration in exchange for good or service transferred to customer when right is conditioned on passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests retained by practice founder at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred including contingent consideration, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration upon on achievement of certain business criteria in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RemainingContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RemainingContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=usph_PreviousOwnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=usph_PreviousOwnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ReturnToWorkAndErgonomicServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ReturnToWorkAndErgonomicServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002579880">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Business, 2021 Preliminary Purchase Prices Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th" colspan="2"><div>Apr. 11, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 86,823<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 23,907<span></span>
</td>
<td class="nump">$ 30,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember', window );">Physical Therapy Operations [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,630<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Other payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,046<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,832)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">676<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Customer and referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">574<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradenames</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,755<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">31,489<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,956)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember', window );">IIPS [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,428<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">63,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,520<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Other payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetPurchase', window );">Seller put right</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,978)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,842)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,367<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Customer and referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradenames</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">58,257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,906)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Acquisitions [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">86,823<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,912<span></span>
</td>
<td class="nump">30,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Other payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetPurchase', window );">Seller put right</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">96,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,033<span></span>
</td>
<td class="nump">35,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">196<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,674)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(562)<span></span>
</td>
<td class="num">(3,169)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,043<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">683<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Customer and referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,855<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,520<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete agreements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,074<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">500<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradenames</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,896<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">2,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">89,746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,738<span></span>
</td>
<td class="nump">32,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(39,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,298)<span></span>
</td>
<td class="num">(6,230)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 96,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 25,033<span></span>
</td>
<td class="nump">$ 35,383<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Industrial




























              injury prevention services &#160;&#160;&#160;</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase from purchase of right to consideration in exchange for good or service transferred to customer when right is conditioned on passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net tangible asset acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-competition agreements recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of referral relationships at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tradename recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireBusinessesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire businesses total consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireBusinessesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663005662712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses, 2020 Acquisition (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Contract</div>
</th>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>USD ($) </div>
<div>Partnership </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Clinic </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=usph_PreviousOwnersMember', window );">Previous Owners [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Percentage of retained interest by previous owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfManagementContracts', window );">Number of management contracts | Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member] | Notes Payable One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member] | Notes Payable Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="nump">$ 12,000,000.0<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">11,700,000<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration', window );">Number of installments | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Notes payable</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.80%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition number of installments for payment of purchase consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfManagementContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of management contracts during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfManagementContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfPartnershipInWhichInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of partnership in which interest acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfPartnershipInWhichInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=usph_PreviousOwnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=usph_PreviousOwnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002653496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Business, 2020 Preliminary Purchase Prices Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="nump">$ 86,823<span></span>
</td>
<td class="nump">$ 23,907<span></span>
</td>
<td class="nump">$ 30,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Acquisitions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="nump">86,823<span></span>
</td>
<td class="nump">23,912<span></span>
</td>
<td class="nump">30,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="nump">2,050<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="nump">96,752<span></span>
</td>
<td class="nump">25,033<span></span>
</td>
<td class="nump">35,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="nump">6,635<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">19,082<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="num">(11,674)<span></span>
</td>
<td class="num">(562)<span></span>
</td>
<td class="num">(3,169)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="nump">14,043<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="nump">24,855<span></span>
</td>
<td class="nump">5,520<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="nump">1,074<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="nump">6,896<span></span>
</td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">2,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="nump">89,746<span></span>
</td>
<td class="nump">27,738<span></span>
</td>
<td class="nump">32,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="num">(39,862)<span></span>
</td>
<td class="num">(11,298)<span></span>
</td>
<td class="num">(6,230)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="nump">$ 96,752<span></span>
</td>
<td class="nump">$ 25,033<span></span>
</td>
<td class="nump">$ 35,383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net tangible asset acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-competition agreements recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of referral relationships at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tradename recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireBusinessesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire businesses total consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireBusinessesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002627176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses, 2019 Acquisition (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Apr. 11, 2019 </div>
<div>USD ($) </div>
<div>State </div>
<div>Location</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,823<span></span>
</td>
<td class="nump">$ 23,907<span></span>
</td>
<td class="nump">$ 30,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember', window );">September 2019 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="nump">12,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="nump">12,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration', window );">Number of installments | Installment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember', window );">September 2019 Acquisition [Member] | September 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember', window );">September 2019 Acquisition [Member] | September 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember', window );">April 2019 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfStatesOfNetworkServices', window );">Number of states of network services | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfOnsiteClientLocations', window );">Number of onsite client locations | Location</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller', window );">Payable to shareholders of seller</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition number of installments for payment of purchase consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount payable to shareholders of seller in business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPayableToShareholdersOfSeller</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfOnsiteClientLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of client locations that included in total operated states that are providing industrial injury prevention services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfOnsiteClientLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfStatesOfNetworkServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents number of states of network services provided by the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfStatesOfNetworkServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_September2019AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=usph_SeptemberTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=usph_SeptemberTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=usph_SeptemberTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=usph_SeptemberTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663004999768">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Business, 2019 Preliminary Purchase Prices Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th" colspan="2"><div>Apr. 11, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 86,823<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 23,907<span></span>
</td>
<td class="nump">$ 30,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember', window );">Physical Therapy Operations [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,630<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller', window );">Payable to shareholders of seller</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,046<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,832)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">676<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">574<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,755<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">31,489<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,956)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember', window );">IIPS [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,428<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">63,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller', window );">Payable to shareholders of seller</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,978)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,842)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,367<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">58,257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,906)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70,485<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Acquisitions [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">86,823<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,912<span></span>
</td>
<td class="nump">30,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller', window );">Payable to shareholders of seller</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">96,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,033<span></span>
</td>
<td class="nump">35,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">196<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,674)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(562)<span></span>
</td>
<td class="num">(3,169)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,043<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">683<span></span>
</td>
<td class="nump">364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,855<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,520<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,074<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">500<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,896<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">2,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">89,746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,738<span></span>
</td>
<td class="nump">32,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interest)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(39,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,298)<span></span>
</td>
<td class="num">(6,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 96,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 25,033<span></span>
</td>
<td class="nump">35,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Industrial




























              injury prevention services &#160;&#160;&#160;</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount payable to shareholders of seller in business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPayableToShareholdersOfSeller</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net tangible asset acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-competition agreements recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of referral relationships at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tradename recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireBusinessesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire businesses total consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireBusinessesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663015051128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Business, Weighted Average Amortization Period (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_CustomerAndReferralRelationshipMember', window );">Customer and Referral Relationship [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="text">13 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years 6 months 14 days<span></span>
</td>
<td class="text">10 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years 1 month 28 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_CustomerAndReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_CustomerAndReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002693464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Sale of Non-Controlling Interests (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Partnership </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Partnership</div>
</th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent', window );">Purchase price for additional non controlling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent', window );">Cash proceeds from sale of non-controlling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfClosedClinicsSold', window );">Number of closed clinics sold | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AggregateSalePriceOfCinics', window );">Aggregate sale price of clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashReceivedRelatedToSaleOfClinics', window );">Cash received related to sale of closed clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NoteReceivableRelatedToSaleOfClinics', window );">Note receivable related to sale of closed clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration', window );">Number of installments for note receivable | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne', window );">Sale of non-controlling interest percentage in partnership one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TaxEffectOnSaleOfNoncontrollingInterest', window );">Tax effect on sale price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">83.80%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the purchase by the parent of an additional equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The purchase of the additional equity interest represented by this element increases the parent's controlling interest in the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents a sale by the parent of a portion of its equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The sale of the equity interest represented by this element does not result in a loss of control by the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AggregateSalePriceOfCinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale price of the clinics sold which were discontinued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AggregateSalePriceOfCinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashReceivedRelatedToSaleOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received related to sale of discontinued clinics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashReceivedRelatedToSaleOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NoteReceivableRelatedToSaleOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note receivable related to sale of discontinued clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NoteReceivableRelatedToSaleOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfClosedClinicsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of closed clinics sold during the period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfClosedClinicsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of installments for note receivable in sale consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfPartnershipInWhichInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of partnership in which interest acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfPartnershipInWhichInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to noncontrolling percentage sold by an entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TaxEffectOnSaleOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of tax effected on noncontrolling interest sale price during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TaxEffectOnSaleOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009932184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract', window );"><strong>Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">$ 132,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Operating results allocated to redeemable non-controlling interest partners</a></td>
<td class="nump">11,358<span></span>
</td>
<td class="nump">$ 11,175<span></span>
</td>
<td class="nump">$ 10,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance</a></td>
<td class="nump">155,262<span></span>
</td>
<td class="nump">132,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract', window );"><strong>Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Fair value</a></td>
<td class="nump">155,262<span></span>
</td>
<td class="nump">132,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember', window );">Redeemable Non-Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract', window );"><strong>Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">132,340<span></span>
</td>
<td class="nump">137,750<span></span>
</td>
<td class="nump">133,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Operating results allocated to redeemable non-controlling interest partners</a></td>
<td class="nump">11,358<span></span>
</td>
<td class="nump">11,175<span></span>
</td>
<td class="nump">10,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests', window );">Distributions to redeemable non-controlling interest partners</a></td>
<td class="num">(11,359)<span></span>
</td>
<td class="num">(12,403)<span></span>
</td>
<td class="num">(10,221)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Changes in the fair value of redeemable non-controlling interest</a></td>
<td class="nump">13,011<span></span>
</td>
<td class="nump">4,632<span></span>
</td>
<td class="nump">11,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Purchases of redeemable non-controlling interest</a></td>
<td class="num">(30,204)<span></span>
</td>
<td class="num">(20,521)<span></span>
</td>
<td class="num">(8,934)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Acquired interest</a></td>
<td class="nump">39,862<span></span>
</td>
<td class="nump">11,297<span></span>
</td>
<td class="nump">6,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation', window );">Reduction of non-controlling interest due to sale of USPH partnership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity', window );">Sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="nump">982<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity', window );">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="num">(914)<span></span>
</td>
<td class="num">(1,006)<span></span>
</td>
<td class="num">(2,870)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity', window );">Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance</a></td>
<td class="nump">155,262<span></span>
</td>
<td class="nump">132,340<span></span>
</td>
<td class="nump">137,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract', window );"><strong>Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated', window );">Contractual time period has lapsed but holder's employment has not terminated</a></td>
<td class="nump">80,781<span></span>
</td>
<td class="nump">62,390<span></span>
</td>
<td class="nump">51,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated', window );">Contractual time period has not lapsed and holder's employment has not terminated</a></td>
<td class="nump">74,481<span></span>
</td>
<td class="nump">69,950<span></span>
</td>
<td class="nump">85,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired', window );">Holder's employment has terminated and contractual time period has expired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired', window );">Holder's employment has terminated and contractual time period has not expired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Fair value</a></td>
<td class="nump">$ 155,262<span></span>
</td>
<td class="nump">$ 132,340<span></span>
</td>
<td class="nump">$ 137,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired', window );">Business acquisition, percentage of limited partnership acquired</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired', window );">Business acquisition, percentage of limited partnership acquired</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed', window );">Percentage of equity interest of subsidiary contributed for acquisition</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired', window );">Business acquisition, percentage of general partnership interest acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionConsiderationPayableTermOfNote', window );">Business acquisition, consideration payable, term of note</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementRenewalTerm', window );">Employment agreement renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder', window );">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TermOfEmploymentAgreement', window );">Employment agreement term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TermOfEmploymentAgreement', window );">Employment agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ProgressiveHealthCompaniesLLCMember', window );">ProgressiveHealth [Member] | NewCo. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed', window );">Percentage of equity interest of subsidiary contributed for acquisition</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder', window );">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries', window );">Percentage of right to sell equity interest on each of the 4th and 5th anniversaries</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries', window );">Percentage of right to sell equity interest on each of the 6th and 7th anniversaries</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionConsiderationPayableTermOfNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of the note issued for consideration payable for the acquisition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionConsiderationPayableTermOfNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of equity interest in subsidiary contributed for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of general partnership interest acquired in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of limited partnership interest acquired in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CarryingAmountOfRedeemableNonControllingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The renewal term of the employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to holder's employment has terminated and contractual time period has expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to holder's employment has terminated and contractual time period has not expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonCompeteAgreementBasicTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonCompeteAgreementBasicTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of right to sell equity interest on each of the 4th and 5th anniversaries by shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of right to sell equity interest on each of the 6th and 7th anniversaries by shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TermOfEmploymentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TermOfEmploymentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ProgressiveHealthCompaniesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ProgressiveHealthCompaniesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663003399736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 345,646<span></span>
</td>
<td class="nump">$ 317,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">89,746<span></span>
</td>
<td class="nump">28,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill derecognition (write-off) related to closed clinics</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,859)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</a></td>
<td class="num">(713)<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 434,679<span></span>
</td>
<td class="nump">$ 345,646<span></span>
</td>
<td class="nump">$ 317,676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663010296824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net - Intangible Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 86,382<span></span>
</td>
<td class="nump">$ 56,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Tradenames [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 38,790<span></span>
</td>
<td class="nump">32,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 45,643<span></span>
</td>
<td class="nump">22,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 17,762<span></span>
</td>
<td class="nump">14,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 1,949<span></span>
</td>
<td class="nump">1,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 6,450<span></span>
</td>
<td class="nump">$ 5,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663005302376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net - Amortization Expenses (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Operation</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">$ 3,698<span></span>
</td>
<td class="nump">$ 3,414<span></span>
</td>
<td class="nump">$ 3,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">2,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">$ 458<span></span>
</td>
<td class="nump">$ 569<span></span>
</td>
<td class="nump">$ 708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Tradenames [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfAcquiredOperations', window );">Number of acquired operations | Operation</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfAcquiredOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to number of acquired operations during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfAcquiredOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663001557656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer and Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 4,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">4,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">4,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">4,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">3,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">23,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 49<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663015047224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries and related costs</a></td>
<td class="nump">$ 23,569<span></span>
</td>
<td class="nump">$ 24,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PatientsAndPayorsRelatedLiability', window );">Credit balances due to patients and payors</a></td>
<td class="nump">6,649<span></span>
</td>
<td class="nump">5,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Group health insurance claims</a></td>
<td class="nump">1,984<span></span>
</td>
<td class="nump">2,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Closure costs</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">1,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Federal taxes payable</a></td>
<td class="nump">2,716<span></span>
</td>
<td class="nump">9,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable', window );">MAAPP Funds Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent', window );">Contingent payment related to acquisition</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Settlement of a legal matter</a></td>
<td class="nump">2,750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">6,539<span></span>
</td>
<td class="nump">1,959<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">45,705<span></span>
</td>
<td class="nump">$ 59,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DeferredEmployerPayrollTaxesCARESACT', window );">Deferred employer payroll taxes - CARES ACT</a></td>
<td class="nump">4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Federal income tax receivable</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DeferredEmployerPayrollTaxesCARESACT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred employer payroll taxes - CARES ACT.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DeferredEmployerPayrollTaxesCARESACT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funds from the CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing Medicare Accelerated and Advance Payments Program ("MAAPP funds") during the COVID-19 pandemic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PatientsAndPayorsRelatedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PatientsAndPayorsRelatedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663008758120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable - Summary of Notes Payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 118,417<span></span>
</td>
<td class="nump">$ 21,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(830)<span></span>
</td>
<td class="num">(4,899)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term portion</a></td>
<td class="nump">117,587<span></span>
</td>
<td class="nump">16,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 114,000<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 4.75% Notes Payable due in Next Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 4,417<span></span>
</td>
<td class="nump">$ 5,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Annual installments</a></td>
<td class="nump">$ 830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 4.75% Notes Payable due in Next Year [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 4.75% Notes Payable due in Next Year [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009890360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable - Amended Credit Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Dec. 05, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Percentage of unused commitment fee</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember', window );">Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount of notes payable</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Aggregate principal payment due in 2021</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate principal payment due in 2022</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Aggregate principal payment due in 2023</a></td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DebtInstrumentBasisSpreadOnLiborVariableRate', window );">Spread on Libor variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DebtInstrumentBasisSpreadOnLiborVariableRate', window );">Spread on Libor variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility commitment</a></td>
<td class="nump">$ 175,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="nump">$ 125,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase on limit of credit facility</a></td>
<td class="nump">25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining revolving credit outstanding</a></td>
<td class="nump">$ 61,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement', window );">Cash and noncash consideration with respect to acquisition after amendment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DividendsCashAfterAmendment', window );">Cash dividends after amendment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and noncash consideration that could pay with respect to acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DebtInstrumentBasisSpreadOnLiborVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DebtInstrumentBasisSpreadOnLiborVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DividendsCashAfterAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DividendsCashAfterAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002673496">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Components of Lease Expense [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 32,021<span></span>
</td>
<td class="nump">$ 30,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">1,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,057<span></span>
</td>
<td class="nump">5,752<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">40,238<span></span>
</td>
<td class="nump">37,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SupplementalInformationRelatedToOperatingLeasesAbstract', window );"><strong>Supplemental Information Related to Leases [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">33,192<span></span>
</td>
<td class="nump">30,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,088<span></span>
</td>
<td class="nump">$ 32,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Future Lease Payments for Operating Leases [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2027 and therafter</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 104,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AverageLeaseTermsAndDiscountRatesAbstract', window );"><strong>Average Lease Terms and Discount Rates [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term - Operating leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">4 years 2 months 1 day<span></span>
</td>
<td class="text">4 years 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - Operating leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.77%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Operating Lease [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Sublease income was immaterial</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AverageLeaseTermsAndDiscountRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AverageLeaseTermsAndDiscountRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SupplementalInformationRelatedToOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SupplementalInformationRelatedToOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002578296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Compensation</a></td>
<td class="nump">$ 2,817<span></span>
</td>
<td class="nump">$ 1,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for credit losses</a></td>
<td class="nump">573<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Acquired net operating losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DeferredTaxAssetsLeaseObligations', window );">Lease obligations - including closed clinics</a></td>
<td class="nump">26,856<span></span>
</td>
<td class="nump">23,819<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">30,246<span></span>
</td>
<td class="nump">26,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="num">(19,607)<span></span>
</td>
<td class="num">(12,650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="num">(24,637)<span></span>
</td>
<td class="num">(21,419)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(348)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(44,631)<span></span>
</td>
<td class="num">(34,417)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">$ (14,385)<span></span>
</td>
<td class="num">$ (7,779)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DeferredTaxAssetsLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DeferredTaxAssetsLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663003109384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxExaminationAbstract', window );"><strong>Income Tax Examination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests', window );">Net deferred tax assets, related to revaluation and acquisition of redeemable non-controlling interests</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Adjustment to deferred tax assets</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties associated with any unrecognized tax benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense', window );">Interest expense recognized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxExaminationAbstract', window );"><strong>Income Tax Examination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Tax payable included in accrued liabilities</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Periods open for examination</a></td>
<td class="text">2018 2019 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxExaminationAbstract', window );"><strong>Income Tax Examination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent', window );">Tax receivable included in other current assets</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Periods open for examination</a></td>
<td class="text">2017 2018 2019 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other tax receivables expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationYearUnderExamination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year being audited in the income tax examination, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationYearUnderExamination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of deferred tax assets related to revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncomeTaxExaminationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncomeTaxExaminationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002968568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. tax at statutory rate</a></td>
<td class="nump">$ 11,782<span></span>
</td>
<td class="nump">$ 10,125<span></span>
</td>
<td class="nump">$ 11,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">2,478<span></span>
</td>
<td class="nump">1,956<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDeductions', window );">Excess equity compensation deduction</a></td>
<td class="num">(246)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="num">(871)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">1,040<span></span>
</td>
<td class="nump">1,185<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="nump">$ 15,272<span></span>
</td>
<td class="nump">$ 13,022<span></span>
</td>
<td class="nump">$ 13,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. tax at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit and tax reform</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductions', window );">Excess equity compensation deduction</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible expenses</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="nump">27.20%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">25.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663011805016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 7,477<span></span>
</td>
<td class="nump">$ 10,506<span></span>
</td>
<td class="nump">$ 6,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">2,107<span></span>
</td>
<td class="nump">2,774<span></span>
</td>
<td class="nump">2,473<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">9,584<span></span>
</td>
<td class="nump">13,280<span></span>
</td>
<td class="nump">8,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">4,866<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">822<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="nump">921<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">5,688<span></span>
</td>
<td class="num">(258)<span></span>
</td>
<td class="nump">4,651<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="nump">$ 15,272<span></span>
</td>
<td class="nump">$ 13,022<span></span>
</td>
<td class="nump">$ 13,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002655832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenue</a></td>
<td class="nump">$ 495,022<span></span>
</td>
<td class="nump">$ 422,969<span></span>
</td>
<td class="nump">$ 481,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">117,182<span></span>
</td>
<td class="nump">94,450<span></span>
</td>
<td class="nump">112,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Closure costs</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">2,072<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">749,426<span></span>
</td>
<td class="nump">594,361<span></span>
</td>
<td class="nump">630,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">117,212<span></span>
</td>
<td class="nump">98,381<span></span>
</td>
<td class="nump">112,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member] | Physical Therapy Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenue</a></td>
<td class="nump">451,122<span></span>
</td>
<td class="nump">383,770<span></span>
</td>
<td class="nump">444,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Closure costs</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">3,931<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">587,801<span></span>
</td>
<td class="nump">499,911<span></span>
</td>
<td class="nump">518,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member] | Industrial Injury Prevention Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenue</a></td>
<td class="nump">43,900<span></span>
</td>
<td class="nump">39,199<span></span>
</td>
<td class="nump">37,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">10,694<span></span>
</td>
<td class="nump">10,086<span></span>
</td>
<td class="nump">8,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">161,625<span></span>
</td>
<td class="nump">94,450<span></span>
</td>
<td class="nump">112,474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member] | Physical Therapy Operations (Less Closure Costs) (a non-GAAP measure) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">$ 106,518<span></span>
</td>
<td class="nump">$ 88,295<span></span>
</td>
<td class="nump">$ 104,120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663008326184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Unconsolidated Affiliate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract', window );"><strong>Investments in Unconsolidated Affiliate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in unconsolidated affiliate</a></td>
<td class="nump">$ 12,215<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings from investment in unconsolidated affiliate</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=usph_JointVentureInterestMember', window );">Joint Venture Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract', window );"><strong>Investments in Unconsolidated Affiliate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership in joint venture interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in unconsolidated affiliate</a></td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentQuotedMarketValue', window );">Fair value of investment in unconsolidated affiliate</a></td>
<td class="nump">12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings from investment in unconsolidated affiliate</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distribution received from investment in unconsolidated affiliate</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentQuotedMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentQuotedMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=usph_JointVentureInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=usph_JointVentureInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663008331848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 17, 2016</div></th>
<th class="th"><div>Mar. 16, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common shares available for grant (in shares)</a></td>
<td class="nump">172,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember', window );">Amended 2003 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common shares available for grant (in shares)</a></td>
<td class="nump">164,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Non Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Amended 2003 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common shares available for grant (in shares)</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=usph_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=usph_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002951800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Based Plans - Cumulative Summary of Equity Plans (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 17, 2016</div></th>
<th class="th"><div>Mar. 16, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod', window );">Restricted stock issued (in shares)</a></td>
<td class="nump">1,583,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding stock options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod', window );">Stock options exercised (in shares)</a></td>
<td class="nump">918,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">172,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=usph_AmendedNineteenNinetyNinePlanMember', window );">Amended 1999 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod', window );">Restricted stock issued (in shares)</a></td>
<td class="nump">416,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding stock options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod', window );">Stock options exercised (in shares)</a></td>
<td class="nump">139,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">7,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember', window );">Amended 2003 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod', window );">Restricted stock issued (in shares)</a></td>
<td class="nump">1,166,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding stock options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod', window );">Stock options exercised (in shares)</a></td>
<td class="nump">778,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">164,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised for the cumulative period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made for the cumulative period on restricted stock units plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=usph_AmendedNineteenNinetyNinePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=usph_AmendedNineteenNinetyNinePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009840424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details) - Restricted Stock [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares (in shares)</a></td>
<td class="nump">60,317<span></span>
</td>
<td class="nump">86,982<span></span>
</td>
<td class="nump">91,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (in dollars per share)</a></td>
<td class="nump">$ 131.29<span></span>
</td>
<td class="nump">$ 104.69<span></span>
</td>
<td class="nump">$ 104.85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663012156360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details) - Restricted Stock [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of shares (in shares)</a></td>
<td class="nump">439<span></span>
</td>
<td class="nump">10,037<span></span>
</td>
<td class="nump">1,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average fair value (in dollars per share)</a></td>
<td class="nump">$ 113.80<span></span>
</td>
<td class="nump">$ 102.52<span></span>
</td>
<td class="nump">$ 87.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002633208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed', window );">Shares outstanding for which restrictions had not lapsed (in shares)</a></td>
<td class="nump">102,682<span></span>
</td>
<td class="nump">127,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="nump">$ 7.8<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Compensation not yet recognized</a></td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=usph_EmployeesMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RestrictedPeriodToEmployeesOnTheStockGranted', window );">Restricted period on the stock granted</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember', window );">Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RestrictedPeriodToEmployeesOnTheStockGranted', window );">Restricted period on the stock granted</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription', window );">Restrictions will lapse in</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription', window );">Restrictions will lapse in</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RestrictedPeriodToEmployeesOnTheStockGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted period to employees on the stock granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RestrictedPeriodToEmployeesOnTheStockGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares outstanding for which restrictions had not lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of restriction lapse grant to employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=usph_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=usph_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663005834024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2009</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2008</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Class of Stock Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Total purchased shares (in shares)</a></td>
<td class="nump">859,499<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AdditionalEstimatedRepurchaseOfCommonStock', window );">Additional estimated shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Closing price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Class of Stock Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Common stock authorized by the Board of Directors (in shares)</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfRepurchaseOfCommonStock', window );">Percentage of repurchase of common stock</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock', window );">Bank credit agreement to permit share repurchases of common stock</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AdditionalEstimatedRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional estimated repurchase of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AdditionalEstimatedRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bank credit agreement to permit share repurchases of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of repurchase of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663013571384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan', window );">Required time period for employees for profit sharing plan</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Maximum employer contribution as a percentage of employee contribution</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contribution expense recognized</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DefinedContributionPlanEmployerMatchingContributionAmount', window );">Employer matching contribution amount</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DefinedContributionPlanEmployerMatchingContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of matching contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DefinedContributionPlanEmployerMatchingContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period consider for new employees to cover under defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663015081768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 29, 2019 </div>
<div>Defendant</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Officer</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsAbstract', window );"><strong>Employee Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsExpirationDate', window );">Expiration date of employment agreement, one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  08,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsExpirationDateTwo', window );">Expiration date of employment agreement, two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsExpirationDateThree', window );">Expiration date of employment agreement, three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsExpirationDateFour', window );">Expiration date of employment agreement, four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 28,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RenewalPeriodForEmploymentAgreement', window );">Renewal period of employment agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmployeeCompensationFuturePaymentDueNextFiscalYear', window );">Future compensation - 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter', window );">Future compensation - 2023 through 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlementAbstract', window );"><strong>Litigation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfDefendants', window );">Number of defendants dismissed | Defendant</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Amount of payments recorded as expense during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlementAbstract', window );"><strong>Litigation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Payment of settlement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember', window );">Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsAbstract', window );"><strong>Employee Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfEmployeesCoveredUnderEmployeeAgreement', window );">Number of officers with the company had employee agreement | Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of defendants named in a legal action.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmployeeCompensationFuturePaymentDueNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum payments for employee agreements in excess of one year due in the next fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmployeeCompensationFuturePaymentDueNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum payments for employee agreements in excess of one year due after next fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the employment agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsExpirationDateFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the employment agreements four.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsExpirationDateFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsExpirationDateThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the employment agreements three.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsExpirationDateThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsExpirationDateTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the employment agreements two.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsExpirationDateTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfEmployeesCoveredUnderEmployeeAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of employees covered under employee agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfEmployeesCoveredUnderEmployeeAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RenewalPeriodForEmploymentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employment agreement renewal period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RenewalPeriodForEmploymentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663002606024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Computation of earnings per share - USPH shareholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">$ 40,831<span></span>
</td>
<td class="nump">$ 35,194<span></span>
</td>
<td class="nump">$ 40,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CreditChargesToRetainedEarningsAbstract', window );"><strong>(Charges) credit to retained earnings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests', window );">Revaluation of redeemable non-controlling interest</a></td>
<td class="num">(13,011)<span></span>
</td>
<td class="num">(4,632)<span></span>
</td>
<td class="num">(11,893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate', window );">Tax effect at statutory rate (federal and state) of 25.55% and 26.25%, respectively</a></td>
<td class="nump">3,324<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">3,121<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests', window );">Net income attributable to common shareholders</a></td>
<td class="nump">$ 31,144<span></span>
</td>
<td class="nump">$ 31,778<span></span>
</td>
<td class="nump">$ 31,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share basic (in dollars per share)</a></td>
<td class="nump">$ 2.41<span></span>
</td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="nump">$ 2.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share diluted (in dollars per share)</a></td>
<td class="nump">$ 2.41<span></span>
</td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="nump">$ 2.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares used in computation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic earnings per share - weighted-average shares (in shares)</a></td>
<td class="nump">12,898<span></span>
</td>
<td class="nump">12,835<span></span>
</td>
<td class="nump">12,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted earnings per share - weighted-average shares (in shares)</a></td>
<td class="nump">12,898<span></span>
</td>
<td class="nump">12,835<span></span>
</td>
<td class="nump">12,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate', window );">Federal and state statutory income tax rate</a></td>
<td class="nump">25.55%<span></span>
</td>
<td class="nump">26.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income (loss) from revaluation of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CreditChargesToRetainedEarningsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CreditChargesToRetainedEarningsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal and state statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663009797768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SettlementOfShortSwingProfitClaimAbstract', window );"><strong>Settlement of Short Swing Profit Claim [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShortSwingProfitSettlement', window );">Short swing profit settlement</a></td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SettlementOfShortSwingProfitClaimAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SettlementOfShortSwingProfitClaimAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShortSwingProfitSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short swing profit settlement from any purchase or sale (or sale and purchase) of the company's equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShortSwingProfitSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140663011965688">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - Allowance for Credit Losses [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="nump">$ 2,008<span></span>
</td>
<td class="nump">$ 2,698<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions Charged to Cost and Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="nump">5,305<span></span>
</td>
<td class="nump">4,623<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Additions Charged to Other Accounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td colspan="2" class="nump">4,545<span></span>
</td>
<td class="nump">5,313<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="nump">$ 2,768<span></span>
</td>
<td class="nump">$ 2,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2,698<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Related to patient accounts receivable and accounts
              receivable-other.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Uncollectible accounts written off, net of
              recoveries.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>brhc10034321_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:usph="http://usph.com/20211231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="usph-20211231.xsd" xlink:type="simple"/>
    <context id="c20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20220301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="c20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_ProductOrServiceAxis_NetPatientRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_September2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2020AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:June2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2020AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:December2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:February2020AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_April2019AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:April2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_November2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_September2020AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2020AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_September2019AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_November2020AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:November2020AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_March2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:March2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_February2020AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:February2020AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_June2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:June2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_September2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_December2021AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:December2021AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20180831_BusinessAcquisitionAxis_April2019AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:April2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_MultiClinicPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:MultiClinicPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20180831to20180831_BusinessAcquisitionAxis_April2019AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:April2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-27</startDate>
            <endDate>2020-02-27</endDate>
        </period>
    </context>
    <context id="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_ManagementContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20200430_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20211231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ProductOrServiceAxis_OtherRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ProductOrServiceAxis_ManagementContractRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_ManagementContractRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ProductOrServiceAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_ManagementContractRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_UnusualOrInfrequentItemAxis_FromTwoThousandSeventeenThroughTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandSeventeenThroughTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usph:CentersForMedicareAndMedicaidServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20151102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2015-11-02</instant>
        </period>
    </context>
    <context id="c20221231_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20130401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2013-04-01</instant>
        </period>
    </context>
    <context id="c20211102_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usph:CentersForMedicareAndMedicaidServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-02</instant>
        </period>
    </context>
    <context id="c20180209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2018-02-09</instant>
        </period>
    </context>
    <context id="c20241231_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c20210401to20210414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-14</endDate>
        </period>
    </context>
    <context id="c20211231_MeasurementInputTypeAxis_MeasurementInputDiscountRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_TitleOfIndividualAxis_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_TitleOfIndividualAxis_OfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_TitleOfIndividualAxis_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_April2019AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:April2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementAndServicesContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210630_OwnershipAxis_PreviousOwnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20210331_OwnershipAxis_PreviousOwnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-30</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-30</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ReturnToWorkAndErgonomicServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ReturnToWorkAndErgonomicServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20200930_BusinessAcquisitionAxis_ManagementContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c20201130_OwnershipAxis_PreviousOwnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:PreviousOwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-30</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c20201130_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c20210930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AprilTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-11</startDate>
            <endDate>2019-04-11</endDate>
        </period>
    </context>
    <context id="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AprilTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-11</instant>
        </period>
    </context>
    <context id="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:SeptemberTwoThousandTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:SeptemberTwoThousandTwentyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:September2019AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-11</startDate>
            <endDate>2019-04-11</endDate>
        </period>
    </context>
    <context id="c20190930to20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-11</instant>
        </period>
    </context>
    <context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerAndReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:CustomerAndReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20191231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20191231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ProgressiveHealthCompaniesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ProgressiveHealthCompaniesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_DebtInstrumentAxis_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_DebtInstrumentAxis_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-05</instant>
        </period>
    </context>
    <context id="c20211130_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="c20211231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_IncomeTaxAuthorityAxis_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usph:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20160316_PlanNameAxis_AmendedTwoThousandThreePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-16</instant>
        </period>
    </context>
    <context id="c20160317_PlanNameAxis_AmendedTwoThousandThreePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-17</instant>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">usph:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedNineteenNinetyNinePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_TitleOfIndividualAxis_ExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_TitleOfIndividualAxis_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20090331_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-03-31</instant>
        </period>
    </context>
    <context id="c20081231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2008-12-31</instant>
        </period>
    </context>
    <context id="c20090301to20090331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2009-03-01</startDate>
            <endDate>2009-03-31</endDate>
        </period>
    </context>
    <context id="c20191029to20191029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2019-10-29</startDate>
            <endDate>2019-10-29</endDate>
        </period>
    </context>
    <context id="c20220101to20220131_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="U001">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U002">
        <measure>shares</measure>
    </unit>
    <unit id="U003">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U004">
        <measure>usph:Segment</measure>
    </unit>
    <unit id="U005">
        <measure>pure</measure>
    </unit>
    <unit id="U006">
        <measure>usph:Clinic</measure>
    </unit>
    <unit id="U007">
        <measure>usph:Contract</measure>
    </unit>
    <unit id="U008">
        <measure>usph:Partnership</measure>
    </unit>
    <unit id="U009">
        <measure>usph:Location</measure>
    </unit>
    <unit id="U010">
        <measure>usph:Installment</measure>
    </unit>
    <unit id="U011">
        <measure>usph:Region</measure>
    </unit>
    <unit id="U012">
        <measure>usph:State</measure>
    </unit>
    <unit id="U013">
        <measure>usph:Operation</measure>
    </unit>
    <unit id="U014">
        <measure>usph:Officer</measure>
    </unit>
    <unit id="U015">
        <measure>usph:Defendant</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="c20210101to20211231"
      id="Fact_dd0adf1d21a34bc6bfbdff6323f3552c">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20210101to20211231"
      id="Fact_eaa2eca240174997b7454eff11917b4a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="c20210101to20211231"
      id="Fact_f0b58e628f0c41068609c3086c6d1c60">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="c20210101to20211231"
      id="Fact_1a02d041c664420dae8094f8e12bafd8">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityRegistrantName
      contextRef="c20210101to20211231"
      id="Fact_1f6f6ed096094570aff6730404ad4533">U S PHYSICAL THERAPY INC /NV</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="c20210101to20211231"
      id="Fact_8794823c7a6d4dc8a98432671f91c8a6">0000885978</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20210101to20211231"
      id="Fact_ff866f137ca54505be4c4f424e18c9dd">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressStateOrProvince
      contextRef="c20210101to20211231"
      id="Fact_331d90dd871243119409f00f669d2f5a">TX</dei:EntityAddressStateOrProvince>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2021AcquisitionMember"
      id="Fact_9e406021f6644e219c3b143ef1491cbb"
      unitRef="U006"
      xsi:nil="true"/>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"
      id="Fact_fcd7d7afc36c4146ae8996c5533e716f"
      unitRef="U006"
      xsi:nil="true"/>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"
      id="Fact_f2ab670c292849e0a6da2f6f425f8ab8"
      unitRef="U006"
      xsi:nil="true"/>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"
      id="Fact_8fc8c722672b4497be0c04af98353c23"
      unitRef="U006"
      xsi:nil="true"/>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20180831to20180831_BusinessAcquisitionAxis_April2019AcquisitionMember"
      id="Fact_b50371aded1746619d40d044e9a29674"
      unitRef="U006"
      xsi:nil="true"/>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember"
      id="Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f"
      unitRef="U006"
      xsi:nil="true"/>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember"
      id="Fact_d7b298373dc646968960932c7a99c477"
      unitRef="U006"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember"
      id="Fact_20d1e6de339f4109b6e30d66a9ab05cd">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember"
      id="Fact_8dba1636fbb14fd492a5df628ebe9b1c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember"
      id="Fact_88c34f0df7f44d898218c12bf8c8a138">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod
      contextRef="c20210101to20211231_RangeAxis_MinimumMember"
      id="Fact_054bc4ad0f534600aebe5987db19283e">P3Y</usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20210101to20211231_TitleOfIndividualAxis_EmployeeMember"
      id="Fact_61e076fe690248718f13697be1324500">P4Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20210101to20211231_TitleOfIndividualAxis_DirectorMember"
      id="Fact_139391eb54254fc583112777fb6d273d">P1Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_April2019AcquisitionMember"
      id="Fact_9ccb1564cfba40339b352148e6a9107a"
      unitRef="U006"
      xsi:nil="true"/>
    <usph:TermOfEmploymentAgreement
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"
      id="Fact_0d92bcc8360a42b4b9b9cf260432b9cf">P3Y</usph:TermOfEmploymentAgreement>
    <usph:NonCompeteAgreementBasicTerm
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"
      id="Fact_0b4b01dde9444fa395f3ee7e597f70c6">P5Y</usph:NonCompeteAgreementBasicTerm>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="c20210101to20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"
      id="Fact_b89ef7a81a69420b8fe8694136cd02d4">2017 2018 2019 2020</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="c20210101to20211231_IncomeTaxAuthorityAxis_ForeignCountryMember"
      id="Fact_19a08fedb1b74db5a6b4b517c5b42088">2018 2019 2020</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <usph:RestrictedPeriodToEmployeesOnTheStockGranted
      contextRef="c20210101to20211231_TitleOfIndividualAxis_EmployeesMember"
      id="Fact_bc274c91f2484d4a9acb65f2349c1f1a">P4Y</usph:RestrictedPeriodToEmployeesOnTheStockGranted>
    <dei:AuditorFirmId
      contextRef="c20210101to20211231"
      id="Fact_e5031b4fde974c0ab8fd6effd4a5c369">248</dei:AuditorFirmId>
    <dei:DocumentType
      contextRef="c20210101to20211231"
      id="Fact_8b138bc4a508432bad32abdc4fc5d1f6">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="c20210101to20211231"
      id="Fact_0c9ac8549f9a496ea33e2c62c660a38f">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="c20210101to20211231"
      id="Fact_66f316006bb241c0af1068a078c78362">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="c20210101to20211231"
      id="Fact_34d6795bfcf44e0781b936b6805a9cdc">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="c20210101to20211231"
      id="Fact_57f4bcc21af54b69b0e85816e88af797">1-11151</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20210101to20211231"
      id="Fact_dfe23e55c54043568a333e75511aa657">76-0364866</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20210101to20211231"
      id="Fact_38473952475c4647b1e37e394c412845">1300 WEST SAM HOUSTON PARKWAY SOUTH</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20210101to20211231"
      id="Fact_5fce8db17a5e46649d62710e69ad6820">SUITE 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20210101to20211231"
      id="Fact_227c5371c2864e8fab46898c42d4f34f">HOUSTON</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="c20210101to20211231"
      id="Fact_2f2a0d2f61a544ccb96ab7bdad3de92e">77042</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20210101to20211231"
      id="Fact_7942a8ca5f714a4384084ccac8a62dd4">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20210101to20211231"
      id="Fact_6f67df2778674ef096d48567aafa8365">297-7000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20210101to20211231"
      id="Fact_664d610ad8d44307b867cb6e0f497ea0">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20210101to20211231"
      id="Fact_f4403032586e4456a16561f63de366bb">USPH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20210101to20211231"
      id="Fact_1a4c883fd0ac4c998932d014b7f2e50b">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="c20210101to20211231"
      id="Fact_1c2b4b221c644bfba8b601c63bff5025">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="c20210101to20211231"
      id="Fact_92e6b7fcda014bd2bc7afe6a49eab002">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="c20210101to20211231"
      id="Fact_893fd61509bc4904b3c8245576a16e1b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="c20210101to20211231"
      id="Fact_70bd826fc0a14ec687b4c6a35bf281ce">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="c20210101to20211231"
      id="Fact_a3a3951176bf4f89b92a67eaa47f960e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="c20210101to20211231"
      id="Fact_febaeed46c4c4d57a720991d62e47ae9">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20210101to20211231"
      id="Fact_c354f2bc62d740b6bd2578a41b5818e6">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="c20210101to20211231"
      id="Fact_c5bccef27fa84c5494f13829d14c69c7">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="c20210101to20211231"
      id="Fact_cc5d4fdf8e6f4b869b31c10e024d3a7e">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="c20210630"
      decimals="-6"
      id="Fact_9273df2b594f4c92b6c6c6a4f0ecb9a9"
      unitRef="U001">838000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c20220301"
      decimals="INF"
      id="Fact_7c7130a0c3a84205a3be0c8549eb707a"
      unitRef="U002">12950588</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName
      contextRef="c20210101to20211231"
      id="Fact_4215a5369ab345179e60af1f9990d085">GRANT THORNTON LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="c20210101to20211231"
      id="Fact_c7b95ae6b1bd4efb8edf79999df50049">Houston, Texas</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a535ef736e1a487380cec1ed89cd22f5"
      unitRef="U001">28567000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_be9cfb14488f44f5ae61950ac34017f5"
      unitRef="U001">32918000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e72303e0e1764b678c8a765c34ac7843"
      unitRef="U001">2768000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_43c922e483fc4473bf117994cde11764"
      unitRef="U001">2008000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_76ecf9bdd9104d74ab0ccb2b6e4586f3"
      unitRef="U001">46272000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d8c29be33f2d412283c065802dd7495d"
      unitRef="U001">41906000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1803d5b8e4d34c6ab952da610c91632f"
      unitRef="U001">16144000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b60a785d75c5498f9f8c85b5963b45e1"
      unitRef="U001">9039000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7a1dc8b4e77d489e8d4801da06dc1d51"
      unitRef="U001">4183000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_fb4a90e0f4fb40ab9583d5789bce0908"
      unitRef="U001">3773000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e8eedf6740184abb97fb8f06d9d9e72f"
      unitRef="U001">95166000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_181d032dd50d43e096704a99afcdc5c3"
      unitRef="U001">87636000</us-gaap:AssetsCurrent>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cbc5d6d16bec4d67aab83ce897c02828"
      unitRef="U001">58743000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_03d18b74548b406bb41a92527d666d72"
      unitRef="U001">55426000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ec1cddb9504a41baaf51be15d8b20462"
      unitRef="U001">39194000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e13cdd10024648feae96cf7ecb37b41c"
      unitRef="U001">35320000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_22214af7dffc4b88918393339547d34d"
      unitRef="U001">97937000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4ae6d370b109429cb93c0541e67cdef1"
      unitRef="U001">90746000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3086730850d74ade8797855a48924ee3"
      unitRef="U001">74958000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4dcda22fab13481481424a3e4ed92d5c"
      unitRef="U001">69081000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cb45fc19b7f84e7e8e07ce186c74f506"
      unitRef="U001">22979000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d5eb708555d44300b413f17e4bd213ea"
      unitRef="U001">21665000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_75a77e2966d7436a9df1684a4fa0642f"
      unitRef="U001">96427000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4dcaa2524c414fd0a543fe7fd31c63d3"
      unitRef="U001">81595000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d6f3228bb15f4163bfc87dceeb3794bc"
      unitRef="U001">12215000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c20201231"
      decimals="-3"
      id="Fact_0e1d5b0f39644aa9b33d8cd942f501bd"
      unitRef="U001">0</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6f92e980b420496683bbebdcfdfab404"
      unitRef="U001">434679000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_9011cafb8ec941f38948a1a503f83288"
      unitRef="U001">345646000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7c184a117b3b44df9784196399c85d4a"
      unitRef="U001">86382000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_caeddf66f77746c194d65fb19932368e"
      unitRef="U001">56280000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2abf96646c8a4d9eaa4dd45e0a13b40a"
      unitRef="U001">1578000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_92a013d44ef74f1bac9a70311c6de12f"
      unitRef="U001">1539000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_71860dd8915e4aee9da560c0fdd5dbe2"
      unitRef="U001">749426000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d29aa4d0b20c4153ba04b98ba98caf55"
      unitRef="U001">594361000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_39cd985855e64dc2849a805e3fcef260"
      unitRef="U001">3268000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_7b2aa506a6d5480a8de0b524d8cbda2e"
      unitRef="U001">1335000</us-gaap:AccountsPayableTradeCurrent>
    <usph:AccountsPayableDueToSellerOfAcquiredBusiness
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0a5a6154cfff4795b74d9935f31abc03"
      unitRef="U001">3203000</usph:AccountsPayableDueToSellerOfAcquiredBusiness>
    <usph:AccountsPayableDueToSellerOfAcquiredBusiness
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f256b437bea84123953ade840fd40419"
      unitRef="U001">0</usph:AccountsPayableDueToSellerOfAcquiredBusiness>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_75e42cb1eac548ff92b25d4e3316f063"
      unitRef="U001">45705000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_5cc11329e9614fbeab1ab488f369fad9"
      unitRef="U001">59746000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f1b27ba54dab47a5899787cbcb4741d5"
      unitRef="U001">30475000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b1ccd3fb1cfe49a4bd9b310f975be4ca"
      unitRef="U001">27512000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_8b4b09b7a12d45be8c319690b273b6c6"
      unitRef="U001">830000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_6e5bf4cde38644dab6a00c2f6d0eb249"
      unitRef="U001">4899000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bb00b0a9397a493ca10dfb763916b7c4"
      unitRef="U001">83481000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d86db25023114b7bba8151c0559b263b"
      unitRef="U001">93492000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4f2bea893e4d45aaa65ffa0cc50f56bd"
      unitRef="U001">3587000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="c20201231"
      decimals="-3"
      id="Fact_eab516cc33c344cc9a60d64eab7a6a25"
      unitRef="U001">596000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermLineOfCredit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ea49635133b14c36b4eb3b681360bbe3"
      unitRef="U001">114000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f72b7a7afbfc40e98376849ab61fc5c7"
      unitRef="U001">16000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2e591c1b081e41a9a37b9a3338b9d61c"
      unitRef="U001">14385000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c20201231"
      decimals="-3"
      id="Fact_5ce10c7da9294f1ebc99b95be7588b60"
      unitRef="U001">7779000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ad800241b89746bcb1cadd1f0aa0a21c"
      unitRef="U001">74185000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f59d6c01a57442edb59924a1cbc3fda5"
      unitRef="U001">61985000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6addd01ebc994509b67af5d345eb381c"
      unitRef="U001">7345000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_0e9ff0b3483943029f9bd77f56b0f88a"
      unitRef="U001">4539000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_817007122e464b6892630a112b2d0eca"
      unitRef="U001">296983000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_5d54e950c607429999675a876918fc3c"
      unitRef="U001">184391000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ec911c927a8a4658b6b7d143894eff72"
      unitRef="U001">155262000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20201231"
      decimals="-3"
      id="Fact_326a987c204a438e984f1aecb8e1a346"
      unitRef="U001">132340000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20211231"
      id="Fact_5910a85d80164a8c94ccc93ec7fe62ca"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20201231"
      id="Fact_6555ceb72428412cac5d1355e6f0fd3d"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20201231"
      decimals="2"
      id="Fact_32d7126da2a34e9f87c13c87392e0fc2"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="2"
      id="Fact_13c581b90c7c4697be8f9f8405a148cd"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20201231"
      decimals="0"
      id="Fact_abbefd204f944846b69b580e5cf37975"
      unitRef="U002">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_67b538724a4e4e9a9c7e374ee13694da"
      unitRef="U002">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20211231"
      decimals="INF"
      id="Fact_fb6868cd0c484fe9ba4ab03851c157a3"
      unitRef="U002">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20201231"
      decimals="INF"
      id="Fact_f43cea061a7d465489233d018a655e55"
      unitRef="U002">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20211231"
      decimals="INF"
      id="Fact_7b82fae694654842b69783f0991d6c07"
      unitRef="U002">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20201231"
      decimals="INF"
      id="Fact_5ce8b91973fe4168a7d03987ee0a378e"
      unitRef="U002">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_678722cd31f942c3ab82a910acf87873"
      unitRef="U001">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_bd15af50a941443fa04f37ed80164920"
      unitRef="U001">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="2"
      id="Fact_7578fe9d1428472bb04c65ec646e6609"
      unitRef="U003">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20201231"
      decimals="2"
      id="Fact_6878e44345ff4e6d9db0c708a71ef2c9"
      unitRef="U003">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_60037128a15a43a6a119db18505fc670"
      unitRef="U002">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20201231"
      decimals="0"
      id="Fact_2c498357c9bd4bbeaad2a4388ada4245"
      unitRef="U002">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20211231"
      decimals="0"
      id="Fact_bcb532b699f745d5a6d1b1e45aca3f6a"
      unitRef="U002">15126160</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20201231"
      decimals="0"
      id="Fact_3c01722b97064a7e94efc2803983b64b"
      unitRef="U002">15066282</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7e665364d7cd45e9932f55055ff8985a"
      unitRef="U001">151000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_a05e645d1c434a57b3476dc7318f2cc0"
      unitRef="U001">151000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6e7f9341d85b48fc9f57b6a66ce336fc"
      unitRef="U001">102688000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20201231"
      decimals="-3"
      id="Fact_a6bf1dbafdc74a7db98ccf18f022cbaa"
      unitRef="U001">95622000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_62ffa77402df44f4b728d9a2e2913c1f"
      unitRef="U001">224395000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20201231"
      decimals="-3"
      id="Fact_ef73fc5fee014a439963f2743ac41d46"
      unitRef="U001">212015000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="c20211231"
      decimals="0"
      id="Fact_6c30e1490a154eb9b7b61b16df8f1d41"
      unitRef="U002">2214737</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="c20201231"
      decimals="0"
      id="Fact_12d4e0b5529247d8815e2a373b01a019"
      unitRef="U002">2214737</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_647617b69a91413ea45866e937f1377c"
      unitRef="U001">31628000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_bbfa80d511344a26a4dbf71ab517c8dc"
      unitRef="U001">31628000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cb793511837f479684d60e06bc107faf"
      unitRef="U001">295606000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e1f1b7f6274f4bf6ac8283c182c41475"
      unitRef="U001">276160000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d29af82b886c473ca26fb5e77d9d2dbf"
      unitRef="U001">1575000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e40f681f4fcd45a48b4abd8541149748"
      unitRef="U001">1470000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6a55b52b78ca4cdf8c0f25d326e2bdc7"
      unitRef="U001">297181000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_3360374067654ad49468bfc306d143ac"
      unitRef="U001">277630000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_65f3fab9f27f410b9768b3a85d71aa9e"
      unitRef="U001">749426000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_85311ecb8e2b4d2db5a31b844c2895a8"
      unitRef="U001">594361000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_e1cb16a9a7334348a1106303e3af525d"
      unitRef="U001">438330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_eb4e2cde723f4d859b9531be372816e7"
      unitRef="U001">373340000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_2f57d1f33cef424d8144ae847a2af67b"
      unitRef="U001">433345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_99cf33b689df4309856b87c82848d17b"
      unitRef="U001">56692000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_26f8c780919f45ed94ab4ea50d7a4952"
      unitRef="U001">49629000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_eb7e08d7018c4eca843ca21f768a7613"
      unitRef="U001">48624000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_4de0d70f70fa44dca67c0ab89749b511"
      unitRef="U001">495022000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_5bd8e260a034454fb1ecf6e5eb567be1"
      unitRef="U001">422969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_2448ceb9b60f484e8691c6e3f19e3c7b"
      unitRef="U001">481969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_f2dce5379cc94d33a4246b8516af4857"
      unitRef="U001">278469000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ac118e49d3df4b09b03c28394cc2427e"
      unitRef="U001">235629000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_7739676c8c9742f8bb915047e85a4735"
      unitRef="U001">274233000</us-gaap:LaborAndRelatedExpense>
    <usph:RentSuppliesContractLaborAndOther
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_819566d9ffb84ce98ecec9cefbf378b6"
      unitRef="U001">94036000</usph:RentSuppliesContractLaborAndOther>
    <usph:RentSuppliesContractLaborAndOther
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_bd759e351de441ef863f34274ef98766"
      unitRef="U001">84336000</usph:RentSuppliesContractLaborAndOther>
    <usph:RentSuppliesContractLaborAndOther
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d38ed5ccb21a4036827265c60910b1b3"
      unitRef="U001">90379000</usph:RentSuppliesContractLaborAndOther>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_fa1d7a23cbe447fcbb6d39d64a3a60d6"
      unitRef="U001">5305000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b0fca927939c4d33a0aa2797f7ffebf3"
      unitRef="U001">4623000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d77e856c27f04d9480dfc39a6adac0a2"
      unitRef="U001">4858000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:RestructuringCharges
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_89db2acd89314d1bb0ec34cca19dae63"
      unitRef="U001">30000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6ec25d8ef67b47429f04added077fab0"
      unitRef="U001">2072000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8b94654cb8ba4b05893337d6f72d88eb"
      unitRef="U001">25000</us-gaap:RestructuringCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c89e2dfca74b48658f80a61777504948"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ef8436762c4944d1a2d5d517b23f0097"
      unitRef="U001">1859000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d872deb8b2f44db5a1bc6207effe9afb"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:CostsAndExpenses
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_e849ad0f67d442caa78fc33146ede20e"
      unitRef="U001">377840000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b95c380a27154f5abc9cf61723cfd4cb"
      unitRef="U001">328519000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_f073ec28271845b2849ba9f45d4080b4"
      unitRef="U001">369495000</us-gaap:CostsAndExpenses>
    <us-gaap:GrossProfit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_2230e8d51ede4d448373e5dbb638f972"
      unitRef="U001">117182000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_28d515e87f0449aeac38a9c1782f001f"
      unitRef="U001">94450000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_69b07fefa0ff46de9c450452a5af4393"
      unitRef="U001">112474000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_03fc1e8461f64735874f7e4bc37167d1"
      unitRef="U001">46533000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_83b4f09b36f041abb628653fa497b261"
      unitRef="U001">42037000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_55ad1d0b62d04f2dbdbe640543a26e03"
      unitRef="U001">45049000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_952bcbf7f0a14b259eb4396153f6501d"
      unitRef="U001">70649000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6776c28acb604859a7eaa192e0ce6310"
      unitRef="U001">52413000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_bbf768e27452478e85e58686cc591d1a"
      unitRef="U001">67425000</us-gaap:OperatingIncomeLoss>
    <usph:ReliefFunds
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_728546326a3c42f1b440dbcc2c257d51"
      unitRef="U001">4597000</usph:ReliefFunds>
    <usph:ReliefFunds
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_8b0c1c78ceb946c4a637158c95be4e71"
      unitRef="U001">13501000</usph:ReliefFunds>
    <usph:ReliefFunds
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_85d89df0cb4349cfbe94c27bd499a633"
      unitRef="U001">0</usph:ReliefFunds>
    <us-gaap:GainLossOnSaleOfInterestInProjects
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_29bb03f6a8914acb9020abc5d239e498"
      unitRef="U001">0</us-gaap:GainLossOnSaleOfInterestInProjects>
    <us-gaap:GainLossOnSaleOfInterestInProjects
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6efb33dee66b41468bcbeddb9a4ca7bb"
      unitRef="U001">1091000</us-gaap:GainLossOnSaleOfInterestInProjects>
    <us-gaap:GainLossOnSaleOfInterestInProjects
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_6708f77dd5864d23b7043f8b871b1d94"
      unitRef="U001">5514000</us-gaap:GainLossOnSaleOfInterestInProjects>
    <us-gaap:LitigationSettlementExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_93ea064547ae405abb64ca970637316e"
      unitRef="U001">2635000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1979805c2f844998906b73f4ca355218"
      unitRef="U001">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_afb4447734344fd18cf5aba59a71f68f"
      unitRef="U001">0</us-gaap:LitigationSettlementExpense>
    <usph:ResolutionOfPayorMatter
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_821a7be2798342d1b165216abbdc83b6"
      unitRef="U001">1216000</usph:ResolutionOfPayorMatter>
    <usph:ResolutionOfPayorMatter
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_77bb66a2f8a64b3fb45d53e6982a5d9a"
      unitRef="U001">0</usph:ResolutionOfPayorMatter>
    <usph:ResolutionOfPayorMatter
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_6ac2d0c3c3cc480eb74b18588d80a660"
      unitRef="U001">0</usph:ResolutionOfPayorMatter>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_166e8c28b7814f5e92af55445e54a6dd"
      unitRef="U001">112000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_8f6df4e7d5ab4d1596dafd7e30a6a7d7"
      unitRef="U001">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_88f2eebdb6104f06bd4d0b7b2e56dc27"
      unitRef="U001">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InterestAndOtherIncome
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9fee0e0aa03c470181f7c7055ceca32b"
      unitRef="U001">199000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2ed55a3e0e7c48b795c53e86984abcb0"
      unitRef="U001">142000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_2801f34e0b68466a9cddf9fbe9708d5f"
      unitRef="U001">46000</us-gaap:InterestAndOtherIncome>
    <usph:InterestExpenseDebtAndOther
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ca1eb9f41c4b4abca02d5fc75b0a9fd6"
      unitRef="U001">942000</usph:InterestExpenseDebtAndOther>
    <usph:InterestExpenseDebtAndOther
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0d68368c452c4fa1801a32142bc164b0"
      unitRef="U001">1634000</usph:InterestExpenseDebtAndOther>
    <usph:InterestExpenseDebtAndOther
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_33aa6abc349e4ee3a127418e52658bcb"
      unitRef="U001">2079000</usph:InterestExpenseDebtAndOther>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_319bded2484846a7ae113bc9022473ee"
      unitRef="U001">2547000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_a21a02c26c2a40fc817ce9704e1f71e3"
      unitRef="U001">13100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_84c93afcc3444dd9b23f850ff4500933"
      unitRef="U001">3481000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_168dad9a2d384e44b537dfb38d75a2d4"
      unitRef="U001">73196000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d6f069bd58a5444a92384842e888b14a"
      unitRef="U001">65513000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_3965e80aabf7448795554f7ccc32b0e7"
      unitRef="U001">70906000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_e6780260503348ae95729d2e93ae06d1"
      unitRef="U001">15272000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b31decfc12cc462c836079d9e5f2c360"
      unitRef="U001">13022000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9720718997994bc6929a4d23de4625a7"
      unitRef="U001">13647000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a0d5ad0a9bca4a2ea07ce389b7385683"
      unitRef="U001">57924000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_8639b728d5944231bc3816efaf226615"
      unitRef="U001">52491000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_70a3a83985d8478cb52c5d11fabfee3d"
      unitRef="U001">57259000</us-gaap:ProfitLoss>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_91185deae794443cae019ab7a71196e0"
      unitRef="U001">11358000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_3d4a560266864bfa92a0d0e283d552c9"
      unitRef="U001">11175000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_632ed812391540a79ba09142720058f9"
      unitRef="U001">10659000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_2bc9ba4cafad45a09d0aabab1917ff75"
      unitRef="U001">5735000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_fdd0996aa22a419baaa026a135e6163c"
      unitRef="U001">6122000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_115f3df3bddd43ae9981778d233517c0"
      unitRef="U001">6561000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_81e4b14dc254429096f3dccefd48da95"
      unitRef="U001">17093000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_7a0d883763904e6cb52daf1593a5082f"
      unitRef="U001">17297000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_e5b40fe8fb4447aba2190a53e0224408"
      unitRef="U001">17220000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_b42c873889694c2abc599f5c7eb23ac1"
      unitRef="U001">40831000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9a34e610752944228b2aea1144ef0795"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_cc457f4209e24a6b88c8889ca65bca21"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_5a7d7c11c39243e6a4ea872da95e5b17"
      unitRef="U003">2.41</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_35784f67f4564a6d95c666aa8871debc"
      unitRef="U003">2.48</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_ec606ecbfa5647b289fa7464dad9c7d5"
      unitRef="U003">2.45</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_db77b7127bd346ca8bfed2ca603f05a7"
      unitRef="U002">12898000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f73218257879473d83230d0e8b136c9e"
      unitRef="U002">12835000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_4629f647bdad4b5386015849d1664364"
      unitRef="U002">12756000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_f0cce43faf144986ad991819bb444742"
      unitRef="U003">1.46</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_82da76377a594a15a189331229ce0c16"
      unitRef="U003">0.32</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_83144a83093c42249559bdc91c056818"
      unitRef="U003">1.14</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SharesOutstanding
      contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f65a950d41ad49d8a56952b7b96a50a1"
      unitRef="U002">14899000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c6cee96b93084403a2b464658770ef63"
      unitRef="U001">149000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_104fc51c829841ea90f0ba005d9200bd"
      unitRef="U001">80028000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_61a7c83b7dd04987815f0235bd67af0c"
      unitRef="U001">167396000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_5c41ebe999384b718db8b093760f38cd"
      unitRef="U002">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_66361c0ef4a3441182f81c7f565e5bed"
      unitRef="U001">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_d65cc14e60cc4c36afeeed093f0117e1"
      unitRef="U001">215945000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6d2bc0dea09341e5b526cadaab62ae4e"
      unitRef="U001">930000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231"
      decimals="-3"
      id="Fact_a84c139914ce463eb331b012593f506b"
      unitRef="U001">216875000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5af9bb97304144bdb88210c8e4149df9"
      unitRef="U002">90000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_87b8d2682cca46f3bd3fa279ce5b2d52"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b995d1af5fa9403f9ec1471b989c39c8"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ff67e8d631a24085a4fd2a0a5bfd31c5"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_578cd881faba47e79c8750d89b61da42"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_60c60798d7b8434e8ec4d2e8f14f320a"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_10b70886ac4c4a57a82a0845c07d818e"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_c1f1d838e81948e6aa95614ab6ba5ef5"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_86c2f6b2385e4873861735a1fffa01b9"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_555060c8d21846edac9b37121d732c12"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_16c3f35c5744424b8bbf4f0ebcd1d3f7"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_679b7f4c6dca4eaf9d16352008dfaa50"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_dca31aa3bb184e68a0aad1e65b3be7db"
      unitRef="U001">-8771000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_0c2cc057e1e74b1fb2757ff47acd9036"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_3d637b5715f5419586f903cb330d210c"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_37a54341c3984ac5b0d314e5aef05506"
      unitRef="U001">-8771000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_46594d29b9f04b669e31d5131d5db1f1"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d0c26eb45caf4ecc8c05ed7a0e85fb35"
      unitRef="U001">-8771000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ef7c001c18764c6ca33ce0cb8ebb5e3a"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_51ecfbdbe31e4a9780319b6dd18e81c4"
      unitRef="U001">6985000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_9bc30bd812c84f45961d55c5763dc9d1"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_0333a898376d4d03b46ee7680c24e588"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_b59865a0690743618aa2e744b73ad0ff"
      unitRef="U001">6985000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_9102bb76729a4de282c03bb5df727a69"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_c054447cf5644f9e8e8b773d48aa76fb"
      unitRef="U001">6985000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b1e66dc2be6a477899075ca3bf9f5f9d"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_3a075a966fc640aa9d122ed30b61d569"
      unitRef="U001">636000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_710389033a6a4d048511eca4c12e36db"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_9ccaf7dbd35d4d17b27901cb668cac31"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_169b4da7298e4680b0477ec9233239c9"
      unitRef="U001">636000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_119af8cfcecb4d7cabf9366a2fee67ec"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_ddcf0949b94543ae9175885c6706afab"
      unitRef="U001">636000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b99189537a49420da988b3a40046ca01"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_df4f7f7a48b64275b2fbf70cb7c092b2"
      unitRef="U001">266000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c8645efa72ab4e7e94fde75c365e52d0"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_5504c990b1df4f01b6193e5ac8578889"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_2c89bb06f9fd483fb2a7beca92eddb79"
      unitRef="U001">266000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_b4db139fd98c4cc489e4c3e7f7e551ce"
      unitRef="U001">26000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_5be009ab42ec41068ea665bf0511a8e6"
      unitRef="U001">292000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6b9c920fd26342f6aaadc626fcddadab"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_eb30ef5795674c1d86ae33fe5f4d7151"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_923f708efe6b48d48863adb24cbca6bf"
      unitRef="U001">196000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_4a7b58fbf1244baa9c7adcf6a7ecd3fc"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_6610368e5b8c453981426f798a39624d"
      unitRef="U001">196000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_e0828cf664de4510abd2eeb9b4483b36"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_3b0cf04a8cf14521b5a611295ace5a92"
      unitRef="U001">196000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c398970de53b44b39befbe8389835181"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_ffa1cf55f64b40bf8682f0007f624918"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_4f2d8cc6a79e454dbb3c80b3d2f71653"
      unitRef="U001">14555000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_3bf39a0a65534c51999c78e2d46d336e"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_180713333e634843b6d3eea7a392c241"
      unitRef="U001">14555000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_f9fbf0f7133046c680fc5ed2006a4b57"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d0259b27cca84863b49e2aa9007f8b66"
      unitRef="U001">14555000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1014efa84fa6401baf97f988feeeb984"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f970d5e17e4645b99a6ad9df4225a267"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_7a39adb025584e66bc328cc0155291fb"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_439dab05d65142868dab667df44f738a"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_542e3eada5fb4492a25c91c3a575779e"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_4728bbed9d7943bb97012942155c4ef0"
      unitRef="U001">6014000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9266ea074f4a425da4e463493df63365"
      unitRef="U001">6014000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1b2601ca43c8415483e68093044b16c3"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_cd4866907f9f4c15a8603a090aea7e66"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_63c20b162eba446eb642b79806421a76"
      unitRef="U001">47000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_20af68715ab74315b1db0902793d79d7"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_06db0da12ff045fb9404fdc97c0f7a0b"
      unitRef="U001">47000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_eeac8ede38be411d85d59621a710d3a3"
      unitRef="U001">-7000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_f68005520a534c698412b0470c925ed3"
      unitRef="U001">40000</us-gaap:StockholdersEquityOther>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4bd5d442ed1843a6aff942f452c7da5f"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_6f7a985c2f04424ca5c4749cffa528e4"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0628d91fda274b1fbf544cb5ca0da600"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_3728ff5e1d0f456cb6c0ef09b69b54b3"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_f1ea5d1da3a04d1abe3f12d7c5776532"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_2cabaa6b8706431586c7bcd5ac1e60d8"
      unitRef="U001">6561000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_c7d5a840e25a4ef7beb459c2086f3c15"
      unitRef="U001">6561000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a72bf0fff1ac4414b4e2e7000b6a361d"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7249bbb5d65841dba61fc28005038f2e"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_45821e7842e54f888c0a3351ad6f95c2"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_ee47f504d62640bf99c708fa5f10b677"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_f4dd992903d2456095ffb2497b5ecf72"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_736cc1625b514b229e6f4223bdb4b235"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_a20dc29a2c23420f81946f07cf977795"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ad69747baa964ed28fdd01f69dfa6556"
      unitRef="U002">14989000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b4a3b5acb12446afaf2c45c214a34844"
      unitRef="U001">150000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f03fd64292c94f6aa25c327ba136f17a"
      unitRef="U001">87383000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_fe3ea87714f7498d89b4c1b767d2357f"
      unitRef="U001">184352000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_59b01c70754840a8ac52c795cb526fca"
      unitRef="U002">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_8bfcefdf830941c490a952050bdd3c36"
      unitRef="U001">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_ebc2e49719cf4a028af04214f23104c2"
      unitRef="U001">240257000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_9d8425c86eca4122ba1ae2c854c16c71"
      unitRef="U001">1444000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231"
      decimals="-3"
      id="Fact_6a1c3f51b93343159b7bac6efb95bea3"
      unitRef="U001">241701000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4053310f060140fe8ea3daae23942a46"
      unitRef="U002">77000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_8f28287e5046473cae30088b5529be86"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_1695601984ff415e8066c7e23a8be7be"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_e28b964763dd40bcbf2d14ac1738bc02"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_ba56103ef81f49aab2d4bf49ace4731e"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_65947c8c7bb44ac1b5a744bb818ab0f1"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_7c20456871414947b57e0a07d5a5df54"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_7772c58cf84e4d619d6e3333f26fa9fc"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_5327af3b1ba34d71b4b3d0e010919722"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_07f8672fcddd44799a52ff91f81abf18"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ff021b80569d4f2e8024e9470449f8fd"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_5646658adfc04525941291e242dc67a4"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_92ec4c4ae5364f268d5d401905fad796"
      unitRef="U001">-3415000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_1eacf60facef464e90a9fef4913be675"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_0f3edcfbde1f4957a8972d5da0347128"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_efad5fb4925b457a8bd0256be70704cb"
      unitRef="U001">-3415000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_a02438b4374c4306b4881f8d2d720263"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_eb8d0c8f37624a0fb122696e2f18b6ba"
      unitRef="U001">-3415000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_825856e9205b4a36974a58ce43613690"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_03f50db02887458ab6b67630e51598c6"
      unitRef="U001">7917000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_134b01c0ec8b42af9a9e58d3069fa98e"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_f452b13455b54bc0acaf1d4a1765381d"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_20761336bfef42dfa8f3237b9fe31cf9"
      unitRef="U001">7917000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_ad8379aee9ae42af83e919bec845a6ff"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_7b5a9138f30b4b628e48ef870a0e04d8"
      unitRef="U001">7917000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7ef94a7487384f7ca0acc08dd025cc00"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_83b40110b9ce40ba97669cd1e7016e55"
      unitRef="U001">486000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_6f8e73e7bc7b42ec8d072d828dc5beaf"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_dad2b0c9f09744cdaee507df3a4b322e"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_50bce6ccda504acfbb3b4ad90a15c44c"
      unitRef="U001">486000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_ce5b3bfaac814aa198a01c6ce40b134c"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_04adb77748204ec0af1eefb6b44f7749"
      unitRef="U001">486000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ba69c822908d4fac9824b6afa21890ce"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e9466cced8ce4764b4a462b73f1f8ddc"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ffe5a42bf0d94891b48041cbf59cea72"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_7a0365a6e4df4c2da67f8ffdfdfbcbc1"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c98c3c2211814863938603ac690a8994"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_1dccad6173564476a16129a0d517b1fa"
      unitRef="U001">168000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_30c184a21c424c95bff12009926d2184"
      unitRef="U001">168000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d19ef9e79d47409183d027e56024f245"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_12c16500b2574740a01c55538f2bef20"
      unitRef="U001">-164000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_eb32b2060c6b4714ad85504b65e33512"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_04195f36ec454c9dbd5eab1f6e6bf917"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_1350f4a10f204a228f1fcc0943eb69eb"
      unitRef="U001">-164000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_eb3ba6e751134ce9847a03b361a80458"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_636ea4acf3b248a8908379e7eb6be596"
      unitRef="U001">-164000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c2cd644ba19a4d9494cc97a4c7d3a714"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b4643b0b2651422e99d7012a4c3b7356"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0538e32285e84e0ca6fa567a5123abec"
      unitRef="U001">4110000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_725de49a678c4b0a80e91068d96fa286"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_d6558ea096094cd8b43465859630f981"
      unitRef="U001">4110000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_0fc0fb7b326549bfbb3e075222231c94"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0a30322975374c9cb09418ae7536f110"
      unitRef="U001">4110000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_efe0a93263784aa18727b24f46ae5657"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_194ab7d2d63a4095a31b63a7e31a14f1"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_b4fea8dc0ecd401280e90a3179b9e5b8"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_ec16dcb0c98448909f0c5ae8d6b9f333"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c5fc98c97e804263bc1bd1e313d07147"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_870c17f5c0c64c18af964f417e92f5b6"
      unitRef="U001">5928000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_869df43ac8eb4a94a5173fece4a98cf3"
      unitRef="U001">5928000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0aa7195a452743d49f46cf852e1583b6"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_d689439de38f4da5914d6d6bf6e310e2"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c64501ed764e4ad5beee7135ed678fe6"
      unitRef="U001">-6000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_62cd125a80c54c3bae032ecd66085dda"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_118eb84613d746b9a60b9778063aeeb4"
      unitRef="U001">-6000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_5ecc0461545f48ffa19bd04d194dfa14"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9f46772ef7d648d8bf15f5a2d2d5decf"
      unitRef="U001">-6000</us-gaap:StockholdersEquityOther>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f1f57627c8314439a10d961c44c9c0b8"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_1d28a74e315843f5880b0657aa078505"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_331b3f8b806a4cc7a47701f3c75c3cef"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_ed3ebc955ca04178886175a50db9fb1b"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_43d1d18df56f4e94bb4472cab470a845"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_74ed3fcee5aa4794893156ae3800932a"
      unitRef="U001">6122000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0a619b7aa53549a597a334de87421d07"
      unitRef="U001">6122000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c6577dfd618643eb967dd96e3d648d0c"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4f80cd3ee291408eb630809ffe352ebf"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_4017f2ac15954542826249b8eb8a33d8"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_638ce848c8304111be1f42bbf5f7ac5d"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_0f02a34292a94ee5989f9a853ec21171"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_f4403508a3964623afe7810e2ce44520"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_febf90f710ae484c8f31f37ab247f40f"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c71f907cb3fa46aa89f86711f64e52c7"
      unitRef="U002">15066000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d3fc114a25984473b546b3d702db134d"
      unitRef="U001">151000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4a2ac7f79f6c42349a10c6597595651e"
      unitRef="U001">95622000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_84ecbcc58204472ebf1855edb61baa10"
      unitRef="U001">212015000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_c04a1614afd04cbe92de64a3156c7ef5"
      unitRef="U002">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_fa745d27696d4b7a990563bd0a07ef0f"
      unitRef="U001">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_7a0f0229e2fa4d658941da25ac7a9ab4"
      unitRef="U001">276160000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_45b8ee601d4443399674992036dfa034"
      unitRef="U001">1470000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4f7101c49fd249ed85b0143bb03fa5b7"
      unitRef="U001">277630000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0c5ef694696b4160877c1a5999db218d"
      unitRef="U002">60000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0633128d5254448b8768534ff359d4bb"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_5ece87b802284608b437f2a7c920a4aa"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d51030e02e1e406584bda9775b9847c9"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_4a34b790dd0f408b978eb7f83d36b12d"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_75020d481b574cfd91d418504ac0a9a5"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_bb175e9d081e4ae298d2925854a396e1"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_3150a6a7c1de4314b2ea52fc5cd99852"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5c79ec1e65ba418980e1abb722f56c9e"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_becade5d0efd4b3db4d87224a4a0d44a"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5be31be5329648a8b5496e6fd24420c9"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_69ed4b5775064088a46ca3a376fc7960"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_bc7b80e20f7e4a6487eab2aae1df2e27"
      unitRef="U001">-9686000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_5f887ba7d35949a0b3b9c6c9aba87fd6"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_c0a2bb97f0eb495a9cfd2f2f2ab44cb2"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_0f7123fe60994c79aaabf35d449e2859"
      unitRef="U001">-9686000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6de3dfcb9bbe4b8c958221c650b92326"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5d1db16e8f2b4830aad30d91c3960a06"
      unitRef="U001">-9686000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7654289dac1d4439af456879a0e52e4d"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e58827f7e7a44205a101c404f96bcea2"
      unitRef="U001">7867000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_323ec51c9849407980ba21382db3e7fb"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_16aeabab537546bf838e06ac745259b7"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c8eab06f645e4152901d848b5c5ca9cd"
      unitRef="U001">7867000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_ff2891a8dc984d8094694e8d52519edd"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5db1343d649c4f119914394ac1ae2d89"
      unitRef="U001">7867000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_724b7965de994b9883e1d768f454579c"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f298860424d7420da50914b3dc010bd6"
      unitRef="U001">918000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_1f141d87fb054b10b26e2262a1ffebbe"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_1a62881e94414e799c8adb2ee326f226"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_4c96544760504a70a5ee07216e560b28"
      unitRef="U001">918000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_f90f519bb62546358da4eade20ee2b95"
      unitRef="U001">60000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_b9a812b619ac40feb316b6e18facca1e"
      unitRef="U001">978000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_26fc20af507648239abefb33b8d2949a"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e2b5f36496454140a153df71b7aa6205"
      unitRef="U001">96000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_5287250b296b4c5e8ff9f9b294ca3473"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_6ce3f558d99b4923a64fd7b01f00d077"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_2b2768b8840646edaaedd8aac4eb2224"
      unitRef="U001">96000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_f4f2ea80264d42f3b92a2dd964750acb"
      unitRef="U001">2000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3bf19cd79ca74c85bb3fd87a6cb5b64e"
      unitRef="U001">98000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c6e2ae60e31d485cb2ee567e1ca00c59"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_78865d08518c4ec3a9724ee91fed432d"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_80eab7f4bf804b73931e960b482d1015"
      unitRef="U001">18765000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_2278173ec8c64680a40f7b8ed0f80cc0"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_14eb957099ce424aad516041177ddbe7"
      unitRef="U001">18765000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_a0824515a09c4aab977f0cd809e15d6e"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_12f6d44d6b83456f91b5cf42423ff91a"
      unitRef="U001">18765000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_823dc5902cad47fa9944474eea8dc5e3"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_37634107ba7c41e6b29c7ec0b6c5fa82"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_5784b63a2f1d4c2aab6011a2e2cdeed0"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_bf99aa2956474c019cc9c702e60c2b1b"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_22b846bf22144656a949eee7daabf95b"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_f5ad5c4ecf994e16b8bc781eed961161"
      unitRef="U001">5572000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_902878980a2b47b4b26b60cc34de53d8"
      unitRef="U001">5572000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_23d0d1ca06f04488b7b9ee0b6f0eaa9a"
      unitRef="U001">0</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4cd963c0b77940bca89177ce1dd066ae"
      unitRef="U001">20000</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_61af570f402e44fe8bd2bbefcc97fdc5"
      unitRef="U001">0</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_090ae4c2fa7f40b481f8f4c2ed4b4d7d"
      unitRef="U001">0</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_dba67ed567764a369845132cbcf9af5e"
      unitRef="U001">20000</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_bbf71a301987403e8764259376446345"
      unitRef="U001">0</usph:ShortSwingProfitSettlement>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_06aca80a047a447f962ecee14a55aac5"
      unitRef="U001">20000</usph:ShortSwingProfitSettlement>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f7ffd7b93e8349f4bfc2adf94a8af6e8"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_3f4f79e66e284505bb35a2bd7c3b9773"
      unitRef="U001">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_37f70da8931240898ff890c497c314de"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_f3ec5305658e4640b327137fbab1d4dd"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_fc06ea9719544bbaa784f85062e788ad"
      unitRef="U001">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_3374a56f2d2b4c0f873cbd05c7165937"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_67fdc0a8a8b244ad9f8ca00660f68760"
      unitRef="U001">1000</us-gaap:StockholdersEquityOther>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2e85c530ed23448da841ff4adedc916c"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b419d606d74948c28b4b575a700c25e9"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_4de69e6cee714f449c6576b0b805451a"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_8a8366ab721643bfbfbcca64ce963500"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_fa69bf700ee84a7c876adb8116ba00ff"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_ecd024862cdf4df685fd26d36212f063"
      unitRef="U001">5735000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c91109f39ea94ae8a2ef6b4e8422ee79"
      unitRef="U001">5735000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6aea6ecf050340fdad5c20bab311cd36"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_ddef1ff20ed64a639ff92e92945e269c"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_fd7ab2fe970a4e5c879b04ffc6613e41"
      unitRef="U001">40831000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_beffb9c4d31041fba982cdba226a350f"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c5b7a3181fb44d0095f5efbb3e022fe8"
      unitRef="U001">40831000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_4f36b3fdc6804ed6b43bbb0221d13d75"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_2e3cc349835747d7879c9de6fa341538"
      unitRef="U001">40831000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_bf105e14393e436c82310bcd74e6d5a1"
      unitRef="U002">15126000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ede24158c0da451689da04c80bc0e04a"
      unitRef="U001">151000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_8d7662042c20475887069f145022d7ff"
      unitRef="U001">102688000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_9b5f263ceb8445ae8a1687a6107016c8"
      unitRef="U001">224395000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_a4d038c71f314f4bb40c55b1d7e0b856"
      unitRef="U002">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_ca12bc19face4dd28ad0d1381ed931e5"
      unitRef="U001">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_b42e53665a3e41febb63a602fd081ae0"
      unitRef="U001">295606000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_7db499b30cd14e69820bb741730d8b46"
      unitRef="U001">1575000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c73bca7c2beb415698dbd291f1e0c599"
      unitRef="U001">297181000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_aebe3da941e64ba396237ffdf4a3b95a"
      unitRef="U001">57924000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_7e1c379e7403437c99a786ff0e73cb50"
      unitRef="U001">52491000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_e651151376b145eda98c369729a2bc40"
      unitRef="U001">57259000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bdb39987c56c4a76b9c4369692718364"
      unitRef="U001">11591000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2af09f393015451581f19c0fdb206116"
      unitRef="U001">10533000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8900b94d82144f76ab91c52126658c1a"
      unitRef="U001">10095000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a58a98f109da47aeb679c0997545edc5"
      unitRef="U001">5305000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_bd0990a93c5f42679c601a713a6dad8b"
      unitRef="U001">4623000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_cdd8920cc868487ab7c22d5176b91347"
      unitRef="U001">4858000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9413ca5b64714d0a9788f6e6de837e77"
      unitRef="U001">7867000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f9b2a7f51e0e4fe182497e1fc152f44f"
      unitRef="U001">7917000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_94f3afab2a7443d5be6a15c325c0897d"
      unitRef="U001">6985000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_cc82b6bbbcac47f0b4320436d54dc452"
      unitRef="U001">5688000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_27979ee698c74a08abbbfc52904a0569"
      unitRef="U001">-258000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_b72ca3ea6c4040c29a62639dba6b8ae3"
      unitRef="U001">4651000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <usph:GainOnSaleOfPartnershipInterestNetOfTax
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_46320f60c5174cab9a50343c27ea9156"
      unitRef="U001">0</usph:GainOnSaleOfPartnershipInterestNetOfTax>
    <usph:GainOnSaleOfPartnershipInterestNetOfTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1291dc53a8fb430095e146b64ec3a5a7"
      unitRef="U001">1091000</usph:GainOnSaleOfPartnershipInterestNetOfTax>
    <usph:GainOnSaleOfPartnershipInterestNetOfTax
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_c4b7acd52dcd4875ad69fc7ecce314bd"
      unitRef="U001">5514000</usph:GainOnSaleOfPartnershipInterestNetOfTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c84c065ad6f14a4cbfef6fd92083c0d6"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0e7c036793ac4bd0b9eb5876dc071366"
      unitRef="U001">1859000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d0a42b7a1ccc4312aea451063dbc97eb"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bebd92a8fe274d969ed96975fea8ca4f"
      unitRef="U001">112000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1b2e0140ef3a4b33837c0279f4ed5100"
      unitRef="U001">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_f73e0b60d9a34000aa9e519d5fcf9a34"
      unitRef="U001">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bbfb8e2a4cfe4f639ad972fc1a7e4333"
      unitRef="U001">-134000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9c20c79ed6a84ba69e3f26322679b50b"
      unitRef="U001">281000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_aeaed84485bc4fc5864e4ea2bc9de08e"
      unitRef="U001">96000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_977ef6d052af453abc8e7bf410ea7256"
      unitRef="U001">9417000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_33c1ea507789402b9ea05876f7d5fb7b"
      unitRef="U001">-899000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_ca8f96edbf824c96a005295b36532e98"
      unitRef="U001">6376000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7f72654063d4496d9aa0898b6476b8f4"
      unitRef="U001">1538000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e3221e3a825d425eacf0da54c1aee456"
      unitRef="U001">-1661000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_33d9666db2a743ffa0152f435ff53697"
      unitRef="U001">2499000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6354f5f011214e2aa40b78db5f3a4ab4"
      unitRef="U001">633000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e6bfc6dedd894c02910ff959356344b5"
      unitRef="U001">-4161000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_7c5e70a9c31e434ebc04b324fbe2559f"
      unitRef="U001">1878000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_db4a41d3295b4f918942870ed577953a"
      unitRef="U001">4657000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_a85933f4d1f9418fbb1dd69307b40227"
      unitRef="U001">12427000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_24c18e186f6342e3bbd2cb9e770283d3"
      unitRef="U001">-4209000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_874d157527804ddb963680bde3dddde7"
      unitRef="U001">-4792000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b7ea7cbf9a4242a7a1923fa35d6e21ac"
      unitRef="U001">4492000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_45761ab5379442d2b6e2f6e7a3809282"
      unitRef="U001">-1020000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_548076878f0e46509b4bc192257f0ae7"
      unitRef="U001">76406000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_083e29002b454f37bbfacb2b025fefe2"
      unitRef="U001">99995000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_43f2f870643c45a6bb4faab86d99ba28"
      unitRef="U001">62448000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_b543eba572e9404a981dcb701b1e2247"
      unitRef="U001">8201000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e5ae60aacea44000af270a4f964872d8"
      unitRef="U001">7639000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0644431f6f1e460f899e30c54a3c2071"
      unitRef="U001">10189000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a389dd9a787945a7b47d7965cae9f749"
      unitRef="U001">86823000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1562bbb7680a454d95c14e2755b68e10"
      unitRef="U001">23907000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_56f62ee67f2743e88b5c483780879eed"
      unitRef="U001">30597000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:PaymentsToAcquireRedeemableNonControllingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_992aa87502c540dba3b494eaec286b69"
      unitRef="U001">28465000</usph:PaymentsToAcquireRedeemableNonControllingInterest>
    <usph:PaymentsToAcquireRedeemableNonControllingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_dc662c6de3ad401a89d799753e47fa01"
      unitRef="U001">20385000</usph:PaymentsToAcquireRedeemableNonControllingInterest>
    <usph:PaymentsToAcquireRedeemableNonControllingInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9b2b78d71cf54e8391fb0cf63227c423"
      unitRef="U001">8651000</usph:PaymentsToAcquireRedeemableNonControllingInterest>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_986c7e387c424f97b61d82258fc32ec2"
      unitRef="U001">1274000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e933834e17464892bb4c50ecedd4ac3b"
      unitRef="U001">238000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_34378ee085744a81b4137f558860fbaa"
      unitRef="U001">428000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_997abf610bda427db40e96dc1675d4d9"
      unitRef="U001">69000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_203a0bea55b24de89d7e50ab3561a999"
      unitRef="U001">127000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_cc6af0bb274044b39b9439c5d24db305"
      unitRef="U001">207000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bccb38feeb7443498232b40fcf454f9e"
      unitRef="U001">275000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_189a247340a3417ca5efde89cd8d6ccf"
      unitRef="U001">839000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0a4a7016a9d640638c1247b3d0eedd83"
      unitRef="U001">11665000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <usph:DistributionsFromUnconsolidatedAffiliate
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_e83fe6d322b44f108a1e6ae7841c0286"
      unitRef="U001">152000</usph:DistributionsFromUnconsolidatedAffiliate>
    <usph:DistributionsFromUnconsolidatedAffiliate
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_31234c4e21e7454aaa35f12b4b82af8b"
      unitRef="U001">0</usph:DistributionsFromUnconsolidatedAffiliate>
    <usph:DistributionsFromUnconsolidatedAffiliate
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_f59f73b06e614327a30cad63aeb11144"
      unitRef="U001">0</usph:DistributionsFromUnconsolidatedAffiliate>
    <usph:ProceedsFromSalesOfNonControllingInterestPermanent
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_e53b7324f2ba4e789fe73003a8802753"
      unitRef="U001">131000</usph:ProceedsFromSalesOfNonControllingInterestPermanent>
    <usph:ProceedsFromSalesOfNonControllingInterestPermanent
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_287b19816b3b43d0a4b03a5d1e787bea"
      unitRef="U001">0</usph:ProceedsFromSalesOfNonControllingInterestPermanent>
    <usph:ProceedsFromSalesOfNonControllingInterestPermanent
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9922d712b4a241d693fc102f3dda4372"
      unitRef="U001">0</usph:ProceedsFromSalesOfNonControllingInterestPermanent>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_43c0698beb274196abe8e479647e727e"
      unitRef="U001">-124136000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9fa3e557b9d54da4b065ce35d62a62a7"
      unitRef="U001">-51203000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_f042b467f349438eb3d8f4f9a18fa3b5"
      unitRef="U001">-37993000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_cdfb3d43a32b42ad84be52cc8b296fbb"
      unitRef="U001">16931000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f2167b68bd214158813dd5f1555dd4ab"
      unitRef="U001">18331000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_820199e8c78945128c6e38f43192daf7"
      unitRef="U001">16235000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1be14e69d82d4f32a993b9b614821132"
      unitRef="U001">18765000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_11225858b61b4e9a86e7e0da8a4ab7a3"
      unitRef="U001">4110000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_fa001a720800471ea899e1a89fe15e79"
      unitRef="U001">14555000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_b264d113953c4caeb8f7f432b3742fa3"
      unitRef="U001">316000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d016fc260cc0468e8ae52fd4597a5db7"
      unitRef="U001">214000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_52028d41e40744dea85eb6031f0a7076"
      unitRef="U001">145000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d974f1c2f4ad49e8a0d63ec986b947c7"
      unitRef="U001">218000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_901cfe99d35b4b23b9172792bccad038"
      unitRef="U001">244000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_03dcc0cfb27b4e9ebf3c16da766a81ce"
      unitRef="U001">137000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ee30fd68d7c640b898ab06ebd12a3e82"
      unitRef="U001">4899000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9bc711f916424acb9b783b5f7906d243"
      unitRef="U001">1037000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_a7704a3035c04e0bbc398386a8654604"
      unitRef="U001">1433000</us-gaap:RepaymentsOfNotesPayable>
    <usph:MedicareAcceleratedAndAdvancePaymentFunds
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d61ac38e258d4d41b917fdb0eefd8ce4"
      unitRef="U001">-14054000</usph:MedicareAcceleratedAndAdvancePaymentFunds>
    <usph:MedicareAcceleratedAndAdvancePaymentFunds
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c39a622adc8f4329b60be01279adcf80"
      unitRef="U001">14054000</usph:MedicareAcceleratedAndAdvancePaymentFunds>
    <usph:MedicareAcceleratedAndAdvancePaymentFunds
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_628c6953f207497690f7c211b73ed988"
      unitRef="U001">0</usph:MedicareAcceleratedAndAdvancePaymentFunds>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_f594b6f2ca4749568ae358d903265b77"
      unitRef="U001">28000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_39aa2eba8f4c4733b7bf629e0439a9ca"
      unitRef="U001">2000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_2332bef3418840acb20c1eba04957952"
      unitRef="U001">-52000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7c61c19f104a46a1b6b93af9326250c3"
      unitRef="U001">43379000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_262bad86795a4a9190dd33243aed00ff"
      unitRef="U001">-39422000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_6f897282c8ea49d9b9deeddf1adcf624"
      unitRef="U001">-24275000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c8826012594c405c9614db698870b9f4"
      unitRef="U001">-4351000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_eb7c273eab404d88ac5eabf5bed779a0"
      unitRef="U001">9370000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_67ccd66d6564481a9424c7f9440272d2"
      unitRef="U001">180000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_6c5e0210a0724dfb8c5ecbb5e4a6d34b"
      unitRef="U001">32918000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20191231"
      decimals="-3"
      id="Fact_9cea4105fce84c40bffe39380dd2f17e"
      unitRef="U001">23548000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20181231"
      decimals="-3"
      id="Fact_bb322f8c206a4458946fd738871ed02d"
      unitRef="U001">23368000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ea9542c3f2ed4433ab77371606f556ba"
      unitRef="U001">28567000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_0cd23253fee84b96b44e0b80a588fbda"
      unitRef="U001">32918000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20191231"
      decimals="-3"
      id="Fact_a6faf8d44a7441d682510c9d6b46533c"
      unitRef="U001">23548000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_f82ad005e0df4693b3abffeef205610d"
      unitRef="U001">12214000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_5944c867b60340f9a07fc366e94655ee"
      unitRef="U001">7677000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_78ef95b4c1c64ba4a09378722bd3d5c3"
      unitRef="U001">9856000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_da3e5e3b5a324d7290c6c86e6aa749aa"
      unitRef="U001">1352000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_bc7505c68f524ef0b9c758d5b98b92aa"
      unitRef="U001">1202000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_e24bca8911674a50a82ccc7bb42a5b63"
      unitRef="U001">1890000</us-gaap:InterestPaidNet>
    <usph:PurchaseOfBusinessSellerFinancingPortion
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_dc8a7e79e58b4affbb7cffb01e676dbd"
      unitRef="U001">3050000</usph:PurchaseOfBusinessSellerFinancingPortion>
    <usph:PurchaseOfBusinessSellerFinancingPortion
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f2797fcac7af4638b214f5c72d7cd5e9"
      unitRef="U001">1121000</usph:PurchaseOfBusinessSellerFinancingPortion>
    <usph:PurchaseOfBusinessSellerFinancingPortion
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_e7516658d2884163ac9fb8e0e44dee48"
      unitRef="U001">4300000</usph:PurchaseOfBusinessSellerFinancingPortion>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6909b3c53f1b412b94898b0459e113bc"
      unitRef="U001">0</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1ae60093f3e84a05bd81bfcdecdd2caf"
      unitRef="U001">0</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_a958e07fef054a4684a59305e67a758d"
      unitRef="U001">502000</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a8ef4c3874654e1dae54528f94d006a2"
      unitRef="U001">1759000</usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_37f6634d2ca14d7583786d02ec6c88a9"
      unitRef="U001">136000</usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20191231"
      decimals="-3"
      id="Fact_4657db2bf24d437089d7c6ee488dd396"
      unitRef="U001">283000</usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_76e8f571a44d49b78cbc403662d1d60d"
      unitRef="U001">0</usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity>
    <usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_7e7af003731a4916aaf408509c4533d1"
      unitRef="U001">699000</usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity>
    <usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
      contextRef="c20191231"
      decimals="-3"
      id="Fact_9498e41aa3554e38906009ed3c197c95"
      unitRef="U001">103000</usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c8b7bfd8f5ff4cd9944217ac88dfb871"
      unitRef="U001">914000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_37607bd3293d46f49d60a246ef4565f7"
      unitRef="U001">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_a24f094016e4477d8bc82fecf9359a10"
      unitRef="U001">2870000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1c978b3fd8b04b97b802058b8ff5f40c"
      unitRef="U001">0</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f9466b66b50240c899a2095b15235406"
      unitRef="U001">994000</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8cda9b50f3104efaa33bd04ba3fc6349"
      unitRef="U001">0</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_0bcdd117a8324b4194c403f1cada0328">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;1. Organization, Nature of Operations and Basis of Presentation&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#x201c;Company&#x201d;). All
      significant intercompany transactions and balances have been eliminated.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company operates its business through two reportable business segments. The Company&#x2019;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. The Company&#x2019;s
      physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured
      workers and neurological injuries. Services provided by the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. Prior to the second quarter of 2020,
      the Company operated as a single segment. All prior year segment information has been reclassified to conform to the current segment presentation. See Note 12 - Segment Information.&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;During the last three years we completed the acquisitions of seven
        multi-clinic practices and three industrial injury prevention businesses as detailed below. &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Date&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;% Interest&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Number of&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Clinics&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;December 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;December 31, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"&gt; &lt;span style="-sec-ix-hidden:Fact_fcd7d7afc36c4146ae8996c5533e716f"&gt;*&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;100%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;"&gt; &lt;span style="-sec-ix-hidden:Fact_9e406021f6644e219c3b143ef1491cbb"&gt;*&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;June 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;June 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;65%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;March 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;March 31, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 2020 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 30, 2020&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2020 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2020&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f"&gt;**&lt;/span&gt;&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 2020 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 27, 2020&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;65% ***&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2019 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2019&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;67%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;April 2019 Acquisition &lt;br/&gt;
              &lt;/td&gt;

    &lt;td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 17.16%; vertical-align: bottom; text-align: center; white-space: nowrap;"&gt;April 11, 2019&lt;br/&gt;
              &lt;/td&gt;

    &lt;td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.71%; vertical-align: bottom; text-align: center; white-space: nowrap;"&gt;100% &lt;br/&gt;
              &lt;/td&gt;

    &lt;td rowspan="1" style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"&gt;&lt;span style="-sec-ix-hidden:Fact_b50371aded1746619d40d044e9a29674"&gt;*&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention
                  business&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt; The business includes six management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;***&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt; The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;
         &lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Physical Therapy Operations&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The physical therapy operations segment primarily operates through subsidiary clinic partnerships, in which the Company generally
      owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests typically range from 10% to 99% in the Clinic Partnerships. The
      managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#x201c;Clinic Partnerships&#x201d;). To a lesser extent, the Company operates some clinics, through
      wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#x201c;Wholly-Owned Facilities&#x201d;).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and
      other referral sources, by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior
      owners typically continue on as employees to manage the clinic operations, retain a non-controlling ownership interest in the clinics and receive a competitive salary for managing the clinic operations. In addition, the Company has developed
      satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than one clinic location.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;Besides
        the multi-clinic acquisitions referenced in the table above, during 2021and 2020, we purchased the assets and business of five and&#160; three physical therapy clinics, respectively, in separate transactions.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;During the year ended December 31, 2021, the Company sold two clinics. The aggregate sales price was $0.1 million. During the
      year ended December 31, 2020, we sold 14 previously closed clinics. The aggregate sales price was $1.1 million, of which $0.7 million was paid
      in cash and $0.4 million in a note receivable due in two equal installments of principal and any accrued interest. The first payment was received in June 2021 and the next payment is due on June 15, 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; text-align: left; text-indent: 0px;"&gt;Clinic Partnerships&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by
      the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as &lt;span style="font-style: italic;"&gt;non-controlling interest&#x2014;permanent equity&lt;/span&gt;. For acquired Clinic Partnerships with redeemable
      non-controlling interests, the earnings attributable to the redeemable non-controlling interests are recorded within the consolidated balance sheets and income statements as &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;redeemable non-controlling interest&lt;/span&gt;&#x2014;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;temporary equity&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; text-align: left; text-indent: 0px;"&gt;Wholly-Owned Facilities&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing
      due the clinic partners/directors. The amount is expensed as compensation and included in clinic operating costs&#x2014;salaries and related costs. The respective liability is included in current liabilities&#x2014;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;accrued expenses&lt;/span&gt; on the consolidated balance sheets.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Industrial Injury Prevention Services&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Services provided in the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post offer
        employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers
        and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;"&gt;Impact of COVID-19&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;As previously disclosed in a series of filings with the SEC and further described in detail in the Company&#x2019;s Quarterly Reports on
        Form 10-Q for the first three quarters of 2020 and our Annual Report on Form 10-K for the year ended December 31, 2020, the Company&#x2019;s results were negatively impacted by the effects of the COVID-19 pandemic in 2020. For 2021 periods as compared to
        2020 periods, the increase in revenues and expenses are primarily due to the Company returning to and now exceeding pre-pandemic results.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company has put preparedness plans in place at our facilities to maintain continuity of operations, while also taking steps to
        keep employees and patients safe. In line with recommendations to reduce large gatherings and increase social distancing, the Company has continued to allow a large number of office-based employees to work remotely. The Company is continuing to
        monitor the situation and will adjust work environments accordingly.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In March 2020 in response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic
        Security Act (&#x201c;CARES Act&#x201d;). The CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future
        limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement
        property, and the creation of certain payroll tax credits associated with the retention of employees.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: left; text-indent: 0px;"&gt;Medicare Accelerated and Advance Payment Program (&#x201c;MAAPP Funds&#x201d;)&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic Security Act
        (&#x201c;CARES Act&#x201d;). The CARES Act allowed for qualified healthcare providers to receive advanced payments under the MAAPP Funds during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future
        Medicare services provided. The Company applied for and received approval from Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) in April 2020. The Company recorded the $14.1 million in advance payments received as a liability. During the first quarter of 2021, the Company repaid the MAAPP Funds of $14.1 million rather than applying them to future services performed.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Relief Funds&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;On
        March 27, 2020, the CARES Act was enacted. The CARES Act provided additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0 billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing,
        and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;For
        the years ended December 31, 2021 and December 31, 2020, the Company&#x2019;s consolidated subsidiaries recorded income of approximately $4.6
        million and $13.5 million, respectively, from payments under the CARES Act (&#x201c;Relief Funds&#x201d;). Under the Company&#x2019;s accounting policy, these
        payments were recorded as Other income &#x2013; Relief Funds. These funds are not required to be repaid upon attestation and compliance with certain terms and conditions, which could change materially based on evolving grant compliance provisions and
        guidance provided by the U.S. Department of Health and Human Services. Currently, the Company can attest and comply with the terms and conditions.&#160; The Company will continue to monitor the evolving guidelines and may record adjustments as
        additional information is released.&lt;/div&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_3bfe6525ba0d44a3beff2ae3e9148eef"
      unitRef="U004">2</us-gaap:NumberOfReportableSegments>
    <usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_55972e31cc0a4cd7b99a6c52383b9823">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;During the last three years we completed the acquisitions of seven
        multi-clinic practices and three industrial injury prevention businesses as detailed below. &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Date&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;% Interest&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Number of&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Clinics&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;December 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;December 31, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"&gt; &lt;span style="-sec-ix-hidden:Fact_fcd7d7afc36c4146ae8996c5533e716f"&gt;*&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;100%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: center; white-space: nowrap;"&gt; &lt;span style="-sec-ix-hidden:Fact_9e406021f6644e219c3b143ef1491cbb"&gt;*&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;June 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;June 30, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;65%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;March 2021 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;March 31, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 2020 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 30, 2020&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2020 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2020&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f"&gt;**&lt;/span&gt;&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 2020 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 27, 2020&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;65% ***&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 47%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2019 Acquisition&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 17.16%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2019&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.65%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.71%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;67%&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 1.66%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="width: 14.54%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 47%; vertical-align: bottom; white-space: nowrap;"&gt;April 2019 Acquisition &lt;br/&gt;
              &lt;/td&gt;

    &lt;td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 17.16%; vertical-align: bottom; text-align: center; white-space: nowrap;"&gt;April 11, 2019&lt;br/&gt;
              &lt;/td&gt;

    &lt;td rowspan="1" style="width: 1.65%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.71%; vertical-align: bottom; text-align: center; white-space: nowrap;"&gt;100% &lt;br/&gt;
              &lt;/td&gt;

    &lt;td rowspan="1" style="width: 1.66%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.54%; vertical-align: bottom; text-align: center; white-space: nowrap;"&gt;&lt;span style="-sec-ix-hidden:Fact_b50371aded1746619d40d044e9a29674"&gt;*&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention
                  business&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt; The business includes six management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;***&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt; The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_MultiClinicPracticesMember"
      decimals="INF"
      id="Fact_5c622a8f63514d6cad69a0244a10f55e"
      unitRef="U006">7</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="INF"
      id="Fact_6a6e956bbc604f3da31c9736c9a7c6d9"
      unitRef="U006">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember"
      id="Fact_effba6035d634988ac4a8d9c20ca6e1d">2021-12-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_December2021AcquisitionMember"
      decimals="2"
      id="Fact_9a7522ec423a46409e1a2703179c67f4"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember"
      decimals="INF"
      id="Fact_8d39611bac3f46b1bf887b9e6dcaa42f"
      unitRef="U006">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"
      id="Fact_52bc541919a849eca4949c1a0e1e3c66">2021-11-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"
      decimals="2"
      id="Fact_d43fe56cbbdf43c7a4bea0f445af0520"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2021AcquisitionMember"
      id="Fact_12590ba149db42dd8433f68e08b053b4">2021-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_September2021AcquisitionMember"
      decimals="2"
      id="Fact_9916d80e1cd243f0b8f3bb18b023fba7"
      unitRef="U005">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember"
      id="Fact_c9a732880e5a4bcc83fc7744b3c0de9a">2021-06-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_June2021AcquisitionMember"
      decimals="2"
      id="Fact_1b3082a8428c4db181324b41a7ebb792"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember"
      decimals="INF"
      id="Fact_e7e0e11d59fc4627afb96445699ffcec"
      unitRef="U006">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember"
      id="Fact_a1f3a0ce19124aa3a54b21a01fcdcf66">2021-03-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_March2021AcquisitionMember"
      decimals="2"
      id="Fact_50db100c27d74a549776db5dd5fa7faa"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember"
      decimals="INF"
      id="Fact_ee74dbcdd9214a2bb5efba772bf5f633"
      unitRef="U006">6</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember"
      id="Fact_a80ccd569817402d86a24ce6d26c2606">2020-11-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_November2020AcquisitionMember"
      decimals="2"
      id="Fact_8aa92f67bb7244cfb205945dc3efdc3a"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember"
      decimals="0"
      id="Fact_dbbc9ed2fc374dd695e2c15352500d05"
      unitRef="U006">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember"
      id="Fact_92734568e7d642c5887b2fbf845e42ac">2020-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_September2020AcquisitionMember"
      decimals="2"
      id="Fact_7e6fea3870294f9bbdf4fb3e9e0630f2"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember"
      id="Fact_9309fc129819408f8304bbdf3fafc275">2020-02-27</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_February2020AcquisitionMember"
      decimals="2"
      id="Fact_cccd0aebc3cd4a079b94f19491d12216"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember"
      decimals="0"
      id="Fact_b5e08bf9b37648fab127ae7dfd4a668b"
      unitRef="U006">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember"
      id="Fact_19ebac35c770443eb34e72fe52e07178">2019-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="2"
      id="Fact_7919083f577a40f9941d7ee83e2b7dde"
      unitRef="U005">0.67</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="0"
      id="Fact_12b229a876aa42f9b92228d7ab14140b"
      unitRef="U006">11</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_April2019AcquisitionMember"
      id="Fact_062e517f1223412cae7892d354bed64a">2019-04-11</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20180831_BusinessAcquisitionAxis_April2019AcquisitionMember"
      decimals="2"
      id="Fact_63088025707d4e868c32ef23614a0fc8"
      unitRef="U005">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:NumberOfManagementContracts
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="INF"
      id="Fact_e42a02e713b94fe8a4f13e0e328c9927"
      unitRef="U007">6</usph:NumberOfManagementContracts>
    <usph:RemainingContractTerm
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_ManagementContractsMember"
      id="Fact_9daf91c9ef3b49ea930918274781c30a">P5Y</usph:RemainingContractTerm>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_809988f83eb14100afe6f91a35570e85"
      unitRef="U006">4</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_81bfda2ce0034f7bb93f1f5a6023c135"
      unitRef="U008">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_7e0b3061a9cd4338868a73ec1a2c9068"
      unitRef="U005">0.100</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_b963cbbcacdc496cb6a712c68faf4537"
      unitRef="U005">0.838</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="3"
      id="Fact_6ada95faac844989838162fdcc97b3af"
      unitRef="U005">0.650</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:PercentageOfGeneralPartnershipInterestOwned
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_a4a526359a01462c9d76dfb79f2526f6"
      unitRef="U005">0.01</usph:PercentageOfGeneralPartnershipInterestOwned>
    <usph:PercentageOfLimitedPartnershipInterestOwned
      contextRef="c20210101to20211231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_d4c2794cc0174ea89a26d1705e311e6f"
      unitRef="U005">0.10</usph:PercentageOfLimitedPartnershipInterestOwned>
    <usph:PercentageOfLimitedPartnershipInterestOwned
      contextRef="c20210101to20211231_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_a29fa724731c4ad5958a3dd83235a64a"
      unitRef="U005">0.99</usph:PercentageOfLimitedPartnershipInterestOwned>
    <usph:NumberOfOperatingClinicLocations
      contextRef="c20211231_RangeAxis_MinimumMember"
      decimals="INF"
      id="Fact_bc22911778194dabb60e90733d00e3c1"
      unitRef="U009">1</usph:NumberOfOperatingClinicLocations>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_7d2f54e023504ec68d0395f939dbaabb"
      unitRef="U006">5</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_d7c30f7fdc2b43f7a95ce6500c693aeb"
      unitRef="U006">3</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfClosedClinicsSold
      contextRef="c20211231"
      decimals="INF"
      id="Fact_6c94a61301244cafa1c738e060ea253c"
      unitRef="U006">2</usph:NumberOfClosedClinicsSold>
    <usph:AggregateSalePriceOfCinics
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_bca129404f72455e8c0abc45427eb8fb"
      unitRef="U001">100000</usph:AggregateSalePriceOfCinics>
    <usph:NumberOfClosedClinicsSold
      contextRef="c20201231"
      decimals="0"
      id="Fact_c374f3bdcae747cab366def74bcd56e0"
      unitRef="U006">14</usph:NumberOfClosedClinicsSold>
    <usph:AggregateSalePriceOfCinics
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_e180d75660e64033b0ddd27d567b9ef9"
      unitRef="U001">1100000</usph:AggregateSalePriceOfCinics>
    <usph:CashReceivedRelatedToSaleOfClinics
      contextRef="c20201231"
      decimals="-5"
      id="Fact_5b73372cb4144087a46dc2e0d4a24a4e"
      unitRef="U001">700000</usph:CashReceivedRelatedToSaleOfClinics>
    <usph:NoteReceivableRelatedToSaleOfClinics
      contextRef="c20201231"
      decimals="-5"
      id="Fact_a1a4863e8d8f4e4d99705f313004616f"
      unitRef="U001">400000</usph:NoteReceivableRelatedToSaleOfClinics>
    <usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_900ca1e20fd04b56a0821a2dae5198a9"
      unitRef="U010">2</usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration>
    <us-gaap:GrantsReceivable
      contextRef="c20200430_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"
      decimals="-5"
      id="Fact_6eb29cf4934447319e4a729da63ab039"
      unitRef="U001">14100000</us-gaap:GrantsReceivable>
    <usph:RepaymentOfFunds
      contextRef="c20210331_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"
      decimals="-5"
      id="Fact_4a3345e6f056432bb93ff947a920e16d"
      unitRef="U001">14100000</usph:RepaymentOfFunds>
    <usph:GrantsAndOtherFunds
      contextRef="c20211231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"
      decimals="-8"
      id="Fact_c44ca1222eea48c19909f8eb1f23e145"
      unitRef="U001">100000000000.0</usph:GrantsAndOtherFunds>
    <usph:ReliefFunds
      contextRef="c20210101to20211231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"
      decimals="-5"
      id="Fact_1ee28e487b514566817134cd45a312e5"
      unitRef="U001">4600000</usph:ReliefFunds>
    <usph:ReliefFunds
      contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"
      decimals="-5"
      id="Fact_824f66b7b8e6459caa75ad173bd8a012"
      unitRef="U001">13500000</usph:ReliefFunds>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="c20210101to20211231"
      id="Text_79869cc327d943d19eacb4165990aa14">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2. Significant Accounting Policies&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Cash Equivalents&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments
        with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insurance coverage and, as a result, there is a
        concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Long-Lived Assets&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the
        related assets. Estimated useful lives for furniture and equipment range from &lt;span style="-sec-ix-hidden:Fact_8dba1636fbb14fd492a5df628ebe9b1c"&gt;three&lt;/span&gt; to eight years and for software purchased from &lt;span style="-sec-ix-hidden:Fact_88c34f0df7f44d898218c12bf8c8a138"&gt;three&lt;/span&gt; to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally
        &lt;span style="-sec-ix-hidden:Fact_20d1e6de339f4109b6e30d66a9ab05cd"&gt;three&lt;/span&gt; to five years.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Company reviews property and equipment
        and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value
        less costs to sell.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;"&gt;Investment in unconsolidated affiliate&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;"&gt;Investments in unconsolidated joint ventures in which the Company has less than a controlling interest, are accounted for under the equity method of accounting
          and, accordingly, are adjusted for capital contributions, distributions and the Company&#x2019;s equity in net earnings or loss of the respective joint venture.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
        &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Goodwill&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;Goodwill represents the excess of the amount paid and fair value of
          the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; from the purchase of some or all of a particular local management&#x2019;s equity interest in an existing clinic. Effective January 1, 2009&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional
          paid-in capital.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic impairment evaluations. The fair value of goodwill and
          other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair value if considered impaired. These events or
          conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of
          continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company
          evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;The Company operates a &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The
            partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#x2019;s reporting units when performing its annual goodwill impairment test.&lt;/span&gt; In 2021, 2020 and 2019&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; there were &lt;/span&gt;six&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; regions. &lt;/span&gt;In addition to the six regions, the impairment analysis
        included a separate analysis for the industrial injury prevention services business, as a separate reporting unit.&lt;br class="Apple-interchange-newline"/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If
          goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#x2019;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair
          value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in
          determining the fair value of its reporting units when performing a quantitative analysis.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;"&gt;An impairment loss generally would be recognized when the carrying amount of the net
          assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2021, 2020 and 2019 did not result in any goodwill amounts that were
          deemed impaired.&lt;/div&gt;

&lt;div&gt;&lt;br class="Apple-interchange-newline"/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below
          their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 26.5333px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The Company will continue to monitor for any triggering events or other indicators of impairment. &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Redeemable Non-Controlling Interest&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The non-controlling interest that is
        reflected as redeemable non-controlling interest in the consolidated financial statements consists of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the
        future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months
        earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#x2019;s
        employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically &lt;span style="-sec-ix-hidden:Fact_054bc4ad0f534600aebe5987db19283e"&gt;three&lt;/span&gt;
        to five years, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death)
        and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;On the date the Company acquires a
        controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated
        balance sheet under the ca&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;ption&#x2014;Redeemab&lt;/span&gt;le non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of
        its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial
        carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated
        statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in
        consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
      &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Non-Controlling Interest&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the
        non-controlling interest, as permanent equity in the consolidated financial statements separate from the parent entity&#x2019;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face
        of the statements of net income. Changes in a parent entity&#x2019;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company
        recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or
        shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Revenue Recognition&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting
        Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with
        Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from
        Contracts with Customer (collectively the &#x201c;standards&#x201d;), respectively, which supersede most of the current revenue recognition requirements (&#x201c;ASC 606&#x201d;). The core principle of the new guidance is that an entity should recognize revenue to depict the
        transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Company implemented the new standards beginning January 1, 2018 using a modified
        retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a
        significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues
        upon implementation. Under the new standards, the Company&#x2019;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;For ASC 606,
          there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which
          establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided
          to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the
          Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists
          when we provide the services at established rates.&lt;/span&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;"&gt; The difference
          between the Company&#x2019;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&#x2014;&lt;/span&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;"&gt;contractual allowance.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;
      &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The following table details the revenue related to the various categories (in
        thousands).&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Year Ended&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2020&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2019&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;"&gt;Net patient revenue&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;438,330&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;373,340&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;433,345&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt; Other patient revenue &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,939&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,020&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,486&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;Physical therapy operations&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$ &lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;441,269&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;375,360&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$ &lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;435,831&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;Physical therapy management contracts&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;9,853&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;8,410&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;8,676&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;"&gt;Industrial injury prevention services&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;43,900&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;39,199&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;37,462&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;495,022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;422,969&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;481,969&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
      &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Patient revenue &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Revenues are recognized in the period in
        which services are rendered. Net patient revenue consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries,
        preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors,
        patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides
        physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the
        Company at amounts different from its established rates. &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"&gt;Medicare Reimbursement&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Medicare program reimburses outpatient rehabilitation
        providers based on the Medicare Physician Fee Schedule (&#x201c;MPFS&#x201d;). For services provided in 2017 through 2019, a 0.5% increase was applied
        to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025 no
        adjustment is expected to be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-weight: normal; font-style: normal;"&gt; &lt;/span&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt; In the 2020 MPFS Final Rule, CMS revised coding, documentation guidelines, and
          increased the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office
          visit codes and cuts to other specialty codes to maintain budget neutrality. As a result, CMS projected a 9% decrease in fee schedule
          payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the Consolidated Appropriations Act, 2021 and reimbursement for the codes applicable to physical/occupational therapy services provided by
          our clinics received an estimated 3.5% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;In the 2022 MPFS Final Rule published on November 2, 2021, there was to be an
          approximately 3.75% reduction to Medicare payments for physical/occupational therapy services. This was due to the expiration of the
          additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021. However, this reduction was addressed in the Protecting Medicare and American Farmers from Sequester Cuts Act (&#x201c;2021 Act&#x201d;)
          signed into law on December 10, 2021. Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year of 2022 will be approximately 0.75%. The 2021 Act did not address the 15% reduction in
          Medicare payments for services performed by a physical or occupational therapist assistant, which began on January 1, 2022.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;In addition, the Consolidated Appropriations Act, 2021 includes reductions in
          Medicare payment rates of approximately 3% in each of calendar years 2023 and 2024, unless regulatory or Congressional action
          results in modifications to such rates as has occurred in 2021 and 2022.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Budget Control Act of 2011 increased the federal debt ceiling in connection with
          deficit reductions over the next ten years and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2%
          reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2%
          reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2%
          reductions to Medicare payments through fiscal year 2027. The CARES Act suspended the 2% payment reduction to Medicare payments for
          dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the 2%
          payment reduction until March 31, 2021. On April 14, 2021, additional legislation was enacted that waived the 2% payment reduction for
          the remainder of calendar 2021. The 2021 Act, which was signed into law on December 10, 2021, included a three-month extension of the
          2% sequester relief applied to all Medicare payments through March 31, 2022, followed by three months of 1% sequester relief through June 30, 2022. Sequester relief is scheduled to then end on June 30, 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Beginning in 2021, payments to individual therapists (Physical/Occupational
          Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#x201c;MIPS&#x201d;), which measures performance based on certain quality metrics, resource use, and
          meaningful use of electronic health records. Therapists eligible to participate in MIPS include only those therapists who are enrolled with Medicare as private practice providers, and does not include therapists in facility-based providers, such
          as our clinics enrolled as certified rehabilitation agencies. Less than 3% of the Company&#x2019;s therapist providers currently participate
          in MIPS. Under the MIPS requirements, a provider&#x2019;s performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional&#x2019;s payment for the
          corresponding payment year. The provider&#x2019;s MIPS performance in 2019 will determine the payment adjustment in 2021. For those therapist providers who actually participated in MIPS during 2019, the resulting average payment adjustment was an
          increase of 1%.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Under the Middle-Class Tax Relief and Job Creation Act of 2012 (&#x201c;MCTRA&#x201d;), since
        October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical
        review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech
        Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the
        manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will
        be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#x201c;MEI&#x201d;) for
        2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;CMS adopted a multiple
          procedure payment reduction (&#x201c;MPPR&#x201d;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#x2014; occupational therapy, physical therapy and
          speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value
          Unit (&#x201c;RVU&#x201d;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the
          same patient, regardless of whether those therapy services are furnished in separate sessions. In 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by
          50%.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Medicare claims for outpatient therapy services furnished by therapist assistants on
        or after January 1, 2020 must include a modifier indicating the service was furnished by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022, in whole or part by a therapist assistant will be paid at an amount
        equal to 85% of the payment amount otherwise applicable for the service.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Statutes, regulations, and payment rules governing the delivery of therapy services to
        Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving
        allegations of potential wrongdoing that would have a material effect on our financial statements as of December 31, 2021. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as
        significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the years ended December 31, 2021, and 2020, respectively, net patient revenue from Medicare was approximately $134.4 million and $101.6 million,
        respectively.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;"&gt;Management Contract Revenue&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: 18pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Management contract revenue, which is included in other revenue, is derived from contractual arrangements whereby the Company manages a clinic for third party
          owners. The Company does not have any ownership interest in these clinics. Typically, revenue is determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically
          salaries for the Company&#x2019;s employees, are recorded when incurred. &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt; Industrial Injury
          Prevention Services Revenue&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenue from the industrial injury prevention services business, which is also included in other revenue in the consolidated
            statements of net income, is derived from onsite services the Company provides to clients&#x2019; employees including injury prevention, rehabilitation, ergonomic assessments&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;, post-offer
              employment testing&lt;/span&gt; and performance optimization. Revenue from the Company&#x2019;s industrial injury prevention services business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an
            amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services
            provided in a given period.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-weight: normal; font-style: normal;"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Other Revenue&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Additionally, other revenue includes services the Company provides on-site at
        locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are
        typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time,
        when the services are performed.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Contractual Allowances&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off
        experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare
        regulations and the various third-party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based
        on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the
        clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#x2019;s historical experience, calculating the contractual allowance reserve
        percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation
        that could result in payments that differ from the Company&#x2019;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#x2019;s billing system does not capture the exact
        change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net
        revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within
        approximately 1% to 1.5%
        of net revenues. Additionally, analysis of subsequent periods&#x2019; contractual write-offs on a payor basis reflects a difference within approximately 1%
        to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve
        percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% to 1.5% of gross billings included in accounts receivable at
        December 31, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Allowance for Credit Losses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The
        provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses,
        includes only those amounts the Company estimates to be collectible.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Income Taxes&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the
        future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and
        liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax
        rates is recognized in income in the period that includes the enactment date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority
        would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent
        likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of interest expense and depreciation. ASC
          740, Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. The legislation had no effect on the Company&#x2019;s deferred income taxes and current
          income taxes payable during the year ended December 31, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company did not
        have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during
        the twelve months ended December 31, 2021, 2020 and 2019. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Fair Values of Financial Instruments&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out payments, accounts
          receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates the fair value. The interest rate on
          the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
          exist.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Redeemable non-controlling interest included on the consolidated balance sheets and the put right associated with the
            potential future purchase of the separate company in the November 2021 acquisition are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of Redeemable non-controlling interests approximates the fair
            value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable inputs such as asset volatility and discount
            rates. The unobservable inputs in the valuation include asset volatility of 25% and a discount rate of 8.96%.&#160;See Note 5 for the changes in the fair value of Redeemable non-controlling interest.&#160; There were no changes in the fair value of put right
            associated with the potential future purchase of the separate company in the November 2021 acquisition for the year ended December 31, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Segment Reporting&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;Operating segments are components of an enterprise for which
          separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. &lt;/span&gt;The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Use of Estimates&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In preparing the Company&#x2019;s consolidated financial statements, management makes certain estimates and assumptions, especially in
        relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and
        related disclosures. Actual results may differ from these estimates.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Self-Insurance Program&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third
        party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#x2019;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated
        future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Restricted Stock&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Restricted stock issued to employees and directors is subject to continued employment or continued service on the board,
        respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following &lt;span style="-sec-ix-hidden:Fact_61e076fe690248718f13697be1324500"&gt;four&lt;/span&gt;
        anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the &lt;span style="-sec-ix-hidden:Fact_139391eb54254fc583112777fb6d273d"&gt;first&lt;/span&gt;
        year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years
        following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The
        restricted stock issued is included in basic and diluted shares for the earnings per share computation.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Recently Adopted Accounting Pronouncements&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;span style="font-style: italic;"&gt;Financial Instruments &#x2013; Credit Losses&lt;/span&gt;, which
        added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses.
        The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low
        risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company completed the adoption of the standard on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#x2019;s accounts
        receivable derived from contracts with customers. A significant portion of the Company&#x2019;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial
        insurers. The Company&#x2019;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained
        earnings on the adoption date of the standard.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Simplifying the Test
          for Goodwill Impairment (Topic 350),&lt;/span&gt; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods
        within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#x2019;s adoption of this change.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Income Taxes (Topic 740)&#x2013;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(&#x201c;ASU 2019-12&#x201d;). The
          objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The
          amendments in this ASU are effective for fiscal years beginning after December&#160;15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In August 2020, the FASB issued ASU 2020-06&#160;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Debt&#x2014;Debt














          with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity, &lt;/span&gt;which simplifies the
        accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. As part of this update, convertible instruments are to be included in diluted
        earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings
        per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a
        stated policy.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;This pronouncement was effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021.The Board
          specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition
          is permitted. The Company has determined that the adoption of ASU 2020-06 will not have a material impact on the Company&#x2019;s financial statements.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="font-style: italic; font-weight: bold;"&gt;Recently Issued Accounting Guidance&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Reference Rate Reform
          (Topic 848): Facilitation of the Effects of Reference&lt;/span&gt;&#160;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Rate Reform on Financial Reporting&lt;/span&gt;. This ASU provides temporary optional expedients and
        exceptions to the guidance on contract&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;&#160;&lt;/span&gt;modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR
        and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit
        Agreement (as defined in Note 9) bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
        exist.&lt;/div&gt;
</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_eefc7967450b475a8ade6715fd4e10e5">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Cash Equivalents&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments
        with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insurance coverage and, as a result, there is a
        concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.&lt;/div&gt;
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_42c7b9ddce6f4ade83e6cba0c46adb66">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Long-Lived Assets&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the
        related assets. Estimated useful lives for furniture and equipment range from &lt;span style="-sec-ix-hidden:Fact_8dba1636fbb14fd492a5df628ebe9b1c"&gt;three&lt;/span&gt; to eight years and for software purchased from &lt;span style="-sec-ix-hidden:Fact_88c34f0df7f44d898218c12bf8c8a138"&gt;three&lt;/span&gt; to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally
        &lt;span style="-sec-ix-hidden:Fact_20d1e6de339f4109b6e30d66a9ab05cd"&gt;three&lt;/span&gt; to five years.&lt;/div&gt;
</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember"
      id="Fact_2325769c7c9f4b4b9a4ce64020c5e4ea">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember"
      id="Fact_cb14591344b048ba82145d638c06a9cf">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember"
      id="Fact_3a72583b8cd04becb9c5b0e5546bc8e1">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_bfb3288357af41029ff059a0b1cfcfad">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Company reviews property and equipment
        and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value
        less costs to sell.&lt;/div&gt;
</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_047f4fa0a6694b9da384168ded9a88d0">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;"&gt;Investment in unconsolidated affiliate&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-style: italic; font-weight: bold;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;"&gt;Investments in unconsolidated joint ventures in which the Company has less than a controlling interest, are accounted for under the equity method of accounting
          and, accordingly, are adjusted for capital contributions, distributions and the Company&#x2019;s equity in net earnings or loss of the respective joint venture.&lt;/div&gt;
</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_8ed549a7adbb471ea29c5ae834094e87">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Goodwill&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;Goodwill represents the excess of the amount paid and fair value of
          the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; from the purchase of some or all of a particular local management&#x2019;s equity interest in an existing clinic. Effective January 1, 2009&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional
          paid-in capital.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Goodwill and other indefinite-lived intangible assets are not amortized but are instead subject to periodic impairment evaluations. The fair value of goodwill and
          other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions and are written down to fair value if considered impaired. These events or
          conditions include but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of
          continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company
          evaluates indefinite lived tradenames in conjunction with its annual goodwill impairment test.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;The Company operates a &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; segment business which is made up of various clinics within partnerships, and an industrial injury prevention services business. The
            partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#x2019;s reporting units when performing its annual goodwill impairment test.&lt;/span&gt; In 2021, 2020 and 2019&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; there were &lt;/span&gt;six&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; regions. &lt;/span&gt;In addition to the six regions, the impairment analysis
        included a separate analysis for the industrial injury prevention services business, as a separate reporting unit.&lt;br class="Apple-interchange-newline"/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If
          goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#x2019;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair
          value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in
          determining the fair value of its reporting units when performing a quantitative analysis.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 18pt;"&gt;An impairment loss generally would be recognized when the carrying amount of the net
          assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2021, 2020 and 2019 did not result in any goodwill amounts that were
          deemed impaired.&lt;/div&gt;

&lt;div&gt;&lt;br class="Apple-interchange-newline"/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;As part of the annual assessment, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below
          their carrying value as of December 31, 2021. As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 26.5333px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The Company will continue to monitor for any triggering events or other indicators of impairment. &lt;/span&gt;&lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_ad0eb764099c4e7ca0b92761607c1914"
      unitRef="U004">2</us-gaap:NumberOfOperatingSegments>
    <usph:NumberOfRegions
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_c88d5a026ebb44478a4f4c201c7b4032"
      unitRef="U011">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20190101to20191231"
      decimals="INF"
      id="Fact_a45e092a76214ccaac88db2d1df7a7ef"
      unitRef="U011">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_234297b5cc1d49e1bd66fbeef7b72f65"
      unitRef="U011">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_f0b84e6e6bee437fa02bf8cc1256c8bb"
      unitRef="U011">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20190101to20191231"
      decimals="INF"
      id="Fact_8899ec852477412b9633c5c7298f1b0e"
      unitRef="U011">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_4b8959a095bf4d10bc1836e645be546b"
      unitRef="U011">6</usph:NumberOfRegions>
    <usph:RedeemableNonControllingInterestsPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_bd0febfaaa72460abc26d90bdff90565">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Redeemable Non-Controlling Interest&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The non-controlling interest that is
        reflected as redeemable non-controlling interest in the consolidated financial statements consists of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the
        future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months
        earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#x2019;s
        employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically &lt;span style="-sec-ix-hidden:Fact_054bc4ad0f534600aebe5987db19283e"&gt;three&lt;/span&gt;
        to five years, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death)
        and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;On the date the Company acquires a
        controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated
        balance sheet under the ca&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;ption&#x2014;Redeemab&lt;/span&gt;le non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of
        its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial
        carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated
        statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in
        consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.&lt;/div&gt;
</usph:RedeemableNonControllingInterestsPolicyTextBlock>
    <usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod
      contextRef="c20210101to20211231_RangeAxis_MaximumMember"
      id="Fact_7ddf7906142b41dfbf0534e9dd4a64ce">P5Y</usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
    <usph:NonControllingInterestsPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_97341a6eb3474169b82059ef26c4799d">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Non-Controlling Interest&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company recognizes non-controlling interest, in which the Company has no obligation but the right to purchase the
        non-controlling interest, as permanent equity in the consolidated financial statements separate from the parent entity&#x2019;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face
        of the statements of net income. Changes in a parent entity&#x2019;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company
        recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or
        shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.&lt;/div&gt;
</usph:NonControllingInterestsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_b554bea11a6848378c16f3b62a6a33d3">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Revenue Recognition&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting
        Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with
        Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from
        Contracts with Customer (collectively the &#x201c;standards&#x201d;), respectively, which supersede most of the current revenue recognition requirements (&#x201c;ASC 606&#x201d;). The core principle of the new guidance is that an entity should recognize revenue to depict the
        transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Company implemented the new standards beginning January 1, 2018 using a modified
        retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a
        significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues
        upon implementation. Under the new standards, the Company&#x2019;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;For ASC 606,
          there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which
          establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided
          to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the
          Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists
          when we provide the services at established rates.&lt;/span&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;"&gt; The difference
          between the Company&#x2019;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&#x2014;&lt;/span&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; font-size: 10pt;"&gt;contractual allowance.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;
      &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The following table details the revenue related to the various categories (in
        thousands).&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Year Ended&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2020&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2019&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;"&gt;Net patient revenue&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;438,330&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;373,340&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;433,345&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt; Other patient revenue &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,939&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,020&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,486&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;Physical therapy operations&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$ &lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;441,269&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;375,360&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$ &lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;435,831&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;Physical therapy management contracts&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;9,853&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;8,410&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;8,676&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;"&gt;Industrial injury prevention services&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;43,900&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;39,199&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;37,462&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;495,022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;422,969&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;481,969&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
      &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Patient revenue &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Revenues are recognized in the period in
        which services are rendered. Net patient revenue consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries,
        preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors,
        patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides
        physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the
        Company at amounts different from its established rates. &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none; color: rgb(0, 0, 0);"&gt;Medicare Reimbursement&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Medicare program reimburses outpatient rehabilitation
        providers based on the Medicare Physician Fee Schedule (&#x201c;MPFS&#x201d;). For services provided in 2017 through 2019, a 0.5% increase was applied
        to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025 no
        adjustment is expected to be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-weight: normal; font-style: normal;"&gt; &lt;/span&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt; In the 2020 MPFS Final Rule, CMS revised coding, documentation guidelines, and
          increased the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS beginning in 2021. Under the 2021 MPFS Final Rule, CMS increased the values for the E/M office
          visit codes and cuts to other specialty codes to maintain budget neutrality. As a result, CMS projected a 9% decrease in fee schedule
          payment rates for therapy services set to take effect in 2021. However, Congress intervened with passage of the Consolidated Appropriations Act, 2021 and reimbursement for the codes applicable to physical/occupational therapy services provided by
          our clinics received an estimated 3.5% decrease in the aggregate in payment from Medicare in calendar year 2021 as compared to 2020.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;In the 2022 MPFS Final Rule published on November 2, 2021, there was to be an
          approximately 3.75% reduction to Medicare payments for physical/occupational therapy services. This was due to the expiration of the
          additional funding to the conversion factor provided by Congress in 2021 under the Consolidated Appropriations Act, 2021. However, this reduction was addressed in the Protecting Medicare and American Farmers from Sequester Cuts Act (&#x201c;2021 Act&#x201d;)
          signed into law on December 10, 2021. Based on various provisions in the 2021 Act, the Company now estimates that the Medicare rate reduction for the full year of 2022 will be approximately 0.75%. The 2021 Act did not address the 15% reduction in
          Medicare payments for services performed by a physical or occupational therapist assistant, which began on January 1, 2022.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;In addition, the Consolidated Appropriations Act, 2021 includes reductions in
          Medicare payment rates of approximately 3% in each of calendar years 2023 and 2024, unless regulatory or Congressional action
          results in modifications to such rates as has occurred in 2021 and 2022.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Budget Control Act of 2011 increased the federal debt ceiling in connection with
          deficit reductions over the next ten years and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2%
          reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2%
          reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2%
          reductions to Medicare payments through fiscal year 2027. The CARES Act suspended the 2% payment reduction to Medicare payments for
          dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the 2%
          payment reduction until March 31, 2021. On April 14, 2021, additional legislation was enacted that waived the 2% payment reduction for
          the remainder of calendar 2021. The 2021 Act, which was signed into law on December 10, 2021, included a three-month extension of the
          2% sequester relief applied to all Medicare payments through March 31, 2022, followed by three months of 1% sequester relief through June 30, 2022. Sequester relief is scheduled to then end on June 30, 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Beginning in 2021, payments to individual therapists (Physical/Occupational
          Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#x201c;MIPS&#x201d;), which measures performance based on certain quality metrics, resource use, and
          meaningful use of electronic health records. Therapists eligible to participate in MIPS include only those therapists who are enrolled with Medicare as private practice providers, and does not include therapists in facility-based providers, such
          as our clinics enrolled as certified rehabilitation agencies. Less than 3% of the Company&#x2019;s therapist providers currently participate
          in MIPS. Under the MIPS requirements, a provider&#x2019;s performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional&#x2019;s payment for the
          corresponding payment year. The provider&#x2019;s MIPS performance in 2019 will determine the payment adjustment in 2021. For those therapist providers who actually participated in MIPS during 2019, the resulting average payment adjustment was an
          increase of 1%.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Under the Middle-Class Tax Relief and Job Creation Act of 2012 (&#x201c;MCTRA&#x201d;), since
        October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical
        review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech
        Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the
        manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will
        be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#x201c;MEI&#x201d;) for
        2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;CMS adopted a multiple
          procedure payment reduction (&#x201c;MPPR&#x201d;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#x2014; occupational therapy, physical therapy and
          speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value
          Unit (&#x201c;RVU&#x201d;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the
          same patient, regardless of whether those therapy services are furnished in separate sessions. In 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by
          50%.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Medicare claims for outpatient therapy services furnished by therapist assistants on
        or after January 1, 2020 must include a modifier indicating the service was furnished by a therapist assistant. Outpatient therapy services furnished on or after January 1, 2022, in whole or part by a therapist assistant will be paid at an amount
        equal to 85% of the payment amount otherwise applicable for the service.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Statutes, regulations, and payment rules governing the delivery of therapy services to
        Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving
        allegations of potential wrongdoing that would have a material effect on our financial statements as of December 31, 2021. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as
        significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the years ended December 31, 2021, and 2020, respectively, net patient revenue from Medicare was approximately $134.4 million and $101.6 million,
        respectively.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;"&gt;Management Contract Revenue&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: 18pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Management contract revenue, which is included in other revenue, is derived from contractual arrangements whereby the Company manages a clinic for third party
          owners. The Company does not have any ownership interest in these clinics. Typically, revenue is determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically
          salaries for the Company&#x2019;s employees, are recorded when incurred. &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt; Industrial Injury
          Prevention Services Revenue&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: italic; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenue from the industrial injury prevention services business, which is also included in other revenue in the consolidated
            statements of net income, is derived from onsite services the Company provides to clients&#x2019; employees including injury prevention, rehabilitation, ergonomic assessments&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;, post-offer
              employment testing&lt;/span&gt; and performance optimization. Revenue from the Company&#x2019;s industrial injury prevention services business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an
            amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services
            provided in a given period.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-weight: normal; font-style: normal;"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Other Revenue&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;Additionally, other revenue includes services the Company provides on-site at
        locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are
        typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time,
        when the services are performed.&lt;/div&gt;
</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_18b8e34835614d9680410c91671d46c2">
&lt;div&gt;
      &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The following table details the revenue related to the various categories (in
        thousands).&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;Year Ended&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2020&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-variant: normal; text-transform: none;"&gt;December 31, 2019&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;"&gt;Net patient revenue&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;438,330&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;373,340&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;433,345&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt; Other patient revenue &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,939&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,020&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;2,486&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;Physical therapy operations&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$ &lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;441,269&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;375,360&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$ &lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;435,831&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;Physical therapy management contracts&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;9,853&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;8,410&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                &lt;/span&gt; &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;8,676&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt; font-variant: normal; text-transform: none;"&gt;Industrial injury prevention services&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;43,900&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;39,199&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;37,462&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;495,022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;422,969&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;481,969&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_84f59c475c6f408bbbb7fcab668e21e1"
      unitRef="U001">438330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_6d084ef3b3c34026a17cce1230475ff3"
      unitRef="U001">373340000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_cb5e96e705e3486789e637a2539a6d92"
      unitRef="U001">433345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231_ProductOrServiceAxis_OtherRevenuesMember"
      decimals="-3"
      id="Fact_84fcfc72fb9c4c848274defa81c449b1"
      unitRef="U001">2939000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesMember"
      decimals="-3"
      id="Fact_a0ed771469bb4d209c28f483531a95bb"
      unitRef="U001">2020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesMember"
      decimals="-3"
      id="Fact_cbd91ee6603d4cdf95643aea6a8e6d61"
      unitRef="U001">2486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_3da6d1fc7ded4bb492455bed635d1220"
      unitRef="U001">441269000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_e56a54c046ae47e4a71fdf85a25f6543"
      unitRef="U001">375360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_18f2405c79ce46368f5f67cbb1dd940f"
      unitRef="U001">435831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231_ProductOrServiceAxis_ManagementContractRevenuesMember"
      decimals="-3"
      id="Fact_eca56bb2c595462dbbcfcc6581ccf86b"
      unitRef="U001">9853000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_ManagementContractRevenuesMember"
      decimals="-3"
      id="Fact_8dc5bf3c0e1a436b9c55ddbcfe6e1388"
      unitRef="U001">8410000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_ManagementContractRevenuesMember"
      decimals="-3"
      id="Fact_b1adb356b0cb45d784aaf9c67d74910f"
      unitRef="U001">8676000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_36a665a0c125474c8468027e9f9ade6f"
      unitRef="U001">43900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_a108043f96164c75a1797e61b187652a"
      unitRef="U001">39199000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_5ebaa7d5fc174703a37d961c5abfa18b"
      unitRef="U001">37462000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_dc53ac3c1c8f4866a23ddbfd62e22406"
      unitRef="U001">495022000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_402f514952a340e1a0f43d880f3ca2de"
      unitRef="U001">422969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_a161480783454c848bec0ecf8193dfb6"
      unitRef="U001">481969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <usph:PercentageOfMedicarePaymentIncrease
      contextRef="c20210101to20211231_UnusualOrInfrequentItemAxis_FromTwoThousandSeventeenThroughTwoThousandNineteenMember"
      decimals="3"
      id="Fact_e156e93da6b34362ae6335c04376b0af"
      unitRef="U005">0.005</usph:PercentageOfMedicarePaymentIncrease>
    <usph:PercentageOfMedicarePaymentIncrease
      contextRef="c20210101to20211231_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember"
      decimals="0"
      id="Fact_08411dc3a6eb4cb2a61642f215f917cc"
      unitRef="U005">0</usph:PercentageOfMedicarePaymentIncrease>
    <usph:EstimatedPercentageOfDecreaseInPayment
      contextRef="c20210101to20211231_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember"
      decimals="2"
      id="Fact_a72438d521c147a6b2babb70e4585e1f"
      unitRef="U005">0.09</usph:EstimatedPercentageOfDecreaseInPayment>
    <usph:EstimatedPercentageOfDecreaseInPayment
      contextRef="c20210101to20211231"
      decimals="3"
      id="Fact_ad266e8000ec4e5da2ace6074f12a93f"
      unitRef="U005">0.035</usph:EstimatedPercentageOfDecreaseInPayment>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20211102_RelatedPartyTransactionsByRelatedPartyAxis_CentersForMedicareAndMedicaidServicesMember"
      decimals="4"
      id="Fact_a613e943e123410d9aa6ee3c43013ca7"
      unitRef="U005">0.0375</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20221231_StatementScenarioAxis_ScenarioForecastMember"
      decimals="4"
      id="Fact_3b2be61484b148bcad6e3b581c127dc1"
      unitRef="U005">0.0075</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:EstimatedPercentageOfDecreaseInPayment
      contextRef="c20220101to20221231_StatementScenarioAxis_ScenarioForecastMember"
      decimals="2"
      id="Fact_77eb84a86ba945dfada89f9491f699a3"
      unitRef="U005">0.15</usph:EstimatedPercentageOfDecreaseInPayment>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20231231_StatementScenarioAxis_ScenarioForecastMember"
      decimals="2"
      id="Fact_e758262019a440da92357639e7c2d66b"
      unitRef="U005">0.03</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20241231_StatementScenarioAxis_ScenarioForecastMember"
      decimals="2"
      id="Fact_6658247e329f42fab7ae785c5a1be1ea"
      unitRef="U005">0.03</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions
      contextRef="c20210101to20211231"
      id="Fact_787ca2d5df954b88b24e628c12e5c38b">P10Y</usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions>
    <usph:AmountOfReductionsInFederalSpending
      contextRef="c20210101to20211231"
      decimals="-11"
      id="Fact_8910c460c9654802b55228e2525e85c6"
      unitRef="U001">1200000000000</usph:AmountOfReductionsInFederalSpending>
    <usph:ReductionInMedicareSpendingPercentage
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_3dc201e0ab884669ae10cf1ab7222941"
      unitRef="U005">0.02</usph:ReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20130401"
      decimals="2"
      id="Fact_0e09100472f74dd8af303564df6bde25"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20151102"
      decimals="2"
      id="Fact_dd8860411f1e44859be21621754e62fa"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20180209"
      decimals="2"
      id="Fact_1d22e32f418847cf9cabbc9c820b71c1"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20211231"
      decimals="2"
      id="Fact_90743b63514242eca6747c151ee8586d"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20211231"
      decimals="2"
      id="Fact_4b2e37bec6234760bd7f5a871d09cc99"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation
      contextRef="c20210401to20210414"
      decimals="2"
      id="Fact_7bab068beef245aeab7d01714b5624cd"
      unitRef="U005">0.02</usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation>
    <usph:PeriodOfExtension
      contextRef="c20210101to20211231"
      id="Fact_43c7758c1db54819a7a0bb20eb81d818">P3M</usph:PeriodOfExtension>
    <usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation
      contextRef="c20210401to20210414"
      decimals="2"
      id="Fact_5e05c31577214845a026b4785b431818"
      unitRef="U005">0.02</usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislation>
    <usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_76b720de3dd04fdfab9815cbdfd2de00"
      unitRef="U005">0.01</usph:PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo>
    <usph:PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem
      contextRef="c20210101to20211231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_dc0a2c627e274ddfabbd5c42e2329bcb"
      unitRef="U005">0.03</usph:PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem>
    <usph:PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_fc26576336b44deda96a41894dcd17b1"
      unitRef="U005">0.01</usph:PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_5a0346d8d824462397d0f9ac788292b4"
      unitRef="U001">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_3ba675a29df34aab8464b3530a2a13bb"
      unitRef="U001">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_77c3ff9bb7ee4be08e8f13c2ce5593bb"
      unitRef="U001">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_6cb6f50a518f4cc680a847c958c83c56"
      unitRef="U001">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_a1c3055defb6464db378210f2beda0b1"
      unitRef="U001">3000</usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_7c71c49351b74fa4a787c218a5727483"
      unitRef="U005">1</usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit>
    <usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_ce7bc07fac93452fbe56b74d6bd2a35c"
      unitRef="U005">0.50</usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings>
    <usph:PercentageOfPaymentForOutpatientTherapyServices
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_de85fb5c01e74b6ab1d9baa803f83ed6"
      unitRef="U005">0.85</usph:PercentageOfPaymentForOutpatientTherapyServices>
    <usph:NetRevenueFromMedicare
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_9ccb919162754f42b1537dbec9633424"
      unitRef="U001">134400000</usph:NetRevenueFromMedicare>
    <usph:NetRevenueFromMedicare
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_5c451e9ef70a45feaf338f7557150a88"
      unitRef="U001">101600000</usph:NetRevenueFromMedicare>
    <us-gaap:ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_2fd8fb3bf1a7468f9e4c7354f30e6bc0">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Contractual Allowances&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off
        experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare
        regulations and the various third-party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based
        on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the
        clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#x2019;s historical experience, calculating the contractual allowance reserve
        percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation
        that could result in payments that differ from the Company&#x2019;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#x2019;s billing system does not capture the exact
        change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net
        revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within
        approximately 1% to 1.5%
        of net revenues. Additionally, analysis of subsequent periods&#x2019; contractual write-offs on a payor basis reflects a difference within approximately 1%
        to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve
        percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% to 1.5% of gross billings included in accounts receivable at
        December 31, 2021.&lt;/div&gt;
</us-gaap:ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock>
    <usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
      contextRef="c20210101to20211231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_f7157d0deb714320b992d870b7b8fef5"
      unitRef="U005">0.01</usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues>
    <usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
      contextRef="c20210101to20211231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_c9aa7243ac7d404da55cda7f26844077"
      unitRef="U005">0.015</usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues>
    <usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
      contextRef="c20210101to20211231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_1df87cf7e1454e999ad86b532b650b18"
      unitRef="U005">0.01</usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage>
    <usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
      contextRef="c20210101to20211231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_4277182b3b524b539538885d6cfba4b4"
      unitRef="U005">0.015</usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage>
    <usph:MaximumContractualAllowanceReserveEstimate
      contextRef="c20210101to20211231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_f2811f47235b4e9aa49adc3155886b7c"
      unitRef="U005">0.01</usph:MaximumContractualAllowanceReserveEstimate>
    <usph:MaximumContractualAllowanceReserveEstimate
      contextRef="c20210101to20211231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_9c822c97684c472c878c6ba1501942ec"
      unitRef="U005">0.015</usph:MaximumContractualAllowanceReserveEstimate>
    <us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
      contextRef="c20210101to20211231"
      id="Text_855ce53bcf2d450bbc43898475aed397">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Allowance for Credit Losses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The
        provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses,
        includes only those amounts the Company estimates to be collectible.&lt;/div&gt;
</us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_d6dbeb5136184bc2bb845429a9dace20">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Income Taxes&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the
        future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and
        liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax
        rates is recognized in income in the period that includes the enactment date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority
        would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent
        likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The CARES Act includes changes to certain tax law related to net operating losses and the deductibility of interest expense and depreciation. ASC
          740, Income Taxes requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. The legislation had no effect on the Company&#x2019;s deferred income taxes and current
          income taxes payable during the year ended December 31, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company did not
        have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during
        the twelve months ended December 31, 2021, 2020 and 2019. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.&lt;/div&gt;
</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b7aa493b1e374351a7c2647dd09abff6"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6a439e12d556494793b4ad5359c62eba"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0279d35b976f4ed29e3d271b32fc0820"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_ee40c3e9bff54c14a70fa70014551a6f"
      unitRef="U001">0</us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations>
    <us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c80c90bc4b4941f7b2f84f5092b4d1ce"
      unitRef="U001">0</us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations>
    <us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1675402b2a7e4fc6acfacf53c410265e"
      unitRef="U001">0</us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="c20210101to20211231"
      id="Text_d0f8e68bab4d45f4b952ccbafb76ee10">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Fair Values of Financial Instruments&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The carrying amounts reported in the balance sheets for cash and cash equivalents, contingent earn-out payments, accounts
          receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates the fair value. The interest rate on
          the Amended Credit Agreement is tied to the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;). Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
          exist.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Redeemable non-controlling interest included on the consolidated balance sheets and the put right associated with the
            potential future purchase of the separate company in the November 2021 acquisition are both marked to fair value on a recurring basis using level 3 inputs.&#160; The redemption value of Redeemable non-controlling interests approximates the fair
            value.&#160; The put right associated with the potential future purchase of the separate company in the November 2021 acquisition is determined using a Monte Carlo simulation model utilizing unobservable inputs such as asset volatility and discount
            rates. The unobservable inputs in the valuation include asset volatility of 25% and a discount rate of 8.96%.&#160;See Note 5 for the changes in the fair value of Redeemable non-controlling interest.&#160; There were no changes in the fair value of put right
            associated with the potential future purchase of the separate company in the November 2021 acquisition for the year ended December 31, 2021.&lt;/div&gt;
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="c20211231_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_61a99f89e6a741ab9bddf40f35f53db7"
      unitRef="U005">0.25</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="c20211231_MeasurementInputTypeAxis_MeasurementInputDiscountRateMember"
      decimals="4"
      id="Fact_8290387510ae420eac5ceeb9d930d619"
      unitRef="U005">0.0896</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_b745fc0c78914a5f834207a4392ccbde">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Segment Reporting&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;Operating segments are components of an enterprise for which
          separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. &lt;/span&gt;The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.&lt;/div&gt;
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_da9f79b50cd34131aba08e77ff538154"
      unitRef="U004">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:UseOfEstimates
      contextRef="c20210101to20211231"
      id="Text_d30eea001f1c4f78b24f9149df7972b6">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Use of Estimates&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In preparing the Company&#x2019;s consolidated financial statements, management makes certain estimates and assumptions, especially in
        relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and
        related disclosures. Actual results may differ from these estimates.&lt;/div&gt;
</us-gaap:UseOfEstimates>
    <usph:SelfInsuranceProgramPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_288fb46274b34b4d90c558a14917e75e">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Self-Insurance Program&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third
        party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#x2019;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated
        future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2021.&lt;/div&gt;
</usph:SelfInsuranceProgramPolicyPolicyTextBlock>
    <usph:RestrictedStockPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_df94358a3a5545228c0f8e9edb6b69d7">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Restricted Stock&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Restricted stock issued to employees and directors is subject to continued employment or continued service on the board,
        respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following &lt;span style="-sec-ix-hidden:Fact_61e076fe690248718f13697be1324500"&gt;four&lt;/span&gt;
        anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the &lt;span style="-sec-ix-hidden:Fact_139391eb54254fc583112777fb6d273d"&gt;first&lt;/span&gt;
        year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years
        following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The
        restricted stock issued is included in basic and diluted shares for the earnings per share computation.&lt;/div&gt;
</usph:RestrictedStockPolicyPolicyTextBlock>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20210101to20211231_TitleOfIndividualAxis_OfficerMember"
      id="Fact_c2f44ce44b9c416fa4faf70f291f23d9">P4Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_35df2706f95e4339a7c18e17deb81574">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Recently Adopted Accounting Pronouncements&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;span style="font-style: italic;"&gt;Financial Instruments &#x2013; Credit Losses&lt;/span&gt;, which
        added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses.
        The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low
        risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company completed the adoption of the standard on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#x2019;s accounts
        receivable derived from contracts with customers. A significant portion of the Company&#x2019;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial
        insurers. The Company&#x2019;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained
        earnings on the adoption date of the standard.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Simplifying the Test
          for Goodwill Impairment (Topic 350),&lt;/span&gt; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods
        within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#x2019;s adoption of this change.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Income Taxes (Topic 740)&#x2013;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(&#x201c;ASU 2019-12&#x201d;). The
          objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The
          amendments in this ASU are effective for fiscal years beginning after December&#160;15, 2020, and early adoption was permitted. The adoption of ASU 2020-06 did not have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In August 2020, the FASB issued ASU 2020-06&#160;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Debt&#x2014;Debt














          with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity, &lt;/span&gt;which simplifies the
        accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. As part of this update, convertible instruments are to be included in diluted
        earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings
        per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a
        stated policy.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;This pronouncement was effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021.The Board
          specified that an entity should adopt the guidance at the beginning of its annual fiscal year. The Company adopted this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition
          is permitted. The Company has determined that the adoption of ASU 2020-06 will not have a material impact on the Company&#x2019;s financial statements.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="font-style: italic; font-weight: bold;"&gt;Recently Issued Accounting Guidance&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Reference Rate Reform
          (Topic 848): Facilitation of the Effects of Reference&lt;/span&gt;&#160;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Rate Reform on Financial Reporting&lt;/span&gt;. This ASU provides temporary optional expedients and
        exceptions to the guidance on contract&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;&#160;&lt;/span&gt;modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR
        and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit
        Agreement (as defined in Note 9) bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to
        exist.&lt;/div&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_ab4577941af4444b8ff1efb979f8074b">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;3. Acquisitions of Businesses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;During 2021, 2020 and 2019, the Company acquired a majority interest in the following businesses:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Date&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;% Interest&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Clinics&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;December 2021 Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom;"&gt;November 2021 Acquisition&lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;"&gt;November 30, 2021&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;"&gt;70%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:Fact_f2ab670c292849e0a6da2f6f425f8ab8"&gt;IIPS*&lt;/span&gt;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;September 2021 Acquisition&lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;"&gt;September 30, 2021&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"&gt;100%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"&gt;&lt;span style="-sec-ix-hidden:Fact_8fc8c722672b4497be0c04af98353c23"&gt;IIPS*&lt;/span&gt;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom;"&gt;June 2021 Acquisition&lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;"&gt;June 30, 2021&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;"&gt;65%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;"&gt;8&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;March 2021 Acquisition&lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;"&gt;March 31, 2021&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"&gt;70%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"&gt;6&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom;"&gt;November 2020 Acquisition&lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;"&gt;November 30, 2020&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;"&gt;75%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;"&gt;3&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2020 Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_d7b298373dc646968960932c7a99c477"&gt;**&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 2020 Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 27, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;65%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;***&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2019 Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;67%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom;"&gt;April 2019 Acquisition &lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: bottom; text-align: center;"&gt;April 11, 2019 &lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: bottom; text-align: right;"&gt;100% &lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: bottom; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:Fact_9ccb1564cfba40339b352148e6a9107a"&gt;*&lt;/span&gt;&lt;br/&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Industrial injury prevention business&lt;br/&gt;
              &lt;/span&gt;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="c25a46c3472f4e9d89f721c383608370" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The business includes six management
              and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years&lt;/span&gt;.&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z9554ae614f714132a1278bbaa794d16d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;***&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;On December 31, 2021, the Company acquired a 75% in three-clinic physical therapy practice with the practice founder retaining 25%. The purchase price for the 75%
      interest was approximately $3.7 million, of which $3.5 million was paid in cash and $0.2 million in the form of a note payable. The note accrues interest at
      3.25% per annum and the principal and interest is payable on December 31, 2023.&lt;/div&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;On November 30, 2021, the Company acquired an approximate 70% interest in a leading provider of industrial injury prevention services. In each case, the previous owners retained the remaining interest. The
          purchase price for the approximate 70% equity interest, not inclusive of a $2.0 million contingent payment, was approximately $63.2 million
          of which $60.7 million was paid in cash and $1.0 million in the form of a note payable. The note accrues interest at 3.25% per annum and the
          principal and interest is payable on November 30, 2023. &lt;/span&gt;As part of the transaction, the Company also agreed to the potential future purchase of a separate company under the same ownership that provides physical therapy and rehabilitation
        services to hospitals and other ancillary providers in a distinct market area. The current owners have the right to put this transaction to the Company in approximately five years, with such right having a $3.5 million value at December 31, 2021, as reflected on the
        Company&#x2019;s consolidated balance sheet in Other long-term liabilities. The value of this right will be adjusted in future periods, as appropriate, with any change in value reflected in the Company&#x2019;s consolidated statement of income. The Company does
        not currently possess more than 50% of the controlling interests in this separate company, does not control this company through contract or governance rights and currently does not exercise significant influence over this separate company. Due to
        the aforementioned reasons, and based on current accounting guidance, the Company did not consolidate the separate company through the variable interest or voting interest model.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;On September 30, 2021, the Company acquired a company that specializes in return-to-work and ergonomic services, among other
            offerings. The Company acquired the company&#x2019;s assets at a purchase price of approximately $3.3 million (which includes the obligation
            to pay an amount up to $0.6 million in contingent payment consideration in conjunction with the acquisition if specified future
            operational objectives are met), and contributed those assets to Briotix Health. The initial purchase price, not inclusive of the $0.6
            million contingent payment, was approximately $2.7 million, of which $2.4 million was paid in cash, and $0.3 million is in the form
            of a note payable. The note accrues interest at 3.25% per annum and the principal and interest is payable on September 30, 2023.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 13.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;On June 30, 2021, the Company acquired a 65% interest in an eight-clinic physical therapy with the previous owners retaining 35%. The purchase price was approximately $10.3
            million, of which $9.0 million was paid in cash, $1.0 million is payable based on the achievement of certain business criteria and $0.3 million is in
            the form of a note payable. The note accrues interest at 3.25% per annum and the principal and interest is payable on June 30, 2023.
            Additionally, the Company has an obligation to pay an additional amount up to $0.8 million in contingent payment consideration in
            conjunction with the acquisition if specified future operational objectives are met. The Company recorded acquisition-date fair value of this contingent liability based on the likelihood of the contingent earn-out payment. The earn-out payment
            will subsequently be remeasured to fair value each reporting date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;On March 31, 2021, the Company acquired a 70% interest in a five-clinic physical therapy practice with the previous owners retaining 30%. When acquired, the practice was developing a sixth clinic which has been completed. The purchase price for the 70% interest was approximately $12.0
              million, of which $11.7 million was paid in cash and $0.3 million in the form of a note payable. The note accrues interest at 3.25%
              per annum and the principal and interest is payable on March 31, 2023.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 13.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The purchase price for the 2021 acquisitions has been preliminarily allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; IIPS*&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Physical Therapy Operations&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                    &lt;div style="margin-top: 0px; margin-bottom: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;Cash paid, net of cash acquired&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;63,193&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,630&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,823&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller notes&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,250&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;800&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,050&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;Contingent payments&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;2,520&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;837&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;3,357&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;Other payable&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;1,000&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;1,000&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller put right&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,522&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt; &lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,522&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70,485&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,267&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;96,752&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,589&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,046&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,635&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,620&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,462&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;19,082&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,842&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,832&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,674&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 60.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,367&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;676&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,043&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,126&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,729&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,855&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;500&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;574&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,074&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,141&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,755&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,896&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;58,257&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,489&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;89,746&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(27,906&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,956&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(39,862&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70,485&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,267&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;96,752&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 13.5pt; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*Industrial




























              injury prevention services &lt;/div&gt;

&lt;div&gt;&lt;span class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"&gt;On November 30, 2020, the Company acquired a 75% interest in a three-clinic physical therapy practice with the previous owners retaining 25%. The purchase price for the 75%
        interest was $8.9 million (net of cash acquired), of which $8.6 million was paid in cash and $0.3 million in the form of a
        note payable that is payable in two principal installments totaling $162,500 each. The first principal payment plus accrued interest was paid in November 2021 with the second installment to be paid in November 2022 totaling $162,500. The note accrues interest at 3.25%
        per annum.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;On September 30, 2020, the Company acquired a 70% interest in an entity which holds six-management contracts that have been in place for a number of
      years. The purchase price for the 70% interest was approximately $4.2 million, of which $3.7 million was paid in cash and $0.5 million in the form of two notes payable. One of the notes payable of $0.3 million was paid in November 2020. The remaining note payable of $0.2 million was paid on September
      30, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;On February 27, 2020, the Company acquired interests in a four-clinic physical therapy practice. The four clinics are in four separate partnerships. The Company&#x2019;s interests in the four
      partnerships range from 10.0% to 83.8%,
      with an overall 65.0% based on the initial purchase transaction. The aggregate purchase price was $11.9 million, of which $11.6 million was
      paid in cash and $0.3 million in the form of a note payable. The note accrues interest at 4.75% per annum and the principal and interest was paid on February 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The purchase price for the 2020 physical therapy operations acquisitions has been allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,912&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,121&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,033&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,049&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;196&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(562&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;683&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,520&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;500&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,890&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27,738&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,298&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,033&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;On September 30, 2019, the Company acquired a 67% interest in an eleven-clinic physical therapy practice. The purchase price for the 67% interest was $12.4 million ($12.6 million less cash acquired of $0.2
      million), of which $12.3 million was paid in cash and $0.3 million in a seller note payable in two principal installments totaling $150,000 each, plus accrued interest. A payment of $150,000



























      plus accrued interest was paid in September 2020 and a second payment of $150,000 was paid in September 2021. The note accrues interest at
      5.0% per annum.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;On April 11, 2019, the Company acquired a company that is a provider of industrial injury prevention services. The acquired company
      specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network of 45 states including onsite at eleven client locations. The
      acquired business was then combined with Briotix Health, the Company&#x2019;s industrial injury prevention services operation, increasing the Company&#x2019;s ownership position in the Briotix Health partnership to approximately 76.0%. The purchase price for the acquired company was $22.9
      million ($23.6 million less cash acquired of $0.7
      million), which consisted of $18.9 million in cash, (of which $0.5 million will be paid to certain shareholders), and a $4.0
      million seller note. The note accrues interest at 5.5% and the principal and accrued interest was paid on April 9, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The results of operations of the acquired clinics have been included in the Company&#x2019;s consolidated financial statements since the
      date of their respective acquisition. The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The purchase price for the 2019 acquisitions was allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;IIPS*&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Physical Therapy Operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired ($&lt;span style="text-indent: 0pt;"&gt;890&lt;/span&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,428&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,170&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,598&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Payable to shareholders of seller&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;485&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;485&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,913&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,470&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,383&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,641&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;650&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,291&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;848&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;394&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,242&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,978&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(191&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(3,169&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(489&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;853&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;364&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,400&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,600&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;250&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;270&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;520&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;740&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,040&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,452&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,237&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,689&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,230&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,230&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,913&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,470&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,383&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;* Industrial injury prevention services&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The finalized purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2020 and 2019 were
      allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the
      amount exceeding the fair values being recorded as goodwill. For some of the acquisitions in 2021, the Company is in the process of completing its formal valuation analysis to identify and determine the fair value of tangible and identifiable
      intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the preliminary estimates used at December 31, 2021 based on additional information obtained and completion of the valuation of
      the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded
      pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill. The Company does not expect the adjustments to be material.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the acquisitions in 2021, the values assigned to the customer and referral relationships and non-compete agreements are being
      amortized to expense equally over the respective estimated lives. For customer and referral relationships, the weighted-average amortization period is 13.8
      years. For non-compete agreements, the weighted-average amortization period is 5.6 years. The values assigned to tradenames are tested
      annually for impairment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the acquisitions in 2020 and 2019, the values assigned to the referral relationships and non-compete agreements are being
      amortized to expense equally over the respective estimated lives. For referral relationships, the weighted average amortization period was 10.54
      and 10.10 years at December 31, 2020 and December 31, 2019, respectively. For non-compete agreements, the weighted average amortization
      period was 6.00 years and 5.16
      years at December 31, 2020 and December 31, 2019, respectively. Generally, the values assigned to tradenames are tested annually for impairment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the 2021, 2020 and 2019 acquisitions, total current assets primarily represent patient accounts receivable. Total non-current
      assets are fixed assets, primarily equipment, used in the practices.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The consideration paid for each of the acquisitions was derived through arm&#x2019;s length negotiations. Funding for the cash portions was
      derived from proceeds from the Company&#x2019;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#x2019;s consolidated financial statements since their respective date of acquisition. Unaudited proforma
      consolidated financial information for the acquisitions in 2021, 2020 and 2019, have not been included as the results are immaterial individually and in the aggregate.&lt;/div&gt;
</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="c20210101to20211231"
      id="Text_223af21ec41f4fddae783f9ea292a114">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;During 2021, 2020 and 2019, the Company acquired a majority interest in the following businesses:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Date&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;% Interest&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Clinics&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;December 2021 Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom;"&gt;November 2021 Acquisition&lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;"&gt;November 30, 2021&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;"&gt;70%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:Fact_f2ab670c292849e0a6da2f6f425f8ab8"&gt;IIPS*&lt;/span&gt;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;September 2021 Acquisition&lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;"&gt;September 30, 2021&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"&gt;100%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"&gt;&lt;span style="-sec-ix-hidden:Fact_8fc8c722672b4497be0c04af98353c23"&gt;IIPS*&lt;/span&gt;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom;"&gt;June 2021 Acquisition&lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;"&gt;June 30, 2021&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;"&gt;65%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;"&gt;8&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;March 2021 Acquisition&lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: center;"&gt;March 31, 2021&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"&gt;70%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;"&gt;6&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom;"&gt;November 2020 Acquisition&lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: top; text-align: center;"&gt;November 30, 2020&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: top; text-align: right;"&gt;75%&lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: top; text-align: right;"&gt;3&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2020 Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_d7b298373dc646968960932c7a99c477"&gt;**&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 2020 Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 27, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;65%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;***&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2019 Acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;67%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="width: 39.03%; vertical-align: bottom;"&gt;April 2019 Acquisition &lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 22.92%; vertical-align: bottom; text-align: center;"&gt;April 11, 2019 &lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.72%; vertical-align: bottom; text-align: right;"&gt;100% &lt;br/&gt;
          &lt;/td&gt;

    &lt;td rowspan="1" style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td rowspan="1" style="width: 14.58%; vertical-align: bottom; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:Fact_9ccb1564cfba40339b352148e6a9107a"&gt;*&lt;/span&gt;&lt;br/&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Industrial injury prevention business&lt;br/&gt;
              &lt;/span&gt;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="c25a46c3472f4e9d89f721c383608370" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The business includes six management
              and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years&lt;/span&gt;.&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z9554ae614f714132a1278bbaa794d16d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;***&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember"
      id="Fact_51909ede401341ca8aab09a0cc7d596b">2021-12-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_December2021AcquisitionMember"
      decimals="2"
      id="Fact_691c87e44bfb4aedad3d69ea7e814152"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_December2021AcquisitionMember"
      decimals="0"
      id="Fact_0b2a1be8955c4d23823a7373ef8d260b"
      unitRef="U006">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"
      id="Fact_16f35fa8dc06485d848a65a032dc46aa">2021-11-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_November2021AcquisitionMember"
      decimals="2"
      id="Fact_fd6699083b5c4208a72273a1a8833a9f"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2021AcquisitionMember"
      id="Fact_94f520edfbcf4413a9974f22968e1163">2021-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_September2021AcquisitionMember"
      decimals="2"
      id="Fact_f60c5ffa5760444b96acb7dd05ac8927"
      unitRef="U005">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember"
      id="Fact_25edb2bd8b2d4fb995948b0d3daecdb7">2021-06-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_June2021AcquisitionMember"
      decimals="2"
      id="Fact_910a905d94df4fa3acafe4621dbf7ca1"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_June2021AcquisitionMember"
      decimals="0"
      id="Fact_2daf28ef48444d92817a3ac5c4e3255b"
      unitRef="U006">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember"
      id="Fact_7cc5e9e048c249ea92af1bec5449c2fc">2021-03-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_March2021AcquisitionMember"
      decimals="2"
      id="Fact_19a760f54e4f4283b8c51ba8b0ea146e"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_March2021AcquisitionMember"
      decimals="0"
      id="Fact_822a78aa9cc7436c8f98a5334dc6b79f"
      unitRef="U006">6</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember"
      id="Fact_a62642426b404beda2dde6c3ff196c4a">2020-11-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_November2020AcquisitionMember"
      decimals="2"
      id="Fact_424cb3bc67404ccebec35cce34e8eb50"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_November2020AcquisitionMember"
      decimals="0"
      id="Fact_030e4c8bb3bb4a54af6f76045f75d225"
      unitRef="U006">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2020AcquisitionMember"
      id="Fact_f5387b4a0bee4d53bc61e7ac94afb6d6">2020-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_September2020AcquisitionMember"
      decimals="2"
      id="Fact_acfb0a2ae1a44067b7296b1efb54cfa6"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember"
      id="Fact_fd681e8d37954cf7978cda4333af4efc">2020-02-27</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_February2020AcquisitionMember"
      decimals="2"
      id="Fact_8ebe68ea117342b08f53feddf56f59df"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_February2020AcquisitionMember"
      decimals="0"
      id="Fact_ac3a41188b4a493f902867ddf0c8eff9"
      unitRef="U006">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember"
      id="Fact_3b33a84861d54d04abd28de3c2c1ae64">2019-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="2"
      id="Fact_c4dd660a96654e5395c1c485be383e3f"
      unitRef="U005">0.67</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="0"
      id="Fact_bd06c8922b254344ba669beeaa1edf4e"
      unitRef="U006">11</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_April2019AcquisitionMember"
      id="Fact_b5ee5dd710c74858909477d74dccaa60">2019-04-11</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_April2019AcquisitionMember"
      decimals="2"
      id="Fact_2c93b02e25af4f3884fb0f7d33ea050e"
      unitRef="U005">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:NumberOfManagementContracts
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember"
      decimals="INF"
      id="Fact_fafc19011a2f4879b6e6b3c72b82abb0"
      unitRef="U007">6</usph:NumberOfManagementContracts>
    <usph:RemainingContractTerm
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember"
      id="Fact_f69eb4a2c6eb4c1582c995cdf1902af6">P5Y</usph:RemainingContractTerm>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_4ef40850141c4b55826bbf823bd711fe"
      unitRef="U006">4</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_b91b1d5f6aa144a389414372099ff55a"
      unitRef="U008">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_a4ded9463916428d8bdc0cf7a4373ca3"
      unitRef="U008">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_32583d5f2c8045069fcf4b423b1ea908"
      unitRef="U005">0.100</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_44240ed4a91944909060a4d2a853b016"
      unitRef="U005">0.838</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="3"
      id="Fact_a63e4972b87e453f8be3cb9888772e54"
      unitRef="U005">0.650</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_e003590e5f8840919eead4dff7fc8aaa"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_847fdc8f431c40d9ba56d7a8606540f7"
      unitRef="U006">3</us-gaap:NumberOfBusinessesAcquired>
    <usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_a260b0ba83914d21b92f3cd00980418d"
      unitRef="U005">0.25</usph:BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_fe70cce6eca44fe293eaec88601ed661"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_53367bfdf19241909e8fb118251f1c2b"
      unitRef="U001">3700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20211231to20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_1b4431721bbf4a389dd3ac362890cb0e"
      unitRef="U001">3500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_2aea88e409624722be50ad75357cc082"
      unitRef="U001">200000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_367fcf17fb924e3ba22a7ab8dad2711b"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="2"
      id="Fact_fb00faf0c3fe47879651cd671f5e26b3"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="2"
      id="Fact_0dfc7c1b36c443a385e0887f18d4e0a3"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_55d37c69b0d64977b1b84f3ae6c7192c"
      unitRef="U001">2000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_d1763181524d4f8199d0929836988bc2"
      unitRef="U001">63200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_8e4f879240754ee584395bb139ca4b72"
      unitRef="U001">60700000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_c417575de67c4c2bbbbf7624a738d3cd"
      unitRef="U001">1000000.0</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="4"
      id="Fact_6edfd779015544e4a1a098f0c2970ea0"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <usph:RemainingContractTerm
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      id="Fact_6ae61204009b4d0faa212cdea9c86e7a">P5Y</usph:RemainingContractTerm>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_7d3ff51e5dd248dd8083f8b1c8ad48de"
      unitRef="U001">3500000</us-gaap:ContractWithCustomerAssetPurchase>
    <usph:BusinessCombinationConsiderationTransferredIncludesContingentConsideration
      contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_4a668e47d40d45a0b8654f9e657784c3"
      unitRef="U001">3300000</usph:BusinessCombinationConsiderationTransferredIncludesContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_67061870b3a74a439ff11fd1dbab96f8"
      unitRef="U001">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_67f741ee9de84cfcbe1a64162df07a0c"
      unitRef="U001">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_f5b5cbedac1044d4a6b62cc87bfd429c"
      unitRef="U001">2700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20210930to20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_7fabaef8355948d08fc7f3f93c7e2632"
      unitRef="U001">2400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="-5"
      id="Fact_e8c859b8fd3248cfb2d95aa682f1b4dc"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20210930_BusinessAcquisitionAxis_ReturnToWorkAndErgonomicServicesMember"
      decimals="4"
      id="Fact_715a4af7886742ddae839207079b46d9"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_bd741ed9668544e5abf223d3172356a7"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_0c24befd5d764fceb7f855ac306e64b6"
      unitRef="U006">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="c20210630_OwnershipAxis_PreviousOwnersMember"
      decimals="2"
      id="Fact_79aaf342ccc045b3abb6aabe00e4a062"
      unitRef="U005">0.35</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_0d3ec5a582724f45a726f7a30ff4c442"
      unitRef="U001">10300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20210630to20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_5d33a58dc780425db3556970c15dfcf7"
      unitRef="U001">9000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_ab8ecfaa9ec44b13a308bc2395e0b5d1"
      unitRef="U001">1000000.0</usph:BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_f32a4ad530534e7197d3247145137e26"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_7cc695c32e4f4dfab1894815a1b8aeca"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20210630_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_ac2e9db4c6714148b52b9b3b961a28b8"
      unitRef="U001">800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_9bccc79dfd0a44a1b3554472884dc2a9"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_15c3ec6cce7947e4828132e51a3ce4a0"
      unitRef="U006">5</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="c20210331_OwnershipAxis_PreviousOwnersMember"
      decimals="2"
      id="Fact_0bdbf1b49b8b4a239a3a1ba0d1603e67"
      unitRef="U005">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_45e88c305151481bb39cb373f1c7d48b"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_7997ab5a9f6844cb89004565d9604cab"
      unitRef="U001">12000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20210331to20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_1a3f7652a1544564af35f52903b5a057"
      unitRef="U001">11700000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_e3cf2f9fb6834cf387e402c3adaeafa5"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20210331_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_f58a4e1484f14fbf8014c4fbde98d146"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_72c2c9d174bd47119b4b1f595426f5b4">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The purchase price for the 2021 acquisitions has been preliminarily allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; IIPS*&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Physical Therapy Operations&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                    &lt;div style="margin-top: 0px; margin-bottom: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;Cash paid, net of cash acquired&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;63,193&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,630&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,823&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller notes&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,250&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;800&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,050&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;Contingent payments&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;2,520&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;837&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;3,357&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;Other payable&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;1,000&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;1,000&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller put right&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,522&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt; &lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,522&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70,485&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,267&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;96,752&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,589&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,046&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,635&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,620&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,462&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;19,082&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 43.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,842&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,832&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,674&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 60.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,367&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;676&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,043&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,126&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,729&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,855&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;500&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;574&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,074&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,141&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,755&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,896&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;58,257&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,489&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;89,746&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(27,906&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,956&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(39,862&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;70,485&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,267&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;96,752&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 13.5pt; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*Industrial




























              injury prevention services &lt;/div&gt;

&lt;div&gt;&lt;span class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The purchase price for the 2020 physical therapy operations acquisitions has been allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,912&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,121&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,033&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,049&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;196&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(562&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;683&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,520&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;500&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,890&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27,738&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,298&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,033&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The purchase price for the 2019 acquisitions was allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;IIPS*&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Physical Therapy Operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired ($&lt;span style="text-indent: 0pt;"&gt;890&lt;/span&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,428&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,170&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,598&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Payable to shareholders of seller&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;485&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;485&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,913&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,470&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,383&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,641&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;650&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,291&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;848&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;394&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,242&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,978&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(191&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(3,169&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(489&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;853&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;364&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,400&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,600&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;250&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;270&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;520&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;740&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,040&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,452&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,237&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,689&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interest)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,230&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,230&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,913&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,470&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,383&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;* Industrial injury prevention services&lt;/div&gt;
</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_63bd36af48894270815cc46c963ba2db"
      unitRef="U001">63193000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20210101to20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_c0e689ac1b0648fe8f7f376d9d17e13a"
      unitRef="U001">23630000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_ad579798c9f945b8a93beddfddd7dcec"
      unitRef="U001">86823000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_aaf9411d8f9e4e009c9335f0ff382bdf"
      unitRef="U001">1250000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_28cc4f3346484ec28711d37f2baf87d6"
      unitRef="U001">800000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_f0fd9390987747079bf0323b04920f0c"
      unitRef="U001">2050000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_76c42aa88a124b4db6f0502587ec6f42"
      unitRef="U001">2520000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_5d51ac831b2e44f59e989c9e45bddab2"
      unitRef="U001">837000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_28d337ba857044b5a33e2cffca374d57"
      unitRef="U001">3357000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_27a094a9eace4a64be08154bf989f82e"
      unitRef="U001">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_6205fa6b4a6e4d379e90d1ad07fc6de8"
      unitRef="U001">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_7e05756573114a3fbc5386da591648bf"
      unitRef="U001">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_11d862d2defd4dca8c3f3c891cae62ca"
      unitRef="U001">3522000</us-gaap:ContractWithCustomerAssetPurchase>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_1a7de6bad54641f7af5427b5065596f5"
      unitRef="U001">3522000</us-gaap:ContractWithCustomerAssetPurchase>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_01ef1578c3654cdb9d9b1052ecedc226"
      unitRef="U001">70485000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_9e9d2c0466cb4bb88683d23202f6a380"
      unitRef="U001">26267000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_23d75c3658db427c81f734b6655588f3"
      unitRef="U001">96752000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_f75bbdaed45746e78fee56e41cedb979"
      unitRef="U001">5589000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_6943e486c96e4874bc9505a208e66ff4"
      unitRef="U001">1046000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_ad35b5cc0c634c2e91708f8366fcc49c"
      unitRef="U001">6635000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_f80eff9fe13e4df08a15f7acb274fc5e"
      unitRef="U001">12620000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_ee1b10ecf07b49bf8d2391c6ec76b4a2"
      unitRef="U001">6462000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_de064a8a748a4105a4f77f07832675d5"
      unitRef="U001">19082000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_2c2db17745e24c4eb66135c92aad7b8a"
      unitRef="U001">-4842000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_dc4cb0d4efda4280bf2e5c4b2d81cbdd"
      unitRef="U001">-6832000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_74a9191c50e1410d859aa8424d872773"
      unitRef="U001">-11674000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_1cdd8b720f4a44a082c6939bf4b22496"
      unitRef="U001">13367000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_b06467cb6bd04db2ac41d1def8954a7a"
      unitRef="U001">676000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_43ebdb84850049b581945b1781448233"
      unitRef="U001">14043000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_494bf47a05ff4579a733449bea643c70"
      unitRef="U001">21126000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_2ee8cf3e0b6f481abec87a833f448835"
      unitRef="U001">3729000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_4d49b65f36a543e2984cc8454568e4f3"
      unitRef="U001">24855000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_46c4521940754dddb49b9e190cced525"
      unitRef="U001">500000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_213c3f5e07bd46218e80ecea04a812f0"
      unitRef="U001">574000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_19303b99b4b246e5963bd832cdfe681e"
      unitRef="U001">1074000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_c24ffdcebb2d493696e3a422d9966828"
      unitRef="U001">5141000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_92afb88ef1c241289b8bd9c80cd4348b"
      unitRef="U001">1755000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_2f314db3fbb544ad8b71fe06c4cba0cb"
      unitRef="U001">6896000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_9d4aac14de6549938264f58e705c3aa7"
      unitRef="U001">58257000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_063ae95c5d0347d08e385bd9c5e13895"
      unitRef="U001">31489000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_311fcc26364949fba739a931101b225f"
      unitRef="U001">89746000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_9d349ef66f714b458c14a80861d985df"
      unitRef="U001">27906000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_4425ed8180dd4538ba8b82beb85e71f1"
      unitRef="U001">11956000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_59d97b0c34e74ae49827e8c469c13d86"
      unitRef="U001">39862000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20211231_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_71308383dd34492c907897ee2a3d7c84"
      unitRef="U001">70485000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_b6ea00c6db6d4e159171f27ca763fa08"
      unitRef="U001">26267000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20211231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_3af0a2c38e024e0dbcd737bf0c8d2978"
      unitRef="U001">96752000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_fb31bbf463bb47289730d583ccf6b4cd"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_5cb71b04d18947c78b9e1f232902406a"
      unitRef="U006">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="c20201130_OwnershipAxis_PreviousOwnersMember"
      decimals="2"
      id="Fact_a5ced06c3bf745a39898bcf186873ff8"
      unitRef="U005">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_5a2b05ef00924aba8085e80fb6947bfd"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_1185c4c2387f4afbb2c377389a74c433"
      unitRef="U001">8900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_2c9fd829664d4dda8974841bfb3a38b2"
      unitRef="U001">8600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_2a83c9539db34a44b199323fd3458a47"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_ebe135ea34b94bc59a47ef42aacc1f9a"
      unitRef="U010">2</usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="0"
      id="Fact_4d89927a1b3e4fd28fbce8906d7ee306"
      unitRef="U001">162500</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="0"
      id="Fact_cc37ec5ff9d34e8982b0eb68f162cffc"
      unitRef="U001">162500</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_949d01c325b242ff91419a5e4453e865"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="2"
      id="Fact_5968a848b9594413ad4c3707c7f809d5"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:NumberOfManagementContracts
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="INF"
      id="Fact_5bf9ad61ce094386b45b774468a403a8"
      unitRef="U007">6</usph:NumberOfManagementContracts>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="2"
      id="Fact_7562c10c2b6b4bf58c299d30b2a3683c"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="-5"
      id="Fact_7fe32f3008e3499f9a6ce98408312de0"
      unitRef="U001">4200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="-5"
      id="Fact_bd5fefa6732b4d29b7d48c96b3299964"
      unitRef="U001">3700000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="-5"
      id="Fact_4e310f11b5774b62a4ce1354774531bb"
      unitRef="U001">500000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20201130_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember"
      decimals="-5"
      id="Fact_f57acd780b844dba8ff1b4cc2f55d7fc"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20210930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableTwoMember"
      decimals="-5"
      id="Fact_1ebc11a42d424700882f5c399a56d166"
      unitRef="U001">200000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_c46f303442954e1fa9c00df7603f9893"
      unitRef="U006">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_8497635bd48a405ba840f67de7b81db1"
      unitRef="U006">4</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_ec41bd1e228b46a09b6430a89cf3895f"
      unitRef="U008">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_e11e6e014d914714b5997a61cd94c2dc"
      unitRef="U008">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_7c444a08a02746a89979100445901ee1"
      unitRef="U005">0.100</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_f69de05990d8447ab118361b3fe91d35"
      unitRef="U005">0.838</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="3"
      id="Fact_37a150988cdd4586b9e8d7f8ae28db4e"
      unitRef="U005">0.650</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_e79fb6d777b5404ebf032554275c06c5"
      unitRef="U001">11900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_7673530f60d147619d2f0bc0dc7bd650"
      unitRef="U001">11600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_59a3d71ea5334f56885360c3f35916e3"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_0c3bf3e3872941f49ab87c6676a38744"
      unitRef="U005">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_65ea10e9ff21488daed0c8e1b250d88e"
      unitRef="U001">23912000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_22055d23595d4a719dfafb660f8991ca"
      unitRef="U001">1121000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_35acfeb8bda24d4c8ca2dbb75374b797"
      unitRef="U001">25033000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_1af412c31b3c43138849c4ec3b0140ca"
      unitRef="U001">1049000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_f12ca0d540e14146bf216360cb674324"
      unitRef="U001">196000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_2964447e878946cb84412627e62e5323"
      unitRef="U001">-562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_abb92068cc184506ab4478a53b78af85"
      unitRef="U001">683000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_ce5fe8ca801c4d4d873ce65a8e646a86"
      unitRef="U001">5520000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_9a772c5b865b405683726ef0b659f96c"
      unitRef="U001">500000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_7039d868aebf42e48c2ebd44f0892ebe"
      unitRef="U001">1890000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_0ce74c29f8e04f58b43d1f75860b4de3"
      unitRef="U001">27738000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_28dbe5bcfc1548f9a0112df85244754b"
      unitRef="U001">11298000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_3456529d650e4626bc92ab4f726983b8"
      unitRef="U001">25033000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="2"
      id="Fact_0809f78b46094055b3e1b873f47f1fa5"
      unitRef="U005">0.67</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="INF"
      id="Fact_4f04251926c44e3bb754df356727fb42"
      unitRef="U006">11</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="2"
      id="Fact_fc15e10d9f954952adbc4bbf8ba49415"
      unitRef="U005">0.67</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="-5"
      id="Fact_27ff3a8732164b2ba0c1595d4bc10559"
      unitRef="U001">12400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="-5"
      id="Fact_686ae0b890a44e48babe15f81444788d"
      unitRef="U001">12600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="-5"
      id="Fact_0ffa2c91aea248ab970d584e84796e86"
      unitRef="U001">200000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="-5"
      id="Fact_21f4975ed0e6454384404b57a88884db"
      unitRef="U001">12300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="-5"
      id="Fact_418617e53e8f45c7b930242b984529a8"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="INF"
      id="Fact_e64f4a38174a46e68485528eaf2eb2e4"
      unitRef="U010">2</usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember"
      decimals="-3"
      id="Fact_ad91b351b8894e088f07d01862ec33c1"
      unitRef="U001">150000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember"
      decimals="-3"
      id="Fact_c02b9991cffc4bd2a8e1b3f07d4d43f1"
      unitRef="U001">150000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyOneMember"
      decimals="-3"
      id="Fact_6deb32a8af9646e18b2008d05b52d98f"
      unitRef="U001">150000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20190930_BusinessAcquisitionAxis_September2019AcquisitionMember"
      decimals="3"
      id="Fact_06d6fb2bb06f4f6e9738270fe49683b8"
      unitRef="U005">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <usph:NumberOfStatesOfNetworkServices
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="0"
      id="Fact_7055f832176345eeb7f381f37145f0f5"
      unitRef="U012">45</usph:NumberOfStatesOfNetworkServices>
    <usph:NumberOfOnsiteClientLocations
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="INF"
      id="Fact_06e9fdc8768f4e58ac5656fd2ecc2827"
      unitRef="U009">11</usph:NumberOfOnsiteClientLocations>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="3"
      id="Fact_e4fd5ef250f24c829f801bc200ef976f"
      unitRef="U005">0.760</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_0a3aa99ee4c9406ca3527a0990fa3046"
      unitRef="U001">22900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_1bb89b2e94e94cf29b44368887e4bb68"
      unitRef="U001">23600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_bd9522d1c8df49488a37f897a883b782"
      unitRef="U001">700000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_08bd8aa6af6a4b62956204f2f2ed1ebb"
      unitRef="U001">18900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionPayableToShareholdersOfSeller
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_1b26b19cc3cd4cd8a77e08b359aece38"
      unitRef="U001">500000</usph:BusinessAcquisitionPayableToShareholdersOfSeller>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_3659249cd7674d909ffba26927075152"
      unitRef="U001">4000000.0</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="3"
      id="Fact_e4dbf83a147442a98fa288ca5f44df89"
      unitRef="U005">0.055</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_0539e081efe84384b08a1850430433bf"
      unitRef="U001">890000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_09256687656b4cb0829a3bba208bbd0b"
      unitRef="U001">18428000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190930to20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_6ff2584eee614ff4b3d2643ff36542df"
      unitRef="U001">12170000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_775cb570a7c64ac99a7304b5be69fcc1"
      unitRef="U001">30598000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionPayableToShareholdersOfSeller
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_6ccec2bf85c84363a31b411049754947"
      unitRef="U001">485000</usph:BusinessAcquisitionPayableToShareholdersOfSeller>
    <usph:BusinessAcquisitionPayableToShareholdersOfSeller
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_f3624d1d7eb648589d35c8fd72de4004"
      unitRef="U001">0</usph:BusinessAcquisitionPayableToShareholdersOfSeller>
    <usph:BusinessAcquisitionPayableToShareholdersOfSeller
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_55512b3d8f894ed988016170d58cd142"
      unitRef="U001">485000</usph:BusinessAcquisitionPayableToShareholdersOfSeller>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_d5231447dfa54dcf8bc822f06da3d57d"
      unitRef="U001">4000000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_5cd42f8e9b2a4b5bb7369d3a1b3fa7b1"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_274149558baf413893e4eefcfe4f12b0"
      unitRef="U001">4300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_2e55eaf9bd1a44fba6fdc7aa37f488f4"
      unitRef="U001">22913000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_73608f8804ed4a269d268d53738cf5df"
      unitRef="U001">12470000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_de19e0979d4a428698aaeab124f70381"
      unitRef="U001">35383000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_f1dfaea40e90417ab9618457098915f7"
      unitRef="U001">1641000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_915f365a88224a39a7a1c5f4abfd835b"
      unitRef="U001">650000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_5a19db7cdb274b94b558423d07af8e5e"
      unitRef="U001">2291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_bfb19040c12b4373b120a149674ff028"
      unitRef="U001">848000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_8dfa0a1cca5b4cbb87bdde8da117b7fc"
      unitRef="U001">394000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_6fe21dd8e03e4885ab5701f7f15788de"
      unitRef="U001">1242000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_24336172ac1f4c7b87d22bacbbbd45fc"
      unitRef="U001">-2978000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_80e83efe85994d188f09da7da0c1619a"
      unitRef="U001">-191000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_a789fcbb560142e7aa9b4633b158f0e8"
      unitRef="U001">-3169000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_e49d6261833247f2947adece9f7d5a9f"
      unitRef="U001">-489000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_8128ae7fbef245f1add5497d788928cb"
      unitRef="U001">853000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_05c86f4c390f4c498e6d7616b6806fde"
      unitRef="U001">364000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_bd807fe1634b42079b82b93a313c6f0c"
      unitRef="U001">3400000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_5dd40f1e219b46098514ee40fc7de3ab"
      unitRef="U001">2600000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_b2bc6fa524214a109a0ce2f7352601cb"
      unitRef="U001">6000000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_5537f26b563e45e3ba14cc86cb093d9e"
      unitRef="U001">250000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_4c37e528f4f54dff970f48ac121ba242"
      unitRef="U001">270000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_cb70a78d54c94dbc8d01adf4b2b11d56"
      unitRef="U001">520000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_55629db4c4fb4f3d94188cadc2e92208"
      unitRef="U001">1300000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_43b13b34d81f4352888b7725458e3c98"
      unitRef="U001">740000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_cc4359b2e26240928f3ac4152d310b80"
      unitRef="U001">2040000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_d9d8787977f14988ac98b2fccb95a943"
      unitRef="U001">18452000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_697b476204a142f7aceb2df1a843b314"
      unitRef="U001">14237000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_6b5e0518893e43a799774212c26674e1"
      unitRef="U001">32689000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_e730f71471494b67be39a111ddb754e1"
      unitRef="U001">0</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_1b9ce831bebf41e182c0c311de2ee90a"
      unitRef="U001">6230000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_938d5513a5c6491297274256b9dcf0b4"
      unitRef="U001">6230000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_1dfbb6b5fc4b48afade4b5fb290ba8f7"
      unitRef="U001">22913000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_0924885764744129957a199800958ef7"
      unitRef="U001">12470000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_5221836f96a143029fdc48dbb920f6bf"
      unitRef="U001">35383000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerAndReferralRelationshipMember"
      id="Fact_7ce6b9b95d694557815a78e1378d2d81">P13Y9M18D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      id="Fact_80041e62f1ef4bab9a747c4902b75b66">P5Y7M6D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      id="Fact_0a1d555197a44dffa6fb4ec555b4e6fd">P10Y6M14D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      id="Fact_b5d3478fcb6444ad8399c092ea4a0417">P10Y1M6D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      id="Fact_ed36d375c56a419795dcceb66aac99ea">P6Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      id="Fact_ccb91713c57c421ca0d3c6ca776b2264">P5Y1M28D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_b4e40e6a0bbd40a0ad44a3b2b7d3fde1">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;4. Acquisitions and Sale of Non-Controlling Interests&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;During
        2021, the Company acquired additional interests in five partnerships which are included in non-controlling interest. The additional
        interests purchased in each of the partnerships ranged from 5% to 35%. The aggregated purchase price for these acquired interests was $1.3
        million. The Company also sold an interest in a partnership for $0.1 million.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;During &lt;/span&gt;2020,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; the Company acquired additional interests in &lt;/span&gt;five&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from &lt;/span&gt;20%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; to &lt;/span&gt;35%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;. The aggregated purchase price for these acquired interests was &lt;/span&gt;$0.3 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;. The Company also sold an interest in a partnership for &lt;/span&gt;$0.1 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;. Also during &lt;/span&gt;2020,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; the Company sold &lt;/span&gt;14&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; previously closed clinics. The aggregate sales price was &lt;/span&gt;$1.1 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;, of which &lt;/span&gt;$0.7 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; was paid in cash and &lt;/span&gt;$0.4 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; in a note receivable payable in &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; equal installments of principal and any accrued interest. The first payment was received in June 2021 and the next payment is due on June &lt;/span&gt;15,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;&#160;&lt;/span&gt;2022&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;.&lt;/span&gt;&lt;br/&gt;
      &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;During &lt;/span&gt;2019,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; the Company acquired additional interests in &lt;/span&gt;four&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from &lt;/span&gt;1%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; to 20%. Also in &lt;/span&gt;2019,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; the Company sold a &lt;/span&gt;1%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt; interest in a partnership. The net after-tax difference between the payments and the
        portion of undistributed earnings of &lt;/span&gt;$196,000&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;
        was credited to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;
</us-gaap:MinorityInterestDisclosureTextBlock>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_e3b6d4bd77f94e8b8b46b6a25521aeda"
      unitRef="U008">5</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_4e6fd6bc4c9c4cea8910a5224d1cf342"
      unitRef="U005">0.05</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_a6857d1bc4064ffe81661d8e2e012b61"
      unitRef="U005">0.35</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_f943401e5c5247b1bf09162a940174c9"
      unitRef="U001">1300000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_0cc9448d33764678920a25d762388d36"
      unitRef="U001">100000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_06adda1b4c1d474eb11f1c36f131b7a3"
      unitRef="U008">5</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_2c12b97615b241ac989a111c23c0d0cc"
      unitRef="U005">0.20</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_ec5e492686bf465ba822abf2969c6493"
      unitRef="U005">0.35</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_5feef8112d7f4adbac23a1c81cd8ea5e"
      unitRef="U001">300000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_1279ae8b401546a4b87f06cceac19b7d"
      unitRef="U001">100000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent>
    <usph:NumberOfClosedClinicsSold
      contextRef="c20201231"
      decimals="0"
      id="Fact_0c786783cbff40db9ed459f7842f6699"
      unitRef="U006">14</usph:NumberOfClosedClinicsSold>
    <usph:AggregateSalePriceOfCinics
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_ae8977d8e0bb468e81689b0adede2a0d"
      unitRef="U001">1100000</usph:AggregateSalePriceOfCinics>
    <usph:CashReceivedRelatedToSaleOfClinics
      contextRef="c20201231"
      decimals="-5"
      id="Fact_4a2f5d214b6a4840bd873f395d74814a"
      unitRef="U001">700000</usph:CashReceivedRelatedToSaleOfClinics>
    <usph:NoteReceivableRelatedToSaleOfClinics
      contextRef="c20201231"
      decimals="-5"
      id="Fact_8d6b53b980f14a69940d72d67f23197a"
      unitRef="U001">400000</usph:NoteReceivableRelatedToSaleOfClinics>
    <usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_5a5df302c59547179b097792df11b9e2"
      unitRef="U010">2</usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20190101to20191231"
      decimals="INF"
      id="Fact_e67a8dc493bd47618e702da5102f52e9"
      unitRef="U008">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20191231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_2d915209ca444f708fafdc5299c23277"
      unitRef="U005">0.01</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20191231_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_81279c5d086846759372924d7fce5fb4"
      unitRef="U005">0.20</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:SaleOfNoncontrollingInterestPercentageInPartnershipOne
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_fbcf3fadf2bf4baabca4de7405f0c464"
      unitRef="U005">0.01</usph:SaleOfNoncontrollingInterestPercentageInPartnershipOne>
    <usph:TaxEffectOnSaleOfNoncontrollingInterest
      contextRef="c20190101to20191231"
      decimals="0"
      id="Fact_7f8292e6818f48839bcf4c22cc4b0ce4"
      unitRef="U001">196000</usph:TaxEffectOnSaleOfNoncontrollingInterest>
    <usph:RedeemableNonControllingInterestTextBlock
      contextRef="c20210101to20211231"
      id="Text_157d9fb6253d471bb38e8f324d462d63">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;5. Redeemable Non-Controlling Interest&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Therapy Practice Acquisitions&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Since October 2017, when the Company acquires a majority interest (the &#x201c;Acquisition&#x201d;) in a physical therapy clinic Therapy Practice
      (referred to as &#x201c;Therapy Practice&#x201d;), these Therapy Practice transactions occur in a series of steps which are described below.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#x201c;Seller Entity&#x201d;). The Seller Entity is owned by one or more individuals
              (the &#x201c;Selling Shareholders&#x201d;) most of whom are physical therapists that work in the Acquired Therapy Practice and provide physical therapy services to patients.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In conjunction with the Acquisition, the Seller Entity contributes the Acquired Therapy Practice into a newly-formed limited partnership (&#x201c;NewCo&#x201d;), in exchange
              for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a
              wholly-owned subsidiary of the Seller Entity.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company enters into an agreement (the &#x201c;Purchase Agreement&#x201d;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited
              partnership interest and in &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;all&lt;/span&gt;&lt;/span&gt; cases 100% of the
              general partnership interest in NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling
              Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small two-year note in lieu of an escrow (the &#x201c;Purchase Price&#x201d;). The Purchase Agreement usually does not contain any future earn-out or other contingent consideration that is
              payable to the Seller Entity or the Selling Shareholders.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Seller Entity also execute a partnership agreement (the &#x201c;Partnership Agreement&#x201d;) for NewCo that sets forth the rights and obligations of the
              limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited
              partnership interest in NewCo (&#x201c;Seller Entity Interest&#x201d;).&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#x201c;Employment Agreement&#x201d;) with NewCo with an initial term that
              ranges from &lt;span style="-sec-ix-hidden:Fact_0d92bcc8360a42b4b9b9cf260432b9cf"&gt;three&lt;/span&gt; to five years
              (the &#x201c;Employment Term&#x201d;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment
              Term. As a result, a Selling Shareholder becomes an employee (&#x201c;Employed Selling Shareholder&#x201d;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause,
              at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller
              Entity as of the closing of the Acquisition.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities
              based on other employees in similar capacities within NewCo, the Company and the industry.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete
              agreement (the &#x201c;Non-Compete Agreement&#x201d;) which restricts the Selling Shareholder from engaging in competing Therapy Practice activities for a specified period of time (the &#x201c;Non-Compete Term&#x201d;). A Non-Compete Agreement is executed with the
              Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing Therapy Practice during the Non-Compete Term.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Term commences as of the date of the Acquisition and expires on the &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;later&lt;/span&gt;&lt;/span&gt;
              of:&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Two years after the date an Employed Selling
              Shareholders&#x2019; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_0b4b01dde9444fa395f3ee7e597f70c6"&gt;Five&lt;/span&gt; to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Agreement applies to a restricted region which is defined as a mileage radius from the Acquired Therapy Practice. That is, an Employed Selling
              Shareholder is permitted to engage in competing Therapy Practicees or activities outside the designated geography (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo
              immediately is permitted to engage in the competing Therapy Practice or activities outside the designated geography.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company
      (the &#x201c;Call Right&#x201d;) or at the option of the Seller Entity (the &#x201c;Put Right&#x201d;) as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Put Right&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment is terminated under certain circumstances prior to the fifth anniversary of the Closing Date, the Seller
              Entity thereafter may have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call
              Right with respect to the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest, Seller Entity thereafter has the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#x2019;s
              Allocable Percentage of Seller Entity&#x2019;s Interest at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="width: 36pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: top; width: 18pt;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;c.&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the
                  Seller Entity has the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest shall be redeemed by the Company at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Call Right&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;If any Selling Shareholder&#x2019;s employment by NewCo is terminated prior to the fifth anniversary of the Closing Date, the Company thereafter has an irrevocable
              right to purchase from Seller Entity the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest, in each case at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company
              has the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest shall be redeemed by the Company at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#x2019;s trailing twelve months of earnings
              before interest, taxes, depreciation, amortization, and the Company&#x2019;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#x201c;Redemption Amount&#x201d;). NewCo&#x2019;s earnings are distributed monthly based on
              available cash within NewCo&#x37e; therefore, the undistributed earnings amount is small, if any.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings
              that is used in the Put Right and the Call Right noted above.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right do not have an expiration date.&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling
              Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;An Employed Selling Shareholder&#x2019;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the
      Company&#x2019;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#x201c;claw back&#x201d; the equity interest in the Seller Entity held by such Employed Selling Shareholder,
      nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#x201c;cause&#x201d; by NewCo, such Employed Selling Shareholder does not
      forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#x2019;s only recourse against the Employed Selling Shareholder for
      breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a
      forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;&lt;span style="text-decoration: underline;"&gt;ProgressiveHealth










          Acquisition&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"&gt;On November 30, 2021, the Company acquired a majority interest in ProgressiveHealth Companies, LLC (&#x201c;Progressive&#x201d;), which owns a
        majority interest in certain subsidiaries (&#x201c;Progressive Subsidiaries&#x201d;) that operate in the industrial injury prevention and therapy services businesses.&#160; The Progressive transaction was completed in a series of steps which are described below.&lt;br/&gt;
        &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Prior to the acquisition, the Progressive Subsidiaries were owned by a legal entity (&#x201c;Progressive Parent&#x201d;) controlled by its individual owners (the &#x201c;Selling
                  Shareholders&#x201d;), who work in and manage the Progressive business.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In conjunction with the acquisition, the Selling Shareholders caused the Progressive Parent to transfer its ownership of the Progressive Subsidiaries into a
                  newly-formed limited liability company (&#x201c;NewCo&#x201d;), in exchange for one hundred percent (100%) of the membership interests in
                  NewCo. Therefore, in this step, NewCo became wholly-owned by the Selling Shareholders.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company entered into an agreement (the &#x201c;Purchase Agreement&#x201d;) to acquire from the Selling Shareholders a majority of the membership interest in NewCo. The
                  consideration for the acquisition is primarily payable in the form of cash at closing, a relatively small portion paid in cash after the closing contingent on certain performance criteria, and a small note in lieu of an escrow (the
                  &#x201c;Purchase Price&#x201d;).&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Selling Shareholders also executed an operating agreement (the &#x201c;Operating Agreement&#x201d;) for NewCo that sets forth the rights and
                  obligations of the members of NewCo.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;As noted above, the Company did not purchase 100%
                  of the membership interests in NewCo and the Selling Shareholders retained a portion of the membership interest in NewCo (&#x201c;Selling Shareholders&#x2019; Interest&#x201d;).&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Selling Shareholders executed a non-compete agreement (the &#x201c;Non-Compete Agreement&#x201d;) which restricts the Selling Shareholders from
                  competing for a specified period of time (the &#x201c;Non-Compete Term&#x201d;).&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Term commences as of the date of the Acquisition and expires on the &lt;span style="text-decoration: underline;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;later&lt;/span&gt;&lt;/span&gt;
                  of:&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Two years after the date a Selling Shareholder
                  no longer is involved in the management of NewCo or&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seven years from the date of the acquisition.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Agreement applies to the entire United States.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right do not have an expiration date.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"&gt;The Operating Agreement contains provisions for the redemption of the Selling Shareholder&#x2019;s Interest, either at the option of the
        Company (the &#x201c;Call Right&#x201d;) or at the option of the Selling Shareholder (the &#x201c;Put Right&#x201d;) as follows:&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Put Right&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Each of the Selling Shareholders has the right to sell 30%
                  of their respective residual interests on each of the 4th and 5th anniversaries of the acquisition closing, and then 10% on
                  each of the 6th and 7th anniversaries.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder terminates his management relationship with NewCo for any reason on or after the seventh anniversary of the Closing
                  Date, the Selling Shareholder has the Put Right, and upon the exercise of the Put Right, the Selling Shareholder&#x2019;s Interest shall be redeemed by the Company at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Call Right&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;If any Selling Shareholder&#x2019;s ceases to perform management services on behalf of NewCo, the Company thereafter shall have an irrevocable right to purchase
                  from such Selling Shareholder his Interest, in each case at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#x2019;s trailing twelve months of
                  earnings before interest, taxes, depreciation, amortization, and the Company&#x2019;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#x201c;Redemption Amount&#x201d;). NewCo&#x2019;s earnings are distributed
                  monthly based on available cash within NewCo&#x37e; therefore, the undistributed earnings amount is small, if any.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month
                  earnings that is used in the Put Right and the Call Right noted above.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: 22.5pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right do not have an expiration date.&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"&gt;Neither the Operating Agreement nor the Non-Compete Agreement contain any provision to escrow or &#x201c;claw back&#x201d; the equity interest
        in NewCo held by the Selling Shareholders, in the event of a breach of the operating agreement or non-compete terms, or the management services agreement pursuant to which the Selling Shareholders perform services on behalf of NewCo. The Company&#x2019;s
        only recourse against the Selling Shareholder for breach of any of these agreements is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with a Selling Shareholder that would result
        in a forfeiture of the equity interest in NewCo held by a Selling Shareholder.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt;"&gt;An Employed Selling Shareholder&#x2019;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the
        Company&#x2019;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#x201c;claw back&#x201d; the equity interest in the Seller Entity held by such Employed Selling
        Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#x201c;cause&#x201d; by NewCo, such Employed Selling Shareholder
        does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#x2019;s only recourse against the Employed Selling
        Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that
        would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the years ended December 31, 2021, 2020 and 2019, the following table details the changes in the carrying amount (fair value) of
      the redeemable non-controlling interests (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, &lt;span style="text-indent: 0pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;133,943&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating results allocated to redeemable non-controlling interest partners&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,358&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,175&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,659&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Distributions to redeemable non-controlling interest partners&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,359&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(12,403&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10,221&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Changes in the fair value of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,011&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,632&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,893&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Purchases of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(30,204&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(20,521&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8,934&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,862&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,297&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,230&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reduction of non-controlling interest due to sale of USPH partnership interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,132&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;982&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,133&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,120&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notes receivable related to sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(914&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,006&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,870&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Adjustments in notes receivable related to the the sales of redeemable non-controlling interest -
              temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;186&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;283&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;62&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;155,262&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, &lt;span style="text-indent: 0pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has lapsed but holder's employment has not terminated&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;80,781&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;62,390&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;51,921&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has not lapsed and holder's employment has not terminated&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;74,481&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;69,950&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;85,829&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder's employment has terminated and contractual time period has expired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder's employment has terminated and contractual time period has not expired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;155,262&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:RedeemableNonControllingInterestTextBlock>
    <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed
      contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_f050711b9b95401b9584fe5779190760"
      unitRef="U005">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
    <usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_f5dd41c7f47b4c6399b017db720ec54f"
      unitRef="U005">0.50</usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired>
    <usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_2c731d08dd884ad4a380c619c58caa51"
      unitRef="U005">0.90</usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired>
    <usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired
      contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_2e52b1f3a05f471d9d54c911e1778f09"
      unitRef="U005">1</usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired>
    <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed
      contextRef="c20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_334b5f2954cc49c78204017403c0e2b3"
      unitRef="U005">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
    <usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_a8d379b21c35487abccff5bd2a9fdf7c">P2Y</usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder>
    <usph:TermOfEmploymentAgreement
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"
      id="Fact_e30139b98051459c9def5619b1e7f3e3">P5Y</usph:TermOfEmploymentAgreement>
    <usph:EmploymentAgreementRenewalTerm
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_e363ba866f044e879151cedc665a0f09">P1Y</usph:EmploymentAgreementRenewalTerm>
    <usph:BusinessAcquisitionConsiderationPayableTermOfNote
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_e3acf3ef98dc425ea6c25a607bc5d37f">P2Y</usph:BusinessAcquisitionConsiderationPayableTermOfNote>
    <usph:NonCompeteAgreementBasicTerm
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"
      id="Fact_cfa0aff43b8c4e7d864d1431b8618161">P6Y</usph:NonCompeteAgreementBasicTerm>
    <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed
      contextRef="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_727ec918566d4d078666533b965869cb"
      unitRef="U005">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
    <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed
      contextRef="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_0e7bdfddc03642dfaec76c6d1c1eb0fa"
      unitRef="U005">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
    <usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_9112d2f2ad5e48cbae551d5255b5efe0">P2Y</usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder>
    <usph:NonCompeteAgreementBasicTerm
      contextRef="c20210101to20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_3651b70a7d154799bf3d62c173787f93">P7Y</usph:NonCompeteAgreementBasicTerm>
    <usph:PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries
      contextRef="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_6937b463ffef4a28a0ecb39ff02e50dc"
      unitRef="U005">0.30</usph:PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries>
    <usph:PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries
      contextRef="c20211231_BusinessAcquisitionAxis_ProgressiveHealthCompaniesLLCMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_e71df80f688545928354fc3800d447eb"
      unitRef="U005">0.10</usph:PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_066936ff95a247458f1624b458cf60c7">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the years ended December 31, 2021, 2020 and 2019, the following table details the changes in the carrying amount (fair value) of
      the redeemable non-controlling interests (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, &lt;span style="text-indent: 0pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;133,943&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating results allocated to redeemable non-controlling interest partners&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,358&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,175&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,659&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Distributions to redeemable non-controlling interest partners&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,359&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(12,403&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10,221&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Changes in the fair value of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,011&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,632&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,893&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Purchases of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(30,204&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(20,521&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8,934&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,862&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,297&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,230&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reduction of non-controlling interest due to sale of USPH partnership interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,132&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;982&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,133&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,120&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notes receivable related to sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(914&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,006&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,870&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Adjustments in notes receivable related to the the sales of redeemable non-controlling interest -
              temporary equity&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;186&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;283&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;62&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;155,262&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_e519461d1594453c82af9327dd95da2c"
      unitRef="U001">132340000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_5a515f7eaaad49808fa4b3463d33d03e"
      unitRef="U001">137750000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_9d5df2714a3342ec926aabb9ab3433d3"
      unitRef="U001">133943000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_96e46e0f159e483381c5292562456968"
      unitRef="U001">11358000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_96a5778ce002420b9e366725ebf8af8b"
      unitRef="U001">11175000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_cc8b514da15c4858a5765b1e6c8590b0"
      unitRef="U001">10659000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_32a79f64882049b8b4bd65b2f5bae218"
      unitRef="U001">11359000</usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests>
    <usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_4d58483eeb044bc9bd74f163500bc909"
      unitRef="U001">12403000</usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests>
    <usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_37f5628af60843ea94811b9f392a7c03"
      unitRef="U001">10221000</usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_bf39b5754c1443ee9e361c4798bd02ea"
      unitRef="U001">13011000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_79ce4d284f3d499889cfae0153d1c049"
      unitRef="U001">4632000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_b3fb834200964fc7b4a19c6754e107da"
      unitRef="U001">11893000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ea1d0d7c62a746eab037585baa978b17"
      unitRef="U001">-30204000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ee3471e034904d46bed650260c9af8fb"
      unitRef="U001">-20521000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_0372dbd1509a4f0ebc3a53bfab9c9298"
      unitRef="U001">-8934000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_709e87f326774ae5983dc641b9e00039"
      unitRef="U001">39862000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_3348f6c84b9a4b12a0bae41e4b5c7d47"
      unitRef="U001">11297000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_de7c4eec0eac4fc3950618484a8d574f"
      unitRef="U001">6230000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_b34815854550435face1e523f9fdfba5"
      unitRef="U001">0</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_4601ff6857814984b70c9c77cab5ca7b"
      unitRef="U001">6132000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_c7214ccd5365418facb3827e8ab63762"
      unitRef="U001">982000</usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_7491aef98ee843cea607d3f63ab6d385"
      unitRef="U001">1133000</usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_f053667ad40945c2923ea95ee54866e5"
      unitRef="U001">3120000</usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_3f613ec2d5f948f1a6a4486838cb87d3"
      unitRef="U001">-914000</usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_4cb4fc05cc3945caad12fa1009a95c1e"
      unitRef="U001">-1006000</usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_a141164931ce455fa1dde312ec349a97"
      unitRef="U001">-2870000</usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_66f8eefb546443149f973d70c91e0491"
      unitRef="U001">186000</usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_61e7812ef4c84ee9becfbeaa7b50a499"
      unitRef="U001">283000</usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_1d4e37f2e05e4d3d9318771b516cc070"
      unitRef="U001">0</usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="c20210101to20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_0375a7f38141449f8149127003f4cd2c"
      unitRef="U001">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ac172e236f804da49c023e94ea4e1d66"
      unitRef="U001">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_367f0a3a666a48b9a332fff57955cbe8"
      unitRef="U001">62000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_fe6f6689c88243759f5541b4350da47b"
      unitRef="U001">155262000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_0f994170ded74fc4b2dd8dbf8b90d414"
      unitRef="U001">132340000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_7c0d2dd457ea49029c5b1ee9a974d17f"
      unitRef="U001">137750000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_b83f11c6501c465f814d328d96c3455d">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, &lt;span style="text-indent: 0pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has lapsed but holder's employment has not terminated&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;80,781&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;62,390&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;51,921&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has not lapsed and holder's employment has not terminated&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;74,481&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;69,950&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;85,829&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder's employment has terminated and contractual time period has expired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder's employment has terminated and contractual time period has not expired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;155,262&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock>
    <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_4cd04cafef8a48688b989b9c4e40ace4"
      unitRef="U001">80781000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
    <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_28ff8ad94bf44a93a8cf5013f2c0f94a"
      unitRef="U001">62390000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
    <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_69ee4a96cf38419c83b182b8d673ce81"
      unitRef="U001">51921000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
    <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_cf8e592db4e24e2197bcd5158a84edd5"
      unitRef="U001">74481000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
    <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_83f618a87a354824a9abf683f3fbbf7c"
      unitRef="U001">69950000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
    <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_6fbe4772020f443fa1a46ef44856ff34"
      unitRef="U001">85829000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_51345c1fb9a04711b569beafb3d2db0c"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_d634f775ef554225abb491072b7b945a"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_21299d4934bf42799b558237962b3f24"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_43830159c4d34fa98c6a68fb9021297f"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_faa2d01a99124a3d85b7f8b8922f1d50"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_5768ac08e2db4a2988aa6103ac584e5b"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20211231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_fae8de90dc1e469ea1baf2422f5df539"
      unitRef="U001">155262000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ecd6175e472343309565aee7733a4735"
      unitRef="U001">132340000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_2b7170e7b46242b2b812e63fe28f4e68"
      unitRef="U001">137750000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_0a042661c4824e7ebff351e883729394">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;6. Goodwill&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The changes in the carrying amount of goodwill as of December 31, 2021 and 2020 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;345,646&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;317,676&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;89,746&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;28,540&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill derecognition (write-off) related to closed clinics&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,859&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill adjustments for purchase price allocation of businesses acquired in prior year&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(713&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,289&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;434,679&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;345,646&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 18pt; margin-left: 18pt;"&gt;&lt;br/&gt;
        During the year ended December 31, 2020, the Company derecognized (wrote off) goodwill in the amount of $1.9 million related to closed
        clinics due to COVID-19.&lt;/div&gt;
</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="c20210101to20211231"
      id="Text_9f5e9a0ef6dc4693bc1d10c3c718ab84">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The changes in the carrying amount of goodwill as of December 31, 2021 and 2020 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;345,646&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;317,676&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill acquired&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;89,746&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;28,540&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill derecognition (write-off) related to closed clinics&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,859&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill adjustments for purchase price allocation of businesses acquired in prior year&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(713&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,289&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;434,679&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;345,646&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e47c6d5df3cb48138fc8a9f449ee86bf"
      unitRef="U001">345646000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20191231"
      decimals="-3"
      id="Fact_bd6f35f59f1a4ba8b4ae81dbe6c78809"
      unitRef="U001">317676000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1ffb8221c72542a483c26c9690720fc1"
      unitRef="U001">89746000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_790e0f0358bb4fc8b85e475d44b9fbc3"
      unitRef="U001">28540000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_797e8407e246469b89ea2aabb71d5206"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d87a5233b3aa4b6fa946627f3952aefb"
      unitRef="U001">1859000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_73af0364042c474cb87998b0ad11eb30"
      unitRef="U001">-713000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d0e866e97e524ff1b1956f67976ad210"
      unitRef="U001">1289000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4c17c6a33889445aa5ba72ca20a67731"
      unitRef="U001">434679000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_eabfde1effd34232a4b41915bb70cbd4"
      unitRef="U001">345646000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_ee7a2f5f46c14e2fb09ac941479d0384"
      unitRef="U001">1900000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_9c7a4877c13a4277b5aef171298422e6">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;7. Intangible Assets, net&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Intangible assets, net as of December 31, 2021, and 2020 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;38,790&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,317&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships, net of accumulated amortization of $&lt;span style="text-indent: 0pt;"&gt;17,762&lt;/span&gt; and $&lt;span style="text-indent: 0pt;"&gt;14,522&lt;/span&gt;, respectively&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;45,643&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,119&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements, net of accumulated amortization of $&lt;span style="text-indent: 0pt;"&gt;6,450&lt;/span&gt; and $&lt;span style="text-indent: 0pt;"&gt;5,993&lt;/span&gt;, respectively&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,949&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,844&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,382&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;56,280&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Tradenames, customer and referral relationships and non-compete agreements are related to the businesses acquired. The value
      assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&#x2019;s annual goodwill impairment test. The value assigned to customer and referral
      relationships is being amortized over their respective estimated useful lives which range from 6 to 16 years. Non-compete agreements are amortized over the respective term of the agreements which range from 5 to 6 years.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2021, 2020 and 2019 (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left;"&gt;
      &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,240&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,845&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,307&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;458&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;569&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;708&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,698&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,414&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,015&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For one acquisition,
      the value assigned to tradename was being amortized over the term of the six year agreement in which the Company had acquired the right to
      use the specific tradename.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The remaining balances of the customer and referral relationships and non-compete agreements &lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;are&lt;/span&gt; expected to be amortized as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Customer and Referral Relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Non-Compete Agreements&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Ending December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Ending December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,798&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;512&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,691&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;443&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,526&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;387&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,382&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;322&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,914&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;236&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,332&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;49&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_5cb1fef2d96c43afa5056d7718b2eb91">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Intangible assets, net as of December 31, 2021, and 2020 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;38,790&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,317&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships, net of accumulated amortization of $&lt;span style="text-indent: 0pt;"&gt;17,762&lt;/span&gt; and $&lt;span style="text-indent: 0pt;"&gt;14,522&lt;/span&gt;, respectively&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;45,643&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,119&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements, net of accumulated amortization of $&lt;span style="text-indent: 0pt;"&gt;6,450&lt;/span&gt; and $&lt;span style="text-indent: 0pt;"&gt;5,993&lt;/span&gt;, respectively&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,949&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,844&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,382&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;56,280&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      decimals="-3"
      id="Fact_c23009a079b94f28bd1d849179d8e8b6"
      unitRef="U001">38790000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      decimals="-3"
      id="Fact_e8540a7b9f6540b1a1c542b2cf0a9494"
      unitRef="U001">32317000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_1897fd8807e8421f95d3ef7b3936e584"
      unitRef="U001">17762000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_7cb2a0c00fd24be2b3a79a43c705fbd0"
      unitRef="U001">14522000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_5e9e0b0393fe438cb6f4cdec95784836"
      unitRef="U001">45643000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_2558758d09bf42e1bff46df0a0260a25"
      unitRef="U001">22119000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_d7fd42a679d94c2b9cda8bfbb35528c1"
      unitRef="U001">6450000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_4ee113c5146d42d394b7b229c85c2f70"
      unitRef="U001">5993000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_31f0719955c14064bce3c53f75a577a2"
      unitRef="U001">1949000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_5ba60ef150f74e1d85a76d1ccfaa9204"
      unitRef="U001">1844000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9a66f2141c1845faae4c74b8d87e47ac"
      unitRef="U001">86382000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f9b52e8e1ac64405b4284babf6723edd"
      unitRef="U001">56280000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MinimumMember"
      id="Fact_5d318f555da1466a97cccfc8301f03e4">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_RangeAxis_MaximumMember"
      id="Fact_bed05098bcc14fc0b960a779f43267a4">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember"
      id="Fact_98be32acfaf04497bc167196dc002d9c">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember"
      id="Fact_b0541cfea7b249d495f4dc02d1e06ace">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_a115d96080de400f8f0366554314df45">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2021, 2020 and 2019 (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left;"&gt;
      &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Customer and referral relationships&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,240&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,845&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,307&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;458&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;569&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;708&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,698&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,414&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,015&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;
</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_80b0f9d1f85d4ee89b3f33eb45b3b0d2"
      unitRef="U001">3240000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_725bb3c760ab41f986346484ef49ea96"
      unitRef="U001">2845000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_c8a7379a422841db80d7efa2e5a52ed0"
      unitRef="U001">2307000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_8deea87710124782be56f0b2375e2138"
      unitRef="U001">458000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_714b2663ef3a4a559d2bdd877ad27e60"
      unitRef="U001">569000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_008922325e104ce99ed52f07f6593617"
      unitRef="U001">708000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_8e4eba3b5c70490aa45429ef805a5696"
      unitRef="U001">3698000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2ba02ac2573745a1821af20ed73700b3"
      unitRef="U001">3414000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8e8d4f748cd742ad9405f2fcdd2293d4"
      unitRef="U001">3015000</us-gaap:AmortizationOfIntangibleAssets>
    <usph:NumberOfAcquiredOperations
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      decimals="INF"
      id="Fact_3a78827f93814f87a945415abd1928fe"
      unitRef="U013">1</usph:NumberOfAcquiredOperations>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      id="Fact_d7ea720f42d74b8e847cdf39a4e3fe4e">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_f6654359e7ea4b029d9a0b1cb1317571">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The remaining balances of the customer and referral relationships and non-compete agreements &lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;are&lt;/span&gt; expected to be amortized as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Customer and Referral Relationships&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Non-Compete Agreements&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Ending December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Ending December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,798&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;512&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,691&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;443&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,526&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;387&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,382&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;322&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,914&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;236&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,332&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;49&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_7a349fd4dd154c2a956149d7b0f71e49"
      unitRef="U001">4798000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_8eb5d9222c3947b28434c6fef6873c59"
      unitRef="U001">512000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_03973a6595dc445eb393b2620139c343"
      unitRef="U001">4691000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_936101413d1345abb87495550c220ee3"
      unitRef="U001">443000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_3f494e10bb5846ea8154019952c4ae4e"
      unitRef="U001">4526000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_7376a63f68b14882a4a41e64761fd3e5"
      unitRef="U001">387000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_17a135f92dcf4866bfe4815177b495b4"
      unitRef="U001">4382000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_10001c96df0142e592ba34c8dac49e2f"
      unitRef="U001">322000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_98e9d84b3d0e4e11b98dbf389721d1f3"
      unitRef="U001">3914000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_04e6a2009bf7403d928696ebe3ec1b5d"
      unitRef="U001">236000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_7091b1aa551d466cab308e7982dbc627"
      unitRef="U001">23332000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_7286d71f48e344f5808ff82bea71645f"
      unitRef="U001">49000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_3aae6a8ce7d84f0c9cd6eddfbef36e4d">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;8. Accrued Expenses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Accrued expenses as of December 31, 2021
      and 2020 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Salaries and related costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,569&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,646&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit balances due to patients and payors&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,649&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,756&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Group health insurance claims&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,984&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,113&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Closure costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;498&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,333&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal taxes payable&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,716&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,885&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;MAAPP funds payable&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,054&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contingent payment related to acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;Settlement of a legal matter&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;2,750&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,539&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,959&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;45,705&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;59,746&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-indent: 20pt;"&gt;Federal






















        taxes payable includes $4.2 million related to deferred employer payroll taxes pursuant to the CARES ACT offset by a federal income tax
        receivable of $1.5 million.&lt;/div&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_333f31417ac64f07989d8c121efd0bbd">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Accrued expenses as of December 31, 2021
      and 2020 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Salaries and related costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,569&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,646&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit balances due to patients and payors&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,649&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,756&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Group health insurance claims&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,984&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,113&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Closure costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;498&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,333&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal taxes payable&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,716&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,885&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;MAAPP funds payable&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,054&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contingent payment related to acquisition&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;Settlement of a legal matter&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;2,750&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,539&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,959&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;45,705&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;59,746&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_db242ccc2c9244cc84464d8287adfec9"
      unitRef="U001">23569000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_20680758040e499e8828edae3c3c2936"
      unitRef="U001">24646000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <usph:PatientsAndPayorsRelatedLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_8f5b7c7e4dd0400dafd0613982372679"
      unitRef="U001">6649000</usph:PatientsAndPayorsRelatedLiability>
    <usph:PatientsAndPayorsRelatedLiability
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d11fcb47847f4e93b13311af94b7227e"
      unitRef="U001">5756000</usph:PatientsAndPayorsRelatedLiability>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ebd9ac765a9d49c2833342f1bcd1f2f1"
      unitRef="U001">1984000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_6611277b24b84d38b3c61593a522e184"
      unitRef="U001">2113000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f4d1ebcdc71b4e8fb023f70a05515eb1"
      unitRef="U001">498000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_c053d55884a44258ba640f60f5dac42c"
      unitRef="U001">1333000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_482263ed051945f3a6499c3a48fe465b"
      unitRef="U001">2716000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_fa7957fd3ccc4701894b882ebca8fb1c"
      unitRef="U001">9885000</us-gaap:TaxesPayableCurrent>
    <usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable
      contextRef="c20211231"
      decimals="-3"
      id="Fact_afb7512ccc944dc3888beb58a12b750f"
      unitRef="U001">0</usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable>
    <usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable
      contextRef="c20201231"
      decimals="-3"
      id="Fact_dc1dd837ba8544a2b4da7ffb5b409a5f"
      unitRef="U001">14054000</usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_aad6409c3cc24ef7900d79239b987a3e"
      unitRef="U001">1000000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_08d2e8b37e654962a4221425c424a3e0"
      unitRef="U001">0</us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cdc024e6654a4f4f9fea96d4f49dd633"
      unitRef="U001">2750000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_574875543e52405d9272a7ca24992c67"
      unitRef="U001">0</us-gaap:LitigationReserveCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ae12d6d5a9ff45a1b4941ddcf0973703"
      unitRef="U001">6539000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b240ca9122d54ba493fe7c51bc849e6a"
      unitRef="U001">1959000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9c711f761ec249ca8d037499687d6b14"
      unitRef="U001">45705000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_3a53721905e240318b347fd51c275f73"
      unitRef="U001">59746000</us-gaap:AccruedLiabilitiesCurrent>
    <usph:DeferredEmployerPayrollTaxesCARESACT
      contextRef="c20211231"
      decimals="-5"
      id="Fact_4ff7861c2d93460994b8617c0539ec9b"
      unitRef="U001">4200000</usph:DeferredEmployerPayrollTaxesCARESACT>
    <us-gaap:IncomeTaxesReceivable
      contextRef="c20211231"
      decimals="-5"
      id="Fact_0b64ae3000c14f2db58dba6076062386"
      unitRef="U001">1500000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_55820ab9458146278380569ef8e35714">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;9. Notes Payable&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt; margin-left: 9pt;"&gt;Notes payable as of December 31, 2021, and 2020 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit Agreement average effective interest rate of &lt;span style="text-indent: 0pt;"&gt;2.1&lt;/span&gt;% for December 31, 2021 and December 31, 2020, (inclusive of unused fee)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;114,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Various notes payable with $&lt;span style="text-indent: 0pt;"&gt;830&lt;/span&gt; plus accrued interest due in the next year, interest accrues in the range of &lt;span style="text-indent: 0pt;"&gt;3.25&lt;/span&gt;%
              through &lt;span style="text-indent: 0pt;"&gt;4.75&lt;/span&gt;% per annum&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,495&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;118,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,495&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less current portion&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(830&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,899&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Long term portion&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;117,587&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,596&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;Effective

        December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving
        credit facility. This agreement was amended in August 2015, January 2016, March 2017, November 2017, January 2021, and November 2021 (hereafter is referred to as &#x201c;Amended Credit Agreement&#x201d;). In November 2021, the Company exercised the accordion
        feature in the Amended Credit Agreement to increase the limit on the facility from $125.0 million to $150.0 million, with an updated accordion feature providing for additional capacity of $25.0 million, therefore increasing the availability up to $175.0 million.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The
        Amended Credit Agreement is unsecured and has loan covenants, including requirements that we comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working
        capital, acquisitions, purchases of our common stock, dividend payments to our common stockholders, capital expenditures and other corporate purposes. The pricing grid is based on our consolidated leverage ratio with the applicable spread over
        LIBOR ranging from 1.25% to 2.0%
        or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee of 0.3%
        of the amount of funds outstanding under the Amended Credit Agreement.&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The 2021 amendment to the Amended Credit Agreement allows for cash and noncash consideration for acquisitions permitted under the Amended Credit Agreement of up to
          $50,000,000 for any fiscal year, and allows for payments in cash dividends to shareholders in an aggregate amount not to exceed $50,000,000 in any fiscal year.&#160; The Amended Credit Agreement is unsecured and includes certain financial covenants which include a consolidated fixed
          charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 22.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20.15pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;On
          December 31, 2021, $114.0 million was outstanding on the Amended Credit Agreement resulting in $61.0 million of availability. As of December 31, 2021, the Company was in compliance with all of the covenants thereunder.&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20.15pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The

          Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchasing of non-controlling interests. In conjunction with these transactions in 2021, the Company entered into notes payable in the
          aggregate amount of $4.4 million of which an aggregate principal payment of $0.8 million was due in 2021 and $3.6 million is due in 2022. Interest accrues
          in the range of 3.25% to 4.75%
          per annum and is payable with each principal installment. The balance of the various notes payable entered into prior to 2021 was $3.6
          million which will be paid in 2022 and 2023.&lt;/div&gt;
</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="c20210101to20211231"
      id="Text_ac30634f26b4412783d5e15e452b5493">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt; margin-left: 9pt;"&gt;Notes payable as of December 31, 2021, and 2020 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit Agreement average effective interest rate of &lt;span style="text-indent: 0pt;"&gt;2.1&lt;/span&gt;% for December 31, 2021 and December 31, 2020, (inclusive of unused fee)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;114,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Various notes payable with $&lt;span style="text-indent: 0pt;"&gt;830&lt;/span&gt; plus accrued interest due in the next year, interest accrues in the range of &lt;span style="text-indent: 0pt;"&gt;3.25&lt;/span&gt;%
              through &lt;span style="text-indent: 0pt;"&gt;4.75&lt;/span&gt;% per annum&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,495&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;118,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,495&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less current portion&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(830&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,899&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Long term portion&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;117,587&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,596&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="3"
      id="Fact_d7d84d5e11bd437e8de14231d7963e47"
      unitRef="U005">0.021</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="3"
      id="Fact_21b7bc5df79648ab867009d07068816d"
      unitRef="U005">0.021</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-3"
      id="Fact_9f073b21e6ca4be7ad40b73d40069c0b"
      unitRef="U001">114000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-3"
      id="Fact_b5fa905fd7f84b75b47bbe45754636f6"
      unitRef="U001">16000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_c072f8455e09497e997be85b87e7d096"
      unitRef="U001">830000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember"
      decimals="4"
      id="Fact_8aa95d218202449eba037982f4a2fce9"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember"
      decimals="4"
      id="Fact_0ec4783a01554daeaa8b0dfd9e9b6cc7"
      unitRef="U005">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="c20211231_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_55330831126f47f2b8e01b12d0972f05"
      unitRef="U001">4417000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_64316e3cc2f4486399915e905de96260"
      unitRef="U001">5495000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a992874ecdc1415ca564e65469705c5d"
      unitRef="U001">118417000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20201231"
      decimals="-3"
      id="Fact_01eeb0810f334ace89eb0b5749879204"
      unitRef="U001">21495000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_fef207e7ec214425868307f2bb6c8b36"
      unitRef="U001">830000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_7ccfc85e1cde4fdb8d561205ecd32a48"
      unitRef="U001">4899000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a7437ef82bf0438a9d23fa2a37385b7e"
      unitRef="U001">117587000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f640ef1394ad4833a9af64667df8e03d"
      unitRef="U001">16596000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_9a1cd50b1a7a4cf4be506ef5d9a93d80"
      unitRef="U001">125000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_87c21b0379134a5c8c20ff826134cbc6"
      unitRef="U001">125000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20211130_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_6fb6f1139c87478b96e3648b9a4ea7aa"
      unitRef="U001">150000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="c20210101to20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_9719444c8f004a13a38f5fe86bd2bd9e"
      unitRef="U001">25000000.0</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_350c861853fc4793923eec5964a1fa4d"
      unitRef="U001">175000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <usph:DebtInstrumentBasisSpreadOnLiborVariableRate
      contextRef="c20211231_RangeAxis_MinimumMember"
      decimals="4"
      id="Fact_9df99134a3f644a1b01653459dcf9463"
      unitRef="U005">0.0125</usph:DebtInstrumentBasisSpreadOnLiborVariableRate>
    <usph:DebtInstrumentBasisSpreadOnLiborVariableRate
      contextRef="c20211231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_7c938954848542afb0f968e417f41728"
      unitRef="U005">0.020</usph:DebtInstrumentBasisSpreadOnLiborVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c20210101to20211231_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_b3b9fb97de3c432ba7b5d5c9fd3567fa"
      unitRef="U005">0.001</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c20210101to20211231_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_73998fb5d05f46c98666913d6490810c"
      unitRef="U005">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c20210101to20211231"
      decimals="3"
      id="Fact_f31c971f94154d489f8178d06f49f5aa"
      unitRef="U005">0.003</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement
      contextRef="c20210101to20211231_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_f639cbae1baf44878ea0c1de720461fa"
      unitRef="U001">50000000</usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement>
    <usph:DividendsCashAfterAmendment
      contextRef="c20210101to20211231_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_98d447c04ea24031aa392ee2b2ae5ce2"
      unitRef="U001">50000000</usph:DividendsCashAfterAmendment>
    <us-gaap:LongTermDebt
      contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_06c5f9366d724ffeb50ce9e3132578f2"
      unitRef="U001">114000000.0</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="c20211231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_7c174ba799ae48c8affa9ea502c84e4d"
      unitRef="U001">61000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20211231_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_d1c648acd5a94de79dfe0afc81400efa"
      unitRef="U001">4400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="c20211231_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_55757610dcb3458ebb31d564822b2cc6"
      unitRef="U001">800000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="c20211231_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_17189d2acf094363adca77e67bdc6d8d"
      unitRef="U001">3600000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20210101to20211231_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="4"
      id="Fact_3d870d9e08a84390beff57bb229d9e57"
      unitRef="U005">0.0325</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20210101to20211231_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="4"
      id="Fact_4bb0ce155b3c4f9ab351980c181e6b37"
      unitRef="U005">0.0475</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="c20211231_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_b66dfafef33248eba0a9c0a78d4d59a4"
      unitRef="U001">3600000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20210101to20211231"
      id="Text_cdbb9734057d444aa98080f53fa7afef">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;10. Leases&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a
      lease at the inception of a contract. Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset during
      the lease term and operating lease liabilities represent net present value of the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the
      net present value of the fixed lease payments over the lease term. The Company&#x2019;s operating lease terms are generally five years or less.
      The Company&#x2019;s lease terms include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#x2019;s operating leases do not provide an implicit rate, the Company uses its incremental
      borrowing rate based on the information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The
      Company has elected, in compliance with current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable
      lease components. The Company has elected the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included
      in the measurement of the right-of-use assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease
      classification. Variable lease payment amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease
      liabilities. These are expensed as incurred and recorded as variable lease expense.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the years ended December 31, 2021
      and 2020, the components of lease expense were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="text-indent: 0pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,710&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Short-term lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,160&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,454&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Variable lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,057&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,752&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease cost&lt;sup&gt;*&lt;/sup&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;40,238&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,916&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sublease income was immaterial&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Lease costs are reflected in the consolidated statements of net income in the line item&#x2014;rent, supplies, contract labor and other.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the years ended December 31, 2021
      and 2020, supplemental cash flow information related to leases was as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;33,192&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,307&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;46,088&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,710&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The aggregate future lease payments for operating leases as of December 31, 2021 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="text-decoration: underline;"&gt;Fiscal Year&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,945&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27,467&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;20,876&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;2026&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;8,492&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2027 and therafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,055&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease payments&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;110,835&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less: imputed interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,175&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total operating lease liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;104,660&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Average lease terms and discount rates were as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average remaining lease term - Operating leases&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.17 Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;4.05&lt;/span&gt; Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average discount rate - Operating leases&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.77&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.1&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="c20211231_RangeAxis_MaximumMember"
      id="Fact_7fefe8b93693415e9fa87570d093816c">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_e7c6545c972a48239cd66b21587489f9">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the years ended December 31, 2021
      and 2020, the components of lease expense were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; text-indent: -9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="text-indent: 0pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,710&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Short-term lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,160&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,454&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Variable lease cost&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,057&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,752&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease cost&lt;sup&gt;*&lt;/sup&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;40,238&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,916&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"/&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sublease income was immaterial&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3a52a0fd562747aaba28db104b42204a"
      unitRef="U001">32021000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c2abb0f991ea43edb5e9389bf4c02d20"
      unitRef="U001">30710000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_693b6ba2f8a14f59b60dbe2849d58a8e"
      unitRef="U001">1160000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ef3e23ac818d4f6cb42c44e78eeaa900"
      unitRef="U001">1454000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_45cfd55318e8430e8abd228664256dc4"
      unitRef="U001">7057000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_a4406ddea50443b5b81fb9580d8fdf10"
      unitRef="U001">5752000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_37c9d93f7a2345308c093a2c7e4106c9"
      unitRef="U001">40238000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2d8530006ec74a9781d163ce2d72292d"
      unitRef="U001">37916000</us-gaap:LeaseCost>
    <usph:OperatingLeaseSupplementalInformationTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_2247309c229e4ddabdd31813b2c5a7d0">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For the years ended December 31, 2021
      and 2020, supplemental cash flow information related to leases was as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;33,192&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,307&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;46,088&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,710&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:OperatingLeaseSupplementalInformationTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_915702139d34496ead17abd32c208d80"
      unitRef="U001">33192000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_a99caf854f304fe4aa1c8dbd80fb92fa"
      unitRef="U001">30307000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_e052d37fb1d34b1a95b622952bb39436"
      unitRef="U001">46088000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f0f7cb3b8b564e2eb2db89017fec57bb"
      unitRef="U001">32710000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_052dc785c4dc44b6aa14a5450de192a7">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The aggregate future lease payments for operating leases as of December 31, 2021 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="text-decoration: underline;"&gt;Fiscal Year&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Amount&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,945&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27,467&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;20,876&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;2026&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;8,492&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2027 and therafter&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,055&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease payments&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;110,835&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less: imputed interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,175&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total operating lease liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;104,660&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20211231"
      decimals="-3"
      id="Fact_31887a6f4b924a64b7539e2b517efaf1"
      unitRef="U001">32945000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3dcdbf2cc29e4d7e8f0eb51b88bab6d1"
      unitRef="U001">27467000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6c9fb936a89549158ae09d506165e0a5"
      unitRef="U001">20876000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2b0015b5ea4d47829763994b80e71dfa"
      unitRef="U001">14000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b1719787b0df46deb6751c9ecbce1411"
      unitRef="U001">8492000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4a4f75b0102b444580140cea26689283"
      unitRef="U001">7055000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b616dc0447fb4f5e9b1b9b220603e12a"
      unitRef="U001">110835000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20211231"
      decimals="-3"
      id="Fact_94ebb1b48970459b81a38269913da18e"
      unitRef="U001">6175000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f116813389474de8ab97a719322c075d"
      unitRef="U001">104660000</us-gaap:OperatingLeaseLiability>
    <usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_8d47354d0a59407b8b3338b4e8039d19">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Average lease terms and discount rates were as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended December 31,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average remaining lease term - Operating leases&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.17 Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;4.05&lt;/span&gt; Years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: left;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average discount rate - Operating leases&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.77&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.1&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20211231"
      id="Fact_64e7e79771ad4ababc643348f87de0ca">P4Y2M1D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20201231"
      id="Fact_c67a6112f822431590579ef07d1f32ca">P4Y18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20211231"
      decimals="4"
      id="Fact_55f0f60fcc454c1990a86a011ce4f264"
      unitRef="U005">0.0277</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20201231"
      decimals="3"
      id="Fact_a34c4798313a4b228d31aae046ec30be"
      unitRef="U005">0.031</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_cb0dfa70c1104063bfc7e17519ae272f">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;11. Income Taxes&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2021 and
      2020 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax assets:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Compensation&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,817&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,865&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;573&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;396&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired net operating losses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;558&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Lease obligations - including closed clinics&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,856&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,819&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,246&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,638&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax liabilities:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Depreciation and amortization&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(19,607&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(12,650&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease right-of-use assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,637&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,419&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(387&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(348&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(44,631&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(34,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred tax liability&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(14,385&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(7,779&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The deferred tax assets and liabilities related to purchased interests not yet finalized may result in an immaterial adjustment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;During 2021, the Company recorded net deferred tax assets of $0.8 million related to the revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests. In addition, during 2021, the Company recorded an
      adjustment to the deferred tax assets of $3.0 million as a result of a detailed reconciliation of its federal and state taxes payable and
      receivable accounts along with its federal and state deferred tax asset and liability accounts with its federal and state tax returns for 2020. The offset of this adjustment was a decrease to the previously reported state income tax receivable and a
      decrease to the federal income tax payable. As of December 31, 2021, the Company has a federal tax payable of $2.7 million and state tax
      receivables of $0.6 million. &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The federal income tax payable is included in
      &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;accrued liabilities&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; and the tax receivable is&lt;/span&gt; included in &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;other current assets&lt;/span&gt; on the accompanying consolidated balance sheets.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The differences between the federal tax rate and the Company&#x2019;s effective tax rate for the years ended December 31, 2021, 2020 and
      2019 were as follows (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;U. S. tax at statutory rate&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,782&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,125&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,274&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap; width: 28%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State income taxes, net of federal benefit&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,478&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.4&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,956&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.9&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,059&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.8&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Excess equity compensation deduction&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(246&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-0.4&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(99&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(871&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-1.6&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap; width: 28%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-deductible expenses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,258&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.2&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,040&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.1&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,185&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.2&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;15,272&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27.2&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,647&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;25.4&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Significant components of the provision for income taxes for the years ended December 31, 2021, 2020 and 2019 were as follows (in
      thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;December 31, &lt;/span&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;December 31, &lt;/span&gt;2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;December 31, &lt;/span&gt;2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Current:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,477&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,506&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,523&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,107&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,774&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,473&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,584&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,280&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,996&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,866&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(38&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,730&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;822&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(220&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;921&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total deferred&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,688&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(258&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,651&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total income tax provision&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;15,272&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,647&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;For 2021, 2020 and 2019, the Company performed a detailed reconciliation of its federal and state taxes payable and receivable
      accounts along with its federal and state deferred tax asset and liability accounts. The adjustments were immaterial. The Company considers this reconciliation process to be an annual control.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company is required to establish a valuation allowance for deferred tax assets if, based on the weight of available evidence, it
      is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary
      differences become deductible. Management considers the projected future taxable income and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income in the periods
      which the deferred tax assets are deductible, management believes that a valuation allowance is not required, as it is more likely than not that the results of future operations will generate sufficient taxable income to realize the deferred tax
      assets.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company&#x2019;s U.S. federal returns remain open to examination for &lt;span style="-sec-ix-hidden:Fact_19a08fedb1b74db5a6b4b517c5b42088"&gt;2018 through 2020&lt;/span&gt; and U.S. state jurisdictions are open for periods ranging from &lt;span style="-sec-ix-hidden:Fact_b89ef7a81a69420b8fe8694136cd02d4"&gt;2017 through 2020&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company does not believe that it has any significant uncertain tax positions at December 31, 2021 and December 31, 2020, nor is
      this expected to change within the next twelve months due to the settlement and expiration of statutes of limitation.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company did not
      have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the years ended December 31, 2021, 2020 and 2019.&lt;/div&gt;
</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_3cf65d4846c84c9584293d577c037d64">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2021 and
      2020 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax assets:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Compensation&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,817&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,865&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;573&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;396&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired net operating losses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;558&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Lease obligations - including closed clinics&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,856&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,819&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,246&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,638&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax liabilities:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Depreciation and amortization&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(19,607&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(12,650&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease right-of-use assets&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,637&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,419&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(387&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(348&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax liabilities&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(44,631&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(34,417&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred tax liability&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(14,385&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(7,779&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="c20211231"
      decimals="-3"
      id="Fact_87574d133e53433fb5491d491cc0b4ad"
      unitRef="U001">2817000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="c20201231"
      decimals="-3"
      id="Fact_cd2864cb95284f1cb681e6bbe03b7314"
      unitRef="U001">1865000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cd2b722e05cf42efad06cf05d355c91d"
      unitRef="U001">573000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f7e6f68a828d4387913c3854c3b64bf2"
      unitRef="U001">396000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e71fdc809bb94df6b9d06a2a7abaabb9"
      unitRef="U001">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4f939afffc2b400f8c94c9276af582bb"
      unitRef="U001">558000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <usph:DeferredTaxAssetsLeaseObligations
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0009c968794943d8a6bac7f255e0e52b"
      unitRef="U001">26856000</usph:DeferredTaxAssetsLeaseObligations>
    <usph:DeferredTaxAssetsLeaseObligations
      contextRef="c20201231"
      decimals="-3"
      id="Fact_51c62008a57741f7a4a10955eab8f039"
      unitRef="U001">23819000</usph:DeferredTaxAssetsLeaseObligations>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1b786c406213482d85406e0cd434a33c"
      unitRef="U001">30246000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_1c4113d9e12549e3a932104e66b1a6b7"
      unitRef="U001">26638000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c20211231"
      decimals="-3"
      id="Fact_938551610d5b4547b0a6647b9d933ada"
      unitRef="U001">19607000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c20201231"
      decimals="-3"
      id="Fact_05205e059b574f279e2fc2956c415ea7"
      unitRef="U001">12650000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_093aa6b6e9934268a181ab9e3b210215"
      unitRef="U001">24637000</usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets>
    <usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
      contextRef="c20201231"
      decimals="-3"
      id="Fact_72492258a04948daaa5bc824e3ef8ad0"
      unitRef="U001">21419000</usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cedf88057b5847a4a341040a8873239d"
      unitRef="U001">387000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4005c6408fb94f5ea4e54c1587356d3e"
      unitRef="U001">348000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_28ddff1cd1804f0f99a886e0e565ce89"
      unitRef="U001">44631000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_37f3b7d41d30476a89d9b9c18dfa301a"
      unitRef="U001">34417000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4617ccacc21b43818ee184244ad91d8e"
      unitRef="U001">14385000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_98aa793e124f4c4398247d26a0e5cb97"
      unitRef="U001">7779000</us-gaap:DeferredTaxLiabilities>
    <usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests
      contextRef="c20211231"
      decimals="-5"
      id="Fact_6fb2adbab7f7478a888c22dd4777c2b1"
      unitRef="U001">800000</usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_8583d17313a34bc7b2fe28146115729a"
      unitRef="U001">3000000.0</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="c20211231_IncomeTaxAuthorityAxis_ForeignCountryMember"
      decimals="-5"
      id="Fact_7c219709944f44e998c3aeaebc081531"
      unitRef="U001">2700000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxReceivableCurrent
      contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fact_214ab719665b479189f25ae7383c4e8e"
      unitRef="U001">600000</us-gaap:DeferredIncomeTaxesAndOtherTaxReceivableCurrent>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_f78cb5eab44f4a7f82b65ad62b7fdc18">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The differences between the federal tax rate and the Company&#x2019;s effective tax rate for the years ended December 31, 2021, 2020 and
      2019 were as follows (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;U. S. tax at statutory rate&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,782&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,125&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,274&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap; width: 28%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State income taxes, net of federal benefit&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,478&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.4&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,956&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.9&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,059&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.8&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Excess equity compensation deduction&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(246&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-0.4&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(99&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(871&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-1.6&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap; width: 28%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-deductible expenses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,258&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.2&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,040&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.1&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,185&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.2&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;15,272&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27.2&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27.0&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,647&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;25.4&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9333dadbb89842ab939c3b351d92d492"
      unitRef="U001">11782000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20210101to20211231"
      decimals="3"
      id="Fact_fc7dc75e92ed455faf98a5670c4635d0"
      unitRef="U005">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_3b7da54ea05f4bfc996203e5f7379370"
      unitRef="U001">10125000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_6a30d1f0914e441191d8c08f2afa5221"
      unitRef="U005">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_5568d7fd8a64412fa2ed10c4e51f0f80"
      unitRef="U001">11274000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_7c35bc4e2feb415ea8c42be0f1a66bf9"
      unitRef="U005">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_21b2465e3bf745eb846694a6afe436df"
      unitRef="U001">2478000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20210101to20211231"
      decimals="3"
      id="Fact_60d779d9a6824895a2d70ee8f6baf11c"
      unitRef="U005">0.044</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d248dbe56c934baba06b58d189ff9330"
      unitRef="U001">1956000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_d5b20f7e3a5b46d3985a99b08dfcb2c6"
      unitRef="U005">0.039</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9bab47651eea4444b13ca51c8b851358"
      unitRef="U001">2059000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_b7e904305a774c31b6b02e11477a162b"
      unitRef="U005">0.038</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationDeductions
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_5a69f284952d46418d777f879ed874ee"
      unitRef="U001">246000</us-gaap:IncomeTaxReconciliationDeductions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions
      contextRef="c20210101to20211231"
      decimals="3"
      id="Fact_a66f2ff266ab43718c54e1ae2e8e87d2"
      unitRef="U005">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
    <us-gaap:IncomeTaxReconciliationDeductions
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_666467fce52347b29ff20230b3e6d80b"
      unitRef="U001">99000</us-gaap:IncomeTaxReconciliationDeductions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_778a2d409e1845ca8f264db588bfcf26"
      unitRef="U005">-0</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
    <us-gaap:IncomeTaxReconciliationDeductions
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_38e182f8365345d2b5d8d26773b5c50d"
      unitRef="U001">871000</us-gaap:IncomeTaxReconciliationDeductions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_5be8a63a33e741cdb7f990a01595a7f4"
      unitRef="U005">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_05d9eccbf2a342e3ac1881635514802c"
      unitRef="U001">1258000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20210101to20211231"
      decimals="3"
      id="Fact_1c1e4e13eb4e4fbf9769bc4a734e830e"
      unitRef="U005">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f68339c2a4a44194a4d7d3762b8a4c03"
      unitRef="U001">1040000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_72b10c55e8c24177949b1bbe3281ecd0"
      unitRef="U005">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_b361a8e469df4a599c426bf334be93e0"
      unitRef="U001">1185000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_0700afa9225f453ebfb4d5c1ae6fb2dc"
      unitRef="U005">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1555021278224f6aa8e8c4c6d21ab0c6"
      unitRef="U001">15272000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20210101to20211231"
      decimals="3"
      id="Fact_91ebc05a6fa8455ba2619e39d0734808"
      unitRef="U005">0.272</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ec3741de8ce640d78ea1ce494f990987"
      unitRef="U001">13022000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_80d432ab568648a3b1d899ab6a81ef91"
      unitRef="U005">0.270</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_2711b9d3ee3f41d6a54d57d5c18de386"
      unitRef="U001">13647000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_735084fa1dc6462ba06ada330178700e"
      unitRef="U005">0.254</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_1631118cbae147aba560298813819f37">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Significant components of the provision for income taxes for the years ended December 31, 2021, 2020 and 2019 were as follows (in
      thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;December 31, &lt;/span&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;December 31, &lt;/span&gt;2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"&gt;December 31, &lt;/span&gt;2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Current:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,477&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,506&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,523&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,107&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,774&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,473&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,584&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,280&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,996&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,866&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(38&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,730&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;822&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(220&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;921&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total deferred&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,688&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(258&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,651&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total income tax provision&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;15,272&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,647&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c435fd1ea291455fb5c6a6a8859c71fd"
      unitRef="U001">7477000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ec5d4e6255914cd3886e5bffaa3f92e0"
      unitRef="U001">10506000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9bac9e5a3c1e4783810f1d7a959b7b9b"
      unitRef="U001">6523000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c61f1bcf3f114612b5d1aff878c92001"
      unitRef="U001">2107000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b5b918fe8b814ef08e8a27e062909d73"
      unitRef="U001">2774000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_93515880ca6142138553120ba39fce13"
      unitRef="U001">2473000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_0dcd1a8d8f104696afa9645ba10b5882"
      unitRef="U001">9584000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_83e04d6bfd064432b6674cdd3336dc37"
      unitRef="U001">13280000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0fcde56b61cc4306b72d46c3f4b35f9f"
      unitRef="U001">8996000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9e6e7320ade94bcd95a0641ad0bfe738"
      unitRef="U001">4866000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ae9fa96d150540eb9a0c3c1b60e31e9b"
      unitRef="U001">-38000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_7808ed8624c647b0ad39c46d8f1b5635"
      unitRef="U001">3730000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_749a26fbf43747dd96a8f3d40187a037"
      unitRef="U001">822000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_480174fd1e8a41eab3a4fc0b957acde8"
      unitRef="U001">-220000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d05103d47c8849398af51c5eeb85c27b"
      unitRef="U001">921000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d442b44bb59d429ab2a9d4bdd0cb70f4"
      unitRef="U001">5688000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_66c3d403d3de463e9d526790b0768795"
      unitRef="U001">-258000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_2e2c9e384f9f41e4b0f6ef8adb4371ca"
      unitRef="U001">4651000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_921de044b03c4609984ed5065ba6b907"
      unitRef="U001">15272000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b73985877e034c7aa2506893c86be3dd"
      unitRef="U001">13022000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_05fe715e4901416e97771b5893defb6e"
      unitRef="U001">13647000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_f3b286cf1e1e4dfbbdbc69796bc746bf"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20201231"
      decimals="-3"
      id="Fact_be753e34b4b649ec93561ebcad6c4cfd"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b57c26c889664a849f4401ad8baa8aca"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20191231"
      decimals="-3"
      id="Fact_646799d8c60a4b6fb4cf8afa606b4c6c"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_5be3ffa4479d41a1804680a0865834dc"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2069a011427a4311a190e01db5911083"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_6f4683897ad44728b6e412d1c8ccd4cc">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;12. Segment Information&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company&#x2019;s reportable segments include the physical therapy
        operations segment and the industrial injury prevention services segment. Also included in the physical therapy operations segment are revenues from management contract services and other services which include services the Company provides
        on-site, such as schools for athletic trainers&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company evaluates performance of the segments based on gross
        profit. The Company has provided additional information regarding its reportable segments which contributes to the understanding of the Company and provides useful information&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he following table summarizes selected financial data for the
        Company&#x2019;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Year Ended December 31,&lt;/span&gt;&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt; &lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt; &lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net operating revenue:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;451,122&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;383,770&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;444,507&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;43,900&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,199&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,462&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;495,022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;422,969&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;481,969&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations (excluding closure costs) (a non-GAAP measure)&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;106,518&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;88,295&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;104,120&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,694&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,086&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,379&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;117,212&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;98,381&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,499&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations - closure costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,931&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;25&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;117,182&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;94,450&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,474&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Assets:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;587,801&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;499,911&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;518,027&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;161,625&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;94,450&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,474&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;749,426&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;594,361&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;630,501&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="c20210101to20211231"
      id="Text_cd3f99d7b75b42b19a09c264e746e13a">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he following table summarizes selected financial data for the
        Company&#x2019;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Year Ended December 31,&lt;/span&gt;&lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt; &lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt; &lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net operating revenue:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;451,122&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;383,770&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;444,507&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;43,900&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,199&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,462&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;495,022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;422,969&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;481,969&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations (excluding closure costs) (a non-GAAP measure)&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;106,518&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;88,295&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;104,120&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,694&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,086&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,379&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;117,212&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;98,381&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,499&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations - closure costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;30&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,931&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;25&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;117,182&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;94,450&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,474&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Assets:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;587,801&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;499,911&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;518,027&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;161,625&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;94,450&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,474&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;749,426&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;594,361&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;630,501&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_08bbc0ae239e4fdcbbe658ff8fd1d20e"
      unitRef="U001">451122000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_46cb9ddf266c4ec3b7cfab81c1966ad6"
      unitRef="U001">383770000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_f3dac2a50e9d44cfa906c85d8500ac9c"
      unitRef="U001">444507000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_1d76abb000d1418088105c84c1c1c4f7"
      unitRef="U001">43900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_d6c760bb16e444fdb69f4101fae0c83a"
      unitRef="U001">39199000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_e949751c86c74d80aa32138d831fd36b"
      unitRef="U001">37462000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_331d4f1d30ea4a24be31fac9fdcf3c38"
      unitRef="U001">495022000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_7af1895063984a198bbecac9dda16a5a"
      unitRef="U001">422969000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_c99f8c477c6e4a0ea05b876a9dd62b75"
      unitRef="U001">481969000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember"
      decimals="-3"
      id="Fact_af85b664d61e4aa3b9d5c0cb873855b5"
      unitRef="U001">106518000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember"
      decimals="-3"
      id="Fact_15f94e91e0cd4ee498148fe1b920ef45"
      unitRef="U001">88295000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember"
      decimals="-3"
      id="Fact_8fc54460aa144492b9582e4bc696d443"
      unitRef="U001">104120000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_2c1ea5cbf8d84078ab403a147f6336e9"
      unitRef="U001">10694000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_8f59b1d6bf6f4b1baea5e2c34d98bc58"
      unitRef="U001">10086000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_c765d9df7c184ef58a02fbda9b554475"
      unitRef="U001">8379000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember"
      decimals="-3"
      id="Fact_d82933349890427a8e65dfb2ddd74d71"
      unitRef="U001">117212000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember"
      decimals="-3"
      id="Fact_a6f7fb79962747c9b54db1bd4727438e"
      unitRef="U001">98381000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember"
      decimals="-3"
      id="Fact_90b9c038251f404fbce4c4f0ccfc5bb6"
      unitRef="U001">112499000</us-gaap:GrossProfit>
    <us-gaap:RestructuringCharges
      contextRef="c20210101to20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_c81d426883804918acfc01dbfff7779a"
      unitRef="U001">30000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_29f92ce2b8894b8cb2d22dc8eebc8615"
      unitRef="U001">3931000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_34aece889196491092208f245812ee80"
      unitRef="U001">25000</us-gaap:RestructuringCharges>
    <us-gaap:GrossProfit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7f48fe3866c6493d834d36f613825237"
      unitRef="U001">117182000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_bf5d8b4aec4a48558ed76e3bd85867d3"
      unitRef="U001">94450000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_498e1c80994841c29815a2ea6474ee8f"
      unitRef="U001">112474000</us-gaap:GrossProfit>
    <us-gaap:Assets
      contextRef="c20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_571c23cf36354b17bfac107251f57699"
      unitRef="U001">587801000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_a6af9c9c506e486b8566ebeac361fdd1"
      unitRef="U001">499911000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_ddc70c3b8fe4484d800c0c747df4e3cf"
      unitRef="U001">518027000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20211231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_52c33044fbf1491aa1fc41a6ac7cc204"
      unitRef="U001">161625000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_8c4d454330464f4ebf86108e33e81ef7"
      unitRef="U001">94450000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_6d49b488712b4596a6db15bc4b19489d"
      unitRef="U001">112474000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f89adaaf0aa24933b7de79666d41f5d8"
      unitRef="U001">749426000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20201231"
      decimals="-3"
      id="Fact_eaea358833d4408fbfbe8f719a61bd3a"
      unitRef="U001">594361000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20191231"
      decimals="-3"
      id="Fact_27806b7ce2f94498ba4e404f3f1268d1"
      unitRef="U001">630501000</us-gaap:Assets>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock
      contextRef="c20210101to20211231"
      id="Text_31f4dd57d03840e2b92858543bbb8fa3">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;13. Investment in Unconsolidated Affiliate&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Through one of the subsidiaries, the Company has a 49% joint venture interest in a company which provides physical therapy services for patients at hospitals. Since the Company is deemed to not have a controlling interest in
          the company, the Company&#x2019;s investment is accounted for using the equity method of accounting. The investment balance of this joint venture as of December 31, 2021, is $12.2 million, of which $12.3 million related to the fair value on the date of acquisition. The $12.2 million includes earnings of $112
          thousand less a distribution received of $153 thousand.&lt;/div&gt;
</us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="2"
      id="Fact_0dcbe31c658f4ff4a8f235873aa17b73"
      unitRef="U005">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-5"
      id="Fact_945e4d32dbb74577b130af790a8103cd"
      unitRef="U001">12200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:EquityMethodInvestmentQuotedMarketValue
      contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-5"
      id="Fact_7f116bafab0e43c0844cee9ed219b2e7"
      unitRef="U001">12300000</us-gaap:EquityMethodInvestmentQuotedMarketValue>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-5"
      id="Fact_52c59c37774b44aa8400c66242872d43"
      unitRef="U001">12200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-3"
      id="Fact_83f9bbce9bd8413bbf10c4f4e1600770"
      unitRef="U001">112000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember"
      decimals="-3"
      id="Fact_1f9da528faa948ed9389cebf39919461"
      unitRef="U001">153000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="c20210101to20211231"
      id="Text_07c6c5b8db9d462395607f5df3a870a5">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;14. Equity Based Plans&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company has the following equity-based plans with outstanding equity grants:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Amended and Restated 1999 Employee Stock Option Plan (the &#x201c;Amended 1999 Plan&#x201d;) permits the Company to grant to non-employee
      directors and employees of the Company up to 600,000 non-qualified options to purchase shares of common stock and restricted stock
      (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The exercise prices of options granted under the Amended 1999 Plan are determined by the Compensation Committee. The period within
      which each option will be exercisable is determined by the Compensation Committee. The Amended 1999 Plan was approved by the shareholders of the Company at the 2008 Shareholders Meeting on May 20, 2008.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Amended and Restated 2003 Stock Option Plan (the &#x201c;Amended 2003 Plan&#x201d;) permits the Company to grant to key employees and outside
      directors of the Company incentive and non-qualified options and shares of restricted stock covering up to 2,100,000 shares of common
      stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The material terms of the Amended 2003 Plan was reapproved by the shareholders of the Company at the 2015 Shareholders Meeting
      on May 19, 2015 and an increase in the number of shares authorized for issuance from 1,750,000 to 2,100,000 was approved at the 2016 Shareholders Meeting on March 17, 2016.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;A cumulative summary of equity plans as of December 31, 2021 follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Authorized&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Restricted&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Stock Issued&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Outstanding&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Stock Options&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Stock Options&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Exercised&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Stock Options&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Exercisable&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Shares Available&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;for Grant&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Equity Plans&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amended 1999 Plan&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;600,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;416,402&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;139,791&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,775&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amended 2003 Plan&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,100,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,166,855&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;778,300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;164,882&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,700,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,583,257&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;918,091&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;172,657&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;During 2021, 2020 and 2019, the Company granted the following shares of restricted stock to directors, officers and employees
      pursuant to its equity plans as follows:&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Granted&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of Shares&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Value Per Share&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;60,317&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;131.29&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 33.07%;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 0.97%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 33.21%;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,982&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1.11%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 2.36%;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 28.07%;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;104.69&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1.21%;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;91,682&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;104.85&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;During 2021, 2020 and 2019, the following shares were cancelled due to employee terminations prior to restrictions lapsing:&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Cancelled&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of Shares&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Value Per Share&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;439&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;113.80&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 33.06%;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 33.04%;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,037&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1.32%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 2.23%;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 28.13%;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;102.52&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1.22%;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,578&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;87.88&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following &lt;span style="-sec-ix-hidden:Fact_bc274c91f2484d4a9acb65f2349c1f1a"&gt;four&lt;/span&gt; anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the
      first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years
      following the date of grant.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;There were 102,682
      and 127,562 shares outstanding as of December 31, 2021 and December 31, 2020, respectively, for which restrictions had not lapsed. The
      restrictions will lapse in 2022 through 2025.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Compensation expense for grants of restricted stock is recognized based on the fair value on the date of grant. Compensation expense
      for restricted stock grants was $7.8 million, $7.9
      million, and $7.0 million, respectively, for 2021, 2020 and 2019. As of December 31, 2021, the remaining $8.9 million of compensation expense will be recognized from 2022 through 2025.&lt;/div&gt;
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20211231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_3220e015fa234b0bb44714a24ff4e7ba"
      unitRef="U002">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_4504c6296d154e079cd650005a4b42b7"
      unitRef="U002">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20160316_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_a507335d277e495185b4f4327874c96b"
      unitRef="U002">1750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20160317_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_43cb9d8298944486beb7e0127c56e072"
      unitRef="U002">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_f5321119c5a84a36ac486d95a4b05a8c">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;A cumulative summary of equity plans as of December 31, 2021 follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Authorized&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Restricted&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Stock Issued&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Outstanding&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Stock Options&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Stock Options&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Exercised&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Stock Options&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Exercisable&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Shares Available&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;for Grant&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Equity Plans&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amended 1999 Plan&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;600,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;416,402&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;139,791&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,775&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amended 2003 Plan&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,100,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,166,855&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;778,300&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;164,882&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,700,000&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,583,257&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;918,091&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;172,657&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="0"
      id="Fact_c963404f30c6480288304ba47456aa80"
      unitRef="U002">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod
      contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="0"
      id="Fact_124b060cd3664fd28edab7d5df7f5120"
      unitRef="U002">416402</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="INF"
      id="Fact_e38ee44592f34e3f93ad65125770b6b5"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod
      contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="0"
      id="Fact_b5821ca78b9c4f11b4d589342498c4e9"
      unitRef="U002">139791</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="INF"
      id="Fact_fde7f5a226d64e5e889f87298d6aacc3"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20211231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="0"
      id="Fact_8bd38b26d5494ddb81f686645f88f175"
      unitRef="U002">7775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_050eddc590d6480882f6009cbd66ff55"
      unitRef="U002">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod
      contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_b4f5d20e9b4042fb8f6957ddb020c788"
      unitRef="U002">1166855</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="INF"
      id="Fact_5ae0a70f021f467491b21b3d734ec647"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod
      contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_07840a8d2dcd497d8c138542260dacd7"
      unitRef="U002">778300</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="INF"
      id="Fact_fc2d455ee1a44d389bc7c9900cb3a990"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20211231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_cbd731943027471e86f8d6f586192145"
      unitRef="U002">164882</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_120cc3f60e184c7c804b2ce034bd25af"
      unitRef="U002">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod
      contextRef="c20211231"
      decimals="0"
      id="Fact_79d19bcf25804a64aafdce8d2db55d93"
      unitRef="U002">1583257</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231"
      decimals="INF"
      id="Fact_51cc6e4e98be40dbbba3342415547018"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod
      contextRef="c20211231"
      decimals="0"
      id="Fact_50b44f56b9ca42a8a2956b06d30126ea"
      unitRef="U002">918091</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c20211231"
      decimals="INF"
      id="Fact_2aba047d14e940c09110ccd0a9c5b1cb"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20211231"
      decimals="0"
      id="Fact_f19d85838fc64b58a1a3019914f2ab42"
      unitRef="U002">172657</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_a8b85f73f749486d9609c98f75b0bcbf">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;During 2021, 2020 and 2019, the Company granted the following shares of restricted stock to directors, officers and employees
      pursuant to its equity plans as follows:&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Granted&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of Shares&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Value Per Share&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;60,317&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;131.29&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 33.07%;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 0.97%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 33.21%;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,982&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1.11%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 2.36%;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 28.07%;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;104.69&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1.21%;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;91,682&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;104.85&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;During 2021, 2020 and 2019, the following shares were cancelled due to employee terminations prior to restrictions lapsing:&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0); width: 100%; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Cancelled&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of Shares&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
              &lt;/span&gt;Value Per Share&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;439&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;113.80&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 33.06%;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 33.04%;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,037&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1.32%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 2.23%;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 28.13%;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;102.52&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="vertical-align: bottom; width: 1.22%;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,578&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;
            &lt;div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;87.88&lt;/div&gt;
          &lt;/td&gt;

    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_af1d2d465aff4ed8b09cb0e433b177f8"
      unitRef="U002">60317</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_98df55e3b54b461faf4f8139b3b0e91a"
      unitRef="U003">131.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_53f83548d71a4e4e9819cbceb4682407"
      unitRef="U002">86982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_accca307d58f4387b2f35ea529d2f33f"
      unitRef="U003">104.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_ee45d14a33c3475196096c431971855c"
      unitRef="U002">91682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_b170dce4303247a395a68f7f4d3f55d0"
      unitRef="U003">104.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_891fa0a315b14b80bf9362cad48aa4e3"
      unitRef="U002">439</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_d1997abdf5104e8c9922bf77f2bf255c"
      unitRef="U003">113.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_cc956308c2854f5cbf8af555c8681b60"
      unitRef="U002">10037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_9c6ec859b6104877b36d384c6c00962b"
      unitRef="U003">102.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_4cc23c8e9129405782c55ede87b1ad55"
      unitRef="U002">1578</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_482ef6de74734abbb4ce542b6f50fc24"
      unitRef="U003">87.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <usph:RestrictedPeriodToEmployeesOnTheStockGranted
      contextRef="c20210101to20211231_TitleOfIndividualAxis_ExecutiveOfficerMember"
      id="Fact_4572149d854e43fc92adac9533876684">P4Y</usph:RestrictedPeriodToEmployeesOnTheStockGranted>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
      contextRef="c20211231"
      decimals="0"
      id="Fact_c8817494c98e48c0825146a80652f58a"
      unitRef="U002">102682</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
      contextRef="c20201231"
      decimals="0"
      id="Fact_5b221a9311d44dc592bc8541093dd118"
      unitRef="U002">127562</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription
      contextRef="c20210101to20211231_RangeAxis_MinimumMember"
      id="Fact_aa58963dd6a04298a290253276476d72">2022</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription
      contextRef="c20210101to20211231_RangeAxis_MaximumMember"
      id="Fact_a779e6f309fd4b8194c5d227da1ac0b4">2025</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_9ada25ff9cf942bb85ffd0aa1ee8f836"
      unitRef="U001">7800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_10b626ab34eb404a87e865ef6f000c5e"
      unitRef="U001">7900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_43809269e58a412dbe1688431ed7bb79"
      unitRef="U001">7000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="c20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_3c4fc1918945431bbfe64757558308b2"
      unitRef="U001">8900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:PreferredStockTextBlock
      contextRef="c20210101to20211231"
      id="Text_583508f2c96e4d68a93bb1e48bae5ef5">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;15. Preferred Stock&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Board is empowered, without approval of the shareholders, to cause shares of preferred stock to be issued in one or more series
      and to establish the number of shares to be included in each such series and the rights, powers, preferences and limitations of each series. There are no provisions in the Company&#x2019;s Articles of Incorporation specifying the vote required by the
      holders of preferred stock to take action. All such provisions would be set out in the designation of any series of preferred stock established by the Board. The bylaws of the Company specify that, when a quorum is present at any meeting, the vote of
      the holders of at least a majority of the outstanding shares entitled to vote who are present, in person or by proxy, shall decide any question brought before the meeting, unless a different vote is required by law or the Company&#x2019;s Articles of
      Incorporation.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Because the Board has the power to establish the preferences and rights of each series, it may afford the holders of any series of
      preferred stock, preferences, powers, and rights, voting or otherwise, senior to the right of holders of common stock. The issuance of the preferred stock could have the effect of delaying or preventing a change in control of the Company.&lt;/div&gt;
</us-gaap:PreferredStockTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_9ce10d54805f430799ac3747b58f7c0b">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;16. Common Stock&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately
      negotiated transactions, up to 2,250,000 shares of the Company&#x2019;s common stock. In March 2009, the Board authorized the repurchase of up to
      10% or approximately 1,200,000
      shares of its common stock (&#x201c;March 2009 Authorization&#x201d;). The Amended Credit Agreement permits share repurchases of up to $15,000,000,
      subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;Under the March 2009 Authorization, the Company has purchased a total of 859,499 shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 156,986 shares (based on the closing price of $95.55 on December 31, 2021, the
      last business day in 2021) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&#x2019;s cash position. The Company did not purchase any shares of its common stock during 2021 or 2020.&lt;/div&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20081231_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_1c5a7dbc41064675a93fb56b3fc2870c"
      unitRef="U002">2250000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <usph:PercentageOfRepurchaseOfCommonStock
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_50c45510ad434de4af4e36eeb9629383"
      unitRef="U005">0.10</usph:PercentageOfRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_f0cfc560d36e4b86bdf2c7981b1d6cdd"
      unitRef="U002">1200000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_08009d570cc54eba83557727002b14bb"
      unitRef="U001">15000000</usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c20090301to20090331"
      decimals="0"
      id="Fact_98418bc5c839418db8cacdbef142b684"
      unitRef="U002">859499</us-gaap:StockRepurchasedDuringPeriodShares>
    <usph:AdditionalEstimatedRepurchaseOfCommonStock
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_8239aa6b843a45119d2dc3beb929f1fb"
      unitRef="U002">156986</usph:AdditionalEstimatedRepurchaseOfCommonStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c20211231"
      decimals="2"
      id="Fact_8e21ed249cb7480fa4970a6b331e6a8b"
      unitRef="U003">95.55</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_509a7e83d0104f87b4bd26c54c256b84"
      unitRef="U002">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_76b5c4a978464958a310dd55788d8d4e"
      unitRef="U002">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="c20210101to20211231"
      id="Text_ebb40e5913474ba7a3ba448849cc2fda">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;17. Defined Contribution Plan&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The Company has several 401(k) profit sharing plans covering all employees with three months of service. For certain plans, the Company makes matching contributions. The Company may also make discretionary contributions of up to 50% of employee contributions. The Company did not
      make any discretionary contributions for the years ended December 31, 2021, 2020 and 2019. The Company matching contributions totaled $1.9
      million, $1.9 million and $2.0
      million, respectively, for the years ended December 31, 2021, 2020 and 2019.&lt;/div&gt;
</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan
      contextRef="c20210101to20211231"
      id="Fact_13d12c8b0511407baa5e20303ea38412">P3M</usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_4e01278b0f864cb297b01cbd28692d91"
      unitRef="U005">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="c20210101to20211231"
      decimals="-6"
      id="Fact_8faafc070f9d463caf6a86305e80f2f2"
      unitRef="U001">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="c20190101to20191231"
      decimals="-6"
      id="Fact_2ea44ff5753645aaaea539f291c3aed4"
      unitRef="U001">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="c20200101to20201231"
      decimals="-6"
      id="Fact_0103112abec44aae9fa11f1539c77cd3"
      unitRef="U001">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <usph:DefinedContributionPlanEmployerMatchingContributionAmount
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_0a15245c97744903a17baf4cc7dd14fc"
      unitRef="U001">1900000</usph:DefinedContributionPlanEmployerMatchingContributionAmount>
    <usph:DefinedContributionPlanEmployerMatchingContributionAmount
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_37ae56f540964b85b5d246acf6d3f0f4"
      unitRef="U001">1900000</usph:DefinedContributionPlanEmployerMatchingContributionAmount>
    <usph:DefinedContributionPlanEmployerMatchingContributionAmount
      contextRef="c20190101to20191231"
      decimals="-5"
      id="Fact_852e23f4bda2460d8ee2cdc8df92e340"
      unitRef="U001">2000000.0</usph:DefinedContributionPlanEmployerMatchingContributionAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_ef6eb7a58e894815a7f840e9ce3563e2">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;18. Commitments and Contingencies&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-variant: normal; text-transform: none;"&gt;Employment Agreements&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 20pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;At December 31, 2021, the
        Company had outstanding employment agreements with four of its executive officers. The agreements have terms that expire November 8, 2022, July 1, 2023, December 31, 2023, and February 28, 2024;
        however, each of these agreements provide for an automatic two-year renewal at the conclusion of the expiring term or renewal term.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;In addition, the Company
        has outstanding employment agreements with most of the managing physical therapist partners of the Company&#x2019;s physical therapy clinics and with certain other clinic employees which obligate subsidiaries of the Company to pay compensation of $52.8 million in 2022 and $8.4 million in
        the aggregate from 2023 through 2024. In addition, many of the employment agreements with the managing physical therapists provide for monthly bonus payments calculated as a percentage of each clinic&#x2019;s net revenues (not in excess of operating
        profits) or operating profits.&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-variant: normal; text-transform: none;"&gt;Litigation&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Settlement of&#160; a Legal Matter&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;On August 19, 2019, we
        received notice of a qui tam lawsuit (&#x201c;the Complaint&#x201d;) filed by a relator on behalf of the United States, titled U.S. ex rel. Bonnie Elsdon, v. U.S. Physical Therapy, Inc., U.S. Physical Therapy, Ltd., Rehab Partners #2, Inc., The Hale Hand Center,
        Limited Partnership (the &#x201c;Hale Partnership&#x201d;), and Suzanne Hale.&#160;&#160; This whistleblower lawsuit was filed in the U.S. District Court for the Southern District of Texas, seeking damages and civil penalties under the federal False Claim Act.&#160; This
        lawsuit was originally filed under seal by a former employee of The Hale Hand Center, Limited Partnership (&#x201c;Hale Partnership&#x201d;), a majority-owned subsidiary of the Company, on May 25, 2018.&#160; The U.S Government declined to intervene in the case and
        unsealed the Complaint on July 17, 2019.&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;The Complaint alleged that
        the Hale Partnership engaged in conduct to purposely &#x201c;upcode&#x201d; its billings for services provided to Medicare patients. The plaintiff - relator also claimed that similar false claims occurred on other days and at other Company-owned partnerships.&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none; text-indent: 18pt;"&gt;On October 3, 2019, we
        filed Motions to Dismiss based on numerous grounds on behalf of each of the named defendants. On October 29, 2019, the plaintiff-relator dismissed three
        of the named defendants, Rehab Partners #2, Inc., U.S. Physical Therapy, Ltd., and Suzanne Hale. The Motions to Dismiss were denied on November 30, 2020.&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: #FFFFFF; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; text-indent: 18pt; text-transform: none;"&gt;&lt;span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In January 2022,&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;to avoid the legal fees and discovery costs in defending this matter and the uncertainty of protracted litigation, &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);"&gt;the Company entered into a settlement agreement with the plaintiff-relator. In the settlement agreement, the plaintiff-relator released all defendants from liability
          for all conduct alleged in the Complaint, and the Company admitted no liability or wrongdoing.&#160; In connection with the settlement, the Office of the United States Attorney for the Southern District of Texas agreed to a dismissal of the claims
          against the Hale Partnership and the Company. Under the terms of the settlement, the Company agreed to make payments to the government, the plaintiff-relator and her counsel. Such payments, in the aggregate, amounted to&lt;/span&gt; $2.75 million&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; of which $2.6 million was recorded as an expense in 2021&lt;/span&gt;.&#160;  &lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <usph:NumberOfEmployeesCoveredUnderEmployeeAgreement
      contextRef="c20210101to20211231_TitleOfIndividualAxis_ExecutiveOfficerMember"
      decimals="INF"
      id="Fact_4ff576c5ffb34c968f777f52b7f67094"
      unitRef="U014">4</usph:NumberOfEmployeesCoveredUnderEmployeeAgreement>
    <usph:EmploymentAgreementsExpirationDate
      contextRef="c20210101to20211231"
      id="Fact_f0b9f09d480e4693b40863e9e8c59d24">2022-11-08</usph:EmploymentAgreementsExpirationDate>
    <usph:EmploymentAgreementsExpirationDateTwo
      contextRef="c20210101to20211231"
      id="Fact_527a10dc7cfc42dbbf6249b71d169b62">2023-07-01</usph:EmploymentAgreementsExpirationDateTwo>
    <usph:EmploymentAgreementsExpirationDateThree
      contextRef="c20210101to20211231"
      id="Fact_041cd29574b444f0aa5dd41122014bd0">2023-12-31</usph:EmploymentAgreementsExpirationDateThree>
    <usph:EmploymentAgreementsExpirationDateFour
      contextRef="c20210101to20211231"
      id="Fact_9607d9b9c5e64f448525c30422e7fe4a">2024-02-28</usph:EmploymentAgreementsExpirationDateFour>
    <usph:RenewalPeriodForEmploymentAgreement
      contextRef="c20210101to20211231"
      id="Fact_edb1999e81e94293a07d5d35297cdcb3">P2Y</usph:RenewalPeriodForEmploymentAgreement>
    <usph:EmployeeCompensationFuturePaymentDueNextFiscalYear
      contextRef="c20211231"
      decimals="-5"
      id="Fact_7ea88b22d0604f66a75ba0134390c424"
      unitRef="U001">52800000</usph:EmployeeCompensationFuturePaymentDueNextFiscalYear>
    <usph:EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter
      contextRef="c20211231"
      decimals="-5"
      id="Fact_8b9fe3dcb4374b7f8fd8b4b2ca76dc34"
      unitRef="U001">8400000</usph:EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter>
    <us-gaap:LossContingencyNumberOfDefendants
      contextRef="c20191029to20191029"
      decimals="INF"
      id="Fact_a156b14aab0d4dafb95ea9436a38bd3c"
      unitRef="U015">3</us-gaap:LossContingencyNumberOfDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="c20220101to20220131_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-4"
      id="Fact_b5dda6daf3714487be1dda1ac4d11b54"
      unitRef="U001">2750000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_2c1088f3a8824a3e8b83de551fb32f10"
      unitRef="U001">2600000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20210101to20211231"
      id="Text_fc8200a4203f4fd2bdc1f600f1982114">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;19. Earnings Per Share&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The computations of basic and diluted earnings per share for the years ended December 31, 2021, 2020 and 2019 are as follows (in
      thousands, except per share data):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Computation of earnings per share - USPH shareholders:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net income attributable to USPH shareholders&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;40,831&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,194&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;40,039&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(Charges) credit to retained earnings:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revaluation of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(13,011&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,632&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,893&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax effect at statutory rate (federal and state) of &lt;span style="text-indent: 0pt;"&gt;25.55&lt;/span&gt;% and &lt;span style="text-indent: 0pt;"&gt;26.25&lt;/span&gt;%, respectively&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,324&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,216&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,121&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,144&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,778&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,267&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Earnings per share (basic and diluted)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.41&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.48&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.45&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Shares used in computation:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basic and diluted earnings per share - weighted-average shares&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,898&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,835&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,756&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_67d65149f3da4caca8b810d743d38904">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;The computations of basic and diluted earnings per share for the years ended December 31, 2021, 2020 and 2019 are as follows (in
      thousands, except per share data):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"/&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Computation of earnings per share - USPH shareholders:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net income attributable to USPH shareholders&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;40,831&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,194&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;40,039&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(Charges) credit to retained earnings:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revaluation of redeemable non-controlling interest&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(13,011&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,632&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,893&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax effect at statutory rate (federal and state) of &lt;span style="text-indent: 0pt;"&gt;25.55&lt;/span&gt;% and &lt;span style="text-indent: 0pt;"&gt;26.25&lt;/span&gt;%, respectively&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,324&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,216&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,121&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,144&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,778&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,267&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Earnings per share (basic and diluted)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.41&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.48&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.45&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Shares used in computation:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basic and diluted earnings per share - weighted-average shares&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,898&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,835&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,756&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9fd1cb79184349b0bc6d05da3dbaa7a9"
      unitRef="U001">40831000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b4a5685075864607a3a0c243a1d77ba1"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_fcd1740cfd3f45dfb4a64786ec9781bb"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_b8243cdefeea4903bbc4750ce7f648ff"
      unitRef="U001">-13011000</usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests>
    <usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_898ef67026e8488eb6309b159c458f29"
      unitRef="U001">-4632000</usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests>
    <usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_f62a843ce710444eaff31352c79fbf1c"
      unitRef="U001">-11893000</usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests>
    <usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20210101to20211231"
      decimals="4"
      id="Fact_5008bcbab612438b9efb1e24d394f57f"
      unitRef="U005">0.2555</usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="4"
      id="Fact_ce16f12188d74c24adf50f9afcc0c095"
      unitRef="U005">0.2625</usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a4e9dcdff2404af6b243256ee56d5826"
      unitRef="U001">-3324000</usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0ab858a0266c4cc1976836aed6310326"
      unitRef="U001">-1216000</usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_abc83c2c53dd43009247d0ec7c0526da"
      unitRef="U001">-3121000</usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ab507a1588eb48fe9f7ceb1f48f35d23"
      unitRef="U001">31144000</usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests>
    <usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_034ba7dcd58348e7aaf2caa2da68fa08"
      unitRef="U001">31778000</usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests>
    <usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_83b649350a314014ac19d196d96f3ab3"
      unitRef="U001">31267000</usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_bab9e6cb1592469d89d2a442dc93f40e"
      unitRef="U003">2.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_0a44547067ad40a4b7f98ec7b4a809d0"
      unitRef="U003">2.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_febfcb465b91466aba62462d09d4b478"
      unitRef="U003">2.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_f63fd6cb88414576928f74d9382699fb"
      unitRef="U003">2.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_9162db6486144061bb7df1092d2600e4"
      unitRef="U003">2.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_05650d94eeb4458f82abb296f1e415bf"
      unitRef="U003">2.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_fb73c7ea3c21491785e4d3c4b95bb5ef"
      unitRef="U002">12898000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_24f90dc0d5a845099e8bb0234c219038"
      unitRef="U002">12898000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_666636c9fbba4022bb0684094ae1af06"
      unitRef="U002">12835000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2af4961613544ce0acf6d884d1d3fe99"
      unitRef="U002">12835000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d1e38dd1e68041e39f9533121f594d28"
      unitRef="U002">12756000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_73328d6e5f40472181dbfcb00680c73f"
      unitRef="U002">12756000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_8999209758944c7d89b7d4b67ff0f159">
&lt;div style="font-weight: bold;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;20. Related
        Party Transactions&lt;/span&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="font-weight: bold;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: left; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;Settlement of Short Swing
        Profit Claim&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; text-align: left; text-indent: 18pt;"&gt;For the year ended December 31, 2021, the Company recorded approximately $20,000 related to the short swing profit settlement remitted by a shareholder of our company under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Company
        recognized the proceeds as an increase to additional paid-in capital in the consolidated balance sheets as of December 31, 2021 and consolidated statements of stockholders&#x2019; equity, as well as in cash provided by financing activities included in
        Other, in the consolidated statements of cash flows, for the year ended December 31, 2021.&lt;/div&gt;
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <usph:ShortSwingProfitSettlement
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_119cdcafd48d421893cff5e9f8f07f7e"
      unitRef="U001">20000</usph:ShortSwingProfitSettlement>
    <us-gaap:ErrorCorrectionTextBlock
      contextRef="c20210101to20211231"
      id="Text_288d80cc8045454c9d93cdc8354fdcb5">
&lt;div style="font-weight: bold;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;21.
        Reclassification of Prior Period Presentation&lt;/span&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="font-weight: bold;"&gt; &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; text-align: left; text-indent: 18pt;"&gt;Certain prior year amounts have been reclassified for consistency with the current year
        presentation. These reclassifications had no effect on the reported results of operations.&lt;/div&gt;
</us-gaap:ErrorCorrectionTextBlock>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_ed4d2d6d59cb44fd8590582c0bbac61c">
&lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;FINANCIAL STATEMENT SCHEDULE*&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/span&gt;SCHEDULE II &#x2014; VALUATION AND QUALIFYING ACCOUNTS&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/span&gt;U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES&lt;/div&gt;

&lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(In Thousands)&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt; &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Balance at&lt;/div&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Beginning of Period&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Additions Charged&lt;/div&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;to Costs and Expenses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Additions Charged&lt;/div&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;to Other Accounts&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Deductions&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Balance at&lt;/div&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;End of Period&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;YEAR ENDED DECEMBER 31, &lt;span style="text-indent: 0pt;"&gt;2021&lt;/span&gt;:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reserves and allowances deducted from asset accounts:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;sup&gt;(1)&lt;/sup&gt;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,008&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,305&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,545&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,768&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;YEAR ENDED DECEMBER 31, &lt;span style="text-indent: 0pt;"&gt;2020&lt;/span&gt;:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reserves and allowances deducted from asset accounts:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,698&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,623&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,313&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,008&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;YEAR ENDED DECEMBER 31, &lt;span style="text-indent: 0pt;"&gt;2019&lt;/span&gt;:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reserves and allowances deducted from asset accounts:&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,672&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,858&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,832&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,698&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;
&lt;hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: left; border: none; margin-left: 0px; margin-right: auto;"/&gt;
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Related to patient accounts receivable and accounts
              receivable-other.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Uncollectible accounts written off, net of
              recoveries.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;All other schedules are omitted because of the absence of conditions under which they are required or because the required information is shown in the financial
              statements or notes thereto.&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_c01876b255b44fc4addc1ae57a419973"
      unitRef="U001">2008000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="c20210101to20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_8de08e8ccc1c42ecaf1889065dc51e35"
      unitRef="U001">5305000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="c20210101to20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_e8f8cd6e34b64aacafe0bf288bec27e7"
      unitRef="U001">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="c20210101to20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_bc6028d882ea464b935160a3eb31031e"
      unitRef="U001">4545000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20211231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_f380bf553cd346c2a31ac62f1d843646"
      unitRef="U001">2768000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_e313c40db53241b49b00979ec95e5131"
      unitRef="U001">2698000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_4bb44463732242d7819623b6d011af8b"
      unitRef="U001">4623000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_dfa002bdb3ce4d798b1df8c05aff1aaf"
      unitRef="U001">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_dc991caa78a94c51a59fc0fa43e35e3d"
      unitRef="U001">5313000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_aefbb5579ec74ddd88e80782a748d3fa"
      unitRef="U001">2008000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_4dcaca7942714fe2b80416f647772054"
      unitRef="U001">2672000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_7907a7e78c0b4602816a43afc63edd09"
      unitRef="U001">4858000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_9b1d4af990444450b191c74057568949"
      unitRef="U001">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_0ce3ac6e75f540dab212aacd9f1cb8fb"
      unitRef="U001">4832000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_803154198e1f41399684f978343a471a"
      unitRef="U001">2698000</us-gaap:ValuationAllowancesAndReservesBalance>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_27a094a9eace4a64be08154bf989f82e"
          xlink:label="Fact_27a094a9eace4a64be08154bf989f82e"
          xlink:type="locator"/>
        <link:footnote id="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" xlink:label="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Industrial




























              injury prevention services &#160;&#160;&#160;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_27a094a9eace4a64be08154bf989f82e"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_f80eff9fe13e4df08a15f7acb274fc5e"
          xlink:label="Fact_f80eff9fe13e4df08a15f7acb274fc5e"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_f80eff9fe13e4df08a15f7acb274fc5e"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_bfb19040c12b4373b120a149674ff028"
          xlink:label="Fact_bfb19040c12b4373b120a149674ff028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_bfb19040c12b4373b120a149674ff028"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_f75bbdaed45746e78fee56e41cedb979"
          xlink:label="Fact_f75bbdaed45746e78fee56e41cedb979"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_f75bbdaed45746e78fee56e41cedb979"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_f1dfaea40e90417ab9618457098915f7"
          xlink:label="Fact_f1dfaea40e90417ab9618457098915f7"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_f1dfaea40e90417ab9618457098915f7"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_76c42aa88a124b4db6f0502587ec6f42"
          xlink:label="Fact_76c42aa88a124b4db6f0502587ec6f42"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_76c42aa88a124b4db6f0502587ec6f42"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_9d4aac14de6549938264f58e705c3aa7"
          xlink:label="Fact_9d4aac14de6549938264f58e705c3aa7"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_9d4aac14de6549938264f58e705c3aa7"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_d9d8787977f14988ac98b2fccb95a943"
          xlink:label="Fact_d9d8787977f14988ac98b2fccb95a943"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_d9d8787977f14988ac98b2fccb95a943"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_2c2db17745e24c4eb66135c92aad7b8a"
          xlink:label="Fact_2c2db17745e24c4eb66135c92aad7b8a"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_2c2db17745e24c4eb66135c92aad7b8a"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_24336172ac1f4c7b87d22bacbbbd45fc"
          xlink:label="Fact_24336172ac1f4c7b87d22bacbbbd45fc"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_24336172ac1f4c7b87d22bacbbbd45fc"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_11d862d2defd4dca8c3f3c891cae62ca"
          xlink:label="Fact_11d862d2defd4dca8c3f3c891cae62ca"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_11d862d2defd4dca8c3f3c891cae62ca"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_63bd36af48894270815cc46c963ba2db"
          xlink:label="Fact_63bd36af48894270815cc46c963ba2db"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_63bd36af48894270815cc46c963ba2db"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_09256687656b4cb0829a3bba208bbd0b"
          xlink:label="Fact_09256687656b4cb0829a3bba208bbd0b"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_09256687656b4cb0829a3bba208bbd0b"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_9d349ef66f714b458c14a80861d985df"
          xlink:label="Fact_9d349ef66f714b458c14a80861d985df"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_9d349ef66f714b458c14a80861d985df"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_e730f71471494b67be39a111ddb754e1"
          xlink:label="Fact_e730f71471494b67be39a111ddb754e1"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_e730f71471494b67be39a111ddb754e1"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_aaf9411d8f9e4e009c9335f0ff382bdf"
          xlink:label="Fact_aaf9411d8f9e4e009c9335f0ff382bdf"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_aaf9411d8f9e4e009c9335f0ff382bdf"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_d5231447dfa54dcf8bc822f06da3d57d"
          xlink:label="Fact_d5231447dfa54dcf8bc822f06da3d57d"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_d5231447dfa54dcf8bc822f06da3d57d"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_6ccec2bf85c84363a31b411049754947"
          xlink:label="Fact_6ccec2bf85c84363a31b411049754947"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_6ccec2bf85c84363a31b411049754947"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_46c4521940754dddb49b9e190cced525"
          xlink:label="Fact_46c4521940754dddb49b9e190cced525"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_46c4521940754dddb49b9e190cced525"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_5537f26b563e45e3ba14cc86cb093d9e"
          xlink:label="Fact_5537f26b563e45e3ba14cc86cb093d9e"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_5537f26b563e45e3ba14cc86cb093d9e"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_c24ffdcebb2d493696e3a422d9966828"
          xlink:label="Fact_c24ffdcebb2d493696e3a422d9966828"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_c24ffdcebb2d493696e3a422d9966828"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_55629db4c4fb4f3d94188cadc2e92208"
          xlink:label="Fact_55629db4c4fb4f3d94188cadc2e92208"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_55629db4c4fb4f3d94188cadc2e92208"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_1cdd8b720f4a44a082c6939bf4b22496"
          xlink:label="Fact_1cdd8b720f4a44a082c6939bf4b22496"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_1cdd8b720f4a44a082c6939bf4b22496"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_e49d6261833247f2947adece9f7d5a9f"
          xlink:label="Fact_e49d6261833247f2947adece9f7d5a9f"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_e49d6261833247f2947adece9f7d5a9f"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_01ef1578c3654cdb9d9b1052ecedc226"
          xlink:label="Fact_01ef1578c3654cdb9d9b1052ecedc226"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_01ef1578c3654cdb9d9b1052ecedc226"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_71308383dd34492c907897ee2a3d7c84"
          xlink:label="Fact_71308383dd34492c907897ee2a3d7c84"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_71308383dd34492c907897ee2a3d7c84"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_2e55eaf9bd1a44fba6fdc7aa37f488f4"
          xlink:label="Fact_2e55eaf9bd1a44fba6fdc7aa37f488f4"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_2e55eaf9bd1a44fba6fdc7aa37f488f4"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_1dfbb6b5fc4b48afade4b5fb290ba8f7"
          xlink:label="Fact_1dfbb6b5fc4b48afade4b5fb290ba8f7"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_1dfbb6b5fc4b48afade4b5fb290ba8f7"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_494bf47a05ff4579a733449bea643c70"
          xlink:label="Fact_494bf47a05ff4579a733449bea643c70"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_494bf47a05ff4579a733449bea643c70"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_bd807fe1634b42079b82b93a313c6f0c"
          xlink:label="Fact_bd807fe1634b42079b82b93a313c6f0c"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_bd807fe1634b42079b82b93a313c6f0c"
          xlink:to="Foot_0e34bd607cfc465daed9bfbfdc3b2e3a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_cccd0aebc3cd4a079b94f19491d12216"
          xlink:label="Fact_cccd0aebc3cd4a079b94f19491d12216"
          xlink:type="locator"/>
        <link:footnote id="Foot_8632189867454c27a153d70883a46e78" xlink:label="Foot_8632189867454c27a153d70883a46e78" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The four clinics are in four separate partnerships. The Company's interest in the four
                partnerships range from 10.0% to 83.8%,
                with an overall 65.0% based on the initial purchase transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_cccd0aebc3cd4a079b94f19491d12216"
          xlink:to="Foot_8632189867454c27a153d70883a46e78"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_8ebe68ea117342b08f53feddf56f59df"
          xlink:label="Fact_8ebe68ea117342b08f53feddf56f59df"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_8ebe68ea117342b08f53feddf56f59df"
          xlink:to="Foot_8632189867454c27a153d70883a46e78"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_2d8530006ec74a9781d163ce2d72292d"
          xlink:label="Fact_2d8530006ec74a9781d163ce2d72292d"
          xlink:type="locator"/>
        <link:footnote id="Foot_aeaed244265844d580a05be145ffd595" xlink:label="Foot_aeaed244265844d580a05be145ffd595" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Sublease income was immaterial</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_2d8530006ec74a9781d163ce2d72292d"
          xlink:to="Foot_aeaed244265844d580a05be145ffd595"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_37c9d93f7a2345308c093a2c7e4106c9"
          xlink:label="Fact_37c9d93f7a2345308c093a2c7e4106c9"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_37c9d93f7a2345308c093a2c7e4106c9"
          xlink:to="Foot_aeaed244265844d580a05be145ffd595"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_9e406021f6644e219c3b143ef1491cbb"
          xlink:label="Fact_9e406021f6644e219c3b143ef1491cbb"
          xlink:type="locator"/>
        <link:footnote id="Foot_b182115cb6ef4d009deff873b8909b51" xlink:label="Foot_b182115cb6ef4d009deff873b8909b51" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Industrial injury prevention
                  business</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_9e406021f6644e219c3b143ef1491cbb"
          xlink:to="Foot_b182115cb6ef4d009deff873b8909b51"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_fcd7d7afc36c4146ae8996c5533e716f"
          xlink:label="Fact_fcd7d7afc36c4146ae8996c5533e716f"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_fcd7d7afc36c4146ae8996c5533e716f"
          xlink:to="Foot_b182115cb6ef4d009deff873b8909b51"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_f2ab670c292849e0a6da2f6f425f8ab8"
          xlink:label="Fact_f2ab670c292849e0a6da2f6f425f8ab8"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_f2ab670c292849e0a6da2f6f425f8ab8"
          xlink:to="Foot_b182115cb6ef4d009deff873b8909b51"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_8fc8c722672b4497be0c04af98353c23"
          xlink:label="Fact_8fc8c722672b4497be0c04af98353c23"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_8fc8c722672b4497be0c04af98353c23"
          xlink:to="Foot_b182115cb6ef4d009deff873b8909b51"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_b50371aded1746619d40d044e9a29674"
          xlink:label="Fact_b50371aded1746619d40d044e9a29674"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_b50371aded1746619d40d044e9a29674"
          xlink:to="Foot_b182115cb6ef4d009deff873b8909b51"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_9ccb1564cfba40339b352148e6a9107a"
          xlink:label="Fact_9ccb1564cfba40339b352148e6a9107a"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_9ccb1564cfba40339b352148e6a9107a"
          xlink:to="Foot_b182115cb6ef4d009deff873b8909b51"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f"
          xlink:label="Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f"
          xlink:type="locator"/>
        <link:footnote id="Foot_089e16638e954876a030f33789a71503" xlink:label="Foot_089e16638e954876a030f33789a71503" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The business includes six management and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f"
          xlink:to="Foot_089e16638e954876a030f33789a71503"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_d7b298373dc646968960932c7a99c477"
          xlink:label="Fact_d7b298373dc646968960932c7a99c477"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_d7b298373dc646968960932c7a99c477"
          xlink:to="Foot_089e16638e954876a030f33789a71503"
          xlink:type="arc"/>
        <link:footnote id="Foot_daa3f0e35dde4f99997e6a382a591d10" xlink:label="Foot_daa3f0e35dde4f99997e6a382a591d10" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The business includes six management
              and services contracts which have been in place for a number of years. As of the date acquired, the contracts had a remaining term of five years.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_266bbf2088dd4f17ac8e5dc1a8aebe4f"
          xlink:to="Foot_daa3f0e35dde4f99997e6a382a591d10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_d7b298373dc646968960932c7a99c477"
          xlink:to="Foot_daa3f0e35dde4f99997e6a382a591d10"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0ce3ac6e75f540dab212aacd9f1cb8fb"
          xlink:label="Fact_0ce3ac6e75f540dab212aacd9f1cb8fb"
          xlink:type="locator"/>
        <link:footnote id="Foot_48f584180c61464eac6330240454329a" xlink:label="Foot_48f584180c61464eac6330240454329a" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Uncollectible accounts written off, net of
              recoveries.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0ce3ac6e75f540dab212aacd9f1cb8fb"
          xlink:to="Foot_48f584180c61464eac6330240454329a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_bc6028d882ea464b935160a3eb31031e"
          xlink:label="Fact_bc6028d882ea464b935160a3eb31031e"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_bc6028d882ea464b935160a3eb31031e"
          xlink:to="Foot_48f584180c61464eac6330240454329a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_dc991caa78a94c51a59fc0fa43e35e3d"
          xlink:label="Fact_dc991caa78a94c51a59fc0fa43e35e3d"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_dc991caa78a94c51a59fc0fa43e35e3d"
          xlink:to="Foot_48f584180c61464eac6330240454329a"
          xlink:type="arc"/>
        <link:footnote id="Foot_c1daa8198f5247f8b265a5b321d9c423" xlink:label="Foot_c1daa8198f5247f8b265a5b321d9c423" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Related to patient accounts receivable and accounts
              receivable-other.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_bc6028d882ea464b935160a3eb31031e"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_c01876b255b44fc4addc1ae57a419973"
          xlink:label="Fact_c01876b255b44fc4addc1ae57a419973"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_c01876b255b44fc4addc1ae57a419973"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_f380bf553cd346c2a31ac62f1d843646"
          xlink:label="Fact_f380bf553cd346c2a31ac62f1d843646"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_f380bf553cd346c2a31ac62f1d843646"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_8de08e8ccc1c42ecaf1889065dc51e35"
          xlink:label="Fact_8de08e8ccc1c42ecaf1889065dc51e35"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_8de08e8ccc1c42ecaf1889065dc51e35"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_e8f8cd6e34b64aacafe0bf288bec27e7"
          xlink:label="Fact_e8f8cd6e34b64aacafe0bf288bec27e7"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_e8f8cd6e34b64aacafe0bf288bec27e7"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>105
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M]8/B@O^16C%O9E*\^I%;&?<:S,4?&+6RB%!<]S]2FXE8@?3\Z6^/3N8:Q,'
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M1)@>;CCSN-0/P/V5$&I_H@<H/D5=_@M02P,$%     @ 4EMA5("T$(D&"
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MT6+T 5O_]<#_F7PLFQ::\B4,#$X3F$%N/\AO3Y18]]^T'X12HNX/5YR!F]H
M?E\*V-GM3O1G\OV?15S\#5!+ P04    " !26V%4?G)DJ4P#  #:"@  &
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M7'YG.2R77ZL"M3<6OJ_-&EL7\V=/CI277X#*A\ZU_*O+E>LZM^,_ 06(:%J
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MCI^WNH MV])\A>]7JN/CJ@V>!1!2@\1AJ,J:X 7LP&,(Q,CFD_23JN'_B&U
M657"^>' :T!%MP8 :!OX?]T ;CS]3-*?FWIU]#.(RR*]-$;#SA_+1T0J_Z(
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M(%GW-<H/D%L%0[A<EE6)</NOF9'O_=H /E-$ -P^?>%A7>9K LE>"L@/EBB
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M8SNF?"/YV6&0>I_+1WDHD<R0@]_"+E:J/[J] !%M^', HW@8KCHGC)TT@6U
M] \W@8ZA^W*KR\VB!X4H14Z=E PYH![6C>2[ N!0W M-N*BX.U\@.3$2;".Q
M8$T3\I(@)R/@L5TKS_B%K&DZ!B,P];;G"B21K0.T2-S[4>=]&'IQG*0J3*H6
MC38Q]M0!_#&7&ETM@2?(!LN]S43[CS[&O&420M.#0\P 8UWJ.  .1"=D^$'E
M@<Y'H9Q8]CP@XZ*GG7# S >J0<33/AI)RD1U2NR[-,NET5T@Z5*)9L0B!$-?
M>-Q)\B4*A;'37J!_6AFY06M6N8I$_-@E;>'#%8A,0,7W90T2$#Z$$YB7D^0_
MM6JY$#C9BV#O?3(=?C*[2/ZF.R<0!8SD3\GIR7EV<C*%GTY>GV0GIU/Z#'\Z
M2SZ3!AH^,\\N3B[@7]QEGIV>OTINUCM#)BY^7VUMSIIX#58[G67S5Q<I[G"6
MG;R:XF<G9]GYR6S_25_^XPDXN<C.STZ2\^QT-H5_7[U^E5P_)W$-NV07TVER
M<I'-+BY@]^STU1R/=W$&P--/<SC,JPO\Z7R&/Z4W\6&M)6ZD5L^I0LMJ7%<!
M5R4V=<CZ7N".H#X*MSNU3P)GB!-*C(%9LU7B.-L_V!0_B17+3X"((WQB"];/
MD5S$O6;-Q$D3<(!==!%4\KI!]R5W)%F4!H-]R,T&5;8YLG\A5 -M9HE@VR^-
M+L9:+4K.=+.4H:^CPF>%1[O7N@>_NEGA ??6'444<,+>)Q06]IF_B!==M,&\
M'%Z:A#/\@QCD&3&#)&0WU/IP;*L+7*[2[+D >_J6%4.H?WR,%-6EV9?(6!0,
MWS5HY5MK\0^T@_YLL[LHKU'YH,V,Q8-Q3H4)RB2.( \2HCTSQ4QI1_G$F\D8
M,J."/:K# 1E+*9T1;%DK!#P^_(C#7TAO*"#)CI0OCCM7&/X-;!HQ6_8,N(AE
M6,WOG"<>ZF;5.;*P*JAC L%PXXBR^H3,A(>XC;0,PNC^),:@5T1P!WWGR3SD
MI,3[7BZ%U(6+L0PM@3@^:IW>Y0!+7_FXSZ>;CW?>.?\XZL-0]GOV&K,<3;^B
MR-4%W&4ZG9Q]AZX;IEXT96?5ENC/6FQ+V-'8'06%8I<L]!*# /C SMJ#&_1/
MJ*ILT1<K8#X0!T#&%7K8GG&?A'(^#:"<GP&I)$& L33BJ;O>!@&8J1)S/^DW
M0<_^5[!?\_40I(A[BNY5Z2ULDZ57G^ZHG-T0"Q<4FBJ:O'<N'<5'-!;V<S I
ML=@O1$04FF.SK"O /@$<'0?$$]0W<"6)TZ???SC^]))68%$!YB!1._N9_#FF
MNZ6!9>28(J?H5#Y,(:43H3.*OX\?/CY.<!+\%0"4$R4DJ0X"2WD]576[YX =
M%24P%%*_B-(FO?@. ^M,X?!X2!9)3-$"9B3Q4C$/._45% N7!SF$_*5YP/A$
MAC%&$$F46.BPS<B560:Y2A:]0<KF$JM_P&L2I7&9=VSL$3YB$]8B4/"%))_;
M?)&5WL=/2F[/98M=TO2MLRU ?6I.;=>!XCQ!P1"BC4QL6^J74KTAHXY$I9-5
M%.VO-$8IF!GY0-SCHJ0<#5DGY*/YD)32;6^%+I#YWS"(2@'U3&IX.'" XDID
M0)U0*=6CC<^<3%X#_%$DP\MFJPA"6^QIY*$& LF#&Q8<-R$SXW%;^G8DU"E!
M[F,)-@!)EL:J?@QDX7>Y>C>\CY!\&&'>@'@6Q024R,U*[N DTHL"%_=&[4W;
M=!A3!/ <5BBN#2X>AMW2CZJEJ"K=[9W^#7@8L^E7R*.PJ5,]!"M\8-4/A>ZX
M)+U)*_6 M^?\%(S_,[#OK)JS7A'APDA9M1<P=+[08JF;!T>CKCDKT)0M^_GV
M\)9KEGU5,37"/1&]48B*E4= -5.D&K8V[/ZN0$R02.O-(MH"WV"<MCSKL;_,
M=ZV\_8_R?9_L,$ %4J/$8%]G8_D@C=%;K>.8\7Q.;&3)+OLG9(S$:P-:,6,G
M$<F(N<:8P;XCNQAU+I;?ARQO<(,3*;&;GV9 S&3.!V7M<'!+\GQR#B$E+,*)
M"#@&G@O<V/Z$>3XIE#9D!=K:$\<ULN6<K_ =ZPFI1*#+I.N?S09*:BE-C!3:
M!&$H24'DV5K[RN[$YA,#C+G>G5H_8KEQ;:M/ZB#,KOJN ;21!Q;@VNUKT [&
M/9$Z(BS_:3:98^E.55%8YB8P84-34ZQ'\BI\8X>$_]SF;AL/119^7Z7S[S!5
M.\$J&$YJ<F3A)*._)=\0IRAJ@LR'7$)) 4T#Q"OWX>_A+$MUK?)N3,K3'Q\[
M= 7XDL+]S3@ UFQ<E@:YRZJ?LV]#<AY!\E$O6N*QB\S^D2 Q_TM 7HLC<WG[
MX8XV-SW=B3NA9[IO*JZDL'QI'3'6P\I*AFGFP-B+'5F'ZCER8MFW;)$-8$WV
M8<4$=26I<5]ZZ8GIU*KO0$U68&6:2CE=9:^!"VX5-UP<0@[B@6-N:!P6G#%T
MLLA7?GIEPL(4-WJ.ILI\5DNE5"!V1-5[3 \F4/P GG%JLL7NX:5S3)"U0-L<
M)I,(8T#]'%ZT >BPQWN9SD8VLNO\M:]U>C*UBN%N^#TP#*SA:^.2F)HEFA\\
M^VYH_&>1_XPA9! Z?:BS3/J]#?8=?PZT&D9,1:O!6C=M>8]*6I+K^B7W3'I[
M)_+:I-,V%%+>%73.<AB.+JWOW(*@9COCFOK&,8XE\C.]VP%:-MZ!OKZY\YET
M)A$I[(G+,]V.MGZ4.S^HQ14,)T-I>+"M<\J8L'L'"R$>L?.ZYYX7FK+1-F!\
M2P)6JN\XSF&1"5?&-?%HX5,/)<6V\8 (KVL_:^K*IBF"J["I#%UCD8MU1KRQ
MAR877\16+L+K$:YQ"-(%O%&P>DE&+ 8P=D>,D^!AU-,):N? QW!@H", N..2
MS4% $=RD.J<@X<^NP0/,C+BXT>4!O*WD%: O00XPE@C&0O>5,!@6.V3<\T;K
MN"TBNC)2YJX+W[8LN7(7( H?\/E^'YB0^!WU_/<RG<$5$@\JJ<1+D*KP4)A0
M!+!MEM9X\O!:CXS-WB3'>A2S;5CKV[\B)+9P8'!@0LN FZA+@LQE#ZGDH+A=
M*HC-6+?XHRN4&+LEHDV*Y<8753C:+GHJON<@%0MXM NI.$)&18QL3ZY.[>(I
M+"VC6R^+HM)'5Q7<9/I%/::W(JCA6O[:+-(K#)PC)7K#8.Z%Q-67VTLO)4R)
MB:K/<$>D,,A0F&=Q+A&D EJZ7'H'Q_O32?9Z.A411?XEY=&+DKOPY=1JX$!3
MF35U9T>VVD91G\F&6+I*>(1"3%"NH\N'"RS:<A"/F)H?B41;,%'SF'53%0/R
M<QF=+T'VXFZK-;#]SZI>]7@]-PKNOVI6.]!"[ 3]2.V-DI[_QA9X6:$*L5LQ
M?)\NKVXOP2]K.<"#X1YJX@!_@;+)28P:F2Z!!$CEC%Q:SJXCDJ@=/B%5"VD%
MCHD@;6=U=UZI<F/D)FV\<.\0/*>"&ZQQM62APQX8Z@SHL-44P0:Y69JP9P!]
M8<TQ..GO92CQ?,&0&&>GZ6>8M9'AZK8>(,8WN%8[RIAS>Y M2K"G U3 B:=3
M'YX=VI6OF?/AI_-L\+ M^1&WV_M?4@  0@>5M%KYOWE5+DKK V"AV8#6O :
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M\?FAIE>\P\7YI<]G9T= \S\,R9LAHXQ9I*%PRV@3]<0^&0\1VH9:DF<>'"0
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MR)C9T,4VS_(]@KIU!$>J?0ZKYA3<T."U)D Q3&']AB:!\LT__F'E>\L_PR+
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ML4.P56F,7/)"<V$]X.XZ#SU"@%;VB01Y9E;$CD@=QZ5QB #O%!"B5]P6,K=
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M8<:=!]P?0![E;G,9JY622^]VAQ!T5F*KG!&] 'X YV$&75+((7S1FP#+P,6
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MEE:''D0ER( $,"5N5MS M4J&LTIVO@A??(2@=MI8P\$_2 (A:_$,!*0=Y ]
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M5].1P?.HQ:*>&A\,#70LR@_P5SYN=51M#<(J&VYYZ .M)WV+@3448"YW&K5
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MT@8\7QOCNPLRT'\MN_H34$L#!!0    ( %);8506*$@?>0@  +,5   9
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MG&63*.XM0^;R#DS\QL%DN:S 1++K D[J[93@7\%633C#'&,!"@F'$W?\R0%
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M A%"X1Z(I:@D]#(^-DX'IO2C>Q?+(956/-)>C3(_7-,P:@:^;=]N9)J+JS8
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M]D"3 >YOE+*G"1'TS\?%OU!+ P04    " !26V%4G78Y[1<#  #W!@  &0
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MYP/8+ZT-PP,;&/]$.?T+4$L#!!0    ( %);850W&);)8@,  &,'   9
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M9M/G3Q/P_8#M#7)M'&H[1SPBX[;F;Q)Z<>#[RCFZ,23!^)5;?P=02P,$%
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MO.[YH*IA5FV,W+D!LI:&QI%;9C3_45D#>K^1)/>PL03U/XKA_U!+ P04
M" !26V%4=C^QK$@L  #CC@  &0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6R]?5MSVT:6\#M^!<K?9+^X"J))2K*EW*IDV9[15#Q62<Y,;6WM0Q-HDHA!
M@$$#DIE?O^?6-Q"DY4QV'Q)3)-!]^O2YG].G?WALVD]FK767?MY4M?GQV;KK
MMM^]>&'RM=XH,VFVNH9?EDV[41W\V:Y>F&VK54$O;:H7\^GTY8N-*NMG/_U
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M2]#E,"N@2N1](VDN;R'2<B(PW''4['GI"@U<F.8@SD0G',O:S((2G-D7[%,
M$5!\Q^A"V$9EZ5>/@B&(]VJ';MY9!I]@R_#SRRR] L*HY#.J0^<O\%>X]G>.
M97QE3'(/GED!MH%)7S?PCZ^@N+I_[2LHC.DQ1>P+:OQKOVQ)@=OWKNY_<:\A
ME"?3RRRU*R%Q2>H!>%X"Z-=4$@5"!M9P_PN!>S*]>/([M^#2Y.46%H6QZ-ZD
M5RLDQFN)5"C)^+FA9].C0R?!T#?LT),#>1L8CA^<]I$D.G!DC3(@G&;^Y!7\
M YQ4(+#[''@BO=ELV^9!Q#4.?HLOH=F4OOV\U46)/_ .N[GFL*2/.E_7]-AU
M R9B[J&+1@2^^MB %9:^G+Z, 4P. )A^FP.KL%5<L5R1G3:6!.Q^9X$!C3S.
MZMOT6TP2%&B,&^=>VQ!_*R"T 8V+7\(0>[JZ1J#M7+:NJ"6)B!10>9FK']-5
M#X*T9G>"@V"UU2@@T# XY$29@P&04VA #LG%A%33DJU<P."F1(<#'7G.A=DP
M,P8B[5Y*CD\T/4TK#J9QAH4C2GS3&S@"F_Z\Y:>I0(&^K%CA@T#F+ M+,G0H
M]X")0P(EAD<1B;IP:'%[!L.ORIKB<E'><78AZ@S\JJ8@:Q]4*8A+YQD17GBC
M."LO7ISC0X&3:S%H*6L@[R$$=I?!M=&JZM:YHJUL'CB^"&_9&%F8BY9, 9E+
M>]A<Z,A$&O@?HCG[+2DJMTLN&0%S+]@,(W))PG0/4DAK5,5A%C1TR!7CE1-9
M@RVQ87=J8XY!&:EES&]I+H-KM0O++4/R$HQ(L D?0V\7T0+,R!:7JLK?:2I.
M<#MR).ALC@",YERL/5B^4'P0 [+?))2+=*1#4$_27YP;$A%1%!GS1J_=-Z[D
M" "T*]P+5L6!6JG+*_K<[JQ Q_A>J +X=-$1 FO@@W50 ."+>-Q6(2R8+((?
M&063]!U )@(E2SI7^<<+1P<W%V$(D'6/6$30^UC-%I#BJI:T(G^2OWG R@*P
M%JUW8$>AV&E+=68LU*@*8'_LLBU.T [9P8@[#,=]JR>K"9<0DJK@,@,L 65F
M6;5J8[#F <B3\JG!EU@[#2_]?\J3 )YH*Y\SO2>P1[ CI5D'S,4RBJ#@ @<D
M/[ UT,G2:U4MK7R5Y3*E4E4C@.0H%L0Z)9S1>"V)G3#IZ6,G+J\<Y*;S6/>P
M@F J)AK;,>4;2:@/LPK[7#[*0XFD\AS\%G:QE_W2[0:(:,// 8SBZ[C*LS"H
MU 2V =$_[ 2ZJ.[A5I>;10\*46H/.RF'<T ]KAM)4 ; H;@7FG!I#+>^0')B
MZ-Z&SL&N)^0E01)-P&,+6][Q UDC>0Q&8.IMS]5U(EL':)%$Q6>=]V%,RG&2
MJC +7C3:Q-A3!_#'7&ITM02>(!LL]S83S3_Z&O.620A-CPXQ XQUJ>, 6!"M
MD.$'E0<Z'X5R8MGS@(R+WG;" 5-5J 813_MH)"D35;JQ%]4LET9W@:1+)<P3
MBQ",">)R)\G'*$;(X8,"/>7*R Y:L\I5*^/7+LL.7ZY 9.)Q@+(&"0A?P@K,
M\TGRGUJU7-V?[*4<]KZ9#K^972;_T)T3B )&\I?D[/0B.SV=PJ?35Z?9Z=F4
MOL-/Y\D'TD##=^;9Y>DE_!]GF6=G%R^3V_7.D(F+SZNM+3(@7H/1SF;9_.5E
MBC.<9Z<OI_C=Z7EV<3K;?]/7:WD"3BZSB_/3Y"([FTWA_R]?O4QNGE)I +-D
ME]-I<GJ9S2XO8?;L[.4<EW=Y#L#3ISDLYN4E?KJ8X:?T-EZLM<2-U*$Z56A9
MC0MA8*O$I@Y9WPO<$=1'>0BG]DG@#'%"F4PP:[9*7'C[@ZW)(+%B^0D0<8)O
M;,'Z.9&->-"LF3C+!:ZX"[N"2EXWZ+[DCB2+TF 4%+G9H,HV)_870C709I8(
MMOW0Z&*LU:+DT@26,O0X*GQ6>#1[K7OP\)L5+G!OW%%$ 2?L?4/Q<I^JC7C1
MQ3W,\^&F26#%OXCAIA$S2(*'0ZT/R[:ZP"67S9X+L*=O63&$^L<'CU%=FGV)
MC+7Z\*Q!*]]:BW^B'?17FXY'>8W*!VUFK/:,DTU,4"9Q!'F0$.V:*7I+,\HW
MWDS&X!U56%+A%,A8RG6-8,M:(>#QX5<<B$-Z0P%)=J0\..Y<82 ZL&G$;-DS
MX"*6836_<YYXJ)M5Y\C"JJ"."00#GR/*ZCTR$R[B+M(R"*/[28Q!KXA@#_K.
MDWG(28GWO5QNK0L'8QE: G&\TSJ]SP&6OO)QG_>W[^Z]<_YNU(>A<H79*TS_
M-/V*(E>7L)?I='+^#;INF)/2E$Y76Z(_:[$M849C9Q04BEVRT$L, N +.VL/
M;M _H3+ 15^L@/E '  95^AA>\8]"N5\&D Y/P=228)09VG$4W?GG@1@IDI,
MBJ5?!#W[MV"_X>TA2!'W%-VKTCN8)DNOW]_340U#+%Q0:*IH\MZY=!0?T1AP
MY&!28K%?B(@H-$>)65> ?0(X>A$03U"0PJ4_3I]^^_;%^^<T HL*, >)VMG/
MY.^Q/D$.MXTL4^04K<J'*:36)71&\>_QQ<?+"5:"?P* LJ*$)-5!8"GAJ:IN
M]Q2PHRH2AD(*3E':I)??8(B?*1Q>#\DBB2E:P(PD7BKF8:<^@6+A>BZ'D+\U
MCQB?R##&""*)4AP=5OR[NM@@B<NB-T@>76&Y%GA-HC2N\HZ-/<)';,):! J^
MD.1SF[FRTOO%4<GMN6RQ2YJ^=;8%J$_-.?\Z4)RG*!A"M)&);6LS4RH09=21
MJ'2RBO(.E<8H!3,C+XB/GBFI'T36"?EH/B2E=-M;H0MD_@\,HE) /9.B*PX<
MH+@2&5 G5/OVV<9G3B>O /XHDN%ELU4$H2UV''FH@4#RX(0%QTW(S/B\+?U1
M1=0I019F"38 29;&JGX,9.&S7&X=[D=(/HPP;T \B6("2N2#C&[A)-*+ @?W
M1NUMVW084P3P'%8HK@TN'H;=TG>JI:@J[>V]_@UX&,L,KI%'85*G>@A6^,*J
M'PK=\1F")JW4(^Z>\U,P_L_ OK9JSGI%A LC=?!>P-#Z0HNE;AX=C;J#FX&F
M;-G/MXNW7+/LJXJI$?:)Z(U"5*P\ JJ9(M6PM6'G=Q5]@D0:;Q;1%O@&X[3E
M68_]9=YKY>U_E._[9(<!*I :)0;[.AO+!VF,WFH=QXSG<V(C2W;95\@8B=<&
MM&+&5B*2$;.>,8-]0W8QZEP\+Q&RO,$)3J4F<GZ6 3&3.1^<0X"%6Y+GE7,(
M*6$13D3 ,?!<X,:C?9AQE,IV0U:@+<IQ7"-3SGD+7[.>D)H(VDS:_MELH*26
M<L"90IL@#"4]B3Q;:U^*G]C,9H Q=]BJUI^Q/KRV93EU$&97?=< VL@#"W#M
MYC5H!^.<2!T1EO\RF\RQIJFJ*"QS&YBPH:DIUB-Y%?XDCH3_W.1N&@]%%CZO
MTODWF#2>8'D0)S4YLG":T6_)%\0IBIH@\R&;4%) TP#QRG[X?3C/4EVKO!N3
M\O3CYPY= =ZD<'XS#H U&Y>E0>ZRZN?\RY!<1)"\TXN6>.PRLS\2).;?!.25
M.#)7=V_O:7+3TYZX%7JF^Z+B2@K+E]818SVLK&289@Z,O=B1=:B>(B>6?<L6
MV0#69!]63%!7DAKWM;*>F,ZL^@[49 56IJF4TU5V&[A"6O$)F4/(03QPS V-
MPX(SADX6^5)=KTQ8F.)$3]%4F<]JJ90JYTZHK)'IP02*'\ S3DVVV%E@Z1P3
M9"W0-H?)),(84#^'%VT .NS_L$QG(Q/9<?[>USH]G5K%<#]\#@P#:_C:N"2F
M9HGF!^^^'AK_6>0_8P@9A$X?ZBSL;V*-J0^!5L.(J6@U&.NV+1]024MR73_G
M0Z[>WHF\-CE%'@HI[PHZ9SD,1Y?6=VY!4+.=<4,])3".)?(SO=\!6C;>@;ZY
MO?>9="81*3&*ZU;=C+:PEH_JT"%I,)P,I>'!MLXI8\+N'0R$>,2&"#T?4J(N
M.FT#QK<D8*4LD>,<%IFP97R( 2U\.O1*L6U<(,+KS@LV=673%,%6V%2&KK'<
MQCHCWMA#DXLW8BL;X?4(US@$Z0*>*!B])",6 QB[$\9)\#+JZ02U<^!C.##0
M$0#<<2WK(* (;E*=4Y#P9W<B!\R,N.K3Y0&\K>05H*_-#C"6",9"]Y4P&!8[
M9'Q(D<9Q4T1T9>1<@B[\P7?)E;L 4?B"S_?[P(3$[Z@51R^=6UR%]:"F2[P$
M*9</A0E% -MF:8TG#Z_UR-CL37*L1S';AK6^_14AL84#@P436@;<1,=:R%SV
MD$H.BL^W!;$9ZQ:_<X428[M$M$FQW'BC"D?;14^G)3A(Q0(>[4(JCI V,B/3
MDZM3NW@*2\MHU\NBJ/3)=04[F7Y4G],[$=2P+7]O%NDU!LZ1$KUA,/="XOKC
MW967$J;$1-4'V"-2&&0HS+,XEPA2 2U=+@*$Y?WE-'LUG8J((O^2\NA%R7T<
M9-5JX$!3_3D=IX]LM8VB@T$;8NDJX?8@,4&Y(W@^7&#1EH-XQ-3\2"3:@HF:
MQZR;JAB0G\OH? RR%_=;K8'M?U;UJL?MN56P_U6SVH$68B?H>SJ/*NGY+TR!
MFQ6J$#L5P_?^ZOKN"ORRE@,\&.ZA4S?@+U V.8E1(YU3D "IL))K[MEU1!*U
MC56D:B&MP#$1I.VL[LXK56Z,[*2-%^XM@GNP\(EX'"U9Z/#0$AV9Z/!L,((-
M<K,TX6$*](4UQ^#D0#9#B>L+&D@Y.TT_P:R-#%<W]0 Q_D1RM:.,.9_GLD4)
M=G6 "ECQ=.K#LT.[\A5S/GRZR 8OVY(?<;N]_R4% "!T4$FKE?_-JW)16F\!
M"\T&M.8- /S9,^;;&U?VB 8A3B];0;7%: 6)V!LN*83*31O%X <B] B4;V_\
M*8?!M!/:0U4T6PY(VF,S"9%DT8?>MK-M?73_]BY<WWY@3R!84O2LYYI082(*
MJW$WEC@F-Q/+&$<?&JI!K'D_B.B--9^>P..*KUW>?"R0EHWF/!-#4N.DLE)C
M:Z5&*+6WV$!.3GOLY5< ;P;,]:DS$YPY8TN4W&ES^\0=YB31&OPG]0_Z!4\!
M6V3?_?.7(:X=P'ZS7*4,=G*C"N;AI#!.QIH^Y*6!?CX&JWW$8&TZ2Y: J/9
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MRLHW-D2+T%W7X</$"VR.A\<0O&U<@(U+\9J-^B0=:(:-UX+6N]1>B(\=V<(
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M^Q7JR:AOP&,#A@>76T;8-5(_JA)K)5B"2LWP;:60^DH\0H64#>&UJT5)B-4
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M&=(H:V/ZNCG26+=-VVBJ$]$(VW48T-"+K(L]NCL]8R(^P :>2MV-3#DW_P]
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MD;H]TLOW> ?F5#7/XM@C>:UWK(*9CV=.@_H*_C$X.TJ :2+7!*L%[0K46+&
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M$Z_;NF*7Z$%^'S_2(C,_&/O5U0#([QNEW2*H$=O+*')E#8UPYZ8%39:=L8U
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MF4OCT+%G+,W"8C+SFSR<Y!.VME!)I$910I>$J3K@:'@K4(+&@:,5/XQU;$*
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MU!J2-!]4\V@T&R-K9]2M-&1[%Q;TSJ*R!72>2[JL=F,'="_W\B]02P,$%
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MA2P\3MR)36O=1#2?;OD&[L'^NEUJ'$4GE$;T((U0DFA8S\(%N[[)G+]W^$W
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MPU3JAZ\70C/3D.82O+S_[RVV7^*.BP=9 RCTU% FEUZMU.'.]V5>0X/EA!^
MZ9V2BP8K/165+P\"<&%%#?6C(%CX#2;,2V*[MA%)S%M%"8.-0+)M&BQ^I4!Y
MM_1"[[BP)56MS(*?Q =<P0[4E\-&Z)D_4 K2 ).$,R2@7'JK\"Z;&WMK\)5
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MPY(>%'#!@=;WUN+)" 3M$[7X!5!+ P04    " !26V%4Y%"?-2\'  "A)0
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M7\X9A<.K%H#/IT*HS8/^F4?]JZSS_P%02P,$%     @ 4EMA5#%"#F'/ @
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MA;E60=D$<YY)B>^!'?7NHHY_ 5!+ P04    " !26V%4Z+!+3P\"  !L!
M&0   'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q]5$V/TS 0_2M63B"MZB;M
MEM4JC=1N07!85+4"#HB#DTP2:_T1[$FS_'ML)PU%T%X2S]=[;^RQTUZ;%]L
M('F50MEUU""VCY3:H@')[$RWH%RDTD8R=*:IJ6T-L#(424&3^7Q%)>,JRM+@
MVYLLU1T*KF!OB.VD9.;7%H3NUU$<G1T'7C?H'31+6U;#$?!+NS?.HA-*R24H
MR[4B!JIUM(D?MTN?'Q*^<NCMQ9KX3G*M7[SQJ5Q'<R\(!!3H$9C[G> )A/!
M3L;/$3.:*'WAY?J,_B'T[GK)F84G+;[Q$IMU]!"1$BK6"3SH_B.,_=Q[O$(+
M&[ZD'W)7CK'H+&HY%CM;<C7\V>NX#Q<%R;6"9"Q(@NZ!**C<,619:G1/C,]V
M:'X16@W53AQ7_E".:%R4NSK,CKQ6O.(%4T@V1:$[A5S59*\%+SC8.W*$VIT!
MD@.TVH38FQT@X\*^32DZ!1Z'%B/;=F!+KK#%"7G6"AM+WJL2RK\!J),^Z4_.
M^K?)3<0=%#.RB.](,D_B4>L-V,6T+8L N[BV+?]T_7V36S1NB'[<@%].\,L
MO[P"_[F3.1BB*Y)WUL6L)79@M/_;U %L%<#\+3ME24I/E_ST8@(DF#K,N27A
M/(=AF+S35=H,$_0G?;B'S\S47%DBH'*E\]F[^XB88;8' W4;YBG7Z*8S+!OW
M'(#Q"2Y>:8UGPQ-,#TSV&U!+ P04    " !26V%41V>\-WD"  "O!P  &0
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M:;;&*6]99B1!C'\ESV.Z)A@M"J,D'MN6Y8\3%*6CB[/BVB.Y.,MR%D<I?B2
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M=]HU+Z$E2P!+WV^VZ1^Q<*?2@,>(62AY%]H'1ZT!HE)W<]A"R<]03] ] M>
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MH$ !13E@P %#.6#  </CK@*/<L"  X9RP( #AG+ @ .&<L"  X9RP( #AG+
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M=8C5^N9%5C8_O<<6ZX^\^;:LBG4KK"Q8I_GN=_)W.Q%#!' K@#L"B%H$2"M
MA@K05H .%6"M .L*$(L ;P7XT!&"5B 8.D+8"H1#1XA:@6BH /*?5\YO(FBW
MY$V\3),JN3B3Q:,G:[S25__1!%TCK\(DS>O]<5M)]6VJY*J+R_E?V[1,FU@M
M[KW)ME2 LGSG81\C[T:*+%7CJIWCW6SE?*4B43U,YZ+T+K.LF">-X)NIJ)(T
M*]]Z)]YOMU/OS4]OO9^\-/>^K(IMF>2+\FQ<*6/K(<?SUK"KG6'88MCGXN&]
M1_R=(8#XU"U^*S;/XB@"Q#^XQ2\W\KV'D%4\=HM/Q5R-CJS&SX:+^X#X]6#Q
MKO%C%1[[&,'[&,&-/F+1]QP4WE6QOE/!4*_Y.V\JRKE,-TT ?+V\*RNI<MWO
MCN'(?CC2#$<MPUTEY<K;).GBG9<K@E!1.:^?)'6D2K& 5F.GD#4*:T9XN AY
MB,G9^.%PTDT4)I$?'*.N313Q6:111S[1O4_4Z=/-ZJE,YTFF=H20R>;)^V6C
M?M=S5WI??Q;K.R%=4\?VP[#76"F^'XZ_\$I-N3&["*/ /UZ#>(?B1RO%B0^O
M0;"W-G!:>ZM(6$@O+RH!Y:-I8 Q*_*YA)B;T+6:%>[-"]R06>97F2Y%7:BJ?
M5.E10=;%H3DRL01EM!\Y<H[\2Z6"L1XTN<L$-&9DC(E\F[O(UXSC.X?]4E1J
M(\Q5Z*>+=A. ^=TW1\?4"!4 ACGFEJE!![R(G%OI0UFEJOP2"^\^2:7WD&1;
M44=X'>A5DB]3-6=>4I:B*O<!/VQW(9UW$1XR4ULIZ^C8#09.%3;F@#-CHDP0
M\BFWS)-.ULB=K7<VYD5^,L!.8FZQB';M-$&<<FRQ4R=@Y,[ .SNS-+E+,U7N
MP"F@U7$X]@F*4-=" ,5#8C-1)V_$G"9^=H06:"TS<P(C76--$ ]LJZX3/^K)
M_$UMJK*'*N[J-DE(J69758L[3ENE&WA^@<3.C20+H$B (XO-.OTC=_[_7,=H
ML=Z(2LWN4@IAR[539*9Y;"8>$\0":C%2DP%RL\$7F2Q$GJPM\6FR0$ -PTP0
M"ABS6*;) KG9(BZ*Q6.:9:!= %-03(*N92:,(!I:5A9K1L%N1OEXG*&;=<XK
M660*N%1]2"6D*"OOS3Q3NRJ]3U6F3DH5K0L5 S7W647>0LYBDW%..";=98!@
M"$7,LO>P9B:,7H(_6RVLAS];V$#^Q <]@YN[9K.;VR&E+=9,@\EK%+=84P9V
M4\:WE[>3'HU?T>]0+]I*'2U52''872J3=SA!$;$LE>8=[.:=GL+XJA4_,L_O
M9NT/V"0::J ^]I@"3U ,Z$:X6^%\^E;=Q].EN0_W<-^@@OT* UQGS$<,H1@V
M/'-;U..99DCL9LB^AF#2(V];/9,I+4T$UCR)W3S9QNQF6WFR/@(%5R T6WEF
MKH!)EX1AW%T!MSD]*Z!)%KM)=EANG_1HL:49DWXQCE"W8@1@@4]#2P%!-$L3
M_U_JJ(CF3C*(._LZE4F/&LL$$Y-+$:?=]@% ,68K@H@F7#*D61S4B$UZ5-G<
M,SO(D'9)"@ A55!8-CPY.!0<TF>Z^[=)CPZ;7V;'>8*CP/ ,@%%%TQ;/=)E!
MW$7!-[9]DQYU-B>!IO6P]&Y]-%&($%LU2'2)0=S<^WW]XJ1'J\U5LUH@U,C[
M  HC%:H65W5Y0-QD/+C-G/0HLGD'50R&<R:(V4[NB*X/B)O?G<WII$?8YHY9
M'"#SW!5 ,72068\=TE4$<=.VHZ>=](C:W &:[Y RW/7'A+$0,]L^T_4#<3/_
MJW;"DQYC;%-DUA?&<IN0$QQ$OF5S4EV#T)<X>Y[T:+$XUDH=73 !]14U#P8<
M]175M0UU%R4'5[F#+I6H+BWHJUP 4DWV],6O *G)SM =( ##)$*=_7D-P.I;
MP-"R1@?7@&YR[FFU8VKR+_:[V7T&H!1SH:X/)HH2&PE03>6TA\J'W5=1@(2)
M+<%1S:[438J]=U;49#[[I175U$<'71ZZ^LV8 C>(AYWD\=":I&C/D?"@G!53
MDU(B'G299P; 5/E 2#=XH*Z8A):S)JH)BD;_4A/(- FP0230UR7%S$S4G!/6
MF5  A7S:*:RO 53-#?!T,IWSV9!^=E#3%S.@.XW\L!L@((QWW0% V-8*,4TT
M;$@/ZV[R8F9VF"<(\8!V'0%PC'<S/80BB%O:<:8IC+DI[!N[NIB9C(.H3[O\
M!<!XV-V\ (APR]44T]S%>H[#OZN'BQE ::K:,;:1"6/&0>@U@.+6[,X.7IOI
MN7D=VK/%##B)]LW0,U'&P>,U!+*=DS!-D,Q-D,X>+68F._*PN[MG  J%D6$_
M=,!-;0YHIF5NIG7T9#$#WK^) FK8#]W?!B3L.@#P->:VDSBF"9NY"?M5F["8
MF4Q]0J*PF^AF$$Y5C9$Q*P#NZ'KS>%8T\[.7.-J.6RV'3114Q@ PJ(P!8(XR
MAM<EQ/$3S<3\>XZ$)VZI^NWWTW*3S,7Y:*-66,@',;J8Y0N5:F6:9#^X_GE'
M_]+\CZU\\I26!Y6[ZIZLUM:\J?N?'Q'W_WOX$RJCQ@<O$:LLOVQ>6B_5@FWS
M:O<&XO[I_L7X2?/^>.?Y!W3Z$7H>H]-/T/-+[I_.N ]\HV9/?;-[55Z;M'MS
M_^=$+E/5Z&;B7IGGOP_4&LO=R_"[#U6Q:5Y[OBLJ15O-GRNA<J.L >K[^T(U
M8>V'>H#]?TFX^ =02P,$%     @ 4EMA5),7I:_M!0  1"$  !D   !X;"]W
M;W)K<VAE971S+W-H965T-3<N>&ULO5I;;^(X&/TK%MJ59J01)#8),*)(Y5)H
MJ^Z@Z<[NPV@?0C 036YCF]*1YL>OG80X <=)F5WZT ;XSOEN]N>3T.$A(M_H
M#F,&7@,_I#>M'6/QQTZ'NCL<.+0=Q3CDGVPB$CB,OR3;#HT)=M8)*/ [T##L
M3N!X86LT3-Y;DM$PVC/?"_&2 +H/ H?\&&,_.MRTS-;QC<_>=L?$&YW1,':V
M^!FS+_&2\%>=G&7M!3BD7A0"@C<WK5OSXR/J"4!B\9>'#[1P#40JJRCZ)E[<
MKV]:AH@(^]AE@L+A?U[P!/N^8.)Q?,](6[E/ 2Q>']GODN1Y,BN'XDGD_^VM
MV>ZFU6^!-=XX>Y]]C@X+G"5D"3XW\FGR&QQ26[O; NZ>LBC(P#R"P O3O\YK
M5H@" /8J # #P*8 E %04T W W1/ *A? ; R@'7J85 !L#. W=1#+P/TF@+Z
M&:!_"C K (,,,#C-P:IJG''LG'$*J?)AYLU.%UVZ2I(E-G68,QJ2Z "(L.=\
MXB)9IPF>KRPO%%OJF1'^J<=Q;'3K?M][U!/+FX)H \9[RBTHQ?0#@ 8T0,$
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M[+E^$H??:4,HMOYRP57]%QP:+)R ?*^T*!MC$T')JN-_\K-)Q(D!2@8,<&.
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MF-_7PAQ1FQ<[0?O!9OXO4$L#!!0    ( %);851O!L@?W 0  #L6   9
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M:F&6-4#]OBA4X=$^U WL[G6?_0M02P,$%     @ 4EMA5 [&2 7] @  #0H
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M%(:)UNZ3Y.K;4.'DXMK[N0]%J'4D$$U\]$0C0&R+OK#DXY(EDK-(87;H(9'
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M/%,B3T!JB]YEB@DF%?IAQ13EB7R%SM"GNQ7ZX;M7Z#O$,_3++C](FL7R8JK
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MYS0@I-TD//EQ/1+G^/-*&XS2Z*Q;P9Y/WHJ&K+1WH:UHP$G/1,XC<>@)>]'
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MZ*7RNV4<3;SH%LOO-/$HF0PU<?HZ;NCXO%G#'A2V<@)Y*>0+*'LFE127\OY
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M)NIVA5P;J/=;IE:['N@ S7UM\2]02P,$%     @ 4EMA5*_TXMJ]!   .14
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M)O0$>+[A7+W<:(#FO&KV%U!+ P04    " !26V%4 1<<R8(#   9"P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6R-EMMNVS@0AE^%$'K1 NM(U-F%
M;2"QL=@"[6[0]'"QV M:HFVBE.B2=)SNT^^04A1%HK6^L45I_N''&<Z0B[.0
M/]2!4HV>*EZKI7?0^OC>]U5QH!51-^)(:_BR$[(B&H9R[ZNCI*2THHK[81"D
M?D58[:T6]MV]7"W$27-6TWN)U*FJB/QU1[DX+SWL/;_XS/8';5[XJ\61[.D#
MU5^/]Q)&?N>E9!6M%1,UDG2W]&[Q^S6.C,!:?&/TK'K/R"QE*\0/,_A0+KW
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M%R/[>("[*Y7& +[OA-#/ W,[ZF[#J_\ 4$L#!!0    ( %);851:^U-3HP,
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MSP)';]#N IXOE;+[A0O0#O/3_P!02P,$%     @ 4EMA5%;$,=?K P  B0X
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M]1N=!IG#@N6I?A2;WZ$4%!F^F4B5_26;,M9OD%FNM,A*,&:0);SX9]O2B#U
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MSH0 6\Y6L=1Q*+R]1E0(?1BT.73-0L=QK18%'1AR?$=/P:LH>+T4)@D3.T[
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MY\&9*5%T*+)O+-%IW^DZ**$S4F3Z0:P^T,JACM$7BTS9?[2JSGH.B@NE!:_
MP("SO'R2ERH06P!PM!G@5P#_6$!0 8)C >T*8$/MEJ[8.(R()H.>%"LDS6G0
M9A8VF!8-[K/<Y'VB);QE@-.#V^>"Z5=T Z%+T#@CN4(7Z!H2FX!,\@0]4*6)
M!N&6+S+Q2BF::!$_H4\+F[<2<C:BFK!,G0-8I412U7,UL#,VW+AB<E,R\?<P
M&=&XA0+\#OF>CQO@P\/P.R);"$<&CL,&^.@8>-@$=R&D=5S].JZ^U1?LT3<Q
M4;B8VK .!8=KJH@-V./U5&D)Y?[]@)6@MA)8*^T]5NX+/J42B5D5=40*G0K)
M?H#5,Y97N^=-R2@5AU:Q:0[+@1]YYM=SEPV,VC6C]I&,8L&YR&MB2Z@/,LTH
M@EZ%YI+D^F\,VSL,<>2'G:B98*<FV#E(<%W;T!@#6[WH\8X:SH?R$=;*PQ-F
M/:JM1*?*>K2;=?Q[ULN[=N2YT>XY''7V5U&W]K#[5E74W648MKM=OYG@94WP
M\B#!._+">,'KVD$_T3W0_%R0C,T8Y&&[2:IC2@Q[FX[MG;#(\-:7 9^JS"K-
MVU$/#S07O.FJV/_7N/_7A<:;#HN#4T9[TS?QFS5.O-LY_[R])4EW:VXP4QY\
M!.<,RC6C,T!ZK0A:J2P'IU+08F%'B:G0,)C890K#)I7F +R?":'7@IE.ZO%U
M\ M02P,$%     @ 4EMA5&R-4S:I P  #!   !D   !X;"]W;W)K<VAE971S
M+W-H965T-SDN>&ULM9A=;YLP%(;_BL75*JT%F^\IB=0FF[:+:56C;1?3+ASB
M)%8!9[9IVOWZV89".C["HC47"0:_Y[P^V \XDP/C]V)'B 2/69J+J;63<O_.
MMD6R(QD65VQ/<G5EPWB&I6KRK2WVG."U$66IC1PGL#-,<VLV,>=N^6S""IG2
MG-QR((HLP_SIAJ3L,+6@]7SBCFYW4I^P9Y,]WI(ED5_WMURU[#K*FF8D%Y3E
M@)/-U+J&[Q;(TP+3XQLE!W%T#/105HS=Z\:G]=1RM".2DD3J$%C]/) Y25,=
M2?GX506UZIQ:>'S\'/V#&;P:S H+,F?I=[J6NZD566!--KA(Y1T[?"35@'P=
M+V&I,-_@4/8-?0LDA9 LJ\3*04;S\A<_5H4X$D"O1X J 1HK<"N!.U;@50)3
M:KL<BJG# DL\FW!V %SW5M'T@2FF4:OATUS?]Z7DZBI5.CE[_ZN@\@G<J-*M
MP6V*<P$NP;S(BA3K&P*6Y7P ; .JKF6G-PLB,4W%A>HN=I@3,;&E\J.CVDF5
M^Z;,C7IR+TAR!5SX%B 'P0[Y?%C^&?,K $,MAT&'?#%&'G3);57$NI*HKB0R
M\=R>>$M=A<N5*>2<96IA"FRF]H_KE9!<3?"? UG<.HMKLG@]6:X+N6.<_E9)
MWM"\*OU%5^W+.(&)HU?_PPR%COY,[(<. UYMP!LT<$?48&@BE0$U.9-[0(4H
M3KOQ6FZ@'[G(#[O=^+4;?]#-ET(*B?,US;>5';;711>G_/@M/SUU"6HGP:"3
MY8OLY)'PA(K3=0E:/F(8.3'L-A/69L)_-X-7*3EE)QQ;EJAV$@T[,;D ?E"P
M, ;4HPIL.<[E*2M1>\:$*.B;,''M)QY>/^J9M5:W!<9Q;% &?GPFV8KPH<4)
MG8:FSBM" !Y1&_XG#%2!CNL8#&  -KB#Z#5 4$4]]N/!P'-0CY\&C'"8C&>C
M +9)V5><!I)PF))GT@!V8-*-PSX<P :3<)B39P,!C@8E;$@)3Z#R;"; -B[#
M,/1[##6TA,.X?(:">EEVQT.A02",7A,*#=K@";:-AT+<?CF +ZE0O8&-[+CH
MZ A#OY\SJ$$J<EZ#,U74%X9@$$1^SVQ!#7O1,'O/!@UJH[BO.D<OG<,4/A,T
MJ$WA,(S<WKO54!@-4_ALT*#1%$8-A=$)"I\-&M0!XL"+HK^?4O;1SDOOD]6F
M8DO5P%.R44+G2F\L>;GU+!N2[<UF;,6DVMJ9PYW:KA.N.ZCK&\;D<T/O[^H_
M &9_ %!+ P04    " !26V%4&IFU9LX"   %!P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970X,"YX;6R-54UOXC 0_2M6M(=6:LD74*@ J9#N;@_=146[/50]
MF&1"K#IQ:CO0_OL=.R%+*:!>P!_OO9DW(T]&&R%?5 :@R5O."S5V,JW+:]=5
M<08Y51U10H$WJ9 YU;B5*U>5$FAB23EW \_KNSEEA3,9V;.YG(Q$I3DK8"Z)
MJO*<RO<I<+$9.[ZS/7A@JTR; W<R*ND*%J#_E'.).[=525@.A6*B(!+2L7/C
M7T<]@[> OPPV:F=-C).E$"]F<Y>,'<\D!!QB;10H_JUA!IP;(4SCM=%TVI"&
MN+O>JG^WWM'+DBJ8"?[($IV-G8%#$DAIQ?6#V/R$QH]-,!9<V5^R:;">0^)*
M:9$W9,P@9T7]3]^:.NP0_/X10M 0@GU"]P@A; CA5PG=AM"UE:FMV#I$5-/)
M2(H-D0:-:F9ABVG9:)\5INT++?&6(4]/;E\KIM_)%$N7D#FGA2*7Y &4EBS6
M>+30(GXA/R0MS$X+$C&)+1-279#?:<IBD(K0(B&W><G%.X B\TJJ"O$&S;0B
M38A:_"P"31E7YX?"/-U#O@3YC'??B$M41B6HD:O1I\G6C1M/T]I3<,23'Y![
M4>@,0Q<))!\%7"Q06Z5@6Z5I<%(Q@KA#0O^"!%[@'TAH]G6Z=X >?9GN#T^X
M"=N>AU8O/**W,'6]7-J6ST2.$T11^PB?;I;8$7R*SR>B=-LH71NE>R3*K\KT
MDHBTZ2,Y8T6S/#_4TUJM;]7,L%I/^E[H7XW<]6ZA/Z,&_>$@^(B*/J.&?G\'
M]<%0KS74.VGHT<X0K!E=@\212%+*)%E37H'UE@C.*;Z&$EU;GP=MUC&N=E+S
M0[\3#/=\'H!YW4Y_#Q8=A@UZ>T[=G0&1@US90:M(+*I"UZ^@/6UG^8T=87OG
M4YSQ]4C^+U-_(.ZI7#%\X!Q2E/0Z5YB:K(=NO=&BM&-H*30.-;O,\#L%T@#P
M/A5";S<F0/OEF_P#4$L#!!0    ( %);851VG+\_R0(  /L&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@Q+GAM;(U5WV_:,!#^5T[1'EII([^@L J0"G3:
MI'5"95L?JCZ8Y"!6G3BU'6C_^YV=D%$*55\2^WS?=_?=R>?A5JI'G2$:>,Y%
MH4=>9DQYZ?LZR3!GNB-++.AD)57.#&W5VM>E0I8Z4"[\* @N_)SQPAL/G6VN
MQD-9&<$+G"O059XS]3)!(;<C+_1VAEN^SHPU^.-AR=:X0/.GG"O:^2U+RG,L
M-)<%*%R-O*OP<M:S_L[A+\>MWEN#5;*4\M%N?J0C+[ )H<#$6 9&OPU.40A+
M1&D\-9Q>&]("]]<[]F]..VE9,HU3*>YX:K*1-_ @Q16KA+F5V^_8Z'$))E)H
M]X5MXQMXD%3:R+P!4P8Y+^H_>V[JL <(+TX H@80'0*Z)P!Q X@_"N@V@*ZK
M3"W%U6'&#!L/E=R"LM[$9A>NF Y-\GEAV[XPBDXYX<SX^JGBY@4F5+H4YH(5
M&K[ +6JC>&+(M# R>80I*Q)J#>UG%8*1<)V70KX@PF]4E!6S/=0P5UPJ>[PC
M<-:?K-2\6,/9# WC0I\?BW!_@_D2U0.=?0(?=,84ZJ%O2*)-U$\:.9-:3G1"
M3AC!C2Q,IN&Z2#%]3>!3;=H"1;L"3:)W&6>8=" ./T,41.&1A*8?AP='X+,/
MP\.O[ZB)VW;'CB\^P;>P=?VR=-V>RIR&AW:]@_NK)76$;N'#.U&Z;92NB](]
M$>5797L)<M7T$<YXT2S/C_6T9KMP;'9.;<;=F-1N]LO\UB<,@KC_VFMVQ*O7
M'[1.K]3T6C6]=]7<N=E!!6,;5#0*8<6X@@T3=!6LL%0*P92&DB0[D4<UUC'Z
M^YF%<6=PH/*(5Q!U>M&!S+=N@WYG<*C3WQL+.:JU&Z\:$ED5IKX K;6=X%=N
M<!W8)S39ZT'\GZ9^%FZ86G.ZXP)71!ET^I29JD=MO3&R=,-G*0V-,K?,Z'5"
M91WH?"6EV6UL@/:]&_\#4$L#!!0    ( %);850O.)PCD ,  #P-   9
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M/?H'"8.0-CATUUT]:%!?=E:GDY9H>F4^>@ZO]P[>.F$*/FY<.NYDAL=;,W=
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M$1X#E;?J^<3(O6M>-])@*^R&"3YO0%D!_+Z5TKQ.K('RP33_!5!+ P04
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MDIT4/N'Z8$])DF19& $LK"!), 2>1AS!%( &#$D2=PX>G$?Q]IR*N]^ )K\
M4$L#!!0    ( %);8527BKL<P    !,"   +    7W)E;',O+G)E;'.=DKEN
MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MQO'PC^.79]J;=GC.SY:_D]S\ E!+ 0(4 Q0    ( %);850'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ 4EMA5,TEDD#N    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ 4EMA5)E<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !26V%4
M]!F<Z3X&  "6&@  &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ 4EMA5("T$(D&"   (B$  !@
M     ("!@0X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M %);851^<F2I3 ,  -H*   8              " @;T6  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    " !26V%4 4O$.*X'   '(0  &
M            @($_&@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ 4EMA5$H91N5;"@  BD8  !@              ("!(R(  'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( %);853E\LHG/PH  #TN
M   8              " @;0L  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    " !26V%4U0=(0. /  "2*P  &               @($I-P
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ 4EMA5*$<NN8T
M*P  V(4  !@              ("!/T<  'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( %);851.HOX$,1   '(W   8              "
M@:ER  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !26V%4
MNR'3[9 #   >"@  &0              @($0@P  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( %);852=[]C0P1   +U%   9
M      " @=>&  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ 4EMA5(&W2?+8 @  $08  !D              ("!SY<  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !26V%4$2LT8<8$  #5"P
M&0              @('>F@  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( %);851%)(>35@,  .,&   9              " @=N?  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ 4EMA5*5_FL*_
M!@  ?!   !D              ("!:*,  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    " !26V%4?--7C5X'   Y$P  &0
M@(%>J@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( %);
M8506*$@?>0@  +,5   9              " @?.Q  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ 4EMA5!26)O=V!   2@H  !D
M         ("!H[H  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    " !26V%4G78Y[1<#  #W!@  &0              @(%0OP  >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( %);852V8)-?.@8  "$0
M   9              " @9["  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ 4EMA5+M6I?_\ P  00D  !D              ("!#\D
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !26V%4Y@#(
M,,\#  "9"   &0              @(%"S0  >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( %);851NE[FFM0(  (0&   9
M  " @4C1  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
M4EMA5 D%BZ8Q!P  4!$  !D              ("!--0  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    " !26V%4-QB6R6(#  !C!P  &0
M            @(&<VP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( %);852F$7J3(@,  /$&   9              " @37?  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 4EMA5'KO>#=+ @
M> 4  !D              ("!CN(  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    " !26V%4;^"J+9H#  !="   &0              @($0
MY0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( %);851V
M/[&L2"P  ...   9              " @>'H  !X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ 4EMA5. ]+>[T P  +@D  !D
M     ("!8!4! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %);852IFN)[W ,  #(*   9              "
M@=$K 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ 4EMA
M5+$1K<4* P  0@8  !D              ("!Y"\! 'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    " !26V%4:\.6H[$"  #%!0  &0
M        @($E,P$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0
M   ( %);853*PP-"2P0  "D+   9              " @0TV 0!X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ 4EMA5!V_$]Q'!0  OPP
M !D              ("!CSH! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q0
M2P$"% ,4    " !26V%4PJ\DL+0#   !"   &0              @($-0 $
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( %);852:3?42
MN ,  %\(   9              " @?A# 0!X;"]W;W)K<VAE971S+W-H965T
M-#$N>&UL4$L! A0#%     @ 4EMA5/^V>L-P P  =P<  !D
M ("!YT<! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " !2
M6V%4AF*VE@ )  !2/0  &0              @(&.2P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( %);853E&F0)+ 4  $D5   9
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M970T."YX;6Q02P$"% ,4    " !26V%4,4(.8<\"  #9"0  &0
M    @('9:0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    (
M %);852+@U**C@(  *4&   9              " @=]L 0!X;"]W;W)K<VAE
M971S+W-H965T-3 N>&UL4$L! A0#%     @ 4EMA5'/O$_@] @  M 4  !D
M             ("!I&\! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"
M% ,4    " !26V%4Z+!+3P\"  !L!   &0              @($8<@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( %);851'9[PW>0(
M *\'   9              " @5YT 0!X;"]W;W)K<VAE971S+W-H965T-3,N
M>&UL4$L! A0#%     @ 4EMA5)?K+757"   JS<  !D              ("!
M#G<! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " !26V%4
M$!.AM) '   !)P  &0              @(&<?P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4U+GAM;%!+ 0(4 Q0    ( %);851URN[6# D  )XP   9
M      " @6.' 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%
M  @ 4EMA5),7I:_M!0  1"$  !D              ("!II ! 'AL+W=O<FMS
M:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " !26V%4+JE#0;P$  "\$0
M&0              @('*E@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+
M 0(4 Q0    ( %);851O!L@?W 0  #L6   9              " @;V; 0!X
M;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ 4EMA5) D<2&>
M"   XRT  !D              ("!T* ! 'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6Q02P$"% ,4    " !26V%4#L9(!?T"   -"@  &0
M@(&EJ0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( %);
M853<OSW(K00  (X4   9              " @=FL 0!X;"]W;W)K<VAE971S
M+W-H965T-C(N>&UL4$L! A0#%     @ 4EMA5),8X:@L"   DBL  !D
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M=#8W+GAM;%!+ 0(4 Q0    ( %);8500@9L/F0,  % +   9
M  " @4#( 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @
M4EMA5$5NJ 6P P  NPT  !D              ("!$,P! 'AL+W=O<FMS:&5E
M=',O<VAE970V.2YX;6Q02P$"% ,4    " !26V%4K_3BVKT$   Y%0  &0
M            @('WSP$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4
M Q0    ( %);8518(A<9 P4  +L2   9              " @>O4 0!X;"]W
M;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ 4EMA5 $7',F" P
M&0L  !D              ("!)=H! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX
M;6Q02P$"% ,4    " !26V%46OM34Z,#  #8"P  &0              @('>
MW0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( %);8516
MQ#'7ZP,  (D.   9              " @;CA 0!X;"]W;W)K<VAE971S+W-H
M965T-S0N>&UL4$L! A0#%     @ 4EMA5'O7P 5, P  I0H  !D
M     ("!VN4! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %);850:F;5FS@(   4'   9              "
M@57X 0!X;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ 4EMA
M5':<OS_) @  ^P8  !D              ("!6OL! 'AL+W=O<FMS:&5E=',O
M<VAE970X,2YX;6Q02P$"% ,4    " !26V%4+SB<(Y #   \#0  &0
M        @(%:_@$ >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0
M   ( %);8529<W/C4@,  $H*   9              " @2$" @!X;"]W;W)K
M<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ 4EMA5.2B%U/. @  ^ <
M !D              ("!J@4" 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q0
M2P$"% ,4    " !26V%4*!')/<\#   %#0  &0              @(&O" (
M>&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    ( %);851!['+!
M+00  %$.   9              " @;4, @!X;"]W;W)K<VAE971S+W-H965T
M.#8N>&UL4$L! A0#%     @ 4EMA5$CRT&<; @  ;P0  !D
M ("!&1$" 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"% ,4    " !2
M6V%43&ULM ,$  #C#   &0              @(%K$P( >&PO=V]R:W-H965T
M<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( %);853$XP;=(@,  ! 2   -
M          "  :47 @!X;"]S='EL97,N>&UL4$L! A0#%     @ 4EMA5)>*
MNQS     $P(   L              ( !\AH" %]R96QS+RYR96QS4$L! A0#
M%     @ 4EMA5(D 4;UT!@  L#D   \              ( !VQL" 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( %);853#)=E(E (  -\S   :
M      "  7PB @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( %);852-G,NK- (  %8R   3              "  4@E @!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@    !@ &  5QH  *TG @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>272</ContextCount>
  <ElementCount>550</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>79</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>15</UnitCount>
  <MyReports>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - Organization, Nature of Operations and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation</Role>
      <ShortName>Organization, Nature of Operations and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - Acquisitions of Businesses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinesses</Role>
      <ShortName>Acquisitions of Businesses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests</Role>
      <ShortName>Acquisitions and Sale of Non-Controlling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - Redeemable Non-Controlling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterest</Role>
      <ShortName>Redeemable Non-Controlling Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>061000 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>061100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>061200 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>061300 - Disclosure - Investment in Unconsolidated Affiliate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/InvestmentInUnconsolidatedAffiliate</Role>
      <ShortName>Investment in Unconsolidated Affiliate</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>061400 - Disclosure - Equity Based Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlans</Role>
      <ShortName>Equity Based Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>061500 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/PreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>061600 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>061700 - Disclosure - Defined Contribution Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DefinedContributionPlan</Role>
      <ShortName>Defined Contribution Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>061800 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>061900 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>062000 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>062100 - Disclosure - Reclassification of Prior Period Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ReclassificationOfPriorPeriodPresentation</Role>
      <ShortName>Reclassification of Prior Period Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>062200 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>070200 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>080100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables</Role>
      <ShortName>Organization, Nature of Operations and Basis of Presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>080200 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>080300 - Disclosure - Acquisitions of Businesses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinessesTables</Role>
      <ShortName>Acquisitions of Businesses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsOfBusinesses</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>080500 - Disclosure - Redeemable Non-Controlling Interest (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterestTables</Role>
      <ShortName>Redeemable Non-Controlling Interest (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/RedeemableNoncontrollingInterest</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>080600 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/Goodwill</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>080700 - Disclosure - Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/IntangibleAssetsNet</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>080800 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/AccruedExpenses</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>080900 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/NotesPayable</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>081000 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/Leases</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>081100 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>081200 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/SegmentInformation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>081400 - Disclosure - Equity Based Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansTables</Role>
      <ShortName>Equity Based Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/EquityBasedPlans</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>081900 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/EarningsPerShare</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>090100 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails</Role>
      <ShortName>Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>090102 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails</Role>
      <ShortName>Organization, Nature of Operations and Basis of Presentation - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>090200 - Disclosure - Significant Accounting Policies, Long-Lived Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails</Role>
      <ShortName>Significant Accounting Policies, Long-Lived Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>090202 - Disclosure - Significant Accounting Policies, Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails</Role>
      <ShortName>Significant Accounting Policies, Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>090204 - Disclosure - Significant Accounting Policies, Redeemable Non-Controlling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails</Role>
      <ShortName>Significant Accounting Policies, Redeemable Non-Controlling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>090206 - Disclosure - Significant Accounting Policies, Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Significant Accounting Policies, Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>090208 - Disclosure - Significant Accounting Policies, Contractual Allowances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails</Role>
      <ShortName>Significant Accounting Policies, Contractual Allowances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>090210 - Disclosure - Significant Accounting Policies, Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails</Role>
      <ShortName>Significant Accounting Policies, Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>090212 - Disclosure - Significant Accounting Policies, Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails</Role>
      <ShortName>Significant Accounting Policies, Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>090214 - Disclosure - Significant Accounting Policies, Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails</Role>
      <ShortName>Significant Accounting Policies, Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>090216 - Disclosure - Significant Accounting Policies, Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails</Role>
      <ShortName>Significant Accounting Policies, Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>090300 - Disclosure - Acquisitions of Businesses, Acquired Majority Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails</Role>
      <ShortName>Acquisitions of Businesses, Acquired Majority Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>090302 - Disclosure - Acquisitions of Businesses, 2021 Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails</Role>
      <ShortName>Acquisitions of Businesses, 2021 Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>090304 - Disclosure - Acquisition of Business, 2021 Preliminary Purchase Prices Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails</Role>
      <ShortName>Acquisition of Business, 2021 Preliminary Purchase Prices Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>090306 - Disclosure - Acquisitions of Businesses, 2020 Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails</Role>
      <ShortName>Acquisitions of Businesses, 2020 Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>090308 - Disclosure - Acquisition of Business, 2020 Preliminary Purchase Prices Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails</Role>
      <ShortName>Acquisition of Business, 2020 Preliminary Purchase Prices Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>090310 - Disclosure - Acquisitions of Businesses, 2019 Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails</Role>
      <ShortName>Acquisitions of Businesses, 2019 Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>090312 - Disclosure - Acquisition of Business, 2019 Preliminary Purchase Prices Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails</Role>
      <ShortName>Acquisition of Business, 2019 Preliminary Purchase Prices Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>090314 - Disclosure - Acquisition of Business, Weighted Average Amortization Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails</Role>
      <ShortName>Acquisition of Business, Weighted Average Amortization Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>090400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails</Role>
      <ShortName>Acquisitions and Sale of Non-Controlling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>090500 - Disclosure - Redeemable Non-Controlling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterestDetails</Role>
      <ShortName>Redeemable Non-Controlling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/RedeemableNoncontrollingInterestTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>090600 - Disclosure - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/GoodwillDetails</Role>
      <ShortName>Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/GoodwillTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>090700 - Disclosure - Intangible Assets, net - Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets, net - Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>090702 - Disclosure - Intangible Assets, net - Amortization Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails</Role>
      <ShortName>Intangible Assets, net - Amortization Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>090704 - Disclosure - Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails</Role>
      <ShortName>Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>090800 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AccruedExpensesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>090900 - Disclosure - Notes Payable - Summary of Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails</Role>
      <ShortName>Notes Payable - Summary of Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>090902 - Disclosure - Notes Payable - Amended Credit Agreement (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAmendedCreditAgreementDetails</Role>
      <ShortName>Notes Payable - Amended Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>091000 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/LeasesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>091100 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails</Role>
      <ShortName>Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>091102 - Disclosure - Income Taxes - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesSummaryDetails</Role>
      <ShortName>Income Taxes - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>091104 - Disclosure - Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>091106 - Disclosure - Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>091200 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/SegmentInformationTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>091300 - Disclosure - Investment in Unconsolidated Affiliate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails</Role>
      <ShortName>Investment in Unconsolidated Affiliate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/InvestmentInUnconsolidatedAffiliate</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>091400 - Disclosure - Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails</Role>
      <ShortName>Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>091402 - Disclosure - Equity Based Plans - Cumulative Summary of Equity Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails</Role>
      <ShortName>Equity Based Plans - Cumulative Summary of Equity Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>091404 - Disclosure - Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails</Role>
      <ShortName>Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>091406 - Disclosure - Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails</Role>
      <ShortName>Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>091408 - Disclosure - Equity Based Plans - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansSummaryDetails</Role>
      <ShortName>Equity Based Plans - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>091600 - Disclosure - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommonStockDetails</Role>
      <ShortName>Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/CommonStock</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>091700 - Disclosure - Defined Contribution Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DefinedContributionPlanDetails</Role>
      <ShortName>Defined Contribution Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/DefinedContributionPlan</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>091800 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>091900 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/EarningsPerShareTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>092000 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/RelatedPartyTransactions</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="brhc10034321_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>092200 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="brhc10034321_10k.htm">brhc10034321_10k.htm</File>
    <File>brhc10034321_ex10-54.htm</File>
    <File>brhc10034321_ex21-1.htm</File>
    <File>brhc10034321_ex23-1.htm</File>
    <File>brhc10034321_ex31-1.htm</File>
    <File>brhc10034321_ex31-2.htm</File>
    <File>brhc10034321_ex31-3.htm</File>
    <File>brhc10034321_ex32-1.htm</File>
    <File>brhc10034321_ex4-1.htm</File>
    <File>usph-20211231.xsd</File>
    <File>usph-20211231_cal.xml</File>
    <File>usph-20211231_def.xml</File>
    <File>usph-20211231_lab.xml</File>
    <File>usph-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image00002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1085">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>111
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10034321_10k.htm": {
   "axisCustom": 0,
   "axisStandard": 24,
   "contextCount": 272,
   "dts": {
    "calculationLink": {
     "local": [
      "usph-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "usph-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10034321_10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "usph-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "usph-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "usph-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 712,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 15,
    "http://usph.com/20211231": 4,
    "http://xbrl.sec.gov/dei/2021q4": 9,
    "total": 28
   },
   "keyCustom": 131,
   "keyStandard": 419,
   "memberCustom": 48,
   "memberStandard": 29,
   "nsprefix": "usph",
   "nsuri": "http://usph.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://usph.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests",
     "role": "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests",
     "shortName": "Acquisitions and Sale of Non-Controlling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:RedeemableNonControllingInterestTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060500 - Disclosure - Redeemable Non-Controlling Interest",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterest",
     "shortName": "Redeemable Non-Controlling Interest",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:RedeemableNonControllingInterestTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060600 - Disclosure - Goodwill",
     "role": "http://usph.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060700 - Disclosure - Intangible Assets, net",
     "role": "http://usph.com/role/IntangibleAssetsNet",
     "shortName": "Intangible Assets, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060800 - Disclosure - Accrued Expenses",
     "role": "http://usph.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060900 - Disclosure - Notes Payable",
     "role": "http://usph.com/role/NotesPayable",
     "shortName": "Notes Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061000 - Disclosure - Leases",
     "role": "http://usph.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061100 - Disclosure - Income Taxes",
     "role": "http://usph.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061200 - Disclosure - Segment Information",
     "role": "http://usph.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061300 - Disclosure - Investment in Unconsolidated Affiliate",
     "role": "http://usph.com/role/InvestmentInUnconsolidatedAffiliate",
     "shortName": "Investment in Unconsolidated Affiliate",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010000 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://usph.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061400 - Disclosure - Equity Based Plans",
     "role": "http://usph.com/role/EquityBasedPlans",
     "shortName": "Equity Based Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061500 - Disclosure - Preferred Stock",
     "role": "http://usph.com/role/PreferredStock",
     "shortName": "Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061600 - Disclosure - Common Stock",
     "role": "http://usph.com/role/CommonStock",
     "shortName": "Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061700 - Disclosure - Defined Contribution Plan",
     "role": "http://usph.com/role/DefinedContributionPlan",
     "shortName": "Defined Contribution Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061800 - Disclosure - Commitments and Contingencies",
     "role": "http://usph.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061900 - Disclosure - Earnings Per Share",
     "role": "http://usph.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "062000 - Disclosure - Related Party Transactions",
     "role": "http://usph.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "062100 - Disclosure - Reclassification of Prior Period Presentation",
     "role": "http://usph.com/role/ReclassificationOfPriorPeriodPresentation",
     "shortName": "Reclassification of Prior Period Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "062200 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070200 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Tables)",
     "role": "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables",
     "shortName": "Organization, Nature of Operations and Basis of Presentation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080200 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080300 - Disclosure - Acquisitions of Businesses (Tables)",
     "role": "http://usph.com/role/AcquisitionsOfBusinessesTables",
     "shortName": "Acquisitions of Businesses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080500 - Disclosure - Redeemable Non-Controlling Interest (Tables)",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterestTables",
     "shortName": "Redeemable Non-Controlling Interest (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080600 - Disclosure - Goodwill (Tables)",
     "role": "http://usph.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080700 - Disclosure - Intangible Assets, net (Tables)",
     "role": "http://usph.com/role/IntangibleAssetsNetTables",
     "shortName": "Intangible Assets, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080800 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://usph.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080900 - Disclosure - Notes Payable (Tables)",
     "role": "http://usph.com/role/NotesPayableTables",
     "shortName": "Notes Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081000 - Disclosure - Leases (Tables)",
     "role": "http://usph.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081100 - Disclosure - Income Taxes (Tables)",
     "role": "http://usph.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://usph.com/role/ConsolidatedStatementsOfIncome",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081200 - Disclosure - Segment Information (Tables)",
     "role": "http://usph.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081400 - Disclosure - Equity Based Plans (Tables)",
     "role": "http://usph.com/role/EquityBasedPlansTables",
     "shortName": "Equity Based Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081900 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://usph.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090100 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)",
     "role": "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
     "shortName": "Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "usph:PercentageOfGeneralPartnershipInterestOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090102 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Summary (Details)",
     "role": "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails",
     "shortName": "Organization, Nature of Operations and Basis of Presentation - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "usph:PercentageOfGeneralPartnershipInterestOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090200 - Disclosure - Significant Accounting Policies, Long-Lived Assets (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails",
     "shortName": "Significant Accounting Policies, Long-Lived Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090202 - Disclosure - Significant Accounting Policies, Goodwill (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails",
     "shortName": "Significant Accounting Policies, Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "lang": null,
      "name": "usph:NumberOfRegions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U011",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_RangeAxis_MaximumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090204 - Disclosure - Significant Accounting Policies, Redeemable Non-Controlling Interest (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails",
     "shortName": "Significant Accounting Policies, Redeemable Non-Controlling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_RangeAxis_MaximumMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090206 - Disclosure - Significant Accounting Policies, Revenue Recognition (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails",
     "shortName": "Significant Accounting Policies, Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "3",
      "lang": null,
      "name": "usph:EstimatedPercentageOfDecreaseInPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_RangeAxis_MinimumMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090208 - Disclosure - Significant Accounting Policies, Contractual Allowances (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails",
     "shortName": "Significant Accounting Policies, Contractual Allowances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_RangeAxis_MinimumMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20181231_StatementEquityComponentsAxis_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "030000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "role": "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20181231_StatementEquityComponentsAxis_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
       "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090210 - Disclosure - Significant Accounting Policies, Income Taxes (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails",
     "shortName": "Significant Accounting Policies, Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations",
       "us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090212 - Disclosure - Significant Accounting Policies, Fair Value of Financial Instruments (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails",
     "shortName": "Significant Accounting Policies, Fair Value of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090214 - Disclosure - Significant Accounting Policies, Segment Reporting (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails",
     "shortName": "Significant Accounting Policies, Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_TitleOfIndividualAxis_OfficerMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090216 - Disclosure - Significant Accounting Policies, Restricted Stock (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails",
     "shortName": "Significant Accounting Policies, Restricted Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_TitleOfIndividualAxis_OfficerMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unitRef": "U006",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090300 - Disclosure - Acquisitions of Businesses, Acquired Majority Interest (Details)",
     "role": "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
     "shortName": "Acquisitions of Businesses, Acquired Majority Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember",
      "decimals": "INF",
      "lang": null,
      "name": "usph:NumberOfManagementContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U007",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unitRef": "U006",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090302 - Disclosure - Acquisitions of Businesses, 2021 Acquisition (Details)",
     "role": "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
     "shortName": "Acquisitions of Businesses, 2021 Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211130to20211130_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090304 - Disclosure - Acquisition of Business, 2021 Preliminary Purchase Prices Allocation (Details)",
     "role": "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
     "shortName": "Acquisition of Business, 2021 Preliminary Purchase Prices Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unitRef": "U006",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090306 - Disclosure - Acquisitions of Businesses, 2020 Acquisition (Details)",
     "role": "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
     "shortName": "Acquisitions of Businesses, 2020 Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090308 - Disclosure - Acquisition of Business, 2020 Preliminary Purchase Prices Allocation (Details)",
     "role": "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
     "shortName": "Acquisition of Business, 2020 Preliminary Purchase Prices Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unitRef": "U006",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090310 - Disclosure - Acquisitions of Businesses, 2019 Acquisition (Details)",
     "role": "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
     "shortName": "Acquisitions of Businesses, 2019 Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20190930to20190930_BusinessAcquisitionAxis_September2019AcquisitionMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090312 - Disclosure - Acquisition of Business, 2019 Preliminary Purchase Prices Allocation (Details)",
     "role": "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
     "shortName": "Acquisition of Business, 2019 Preliminary Purchase Prices Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember",
      "decimals": "-3",
      "lang": null,
      "name": "usph:BusinessAcquisitionPayableToShareholdersOfSeller",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerAndReferralRelationshipMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090314 - Disclosure - Acquisition of Business, Weighted Average Amortization Period (Details)",
     "role": "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails",
     "shortName": "Acquisition of Business, Weighted Average Amortization Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerAndReferralRelationshipMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "usph:NumberOfPartnershipInWhichInterestAcquired",
      "reportCount": 1,
      "unitRef": "U008",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests (Details)",
     "role": "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
     "shortName": "Acquisitions and Sale of Non-Controlling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090500 - Disclosure - Redeemable Non-Controlling Interest (Details)",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
     "shortName": "Redeemable Non-Controlling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20181231_OwnershipAxis_RedeemableNonControllingInterestMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090600 - Disclosure - Goodwill (Details)",
     "role": "http://usph.com/role/GoodwillDetails",
     "shortName": "Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090700 - Disclosure - Intangible Assets, net - Intangible Assets, Net (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
     "shortName": "Intangible Assets, net - Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090702 - Disclosure - Intangible Assets, net - Amortization Expenses (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
     "shortName": "Intangible Assets, net - Amortization Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090704 - Disclosure - Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
     "shortName": "Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090800 - Disclosure - Accrued Expenses (Details)",
     "role": "http://usph.com/role/AccruedExpensesDetails",
     "shortName": "Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090900 - Disclosure - Notes Payable - Summary of Notes Payable (Details)",
     "role": "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
     "shortName": "Notes Payable - Summary of Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060100 - Disclosure - Organization, Nature of Operations and Basis of Presentation",
     "role": "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation",
     "shortName": "Organization, Nature of Operations and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090902 - Disclosure - Notes Payable - Amended Credit Agreement (Details)",
     "role": "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
     "shortName": "Notes Payable - Amended Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091000 - Disclosure - Leases (Details)",
     "role": "http://usph.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091100 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)",
     "role": "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails",
     "shortName": "Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091102 - Disclosure - Income Taxes - Summary (Details)",
     "role": "http://usph.com/role/IncomeTaxesSummaryDetails",
     "shortName": "Income Taxes - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091104 - Disclosure - Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)",
     "role": "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails",
     "shortName": "Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091106 - Disclosure - Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)",
     "role": "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails",
     "shortName": "Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091200 - Disclosure - Segment Information (Details)",
     "role": "http://usph.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091300 - Disclosure - Investment in Unconsolidated Affiliate (Details)",
     "role": "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails",
     "shortName": "Investment in Unconsolidated Affiliate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_JointVentureInterestMember",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091400 - Disclosure - Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)",
     "role": "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
     "shortName": "Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091402 - Disclosure - Equity Based Plans - Cumulative Summary of Equity Plans (Details)",
     "role": "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails",
     "shortName": "Equity Based Plans - Cumulative Summary of Equity Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "lang": null,
      "name": "usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060200 - Disclosure - Significant Accounting Policies",
     "role": "http://usph.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091404 - Disclosure - Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)",
     "role": "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails",
     "shortName": "Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091406 - Disclosure - Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)",
     "role": "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
     "shortName": "Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091408 - Disclosure - Equity Based Plans - Summary (Details)",
     "role": "http://usph.com/role/EquityBasedPlansSummaryDetails",
     "shortName": "Equity Based Plans - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20090301to20090331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091600 - Disclosure - Common Stock (Details)",
     "role": "http://usph.com/role/CommonStockDetails",
     "shortName": "Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20090301to20090331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091700 - Disclosure - Defined Contribution Plan (Details)",
     "role": "http://usph.com/role/DefinedContributionPlanDetails",
     "shortName": "Defined Contribution Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:EmploymentAgreementsExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091800 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://usph.com/role/CommitmentsAndContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:EmploymentAgreementsExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091900 - Disclosure - Earnings Per Share (Details)",
     "role": "http://usph.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "usph:ShortSwingProfitSettlement",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "092000 - Disclosure - Related Party Transactions (Details)",
     "role": "http://usph.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "092200 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060300 - Disclosure - Acquisitions of Businesses",
     "role": "http://usph.com/role/AcquisitionsOfBusinesses",
     "shortName": "Acquisitions of Businesses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10034321_10k.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 79,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r110",
      "r261",
      "r266",
      "r274",
      "r462",
      "r463",
      "r469",
      "r470",
      "r521",
      "r597",
      "r609",
      "r611",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r110",
      "r261",
      "r266",
      "r274",
      "r462",
      "r463",
      "r469",
      "r470",
      "r521",
      "r597",
      "r609",
      "r611",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r110",
      "r161",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r187",
      "r191",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r271",
      "r273",
      "r274",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r110",
      "r161",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r187",
      "r191",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r271",
      "r273",
      "r274",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Directors [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ExecutiveOfficerMember": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of executive officer.",
        "label": "Executive Officer [Member]",
        "terseLabel": "Executive Officer [Member]"
       }
      }
     },
     "localname": "ExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r279",
      "r317",
      "r367",
      "r370",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r585",
      "r587",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails",
      "http://usph.com/role/IncomeTaxesSummaryDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r279",
      "r317",
      "r367",
      "r370",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r585",
      "r587",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails",
      "http://usph.com/role/IncomeTaxesSummaryDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of officer.",
        "label": "Officers [Member]"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r193",
      "r350",
      "r351",
      "r534",
      "r584",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Products and Services [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r193",
      "r350",
      "r351",
      "r534",
      "r584",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Products and Services [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r279",
      "r317",
      "r364",
      "r367",
      "r370",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r585",
      "r587",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails",
      "http://usph.com/role/IncomeTaxesSummaryDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r279",
      "r317",
      "r364",
      "r367",
      "r370",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r585",
      "r587",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails",
      "http://usph.com/role/IncomeTaxesSummaryDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r128",
      "r368",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r128",
      "r134",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r128",
      "r134",
      "r255",
      "r368",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r365",
      "r514",
      "r515",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity owned or controlled by another entity.",
        "label": "NewCo. [Member]"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r198",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Relationship to Entity [Domain]",
        "terseLabel": "Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r116",
      "r117",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Accounts and Other Receivables, Net, Current",
        "terseLabel": "Accounts receivable - other"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r16",
      "r40"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable - trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r11",
      "r28",
      "r199",
      "r200"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Patient accounts receivable, less allowance for credit losses of $2,768 and $2,008, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r22",
      "r553",
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Tax payable included in accrued liabilities"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r15",
      "r16",
      "r46"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "verboseLabel": "Group health insurance claims"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails",
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r38",
      "r240"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r29",
      "r393",
      "r524"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r390",
      "r391",
      "r392",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r372",
      "r374",
      "r395",
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Compensation expense - equity-based awards"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r374",
      "r387",
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Allowance for Credit Losses [Member]"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r34",
      "r202",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for credit losses, patient accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Deferred Charges [Abstract]"
       }
      }
     },
     "localname": "AmortizationOfDeferredChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r92",
      "r226",
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Total amortization expenses"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r452"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as current.",
        "label": "Contingent payment related to acquisition"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r106",
      "r169",
      "r182",
      "r189",
      "r209",
      "r261",
      "r262",
      "r263",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r272",
      "r274",
      "r275",
      "r462",
      "r469",
      "r483",
      "r522",
      "r524",
      "r551",
      "r569"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r57",
      "r106",
      "r209",
      "r261",
      "r262",
      "r263",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r272",
      "r274",
      "r275",
      "r462",
      "r469",
      "r483",
      "r522",
      "r524"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r375",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r366",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r366",
      "r369",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the business acquisition agreement was executed, in YYYY-MM-DD format.",
        "label": "Business Acquisition, Date of Acquisition Agreement",
        "terseLabel": "Acquisition date"
       }
      }
     },
     "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails",
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r445",
      "r446",
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Aggregate purchase price for the acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r444",
      "r447",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent payment consideration",
        "verboseLabel": "Contingent payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Description [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails",
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions of Businesses"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Goodwill [Abstract]",
        "terseLabel": "Goodwill [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails": {
       "order": 1.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "verboseLabel": "Other payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails": {
       "order": 3.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails": {
       "order": 2.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Total non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions of Businesses [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Net of cash acquired",
        "terseLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r10",
      "r35",
      "r94"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r18",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r88",
      "r94",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of period",
        "periodStartLabel": "Cash and cash equivalents - beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r88",
      "r484"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing transactions during the period:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r336",
      "r337",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r51",
      "r254",
      "r559",
      "r576"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r257",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r27",
      "r524"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $.01 par value, 20,000,000 shares authorized, 15,126,160 and 15,066,282 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r362",
      "r363",
      "r371",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Defined Contribution Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r227",
      "r231",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software [Member]"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent": {
     "auth_ref": [
      "r335",
      "r468",
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the purchase by the parent of an additional equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The purchase of the additional equity interest represented by this element increases the parent's controlling interest in the subsidiary.",
        "label": "Purchase price for additional non controlling interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent": {
     "auth_ref": [
      "r335",
      "r468",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a sale by the parent of a portion of its equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The sale of the equity interest represented by this element does not result in a loss of control by the parent.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Sale of Interest by Parent",
        "verboseLabel": "Cash proceeds from sale of non-controlling interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r468",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetPurchase": {
     "auth_ref": [
      "r212"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase from purchase of right to consideration in exchange for good or service transferred to customer when right is conditioned on passage of time.",
        "label": "Contract with Customer, Asset, Purchase",
        "terseLabel": "Ownership rights",
        "verboseLabel": "Seller put right"
       }
      }
     },
     "localname": "ContractWithCustomerAssetPurchase",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for contractual adjustments and third-party settlements.",
        "label": "Contractual Adjustments and Third Party Settlements, Policy [Policy Text Block]",
        "terseLabel": "Contractual Allowances"
       }
      }
     },
     "localname": "ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating cost"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating cost:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r417",
      "r425"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r417",
      "r425",
      "r427"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current [Abstract]"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r417",
      "r425"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer and Referral Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r103",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r293",
      "r300",
      "r301",
      "r303",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the total principal payments made during the annual reporting period.",
        "label": "Principal installments",
        "verboseLabel": "Annual installments"
       }
      }
     },
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r105",
      "r110",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r305",
      "r306",
      "r307",
      "r308",
      "r494",
      "r552",
      "r555",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r276",
      "r305",
      "r306",
      "r493",
      "r494",
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Aggregate amount of notes payable"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r48",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Percentage of interest accrued"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt instrument, measurement input"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r49",
      "r105",
      "r110",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r305",
      "r306",
      "r307",
      "r308",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r49",
      "r105",
      "r110",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r302",
      "r305",
      "r306",
      "r307",
      "r308",
      "r330",
      "r331",
      "r332",
      "r333",
      "r492",
      "r493",
      "r494",
      "r495",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": {
     "auth_ref": [
      "r361",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Period in which restrictions lapse on stock granted"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredCompensationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Abstract]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r418",
      "r425"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r92",
      "r107",
      "r418",
      "r425",
      "r426",
      "r427"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred [Abstract]"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r24",
      "r25",
      "r410",
      "r554",
      "r567"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other tax receivables expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Tax Receivable, Current",
        "terseLabel": "Tax receivable included in other current assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r418",
      "r425"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Acquired net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r401",
      "r412"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Contribution expense recognized"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Maximum employer contribution as a percentage of employee contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r92",
      "r164"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue, Categories"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Equity Based Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Based Plans [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends paid to USPT shareholders"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r68",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r135",
      "r137",
      "r139",
      "r140",
      "r141",
      "r145",
      "r146",
      "r477",
      "r478",
      "r563",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings per share basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r68",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r137",
      "r139",
      "r140",
      "r141",
      "r145",
      "r146",
      "r477",
      "r478",
      "r563",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings per share diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r108",
      "r403",
      "r428"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. tax at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductions": {
     "auth_ref": [
      "r403",
      "r428"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Percent",
        "negatedLabel": "Excess equity compensation deduction"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r403",
      "r428"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Nondeductible expenses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r403",
      "r428"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit and tax reform"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Salaries and related costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "verboseLabel": "Compensation not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r61",
      "r62",
      "r63",
      "r120",
      "r121",
      "r122",
      "r124",
      "r130",
      "r133",
      "r148",
      "r210",
      "r329",
      "r334",
      "r390",
      "r391",
      "r392",
      "r421",
      "r422",
      "r476",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r588",
      "r589",
      "r590",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r66",
      "r87",
      "r92",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Distribution received from investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Percentage of ownership in joint venture interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentQuotedMarketValue": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available.",
        "label": "Equity Method Investment, Quoted Market Value",
        "terseLabel": "Fair value of investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "EquityMethodInvestmentQuotedMarketValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting error correction.",
        "label": "Error Correction [Text Block]",
        "terseLabel": "Reclassification of Prior Period Presentation"
       }
      }
     },
     "localname": "ErrorCorrectionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ReclassificationOfPriorPeriodPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Values of Financial Instruments [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Values of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for charging off uncollectible financing receivables, including, but not limited to, factors and methodologies used in estimating the allowance for credit loss.",
        "label": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Preliminary Purchase Prices Allocation"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Amortization Expenses"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r227",
      "r228",
      "r232",
      "r235",
      "r535",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r227",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Federal [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Equipment [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfInterestInProjects": {
     "auth_ref": [
      "r4",
      "r244"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) included in earnings resulting from the sale of interest in projects.",
        "label": "Gain (Loss) on Sale of Interest in Projects",
        "terseLabel": "Gain on sale of partnership interest and clinics"
       }
      }
     },
     "localname": "GainLossOnSaleOfInterestInProjects",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation [Abstract]"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r214",
      "r216",
      "r524",
      "r550"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r221",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r92",
      "r215",
      "r219",
      "r222"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Closure costs - derecognition of goodwill",
        "negatedLabel": "Goodwill derecognition (write-off) related to closed clinics",
        "verboseLabel": "Derecognition (write-off) of goodwill - closed clinics"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r220",
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill adjustments for purchase price allocation of businesses acquired in prior year"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedLabel": "Goodwill related to partnership interest sold"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrantsReceivable": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.",
        "label": "Advance payment received"
       }
      }
     },
     "localname": "GrantsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r72",
      "r106",
      "r169",
      "r181",
      "r185",
      "r188",
      "r191",
      "r209",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r270",
      "r272",
      "r274",
      "r275",
      "r483"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed of"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r237",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r65",
      "r169",
      "r181",
      "r185",
      "r188",
      "r191",
      "r549",
      "r561",
      "r564",
      "r582"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income and equity in earnings of unconsolidated affiliates before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r66",
      "r92",
      "r166",
      "r204",
      "r560",
      "r578"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Equity in earnings of unconsolidated affiliate",
        "negatedLabel": "Earnings in unconsolidated affiliate",
        "terseLabel": "Earnings from investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF INCOME [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r108",
      "r404",
      "r408",
      "r414",
      "r423",
      "r429",
      "r431",
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationYearUnderExamination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year being audited in the income tax examination, in YYYY format.",
        "label": "Income Tax Examination, Year under Examination",
        "terseLabel": "Periods open for examination"
       }
      }
     },
     "localname": "IncomeTaxExaminationYearUnderExamination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r109",
      "r132",
      "r133",
      "r167",
      "r402",
      "r424",
      "r430",
      "r583"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails",
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.",
        "label": "Adjustment to deferred tax assets"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r398",
      "r399",
      "r408",
      "r409",
      "r413",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationDeductions": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Amount",
        "negatedLabel": "Excess equity compensation deduction"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "U.S. tax at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r54",
      "r558",
      "r577"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Federal income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Increase (decrease) in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "(Increase) decrease in patient accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables, and operating assets classified as other.",
        "label": "Increase (Decrease) in Accounts Receivable and Other Operating Assets",
        "negatedLabel": "(Increase) decrease in accounts receivable - other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (decrease) in other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "(Increase) decrease in other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r225",
      "r230"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other identifiable intangible assets, net",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, net [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest expense on prepetition obligations included in the statement of operations.",
        "label": "Interest Expense on Prepetition Liabilities Recognized in Statement of Operations",
        "terseLabel": "Interest expense recognized"
       }
      }
     },
     "localname": "InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r85",
      "r89",
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r206",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in Unconsolidated Affiliate [Abstract]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Unconsolidated Affiliate [Abstract]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities.",
        "label": "Investments in and Advances to Affiliates, Schedule of Investments [Text Block]",
        "terseLabel": "Investment in Unconsolidated Affiliate"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliate"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Labor and Related Expense",
        "terseLabel": "Salaries and related costs"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r508",
      "r510"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Lease Expense [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r14",
      "r239"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease [Abstract]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Future Lease Payments for Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/LeasesDetailsCalc01": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2027 and therafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetailsCalc01": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r45",
      "r106",
      "r183",
      "r209",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r270",
      "r272",
      "r274",
      "r275",
      "r463",
      "r469",
      "r470",
      "r483",
      "r522",
      "r523"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r106",
      "r209",
      "r483",
      "r524",
      "r557",
      "r574"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTEREST"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r47",
      "r106",
      "r209",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r270",
      "r272",
      "r274",
      "r275",
      "r463",
      "r469",
      "r470",
      "r483",
      "r522",
      "r523",
      "r524"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r6",
      "r7",
      "r8",
      "r238",
      "r242"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Closure costs"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of the credit facility.",
        "label": "Increase on limit of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "verboseLabel": "Average effective interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility commitment"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining revolving credit outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Percentage of unused commitment fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r51",
      "r254",
      "r256"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Settlement of a legal matter"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Payment of settlement amount"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "negatedLabel": "Settlement of a legal matter"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r23",
      "r290",
      "r304",
      "r305",
      "r306",
      "r555",
      "r571"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Payments/Long term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r110",
      "r260",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Aggregate principal payment due in 2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r110",
      "r260",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "verboseLabel": "Aggregate principal payment due in 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r110",
      "r260",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Aggregate principal payment due in 2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long term portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r49",
      "r258",
      "r259"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit, Noncurrent",
        "terseLabel": "Revolving line of credit"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Amount of payments recorded as expense during the period"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNumberOfDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of defendants named in a legal action.",
        "label": "Number of defendants dismissed"
       }
      }
     },
     "localname": "LossContingencyNumberOfDefendants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesFairValueOfFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r55",
      "r106",
      "r209",
      "r261",
      "r266",
      "r267",
      "r268",
      "r274",
      "r275",
      "r483",
      "r556",
      "r573"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "verboseLabel": "Changes in the fair value of redeemable non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to non-controlling interest partners - permanent equity"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r334",
      "r460",
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Purchase of partnership interests - non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Acquisitions and Sale of Non-Controlling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: net income attributable to non-controlling interest:"
       }
      }
     },
     "localname": "MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Percentage of retained interest by previous owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r88",
      "r90",
      "r93"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r8",
      "r58",
      "r59",
      "r63",
      "r67",
      "r93",
      "r106",
      "r123",
      "r125",
      "r126",
      "r127",
      "r128",
      "r132",
      "r133",
      "r138",
      "r169",
      "r181",
      "r185",
      "r188",
      "r191",
      "r209",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r270",
      "r272",
      "r274",
      "r275",
      "r478",
      "r483",
      "r562",
      "r579"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 0.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income attributable to USPH shareholders",
        "terseLabel": "Net income attributable to USPH shareholders",
        "totalLabel": "Net income attributable to USPH shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r58",
      "r59",
      "r63",
      "r132",
      "r133",
      "r465",
      "r472"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTotalLabel": "Net income attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Computation of earnings per share - USPH shareholders [Abstract]"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently Issued Accounting Pronouncement"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1": {
     "auth_ref": [
      "r97",
      "r98",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Purchase of business - payable to common shareholders of acquired business"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionPayablesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": {
     "auth_ref": [
      "r97",
      "r98",
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.",
        "label": "Note receivables related to sale of partnership interest"
       }
      }
     },
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Non-compete Agreements [Member]",
        "terseLabel": "Non-compete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions and Sale of Non-Controlling Interests [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": {
     "auth_ref": [
      "r335",
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.",
        "label": "Noncontrolling Interest, Decrease from Deconsolidation",
        "negatedLabel": "Reduction of non-controlling interest due to sale of USPH partnership interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.",
        "label": "Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r334",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-Controlling Interests [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income and expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of clinics",
        "verboseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails",
      "http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r169",
      "r181",
      "r185",
      "r188",
      "r191"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r501",
      "r510"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future Lease Payments for Operating Leases [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetailsCalc01": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r498",
      "r504"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r496"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r507",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted-average discount rate - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r506",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-average remaining lease term - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Reportable Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Nature of Operations and Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r9",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Nature of Operations and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r46"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r56",
      "r524"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income and expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Shareholders' Equity [Member]"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Expenses [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends paid to shareholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to non-controlling interest, permanent and temporary equity"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r78",
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid for acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Purchase of majority interest in businesses, net of cash acquired",
        "terseLabel": "Cash paid, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedLabel": "Purchase of non-controlling interest, permanent equity"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r79",
      "r453",
      "r454",
      "r455"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Purchase of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Acquired interest"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r375",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r26",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/PreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r26",
      "r524"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification of Prior Period Presentation [Abstract]"
       }
      }
     },
     "localname": "PriorPeriodAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds on sales of partnership interest, clinics and fixed assets"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.",
        "label": "Proceeds from Divestiture of Interest in Subsidiaries and Affiliates",
        "terseLabel": "Proceeds on sale of redeemable non-controlling interest, temporary equity"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r80",
      "r105"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving line of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Notes receivable related to sale of partnership interest - redeemable non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.",
        "label": "Purchases of redeemable non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r8",
      "r58",
      "r59",
      "r63",
      "r86",
      "r106",
      "r123",
      "r132",
      "r133",
      "r169",
      "r181",
      "r185",
      "r188",
      "r191",
      "r209",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r270",
      "r272",
      "r274",
      "r275",
      "r459",
      "r464",
      "r466",
      "r472",
      "r473",
      "r478",
      "r483",
      "r564"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income",
        "verboseLabel": "Net income including non-controlling interest and earnings from unconsolidated affiliates, net"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Assets [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r38",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r37",
      "r239"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Fixed assets, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r241",
      "r524",
      "r565",
      "r575"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Fixed assets, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Fixed assets:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r19",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r69",
      "r213"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest, by Legal Entity [Table]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestByLegalEntityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable non-controlling interest - temporary equity",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Fair value"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interests [Roll Forward]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmountAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r365",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r365",
      "r514",
      "r517",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r512",
      "r513",
      "r515",
      "r518",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r83",
      "r105"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving line of credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Principal payments on notes payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r92",
      "r246",
      "r248",
      "r249"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Closure costs - lease and other",
        "verboseLabel": "Closure costs"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r30",
      "r334",
      "r393",
      "r524",
      "r572",
      "r591",
      "r592"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r120",
      "r121",
      "r122",
      "r124",
      "r130",
      "r133",
      "r210",
      "r390",
      "r391",
      "r392",
      "r421",
      "r422",
      "r476",
      "r588",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r160",
      "r161",
      "r180",
      "r186",
      "r187",
      "r193",
      "r194",
      "r196",
      "r349",
      "r350",
      "r534"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenue",
        "verboseLabel": "Revenue related to the various categories"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r64",
      "r106",
      "r160",
      "r161",
      "r180",
      "r186",
      "r187",
      "r193",
      "r194",
      "r196",
      "r209",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r270",
      "r272",
      "r274",
      "r275",
      "r483",
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Net operating revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "verboseLabel": "Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r505",
      "r510"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails",
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "verboseLabel": "Clinic Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Significant Components of Provision for Income Taxes for Continuing Operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r49",
      "r110",
      "r305",
      "r307",
      "r330",
      "r331",
      "r332",
      "r333",
      "r492",
      "r493",
      "r495",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Credit Agreement and Notes Payable"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computations of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r8",
      "r106",
      "r207",
      "r209",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r227",
      "r231",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r227",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r221",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r38",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesLonglivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r169",
      "r172",
      "r184",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r169",
      "r172",
      "r184",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Selected Financial Data for Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r382",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Cumulative Summary of Equity Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r375",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "verboseLabel": "Restricted Stock Granted and Cancelled"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Amortization of Customer and Referral Relationships and Non Competition Agreements"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r156",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r196",
      "r247",
      "r250",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Information [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails",
      "http://usph.com/role/SignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r156",
      "r158",
      "r159",
      "r169",
      "r173",
      "r185",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Corporate office costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Acquisitions [Member]"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Equity-based awards compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Number of shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Authorized (in shares)",
        "verboseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of common shares available for grant (in shares)",
        "verboseLabel": "Shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Stock options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r379",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Outstanding stock options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r373",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Equity Award [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Closing price (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r502",
      "r510"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r101",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r156",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r196",
      "r221",
      "r243",
      "r247",
      "r250",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r53",
      "r61",
      "r62",
      "r63",
      "r120",
      "r121",
      "r122",
      "r124",
      "r130",
      "r133",
      "r148",
      "r210",
      "r329",
      "r334",
      "r390",
      "r391",
      "r392",
      "r421",
      "r422",
      "r476",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r588",
      "r589",
      "r590",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED BALANCE SHEETS [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r148",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r26",
      "r27",
      "r329",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r329",
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Common stock authorized by the Board of Directors (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r26",
      "r27",
      "r329",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Total purchased shares (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r27",
      "r31",
      "r32",
      "r106",
      "r203",
      "r209",
      "r483",
      "r524"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total USPH shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U. S. Physical Therapy, Inc. shareholders' equity:",
        "terseLabel": "U.S. Physical Therapy, Inc. (\"USPH\") shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r62",
      "r106",
      "r120",
      "r121",
      "r122",
      "r124",
      "r130",
      "r209",
      "r210",
      "r334",
      "r390",
      "r391",
      "r392",
      "r421",
      "r422",
      "r457",
      "r458",
      "r471",
      "r476",
      "r483",
      "r485",
      "r486",
      "r490",
      "r589",
      "r590",
      "r623"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total USPH shareholders' equity and non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r104",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r334",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r491",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r491",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r491",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Federal taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Tradenames [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r52",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r52",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r52",
      "r336",
      "r339"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock at cost, 2,214,737 shares"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties associated with any unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails",
      "http://usph.com/role/SignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "terseLabel": "Interest expense recognized"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r111",
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Additions Charged to Cost and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "Additions Charged to Other Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r503",
      "r510"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r136",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Diluted earnings per share - weighted-average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Shares used in computation - basic and diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Shares used in computation [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r135",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Basic earnings per share - weighted-average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_AccountsPayableDueToSellerOfAcquiredBusiness": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred related to accounts payable due to seller of acquired business.",
        "label": "Accounts Payable Due to Seller of Acquired Business",
        "terseLabel": "Accounts payable - due to seller of acquired business"
       }
      }
     },
     "localname": "AccountsPayableDueToSellerOfAcquiredBusiness",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_AdditionalEstimatedRepurchaseOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional estimated repurchase of common stock during the period.",
        "label": "Additional Estimated Repurchase Of Common Stock",
        "terseLabel": "Additional estimated shares (in shares)"
       }
      }
     },
     "localname": "AdditionalEstimatedRepurchaseOfCommonStock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_AggregateSalePriceOfCinics": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale price of the clinics sold which were discontinued.",
        "label": "Aggregate Sale Price of Clinics",
        "terseLabel": "Aggregate sale price of clinics"
       }
      }
     },
     "localname": "AggregateSalePriceOfCinics",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_AmendedNineteenNinetyNinePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the equity-based compensation arrangement plan.",
        "label": "Amended Nineteen Ninety Nine Plan [Member]",
        "terseLabel": "Amended 1999 Plan [Member]"
       }
      }
     },
     "localname": "AmendedNineteenNinetyNinePlanMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AmendedTwoThousandThreePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the equity-based compensation arrangement plan.",
        "label": "Amended Two Thousand Three Plan [Member]",
        "terseLabel": "Amended 2003 Plan [Member]"
       }
      }
     },
     "localname": "AmendedTwoThousandThreePlanMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AmountOfReductionsInFederalSpending": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reductions in federal spending during the period.",
        "label": "Amount Of Reductions In Federal Spending",
        "terseLabel": "Reductions in federal spending"
       }
      }
     },
     "localname": "AmountOfReductionsInFederalSpending",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_April2019AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "April 2019 Acquisition [Member]"
       }
      }
     },
     "localname": "April2019AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AprilTwoThousandNineteenAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "April Two Thousand Nineteen Acquisition [Member]",
        "verboseLabel": "April 2019 Acquisition [Member]"
       }
      }
     },
     "localname": "AprilTwoThousandNineteenAcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AverageLeaseTermsAndDiscountRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Lease Terms and Discount Rates [Abstract]"
       }
      }
     },
     "localname": "AverageLeaseTermsAndDiscountRatesAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank credit agreement to permit share repurchases of common stock during the period.",
        "label": "Bank Credit Agreement To Permit Share Repurchases Of Common Stock",
        "terseLabel": "Bank credit agreement to permit share repurchases of common stock"
       }
      }
     },
     "localname": "BankCreditAgreementToPermitShareRepurchasesOfCommonStock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessAcquisitionConsiderationPayableTermOfNote": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of the note issued for consideration payable for the acquisition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Business Acquisition Consideration Payable, Term of Note",
        "terseLabel": "Business acquisition, consideration payable, term of note"
       }
      }
     },
     "localname": "BusinessAcquisitionConsiderationPayableTermOfNote",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.",
        "label": "Business Acquisition Cost Of Acquired Entity Debt Issued",
        "terseLabel": "Notes payable",
        "verboseLabel": "Seller notes"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityDebtIssued",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition number of installments for payment of purchase consideration.",
        "label": "Business Acquisition Number Of Installments For Payment Of Purchase Consideration",
        "terseLabel": "Number of installments"
       }
      }
     },
     "localname": "BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_BusinessAcquisitionPayableToShareholdersOfSeller": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount payable to shareholders of seller in business acquisition.",
        "label": "Business Acquisition,Payable to Shareholders of Seller",
        "terseLabel": "Payable to shareholders of seller"
       }
      }
     },
     "localname": "BusinessAcquisitionPayableToShareholdersOfSeller",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of equity interest in subsidiary contributed for acquisition.",
        "label": "Business Acquisition Percentage Of Equity Interest In Subsidiary Contributed",
        "terseLabel": "Percentage of equity interest of subsidiary contributed for acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of general partnership interest acquired in the business combination.",
        "label": "Business Acquisition, Percentage of General Partnership Interest Acquired",
        "terseLabel": "Business acquisition, percentage of general partnership interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests retained by practice founder at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Interest Retained by Practice Founder",
        "terseLabel": "Percentage of interest retained by practice founder"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfInterestRetainedByPracticeFounder",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of limited partnership interest acquired in the business combination.",
        "label": "Business Acquisition, Percentage of Limited Partnership Interest Acquired",
        "verboseLabel": "Business acquisition, percentage of limited partnership acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net tangible asset acquired at the acquisition date.",
        "label": "Business Acquisition Purchase Price Allocation Net Tangible Asset",
        "totalLabel": "Net tangible assets acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful lives of acquired intangibles"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination Acquisition Fair Value of Redeemable Non-Controlling Interests",
        "negatedLabel": "Fair value of non-controlling interest (classified as redeemable non-controlling interest)"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationConsiderationTransferredIncludesContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred including contingent consideration, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred, Includes Contingent Consideration",
        "terseLabel": "Aggregate purchase price for the acquisition including contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludesContingentConsideration",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration upon on achievement of certain business criteria in a business combination.",
        "label": "Business Combination, Contingent Consideration, Payable on Achievement of Certain Business Criteria",
        "terseLabel": "Amount payable upon achievement of certain business criteria"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationPayableOnAchievementOfCertainBusinessCriteria",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-competition agreements recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements",
        "terseLabel": "Non-compete agreements",
        "verboseLabel": "Non-compete"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of referral relationships at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships",
        "terseLabel": "Referral relationships",
        "verboseLabel": "Customer and referral relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of tradename recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename",
        "terseLabel": "Tradenames",
        "verboseLabel": "Tradename"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CarryingAmountOfRedeemableNonControllingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Amount of Redeemable Non-Controlling Interest [Abstract]",
        "verboseLabel": "Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]"
       }
      }
     },
     "localname": "CarryingAmountOfRedeemableNonControllingInterestAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.",
        "label": "Carrying Amount of Redeemable Non-Controlling Interest [Table Text Block]",
        "terseLabel": "Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "CarryingAmountOfRedeemableNonControllingInterestTableTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and noncash consideration that could pay with respect to acquisition.",
        "label": "Cash And Noncash Consideration With Respect To Acquisition After Amendement",
        "terseLabel": "Cash and noncash consideration with respect to acquisition after amendment"
       }
      }
     },
     "localname": "CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CashPaidDuringPeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During Period For [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodForAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_CashReceivedRelatedToSaleOfClinics": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received related to sale of discontinued clinics.",
        "label": "Cash Received Related to Sale of Clinics",
        "terseLabel": "Cash received related to sale of closed clinics"
       }
      }
     },
     "localname": "CashReceivedRelatedToSaleOfClinics",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CentersForMedicareAndMedicaidServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An approval authority for Medicare services.",
        "label": "Centers for Medicare and Medicaid Services [Member]",
        "terseLabel": "CMS [Member]"
       }
      }
     },
     "localname": "CentersForMedicareAndMedicaidServicesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income (loss) from revaluation of redeemable noncontrolling interest.",
        "label": "Charges To Retained Earnings Revaluation Of Non Controlling Interests",
        "terseLabel": "Revaluation of redeemable non-controlling interest"
       }
      }
     },
     "localname": "ChargesToRetainedEarningsRevaluationOfNonControllingInterests",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ClinicPracticeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which provides clinic practice services.",
        "label": "Clinic Practice [Member]",
        "terseLabel": "Clinic Practice [Member]"
       }
      }
     },
     "localname": "ClinicPracticeMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combined physical therapy/speech language pathology expenses during the period.",
        "label": "Combined Physical Therapy Speech Language Pathology Expenses",
        "terseLabel": "Combined physical therapy/speech language pathology expenses"
       }
      }
     },
     "localname": "CombinedPhysicalTherapySpeechLanguagePathologyExpenses",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ContractualAllowancesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual Allowances [Abstract]"
       }
      }
     },
     "localname": "ContractualAllowancesAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.",
        "label": "Contractual Time Period Has Not Lapsed And Holders Employment Has Not Been Terminated",
        "terseLabel": "Contractual time period has not lapsed and holder's employment has not terminated"
       }
      }
     },
     "localname": "ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.",
        "label": "Contractual Time Period Has Lapsed But Holders Employment Has Not Been Terminated",
        "terseLabel": "Contractual time period has lapsed but holder's employment has not terminated"
       }
      }
     },
     "localname": "ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A credit agreement is a legal contract in which a bank arranges to loan a customer a certain amount of money for a specified amount of time.",
        "label": "Credit Agreement [Member]"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_CreditChargesToRetainedEarningsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Charges To Retained Earnings [Abstract]",
        "terseLabel": "(Charges) credit to retained earnings [Abstract]"
       }
      }
     },
     "localname": "CreditChargesToRetainedEarningsAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_CustomerAndReferralRelationshipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts and also includes referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer and Referral Relationship [Member]",
        "terseLabel": "Customer and Referral Relationship [Member]"
       }
      }
     },
     "localname": "CustomerAndReferralRelationshipMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_DebtInstrumentBasisSpreadOnLiborVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument Basis Spread On Libor Variable Rate",
        "verboseLabel": "Spread on Libor variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnLiborVariableRate",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_December2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "December 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "December2021AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Decrease in Note Receivable form sales of redeemable non-controlling interest - temporary equity",
        "terseLabel": "Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DeferredEmployerPayrollTaxesCARESACT": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred employer payroll taxes - CARES ACT.",
        "label": "Deferred employer payroll taxes - CARES ACT",
        "terseLabel": "Deferred employer payroll taxes - CARES ACT"
       }
      }
     },
     "localname": "DeferredEmployerPayrollTaxesCARESACT",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DeferredTaxAssetsLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the lease obligations.",
        "label": "Deferred Tax Assets Lease Obligations",
        "terseLabel": "Lease obligations - including closed clinics"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseObligations",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of deferred tax assets related to revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests.",
        "label": "Deferred Tax Assets Related to Redeemable Non-controlling Interests and Acquisitions of Non-controlling Interests",
        "terseLabel": "Net deferred tax assets, related to revaluation and acquisition of redeemable non-controlling interests"
       }
      }
     },
     "localname": "DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to operating lease right-of-use assets.",
        "label": "Deferred Tax Liabilities Operating Lease Right-of-use Assets",
        "negatedLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DefinedContributionPlanEmployerMatchingContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of matching contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution Amount",
        "terseLabel": "Employer matching contribution amount"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionAmount",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period consider for new employees to cover under defined contribution plan.",
        "label": "Defined Contribution Plan Period For New Employees Covered Under Plan",
        "terseLabel": "Required time period for employees for profit sharing plan"
       }
      }
     },
     "localname": "DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.",
        "label": "Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage",
        "terseLabel": "Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage"
       }
      }
     },
     "localname": "DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between net revenues and corresponding cash collections reflected percentage of net revenues.",
        "label": "Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues",
        "terseLabel": "Difference between net revenues and corresponding cash collections, approximately of net revenues"
       }
      }
     },
     "localname": "DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_DistributionsFromUnconsolidatedAffiliate": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the distributions from unconsolidated affiliate.",
        "label": "Distributions from Unconsolidated Affiliate",
        "terseLabel": "Distributions from unconsolidated affiliate"
       }
      }
     },
     "localname": "DistributionsFromUnconsolidatedAffiliate",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.",
        "label": "Distributions to Limited Partners and Redeemable Noncontrolling Interests",
        "negatedLabel": "Distributions to redeemable non-controlling interest partners"
       }
      }
     },
     "localname": "DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DividendsCashAfterAmendment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends Cash After Amendment",
        "terseLabel": "Cash dividends after amendment"
       }
      }
     },
     "localname": "DividendsCashAfterAmendment",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal and state statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation At Federal and State Statutory Income Tax Rate",
        "terseLabel": "Federal and state statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_EmployeeCompensationFuturePaymentDueNextFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum payments for employee agreements in excess of one year due in the next fiscal year following the latest fiscal year.",
        "label": "Employee Compensation Future Payment Due Next Fiscal Year",
        "terseLabel": "Future compensation - 2022"
       }
      }
     },
     "localname": "EmployeeCompensationFuturePaymentDueNextFiscalYear",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum payments for employee agreements in excess of one year due after next fiscal year following the latest fiscal year.",
        "label": "Employee Compensation Future Payment Due Next Fiscal Year Thereafter",
        "terseLabel": "Future compensation - 2023 through 2024"
       }
      }
     },
     "localname": "EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person who is employed by the company.",
        "label": "Employee [Member]",
        "terseLabel": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An individual who works part-time or full-time under a contract of employment.",
        "label": "Employees [Member]",
        "terseLabel": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_EmploymentAgreementRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The renewal term of the employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Employment Agreement Renewal Term",
        "terseLabel": "Employment agreement renewal term"
       }
      }
     },
     "localname": "EmploymentAgreementRenewalTerm",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_EmploymentAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employment Agreements [Abstract]",
        "terseLabel": "Employee Agreements [Abstract]"
       }
      }
     },
     "localname": "EmploymentAgreementsAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_EmploymentAgreementsExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the employment agreements.",
        "label": "Employment Agreements Expiration Date",
        "terseLabel": "Expiration date of employment agreement, one"
       }
      }
     },
     "localname": "EmploymentAgreementsExpirationDate",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "usph_EmploymentAgreementsExpirationDateFour": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the employment agreements four.",
        "label": "Employment Agreements Expiration Date Four",
        "terseLabel": "Expiration date of employment agreement, four"
       }
      }
     },
     "localname": "EmploymentAgreementsExpirationDateFour",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "usph_EmploymentAgreementsExpirationDateThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the employment agreements three.",
        "label": "Employment Agreements Expiration Date Three",
        "terseLabel": "Expiration date of employment agreement, three"
       }
      }
     },
     "localname": "EmploymentAgreementsExpirationDateThree",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "usph_EmploymentAgreementsExpirationDateTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the employment agreements two.",
        "label": "Employment Agreements Expiration Date Two",
        "terseLabel": "Expiration date of employment agreement, two"
       }
      }
     },
     "localname": "EmploymentAgreementsExpirationDateTwo",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Fair Value Of Net Tangible Assets Acquired [Abstract]",
        "terseLabel": "Estimated fair value of net tangible assets acquired [Abstract]"
       }
      }
     },
     "localname": "EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_EstimatedPercentageOfDecreaseInPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated percentage of decrease in payment during the period.",
        "label": "Estimated Percentage of Decrease in Payment",
        "terseLabel": "Estimated percentage of decrease in payment"
       }
      }
     },
     "localname": "EstimatedPercentageOfDecreaseInPayment",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ExpectedReductionInMedicareSpendingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected reduction in Medicare spending percentage during the period.",
        "label": "Expected Reduction In Medicare Spending Percentage",
        "terseLabel": "Expected reduction in Medicare spending percentage"
       }
      }
     },
     "localname": "ExpectedReductionInMedicareSpendingPercentage",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_February2020AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "February 2020 Acquisition [Member]",
        "terseLabel": "February 2020 Acquisition [Member]"
       }
      }
     },
     "localname": "February2020AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_FromTwoThousandSeventeenThroughTwoThousandNineteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance products service years.",
        "label": "From Two Thousand Seventeen Through Two Thousand Nineteen [Member]",
        "terseLabel": "Year 2017 through 2019 [Member]"
       }
      }
     },
     "localname": "FromTwoThousandSeventeenThroughTwoThousandNineteenMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance products service years.",
        "label": "From Two Thousand Twenty Through Two Thousand Twenty Five [Member]",
        "terseLabel": "From 2020 through 2025 [Member]"
       }
      }
     },
     "localname": "FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_GainOnSaleOfPartnershipInterestNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "After tax amount of gain on sale or disposal of partnership interest.",
        "label": "Gain on Sale of Partnership Interest, Net of Tax",
        "negatedLabel": "Gain on sale of partnership interest"
       }
      }
     },
     "localname": "GainOnSaleOfPartnershipInterestNetOfTax",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_GrantsAndOtherFunds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.",
        "label": "Grants and Other Funds",
        "terseLabel": "Grants and other funds"
       }
      }
     },
     "localname": "GrantsAndOtherFunds",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to holder's employment has terminated and contractual time period has expired.",
        "label": "Holders Employment Has Terminated and Contractual Time Period Has Expired",
        "terseLabel": "Holder's employment has terminated and contractual time period has expired"
       }
      }
     },
     "localname": "HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to holder's employment has terminated and contractual time period has not expired.",
        "label": "Holders Employment Has Terminated and Contractual Time Period Has Not Expired",
        "terseLabel": "Holder's employment has terminated and contractual time period has not expired"
       }
      }
     },
     "localname": "HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.",
        "label": "Income Loss From Operations After Revaluation Of NonControlling Interests",
        "totalLabel": "Net income attributable to common shareholders"
       }
      }
     },
     "localname": "IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IncomeTaxExaminationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExaminationAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.",
        "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal and State Statutory Income Tax Rate",
        "negatedLabel": "Tax effect at statutory rate (federal and state) of 25.55% and 26.25%, respectively"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IndustrialInjuryPreventionServicesRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from the industrial injury prevention business are derived from onsite services provided to clients' employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenues are determined based on the number of hours and respective rate for services provided. The Company has agreements with third-party payers that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payer contracts and historical collection and write-off experience.",
        "label": "Industrial Injury Prevention Services Revenues [Member]",
        "terseLabel": "Industrial Injury Prevention Services [Member]",
        "verboseLabel": "Industrial Injury Prevention Services [Member]"
       }
      }
     },
     "localname": "IndustrialInjuryPreventionServicesRevenuesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_InterestExpenseDebtAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt related expenses and other expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest Expense, Debt and Other Expense",
        "negatedLabel": "Interest expense - debt and other"
       }
      }
     },
     "localname": "InterestExpenseDebtAndOther",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_JointVentureInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The joint venture interest in entity which provides physical therapy services for patients at hospitals",
        "label": "Joint Venture Interest [Member]",
        "terseLabel": "Joint Venture Interest [Member]"
       }
      }
     },
     "localname": "JointVentureInterestMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/InvestmentInUnconsolidatedAffiliateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_June2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "June 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "June2021AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_LeadingProviderOfIndustrialInjuryPreventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which provides services include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.",
        "label": "Leading Provider of Industrial Injury Prevention [Member]",
        "terseLabel": "IIPS [Member]",
        "verboseLabel": "IIPS [Member]"
       }
      }
     },
     "localname": "LeadingProviderOfIndustrialInjuryPreventionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ManagementAndServicesContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which holds management and service contracts.",
        "label": "Management and Services Contracts [Member]",
        "terseLabel": "Management and Services Contracts [Member]"
       }
      }
     },
     "localname": "ManagementAndServicesContractsMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ManagementContractRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. Revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed.",
        "label": "Management Contract Revenues [Member]",
        "terseLabel": "Physical Therapy Management Contracts [Member]"
       }
      }
     },
     "localname": "ManagementContractRevenuesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ManagementContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which holds management contracts.",
        "label": "Management Contracts [Member]",
        "terseLabel": "Management Contracts [Member]"
       }
      }
     },
     "localname": "ManagementContractsMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_March2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "March 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "March2021AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_MaximumContractualAllowanceReserveEstimate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum contractual allowance reserve estimate.",
        "label": "Maximum Contractual Allowance Reserve Estimate",
        "terseLabel": "Maximum contractual allowance reserve estimate"
       }
      }
     },
     "localname": "MaximumContractualAllowanceReserveEstimate",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesContractualAllowancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_MedicareAcceleratedAndAdvancePaymentFunds": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of medicare accelerated and advance payment funds.",
        "label": "Medicare Accelerated and Advance Payment Funds",
        "terseLabel": "(Payment) receipt of Medicare Accelerated and Advance Funds"
       }
      }
     },
     "localname": "MedicareAcceleratedAndAdvancePaymentFunds",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funds from the CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing Medicare Accelerated and Advance Payments Program (\"MAAPP funds\") during the COVID-19 pandemic",
        "label": "Medicare Accelerated and Advance Payments Program Funds Payable",
        "terseLabel": "MAAPP Funds Payable"
       }
      }
     },
     "localname": "MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_MedicareAcceleratedAndAdvancePaymentsProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.",
        "label": "Medicare Accelerated and Advance Payments Program [Member]",
        "terseLabel": "Medicare Accelerated and Advance Payments Program [Member]"
       }
      }
     },
     "localname": "MedicareAcceleratedAndAdvancePaymentsProgramMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_MedicareReimbursementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare Reimbursement [Abstract]",
        "terseLabel": "Medicare Reimbursement [Abstract]"
       }
      }
     },
     "localname": "MedicareReimbursementAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_MultiClinicPracticesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which provides multi-clinic practice services.",
        "label": "Multi-Clinic Practices [Member]",
        "terseLabel": "Multi-Clinic Practices [Member]"
       }
      }
     },
     "localname": "MultiClinicPracticesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.",
        "label": "Net Income Loss Attributable To Noncontrolling Interest, Permanent Equity",
        "negatedLabel": "Non-controlling interest - permanent equity",
        "terseLabel": "Net income attributable to non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.",
        "label": "Net Income Loss Attributable To Redeemable Noncontrolling Interest temporary Equity",
        "negatedLabel": "Redeemable non-controlling interest - temporary equity",
        "terseLabel": "Operating results allocated to redeemable non-controlling interest partners"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NetPatientRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered.",
        "label": "Net Patient Revenues [Member]",
        "terseLabel": "Net Patient Revenue [Member]",
        "verboseLabel": "Net Patient Revenue [Member]"
       }
      }
     },
     "localname": "NetPatientRevenuesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NetRevenueFromMedicare": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net revenue from Medicare.",
        "label": "Net revenue from Medicare",
        "terseLabel": "Net patient revenue from Medicare accounts"
       }
      }
     },
     "localname": "NetRevenueFromMedicare",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NonCompeteAgreementBasicTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Non-Compete Agreement Term under Condition Two",
        "terseLabel": "Non-Compete agreement term regardless of whether the selling shareholder is employed"
       }
      }
     },
     "localname": "NonCompeteAgreementBasicTerm",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Non-Compete Agreement Term under Condition of Termination of Employment of Employed Selling Shareholder",
        "terseLabel": "Non-Compete agreement term under condition of termination of employment of employed selling shareholder"
       }
      }
     },
     "localname": "NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_NonControllingInterestRedeemableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Controlling Interest, Redeemable [Abstract]",
        "verboseLabel": "Redeemable Non-Controlling Interest [Abstract]"
       }
      }
     },
     "localname": "NonControllingInterestRedeemableAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_NonControllingInterestsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for non-controlling interests.",
        "label": "Non controlling Interests Policy [Policy Text Block]",
        "terseLabel": "Non-Controlling Interest"
       }
      }
     },
     "localname": "NonControllingInterestsPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_NonQualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-qualified stock options are stock options which do not qualify for the special treatment accorded to incentive stock options.",
        "label": "Non Qualified Stock Options [Member]",
        "terseLabel": "Non Qualified Stock Options [Member]"
       }
      }
     },
     "localname": "NonQualifiedStockOptionsMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NoteReceivableRelatedToSaleOfClinics": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note receivable related to sale of discontinued clinics",
        "label": "Note Receivable Related to Sale of Clinics",
        "terseLabel": "Note receivable related to sale of closed clinics"
       }
      }
     },
     "localname": "NoteReceivableRelatedToSaleOfClinics",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NotesPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note.",
        "label": "Notes Payable [Member]"
       }
      }
     },
     "localname": "NotesPayableMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/NotesPayableAmendedCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesPayableOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable One [Member]",
        "terseLabel": "Notes Payable One [Member]"
       }
      }
     },
     "localname": "NotesPayableOneMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.",
        "label": "Notes Payable Related to Purchase of Non-Controlling Interest, Permanent Equity",
        "terseLabel": "Notes payable due to purchase of non-controlling interest, permanent equity"
       }
      }
     },
     "localname": "NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.",
        "label": "Notes Payable Related to Purchase of Redeemable Non-controlling Interest, Temporary Equity",
        "verboseLabel": "Notes payable related to purchase of redeemable non-controlling interest, temporary equity"
       }
      }
     },
     "localname": "NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NotesPayableTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable Two [Member]",
        "terseLabel": "Notes Payable Two [Member]"
       }
      }
     },
     "localname": "NotesPayableTwoMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Notes Receivable Related to Sale of Redeemable Non-controlling Interest Temporary Equity",
        "terseLabel": "Notes receivable related to sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_November2020AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "November 2020 Acquisition [Member]",
        "terseLabel": "November 2020 Acquisition [Member]"
       }
      }
     },
     "localname": "November2020AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_November2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "November 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "November2021AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NumberOfAcquiredOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to number of acquired operations during the period.",
        "label": "Number of Acquired Operations",
        "terseLabel": "Number of acquired operations"
       }
      }
     },
     "localname": "NumberOfAcquiredOperations",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfClosedClinicsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of closed clinics sold during the period",
        "label": "Number of Closed Clinics Sold",
        "terseLabel": "Number of closed clinics sold"
       }
      }
     },
     "localname": "NumberOfClosedClinicsSold",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfEmployeesCoveredUnderEmployeeAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of employees covered under employee agreement during the period.",
        "label": "Number Of Employees Covered Under Employee Agreement",
        "terseLabel": "Number of officers with the company had employee agreement"
       }
      }
     },
     "localname": "NumberOfEmployeesCoveredUnderEmployeeAgreement",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of installments for note receivable in sale consideration.",
        "label": "Number of Installments for Note Receivable in Sale Consideration",
        "terseLabel": "Number of installments for note receivable",
        "verboseLabel": "Number of installments for note receivable"
       }
      }
     },
     "localname": "NumberOfInstallmentsForNoteReceivableInSaleConsideration",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfManagementContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of management contracts during period.",
        "label": "Number of Management Contracts",
        "terseLabel": "Number of management contracts"
       }
      }
     },
     "localname": "NumberOfManagementContracts",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfOnsiteClientLocations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of client locations that included in total operated states that are providing industrial injury prevention services.",
        "label": "Number of Onsite Client Locations",
        "terseLabel": "Number of onsite client locations"
       }
      }
     },
     "localname": "NumberOfOnsiteClientLocations",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfOperatingClinicLocations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating clinic locations during the period.",
        "label": "Number of Operating Clinic Locations",
        "terseLabel": "Number of operating clinic locations"
       }
      }
     },
     "localname": "NumberOfOperatingClinicLocations",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfPartnershipInWhichInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of partnership in which interest acquired during the period.",
        "label": "Number Of Partnership In Which Interest Acquired",
        "terseLabel": "Number of partnerships in which interest acquired",
        "verboseLabel": "Number of partnerships"
       }
      }
     },
     "localname": "NumberOfPartnershipInWhichInterestAcquired",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfRegions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of regions of the entity operates.",
        "label": "Number of regions",
        "terseLabel": "Number of regions"
       }
      }
     },
     "localname": "NumberOfRegions",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesGoodwillDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfStatesOfNetworkServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents number of states of network services provided by the company.",
        "label": "Number of States of Network Services",
        "terseLabel": "Number of states of network services"
       }
      }
     },
     "localname": "NumberOfStatesOfNetworkServices",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_OperatingLeaseSupplementalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental information related to leases.",
        "label": "Operating Lease, Supplemental Information [Table Text Block]",
        "terseLabel": "Supplemental Information Related to Leases"
       }
      }
     },
     "localname": "OperatingLeaseSupplementalInformationTableTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues includes management contract revenues, industrial injury prevention services revenues and services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.",
        "label": "Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues [Member]",
        "verboseLabel": "Other Revenue [Member]"
       }
      }
     },
     "localname": "OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_OtherRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues include services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.",
        "label": "Other Revenues [Member]",
        "terseLabel": "Other Patient Revenue [Member]"
       }
      }
     },
     "localname": "OtherRevenuesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PatientsAndPayorsRelatedLiability": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Patients And Payors Related Liability",
        "verboseLabel": "Credit balances due to patients and payors"
       }
      }
     },
     "localname": "PatientsAndPayorsRelatedLiability",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PaymentsToAcquireBusinessesConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to acquire businesses total consideration.",
        "label": "Payments To Acquire Businesses Consideration",
        "terseLabel": "Total consideration",
        "verboseLabel": "Total consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesConsideration",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2020PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PaymentsToAcquireRedeemableNonControllingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a redeemable non-controlling interest.",
        "label": "Payments to Acquire Redeemable Non-controlling Interest",
        "negatedLabel": "Purchase of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "PaymentsToAcquireRedeemableNonControllingInterest",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PercentageOfGeneralPartnershipInterestOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of general partnership interest owned during the period.",
        "label": "Percentage Of General Partnership Interest Owned",
        "terseLabel": "Percentage of general partnership interest owned"
       }
      }
     },
     "localname": "PercentageOfGeneralPartnershipInterestOwned",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in payment adjustment for therapists participating in Merit Based Incentive Payment System (MIPS).",
        "label": "Percentage of Increase in Payment Adjustment for Therapists Participating in Merit Based Incentive Payment System",
        "terseLabel": "Percentage of increase in payment adjustment for therapists participating in MIPS"
       }
      }
     },
     "localname": "PercentageOfIncreaseInPaymentAdjustmentForTherapistsParticipatingInMeritBasedIncentivePaymentSystem",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfLimitedPartnershipInterestOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of limited partnership interest owned during the period.",
        "label": "Percentage Of Limited Partnership Interest Owned",
        "terseLabel": "Percentage of limited partnership interest owned"
       }
      }
     },
     "localname": "PercentageOfLimitedPartnershipInterestOwned",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfMedicarePaymentIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Medicare payment increase during the period.",
        "label": "Percentage Of Medicare Payment increase",
        "terseLabel": "Percentage of increase in Medicare payment rates"
       }
      }
     },
     "localname": "PercentageOfMedicarePaymentIncrease",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPaymentForOutpatientTherapyServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of payment for outpatient therapy services to the therapy assistant.",
        "label": "Percentage of Payment for Outpatient Therapy Services",
        "terseLabel": "Percentage of payment for outpatient therapy services"
       }
      }
     },
     "localname": "PercentageOfPaymentForOutpatientTherapyServices",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of payment reduction waived through enacted additional legislation.",
        "label": "Percentage of Payment Reduction Waived Through Enacted Legislation",
        "terseLabel": "Percentage of payment reduction waived through enacted legislation"
       }
      }
     },
     "localname": "PercentageOfPaymentReductionWaivedThroughEnactedLegislation",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of payment reduction waived through enacted additional legislation.",
        "label": "Percentage of Payment Reduction Waived Through Enacted Legislation Period Two",
        "terseLabel": "Percentage of payment reduction waived through enacted legislation, after March 31, 2022 through June 30, 2022"
       }
      }
     },
     "localname": "PercentageOfPaymentReductionWaivedThroughEnactedLegislationPeriodTwo",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of practice expense component of relative value unit during the period.",
        "label": "Percentage Of Practice Expense Component Of Relative Value Unit",
        "terseLabel": "Percentage of practice expense component"
       }
      }
     },
     "localname": "PercentageOfPracticeExpenseComponentOfRelativeValueUnit",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfRepurchaseOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of repurchase of common stock during the period.",
        "label": "Percentage Of Repurchase Of Common Stock",
        "terseLabel": "Percentage of repurchase of common stock"
       }
      }
     },
     "localname": "PercentageOfRepurchaseOfCommonStock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of right to sell equity interest on each of the 4th and 5th anniversaries by shareholders.",
        "label": "Percentage of Right to Sell Equity Interest on Each of the 4th and 5th Anniversaries",
        "terseLabel": "Percentage of right to sell equity interest on each of the 4th and 5th anniversaries"
       }
      }
     },
     "localname": "PercentageOfRightToSellEquityInterestOnEachOfThe4thAnd5thAnniversaries",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of right to sell equity interest on each of the 6th and 7th anniversaries by shareholders.",
        "label": "Percentage of Right to Sell Equity Interest on Each of the 6th and 7th Anniversaries",
        "terseLabel": "Percentage of right to sell equity interest on each of the 6th and 7th anniversaries"
       }
      }
     },
     "localname": "PercentageOfRightToSellEquityInterestOnEachOfThe6thAnd7thAnniversaries",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of therapist providers participating in Merit Based Incentive Payment System (MIPS).",
        "label": "Percentage of Therapist Providers Participating in Merit Based Incentive Payment System",
        "terseLabel": "Percentage of therapist providers participating in MIPS"
       }
      }
     },
     "localname": "PercentageOfTherapistProvidersParticipatingInMeritBasedIncentivePaymentSystem",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage reduction for service in office or other non institutional settings during the period.",
        "label": "Percentage Reduction For Service In Office Or Other Non Institutional Settings",
        "terseLabel": "Percentage reduction for service"
       }
      }
     },
     "localname": "PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PeriodOfExtension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension period of 2021 Act, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Period of Extension",
        "terseLabel": "Period of extension"
       }
      }
     },
     "localname": "PeriodOfExtension",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Period Of Federal Debt Ceiling In Connection With Deficit Reductions",
        "terseLabel": "Federal debt ceiling in connection with deficit reductions"
       }
      }
     },
     "localname": "PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical therapy operations excluding closure cost a non-GAAP measure consist of net revenue from physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries.",
        "label": "Physical Therapy Operations Excluding Closure Costs a Non-GAAP Measure [Member]",
        "terseLabel": "Physical Therapy Operations (Less Closure Costs) (a non-GAAP measure) [Member]"
       }
      }
     },
     "localname": "PhysicalTherapyOperationsExcludingClosureCostsANonGAAPMeasureMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PhysicalTherapyOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.",
        "label": "Physical Therapy Operations [Member]",
        "terseLabel": "Physical Therapy Operations [Member]"
       }
      }
     },
     "localname": "PhysicalTherapyOperationsMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusiness2019PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/AcquisitionOfBusiness2021PreliminaryPurchasePricesAllocationDetails",
      "http://usph.com/role/SegmentInformationDetails",
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PreferredStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Abstract]"
       }
      }
     },
     "localname": "PreferredStockAbstract",
     "nsuri": "http://usph.com/20211231",
     "xbrltype": "stringItemType"
    },
    "usph_PreviousOwnersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the previous owners who maintain a minority interest after acquisition.",
        "label": "Previous Owners [Member]"
       }
      }
     },
     "localname": "PreviousOwnersMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2020AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Proceeds from Sale of Redeemable Non-controlling Interest Temporary Equity",
        "terseLabel": "Sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ProceedsFromSalesOfNonControllingInterestPermanent": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sales of non-controlling interest-permanent.",
        "label": "Proceeds from Sales of Non-controlling Interest Permanent",
        "terseLabel": "Sales of non-controlling interest-permanent"
       }
      }
     },
     "localname": "ProceedsFromSalesOfNonControllingInterestPermanent",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ProgressiveHealthCompaniesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the acquiree entity Therapy Practice.",
        "label": "ProgressiveHealth Companies, LLC [Member]",
        "terseLabel": "ProgressiveHealth [Member]"
       }
      }
     },
     "localname": "ProgressiveHealthCompaniesLLCMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Promissory Notes [Member]",
        "terseLabel": "3.25% through 4.75% Notes Payable due in Next Year [Member]"
       }
      }
     },
     "localname": "PromissoryNotesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PublicHealthAndSocialServicesEmergencyFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.",
        "label": "Public Health and Social Services Emergency Fund [Member]",
        "terseLabel": "Public Health and Social Services Emergency Fund [Member]"
       }
      }
     },
     "localname": "PublicHealthAndSocialServicesEmergencyFundMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PurchaseOfBusinessSellerFinancingPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of business - seller financing portion in noncash investing or financing activities.",
        "label": "Purchase of Business Seller Financing Portion",
        "terseLabel": "Purchase of businesses - seller financing portion"
       }
      }
     },
     "localname": "PurchaseOfBusinessSellerFinancingPortion",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_REDEEMABLENONCONTROLLINGINTERESTAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "REDEEMABLE NON-CONTROLLING INTEREST [Abstract]"
       }
      }
     },
     "localname": "REDEEMABLENONCONTROLLINGINTERESTAbstract",
     "nsuri": "http://usph.com/20211231",
     "xbrltype": "stringItemType"
    },
    "usph_RedeemableNonControllingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the upper bound of a range for the estimate of fair value as of the reporting date of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity.",
        "label": "Redeemable Non-Controlling Interest [Member]",
        "terseLabel": "Redeemable Non-Controlling Interest [Member]"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The commencement period of redemption rights for redeemable non controlling interest, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Redeemable Non-controlling Interest, Redemption Rights, Commencement Period",
        "terseLabel": "Redeemable non-controlling interest, redemption rights, commencement period"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestRedemptionRightsCommencementPeriod",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RedeemableNonControllingInterestTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a redeemable non-controlling interest.",
        "label": "Redeemable Non-Controlling Interest [Text Block]",
        "terseLabel": "Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_RedeemableNonControllingInterestsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for redeemable non-controlling interests.",
        "label": "Redeemable Non Controlling Interests [Policy Text Block]",
        "terseLabel": "Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestsPolicyTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Combined physical therapy/speech language pathology expenses during the period.",
        "label": "Reduction In Combined Physical Therapy Speech Language Pathology Expenses",
        "terseLabel": "Reduction in combined physical therapy/speech language pathology expenses"
       }
      }
     },
     "localname": "ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ReductionInMedicareSpendingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Medicare spending percentage during the period.",
        "label": "Reduction In Medicare Spending Percentage",
        "terseLabel": "Medicare spending cut percentage"
       }
      }
     },
     "localname": "ReductionInMedicareSpendingPercentage",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ReferralRelationshipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Referral Relationship [Member]",
        "verboseLabel": "Referral Relationships [Member]"
       }
      }
     },
     "localname": "ReferralRelationshipMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionOfBusinessWeightedAverageAmortizationPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ReliefFunds": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Relief funds relates to social welfare, a fund of money set up to provide aid for people in need, especially in disaster areas.",
        "label": "Relief Funds",
        "terseLabel": "Relief funds"
       }
      }
     },
     "localname": "ReliefFunds",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RemainingContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Remaining Contract Term",
        "terseLabel": "Remaining contract term"
       }
      }
     },
     "localname": "RemainingContractTerm",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RenewalPeriodForEmploymentAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment agreement renewal period.",
        "label": "Renewal Period For Employment Agreement",
        "terseLabel": "Renewal period of employment agreements"
       }
      }
     },
     "localname": "RenewalPeriodForEmploymentAgreement",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RentSuppliesContractLaborAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to rent, supplies, contract labor and other.",
        "label": "Rent Supplies Contract Labor And Other",
        "terseLabel": "Rent, supplies, contract labor and other"
       }
      }
     },
     "localname": "RentSuppliesContractLaborAndOther",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RepaymentOfFunds": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of repayment to Medicare Accelerated and Advance Payment Program (\"MAAPP Funds\") rather than applying them to future services performed.",
        "label": "Repayment of Funds",
        "terseLabel": "Repayment of funds"
       }
      }
     },
     "localname": "RepaymentOfFunds",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ResolutionOfPayorMatter": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income received on resolution related to a payor matter.",
        "label": "Resolution of Payor Matter",
        "terseLabel": "Resolution of a payor matter"
       }
      }
     },
     "localname": "ResolutionOfPayorMatter",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RestrictedPeriodToEmployeesOnTheStockGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted period to employees on the stock granted during the period.",
        "label": "Restricted period to employees on the stock granted",
        "terseLabel": "Restricted period on the stock granted"
       }
      }
     },
     "localname": "RestrictedPeriodToEmployeesOnTheStockGranted",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RestrictedStockPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for restricted stock.",
        "label": "Restricted Stock Policy [Policy Text Block]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_ReturnToWorkAndErgonomicServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of a company which has return-to-work and ergonomic services among other offerings.",
        "label": "Return to Work and Ergonomic Services [Member]",
        "terseLabel": "Return-to-work and Ergonomic Services [Member]"
       }
      }
     },
     "localname": "ReturnToWorkAndErgonomicServicesMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2021AcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_RevaluationOfRedeemableNonControllingInterestNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distributions during the period on mandatorily redeemable securities net of tax.",
        "label": "Revaluation of Redeemable Non-controlling Interest Net of Tax",
        "terseLabel": "Revaluation of redeemable non-controlling interest, net of tax"
       }
      }
     },
     "localname": "RevaluationOfRedeemableNonControllingInterestNetOfTax",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to redeemable non-controlling interest.",
        "label": "Revaluation of Redeemable Non-controlling Interest Net of Tax, Shares",
        "terseLabel": "Revaluation of redeemable non-controlling interest, net of tax (in shares)"
       }
      }
     },
     "localname": "RevaluationOfRedeemableNonControllingInterestNetOfTaxShares",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_SaleOfNonControllingInterestNetOfTaxAndPurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Sale of non-controlling interest, net of tax and purchases",
        "terseLabel": "Sale of non-controlling interest, net of purchases and tax"
       }
      }
     },
     "localname": "SaleOfNonControllingInterestNetOfTaxAndPurchases",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to noncontrolling percentage sold by an entity during the period.",
        "label": "Sale of Noncontrolling Interest Percentage in Partnership One",
        "terseLabel": "Sale of non-controlling interest percentage in partnership one"
       }
      }
     },
     "localname": "SaleOfNoncontrollingInterestPercentageInPartnershipOne",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of business combination completed within the physical therapy operations segment during the period.",
        "label": "Schedule of Business Acquisitions Within Physical Therapy Operations Segment [Table Text Block]",
        "terseLabel": "Acquisitions Within Physical Therapy Operations Segment"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_SelfInsuranceProgramPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for self-insurance program.",
        "label": "Self Insurance Program Policy [Policy Text Block]",
        "terseLabel": "Self-Insurance Program"
       }
      }
     },
     "localname": "SelfInsuranceProgramPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_September2019AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "September 2019 Acquisition [Member]",
        "terseLabel": "September 2019 Acquisition [Member]"
       }
      }
     },
     "localname": "September2019AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_September2020AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "September 2020 Acquisition [Member]",
        "terseLabel": "September 2020 Acquisition [Member]"
       }
      }
     },
     "localname": "September2020AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_September2021AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "September 2021 Acquisition [Member]"
       }
      }
     },
     "localname": "September2021AcquisitionMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesAcquiredMajorityInterestDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_SeptemberTwoThousandTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the principal installment plus accrued interest payable date.",
        "label": "September Two Thousand Twenty [Member]",
        "terseLabel": "September 2020 [Member]"
       }
      }
     },
     "localname": "SeptemberTwoThousandTwentyMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_SeptemberTwoThousandTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the principal installment plus accrued interest payable date.",
        "label": "September Two Thousand Twenty One [Member]",
        "terseLabel": "September 2021 [Member]"
       }
      }
     },
     "localname": "SeptemberTwoThousandTwentyOneMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses2019AcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_SettlementOfShortSwingProfitClaimAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement of Short Swing Profit Claim [Abstract]"
       }
      }
     },
     "localname": "SettlementOfShortSwingProfitClaimAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares outstanding for which restrictions had not lapsed.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed",
        "terseLabel": "Shares outstanding for which restrictions had not lapsed (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised for the cumulative period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises For the Cumulative Period",
        "verboseLabel": "Stock options exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made for the cumulative period on restricted stock units plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award Restricted Stock Grants For The Cumulative Period",
        "verboseLabel": "Restricted stock issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of restriction lapse grant to employees.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Restriction Lapse Period Description",
        "terseLabel": "Restrictions will lapse in"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansSummaryDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "usph_ShortSwingProfitSettlement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short swing profit settlement from any purchase or sale (or sale and purchase) of the company's equity securities.",
        "label": "Short Swing Profit Settlement",
        "terseLabel": "Short swing profit settlement"
       }
      }
     },
     "localname": "ShortSwingProfitSettlement",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_SupplementalInformationRelatedToOperatingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Information Related to Operating Leases [Abstract]",
        "terseLabel": "Supplemental Information Related to Leases [Abstract]"
       }
      }
     },
     "localname": "SupplementalInformationRelatedToOperatingLeasesAbstract",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_TaxEffectOnSaleOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to amount of tax effected on noncontrolling interest sale price during the period.",
        "label": "Tax Effect on Sale of Noncontrolling Interest",
        "terseLabel": "Tax effect on sale price"
       }
      }
     },
     "localname": "TaxEffectOnSaleOfNoncontrollingInterest",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_TermOfEmploymentAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of employment agreement with the subsidiary entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Term of Employment Agreement",
        "terseLabel": "Employment agreement term"
       }
      }
     },
     "localname": "TermOfEmploymentAgreement",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_TherapyPracticeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the acquiree entity Therapy Practice.",
        "label": "Therapy Practice [Member]",
        "terseLabel": "Therapy Practice [Member]"
       }
      }
     },
     "localname": "TherapyPracticeMember",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.",
        "label": "Transfer of Compensation Liability for Certain Stock Issued Pursuant to Incentive Plans",
        "terseLabel": "Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans"
       }
      }
     },
     "localname": "TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to weighted average lease terms and discount rates.",
        "label": "Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "terseLabel": "Average Lease Terms and Discount Rates"
       }
      }
     },
     "localname": "WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock",
     "nsuri": "http://usph.com/20211231",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    }
   },
   "unitCount": 15
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a,b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55733-112764"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3111-115594"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491204&loc=d3e4869-115612"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r600": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r601": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r602": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r603": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r604": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r605": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r606": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r607": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r608": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r609": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r610": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r611": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r612": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r613": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r614": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r615": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r616": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r617": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r618": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r619": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r620": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r621": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r622": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>112
<FILENAME>0001140361-22-007247-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-007247-xbrl.zip
M4$L#!!0    ( %);851ZGB:5PLH# !AZ+@ 4    8G)H8S$P,#,T,S(Q7S$P
M:RYH=&WL/6E7X\:6W^><^0\:WLM,9P[0VI=.PCEN,(G?ZP8&T\G+?,DI226L
MM"PY6J ]OW[NK9)DR9;!!AMDH[PEV-92=U_KUH^C=!P(W\9!F'SX9L>!_]/!
M*$TG']Z_O[^_/\9OCJ/X]KTLBLI[/TQ2$CKT(+\^\,.O#UR./]LD*2__MG#]
MO<*NEBS+>L]^+2]-_*8+X;'2^W]]_C1T1G1,CN;7@Z]W9S=65Z._YS\6E_I)
MI,J2\1"P_(KRAF_+KI40,;!X^J^/UY]FEZ?-U\\N?9_&)$R\*!Z3U(]"?))V
M),I'LEYYR%%"G=J#X//Q;73WZ'/,(T4JGI,E1[>$3,KG>"2QV6+R'^ 663H2
MI<HM+IW#8_%>^(%=_I=:/CV-EZ+1>@^_%A<Z41:F\;3YN?F/[-GE#5D<T]!9
M=D?^:^V6D/A.TGP]^ZEV<>([S9?"#_4+TTF\Y$KXI78I_>:,FB_%7^I/C=-%
MDL"73>1(XZ-T.J%),Z;AY_?X,]XIXIURA?:3V7KPP[$3C=D;)+E\_G*A1.UP
M</+O_R8(/XXH<=E?\'?JIP$]^?$]_W?^Y7\<'0F??(>&"76%-/H@?(PCXL:^
M>TOY%>R?L\C)QC1,!2>F)(4KL\0/;X7^V<^]:\\'IKY-A*OK2_B3"N:Q!/\1
M*W>?1I-I[-^.4@'6IPE' D B5UXD'!T5RQG3E @(UQ']*_/O?CHXC<(47GQT
M Y@Z$!S^Z:>#E'Y+WS,XA?=P[X_O<T#A3SMRIT*23@/ZTX%-G*^W,7"I>^1$
M011_$/[FL7]^$(K/(OOG!\37CZY_)_CN3P=GPZMS'\7T%]]U:7A0/,[UDTE
MIA^$, HIW/*C_^T#OIC&_$]V-?L3+K@ C,6^(X1DC+=2_T,/4.@B&L\#<GO
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MWI'BYDL6&MM.I[TL8.TLG3KJO'3Q5P7'XTN8)1D)+N-!Z,7TKPQ6,DCIF).
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M[D<4*!_/,]0[Z7MA!!H)N<@52!"4K%3E,9OF%\ S'V"KPG\H; ZPF>""-H/
M$7^>Q#CC%C])LL!V"23".W@&>"A"DD&8E(S@S;!&?M GW$/2^?7>DV21^]G-
M^;J_!P4;NL([F<-E@Y\#O]M_PJKQ>G8IW(2KR)^#3>4)6P1;)$E2P1(%ETR3
MX\>Z-4^S.(:[>2,Z^LLI2;,J3X._YD'$HHF6[:B6J-J*8\JJIAGH.5-I%7_Y
M=SR;<^MJ4KB(-JL,]E!6D)^ E<9^F@+ST0!8*HY"C#N"J4 A!ID* _2$@/#^
M'17.2$J$<ZZ=:Z)4/J.0DZK6KOH#U_0VX]OVA>'1S;9%B2^KE!":?/\H_U?
M16AS<:BFL$7;-67=<_ 80.KHIF&KCDX4#><?2,XJU:Z._]O"_\RS#<"'IP)Q
M'.#_F* @(*^@6QLV?HO1P%'C#\D8!(?&A1#$A1(%>,> P2F:%W@HZ&>,&FX%
MB$3NTU'QZS$8(LI6R)QIMB$H0:'!LHPL_K!LG>QGZ8?BLH4+\M\/BPOR52XN
MKW@06IO\VB5++:XLO'U)MH_D>9O)?+*NY+"TR&H<+ZU  [_Z*3U")%",/N]C
MLGJB<Z/!]@J;.^)3X+7;*)Y6M"11B&)IDF3HMJ=ZIF5;,M$-2HAJ>)8NKJ E
M%[,\[(6,HYW\A9CP^=0L%1O,QREJ,Z'RE%Q[:%7J_Z<7_N5C:R= [2W2^^F)
M;>U85'<!Z-(<;[?2\I!B>A6X+YKL[?8$^G7T[$8\M:)9X-U9Q+(JW /RO9EO
MLFCUG]4H]+"^>!5,#I<!NCT5T4;+S-#P,4O\D";5^-VC-J'4Q7/7'-75#&+(
MHF5)KBY3U2#4VN:.\M?46VMVKCVJ(]9\7ALEI=_LW+\M.2F0\#/#P2E'045>
M'$53/=EV=-DU5-'6;5?6#).HDJV9DDE7&&7U<O*RT1KEUB-U[X%8^!!"RQ4+
M")C#8IDK\ S0YJ61D"4\CH:W4GBI*Z3EA(TB?00T*;"&KPRFN(9['U: <7H(
MP$1H0N[\A#D<(0D=GP089T19R*Q*DD*<3&(W$29Q=.?C:YIK%>_(0CJ9ERLP
MBA:EC61]=BM)\TR(U\]QYK6 W"<0HG F1)CL(&E*@9R,7D Z/TW@B2&Y98GT
MO"DV$4B2@"G%KPIR4L^C+%6(-A:_Q#M]S""&P"NH%^(H$"+0AA46FODEK-VJ
M9!155+%OLRB:DM@F\-BCRV\!G;*ZPSM)$W#W^NFQ8,@Z-GE^CQB8@8O=6,"#
M=@!JKL*HGA^/>;IT N\F>!'P-JO=NC,\X-))YOIIOL#CZKB*Y5G3@>/%/;PM
MBGLS+)X'Y+:J0S4;W'=/-CQBJ@Z>9NM)BBE;KJ0ZNN6LL+%S-1W:-$]L=Z3B
M":G+9$2#H,PNOFNHPR_-S'W/RZ6;T4&/^:*XS ;3ZFBNZKD>6%%/M4W=LA7)
MD40JRJJK$.,I2:*53>M&4^2[54Z] 4X@M[? 2\ALR&,TY=V"!9\D(] 22?%I
MQG2E*G1XRV'">JR N*R,RM+B'E8BX;D-=X.:%?Z1A5101#XUK5 ^6+;Y>\Y"
MYZSX L^>YZ$KIM?.@XBDM0J[H;C@GFF@4E3'DFW=@?\0U1.I8UND,9K1%?$
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M4K<*OY\+YD/K@__F;T+0<YIQ.A[6B<@7YY&\G18<&GBTSXEQ"*S.%4D8I4(
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MM> ^Q;07R @\P&7^(TEY<89;R,/</.97!Q&  5QP1X,B&\U3Y2/"3CP0B O
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MO.'&Y1LXO+(M#M0<&*2\$2ZN:;GJ-KES4'FX0P)3XC.N%"[1#J)X,F>Y0&/
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M,#ZP&!9P@3:X[6 [7+AEH[;!=\$.P$'H'8P/_@[^31/,T1@8)1]Z-<E9].8
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M[JS(FQEK[U=@PJ*)G>SK]N)^L%*%!<!81-FWMT=/8,EAA;HQ'7_X6+A,)*:
M(A$;#C?;_!&;^F##Y@V-8=(Y5>KNCT5>L\81@<4(G3QH"HZC,2G!:,7;'S\+
M5B6H]DBJS('@;>^\&KG1&3!GJ\6!AK6@NV@RP8?351:O ;[@35VU<$QQK'[5
M\$0=S,$0'./%F=5SLO)07$_!$@99A\$=HC:"$?B[E 8.O_ F)AJ7]%)8 [!G
M<7?5@0+33D8NZ_NSWMX78,=5G1RZAJ:9ET&ATI1Y7>!4E$L,;/K#!Q(RR]K8
M $!=9=9#-<.T ^,.CUG/J9JRB%[F\&>->WE!VT5!&SA^:P[@'?K+<-Q4%M.;
MBQ'>3$6'EXE?,%K]_FF2"P 6JW<0T0A*7#:>X=\B;=;@"QZ28,$/CU*[2EU9
MH.R#@NP*MGI@D_1(\&G*>/?$3L:WS,&("!8]2%C3P6MY8"#S,_A_/-@4<=13
M)6_?WS##":W?G_G&QM@,^!UTKD@6]_9ZYL+4@6: %9FX,[ -'%C";'Z,T0F5
M,X]7Z<3!ZN2MW4D,#M S2A@$C*24G>'[$SS<&M>N:V&HX+:8;]K-(IN A]!@
M1!Q?#QHL%H2O]T;[25O#(8*OCY(WJH0CS>PM=_P7.'%H@HBZQ)BN'X=_31A0
M:C^?)?O?@+ M1LGK$D0;WII08&;O8<I_N^9F0!69@[-*IH.;C!+:CYPB$$T6
M:4S9I; [CU-P%#,RG5;N+OHC)@<FLG5V*,WP6-37G^8-1@'4#GC<']3J2)Y&
M(WGNSNHN@Y/T0ZI_I)$T[SD0._G>F)[PF X/3HY.:1Q-1SL5)NNUQ;4W<S)1
MA2+WKMA&V9*W$CP*71E_@TCT;5>&<2/]-NUJMIVO'VI7MGEAI_\RJT'!:,S/
M"MLC;XB&Z[\ UZ#A5! )F.X-75"7&9F-:]^MEU3MT**G/(]1I_SZM]&->#G+
M87#XHIM<NJDJ>C3X86&=VYF#XIFQD#3!H(E\W6]@<_3RK\%3<U/KY6(0:[T\
M1XL'IV-:%058+!..WL$ $AH B<#>P(OT.7_K2I<\Y&GLJ^UPVO\T6$#JLZ@'
M7F($%Q<C?L)F703!>7R93R9@&1]BJB!YF_V1G,B"PR3^5ITEAW C<%C6*X!]
M-L3VOO]1_N?EX=N3 \D#RO]\"XHSQ_S<:S!!22)(/<"&A(CS#/Q(T"P@@NZ/
ML7,H)%\_3)_L[HH=1N8QF+ZHE-NNCOVK"8?-LYXK,\LN')A3L N1WH:5P "R
MQDDQ/@ K!'^:.-C->0X[=3ES=&*CT#"?EW&=PZ?RC.\/&'^#<6L^&3)B%*UF
M5A43% DCK!JGEM#TDM;U=.$<".FO67G>H1/Z)FOAJ]7YT@=2?\34+\:9T:;D
M5]C)KWL;;NA 0'S)0_6'YF \1C,(AW+XXO@-;#G<@;.JEC2JO75"_.K@D/>8
M#.X)W."D9="IQW@ VDA+C2@-+#6H27HGV4YB.U>-DS\W; :7H$C &)--6.IA
M'Q=9/F]$2"1P95=C90LXJ /G-)MX^]IO-)U-4$99#=<:ZH6LR4U,+R._P''\
MA1TH,?9QJF#[-&)*>,WO;G!E1I>B?W5OC?",3L'A)\/FK!,][>1+?G9MU9O\
M[N[Z2^L)QQKAIZ=I[SG9O(*KQR]0,/XDS[%P-6:#44!]P#'O!3V/8$&J.9A.
MQS#V/X*P'!U[49G*ZV57*(B.:A1>S4;A^E'YUT81UW$%IG:SJ,A4B[ *5PSX
MZ)@&0N+7&\&&J684LVQ2+3A(-@<O)%\4C@_0I+.ND;_%^^KXS9N3GC8>#J')
MXDPI0-(MT*11+4*1$_Q2/U*T)Q8!OJ1W*]N],.'2U2@7IHPX[A"BYW!VDI\3
M&N_^C\E0I"1=Q<Q0(HR4Z4ZARG2ARM2&2!=@L8V7:2R\&OZ'!6TH9:[!%9].
MH<NG<108JTK)^.$G3BB/!U?-[QA3A1?E;7\73G[_K;<)D8DKAI?.)&PO^53X
MIUE^#OY)NSH:>'+*EH95$#[6)T^^8A+ZD<9AAI-7,9R)E2%1PJHK,;EL[>:N
M+CF6-@D9[":;@ZH%8]J_ G\ADA"YXABDK"?DCL-#]?+E2V%%8G"WPOM0B>C=
MV+#CSD C]L1N9?(?/DNRC7EC2)4^WAT*Y*S$0U4+@*GX>/&!Z(+W3ZMM 48W
M!!A]OP48;0%&MW*_^^M'S%K*,5YQ6P8-Q':9 %Q@X7/$@*!2)@@"B5OR-[2^
MZQ#,( B(^.!H3E L$SZ'J)JQ0%%(&;*Z ]T5W5+VW=G0VT?)ZQN-??T8]U&?
M@R^(.UH3&F?MRQ+V^,%Z ',<DS-L*X+J1IN@2IX^#E>XW(;R$4ID7N:,X%3W
M+MP$--P-LP-/VZSM6LQ12[B:PY&$<%4+L(/[,SG':&NI.XF9;?BWIH_C_;!1
ML3-74N"6T2PDD BD 2M>KD3UGBEUNJ@=9\]'R=_QNV#V7;C8)<5PDTLTP>A!
M.2E!5<":QXAM+1@4@OJD 91D=@7Q2!(H]M-F2!,\N:Q@2R\S1NA@4D8CMK25
M&*IP').ZP$S->::)A8NJN*!P05$X_2VB;"I4'SBFRQH<STG%JX@S(2 -11.R
M,'+),S,".XY8*L"&X%4<DLKH'7V/#.SG0[\XO +DE0S.&[-B9U',>MIA*$0V
M7?P \A[9O;);E>((+AUCBRR0W.0_)-W!&@)G/V5<!*QK!IZ'0B3 ]RXZSBEB
MN+3G@/<M:O8YUR :_3IHDF0W58D P2W 2!\"+,89[$M7]S-F7^\]?#1ZE,PY
M$T#/_GIO=V_TO?XJ?LL='O;(0#D#GW==8FT"NIO$[KC\1P=[]886@_9+XT0;
MIK*&$$V4)O;%#7H581R%, HTLT68&9\ B[PBH. 4C3;"^R_:?"Z!*OA+U;0[
M%9Q*D#(X4Q7KQ18//^)^IETY9B<R N5DBVR,")L Y.&3Y^IS"6? E0.CE1J!
MMQ35^D=5!U1.XV+G9(S9-(Z[LTXC+0T7%:4<*%B&,9VEC)(J,L*9RY*2S$Q\
M.)R<%@/'CW=W&8]1PB&$6Y9A0P6'3G45"XPD^6(+>BM\+J_]>*J:Q]]$YS4:
MNBPN90DXAF0D[W0!PQ$,(P9)W]355%.E, 4*A]%:X]#1B.S[Z(15I"3_V\.U
MM1!W<NB^^NGDZ)???CUX>_SZ57+PZEGRXNC@U[<O,,N4G!P]?WWR\GV\MMW/
MYK/=VGO!M7$U B DRYJN0(/M320_.ZG!(34<Y(@$#UUW#.K+Z4<)@*O@%*M_
MZ,D-YXHD@X1GBL+[^&6Z:.D&Y/1P+[(G\&@T5/@ H<1),=#"BJ04 .'[PT=V
M"'4- F[M(+A5P>+ V #% ,A*H4*E<=;@K1?@O9D!]9+=43KXS@,R$W+XY,3-
M88':V@.[,UE(>\UR?+U=2E;<D6;@NS78#E.7-?E9+NB_*%Q2PLZ95?"HLSGH
MJ+%3,#I^:F!_OL4<(NB?JO2 -[\A83L(PE"BGJI )_ $-%4_N 1J/_/')9=7
M75G;I@H9-5I7]W0$@;D9\1;-?::((RXMH#%->GM(MHZ)\4L,FS?"SQ)^M?3B
MZ8%7@T5@ >*(9J9_JUF')C7E8/ %&4HC(.R^[2B@[-B&]"N3!C&(\:-2@2#W
M(H-2<)EUS=<IU2]&30U$#GJ1@A.CI@360EB5YW76<8#O )89JP,X1/"[ +\4
M72+E%*W70*+I+&K>UEIZ=V*H4!)WY_HA:_4?C6?@Q,JES0/2V_Y44#=[>_M/
M?WYP]JV>Y=.*!@E_[DC%$%3NT7[RV^@4?(U1@B][\F.R]W!_-]MY<O;_G?W_
MWZ+Z<HED:WKKE/R:76KV)I4X/1^?<7Z1\W*-:S#",#;O_01Q52( SQS,,S@S
MW0+A\U2]0EG?%+UR-!DDY LKB<6@:,6EQ$8*QAGFB0F=I;5%M9N#651K>2G\
M&_P@!C \R+\5$ /6?<*@T+/3+'- ..!$Q%+!(PWFYSP),'SZ($]3W6N\G\[P
MFIJP$^N#%(2LK6&,%*AX+F+$VQ@;FB;+\"#8>Q'Z48MHX"S07& RBZX>S^ J
M0!.V</(#1?SD)]"$=5:>D[^&X2-:)KH+Z/E7?I\F?UY5H#)#U9$L CV;%N9#
M5\-./UZ8]UP-&V=@E]RJ2YN<P*_YW_/"J />CT7XY$KC#.PSPK3:/] #SNHJ
MFV !%9PM1+*)D<VX3BW)GK+='1G9B)J?HB_!L0V%)?G?8W)9(QMFT-9"HE6A
MU5UBIA\N3[A^^$Z:@%N!X'VX$ A@7N/"M90&"7C,!F>E08F&KR3%!QF-U\!A
M!E="<W\#^D!Q/RH$%=W$Z"20/XT;5/:C JI>!Q[WI=]9Z#&^YM(*T=''7-X&
MQ^475]*R:*[\]?$O/E>.]80O3@E2FC=-Y^)@T,0UH'?/\,Q$Q?;AGHH%"0_-
M%*-K*/5DR,HK3[.I2UYD]5E5RZO)!([#>:ZF<J'4Q]TPRL1U^3E%T8I8)P<@
M^="&6QLK'I,93#*I8"7Q77-'\B00ZX$'TAH1SN<BK\BZ_S'8B02#.?Z%UY$#
MW0J(FUXU#+L ,B(4>(V^8<0Y+#"'1A4S 3O3@?V_E&7P2QT.^3BOQ]T<X]AP
MO^NR8Z3B3W$88#>H)-6(MI05)5/>W<+5LE+Z!["8\X9+TT#@8'5).8+0Y:*"
M/;\#WGV8H/9%4VAZU+34K&"-"D: HVI1CD-'N(7I>A%^'=PGG,_@^-75%%6*
M#A4;),2.0G>EKQ/DXBLBMU#K"+%P9<L^GK\(:*KZK8;-'&_@<'A*E,C>DQ\;
M5NQ8^X:W19D$[@JK''+1#SS R)!51*7H^DG>G'=43?<N'[_#5&*CL_.#0O3%
M!&2#64M@>[IQ,,<:NLIK M*1=R=K07@<]+C%:]1B)PKU\I?)F DS]Y$"+/HJ
MQ<%SB\8G']1>()7E$'"&>2:JL6WHU./G\-BC5>0:K8V.$54M%=S0O0[V*SCD
M121$9UA<YT$:/!799JO*UM^E'\,(<FN',I;E(#OKCUZH[='CH_DB#39V_1LH
M0%'$HL)7HGDIY]PX._GJN^V>Z#"2'*?.M %JW("I2Z'7&B.18]I4<"\*C"W-
MX+9L.1I 0&Q4XF: J>PU?-&5?%=3B*1F X=P*>3WD$.O-PG575?ZZ-Z-( LZ
MTFN^$- 1?3G/R/GP8[$+]X\JAR=@%!P%-4[#FDEK7&/=/K&DHFIKT"O$$9+N
MU<]5"SAD/N'CV)(EB#2<M;]LYDVT1:G<%*7R9(M2V:)4/D6(+?H$'90)DI.0
M1?47MGFQH!ZS"O#@7W.^77X6KSRP3=#_) ?!<L-8:XEA7/Z&]^.]=W19NMK[
M1YPMD#Q"1N'NE6_2'2]Y<Y^'9,UL5]8_F.X]N@/(VA"S2K$))0>IV 7'Y$:(
MDLO#FX  1(-&7.E^="EK)/)_N3K'ET0@4']WVA&<UD_W&L?@[O=Z18^S@-J]
MWO0I'&8+"F"<:.P0RX/[\HH6MKWG,=A28?R3LR6UPB,06$ [+D)QM8P1JCUY
M4 5;/OC0O1P 56I2J&U:=&JJ^#=\&D'Y# PMM[N5O^9MRQ')5U7R<U5FR7-,
M\Z@22D[RYEV\L>([1;NTJ/,Y.@VTZOE9IV$[7&VUSO(F.#<_PE#!!'D',RO\
M ,K*!&5B.@#6)PQ0(F$2$'Y(!$T<8Y0$T(6F7VV3;(K0[VD-"M$5Z(N@<4YR
M5E=3!&V?DRF*IB"Y5OBKL8B]#YF?L=AOQ8AQ=XUG7^FM\I  ]3]#15F,(-LY
M8U@=F.8M<<D,Z(7!6XP)-M'M8$.P6,8J 1\9$(S][40X?$NQ%ODKXUW:D)N_
MR&MT.Y!XBYP+S-;:NA "^U^6S)?+(7:NR#%0DWZ.96Z_6,*%N!4H$JAQQ21O
M'A[UQA!R?+"0>?,#=C'EA'6Y3%7$K*&A#*W(H.I][NW64.8X!+"'%EW*2 SR
M4]A7@C&0:EQ<9)_5->;4\L8>.'_N!3*Q()R7G$H\6S'UP;ICYA5$0#0OKI$F
MGDH4JU<0I[_1-')! WR0C]S(Y\*F4O=C/OXM!>#4#!^/"6)-?Z=J*!ST155T
M\[YAKB_0"VDKA22%1V(]@C ,":&U/,^T8)(7DBD\/=R)0VN66@[W!U'2*D*:
M<J?L2L5U491%Q@?Q,QF($P7?]*4K.JCW_O47B)6O8&II"'L#I.#68EO/ FM3
MF;6!2]*<7 _=24EGZP<,CYSW&FTT5<*9_1 E!_=[05"3TC9A<?@1P^=1L)LB
MZ1Q%YY(\7Q+2UMU8)T (]3BWWL01]J;#;$;.KO&$/9TN;V9L&*C"0=RL!#]%
MEPC ')Y@B4HY=T*8*W[=57D9/]4\)&=DRHW..:& GM!5V 6(@KEK [)I0OQX
M ==5WAS/M05Q??7300'J!K'%UM4AYEH4^BC-LP-:@S&9"6BH!>I3^=4*K-
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MC&,,9)%$OD$\GMPX=/HX;*2_"A;&]Z%Q!LXR<.;3/Y,Q%7DC-5(#DLF9,&5
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M<D!3FY"\G$7SPL?XXYLLV"AYYGSU?&E!DY3MR^>"<*/0A XE]LD1>[0Z-)J
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M+'PZ2_C.$"N+RW&\AD-J_93@;=R)"//N_/'+ 2YEKDNF?+NU)KR^WQ1(QJ'
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M[HQZ'N% JK4:W!)37_-LIB@.D[@6G9Q^!GY)0^;@#.6,1!WG/?5" H8MR%H
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MYMC8535FQ?Z4(!CT&6<K#YN[.O"?!%M%+OP5[P@_B%IT7E&WS/5_\ZS/J>Q
M*I[7'XN]\ 8^CJ,EO+K3?0&[="X&G8L7KFK?Z42 ""\(G/,1?G_M<39SHE!V
MK(6XT0OJ9&J5QM,%_!Y[6H;<HZZCQY>N>[E@.W5Q/T1CS1\9]U%G(EH+'3(+
M331C-@=ZAM.LIZPC=(=W#51RG9GHSDDW)%#;XIDFM0-6E)!].3EGLAEIIK1)
MI6+WS;K>P#J6_#!G0HVVLD.LXEG9@QC;<W+X;Q!@G]OL2_4^[!T,3,F^RO:I
MJC&HSMLU/3R+*;H#$TCK?(IFPF$A=O;=Z+]$Z.91 )B^C=1N!5Z\FYN8W2!&
MN!=0>V"PA,XMH.=YM].#\ XP! +B[/:F;OZFWE G#CJ(?I3R $D7(<UWA:*7
M0^$B781E!N#&ZF/Z';7SQ;[)'A?]?>$7P^P7\ 48[0C6CP%B_PORIPO/K(E1
MD6L!+^S?*7FT/ '-(KIFP_L E'#JK^ ;7!4T&##_-$Z)V84>T[7<W(]!L<'"
MY%P 8#H2Q+N%F.2W/%6G[1"8(GO2YR WV(=9_+ W(O3V'\-T=@[*SG-0^G8.
M2B'W\S3FH.BR\A _KZ#5>Q?D,_W)2$V@B$<4!_@AB#7\&XP?AW^A*RW[GFLV
M%:S4BAJ-PU_8C7X&T740K4!%W.;.%ZP)QBS<-&/[Z<Z]MR$2;\'OFR9$P/?_
MW]N?SO(4\Z/@V\3V VWH)=>MT\SGTD"1S8#0$'OP _!S'[![PX4'BOKZTYLK
M(L(\C:G[.SA*T]B_%D^*UM_X+_0C_D\*C@.+8?F/3+1L!QK_#*H)1.OL_U!,
MF63&0W@@_Q:/\%)T2*5W1'I8]C(,T6*)-?4E_]]LR>VV.J)A$1P\.VR4'J,-
MNJ%Y"@"I3V2#YZ[7M!*;S]DTR<)<14NP6+ Z-N6'O>*J'82"?D+6#=PM/YJA
MNT7M\G$B G"__+HKOW:EXSX%-<G)'E,^*14=V/7]LZ_ \ESUQH]]4)P^4DT(
M%>XG<QYCEJ2QB+(C0ED8W<+S4\;D$ 5VEL$ND7"(OO;]SNCAO GJ@W(0JQ0G
M8##"'VUN%8"#FV<EO(3V/H= /2"=@7O&) -P8:CTCIR/D _[<-&9"L18"O#9
M_T:T\(2MZ.F_&5NI>0BR$[Z<U(&>\YQUG+>A3ID !Q"0<(";$RW!BYG)V0VP
M&("=3M5 !& QD!<2)EPU(SN/< 0!2F#BA5,:"W'+"DH3_#*@H2?7R9,PT7P.
M_N*9" -SF.$)G+Z!^19P_8*UF,$!C+.,0+-&F4,+2E?,F2!X;L%G!+W\5PJR
M2(^S\(L?1Z'P",'Y VL,3\)R1V.#9F;?8*+7R:ZW=X58\A60E"D9WM "0I+G
M;(;AN7.#87HH\FPK'#PB8[VK"/#I 593[ESZ(/X?6>"SN4OX?S.54SX^L6E*
M0STNP7R\Q,E0_>YW5Y<?WWS"3^COWG>O1 !!'^OLB,_(42<<.86!1P0<X7T5
MG_)LJDA$RAO"/ APX1=+8,4T9H4!( FP5!1C32[$J^$-0]URX\4SQ3^@AS K
M2+8 = YST@3$\#_9*)B0)4KJX FP+IQ&S&RL*I&ZL5S@+^6P%3(<6?YDAE(E
M)%G?>KXP3SFJ2PD&SO5 =:!BC)A1DE+PM3(8:@**@S9%/OA)"&9&#\"BV,!T
M$5)4#B*!,U0(0$K;B"T@M@-VX_- H&(N/YLQT&6P9%("#.,O,7@$C ]R"X$)
M_P+<)6LWBY107Y2>+<2:WCJ.0(;Q5?!3<+!P&@=IEVP"#"X#!D*>6< ZF=8P
M;+:)L@!9[*@GGZ]9R.:X/7#VF:!?)A\Y_[I@$Q.,?@4CD06NFT"R+9 LAGSM
MRP\_OJ!&.O5548=@B?L=J5_L-E1P(\)[2-T8*,OS^Y[Y[YAR1DOIS]<['/<_
M+.><LS39?R;&-N7*8L&\(%E,A4>H)F.1TT$B [;\BT?92:GX=''),GPT0PF7
MN)P"#U..<$8*YU(\[7Q0#W^(HYO86V86Z??+RP\?<(#5C"N;5)U[GN4IM V[
MV7'^D##Y-*(+W^!6[VP:I<$,;$84"3M<OTU$DS0AV?9X>0Z8<(I6J\"7B!4C
MOI2V(;.-B=?\1;AAL5^A[*\HRR->I]Y3C8'_\I; .^(W_BR?2989]]\_*12B
MMZ$*PC"H^)-4("9"A UXWAOFB4&*U22=LMWG>^#H,OIB9MFZD,J449:,D(J]
M8<C[1)_;%V_4Z(RZMPA 3#XMCJH+"9EK^88E(*X:%Y(P.3W4H*_:PXA]EI/4
M&+6:[(G5]5;7'U[7@XB#YIT*!P6<Q#DE5581YL2DO"KO5(Z)A4AT@4JMSD<E
ME90I!$P2D,*2,<U8I4'49+V*#(GRM<_FF)2A()B%H)37]$$Y!L[_KS"T1)QV
MH1YY7M 9<I"D</M!F=.68TV#JY,%45U0<:P#Z_7OL1X>*\A"")'?DB<92CGZ
MK+[0P&H?JWU.6?L4/<UL2JJ6H+_UP)W T: Q\Y?7:<PI/G4=\-7"1$\F"!\!
M\U4<YV]*-\XI^7';W$$]^_ <6+/3=:XS5Z=:XY"G!@Z3S!.H>/Y#>AWX4^=7
M 0+"F&E*Z7B\6;+XAH73M?,SP.V*;&"L5 ?M0JPD(9?)&OEK^/Z:.2F7SJ,J
M!,2H4R0LZ9_"I\3<T4PF9$5=5)8&$C_!%11R\7?PHAL?A5_#8/7N<[3B&D'$
MDT(*N4 "I2>S7#(-&,9OO"2)?0B62>$ D(HN>4Y;#!6M/6;'5U58D22O?\DL
M%PYGQ3EL!(H^*CGW<X$'HB59-R+N5W^)1SUKU/KGU6A0IH .P'N#SB@_.D?T
M8XX&D_MTD%X1#>7\KSQRC=8\S[C]D3]1VA6F1U.BO[."W4W7KK1%V=OHG"';
M(O"6F)TK]TH+];[3>2R;BRO$"NF$N0R9O9I)#A2.>C56TA6B),%APWF:EZ;"
M^A0R4$9():&P)(_+7X1"]D6B'%P&%7I1?1(2 VM@<7*PJC]B7Z+@"VZ>=(+^
MCE+6\28%RF>?S_)CEC\ZGR!"0<$1XZ>!4)KL_IJ"^LI$M^-<I2"D81((-%?O
M7I((>%\A(=__.L^&5>U;^1]_,I$5UW/Q,H<NW+)LV[ MAB<!8J6EMY:DE@EU
MF4/GNEKU0YH>383QD?L#/ TX9ABTSR89M0FTXQRV7GU\^_GMU>5OSN75U?L_
MWGU^^^X7Y\/[W]Y>O7WSR82"I2MPSBEE7%84OCS32Q:4UD"-3'E/S^% #W\.
M#V%9C#Q+#@M'EX5#+6%(_!"/D. ](GP@NZF85%\0YX^C('.I3^![G3OP+7^E
M,SG<_CW6/MZQ@9K$ZMX1><\C(5O\LW/QS\ 6_]CBGP<6>1<V5ED0]%%XI>#@
M3*.;T"]4'Q\6G/OKC'T507W,/''I^L'&_Y-7"\L2$?A+>%E92E3\''U-3%._
M8XFJ0%"^/3G1$&&1"<C\?8I#R@7#%)U-I^G*DVZ'_$)G%%5:1=9'.F94)T)Y
M'X@ISJ29 ;M$D00=2.)A)+EJ^-XH!@.VP@1W%F;,?$XB#%XDI^*?,_4-79ZB
M B\9-N5+H[^^$$F9[*B3?HX'F%'\-T8Z5-/"TAC(=$-A<WG=:IR]E!\4*U,E
M[@(L+E%&<9;=7,$R(\V#>R4<M8R07B+<P.PY//$&O. A.%6"+]%4RN."9.''
MLS-T<-<8%42(F*RR) NBJ;B%?96^-J(V8PO%$L N#! #\>V--/UY)".\65FK
MI'9!#,7AMQS/C3HZ B#"P,L,"  Z&708DCUVS9);O 24\NP(6B&50@OF =>J
M3]#+!U_A%Q;2#07RS&%=Y+V87-];EO.6XM(Z[LPV[>*3]![Y21XX8*DP'6)-
M$[UH8!-=*G*:L14C 2UX.J%>!9<]P[-00QU$>S<QDS4#,G8HD[,H/X44+,0-
MB,0DXXB9/Z?+ XG@#2JZY^BE^WP!K\=C.%4BCF=_%#+ABG>R**(EOQ:BN($
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M'Z19*:N8Y?.IJ'_G:@6,0J_6<.-N-( M3]OQ@JGZ<<=Y@STDE_#;A=X-44<
M05X%I!@.E/>@S&&N@J#<_#&?^:/UU%8]6/-Q+;C)-37_SF8NU^ ,.1\P3\U5
MT<+@B!K9LQ#T'.=5?2H!Y"!OTRG[)P/LA?WK,'6<'W7":!O*=^'F*)8=?W>&
M5W7&)_P%[ L+L!<T3^=S''H94J]56@ []6H=<46;;]@'QQ;QHHNC0!\V/?>F
M<O:L("4A7O7NSX9R=IQ?HUMLFKXQWC9O/9LF"]CM?Z0VR.=V4WO_H**1+/7_
M3*__DH,]2GQ,[7[%G%^IM?Q0FU^%WPKM51A8I<#]0$B2TQAB-7P@ZRO^Q><T
M' V10C-7J+$I]3,'*N#WH(T)1=GT%4EJ?>_YS-(EV#14=,NLB$X,*:59X3CI
M=,T3MN2D1K!)\-1;T6PP&M;V%4OM9,-]I0RV\D3>H!UW+N<J(,'%'!'1)AYX
M%H<YP7HQ]7J/Y%Z$=E"4QXFMJ=8M7HSH)FFK T/'@(1(-H[/=R]U3HQ]VE'9
MQ]AM%1?T^$*3;F+3:11K$\G%P#H)S9)YG";M20,B)T?<P.JJ5S&.!9/B=W:]
M/LN5C0]<\+;TA%M6-!5=D0L B"G,.GRX QT#^F9P1$:XED-=YC['-^"<<F?A
M<>=&S:'#D>Z!L)2>#@ *H1^6)HSW.MT7B*1>9_1"M=A5T'6<XD@5P'ZPYCZU
MXL4YYNS?*757)Z[0QYUG--6ZYA(>A6HAY"DH>160.@*VP*M[%(J+,N+I<%0I
M.ZXX)VLN6S-J;JO*Y#R:^IZ8(2"[L7-OF0TC8>%,:7G IIA5@+J&6HQ?X^CS
M+]D "?#&.: :#(.^_<#_FV73"+0A4[N([RUI-]0'USAV@O0!&+->@>+"/$E%
M(GBLPE0!A!L=#$6C\54:KR+L\0QKS1@8<Y[$N?'AC.: ?*%)+7,Q(3&#3]JQ
M\FCY;*9S40[DK'+@0WT'X#0AXIA#O>[EOZ66JV:&K005*,L6BN+L!:XV=PFE
M(:R8N(E3Z KL^KS7&3A+Q*T83@%_3[*_E<M&(HQ# 68%'.N[%^C62J@E[PAM
MJP9U2.[(\3O?@5L4%()C>04@]';13Y 4%O9\$T/U!&N!!*JY&4J4LK[=8IPI
MM>PVJ#/S(=Y;U=&:,S$$@HP+]=PGUP.9,B9MCURZJN]DCEI*$G%&?H!J_C\S
MN.VU]MZJRY>%^/>1+;+'QVB13:F-^W?(+O?(KC^!/5!;Q.'Y0UH'F]FC\5%P
M[:<PX;PJ6WQGFO%ND=(U;77.N"9K;"JE:NH/#L+_NU096"$YGI!4=J;=@Y!L
MZ9C=,NDX0;C,9IWZ-M@MXYQCZE5=.^Y6Q5:M0^^BZ'YN;?Q"(>P6/WK?]#>K
MXZ0!%YP?2>?:VH']B^A1FTS>$PF]_L0=X4'O<5!A!FM:6;*R= A9ZDW<WL71
M+/^1>ITT8?]WKT\_DKG_#4^9JD^NS3#T^[^F<M B0>&L-PKD@ZKZ[@7WHQ7*
M1=<=7C1AFQOA)LOXEO$EXX]';O^\IM-!RQC?AM!U-O53>IU$"=C2,QL_F^7V
MG:A_/IRXW;H1):UTSRW;FP*=T6P_<">]4\KPV*A4CTJWS(4WPX9:#_T$/?2^
M.SZ_. D'W?*]Y?O[\'VW>QI\;XH5I5NCYD>K^GA:8\/5'7';N+M\KUOD]FAK
MMVOF38<9YVY_7-/8Y*BJL6FFMZ)K"DM:T=U1='ONI&M"NOV@3%_C\.A_5;:8
MV+F;Q+-[=J(XZ#V0%5ZV01_ESOL>-_C0]5I=8L8+!H^]!')/1!SZSL;$WMG8
M4B1Z8<O1D_W5%/>Z1[BT86O3#8:K97QD*]6/I$V/DZ<HM-FA1V9L&HE1D]\Z
MX%2Q./!#AB,IT=Z7.CRUF@<:E]E#W2>I6E0Z6E=I'(L^*74DQ/_K];O.3]YZ
M[P=";2.SJ7"9S7[ /?^/91^#X3*;?3YCD9=E'3/A,IMUK.$[<;C,9C]K^ R'
MRVSV.1W#UT"M  72YI<%_"X[KEYY,?L&VXHM68Q]Q)P/@1<:4H!G^"FB/2)L
M&@F]@3NY&)U0A; 5)2M*S2"A[PXNCG8R8P9C6DFRDG0(HW3N#AJY VI%R1QT
M6E':DW_7'0VL*!D-L!6E5HB2.QZ?TEU**TE6DAJ2I*%[T1^?D"@UE21M-/TI
MAU5](_[AS\S(>!J@8<R\0WD<9W,X;.(>D)EVT+)B@ZSHG@^:R"!83C0,A.8Y
M<>1VQTW<&[>L:!@(S;-BUQUWF_"[+2L:!D+SK.CV)M8^-\T&!H#0/"?B#>@F
M,N2MS#B87Y;U9Q3_S6).<QY9R.GVTS_-R$V<<&+TZ?56'+GG7=M1U&R VPF=
MR5S?<P>])C)\ENM/!9UMY/IS=V*YWG+]D^/ZT=A6X9D-<#NA,YGK)WW+\V8#
MW$[H3.;YL3OJGI)_TU1VK-&9.BR8GZV\M1FI+@-T@)F"?HR>GNY@W,1%)#,-
ME>7$YCAQX YZ]I2O:38P (3&.7'LGE_8RH>FV<  $!KGQ*';O; ZL6DV, "$
MQCEQX/:&EA.;9@,#0&B<$\=N?]"Z>P--)1DJVSV97Y?S/EFP^)^&5.+LB,/&
MDX9;<V55%-Y3!W)3DJ 'W>(>BB%ZYDQ";-T)@FF[L#+83AF\Z$^L##XA&=R-
M]1[A$#4O@\?=XJ-EL.].)DTDUTSCWJ<C@]8.FF<'>^9,)[8R:&7P2<K@H)'V
M%Z9Q[].10>N+FN>+#D=-7,LZ*O>:DGJFH;U-)I5ISH(AO?9W1TZC2JIJ!O43
M:GQG!#) (XX::7#<"(]:<;+B=%B_N^L.&VG-:L7)BM/IB=-PXG:')OC05IRL
M.+5?G 8C=S2PXF0>J%:<VBA.%^[@POIZYH%JI:F-TC0<N)/>:8A335)4_^M_
M_R_X@0?XU7ZC]JY]HB%P&C OI@TL %O?7\?.-]N?I>6=*0L0YBGL\(=GW6?T
MM]RQ^#OP./_AV4^?/OS\F\^3S_C0LQV))J;/<O\_@*->=Y5S5:_;?5'D.DR5
M?N>HU+/@L%)N=A-95?GCG.(2QBPKO*I024FTRMY:/";8;6OXBF\=/X'EI@#N
M/VO)7062ER91-4A5XE*@]=X@5CT(IUH/0L?GP/3^S+E>PPN]A#G>;.F'0/W8
M2R+X<10[R8+YL3-C'&"&7\P<[X:%">]4RV<%6BIE(/]W)?_CTDJL+#L?@9W;
MQ\]4N^_XX31(@3F=5>POO1A6< (_\6\$>P,/^$ON>.',!>@<#ZC%.3P%] ,>
M=F$'"W^:!AZNP]/8"Z=,/G-P]GX40@JG3L0@FW; <3XR?WF=QIPM8;.P9NRH
M^2C.-0O9W)_Z@#%8&K3 M<=!M-,5(,USYHPY?+I@LQ3D; 6VW^?P!RJ)7W_]
MU'%^AI4\9QG!.JA, @9Z T@PC?T583V:.U&*BL./9V<K+T[63LR^L#"%5>&+
M*>.NP^$5__6/BWZ_^]V/*?=#H O^V>M_]TG\!%?Y*)ZBW_6^ QHY;Q.V='J=
M:OM8KS'*H]/5&5Z?9/LA) !\H_TOZ),RA_X21;-;/P@ZP!_XX]>?%\R9>Z!-
MP44!9, .;^1/D$6=2' T@N;/?5)R?IAXX8V/_P1MQA(.BBA9. C_'/0T(#[P
MOP!D2%.&JY*&!E+K?. O0<?'Q 1> B+@<?A'&*9> -*"+R:RP\N=:#I-XYBA
M& !P4Y!O#Y".5$C(%DRC<.8CC4FFZ*VWL9^ ,(&/>!NBC&G[\^?X (<-Q0"4
M@(+-.@Z@@;/J5:4X.]=I0JN'$0#L+WW<51*!XG'0# %VIA[N9@8J")::+@!)
MB"S<A+[S:\E:#@N_^'$4+DGJ8W8#,@_V;5W\'$ )V(T7P!ZF:/V^@]<)?"3.
MBL5^!"2"_X)J"6\(;H\OG'D0W3I!Q,FP7L/;9H)$GK, JX/O $SR=+J@'S':
ML ?:*OJ+396T  )@S127%3_Z3OR*>T!W^-?,YZN(^^KG122LHCC[0M][S.@;
M6#,%1B&LE^@;A?2?I)X<TR@-9OK;@&&0CE-DH )?(=1<H#%D(+X K<!3\7=
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M%891$XV2CT"ZINQPDQ866_1BANDG;[WW^7$[4-4 G6"FM!]C1&0C<OR$*6X
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MH3O1'W5&HQ>B"NV\TQ^]<+7I/L&Z>257??+7N'HKGMW*4A9Y?ML@B'=HN3U
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M!C#0 [W7/ H#X7_LL H#?>SAN>77$P79BI@A(N8.!DW$,4=E61O;2D_A'4L
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MX<TN'J\?MH3=]YQW=3!*[N%:_C'!. 25:HY]]KO70S4@V,,UE'[?'=;5CC1
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MPI9H *Z\M7"?E",,. 3X<(YZ$DD#P1?@\2T@>F$Q_0Y5Z@U <0,*&- "O)G
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MV<;+),S=SN %,#TA%[[< 4-98"ET Y ; \2J>>/;X#WUL.I]^( Q[5&XG<;
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MH3.V>T2=^_+\A9N@_/\\=!W4A*X5[-?3N$CGOTDI3UCDO[*3K%@@RW,++;'
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MGZZ_:3D6XTEI5XZCP"6!2WK")84[-YH8Y_0NK'GO3DR\PV)*UHX[JC>9MG+
M&8LM']MM[O17)S,*,RYR49VY%$9/5.T #-0>J+TWU-Z2"?.(7\6Z."]<=6Y3
M>T'*VGMWG1750>9=?793&PR.&Z[<<<_(_\B:D%:!,F5]O#I[F%.R=,44LI%
M*C^P][(/_6S\:7!S0A1X)O!,KWCFWC%*:K0+>JM"'L;.8ST4GQLMZLJ=RGN+
MVAO>WK58A5=Z][:Z<PK5+#K!F@Z9,]RMWE3%9E8\8*](G9?+W:GB)4N)N:H.
MR=*ITG9K1M9&LOSFS9E&8VM.?NX"(P5&ZALCF7'F-*1!9%0^RJT)[V3.O"BR
M7^BL\4IYXZ,Z(RIK@]T=,-4'E_7)<V'RXDJ,+(VXN[F#J\H:<49*8[C4 42%
MD2Y.V5KND;VL]BQ\7__*<8_*J_CE1KIYUK579@O1K=7_/A<NQ%WGGT?NV=6[
M/$T=FU_EN?Z<#2NDR'UHC[.<1E=9%=9=VCD%]@SLV1/VG/?"37UGC0/9"B]+
M07/&_=BYO2R/5!%S512UNTLM(0>U>*RO'N9V&I8*/AG[3<7**I\,]?0@3V@[
MV7(V"'?<(%(K[JX&46VF#6K^;,(!"U-.AMZ)V,6;,__V#X'- IMU#V);)ECM
MLZXHN!(74SO*ZG4^^*UB-Q=_ZYWAE0O/.-4PZ':!JOM$U7/GBK49Y$*HYY2Y
M1J=:M*!:AE.@[$#9?:+L&2R+MB:_X!)SV6T^YM['KEI])3.?RT$=G91=U5X!
M;\M;+O"9&2USQ@L!:ZZ48E1'OGF[Z'8RGHH 4=Q4!YDC51@?6>=UH< O@5_Z
MQ"_-@8H_L1>%R^UMPOD#P >"[1_!#LV50_8&N=N6:7/05[F99L";3QL+SLS1
MB:5TYT'2T3"K@I,S$V@]T'JO:+U.V)]Y7V?Z>2#50*I](M6%+ \'M<Y/XBI*
M5 FLM]=WI1N,=^R+VRQHPX&*>T;%5E$H\]'(#%TJEX]_^-30<^$*E?C2-W^8
MNVAZ8:#@0,%]HN#6J6UD1I^R(A\UN5;^Q&BD[9.*S)?W^>>DN',5J%SRE3LG
M*DWQ*7-9X8U[<%Z]GKD]F@(&S0%37OB: (555SX+7\S'EP>P2KHKZ5#?-A*%
M*\[3*FY0N6::<Z1I//?B"D2^8('YU\3XI/4J_U*,IW=V@;&!!P,/]H0'VQ77
M!K/B+1-EB;=,)T-?,..JSBBN$RI:R3WU)_XNSD"=E?\*-!YHO"<T/COU=[0Z
M=Y[D<[M=7</BDRO(YJ7&M"1;5;>@25NP7]IA31G!:U9U_9U:Z6I^W*X#464R
M+"][8^72O0J'KP/G!,[I"><T"3E-4=!6\*A]H+H>V9E?W47E73DV-V45Q"JT
MJ\PXMD)$I.9J(@I=U7 I\K%S>(HKX8HU1NI.FN) C,="_1%LZT#WO:)[8=5U
M-?&X[!+VK5E1)ZM9.>#^:1_16HM$YT59%V?[&HNX,]EYW_\LSZ=]7%"+E*Y3
MVOEC71%]RO+AG'[VJP_IZ3)-3MTY@H\W_Y 7X[8+[*@J2-%\=%2%Z@'.R?Q=
M[2UF\[N<S<_9.2>-Z]?=\-A'Q]IQU[^S=PP,'AB\)PS>%FQJ6)6/FR5N?S;.
M:>;HW 6@BLH/T'(#-,Z'JG#F%"**>4>#8QL?+][R+\SY%>1=E6/>#*!R72@Q
M*4WK'+ )1*W*U0V=YCJ^%J,N]FY*VP5&"XS60T:;:H;>UG$RK;:)@K,@$&P?
M"79DG!?,U:3-IHJ3*W586)$03)9 MWVBV_:A]J JV5SY<R>5(TJ)6U<_JR);
M]T4@W4"Z_2#=SZYNNN]W,5.P1>F-WE3X0L&':R56=^NGED=\UF;XMB+#,H\^
M9N4?T;MJ;LZ(/QV;FP@<539#5D9'55>3C^;6FNG.<?W.V2(@/OCO91UI[,1F
MU=3:<V^N_VEQ 7\24:;_^NI_?C\ZNSR]/+H\_=^3H[.W]NW[ZIVEZ/\\.#@:
MJ>N\.#AXXRKIV?L\CK7OD;7GR2>7Y.P&B"5TO$ %XVG!Q"Y2[FZ(M< 2G5Q0
MSPHCS_9=]YFGEE460;U7,O#T\N2WB!XM89"* #H[<W7,=6Z$#TW< \26)SY'
MFFT2CBP-1S,B/HG>GEX<OS^_^/WCR45T]//Y[Y?1;T<?__OD,OIX>O'?3U^X
M3H29K>?LW2+2=*)*-S\_I\SNBAJ(U=TOIL6X7$5C;7P)91>IX;SWQ:3R8#0E
M\N8:&T7E9W$[Y^D81-=&7U5!S94OQ-7)\SV4RME'33^*8?:'J<J:YR-7Q<+.
M2HZ-KL[L[O</6VC^Y=LW^%/JKJY?J>]+8HJZF94_YKO?[:QI7-4T :LR:T;+
MVHCEL_KKBT77W:T 0(?QM*.8;UG1=:NJ&OJ#=\OF9M^J%94.)\Z_-)X[6_2%
M=PZCHPC\I2Z8,XNL:6_79^]VNLM<ZY2YTMYVZ(=@N@J^NDC].^=H&I6F:I3E
MFG9%O"D#.M>N8U;WT"?C5413%P354\''OE(#.10\?KI*O,Z"QR04/%Y0;O:\
MX/'\^_:[]FO__O&:_Y*J[E_5%QQO^W7TT[LWM+8TKQ7<=Z=G1V?'IT?O+ZQ&
M</+;R=GEA=41+G[_T'\%][X5\T2E=A7J[(/ZW/T57$+9U>X^6[]U F(.<>8)
MNM,(7*EF^Z0U>'A!YN;W]+X'G? P)?!H1N%.#>[2:BW9?WCO+SGZ^/?H[='E
MT9,6MT/[;5[=UW@[&+,-2(M??XN\?WBEYF1?7:KY8.A2IYT*NN1[)6Y;7PW-
MV(JP@QH29I_GQ:W5K>R%R;UZZ5Y0^4]\VQ%WFNA^-3(+S8NK&UD*S#]7]_EL
M)=KL2?Y&EF[D'YF]E[NA5<#S/\Q4XKGO%\6:6[X$8ZL5UW]>U\/11N55_.;!
M^#I3?SC%VA+3*'-!"(O7-,2V[/OZ<?/?SVLXG9P]!>EYJON*LK2B]B%= _K]
M\.(P^O#KWR].CRTG7?YZ\O'HP]\'T>G9\:&W*2]^__GB].WIT<?3DR65^+<S
M[M.SMR?_?W1Y'AV?GUV<OS^U/'WR-EJ&"=''D_?^@M.S=^<??[,F\OG9$AOT
M:PKTPOLG2<YO\^_62I]=U:%E4WM-\^KQ2L2#4O9K$J7IS@X/(?O+HDQIVIAW
M:)O'QR<G[]X]5<BLJGW/3)/\>/+A_./E^3M'/A].[)^SRX\GOYQ>7+YZ4_D=
MO2%\.JKZ)#GS\Z.YLCJ*ZZ$9?:@JZ1]-V]A$[S)?.B@!R8^_6+P;6SLW+T9C
M:SB^?__!:5;1=Q^.C\Y_CD[?1I4E$<T)QX/2J(/LR\%UINW#?G#.T7\8'$,@
M4:H-ITC%0K)4$Y.F&@FL(.&OWB2(U=+K]7-U@WHGR2%)GK61W:WH'[V[A>/E
ME6TO9,^5XBNF_"V1]WPWD?600I_V^PGS7?^>]P_MCEP]' M7[Z9^J(NI'ZJS
M<-^+ XQ>$5  C9>WY_T#C9F*]//1>ZM#G[QZ<]QV:O]<.^PO? ]J=_S1>0[1
M]&ZL_'&;A1IO^\7(C@2R.=MOGIZZB1+%@?4#Z[]PUK=6__EO]SE_ICQ4II'*
M;V8==KO:N4:S1KH."FI, 'SW, $$3 B8\,(QX>1_?C^]_/N#F' \:TQS4O7\
M?1GPD 1X"/#PPN'A^.CBUX?!P14;>#?,/Y?/0(4$[!XJP( * 15>."J<G5^>
M7+QZ<^;C#<=Y-(</77[)W6-S]"U1 O,;<B_,CG7D52R<.C9'E74LS='M[= <
M^%#%*NKQ8&0^NZI;BR%=6X]CJH>Q_C#$?0M!I$M"$%<3?MB_T,-O"#O<;LCA
MXP,)[T6";"^>HHX:?.!\?"%JL+HV.G\7M:Z.JLM//IZ\C3[\_O/[T^/HZ/CX
M_/>SR].S7Z)WIQ]_ZX2R^9U;+JF>+I2>DU/PC8_\.1>%]O[QK#!5NI-39R^N
M16&N[7*;HES_(*K GJ:B[Z6OZ'LW</Z[9=E4FUZH3CH\O\U&/O"^"MKOBJ5?
M_]K]S=1-U.J3U*K:GZO<*49W=4;'3)]I<AG*ZFC$[OL#:Q]])^S#/PDM[$V*
MVSJ>['75NV<BRTQGHG M2+]S#_6)C/&/Q]63_3OPX^N.TY>V'C)W$#.HNV)5
M3>?FQEW.V6F9=^P.VEV&C7?F#&8UX]*I&=>4!_*%1BUD-D9=G6MQ:XHLU\M-
MO%F_N6I<56**^[1CPZ-271L]&9I9$D65-E(E$.+OQ.OV]+]S05'&-PX?NII!
MJ2E<\([50NL<F7I1NTBK6>%#NU=5Z:.*' =+B=&59RW=(%.1%<.[@:].-!Q:
MG<4"=M7'W+>Q*>_?XC:O,F^:5:SW^*LG:^W%:YKU60%6M@I4ME?#=[AQ9596
MNG^N$6CN:R(Y;U]5 6T6%75;V(W*;EUCZKI OMT(^[VY'5<),.X1OX^RJ;/
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ML(:D/#&<Q1(E,;)6.8-2&JE5JE,A4=S1:V5UI1HA&I ^^?J#01[XY6O\PF,
ME$@E,XHCD$+&$1- X!BF#"9LK443$1Z0/D52[K;QW6MA795QSMSSLC3S_2BL
MKBA&5YE[&:(#PG'C&N#N=$IA57VV,S,^^:*&$Q< U &%5+DBB@!0"25".N64
M(< )Y%PQK%''L>/*5 =&!I#UJ+U5B!((;+LK;*N$T3HE)*64(J( 1YK@5 +.
M80(),^NLO$$&">M1_NI.1PML)!5D'5K-MLL]AU#P?0T%;Y6[/\M':J&\;")D
MRHFUH1032',C[%^-L(D%@*X$_CI/.0:8AIR-P*B!41_#J#P1,8 :(9-2E (K
MI[F@,01 $6U 5Y30RG04RZA]:J"UJ_D7]\>-W+@WYXV!\)#AE3>LZ)OF\K5%
M[1U6ZGSB_%=/&O?:H>K/J]C0E:)V+Y?I,17]V]XAP$BL->, &R2,X5I@$JLX
MU1IK:=99U8PBWJ\*CT_DV]XK8@%W N[T%7=TPIU9%\LD5@A@*$6,)&=2<*9$
MBO$ZW5L<#2#I<?+NFG"GAR$VRJJ&IMB\A^O]Z='/I^]/+T]/+@;1QY.W)R>_
M'?W\_B0Z.S\[.#X_N_QX_O[]Z=DOT>G9Y<G'DXO+0?3[Q8=?%PFD?S.[^/7H
MX\FOY^_?GGR\^*\_L030'Z.3__G]]/+OT='9VZ43#-%&H;]&")X)V[]]T;&S
ML2!UF[1HF F9#;-Q9K;8M:JG:O].GQ_W9*GZ!N&[MGZ!U/;I>/UI,F$E4']/
MLO#%PHS,"X0CI>RBCDMKW]WYT,"#:%P(;5Z\KKW'+IM^.5UJ OQ0T=^E([[%
M9JZ0*\T99A@;@K1*&.*"Q=C 5)DT(?$Z^UH,$M*CT_:>"=; KH%=%]F5RD0(
M'!-!-$8L%DR;6.($:::D%LDZXP+! ,)05& =10664]Z<8L&7Z15Z8J)Q'I5F
M.#1%E*>14/^:9(71D9R4V<B4Y6)! K<*?;1.0U[T-YL23\V+OKV^#SYO)^8R
MO_#D=)X>U<3T<TU+[1QH@04!&*DT31'E6%*D.8<XA4!(%:^SOK)5'N*N5I[]
MM)E"/8+>#7"7^2Y-,)$(4FD$0Y:C.(:NNCF*4XUB!'BH/; /M0<V[:XH)E9C
M,%]NS:@TH4K@RTVHKDGA_>PDH\,.P08E2@(CE+5#TI0G,L$:&0@!26.R3LF/
M\(#&NV^(!/YYR?R#E0( )MQP E!JY;BT&C-B+(6$IT*O5((O!$#UJ]733AKR
MCH*2& VB!#+[!^/7?1;NS>'TK>NP8>DU3Z/\7J'@UKEU/QT#O31*^FF(] @+
MYZNE-I!XMPB(*9 )E0(C;7&0"LPXIXPJJ>P[!'1'1.CJ7 GQ -$>*13A\#\P
M;/\95@*E-$SM/ZE!7""IN80@3CG%TB"UUGX&=(#!7A<6V:1R\^T5"K:MRXSR
ML9F>A_0G\2]D0C^ ACN5"?T^'UU=FN+FK9'C121D$LF82RI HI$%/Z8@X(3'
M5J&!DJAU-F)BL$>%6D*Y@L"DO6528K!,D=(&,H*<D4%$'*LD)3HV,D'K=+B@
M@35F]I-->Q)-L>+,@!4WBZS*$JC%!('@: EVV\K0[R%OLY1Q+&/!(:<"<:@$
MB'4J*8$<$$G5.NM',SA ?6J5&YPK@4G[R:2:$2T3'%O& TA2*04#&*@88RX3
M N4:-11NF90'A\HV@CPVG:=XUO:5^.+4SH.BYITJ(?CCQ1Y>-U:4IY,Z+*W=
MU2Y-7- 9AP9IA(40!*>IB)7"<8I)5]>;%49\8A8:0P;.V5'.,4)B0)2"4$&$
ME.*"Q)H@^S$51"3K+7D3PCWZZ6E8K6S_:#[EPT\^IB,;&2_7"Z.ST'XBF# K
M1[GWEL+.TV-/7W,HASB!&$ H 5*02&0DE(0!2&(IS3KC0JW5-(CC'IV'!%=#
MX-.^\FE*$ZMW4)'*5*'8< 8I<:G?DH!48477F4=*]IU-@[.A)M&W)C6%RT,=
MBR\AI>0%VT8-(9R.5'YC+L67EB?TS,QU?S"8 P5DS(!!0' !J;1_(&22:P+6
MVN,:#2#K41QHSY2$P$6[PT58&1 KJ@5/.$J!D8ISR;$T%#,FNZJZK$R\TP'=
M@W:QP=WPB$91RU-(>G>P$"R<O;-PED2J=[:J$9K%<8* 9)PB(I4$2F@-TEB(
M6"1KU2HH&H ^:17!*Q%X=B=X-L56X5<Q$)@BE!@M,><)$D!)!5,MUGE@0L"
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M%X?Q("%[G1X<^#CP\6;X&"9$<$8M@R)AN==PAE(@C)+,  %11[&PU9EB,!E
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M8?7"ZGW;ZFWH?)Z@'6YX?6;&%J/'F3LE+\PG,YJ8D"_[K$'M]?%77];@:W7
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M2-LA%YD8GH[^.2GN/GB><1.N;URN'ITQ&1#>HWX;H69#@)*=A9*$I$Q1%G/
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MN$ETJ@1%$C&"6<IB00"E%,>(HX[VV*O0^O]MBER+\OK5FX/^0.T3V:IONDV
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MV_,1AE"T;9L:G@P^>"IH%TM/8&R8QL!H@S1"#%JK VLI"60IIQW=ZM;@Q0.
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MN_II/>DU(!R\2U!,HE05D/>)K2Y.=_\I+0[6HB_I@ST+OC:*KXU6FUIJZ9G
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MT: (%(\"BIL,E;E%Q*X2).,(.BA24<9YXJ""@DP[$7](@"P!\IZ1P 8ABLJ
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MJ:C8T@5DDV(QR;CHH%LPQ4L6QCV-$E8>"21<(%S0:R[8&E2M=@H]AJP+@]5
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MNG>ZCL]:X6[HPGX.+MC%5@C!Z;[B-"D30TQ1H2$(!&0\M:@Z6RCL;'EX6Y*
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MGV+88MAK33XM9V>5\RXR>%!D3=#-F1&2+E#VI',OV!9L"[;O8#LKSYB"3@Z
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MZ$7S^>FW?G?*F?&DW;9/%_H[-?\SF([/1F4[E_U,;<U*UWTDQ9XGFF'?7+C
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M34=EA),13[MYC;6.SD8XNW42+46? ]O8D3'4%,CK$HUQL69K6@*UE=Q)#TV
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M6=L[$U^R,W$SXVUGM]<EJBZQ6]]30>SZ#F? ;L/(#T0DF$T]CTA'>JV]ROK
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M6E-WDY'2B3K:6JKQ#<7>=LKH+]7XIHNB779#&76%1P@/8H^Z#I.>X-(+N4U
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M]_!BE8QY#)?!HV*5@2:'A\ASZ]_^$A!B_]RR"?V+\_,/L!FX$I@H6,Z9!0<
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MTKY6%:JZKJY1+0M5YSP.8T3E4?DL7/'"=U]!A^+CQI5Z]=JKA62 WVL _*)
M#5-Y[?=!;F(D0X']O';3Y4:**1!!LF2O)HK'H_2K A5VIJ49DBQR%G3Y 9-2
ME5M-ZELX*))3PWNJ2'X=(]XEB.-+$KM,V6 RV$P)+Y V#=TX!,2(.'":1]JI
MG>,R(%66N0GLUV0E[V.GTA?4COU8"A(Q&OL\=(7R7-L67DBY:MFI7>W4WM].
M0<57+5M=<H94-@$(J@G8-0 @-&T AZIH5</CFI]OF].Z7Z<CZ90\1<B1G(Z+
MI6C;<'DQ4CS3>>O#GT&[R4"Y.9NFDY+U%-^8M/;R-<TP^#4H8[]DBO]Y ?]I
M,/+U=69+CS X;9XQEQ'_"!@$2W[7=5QP8X"_7M:;MXR5*?9SF#2_SPG<<!8A
M+,ZTV?F3Q4?W_"%? ;"Y?+YA5CXE M)1V5D1?K<GWV"IRV?TD\4FW\RO<XD,
MPV+G1-]7% G:^G^M]8/%3V\:0JYM:\UW+.WF;XI+!%)C.UKC6#K&Q6,J3@2L
MDE$B4-AR"]@%,)R_Z,2*-,:\&[3NP5K34@25U.*KO_[(WZXH>UC:R$$"$*13
M7@RAS\(X?C<KK4Z=R60I^%E:[\ Z,E7UQ;2C>1,G3T=R&Q/@<I2"I#?Z?WX#
M-S5CAB)DW',HB"#&!(^Y(WP:*!M, $Y<VM;.=(_"ZCY=I>,7^1'\]C93MRB-
MP"8$P((9*Y1U#[;:OZ[9^$5YUPW<=(VW !#T4^>L'NZ0D-DL]@ES714(FT>"
MN8SX*@KBQZHF3A,&9VX% F^M&],^7W:B6X!*([1NK!HK2M):@QQ&L=L'3F#+
M[9A&$FLAF2]X1#U/JMAG$0Y@4':+*K,!)[8NY%WN8*/3UY-TEJ.;0B_Z:!BB
MG,"6ONL!+7C,IC2RI93$!QCX4:CB\)$J73<,<=9@R  9M'$+K=OL)<^'GXVC
M17Y&)YF27U+<.*+!XJ;=" Q_GXB(.8S9@<^9!RJMLB7CA''6TBQA;UNUSY?;
M'I1;U2<ZX4GER@%-5<"^M-&R;O,?,<E-;QXEVL;M<X>SP*,JD$',%)-AZ-MN
M3(%!VLQSVD(_>]Q^"_:7VR]\;%-5N,RT>):SM<EV#7*_&N<@]$?:=?\AS>:!
M<C5&:("@1\O3>-::^;Y@PG!'$3N6-HM<C]L!&)-$<N4Z8< ?2058G[8_6:'^
M.=-U+O7FD"* !8Q%,H%?$#E04G(ALIDVD8TKTK"..,GR*2"5\3,C@A7N2&U+
MUU/<\2DH=\>PR>KR)-?@3XL+'5<S87) EQ3IE$M"V)&#&*13H@CI7@^XQ_R1
M>06Y):>D)7%Y3IU# ^'-VQ;'[@'AW2G?A!P[WX1TRC<ASR/?!*,W& "I0C M
M&&!T=]#?,&ILG&VCQ(2'=/AA.LV2:&:\=]/4,)R%F$J5!S%HQ&Y,^#:J4DZT
MOW IPKTZFHT9V_ W6L%2QR\*/V+$1WP,JE0^5*5S$-@JQI.!VTZ+*##PS!:S
M<\',7+4-#/PZY.>) JX_1IX*[#R9/A16IHF)K8.HB;; CTK=(=A*"*P#V]P1
MM("\?MKJQZP$&5P-^G>"!3ER%_@MLJ6-Z+D \"TV40"Y.((#K %V.$DS#./-
MG^H!.4RG(#\Y=I"?= KRD^Y!_M.3CRL"G >$>:=H'EV,YAT:-6BGF!K=9TSM
ML#)R563;)&NLSC8:8!8]G\ 5H-N;<D=0Z%'USVM&C.D".IIUE\[&4V,(-)]8
MB@=4VQO9!&7>UH]&)*99Z5@PCX$WJ&\3-4;' \]-FL(X-P=;\'2L>-4FPWQ^
M NQ!I" N"AZKDQJTI!\7N2KHRL +S/OJ0$RE%SS@V^=>,,LR%)0-Q>%P'+PT
MFHKMYP4'+_-;U@B[ S)YVBDB1,FQ*;F3LYHN.:N/F2W?Z!QQ93I'7%>=(ZR;
MHF+Y@"#K9-[28YNWM)-Y2_?9[N9P/'I>&=TA#6+_.D>G9(H2:U$2?$UDG221
MK.F24E?GEV4"!0NVT$.&9;9+=QB6/C1,F9MD-! "VI^%;#&=3).[Y'_*7TQ&
M<*RR.H;62'B<*IU\-K#BV5C[N6"1@F-%-@@$]96/9F7R';Y69;?I.+W#O!#,
M3,BUO#02Y8[_D69U\F&NZIVA!5,V"2AL&/TT]+!J05I9B]%#F0Z8Z:H'A(06
MSXU$-A#M4W2"N;:M!20?@V ZMS[I/$L0BMK4*8$(4O 689C/,GAD#8'"RY9D
MU<(J45P&O J0YHN[*6LV&ASL!HP/>.EO2B8B@:5=@RH T-'0A'V@\"IR_&#]
M&.AMS3/5O1I *L,3 2U!7&-9=IR@*C =CM044SDSGNALRN\OOESFF,0\%[<^
M  /JY.^AWL$2K_:9EV8=B8EW<D;1)6?4\<3S8W+2=N&85T!I0BO/EY_^W]6[
M,VP^>K!3Z&2PTXX&^[)%7.5I=).=[=W&=@!')\< ?1[9_Q=Y,Y +2RQBN3JN
M!8Q<YS?'5IR,M&NNRJ.^>7^IN7 \R[0TD2H761*9.R4FGX^JLA\C);1!Y/^<
M6_]W!I:=RN!UGY61!LT.:""S[F"]9_^WLAM-.$@GT%G_-/?J->EY<K@&['-Q
M,1ZCW6F>B*90^9S_KWK.^AA]VTI-LCCL6F489;KE)AW/2C0QUAG]"G0&,:T:
M_Y04"E(;WH8J $ "WV)<ISIV!2(S265>FJ[<%.748-";*RX:%*J1R!167,/#
MM(8S*VS6T@[4RD-=.:G-Z70N,253TUEFV@VE^M9Q>@^W"Z6TZ@"(<%8MN=C[
M1I-Q)\KJY/YA[>Z?S:QFEZ6R3BX@]CQ<0$U=#NLS)C,LP54:*W72,2QYG->M
MK_A4TURC2$/7HR1C77-2@*E0<)M%*??#!%.@1SF@)?\342Z?JDD^A_A_*C5I
M%+H8Y7=J5-6<QTJ7EHQ0=2RB#$ ^H%O+HH(8%@*+GHE2GP6:'>K*H<K3;X@H
M3U%Y1(8W!4M J_6+52K5<6MJ&8V 5GCQU%K%!G,!5-TS4V$T5Y]SGV9_8CEB
M.@66,:\O)]7##2W6N[]+Q\FTX%=@T\QJ?]9],AI97/X!BK1YM!I_3;)T7,0K
M!#K;X&GPJH.202<W#VMW\QR88CNY>MCSR$L$&OB-9V)HY(26"/D$\+]F^8LR
MR.!WK*0N [_%UB=CT_<.W;=?BXJ#RQ10B@-BS7+K(I$#$*A@)L;&I'TOC$5;
MH^N-$C-MR5Z ;OI]62%[\?G]#7[3J(O%1Y=?ET9_CF2D0'4&<N'?S+>Y)F(M
MU+5: :;@W6P$5]P!U8)A.F?JUJ$L,427- KL6Y[),F-3U]856@H(/F7-IL"O
MC+6/M#M6TX9/&/2>')^__-0"I(N/J\&@2XT+!J1S@HK".HF<J.!]]6/S68X"
MNU@$FJ[(-<O\E4SIP*HAZU)U*2U]"[6;XL8;P\&J(P 8FN6+X5C;R\ 1T%>@
M5Z7K\<T&$-8C=9ODIBK3O .^DPI8/CQRNK P3.4QMC6H/8@IN+1Z[^C[ARL?
M!E4Z#G+8Q8? [C#2J5\$O\M$QU@U$Z[\'";,.RU<-UCN5[+3P[*T3OY-UN[?
M/#!+Z^3C9">1PM,A'*F=1*C47@BA1KK&4FHLNY!?M?ONNJ"9ZRR]S?A=Q8%^
MN[BXOK8^@$U>%;$?]%@Z>7[8DN?GB:MA=@)!)\<->QY91%?'%:]S4K5FM%N+
M5ZVJ%G'7FGD/%1]-A\+8B%K^9H6V7%1Z&YJ2I2#*BUX3N.P&/965BZU .+=^
M+^Y)M&L?B7+0_F:1SD82)&R:&J"N7@9N8U'@5IPA7PPDS"O: /Q14H"B4=8N
MBU.!D]*"\5(78YE758_^-WXW^;GXF,@JT%:?PV\WY0F@ E9.BD(K_\N<S5V$
MP1%B*Q.B34'C?V8<=EPG #?K051$0A&SD#*&G5^ H+A/0@FTQ2.;MF;[,FK_
MX_?Q+ <<^)1=C6-4+6"G5Z"*F.KP8JL-]GHQE@5S+7AK7O#6MA+RCHGS;$WF
MO/8[%=R]PH#ZU+#=0Q6$;]9A%$ZBPCU4>(<6RG+0H$WD$D+#M>ORU#^K8AV?
M8GU]XTP8Q]Z]RHMMUV.4Z-:=<<A\'A);.9YLJU2AU'EV9Y)I&]IT-D"*>BB
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M>$X2)X!,TXN*IJ^1I$& H?;QRR@5?[ZIE1$_#+Q0"$I\&3(JG5!Q;&;AN6"
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M'W-XB[[_9EC/N?5>-U5&O?:_.!!2]F#I8MH#;S.)YS=IQA;KO:W"E[(XKS1
M3!JU5M23IBFBA_>EZ9\%0A6^Z&EBZGO+-PZL\AFY?H0.X\<(X&*FTNU8Q_DQ
MI7K<**+3V=%5Z5P3UY$:SO187FV,;)Z$<!!NVLEK3=96;VQFC!VXZ>/]Y <!
M5R=7.5E;O[%YYQW ]3SFY^S72J'G%/Z''I!-CIHSV![7OHH5OP--+OY4:HH,
ML[./Y<K9KN?"K@Z?$C?@&YUA^"\8P /V!I" S8]2/JWLNDK>UPUT\$Q-L/%L
M5 R#7@Q(EB7?=3I4-#,]3;#D17'=9N$/$"O(+4UW?>S.7P<L&V-\BEG4<QK
M;6-5319;+'"MK#?1TGH31<04%U>\M7 :-98#,@+SM;!0&\<;C$Q\=ONH:E7
M;29NPZONLP0P"O2*]'ZLV[?5^P/15U8PF6:_16C5U-173VWNN_&"4O$I 8['
MH/LBZ\*=GW":1*/ZE4MLFJ3*LOERM&VI4S5ZFV-K@EM0*$!+>IC_7E='W6(/
M1S.3Z&=T]A6#^,S9-KH[:V=</D0LNS?^LZI2JJC"&FI-3!=AY3/0Y$P_:*W=
M8'C\#]-*>4&/+!AFW3_Z9W-#SD=:,3*1Z*2L:IH'0J.9,R]BU/@@[/5@D&_^
M?($PZHE1K8=L6A$T7E'-JD!=H8E7U4BJ@356J&KH_M48!)^[#HXGP^JI1LI
M<_<EWN:+:"UQ_!)0 [\S7EI8XQ_%T*R"#'3BCA[94=%4X[W8G.")])1.D3FR
M-C*W689V$+R/K_<Z"+@Z16?(VNC,YIUW -<^.PV?K)'<S.PQK \%3.4B7=M[
MUE2V?8H_E2SSQ@S9:W;%X=)6D>\Q&Z#+E"^X'<%9>HYG^\()MVKAT&QDPYJ-
M;*X^?J@ZV=C+V;'CV5V5'3N]3Y<ZV1P"G"]3:WPY.F(U![+2&ZI$]3N0/J G
MH;Q$H.&,">-7R,NY\)/&P'K380]%WU;C)\O7:;G8E(?6W%.+88ZP^K&1U3&J
M,G/:&+^]Q9$517&S5NDJC:7<W @6,*J:%TYF&::VX<.DPBS^9%SUBUR:7M74
M*,HJ<M.>5_LOMI?!.'/'-%2NAFX1VSFL)\:4B>LF4!L8V&18<:_/!L#-DI @
MD"ZWB:>B"%MG!YS%#%B3(_R(V71S)Z\YGN4X'7E6I[5SYBH[)-SWB,.$X!PW
M$Q'IR-CGOEHN9W'"<NW CI]V[80R GJ *X0C6:B<2'I>'"D5^Y%/8F^;YBG[
M6'N>?%N6%9N_. 1"%\1_7J+SU;ARV)74WPG2L1T%3'G* ^@RZL> [%AM)1SB
M>B*(HB-!NM/:@R ,E0A<PGR?.20*/4J%*WP2!K$3V>J4,9Q%08C%&2$HMDPZ
M=B2<@'K8+S!26%]T),[2#<-+;"QF"S9,PS$?/>1)HTM)->@>!T*"@,.<[/*J
M2BX]3G(6'4&JQRT8OZB,%]T$+B:3D3K3KG;C*S@;JWM4#-X\G<W3*>6%K*W6
MWFR^=+!YV@>R'AU<G5),R-IZ[<T[[P"NYS&P]64:)2_9E8TC=GDV+2/(+;QV
MOC\G<E4]S:39N-1X[,P\'W35F3FT,2CQNI\G8+MQOX*2KWW1M48/QE":H5ON
M3[Q%1R+1-UO[=Z_F/)I;W[BTZ"G:%\TUZ\ZB"J4%KAO(T2R\%AX D7*]BP[0
MRHII.JB;T533L6NN=$>/!BT]^/!M^6QL$K5B,T4+*./G;X*A<ODO+FSC*A::
MK58]P;![Z5>N8PQKJIZXCGHO)1]DRV5*JYS&RV_&'D'E"&$,V)M&K-F?JIA.
MQ77>0G/WBZ;E?!0DF6XV+E<<^1,Y=3LE\%%[%Q'4/MED4[K4XW,&M^SK=<!Y
M)SNU=.R4ITB=G7+2VJ>L;+KK">NW>BF]QPJ#B[D(EPX%5FTM8*4808M4,]-&
ML[;62E$CT,=JVN2=1;2WA3\7\UMR9(@+P>2M(LB#*K5HOAW/<I9:FURH0]MS
M+T]:/7N@W\BB>3HV;30Y6@^-)1=UN%IFH8]N7GJHNV8$^=@E0[13HBO=+=&U
M4Z:K,Y_JNHW-VTD2[*U>@'9KS+Q34FQ[>X"-=YUV6FPO$YZ?Y58$2YK)$W-Y
MGU463VEXK-+TR]8&LNAT8(:.;390UC'Y:EZ&G.'XU$B-TON%C.>D8444.:A:
M3BT-L<%V"E7#WF8SJ+9ME[;"PFYP\:MW-"?[&KDBZ[96RI.5JWX2VX)V2FRE
M.R6VMK> V'@7VR-'G&-PU-LF+++()%\/1RSA1+QSMUCB"^.4UF*]^-/08J>L
M:;I3UO1>J:K7,UZEGK'56"4SPQP$:9;<WBH]);36+ZH,:=0KTDP+R-K*/=^%
M'/= EIUR*FGWCO9[6'*GO$:ZNFVWGC2'AC&:]A_3\65:%1)=E75G:_H"2CM6
M4<PY]PGS;!X)XLG0CB1P(MO=*IEB4PFM$S!D:G$0>I0)XD?(\/Q8",DXLX,C
MST[:HH2V!J<%\#QK -0J(7K4X32=HL)T;51X\YET.,C3J*ZEG:+"=&U4>//.
M.X!KGVZ$9]@H<&71H['U&FDBF8I'2IC.WVB&EL2Y\@E%T8=H-GBIQ^SHWN6F
M#XR.9.73PCK$[,>YQB_I_5C/W)EOHV(-^=>Z#!?7<S?1Z)(AX'2]KC'213DE
MT5+?5":2W$R4R-!8-8FAQ9S'>IHB%NF,Y[N>QS/4? 9E_+.VV\OEU&6S6;UJ
MW4=P;3&R-52C:ORCOF>@"W6*?34K?#+=LMTX>Q?J5Y.\*B3&&"/FYC3,=L2#
MV8C7$RNY!9^GR<1,UL"F\'I-TWLU^EH.)ZJW7G6F*<)_>O(.QS?&^O'%.3<:
MU91U08UL68O?9LJ<M]G!THGI.'>D2OU'S4.E!&L);IQVA%4\NKR6%S'0PKL0
M XS3^X8"I5&E*+:1@/X_6 8VE;>\>DT9EF[L_FXR2A^J2B6>R9%J=N?A.3Q"
M=U37RZF?:W"+_&#2>GF>X[0D+#X"*"5Q OL;Z]0S_,Z,'-8C9 S-C%(]!+QX
MBZ9FD]@U:,QSVMB:VW99)!@'Y<*EH%;87$7*#0-?1DY( JKF6W,WIB"O[-&]
MA9KSN3K8S_I<X<3NL,1)-W#495N-'#M?RM@/;<]A)&*.C*/8AJ6J4 )W]IA8
MS@]<ZM^]Y_[;@Q;,7HO.J["Y*E6<35,<<2H0@X%VI*ET^UXW@M>5?E+QZ?"'
MQ8'QALVH1/.PE60 )U5P-67"]N;E=4BKYA\-NV+:NF)-);HI00[KS1%%.X5V
M=E :.L7QV=HX_F;YWT%I8.W]D5HE]XE,G7\:CPWK%/]G:^/_FP^GPXFZS^]$
M5[CDCCV'LE,PEJT-QFX^K XG[#V_$]Z)9ONI?X^?^N?U4_]>Q=2_'=A=IP0)
MMC9!8FO.]?I<%)^,&BO+.0&5^6?:="W.F&UU0O"FXCZH_ AKM?K:HFO^C&_0
MXX27E6=4]>L.L\522ONM6/5@1:!_M0?%=(3*9&V+-+TI]=:+(<!6/E1J;AU\
MF2R[17.VC]T<J[OP(^(O^J2T:4]^+LW7@INL<6 91\5XH"<08PYUG;50M!_1
M):S&:L?VP:,B$[T>J3;?.6Q0&5X;76=YW6>X*!T$S.1FW%>C<FM:9.67;5$:
M>%DEEA< 6T@-&=3>(.V?:'48=?3PS*67F$UOC>_:9"ZWKI-<]"Z+332(?6XW
M\YGQAF9R'4UK-%"K=C$/HX%NOXQ+X]^P=3/<C<Y" 'NFD-IA'94'K*SK-IF3
MI3^TS='9<&]BJ$XGY@-<1M-A.KLU?LUZ:?EV#ZUWW_;T084%=3MK*YN-5+[:
M:5F\+E]<SSQ,BJ4T_8# :73U.Q]A,T $ICF".G,6'U#6(TQ--VR-\QJNFRF@
M</HF5>,A.5?", ?KQJL*=(ZYJ+!MS;'4-ZX:(+Z,+M;WR3E<WI(O_,-B2TJ>
M&:&5\[MCM>MFG;*5V#/V9U0JW7-;^"$[6K-.B3+,?<*(/.N41,"\=1'YM7'X
MU='XT*?,X9Z**/.9XX510&PW5#'Q!//#<!]3^AP:$D\Y=N2RF$41B9@=21&'
ML1<[1-'3B\:?0@B>=4K:8&N;46T^B ZG=QHA>-8I8X&MSUC8N/,.X#J]$/RJ
M:'E3P]350_E*#6:P>GK).+722)M?"%MLJ*@5#3VU&?M6EK'=N0#TZO=PK9'!
M3G2#RVJHR':Q]ZI%0]W_F6LE$@N5IHO#2AZAY*WNOCVOTVVCRM50*'2ZU6K<
MI2ZHR2N[OV4K1K5$BV7>2Y#/HCR1"7:BUHJR3!<JI- 8+=>*)Z?U.VV6Z9R(
M O2-8&U>M9MN+J2P*W)37-P 47U Y<)6=&9LH!^W;C%/H!P:4PR3*4"HPX!S
M&].) DV(GULWZ.68?TANW2F>SS(]-KJ]1KC-CJMPKQK(5ISA(N#PS4<.+;).
M^4AL?3[21K[6@1F>1G]JUBD2ZZZ/Q&Z[\Y,6 W\O0^O[:"'?J65\PPW0J7?\
M4L-XZZ+Z36<_52WJBA:YNI/="/O]%_ZHU;Q=9S5HMJ.=I\5=B 9",TID6.A5
M$LFT<EJ6+896 J]P,CW1/%:W4PC;=9[0EG([Q61=LF$ZT&<\W9GZ )J"-@5
MR/T]F0XO <M VF1KTIM=ET6*.V!4!2R@?B <+Z:11[C'*2W[^.]F4+F".($G
MXU!%S(>7,>4H+ABUI>]YMGMB!M7C7 8%X*W/AL01&8YI=[F=8E[N^IC7QO/J
M<,BDW8UUDF/+#G)0G;Q_[MI:Q<TP[W!0]&0.ZC22:-Q._CIW;6';YC/H<' K
M',6OA\(Z>2G=M>WC-\.\PT&=WMR675,!KL;6;_P!NY>P ?P%JC'^[0VL"U#
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M)8.T=QS?>-=K3P?Q.J6#>#NE@SB=\D&<%0V.7J\3H%-XUMLI/.MTBL\Z+R1
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MK;F#7<[#B!/J7O*-AKRW\)GZ! ^\ZWQ]+*.:K&Z"L@C_<&=6A>56U[N\JE\
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MX_++ <Q\J9/6+W,-'96YEO?*7,O9Q>0QEKZ#;8E!K>7?\8KCTR"#*JCL=):
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M5U;XMZULQ(W>5B4&:W@"T#IY&V/T:;&8C_1R$6W T(5]2^"[ RUV76)&B>S
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MU]W#XCF1_SJ[5^R[:6?OBOUS[D&HNG-%O:\.A %L80K_>50L(MKOB< !GXH
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MA*IKU1$ZF(1A=]Z^???'_SIOL4]/=O%TI=R=^::?+)*]J_*QWY?YV+_5>OC
M.0,,'8/'TL"*ZV6F,]5T,W+5[96BBSNY<49IJF8PI-<C$<__LE8XMK; ^W3?
MN6<2.<72 0&==R)F0&L@%!04$!S^AW5KY!&"TJ/>VS+>]B9EJ4CN7+U1^EG+
MWY<*]&$ P"'Q[1HADX@R)CBC3!,3I!E)A;56" BM+7A$A.P7I^()\:[,MDJ"
M769JO$V)&N_J/(TCYER*$4$]:K1R_-+[ 6T&M+E:M&'>HUARYAR#Q'NBL46,
M8.\QHP39>R2"UQG=U0W_<!_22A+F5+96:6JM+*TC(@P:0=ZCEJ8#P@P(,R#,
M*@^94Z,I!XH;1I214G$<BS2U8]*;]C*N_MLG&(QHG_K'76W7S^@#Z+NA7V9C
MQ4AW,_TH6OQ% LW09?YDZ-@3"'Q<FAXSQAFDO:!&$,RPPE '2PW$XG4BR8-K
M"BYBR1&QG?%T;7WC!SG\JN4P6#6(6&BYTRRPLY 6!XGTEB/K" "[ZO$O8./\
MR^4S&Q2J9Z]>#$(W"-TU"QVE%"*-K?"QCX.50@#(8&IU8RQL[>W56[7_*9R!
MYPSNM08EKS?B]\<J7?Z"#?I[ZLDY&+[OZ2B6HZV[9_A\[RH72P/<$L*M5Y18
MXX4V B$/F%784M[:NZU_UDELY-$?;'Z@W%[6,SR S  RIP89:BQ!7CBID8K>
M7\TQ"^:7BBVE%->[NDE=/KR$!U@98&6 E9[""N($$DFIT,H3B(7$CCCGC7?$
M!ZL37)5Q.?H:L>:2YBAYY'0YR%ZB+9L3T>+%(PE.2B4N6C-4'3\N9'N27@Z'
M:\SG^8I2!OI&B^,.)$*.4J>\U!8J0KQ6S%O#5>S 0H3PK7[ZWEFD"(TD[/LD
MHEXIB / # !S'H )QB<07@A G"6QHXM%3%B*.1;&TYUICY>W1B$:D3XE.PZ@
M,H#* "JE']U!Z8#D,D *08))H913&B+B.<"BS<756UL4TQ$63U1Y.:?%>:'A
MM/WTLO73AW9=I!IJ" :^&OAJX*MK(=45'-)]SSKZ:;Y(7<QMYM4XCP^Z3&W[
M8M.!A9I^&$?M607-=#&OFP]\.Y0DG$P$+RAG0P;NL-?#7@][W5A,'RS9JXB@
M+O,\3D I#LJAATP/<D*&FNM#-=<MLS]^=V;V81HN8=]&&1K[<:S">)VXNDJ8
M>3VUOX27QY/4<CF\M[QU]DTA ,4GPU7<^&/\9G/LBH?6*Z<(<#&>RI66# I"
M.9!"0NJOHTX1CAB!_?%<#B;W $T#-#T:FB+^8$:5$ @1A:7B"AKJB=+>"DQW
MC?J^?,26M0P='<!H *,!C*X7C*B"TFINK$:<:$DTI8(@; %77CCJKBG2BT9(
M/FEUZ5H\R6>SA,,^O[B$-3PXE9X23/XZFYHF4C9')WH=#4-@(-($<ZPA @H2
MR3CQ'J '3Z6[B!DI2(_:>PV^X$%L3RZVPGH5Y-0816/G82VXMM8)JR#DFGO3
M6Q,+2S*(ZB"J7Y&H,N\0M%8X@!T1@JK881-Z[B'E0MBK,D#@"!%T]?)[SE#<
M.;OJG,TJF:SX?^BM,]2GGQO6GY\1U]VB6>M(,&:0(V6@)X8'K<LB%,BBM;:$
MMFM=ES&6YHDQ7ASP)DG>([OI^#7L)V?$<XVW&=!O0+_+HY\ 3N XNHI*22P4
MP@-I%;<*&,B@5)>U.>^#>+!/WO,![P:\&_"NQWBGN) ^Z':4 4B0XTI)31C&
M&M( ?:[--7Y9P_T^$(A'D,D!!$\*@M<2Q:0O!=UR&&!<OGHD<OVZI_+EZXIE
M/N'<D[X<"3NZGR]S<Z/F[ET^-N[U9#(SZ9@(G/F^9,QT-C2@WQ%I&6)08(P(
M]T@2K@*$.NFYI4JV]ASIKZ%/1(\0_RH0?,"= 7<>/W3AP; C(!+*<:^=1X1Z
M&)0C2B2W7 B)A.EOXJR@/>H_,D1U!YF_'ID'U CFB<$2A+^)%(Y9SB#33 #F
MKRL\C-GU)W><,SA\O=-5 I^X/%>3+'>3XC"Y&=\-E9K]\_/UQ8MW#Q@]A@>O
MXLO?FVS93'>U G#O(,-$$P2XU )I&8<\8L,\Z%$$=Z\/C_2I^?A0J#3 Q!.#
M"6HM 1XZ!*/+'TA!(7$NO&2X=5CUUQ!#(S9 P^6E<("&)PL-&NF@*2B*"()$
M02 5, YYCBEB +;Z:'IKK[%^#6+[>NL)SV"Q_1HK"6>W=^Y<\S#[X@K[&@L<
MCHR)O\8I3Y%U"MCZD+NDY*QI3!1SCYBF##M"'=8*$F,$,SHH1E:VN;'Z9UBA
M/O5_&-S8@^R>1W:)P=Q1)#SQE%CO)0>>"&4@@EJAUJG?/;%V^C1>8Y#705[/
M(Z]&<Z"XL)082:PVP@*HK"?!-('04G9-)@A%UR_"0\CH7J6#N0IW"T(S1(D&
M'\]E,;9FQ34#AB%I-3'$:^*#R4*@$$99@YQ$"%Q'(Q38K[&T@_MW@(8G  T$
M:X@U)E9 3W PE(30G"-*J'#8R%9HZ(5]Q,D !A>7NP$,GA08&!,@0&KD$$,$
M2"0\5H9 BBR&0(NKFF*/1N!I(\00_ZE%YM]G,_MI/)D,P9^3X6-/0'"]+O9P
M<G+%&3]]OG-F$5!/??[1V66X:$3)VR"/S7QE*ZW@@DO./212"!44((V\,5I2
M)0F^#CM)C B]_D96@Z@.HKI'5)GDFG"& %&0(,\#=VED/50B6#08DM[:+9",
M$.:#> [B^:3%4U,'*!1"8D>PXC*<J01!9!!CG+CKFD&.1NRZJHPO;2^<LS.D
MW#(NY!$MBY_7)YVF/+/I(I]-)N'QLG%@X=S-%]ES,U'S>3"^G<W4/ LVMW.W
MT1#?^96AW="6A3RT&^J7:ZF!IE$,_C-*P6_^]YJW4S2_YNRW)6,W@_F.8^ Y
M).%_DFC&M<-200BMU9RVGP(]L*?^Y?*95?.;9Z]>] ?TC]],Z(1NYP%T!M!Y
M4$.;HZ(.U-(X@:%VVA/HH$ &&!Q0QR'G)+AP+\>])0L(]\AE_23[EPT -P#<
MM0.<Q,)2"K&BAI%@-TN.@G%-F9;6>*#;?%^]-:X'S'M2/1NW"$@" <^J:Z8;
M]@YO[6P9O0';BSLY>UQR:&??:+$'J-^I+TG7>S\KLR8JV',!NZ?S:&XF]&[J
MF=9KS33UAF@BE%?6D?";1A)H):YD2CE"(PE[U."L39S[9<P. #, S'D !D@4
MAVIQ1C@A0<V3E"LHI0! 4N': :87ABQ$(]*G\K4!5 90&4"EK 5!" K,O&0*
M$@R0]-808;66"'BFV]H_]]9XQ'2$Q1-57K:,MN+?__[?PHO13? J_A0>/.[6
M>+I4Y9-OOE(^Z,;+B1W>AT?\+XT!0T0"QH4@'$+EC52,4VHUYI[)*I,F?-/9
MUXO[?HL6;-M^3RRU)8 #0X$BWGC!O#=8@' M2#&PA+7=\^"W>)3%*'^OOM=Y
M]K?JT4MF. NQ'O?8O--CB^JQ=[/ND8#H?V4KBR0;)Y,DNZMMDFSN\H]CLQJ;
M> R*W^/IN]!,/I!5'KU,V669%&PL\W0+I*#3 N$F[]GQ_&ZBOD0X=O'H6E_V
MZ9ET/3D$BJ(Z]\9E?CP-=_N7L]E=F=\46#=R:W8W6<ZS1?S(6JY'?&57\L8\
M'DKI$ZIQKH6W,P00R-349O'<S#Z%3U?PK8I,JK" Q6S'[38FB(S"!4U8W/AC
M^L2X4=\15[(^=R1\^*5[F2UB54?2$,(K>6LCV[2\Z:IC4J;J.OQ1>J\Q 35>
M/!:+9#H0S&:!H]97'CZPV*1#9L-3CL*QN+B);]7/GU+$,O?9.!</R:TK:1=?
MS9V)^E=*H_E0IIR]S'X.Y)[/;E>4VB8['*5W8G\!-?V2C=/K\96[?!:V>1Z_
M&I]XXA9I*XM-#&I$NG\A+BKP2#".YG&+2G)_222Q@4[Y;=!DVG:NWHCPP>8F
M54^^M5?U#J>OQ"NVD/QE]OYF.2\>*C%OQ4%QH249UEDYNU5?,COV8=,SG\]N
MRZ=WDW%8N0I8'3AW'!6S>;:,NQFV[D=GDC*6X4"^2,351D=5)MXK07VA@Z4[
MZX4*="B67M%SM:(5+6>^>O[X^G[F?9F]N0FON'K/JI7:M0NFMW;1LJ#4_A4=
M6$:]'8VKZ"]K;%5>M+K.:COBF\MIQ;W5HP?JOVB*1@&Q']S4C*. ?@HFN%MC
M@,2X@6.UJC@JL7LA.T:%];@@(FH>]D5/5CMJH[Q-XO#B/UUX.6#4<K*(Q%3V
MG^' 3L(=F7HE4>\;#V5G@?+3613.F-M9W'+]BSIR5Z'2OSSA*00[G4+HS*<Y
M19V6B:_BL/QY]\E60FR%_/,XGV=UGIG +P&B\\2U#SYZ,A4D(1T!C0,C&%S_
M*FX0.7,:@,[]OV1@9K-@C:6[!E://!O/R!5H3,*O\^+4N,>JBJ?ZY*(GP-D7
M*EQ:?7#5_0O>N NL/[-1.$MK_-> T0%T[Q/K#>#T\SC8NNZ7L"S[MD:=5*3Y
MC[GSR\DO8]^LP^3&,2VUI)9)0BD7D"HN',1<6&3%=MX<@B#\MYC%GY*UOON&
M\Q^^_(?ZYRQ_$S-6DP7_IB31ZVEK@]#*7&_8X2_FSGQK@_KO5/[L%<0OZU'+
M)5EJHS5^HMR)72I'WX@O "#0,>2A\R3@L%2<<!.L/J0YU6R[ ]&CB/_K;%H2
M9=4.Z2#%Z4NV2?"*TN]W"&A5[5L(6M !%JM32DVGA51%K78<SH1Q'M=Q2J#'
MG1"4G!OH6YT?![]%KQWH5R;,7L3O#<C?!]>S?=#R29T'6X""@3THE%R1V(U0
M,:^),^&E\ _S=AM;0(TMX,'8T@W-P4M*=L%YW-IST$E3BPD7WFA&"%%68"D-
MD,@IH@(ZMT:^2CJ5[NIST F"=A1NLZP*D=IX-<K7BK<G7^Y_4+9R<VUUG)>I
MG<7,8DX-98H$U@YJBS$NG)1*&2G==K[MHYBZTX')7H*=>W4FEHY%Y)!#;&A0
M)A T"EALF%&<,XT0:RU8[<[2'=4*N*57K"ERCV#L?W?3P+ !U7>?*&TJRB5T
M$]KIT&?GUDTZ!4DHORK=I# ZUYVJ37TE,--L$<Y]L\SS\/W*CW.7!QTA'R=/
MR%W@P_C67:!O^H@QT9D2B_2,&W^,?I:@-:>K). MKE0?>*5C*(].N,_)+5EX
M6U>W"-K*^"[RY*APJ]5NQQB--$%%.2$/=(H847%N5MT*4?62Z=XGSU\C:AYX
M9FP3\#AE;EI]S_&,#1^/F!S>S&?+#S>!66[_Q[\)!/EW\[#FZ8?%339U'V:+
M<:%<A$-^.4T>\"J(8-3\)KN+YWAYR8K[JBLG;V[R8SL[7_EV2_]=?;/<?9Q-
M/L8KFW ^C1>95R8Y%0NSL/ *)D?XK$[Z:7VJFZ!=!#W=38L(A%UQ]>8M([UB
M2G[2R*.;>FIB<'!>92#-LW!^FN3C'.=-/3Y^(_E-5_=]F?UCJI9AW3%(D\_2
M,5518L=]FI[I/2&930P9%4\879[K3ZGFE;V1*!7%?ESG,H2/K5(<"F]_013U
M(9RQ'\*G#HIZ*4F[1&_U=IU",@GG;LHUN*FKG!>SNXJ-RU>J?(,B3INE8N3_
M_>S'/][]_"[HB#_D3OWY.ORURE79)6+&Q0C7]B6"-A .]^(:W\>\A>K+#Q"\
M*&3%[X42&Y,A8ORE^E"\X.JU-C'?L:R@N-#O_Q97]6J=D.O/>1>^\$)'6KQ0
M/CSEMVKR27V9[Z!7,Z_G^YN\NDA!\)39D8&4W5%F?P"P2ATJ7P/?93?EDZ8R
M@JIVH$@H:BTKJ-YJ;ONS!C2V/5=S!5O/\G<7E*I\[6$2\VWMX>8>E=LQ#N?B
MV$2(5ME-'C73?WL?C\R9CS4JJ7?WJ_1"E.7JI>__IEY5&]+@\FU.W^+\QF_-
MG]/OC4?N!O<'CY%GK[+54==B#Q0M,_YC''@T@&I5F?/C>&XFL_DR=_$P_&$R
M,W\^:Z2,$$> 8PKH>$8JH&RP9[%&FEOL;4L)]*8W\5GFYD;=14'-EZ[MO _6
M@5<06NB]()QKY25WV@8[C!D9?MX*TI_J4%T3;CV;V$!1\C)KYGXEV/Q#%?P2
MQ_8T2IVRNM9I#4:WC)'C<L*^C)W#E.VP'9O1JD-GQC[-Z_"].BRP>YSJB+K9
M&GMN(V6\!:(TG.OE7]\\X&Q)KWT,VKN:-CZ9;AN,T.D\ZA3Q]?"TK8KBC\N\
MX<+,6K(/5@'^9A2]2AX):L.>G,[B4/O-OU/Y(MC,T1GU=OI_;L;FII*/R@/1
M],%@S2P)F\B])$YHH0G33 7"(*B<;?'!;,%,,QU3--,QW_[Z<YV/";;=!]/E
M[:=P[@4CZ]DK'U2[K73,H$;73S*/Z9#FIM"L&KKEKDR;0G-=47%%]!4YJRR(
M=*&FIKYVWSPF&)2J],-[(KD\JD;A0/W-_^=LT:S+;-F,Y,IEVA CP_^=$A("
M11$B%AJ/6V;.E'&C72FV;P))QN9=:5 6;IS_^CT^3WH['$CCV^5M6UHM;>XC
MJG?Q!=H_MV)K"_\:'30GIIIB@G(+ ]D (]X[ 1F#5CCD $2:M9V4CZ*:^GQ<
MJN$6LI7L6]D'F\EGE<TR=RO$6/%UM"W_LI_H;VJS*+SW2R#"^QL5L"((T9??
M/DV=_6.I@SD[5OF7@"9A*^*+):(4=RGS;JJ>7S&-NWCCA_(;C0T*R(()@(X:
MB@C74'L@(4-*AA=YX/4'8LQZRC>MR<SVEY:\W,[W7H%".&0FR9)LIK>$&\QB
MX7AT)JY:-L7DF"9"I+TX$[FC K27U, 828BP&'-&&!<2@8#EEC.$17CU< SZ
M&*0&+^$VEE<4/J76TAH</O0E<D0?T]JAC\ 1^XEEZP;109_;NGG4F:*M<>Q#
M7SIF&/LH#KI=5FO#^MASBW:+K]#ELM)<C5ZBT2EN\T#ML#2>CZPD A9NJ* F
M!EK"B=,0>F@P\Q!#S=5V>^/-0-T)E<23$/V(BN?C],W]^WDD!0J9H"=)SB#5
MB,#8NSHU6S,(&V##B=*RO;U2.UNFI?WU-+(X.]...$,=D8@)ICUA5"N!D-(>
M229CYY8V@>N]2GN*'7FTFEQN9Y^T9>J=\R(H8Y9[HJQ600X5- *:8-,HNCTT
M>#_8=E7AMK7E2H4[W49V4+S/NX$']6^(N%1.Z&#94,(4T8)[P$RPY0V4FA_.
MTSJU_GV:S7L=-\Q>0"-*3')_K>?-9!:.WP(-YW^$[ZZ93EP$BPD;[3T!5DMG
M"96>"X(\8[+%2FW9,-;<,+!#L=GN['XFK29W'\>SY7SR)3.)$.&?1(D-&,WF
M8='S$D+O@Y*!PJ^K+T<121W  [73Q9N>&B<DYP'&@-:$B>BI$5(#%50JAQ0X
MCW3 ,TO'*&IYA0YY#SJ^4?.;WU."B;,IK=#9][,"=DJV;?H+%?+4(DAT@!I!
M@+:"8X]E,/B)@*0M@>YX&+,]BN"45$Q\F-(JPC&0\AY2_MUA@OXZ6[C?ZXR=
M@R05EFF*M13 !P(&L0]0P)%EW ?"27Y:DF[CP$E)F@[4::!/(Z4IT/A+6>3V
M %Q].YTOU&22$C=^GN7K-'\[C<3>V59"4>LQ0(9*2CCD 0\"1L@XD@,&#&[Q
M>>_#! @ZVI:+3[/S@'#*40_471$LXD/ VJD9W\5BS:G-"EO?Y,N&OEI@M!_G
M\YB2EKIW))G(2["(&_;_+:=%ZEM= #@-A*L_/IZ',]K%&LWTP7)[(3W),5WU
MIJB4 702S:,U6^ D^U;>Z1'9;H?=9AU\;<?.'KWW_;XFWQZ43]>WYQA7PAHB
ML;:$,R@<!\@J"D'0+9#;5GLWT\N/Y-N;+?/!MW<"WYZ5D"(@C2*$> Z$5]X:
MBJ0T""/>5A#3*]_>MJY^.M?>:7="1-^ H18()@CC5&*.)"*6>^.H?WCSY7/[
M]-J\K*7EOT*G\V!EX1JZ!R(66GZJ:=EJC+W:O;?3!F+^-FT6WWAM//;*>J1C
M3:_208ZLXP10#PRY1_'--<G 3D];@7M3M\A2 NR+A?I<]@MQ,4=;N\6GF U=
MP-V7LF*ST$!7(?8R3SWB8DQCC]V@]#+Z;)W*IV%?DAY\#X/NO?K\4[BU6?PV
MW;>]S:IX+X*D.2:@\$0(+,.F$H.0,40#XQZZB;"3CT>R$0 MK2U/L)$KFD<#
MH4CI+TJE&D=7M*5?)%OZ+N;JOMQ(A'Y$(GH/$W #VQSJD]^6@PLIM])KAB@.
MNA'4&@LG/ Z@31BRK"4,\^ <7,2 (-Z&:TM%D 0"0.Z5MBBLEB,!+YJ#2U]F
M*[+MS+H]D'2[T]0X_.@=Z(4.TNO9D2REPROIL/QCMGHY:"VE#]C8>2@]VK<1
MEUT>]M9M?O(1>;1'Y,[NV;BI1BLV+<XJ?6DMN;S&OBUGPNG8HS57Z="7MG*5
M6K@[.\_Z6S.##GWI.AI<_)$JSWXSBUDL3 Y* $\=MZ9M]GI0=++;6$*=6G#5
M8QWC)V.M&P+?-1@MO0*_^Z94L,I^VO&RB3>+:$RVR:K5<?Z\Z%91GN3SZOJ;
M'Z]N,BHCWUN<GX2C4#^"SF7,,B_6,T\->:,6-E^X-=O8AE,L:&NQG9^;S#X]
MHC#U,(-TX*HMG]3%,+^UM/K0EXK*ZM2;-S-N$MO[FG"^)HTR_EXV!RYTS8YJ
MU%JUV3UUJF9)V"]!7T_E6BOM\KXS83:JS<IS:'=?Y9;/;[507LSNCI99"5_>
M>S%JN9CM6$P+RYV\O_>[?!SS6XJ>.@V8*4I*MN3>?1Y'3Y6:)UD/YET,]4[<
MAX! L2EAP*\F;/T1."^@WT_IG0I3"D-P[:T859C%'(K8\3"@>!:6=#M+#K6J
MZ'6^3HELZSY1F_SC)B#-3= [@\E9X^3M+(!I"I_.;A,2;6!F>J#%C5IDGV;Y
MGU59;>5\V29!-$KOBC$IV_!;M2&.%"V+_E<U^(V-/$*[[<?B3&OY_J$O';MZ
M__#].BQ2#F!X23!$5PN&;U.3U'\NIX7#J.HBO(V+Z^B5/$?)$34_@!U!N9O%
M>+G[-/GR(MH6J978;=%UH)&5]KP$MK#<-[.5,A;# I]-2B/;A,.8QQ:1\R;8
M5_'6=X5G,KO/?, =[NB?PJNK2N.WTU6"VYOZ@9O.:0\HX#'@KB4E(/Q+@Y0Z
MRKF$$G &'EI#55)OPSO]IM&,(=$_Z)O%+(AJ>>&%(\8.6OQM?_VF"LQ4>Q?/
MA ]%DZ&U?5P+OJ7-3*=?4,+#Z38JSIIP]D5=>52\'[1C,TMMB#9W^%-*-7Q1
MG)/S>B^JI:RQ9$^/G-9&] ==.)N-Z$]]YL#6=O0'OP6'4^>2IPZ^VE.GF;6<
M6J#,RW-BNNK MZ;N5BG@6=U>K59VX]>*TV?5J6?]L&JX&I[G1=_SO67)A\^)
M7PH07,L8V)DJX*FU!!KN"=?$,"RE#H)D-4? &4JV)P!U.B1.69_<<A[LB_P>
MF7[(< PM$-8*090E"@M@&)2&"J,4?7"A\D'Z'3L$+.]QGFX>?6U':M4#Z5'!
MKX<XL]5DLN[CC2FD;OZ(C2_;$MYSXQU%&GJL  VR ZVTE!@)H8.<"P_:"J"O
M5+LJF6&3"?;I5^OJU?9L@;JDYWS:,,9Q'BL*JK Q1!HN$$BEZ@ ;X)!NB_M=
M]WZU&C+U!@6U5BWGKCZ0UGJ8%'^:WIM1W=!NZP0;99]4.! #Y-ZJ.$4C^IVG
MR7U4W/*NWK2"&=:[ZE6-VAKD+:9>5!T5&[G+:?I)($::WI+2Q1>IZ"&ZFE**
M;38/5)GL"1BG,/%Z)]3W+K_]1X25L'5%(/TW_S[-=U'%+S_=WDUF*0&B^MG9
MDF(-"C4K(H3%7&H$#:9$<*6-\9X&S51);SUO*;W<[!E_0IYKZ??:S)=^$5N[
M;C7'3?GD80,F8[<LYIO$&'@^^]2N!J52D77WXK:*E"WG1>^\&A0B50KN^9+Y
MY6(9=*:81O)BMEQ$!^0L^O160U,6&XR4/(;C+;=DQ3ZE1W5=]RIYK\U=V5.+
MK5L '1Y[*,H];MAEF7@PV2YILI$G8;)591(;9E;,:72?G5G&1NIK9^(.HZ[Q
MB6V[+AY;A7\HX4[J"QQ>*_V3:8YLD2XWTX$2:]U5-Q%JG\\J-<8K]*C7,4NO
MW?O9&',6?]VXR.H:/86T3ED3\-CC/^YQPR[+I .D71+2Z-5"VNND%$5<T+./
M;EW0M^VHN/?WT?M7CN\=.)F[J(/%<'(CM_>AKH#Z'L_; L]UDF&M(O84F#HE
MKL!C5V_=XX9=ECEDJ%P4F-C5 M/;:9'"D;QMHW(2:QX'DC9#7YOV5.%)KQWI
MKC:J=ZA?*ZN[1?M*@> "8=*/J:-(4(ABXD<PW9-.M@E4:[[UII,QFL$OQI]?
MW(RM==-OB[X15J)@M@O,0) >36(,U?@@4P2C^%.PE6_"HBK'X\K=W.)SB,Z$
MIA>A?IRUCJT 8ADKU"DD5!IIG:<,2@T=]]@=3DH_G<M@M^]YGRLAMO4JQL3L
MFB%3_=FQZ9%JJT![L<M!#F)[?[.'V"UD_CVHPY_4)%YPC>(,:R48\X 0)[B$
M%!IG#6-4@7;W;3^<-+.I:W?2Y,5S!I%<3B=QQG%#QJ)E4/JTTCR%1HZ9BT9*
M(;<KXFUN4B1>,$&B6E",0QB%GUK$?!4MKT3<N5H)J)QG;5^L17ME\$2;KO$(
MA=MIWS6JD;B-)RT']N[]5F7)E5P6?HW_1J=3\I".-FFA%LE#M0A0^3*H,H$0
M/N!E8(#BX)[O(DVMM!4TJNB3%KG2R,;%9\;3.+TCO-F .C^;3&:?JFG9I>/S
MN\(Q.@LZ8',)\Z6Y:<?A>7BQG, 1,P1SUW#5-A6XE6JX28#*HJ['A50^V/+7
MAD#T5;/KE&NWE6QW0IVN4Y[=D&AW\/,GU>GXU>IT[\LYYVXZKX>8IX+WO<@9
M,Z7NG!G[\6HF4)O>5@%;,7XYYDB5\^+#F_-E2EE.,!=3KP+\1C=_' X4W?MI
M#GHX&3<QJ)Y,7T0%JK,FF;?S8*E.5#P.(OO';Z?+5T;I1G/^T@H>3VU87=[7
M3*UNJ5KHW*E:J%.J%AI2M2Z*6^*J<:O-[[^)5,^+3B#QY3A&:2^LE6-IVMZ(
MFMF6VO9-(ZS0F-:ZI3:VFKE%_6TQWK7%SDW56E$C"QK^8K[S\9)1ZZ8?U(>B
MLTF!Y3%.VE(N$4>N%:@8@QBJ >'EJ-BHQ@7:[UQGTS0+1D'6^@P1[TNZV#IQ
M>RO#H(W(,0(<5-3D7HA60 KKCC+W,<YFV^E@V%*O#Q@+HYT7&L]KBE=M79JD
M5?N(6[;+C)?>I%A/#Q;4K2*[8T!Y&&;WT&%VK,LPNZS+-+N->75I2-WV'NV:
M=M=QN-U7.L_N41+;*;<"#;D5ASY_4AU+7K6.M7F8E<:;25.[*[]/-<5U,YTO
MJE/N\UTJK)\55N+9DH1C9]A\/4UX4PF9^6][>C1W2HQ YTZ,0)T2(]!7E1B!
M6=_P2%TM'NT._K1$9-8Z%+\K<D&+@%SL9[P6#U+&8^=E[)N)J%/,(*H8X-I0
MBWE;'4P_XD'O/\W: VU%7[<5,K<81%OVV$:]/N3?[8XB/=]CC#7"0/N,L&^R
M6=Y3[.V4^X%6N1]GZMB#.B5_H*\J^:-_X*NO%WP/9DYHH@$,O\O8FU9A20.J
M.NZHY)X#$P3DYS3QZQZ)$RW%&C^H^=AL1/*-5T!Y3[ 6ACAN!2,6$@RU8%#
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M<7A<\,7@$XYP[&'11_3LF38V".M3$59%.1?& 8 ( EHZS!A'U&DOE!<M8Q9
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M")%<&\@XE,P: )"5=3;&":NPV?=R!(?2UCD4T&![>1?V*D2D)9)Z$NB"+'2
M!?7B$K39GT$W\6=[VSX_9ML7'4N<%\=,0NY(G-]V-%HY#_WEZX,;IVYC!KV"
MD-H DP)81P#P(E:D9902#(GUI";\X^ ,>F9M>+QQ,DR98$$UM\IY18T0' J!
MKR.#_N-2[GN>QVS=3 U'Z4I=F*48 Y?3/XG59::Q#DVF&ZUFXV>?E@5KT@T5
M:XIDP"(W'\K+)>#+HRI^@&WIX[N9Y C.6F3@K_+0&3+LRS*L!Q()GD*D?2H.
ME#KOGJGXJ]GQS>?F%[Z4E;3\%3-ZR:1>.0(X3R[^:I6I6I]$0V7H3BU@N^=
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MW07,J,8I>R*)@T!K*@AS2D!* )22(D-4?91L]]0BBE@G/$G?@-.HAYD>9HZ
M&8XY4PQ[)C0D0B!%%(&.$<Z@M]C5==?JF&*$Q3Y%''MO4><4(]H;<KTAMQNQ
M?IW,IQ7 @EQ!3+U$UG@B&-/>D: ;0<YUL.AT70?5[NE%6#3LX>[=13W*]"C3
M(,J (-Q&,NL!),A1B;3"Q BK#)$.^2M0B]"%#]%Z?]%Q@,5Z0ZXWY/8 K'#M
M4DMS)ZT@&EO@B(-02V&UQT)R!"WTUW"*A@=RK[(]O;NH1YD>92Z",H XIA
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M<A_$Y#')DCOSD,Y)HL;)[;T+1+%9ZM-[EV;!?LE:UEX60*L"Q>[OA[/LDYA
MI795R*E+0"LB^7Z:3*=91877*N;$SQZKB2DJ&/ 4:*BX(H$;M*. .4^M5!);
ML1YF 7&T\AL--M^[T@ZB-^NNOTKUHN+]3^MC<N+Z8B@WR<>[89JH)UJK\%>Q
M*L.P0/-/\W065S*LY_]60?*FC_$O-DA^5U-S%W_G@^3-Y'.^ZOF?3Q>6A2TJ
M%R"8_/4N<('R@1>2\/)I65@I\D2:_,=?!$+@;R5KK')#]C7\VW<WR6_CY<>N
ML-I7-S7#F"L7/U7&A&T^T.2)$MYEU<C*<.%-[XNC&HX#V53JL@M'P\"%R22_
MJZ1CXJ>3^Y884G"#H(X!Q! 318T(/.>#Y<#"GT:;=<=R=QDRT+(=&C&OF8=!
MLS&"$RZT9 XS$GXJXH(<UQ3(AN%J<!D:4;"%1H,"[L;)_,%F>+C@W07+/DPG
MGX=1?<F!,&@R\1%JE)B",GO4#ZM/S\WY/(!X]O/7R33/SWWCEE+W.)1ADS3"
M T 4Q H+3[T33%NDK:RS71O-5CZ.[%LY,\.. $23#!"RV4?R9M#Q60U'1>>V
ML";M\3"FP @&!<7>!(4$2X2=,T%K#C3VBFP*D[D,#_-MU+Q9[G-V2M7+W5K:
M$:J=6%7M3E"CSE,\<Z<R=CZ*BV,H+GME>OOZ?;QS3ZK)1ETD:$OS<>J"95\H
MS7=!81I-PF9A@B8T#B]*!T5]S@A?4_>O^7":W9H&+%-!O7-1C7X8/3XIU>/L
MM"W;:?SP:_C7W*GI)Y<],2N6D549S=ZV=/'(5;^_2=Y-)\8YF^:JT%:5ZEX]
M)MHE>26#L(-]F4S_7-92U<-PID:#:NOE,+.'>5 YP[Z4E5";S*>923")>4<3
M\^<@"5PS#%QARQ[.:<3JU<ON)B/KIN%AQ3N"HO@0[AEFE6FS64[B5A#NF3Y,
MLJ(@X:T/D_#2J"O'O7<8BV@EGZ9#&]=#JSB+\/3\11L)E!,\VU >'D9#DZ4&
MI@]AIPEWAPN?)O_WWWYZ^SY+7\MV^$C-K856J]'=/X5]*_V0/?7M^.]#/9G&
MG,3XKIA-5=W#K9>9/HD](V&#T4&GIYA0:8V7A&WJ-]1FXAFL2SS[][B&S4^?
M&XF%I$0000E27@,OF7 $<A_^CVK.:M>FOV=.V $E1-8WU$J^71"3S<R3??53
MM%#B//?CG;K4NR7Z54D'J]G86$NO);<.&X*15EQ32XWT%E/&?9VNO:+^'<Y$
M>U,1U!1BV<I#1Y.!8RF%#U,'U!-FI&",!8FRC,@8\&@.(L.>S(3VEJ5U(MPD
MOSH7]P];\,OF728O\)S9('FYF:KKQ>5)M0=KP/_('E7JO:\73PRCJLWO]!B:
M8&D$-(*46"*D%Y +"Y@GTM-:DVZUX&@3[(2W"F5>H%/=!Z4A:_?K WG#[C2?
MI;.PE409W$WO/4HB'Z^MR:/J H->03ZAX# XBN9-5K==5I'1#6TPVF,IU?OZ
M^2+J='GYK2B>I<=O*SZJ6(XWS317H]*[3&D,3\M^-]6.[[E[IJ+"QM3N 'M1
M.]P#AV.YK^AOJ)Z&;:NY_SH,X'9LW^1#6>H]_W^"\OG>I0_.S#Y.*JWJ;Z,3
M-A_ _>I9(99&*P>UBNF&7#@%#+2.(T 8W&>7K\D[S*>XF.$AB?9+?@JPP&^P
M/1T1Q&(LM059\K49/P:C)SZJ*"81E[*RO M#8CC.E[HT,3+3(@V&DBOLB7A%
M$ OU*<SM4]3!BCUA/,GXR7V-MM'VC@GEH[-E7*S+RK)(80GA!A"GLGXS2F&)
MG$,:*4>-0U>_+!D=EU;E)C]9S:RO_2WC19<*XZ8S%9[JA\$^-L/H)2UMY7BJ
M:^Z>])T::[@J>YL-8[7-\AO$4PWKPOOS,Y5,8ZAL_EG5AU8WI*-*X,.U8MH=
MW9"29[8C+6LJ45?9ET,NM@25P1[/I4?U.("X/<_B#6R.1A=U+KX=5V&LIO?
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M%V4J?QN_"23Y^,6-/KO? WWNTJ629)QR!H$U&A,JG-886AJHC()I:VJ"G"Y
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MA7ME]&S@TWDR;5=&,^%ZZ_^1NMLH66\+N?IM_$LA5;].ILL*Z]\+::JV?7>
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M)\PZS3B%1CJCC8.+#O6M@(<8D-K,J.XS3T>5E*X<1F6(Q;-"/K& E?(S-^U
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MGB#  >EJ8$9GQ?B<SK?:Z)2K]<B]G=VY:2=@\G#"=C<^KJM9 2>-NYM6;,;
MU:QB9[T0@')-!8D1=9C$"LU*"(X1EFUF%6/14?7K0,GJ+L[W.-3CT)7@$ &
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MI<(+9FHX"C2,%!^;,*/%Z@\#.7W@@&G$VK#(Z2RP2J1UD.,']9BQ1:6K<'B
M&W[./RWJ@B=J- G+^V4XN]OPM/4E7-HS'I\>M>4A\=ZIF\VGXS1K+Q%5R9LD
M[DD3[^,CPV1F=\.TRD)?,DH$HDVS&/V"HQZ"  PG\W04.?!A,HVBD;]CF#<C
MSU_U--'(^R4!5A]6#K1R:T&VF^0VX]2U=J3+0G"7C;%\3.7^/;@\*]M>\5^[
M]/4\$'HI^R8@#Y0<2$F"ADZ<E,)@Y933!@A(\290^F/QT-OY[&XR#<MT^W68
M_O'K9.K"GO ZKM?T\?=L9DTP-+I9=W,_,725"]99<1] 6//U9W7OLX"+\,?[
MQ;/6"8@@"8@.)6-4$RZAD!Y1Y3@6V!"WT;&SB8 ?XCQBV_5)(,O_#M"8VF$V
MX.9H"6[6BPJ5M+Q)?HPF3KG+U_<]W;R?YUK@9J9/ADM=S,NU^O'[^-)7)[VZ
M4"7BS3\$C BJB0G#4;D(+,<2G/ZR%Z\RIHN"NH(&P_+Y2]W:6YC9)/)F8G)^
M7*04Y:^>Y/WA(VYF*)*5D=W<++Y%U5D>HY5"L*J6KFF;+P[2JD^=!01'30,N
MR@R]F=\'>\6L@,X'<^?L?.3>^E^\=T$0/[L%*KP/Z_1^:3O^&/DKOOBGT<3\
M^>)I])X+HV-!QPCABGN!-*/*,A0436M*PV"KQN$"<#Q$.@=AJ9LJ9LIR:KUA
MP!%OA.*.&@HD9]AZ026\"CLBLU"'@=1!9$QX@':S+\Z-ES;J3)SC5E+*=[$1
M_\=?!(+\;VGBRJ5ZNC3J&_'21Z>FX8)Q%/J:;3VJ)%5E"0$HDR]A,%$C\Y/8
M6R5-_CJ,XPGJ1[@P_>Z')<Y^8J2-3I03>!P>Q>,HY_'Z=^YFFR-X#34&#BT0
M$1U%1'P*$7-Z9/ZVQ+A1=%&: /C_^2*"5OB[\#;F?X_"1A$PP,^RZU\L;4D'
MB]=NL2V=G@!4T[5:.F.O#[]IQZW?=*@/V_G&DP)FJLME7#3$F\+9[(,O+IYL
MQ+&.;!;%N8)]E_.ZG[DT=\\N#; +Z-FE9Y>]V24FLEXKNYPIZ@R)9NN)[,HI
ME6L9I;+!=-)_W"0?;G)?X2QS^\QGD^ECIHEW(TJCFP$9?;1%EPL./]G]2S;_
MAG.*V]FON;GZH63_);_!4NTWC(/UH;60@B"E)98&:TRAE<@26=.*\X#3B+T#
MT." "]3-6(R^D'G?F^ZLDKZ/JV]_^?:&6\.ID\A90JE77@I%&0>&,$SKJHAL
ME6]:E>\G\7Z)=M03J3ENO$[I;ITY_KW747H=Y3J1JRT=)69/*4J< M03[8V4
M# 'LJ.>82\SK*B$M,*RY4I!@ %%'@^1[':774:Y81V$* PL]D) X0B",^2X&
M"(^45Q2AFA"3K?+=ZRB]CM)-+.EUE(LC5ULZ"J5,6.YCR]L 8<BK8&_!8&0Y
M&H#-BW4=!<H2PP+>->='09P\$Q3K=91>1^F.CL(-ICJ(,_).9V7GA2%(.^"A
M8DS[]2(OV^6[UU$NKZ.T?KA6,_'JB5MW3] ^K$2SNW209=!,_"(,3N<;9"<4
MP;ZX]27P=8,FM12?7HF67XJ(UX@PZK#VG%"G!6%,$L64=P0SZ\]RYH0&A'>T
M1&'']*%>O"XA7ONH+WO(&@.6<VFE8@(1(:E"E@/GA&=:>0CKVE,W?_Y#;CIJ
ME'16-^GE^KG*]?';I@T";+6CS$A,M-(*,$V%C0EE7F)\IF.0@:0=;3G?;YN]
M>#6U;5JJ$?#<844U819+0964&@CKC4:&G>5( M]TM#Y-OVWV<GTUVZ8,6R7A
MC$+G% G_T1 ;1:$16E"(Z7KV8QN>>30 ]*J$N=\VORGQ:FC;U-Q)0#"@BG-B
M,-1, ^0@))PKR) ^BY<<U]2RZ;"D=6#;;-T3_AS33'[Y:ER:)NY?\UB")A92
M<.,T3\VUSLXSONN$PM*?9U[)>>:.8IH;5*"?2V:K C%53'HDB*3($D:@L)QS
M+[AT5G#BZHK.M.!B)QWU%'3OM+(C]8-[I+@.I'AYNC97"QN*,8^\1XP%FPES
M* PE#BJ'G'""VT.SP8[3WT!73PNZ!QO=\(CTL'$EL-&@@L$8(XQ[XRC"A&LD
M VH A('&CED!UBV]-@XC9$==*MT#BEZ_Z('BK,ZB6M#@7*A@CP 96YM0HT30
M-(C55 CM3?C]U%.5;"5>[JUGK(''#6AU0[UB_.@5C1X_+J-H8!'  GF!&<6$
M6J2I%18QSK&.5>[6>ZFW<7PC>$>;;'8/*7I-HT>*#G@RJ'9",:PPCB4UC=7<
M2PD4@%12Q3TYRTD4K"FDW<-&5P^I=J1K-- $_9S'4V\FXY?%.50L_.KRO,:^
M47K?"/E<L3F! Y\8L,BKK2 TH%8Z8[1'"A/DL#)0",@PI9 (@ Z-3#\VG!71
MCD8+G+G4:"_(O2#OHVWMD&IHH",.8J>)(UY[R9G4ABB.B1,8''KP?&2>[$U'
MBPEVJ>=Y1UPZ/8(\)P0Y3A7P3& L#5)$$0)E^-=RBSE#6BAB #Y39@L@'<VN
M[U6!7I"O3Q7@2$-@*'7"( (YET1JJ+7#2$!GZDJ/ME'6ZZ:CGMM>%>@1Y%DC
MR'&J@,8,*N$(D]831:4T!#'M,2;:2>S.5$=K $5'2WWVJD OR->G"@ .@/)*
M(D0]H=AIKXFE!BH7>U[;=5]?*]6S>J_ 59S#;#ER(9$RYSS:/1[SSC[44^'0
M3N;QH&CGN%MGP:X4,>TXF8YJ8%_UU%)* 8*("X2(9RIH7<(0PRR"2H.Z$@=M
MG+_0 >)7 LL[EKSS6MBS1:3.*6]7@A'UBMWK2=9D-G#.VP<W5:N!-1(Z;0!5
MS"M!*-4*,2@=EA9P3 38IYET ZH<OQ9=[CC0Z(":UT-4KS1]:X"X6VER!G,"
M;="4'"/ <N$4-(Y($J,+I>#G.:G" X">-?[U2E.O-'44(XY2F@2P!".E*1.,
M"(4UM$)*I9D2T'D)SW,4QKM:/;Y7FGJ(ZI6FSI+I5*4)<0BUM-@Y[(/RQ!0E
MEO+H_Q?68;'N:6KE3 \/&.'/&?]ZI:E7FCJ*$4<I31Q3((A7T!I&&(KUKI55
M& /(!0<UH<2M'!K2KE:C>39*T]J!8O[S__U_PH<J</>K^%M8 9.SBRJ68/63
M\J[L#2M?9DSU,5#Y#VN5%11@"&->H!,:*N @D(I33P"!L @V#7<Z>SO;]RX2
M*1FI]^I'/4V^+P933KVUP9*C!DL7XOIF?N^F0[,BK1_,G;/SD7OK7T_N'R9C
M-YZE;_V&??YC7*+XWI]&$_/GBZ?!0Q9& (71RD'"E5:4 22%@%A Z7&-JV3-
M4>R"C#Y$^9C.7=U,J5<*8NL@UH0PHQ1W0&ALE# 2,V%@N2HE3]MA^C!2CW'J
M+H)6ME:+5=J:N]>(."QG $*1=UL*;QGZ(.WC659&,B=X;+8TNW/)PW3R>9A&
MM@@HM=23*?L@7O+HU#1-7(S 2'YVQMUK-TTP'"21DMF_(%%CFT1<3+ZXJ4M4
MO'DTFGQ)D[\.QZ7<S>XF\S1<F'[WPQ+G/C'*1K$[@8?I43S,<AZN?^=NOCB"
MF="!(MX"J=A1I.*GD"J?=8;#B7&CN'69L.O\YXL8B1?^+G:A_.^12L/>:OPL
MNWZQO1TG);NEK]P, :A64&XX+&4V>3@H0J<=Y? L87]HYS!V!JN=5,/7!-QS
MTR-0-?O@BXM*<QSKR,9UB'-:XL"U.[:\HH[?7KQ: M<?OX]O>!4Q]G+ZX)G#
M07OVO$+V!#U[]NS96?:$\GK9LZU0V$SG.+T:?D,6_.OY=!KME7,YR\\OF.?Q
MI^[P[)P=%7LZ]W3N!)W;A='<2&3DO+U'^ U:*^\$R0UIL,)3T;J^&X?2%S^M
MND3ML^L]<;XD#;8?%17:1L'<VXZ5#<'46^@4DI!0ZC4U3#$E!)6&0[]>&;2-
M! 8^(+RCI\H7%\D>/7KTZ"QZ.$,M<0Q1&M##6"P$<U1[KQ3V$M4DFK<2R0L&
M%#R7&J$]?/3P\<W APRSD(XJ'.O=<8$%!!Y:KB25FFMY:*?+X^"##2C"SQD]
MSF89-I*"WP&;,.O1V@V+\(*52IJK#'(!=]&)Y4*Z@J%+W8*WFG$,>JB-QQY"
MPF!L\ "5]X(+(U&&C.=H53F H*-FW-56_.F%O7O"?I9HWT,10%,MH?!.: &)
M\T XH1!W@"$)I.7G*?^)!IQ?2:1OCP ] CPO!)"80BH$,(I!@B 6E&*(@%98
M>N/@.@*T84VA >$=M::Z':BPRXYJ]=BM(7[^.)FI46)RONVP 75%KJZ=T'61
MN;2%P]WW:NU.U 36!-M+6.$A($RR6+*1$:H5!+%)YZ'MOX^#83F@XIH4L8M+
M9(\H/:)T2.G;#3,".T LT]X"1@A&FC%.C+488V9-7698.T5TD+B2>AC=D-,>
M9WJ<N2J< =Y81YEFT!B" =,<6<(,]D1CZJ4_BU4I!E)V](2_13$]F\%YN@&Y
M=!Q7'-$UQ,<_.^\"K]K&0^>/@^6.P6S7D/*;(4_//3WW]-S3<T\CY#G;3M^J
M%[E%):!/T[B>\-.+!S2>Q8 JU=*",W<;4M(QQS$"RCI)M+&2*L (5!9H'[XX
MM.;[<884&0C644/JXE+5 T / $L \->&$4 Y&<^"+*2 $N"T5,!@ S4##D-7
M$^Y\M,LVS9;HY58HP.*9X$#K?/!=KW;TJ'/^$^>#\84+()P5#!'#"-=!T\#2
M$!9/HC5EF)[%58L'''?T1.C*O+(MI5.T:*7UB1-])&5'0',I:G(/Z"12(>:U
M)Y@3;JUD2GAL"8""*[!7G=4&3KFNI1]-'SO=2_RE8Z?W-,X.Q $B .0D%L00
MBD"G-%;$&Z EY<I85^.D:=-$0ZBCFE27FBUWQ#KKX>>;@I]6T,<""D'0.K@1
M@D@LA?(4&NJ<%M0@?IY\>!E+\5XYZ'30<+N>_ U;,&^'<?6*7&%]&&3'W&E[
MP# A2!.B-966(*DT4N$7;2TPF@-/SF(,T@$3'?70=U,D>TCI(:53IN=NH&',
M1!\3MM@ZPK"3EB+&)=" ,\'ENL.^76N3/FN\^:8-T1[=>G0[LQ:%'#+284&\
M] 0ZHH%GS@ME-<$<&G468Y8,&+TF<_;*CRA),T>4C9JS3]W>GMK =1.IMU"O
M:W!<;9GZ[=3<[ (M3NTC+1&T#@3K%F!#&)!2$&<I8%0KIB4XSTDGI /$K^2P
M\XQ2V4-'#QT=A@[-L114<.X )H8KA0)N"(F-8-IA6],KH)V2 ^!:XB1ZZ.BA
MHX>.K(H ]8Y#ZDBP\0AD3G+.H:8!/*SSFAW:AOYHZ&#D2@K4'BJ5:R9?_O-"
M_=\++?+ 'LOBJ/[O2RZ0D5/3C+YWBT#78+26+1>+3TH:Y[Q==ES^^<.[7]^I
M3^ZGJ5-_WH9_GB1H1[?(M4>\F<<6C?DSUIM [B=X8JVKY#AR]JB\*#[PZ;,Z
MBWG#L%Z\8KAH'%F2MFZ>#^&&ESK2XJ7R898_)&KT13VF&PA6A9L?[Z;E4PKP
M*A@=1*:N6:.,W?-OJ^VHD[MBYIEKI/2'Y/A7ZRHIOGI1Z4=?-[6EEM>KL_EO
MIVPD4F4Z&4>N+>/J,A4K,IP%YC 1,E5R-XUX]9>/40 G_G5$N/$L??$J^R#V
MIB\_^O%[]:I<DPKK5]E_,9&EOU?^.EYBQ5$2*TN)+2ECA^G#2#U&?'61!MED
M%A+<OM-GN5D %'GR\&2:1.MU$/\%B1K;)&XK@V1VY\(2W >R/R8/;AJW#F<3
M%?:6F1J.PJ]3%XABAJ-A3LZP8L-9FO@\(2-[4!HC?*)S*0SL03UF"QL_#W>Z
MX>?X9[EPRIC K.%V-9J,/P5&G]UM>%H9@)'YK )SNEGV91B%#D.9/2X>=9-\
M##-0]I_S='8?^2CYXJ8N&=Z''=!-AVJ47U!.,<PE'8:7I6'BPW1U<@_3B7%I
M^&Z2Z#B'\+_ 1J.,+::3T<U.'#Z>^>0QS(? <=O%T<-$X*AAPJN0D2J?9+SQ
MK_DP8\%)XM*H00S3NR 90?TIR*9&H\D7-38N:EPU+)LF0S\(()V&#\/E4=3R
MC2Q*D?H<Y"N3%?<Y<&1XRB#(0BDIX?WWD\#'H^&?;O08;@W,.)[,XB^S)(W.
MW(?)-!?(:1Q'?&)\?MT@O@S#]_'FP--AGQH%,MA<*N:CV3#*2?'Q0L)KIY*&
MCX-J&TF6S!^*^7P*:NYT<9^?S^;3# JRB15N9SN?!K4NNSP@S'!BP\/&4;$S
M=^'#21IN</=A.FKZ6$[?#GT8021*&D:=/\79>5!6PW-ODM_5.&Q34=R7!-I%
M ?ZG,[,P\OJA1 S)O."C(-EQ4.DLC-Y]&KIL3/?JSWRD8;)QVFD:WW&3_)0M
MX6+2(_?9910/U\TFTZC6UKVH&$R@39HQ2/V0AN,J94H"E-2I7U$UK=)C$,:]
MH(=VHV$87IIS2CVWAME%=B@9?! >&UAO.\_%H4Q=&C@FK:STY*%8_8++"G9P
M23KW?FB&<40K\PW25##AVO06VT0VRQ;1%L&C8 R=&VW14</$UX:V__$7@2#_
M6YK\X^;#S4(9F+K 8N.(P_<J"$E@M7$&Q5_#B\<Y):-4+6FE+U-G7@Z_OKP;
MVO"R'S*[&TH%1'BHAIH3JZEBFF@*N:&:("""Q14T(1&8,2C2G^XR_:C00S,I
MSL:4*R7_#$"6VF$ATBKG_WP4);!-U?A3A! _G=SO'IH6TGFN!%1,AK'HV+LB
M_ 8Q,Q8@2[*A\;JAM2D<^"BN(^<6#G+4,.FU"4=B)RXMMN\,VG,\#GA]%V [
M7A #FX8!;57<F .^3V=17K)M;I(."V:=)3\'=3P:OPG.K0"8L??JIV$6P: .
M>T$)QMEFZ+X^Y-MJ$$ 3]H5/+E/>B[UK'&:0S+ZX41C<?9C>75 5YAG2QV\#
MEL]&^>847Q@>-7S2&*)@S6<NVU-&P_M@.<9OVN1N>A3;L'-S-[L^/AW:9+N/
M]!_C:&\%9@T*Z$?UM7"1IK]%#U+0L-^.%TY4EQ9NU(K_U&.-!#,>.NB(]5I;
M;9CDDFG#"=/K55B;.+6-J!U]J%\F4YNZ\2XO\,89%O-ZY\8JZ-PNO1W;<MJW
MQDP#+U8/F1RGV&$2]BE&I#,24P:=-LHR0TQ=0^JCCY::FM]>*Z@I-X@9(21C
M1 DB/2$ !D'02@E5$P[5Q.'915:0$<:EM,(PH,(B>AV632BO& C*AV&FQM=_
MZ?GMM8)4.^R](H1+2Z"" A F0-"O&!68V+IYG7Z&<9$51( %O1%"@K@B :95
MF(D#,.B/$D(@:GJ)-8<QXTG- 4T+'RR\#7?JL\M4"973(=AJ.5V23+4MZ!7M
MLHD9JJ@'9*Z[>,>\0NU,Y] %O3,UXDNAHBR>YW*62BHW5=P#CTX%0S[Z&-85
MDU77Y4X=X>EHI';/SD^+GG[/_C[A@##9;]]]\:IRM!06X\W\/I@.9H6'/[A/
M46%Z[S(OS_C3S\/4C"9I,+FC]O#3:&+^?/&D3# ?I! +R94-DHF$9BYH$!8:
M88PE9ETJUW=&%SCS(2H/8?GK%"1(I? @RD303Z2E6DEC .9&"AD$VZQY^-K2
M0I:.@_1D9 -%(;I)"HHEOXUSR:I$.)9\7Y!ZIVZV>ZY'$*AIW\'N]QTQR.OP
M'&PZAZHPR.97U#L>IIF@96ZJ-&>DZ \TH[G-O50/=X]I[N:[<U/UL/!3)E4/
M6'%G[F2\BPXO.T]G\0PB_/K/^?0Q>9@&^VV<+63JII^'T;U9W'63W([22?E2
MNW +KKRX]GW3B*?AP?/PN,SQ<+_D'YU%O']Z81S>)#[NZ:/<VUA.>/'QTME0
MC!NV+JW,?!SH/G.#))V'FP/0I^9N,AGEODXUNQNY6<"U\/+AV$W3T_T6NYGW
M"(YOVFNQ^WU'#/(Z?!;-B67B<J]U/$_,CR0SMW5QQ+$0T,7!RJ?I)*TP9F#5
MH( LG_M%7TG!PC:)<29QV3+!7&P7088^J6F,0,G.).L@(9>33*2&.G-;%#Z.
M^3@>0<R":,7;BX&6[R[. C+Q2>:I\_.E][8O&;4NCUTW'>?Q.'6H[)BA\H5)
ML$&;,G?.SD?NK5_5JRK:PD^/Q9=U&I:QV =[CFL>G<8ZNI1E,&6)XX0YB&LL
MUX,U+($8=\)1R34A#&A)E&+!RJ+!ZA>6R2LY0ST1!>[B66H\J,I,@ESZYO?W
M:AH>$G>\47&Z-QP'2(@[JU4SE>TX0>*>(&"/_?TF>3<=AONBS;$XV0H;=!H#
MFFP2]D<7]N#,,M+.C0NW9^X!G61L4PI_T>RSO'FS4%=TT.:%O#;>;-=-(I><
M^C?NYL@CV/A0/;AY0ITTYWSX.2<9-XJ!CR:PZG^^B($1X>\BAC'_.X^J,GZ6
M7?^B9<MR*6[L*7BKX?RW,FZS+G7O13*=?"E#05M-.=V_#DY30P('A3 749&K
M@<MAF$7BZ\K*[3OR-7!=LH1KX@'C>Q"E@Z3\Y[M&#?&5$,SLL\\!K-6X$JR9
M$2;8 >,THF;\/-NP_F\$WE_6?#T;8@#/%Y'<)&^UE86Z50I?75KF3I SM',8
MS9=#JQ/<]IQ542.\7+C]F4OT];S4-B^!GI=Z7FJ&EZ"\7EYJ>:-MEX//SZSU
M;TPNIW2='S:Z0O0S)YA^LW2^#N9N'<?VVVX:K4'SQLW*8ZOQI_*DJO%6QEWG
MOU[.>SKW=+Y^"-VSE^QA2+MTE/)25A*U\QY%V>E*4WC\;G-,03>*@EU1I<;.
ME2[L2L6.SA%F>]#H^R)^IEJO0VAM@'((2T>\-5H[1H7WPEMH$5BOU[%ZYOO'
MZR!1T?S/9.NWF;M/;[\.TS_>EKI0<>"<_IXYO__(.B7$#WZ:I\.Q2]/R^^RN
M4FH_YD+[=B&S^=V-5(JD< "[6ECHXJ#0XU>/7]>$7X09+:WUB#%#G,&:&Z^T
M@ 9*QI1E.[,MK@Z_L, #SCO:+^KBH-#C5X]?UX1?'EMED*+ 24M(P"X)F!$T
MIDT"9>3N7*.KPR]"R(""CE9GZW99[CKCO#XXHK-F^6_[I MTPT#O&_U=IE/"
MM4 WM)PIK</H+210 "$@H$80$Y1/0_SN MO-0O>39/V6"=:[A5Q]*,2JG$.#
M6(X'$G14%>U[&?<8<_488YGA#&@-F0MZD[>:Q1XK 'KE@!%U*1FMFK>7P!@L
M!U#*'F-ZC.DQIA6,<9)(3J$1 6N(%4 IC" 65F#H+6:[FQ$_ XSA \(Z>B30
M\:#!W6VBKO+X.&\I5638==,>W4'<*X'X:GN#[OGSNN+HO$;:';P180PM\=!B
MX!11B&@7=B!EI+?&8X/%63I6$4FOK._,Q2&@A[ NBV$/86>$,*X\%)("AJ4@
M"DJAM3,!PJQ5D"G:3O&_-0A#:"#9E9C,W8" 'L*Z+(8]A)T1PHR47AC"N6&.
MJ*"* :H%9RI@&$.:K_>J;Z6=LX#?)(2U9:RO-G0^S/)>,K-E@U9V28,NF-<=
M ^JN^3N_&?+TW--S3\\]/?<T0IYS.M^;\K,WM+?_5ZQ7692I;#P/M@_Y[8QP
M]D3M.;7GU&= U)Y3>TY]9@'SI[D]NI*OGOS5?8U%ZV-AD:)!1GAK.DN_2_ZJ
M8J')E_]U>_LNN7<J?O7=>@F8).F&_M4QWOVVO=F=]$=G1L.[S&:HN*25%U0S
M1BR#CBB%M;34 *,%QX)2O>Z2OE"2^B^EF+[.I?1U%-+;-Y-QE,_?<_%L+F@-
M C:@4'331]XU-:6'GAYZCH$>2+TD3D('C"7.$2D@$=Y!+1%PGM1 SV7RR\\+
M/4(,D*0]\G1G/#WR/#?D$=[0V)U!*4@(D4A+*I CL1TLLX2L]V:\4&;XN94>
M,H"HHRF'';1XZ],'KC(D_]I3QZ_(J;,SM^F:?&G-3Z:3^P4RT"EJM!=6$,"%
MT@3@L'=PSS!F3GX#Z>@0#)@DW=P;N@D)/:3UD-9=2!.>2@TMTYYYHJ%6 > <
M,IA8*;2A-0E!SR[[/4 :$*R'M![2>DA[#I!F.*-66L\-%,1Y*A1 7ELE-0W6
M_A[1]=</:6* ^95$]C<H1=T\XNXC^[OB)>H]L)W#:BN0Q!@3*20@B"OA G9[
MC:RUG%@.F[:H&]$7(1\@V-'T]:XI@#TP],!P5#P*\]QK+B5#G' 3=#=B@WEJ
M"0]_8U'3-.$TN[0)8)!![1*PQX7NC*?'A>>&"Q)H:0 6B$)/ /':.&*(!\9X
M0[5>;T9PHG'7C,* !J2K]14[:%\]HP/5;2''+Y<CC;MAR/4.N]YAUV8MC'0V
MG9O9?!J#6>Z"V"W7Q1#0$L2$P (0"84*H Z@U=Y[SKFL*>US[9VR<$?#;+H)
M SV,]3!V!3"&I)?(.*2%D$0+HY%%R!KAG#:"P<X$-#<(8P.).VKX=A,)>B3K
MD>S_9^_MF]O&L7SA_V_5_0Z\F9E]NO<J;H($W[IG4N4X=K=WDS@3NV=V:NM6
M%PB %J=E44-*<;R?_CD'("5*HM[?: <S56F+$DG@X)P?SCN> 9*YE$DN <9(
MY(-"9D>.8X>)0[V0.%*&=EL2I/>'9$Y+2RY>0-BTL:E;BVWW>G>5=AKG]/D<
M,U'OX/AM.UO;2Z!M_+%!@K5Z;NC[''8(5X0N%:Z?^ 1=M(Z[^H2N?45D2=C2
MB.P)A=8@BT&65A!H&V2)$T^$,2J@E-'0\T(I E^ZL0B]T _$?''>(?I\1[1#
MO6?BHS/ 8H#% ,MJ8*%1* D/[2BB(27<B4+B,4<RGP84C-KD*-VW54PX>":%
M5)L*[=$LRGW%A+^)'-UGY#1\1BY!0U3#J893GS]1#:<:3CT140^E+LT,>//2
MI3TI0?J@S_.BD,.B)6W*6\9';9/ ;X8\AGL,]QCN,=RS%_(\.[='6U+AVZ$3
MO&"U\YMQ5+>.,,L=U%HGKOFFO8!PQ^6)Z[L>C4D0)XP3.\!J)R_PHZ8.8\\R
MS<H+@TYHMS1E].1 8##+8-;SP2SFLR3B$?=L7]+0CT//]V4L&7=]D@C1T,/A
M>2:YTRCJ1,1@EL$L@UFM(\R&F"4$#VSNQF$B*0VI"&V;VSR@@4BH!/VK(0?@
M66*61\*.[00O&;..9G4WI>"WV-Y^[KV\V[87K*S]:9LC;=L1MPVK/8>[KDUI
M$B>$1H0QDG!*0.OD 0=DID>QB4_2F-8G'?]9%22U3=4TP&* 93&PA)P*ZE$$
M%Y^"WA<GH4_L4+JN#(E,&FI77DC'Z^>4U6YPQ>#*,\,57] HIF$8$">F7N0S
M7\3$BSF-243#2!S%N#R)PO*<DMHW%8&3V9GTV78_TXE?%]D#K-]3.TW-%<1]
M)J!>K\1IGV^N+4[+YTB[#;>>)(R88"RQ&7-HY+IQ(&00^3YL203K*1?8ROL
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MV*K=E.,^"\0#WLZESB4[1*]>$&N=JU!K&OZY!BR_,/$Q&[Y'09YR^6&B&(T
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MD?+-.*5O9OJ,VD-(E\$X@W$G\M D;@BJDN>Y7+C4YPYS">.^DQ 14M>G?@/
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MBB.E@?? +_S!?QIXW7EI5 MU<CO>:S4$_F]?H_%>+VX<AU.8J???;R_/+T>
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M-=_\!F251#I<?!Y/=?* TD93\/!D<C %140.#EI\ZV@*@^/'";MP,PXQHQ
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M_4-EB"'FB[U"#A_0XO 4Q->F7O&W_,U4X/$:) ^T N_C<M#.!!JW@[("=WJ
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M?>2^[G7V<WE07S<*3\+P_N@4-,$J<QEQM0J1CH[JH1M 99WF])71+^[Z@74
MX?@>C46QXQSIIA"PV_'2=X^LVN79\UK78J'KWOF^^,]5I$S6\XCU2Y?1LJ'$
MCF,9'$J@#$0IG=FH:O517;\/LL0I5-YPJ,VD-0LEI<8NL*?:G&@#+,=\6OOL
M7%P"*GPFEHH2]SSDHSM-DQEB#T$;*B.%%J\XX" =<Q6S3UY]VRK)N#^HX1O3
MYDV#PO)'-^XMM0?1ID.%D&J*RTU'$8.T?-*](5B9^D>,4WN.T+1#Q 2Q^,=*
M8AH%R[/P%/R.<A9HX&"WF/=HV!HN+5:PU]?/4RSC_%%U<LS^D0HX/**C*7EK
MB523D7M,DQ[2H58_GE]3.95XAI!37;XEW1?9:2L>T  ^CA/R@0U/2*8ZLOGS
MBM,G%9<6ZI0WG":IKS/=R&F/9:_&]OQ5J-A]1)FN/3SLQ82WJ9:MQLUC2F31
M$YKF/DT^164@%1X=!]I@J@RJ%ATF;*L0KHT?QP9YWNGY0?E?==9A W.;8[K%
MXJQ-;$3^T\R>PO#;P51$HTILOA6#KS;G6_S3C(7S5[GDX2B?T]6&CQYB\PLC
M,7X429IA_N+Q,>Q&I@W71UACD:@IJ=Q:T["1NRO#JEH,? D;:X>&U:XL'3!U
M.KP8CJX9N5EUM*Y.^Z/"V<X9,:>WBO9MJ;N>K6<I^235/J;.#GH&3G$%A2EV
MYM@8;!&!AFNGL0@U[P&*B!<P&0@4"M^Q#O-A"U*RB$WQQ (0B*XNYXUD5N7>
M(@.YRT<E18<+4UB^Z0KLA>P2=1=_-"?IG#"C<W8<8W[..7$ I7A4')W[F K[
M"">8?3.O9+;:CD[O:=!-3Q'I] H:%_K9%;"Q@@%"#WX;2C#-D@$,IW2@6+M7
M;W+7E6&76_&YC10C0.=,]XSA Y/E2@"O!0KYV#E62N%=P$1,?0SKML&6+=J-
ML!T+&/]-<;%*M 'F+E^'.BUZ;6<_V\+;EF69(C;3!Q -#3L)&SJF ;V#-5OV
M8-I>ZA"6[_NX8^U*EMWMB\OJD]B%X_S<6;MX.+N&%#84;]#2[;5#?)^<N>!D
MV]8859D-(*\")W^Y,&+#5UQICAL;A-\:=$WGU"I-69/ 59!/T8=^OO8+7=%4
M0S-W7 Y7O[M5:2JO%YM70S#;#90Z E%N2E';-(4#:>?\GMT:'0;=\%IYD[G;
M:.&H'?9&,(U#\H-4*$]UGPWWKIF'?)%2']K2F3F_!Y<O6$I':SGRVA#Y@3G;
MR2PW9-Q@#IKPT4$AO!.Q'PFJ+$B <9#W^-FIK3X@4#0>$'3D>BJZG25X]P+S
M-3=K(9;3!WPUT_BES-M[OZ:TRV*YNK>@;9:,G&AX3A=W^%QG;HG#5-\R*W9N
M S6H/J&M@:4UB?'K']JRIF=3.JUX_)NZMA#5]7)YO_%$9GM=YPA6WA] %PV@
M-8O-Z-LOT-E$AN2PE@YN/::KM(N-O.=DK /[^[IUXX9:.-R&17RG1-Z=NFS;
MFFX+JRBO!V)"]RW'$GX>+9S05,GG=197O6FY'_7T(ZFU&UBY5R $]38!4C?@
M%"^Q8]Y>F][+ZB[@FC+&^-1I!OZ4)9=U6-7B&-B=)'1/\H2NOGS('%$Q_/NR
MV3X"YJ73Q>YW;L)UZH1#*ZZN<6K1\F)'9ZS#O)J@/C?K)2N^QHTE/X).WTG0
MJ?+"%B+! 1B:IERB9PH^A2E5WXV!^$%K4+H.S#.[M JUI]#)JW*#.92!E%YH
M96-]<UY6FX>Y4!>3TM?UTG55H-ZEFIHG;U"[YPGU0NFMKX@+T;MQ&-SJ9C,K
M-DF8BTN7!SH]26F&I%"J3JJO7.2JE9QV4O@X/EM;9'FX"]!)##*'*LMEGU*/
MZTN7K4MS[2$%DT[Q 'V@#M?TTV<C<XV)G#P_0_-_;F5N!<1!Z@%M2W1=!'QG
MU;I?L$17](K4Y!5")QC_FE"#TWM).58RTW7H=ZIF> -]6O0^-).AI3T'6<M]
MZJC[L3FZM,>\J\^FZ'8CV-.+X@-.YZU0!@M$BXD;@.XCQX'PM@",@%S 6_],
M+;U$"9-,M=U>+(&8JG%&Q?1<MDCS4#-?TY]$KXAKM?U[2W*&9S!6";-FF:2:
M]?ZRJ8I#![*"D:TG33$DOXF9%I.&Z,BO,6% ;Q"=:-0]Q;EVD<,=B)1&I8SX
M9O5SIS6EPY.YF@+IBG:SU>;:X<(W==:58X65N^Z7!I%9)O$[<P5<*9UB#C*9
MB2H#+PWK['H1VM)L6I@7LM5$$O2B6=-#8'ZSW7J^S6Z-2[LU_A*[-?ZJNS5^
MZFZ5P?RF-Z?;BP)W=U-@][H__&97 A[BO7]=CMUHTFS6UY36W&U?"A+G_FK#
M!HAR\]8<7BY<UZRO9B_<Y%D,+/II%S2&#2=M"*(7+[30++/=Q:Q-G6KF?CEN
MK*IXH6@#S5Y"5-Z?2\?+W2H4 &[%%R9*%P3LFXDV0N*;_ZC#,-L%&) 47_3B
MFM8WJ*MBWE1'U]\,K2344T R(*3.G1Q$O*'S;C%F30J?+Y[FJ[LQ8T293I0=
M18L?1J:]\M;&NP?@>\<MC%3QCENZE\)+-F1,Y-'?/EOAHT]_BPXL.K\YUKG8
MUAALM/14GZ9!.URECT)$+E_]1KP:X;8'*5EH\ 7@:,*6+;-!L0+=*7&'=V=!
MLC!G?23=Z\*),A*X9,6E6R+B^Y"X.Q6Y%Y>C2Q"\>#EK[\V;7G=T^7NOWQL.
MOXT8/B(QK*_A[MHKBZU$'GF2SDJ30E9,6FHT!29K3('G8DI?C.0X\@^TC]K7
MI[@+]W]G[BGC0K3=7@/N!_F1I-%H-W<K<;+#N0 "7#$@3+*I-SB$^[L[FM8S
MO1(M3AYT1/R^ BC-E^N\![=%+5@WZ[P58T'>-5P)L?FZIATE*,'DJE%]XH*/
M#^&NI(_$!CE6>$DX=^5$+W=JY)W;C7_J3"'T3>N4 &)A::*ZSS'K,ZL_K5/(
MT16K,^IT^X^ KQ[F+QWPY:-2E0<;OQ\*QU.]VY)WL0*G:FF[:[;T+D@G*@PE
M1<?9;-(KM08-KCY4M_DE&G47&&18^RSU\3XT@-1BR9?-DIRL5'NNVO!ZO5<K
MF4WGA2G8Z4>JL/5'JL+OP^W\?6=3O+L<=GM75YU^[_K]-[)ZCNU]]+#=F*A.
M;7SD6E=0V<,5=89*0]B  D8BTOI(2:$G1Y4!CO8O3XG-ZRK'\<SOU!X-+1%K
M$^P)8VF;6P XAZ#?T'8[IM9MN);R"[J,<E.HQUCWB"+?\#?QE05&>>O=" I[
MZ_(N3(N2U_.-PF+'V/YJX)0,&(_K@TP2O)8F=[*,S63)9.3Z>[;L@%^_Y]=3
MK^?:SJS'2Z[GI'@ZD61^=8NT9UTD'V_])R?JV"+4Q4[ZF#8YGHYS7#(F=V<#
M%GP,6QWM6Z\(H(:V;,L:@DRS(%MEA6M%;3TMZ84&)C2"J5>,E.<(P$^-B&K)
M'ZA(U.R8:/ED-5_E=(? ZC@-^L_*M+(RNVFO\M5:4)H&Y0V=">4#]UR\SP6]
MN :NDJRY(L8+V]R _N0K":SI4*--JTBJ$#'R(B\$DT8UU_3=2BQ2:91",E^%
M"G4CQZ1"&-SGPL!K%M@!\PL,1_%[G>GT># PJH(A.DW-24(BT_&M,XZZX/%J
M'4[AHP$QB'#=Z,&I9PMUNWRL]Z.3V5S@MZ.>"]@1H6\;IYA6*AA;I)IX;*\7
MZBH]?:&IU@GVI(B5 ,85K3?16!_M:"&S_3H5:N-5MB#"CP'GQ05\(Q(?5)RN
M)GQ88!%/67V6+4RR.?0;3B":FZO-@/#0QM=96ZXT7J'916G6;Z<_CU!_RAF:
M ;9^Q,%!M;;T;8FTVN8@?$P^1O%]J*:WRH0^>:YT9\J42PO)Y!FCJTCI9AN<
MK6WXD3?0Y5YAN[R_V &1.[?X]Z?&8^S13%*6[EQ$,ZR@UU&%:8\.C5EWP[X5
M(1TWBRD"2SD5CEBNZ(4LI/GR0/?&+?L1?C'#_,7#+UO0W@EZ3$N2K-4"*R^^
MPM(K)L!4V_I*O[DQ&U-C,]%]I8DQ.XT!Y1JZ%3'=0M=34[U33G9RK%RI[>'T
M[603CFA46<&V4W*[V3K>T!'NFPF4TZ9XHX_G=-)TE2#H#V^OJ>+);)-;<[#!
MG@TSI]@VX)$.%N!)>NN(X1WD8$;"=JZXJHS./V9F=[UJA]U:NEN@[CGFY<FZ
MP!1F6B>*]3$-ZY_IJHMH15=]P,HFSB -&P)A,_4>2R33N,Z[R_O'XRF< (00
MND+8?E/W&G=:E16R0$8QQ)&R=F0J%XAR3'^S<KEPV NM8P.% S+7G:7!;22I
M$1/*V(H,B^<NF2AD[BWQN=%\8;;ZE=I6S.0GMG$706I/'!TL))X'=;_>4\W;
MIDF<+:<S4XP'CYL.X\',)LX,\KPZ2#=5YPH7NHN7;PFHPX)?^<N]CJVH,:65
M]L!E-:MP 1PEQ(FMMEVY)03+FAQ0<>I42_ 70ZIZ*=^,GUY@O8/HL!O3$%TR
MV1NBETWRHJPJ'Z_@"IL3"D6C6(?A4FL8<H<481\S^)<&@@GVW^"S<EJZL1OA
MJ1:N%D:O0RZDF2L,^+)K'1F[AQFQ1%E\#")R<)A72&.$\EX7+R(OX,9K#W^#
MV/3RD=J>W:BH3*TXOZ._=FU;NB.%AD/7,5XKS)7XIX0P8W++F1.M\0J!BVF
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MG6'/8^4))_/IUU_&8)?1AWFV".'#_P-02P,$%     @ 4UMA5./#@D5B1P
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M#F/&0O$S]QM^>VDTJ2&>BWBNL"VOT?'<S@7BN3O&<S7$<[=5OIBY@S3#-0V
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M/2R:]REGRV;7^Y ?8LBXNC_/8_'N[>_]R+O/WXS2<<#?_/]02P,$%     @
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M:&,Q,# S-#,R,5]E>#,Q+3$N:'1M[5MM4]PX$OY^5?<?=).Z7:CRP P)V62
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MM^V]&]O5XES^81$7_;]>_@502P,$%     @ 4UMA5$EN$/,BB@  1_T   X
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MAUQ!]KR[+HRV%YCUV,C?&W&BJ/?=,<$]^>H4A0?6M]:[2DJ':FQ1Q&HHUNY
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MHJU)-C@:C4VZM]"GQ(MXP"+1K!566WU\<B+I-=*KSU8)1X??>_VX?XO>2R]
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MB:/@6*X[,V](GQ1.>,- 8"<VQ*9+C\S0YC"$V9O=P_1TZM+Z)D&0!6MNY+W
MBC8C. RJ@HQ!:\VYH#*1O27?X,L,NC(:T;#]A%KIJN6PTCW$:^]+G]U!=XW
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M5&5_22-07T.GS4%HY2T<J"+,'3ZOEL4^X.[.X$HVZ-8;(2,1'V_K=.@-+S!
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MG_XF.?CY\FF<E>%6.F<U ;@+TD$#U1!WOX]J&H9XRQ:[\)NGV<0VLESRHN?
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M&V&M.<:9&N8]%=U]1#B3^V+I/]XKVK_2&8J)J?O<I_E<V2FF%J=.4?>ER<F
MKOGK %LR"A+&NTN4IR17HO<NX9[6^EB+_3#=-(GO]-GAND9B1)@#Z<UW9&LI
MEX-%<M)$.,I=9*!0V QX;_ <6-KLXW?GG,\E)2ZK#&-*.&WK$!".ZYIY'#@
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M&S[NGB[X@Y"9XJ +8  ?A_98+H#%S;JOE:>]L%68FSAWYWSC@@(&? &DXET
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M!T*UJZU/BA&P6X 0:IFK#TFQ;]1%ZR@0W5%WLIWH E*N;HBHO6]<@-R46JQ
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M(3+&QN;NAE8L3JS,3K>3S-?:A=>C$H'O*-G@G6T^*G>1A2F5!A3Q#^-1(\&
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M! JY "1<=]\%9'Q=/RT;X]'7/BG1F"9*,JQ/,/*Z2>/#,X*T9;T$#Q:%F"Y
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M)THLX%^2(J2Z\814L,"C@5V7"++=AO0_0:8F&(S6'1!7.LXLWGL_E7*" ^K
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M38I\58;KN+)F+D%WRC>=C8'YN#=-^P=\ BW;:OO2C;7(*[4/W;:%!-:/22\
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MAB)JT6,?.C!WJ"6V.',PDJ/3OG]I0MC@4U$@QQ?(4UN;J884_QSGK&?H(%"
MJ%2^5+[V['CY:'EGJ;936%R1RC=4J&F!F^H<N<:LCOMSI-@T?VD/U!+1X-Y%
M_?#.FH1NJW6UZ(W#S U'RFAWTX'"H2''TA"%%"&..]R&,NQ-[ .WUR6H+'*=
MEUIQ\._5PC:+1N#+X2TFO_RM^" >B>OXQ>1>5,5=S$%-]UX'1I3#"3D_\#92
MU-T-._ID5#GFI$0?LAU5:DD3:YUW+UOP\&B5!X*ZDK$P%YPB6!THV3A:MIHX
M87K7]AI+$*8PUJ]S.BOY](U*9<.M,4\&T"T+IQKW1!X]\RZ#3*V99#E5([+=
M6-(J!5:J#2&,!+MN+XI'!KGO7+&K,[RC1M4P:O,EA%EC[+'1MQ_B'DVNQSMN
M<ZB.\(*\ P@Q)&.V)4-[,Z^V7/NC^TC94^_ GH'B?NHEWT/JQ(A@4<U%TNN*
M"RI(M4)H@4Z3Y0Y'5BA[XB7^.A\=S+21EYC;\2QBNQQ,XJS]='B[C AV:^TH
MBKDBS>S-_@,C%3P]/A9" MNK+%'#T0!H?JJ0G%9SH7XL3U3QB_P5='F(=#!#
MM.\/RP^MM\)M>718@OC$8*V-5S"R+G9YV]IBRL[&$5O%<'$*!R(Z"1IK.9%
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M7]ILD>[: 1NS(B$P N<Q,V8E5!==++4NA-X'1 #2"I@\;M&*:.&DFG6VG;2
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MXD\2>$Z"SBG@^^EL$\DF_EA0;Q+\+']OCN.T=@K25'-CJ+2O6-9&?;WTJQ+
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M[=36*/G41#.TJFEE1$.1"B6YE)IQD%S3K*&Y%MI*.@M)'>(D"_Q8/0L]7=,
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MGX-54&#J#TULV]6QP+L\K:)@@G! N1.7+21D+B]!:IU+6D1A+U$.+U 9"U(
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MA-TO S;B60G-#N;2 .*,[A5OC\WLNKB3]XX\!W%>_"!>MRC>2NT\O*Q>#_7
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MFC'A6DA2G<O;!.5DF,P!>MDF"!APQR2ESM4UW.W2<@>P!K!:KF%>8L)X]*?
MI/MDJ*KS>@/6:0YJ<BC]4A&%S+,D-^!31%&O/V'^4L+E/PS[;TA% W'_K-+R
M<(7GIA61JGBI=KL$'4R )Z!HSN,S*+ JEGCLU=)?D^DOR\#JI@(+>(MYA <
M%@#MTKR>2XHY2B%:P*X>^>DAV1<8;Q;E=,&5];[Z&<]3^.\%O$D16)80%4_K
M=;K$ZSH>@QV3Q;Q"184++N!]6304:V+N>LL27^;]=5WM*CRMIZ^@Q>W3VDT'
M2#9D+M$,3[$KL,+]2/J<K%A=?]8]_[3O9C2;TFDTJB[I??Z*B9,5Y#[_!6]&
M\P)FZ8HT-EN3_2;^RT D%>KJO+^ 34-Z#=&NG@],]D]L8CJ]BO\$B^0-%"_I
M)D_Q,,1##J\V>YB3Q?II/4?P-24'@3N(>J7QOYI5O,)3V-.>'  ,=UC.6#'J
ME9MTO08([U1 <07*KP#D=V"%F\CPUV>,BGHWL]LG^>'E%I=<DC'>?L)\X?%0
M981U=WUU"0;-<&6\R> 0,^*LCRV\\0,(X44I>9L5!:BWJ0]I\@6/_1)O4G&M
MK,)SW'U^W9L;KI*,+/PO6P",CD3N>5+OIP> Y_>.P'62+7_XI",:E8PA-\9\
MZ'#P"$N\)TD.R9<,M O>-=9-6LXV"  R(QMPIT#<C//C]J/_HR7&^;35^9XM
MEZC">XFW/<C-E,^BI#-[E$F^28F:ZA'Y",K9#J(R_5<]93ZMG^LQFV3U?0&9
M1+?IGHS;1TC&^!Z4:7WAT:G5;-9PQ8OU?K&@0]46K,A ^<FN"+P&U"7X&<+5
MUS3+#'@<D="Y?5MA0)'!7P,M+_&OY#X8RXHW*H5)#TJ3UIEM\*FFJ$<$&2,O
M20;(3$9KQ6PJTFC&2)JG]555I#DHBM] NMF2(\TKWN%M0'_XS %*X<J.7#H-
M6I+PQQ\^_31'($O)O0LZS"NTW.)U?XY2O#V>95G[0F!;3M5FS=!Y:A?4+?>^
M60*F3 O6-/;C#UXTIM:L38W]^(-KC=%;L*>Q3WXTIM2L58U]<JXQ:@OV9*A_
MQR>*S\GO$*7EP<):K-V4QOW9Z3ZH?1W$R^0<GWC)^]'@<MGD9DVG&<O2M+=[
MSV!/UDJC-PN]=BS+<Y>DB+SSXEW.'1ZX^3)-LOL<=V5E>ORQTJQE:?OW<HXD
MHS5A68KZ]3-9EE62D8GU*[E/<B8/OS'K<\4KR"M,90EQ*=.+>,V6K,OD[+AE
MIUW+\EHXY*K1M\S_ \PW6?J*3T7UB=^5&*QFU*5Y0ILD;X]MCTE9(3RIGAX)
M\"'V*BG2^GD&%'ARK7\VO_2WT>IE9+6S-[35LKD=TH*,:2MF2!TE\W=M YX8
ME&R\XNISQ:9E]**ESQ"%B.XKC3X3Y_7-7CKTN:!1,7Z]T&>'0<C*_;8)7IC$
M].^M]=D94K!_:ZW/FRQE>Z=]$[#Q*5K>"QE,H#)D+[/^ZPMATIIE373_M:Z+
M$V$-CB5-Q5V:H>O-)<LL*8JZ3YI;S-K\LWGSZ"M3;SJ1)F[/<MZFR;R-/:J-
MW:EEZWC+9O$6[>$M&L(;6L ;FK[KM(Y'1&-%I<W D(+Y:<;&.<:1#:TCXUD[
MYRT[)RW#,Y;AZ4K_7*5_HC(]2YF>HBR<GRR<G"R=F2R=EDS.228G)!=G(Q>G
M(M<V/*Z-=VR>YVR>Y*R?'*R?&"YU;KO4B4UOSW1:1%^(2\VN,0F_3HKM70:_
M:NXVA40M<KK%,QYYKFPV+E;Y'9*VQW6S4-MDMJ-HQN.953\^46':6U#B :2U
M%LA2MLBS53:USD9P6;_]$Q=#/-T0NQ2C?26?7I^_!"T[%ML_^UP>_?;3O/Q^
ME>Z^;\M\G\BL\XQ( 5T  !+ X$\UN\EPY=?D"O^--U-8QN]68)U4F<3:+\TC
MA;9=CN$N2264K<-P2]H&OS6I[W9@]P4@F\R>T[7 Z18SA9;5%_#=L2,L\DNE
MWN=Z1:XHZ@W. _[G6</@K:R=:+JF";M:\X+]]B0G-<>-<29Z^RU3EL.ZO:[%
M#"[/FJEM.2$:XZ;HT+A.BB\U<JKBNTV2[+\G4_/W("N+[I=ZLO[NAT]MZ);_
MU?[\/T=>L'#@'O]Y7)FRY O(_O8MNP &!Q&75N![;_*T=D;%[$M1FU$-I&%]
M;F49?SZ7Y(2%&3J7"<\!':UV.M"<V=8([KB]#H52G+C\ZS=C0M^4\)LQ 8A6
M +6QC?QI[QH6]<UO=T7!T**H6-L/[&)!:E52*K%VV81:+?_H5\L_(U@4<P37
MZ5"QE"^MU&=?@E0?FW>QQL[JMDKZHU\EO8#Z_J8)9I9A-,U6.RP%01)QF6^Q
M-5PLE"IU"XADI2"UKB6Q&!"R9%NL_)M?K+0W/N2VC^QF'C"8!\#@E&C[A%HB
M2)6+91'KETJC5>:?/"L3;X/1(\SA.8LMY!@KLEJE3N62E<)$@8[$$L"0)-MB
MY=_]8N6$WCO<9;28*5< GQY![[WO]@U+@+FOO=9JL?EO*"W +M!2JR.G+04)
MY<OUK1C_3GEI!\V?0Q@TF/5V4%_A17Z\%1:4.@,KI53 0!/)) L2"IU6P7_Q
MJ^!F(T_9!8T_M"+W/P2I.2;G8F7UJ[;Z^<FO?CZG^9DG[GU>1Q[I)IXZ^-?Q
MLJZ^!$V95Q%6:+5]:4@K2.#8[!\QU@Q;ZR[!?O"+SS.>!WBC?FO[9_ M2#SP
M^!?K=U"[TY?G6\NA(2VQ>5CB,_M-FE7EZ76@U:!DZ;9/A*6#U+*:C&*]"^EU
M2/!\LSD(\/-8D8Y[6M<\/U4E"59/D@;P 6)&I.U372)!PLE*CXA1IMM,!S[/
M-[8]P_";]#5=@7S5"X"_S/!_AE!3J7)\5)&I$B2,-*25>6R1(=I!1/>B=FQO
M0WXYWRG,RL8UH?;3A$(O.[#;0X1/S.?V:+1MAA7"M#V*(>$@0>:LYQ1W1X9-
M=X#5O8Q6!RR=,3R4=@F)_ZL*4R5R8G!*DIL:)'5ZR0B(D@UV\/-\OZTLB"D^
M30'Y7A#H'G(GC.E>!S.FN&>0I6!]5^%]P,CX:/3E:'?4^Q*D!MF\RU@;]>IV
MO>[YCO9GW WUE5#>>*V<;HSF"/X.EN50>?(5.HL5B0I!JEI94@G[%@F2'3 \
M7PX_8$$V3?0D4&+QB"QT8Q>)DFT'<4L&B0%YV<3*Y]+J+-)TKUR9DW !LZH-
M!Y <(/J<E.6I"XX3,K?4<7)FE I2<W(RR4S:##J=QCQ?NIX_%#?[QL^@W,+5
MR?UZ.(<KU:&: S#K!(D%'7E5G^B95#N<>+Z2[9::6;ZJ;6O./=J.P. 5.B*!
M7BA0U4M()*-K.IE.N;I7GHQINVNN71YNP)=CRPR-<4H.U$8M&;3NQ++)*Y!*
MJ].B9_-1IKG;\#0M*M>=FMGE@M2WK%P2IV VI4[7GJU+'Y(O$-69$>M@2(R=
M-;=0MZEF% I2Q5(226RE&60ZY>I>ES%WT7GY4NWW62\N=<<";5*6+G_<60O+
M!ZE-53EE=MM"BIV./5LO]I-.WL#J2[FNLF'<N9.YF[#HR0".4S1($"A()V4D
MQR'6J=[SG5F=\J%:EA7"R\OU-D$;,+[B9!<Y':<I18)4L80T4@=I"I%.I9YO
MN[HH2/>[?9*BFO>QS1F_4'?=R2@4I&*E))*XUF20Z3SX/-L1#OU 1\8?],\,
M[]E 52F00MU;]J0^SS=<K9-VYP=!M@2_I>7VNBI*O+%'MV\DW2V)S$K"6!5U
M6MS1;*Q-X=PA7HU"D#@Q[PMIMWJU-CJT>;XG.TJTZ$<X' :!./LX# "QZ,<V
M=*/^7A @*>]<'M\27KB#ZIVJZENO\M-?EQG$6OS;MWA]!\T/6.O@K;QM'CG^
M]FW1!-NTJ-<"E3V=XG\-]8E_(GOT%=YQ/*$7@%[3)9B]I92].;/(:4].*>)2
MNYP .@-MG^L32LE#U7=-J-V!4P@X"8NAHL,ZKF+#47%S%J_I7)'L<N?:I)5S
M.E\SHDTU^N1J#<H+UU<MC69/P31:$];R__P8G)[/XZ 9*GHDGY&J"37#&"AL
MP\9Y4J: I!!L8NM\/MNBG S"N,5.=E^,8I[V5N*!"*6%HVAP3+>UZ6+0,QRP
M#!W6%VU=4_=YNUG[G.3)IEXKNCW=,7I2OKK/5Q7)@TFR*?Y>H<,<D6^-K4,C
M#A<.%VRQ'W/!=8LA@_3R72Z-]XNP-I[^_N/[@9KP'O@?%PN -PQ>Z_\ -#I)
M3#,2'@80(M'N;T#SW_O&264+,PR HNGM9YAE=Q!]3=#0,TBS]LEH1JUVD%<&
M9GT@94BC1C^,('UC)H]SU9PD3\9:4[>4MTOT."#M$ T2G4YZ3.9.Q$ZS880B
MK-WTBIYSYQ"6K.\=PL;?PP2+0 X)O8\I!!*HD #ROB@JL+JIW]B:S%]UMO-!
MDOH9F4;QJ>)IC:?4-4A)OH+Q*F^'7'\*,B(7)I[L]I+DM&/48!BA$AER-*/+
M'ES5Z?'QJD)O2H#5[B=MQ*JT:!@0DFG5]=IE>'Q:GSD&7X\7ZIHIZLNB/HW3
MVZ(.C2#A9:,_I-X7=5HQC!5I$T8-^FV Z9R2":0Z2N\'6-2^<02OKJTP8BO.
M5K]7K0?* LY6JUK>))LGZ>H^OT[V:9ED-<=?2.+(:[@C-A^UQ,^@R0\&VHNS
M9K9^!DNX:7JMWFH,D'NIYEH5NF\NR#%PX5X6#Q3W#!D&LF1,V776X36):=3G
MZ2%-OJ09/LCCO<<U0"564F_O,J]0425YN8#XG$^NEE_!6<[6=B2X(-WJPR[I
M(!'NL/?$:+;;>)@A/KLK5F*:15:VW9[(. 2Q8BU&V$YFK2"AIR>S>BA.)EW3
MH)N,N>Z8C)2S=YGE!,C+;3(VCM6MWAVCE:L'"0[#7I X)"LW$$C,SV.LMU[\
M-Y(W=  C4;&VH]C%@H2%I%1B];,)!1+0DS>+W9!T+.2A@\QCK(>.OS<O)0H+
MC0Y9B95(C6R0L'/4:V9KF5K#IJ%"68O=%J+RY2NY9*RCK9\"K8S>LT0%CP];
M[()!@D-:,IFG+C8ITT">SM[@:?ZX@E+,5_*0?6_E9-)YQS[WLXV1+V/DRQCY
M,N8@D,U!X/GB.[IO2;MO-:$G_;AOZ>NUF1_(#1TDTT5!\>F2*CO4.KULH%Y>
M*A+RW;T$E,*PM!SP1O4,XI;IDHC0R_CS^Y+3(Y23CJIH&N$ZDPB=X,3U/?*2
M\JMQF@>8F<JY;F!Z2K?@"V8_<0?52XCY?9R2P[,'#G^X0K$H?;52B0U2;EAR
M"+-F?4!]"J8J5:KL\=V?6S949:N(**5X <$P1O,S(&^E8-7EK*)JGU_H:,U$
M+Q2JOJ6$DE(TBU(8%N<+<OE;H0-[QN:4.!HU4$J$JEBQ.%):I9()PRQ[GB#,
M*E67M$^=K_W9IU"UQQ% 2FWG]<-(4D^_3*.[W$L4/06.Y10-5;\* DKIFT]O
M;$SLV7\X*;9W&?QZO+2PV>@3VB1Y^J_:(.HQ(5;Y3^M3)O)9OB*Y #$3<]Q#
MF)WZ9Q=\O*2;/%VGRR0OVZB0M;M=EBY3X$3PV;*Q4R1B/JVOJ@*OQD7AOBWB
M%]^9A%! Z*1]46XT%VUVD0-=T,9\)_DFQ?*0.&-E\0B<B("!B"HP"@]HLXE'
M6()BGASZ%],VZ3^ Q!'GQPSU;LB_-!?3]_D:HIVS6>>4SN$^_X6,C.,$/%NO
MTRS%?[EHMEF8KHCI])G-KLTV\(2]!@BU[E<N6NA=4K@@?T.H$-OR_&A]0CK+
ME21I8^V.IV?2(IX<0>YJZ1GF>G8SY=?QT_'.MCS4YL_)\LQ&UVY;RRPIBGKY
M;EQKYBB%J+'\=[YQ6&[!JLK ??IKY]J#=?A?59*EZP.)1#F(L7VQ38O+S8O.
MKJU^&+I\-[AKEK6#<]>B,,>LLY:[W92[%BA[*I>J.]M9N6NHO[]RUTJSRW*I
MF^->R^$H'NVXW+4UW  Y;&FPUKIK26=.[DUA-^1"."O\10?K)M >3P^,.&$R
M1=O[&'Y1?]=K'5]XZ_<ES9-& \42I;73SNQ+4<>A8\@M5VG0 Z)*GB[?I'0)
M-67OW\;Q&B*7<K(-N(F,^5B1KGE:CV,1CFP#Q26[RU9>R<#5+2^EBHZY5-V$
MK7T&I"](8I*VI05 N]%;):?,\:F26B9P-<I(IJ) !CW#5TO!F"2'V!R@8ION
M[_/?MNER>TS:2-A$I^5Y,$3E*PY&K$S%P#6OW0<ZXUFFD3">03N.G\$>HMIN
MO=WWLJ9Y=L$!9F@%)X(1H8PZF* 1#>-IE2+!35+B[7KOA]D&@7J!^B3>^TI4
M9N^&N94#QX]17^CL#64;,HP'Y0YG^!A*@DG@S<_3^E=8]A_^&&N9&1$V[J2(
M3 ]_ZGUCB$.I!L,('=7-S*>K4L'^B5UPL/;1"@:.'6D9==8^&E'#@$>VO&W:
MYY(3C_UK]*M#[U]4/RO-ZIU/CG+UB_IJR6+'L!=4$*7>5#\\T41<P"BB49R_
M!*782UT(#E^ZB*&O<B)G,,76&$M;2(YB-/::J150G8BDRW-@,RCOSYE,A  &
M2'CR"N:@SJ](@NP[Q<?('RL<A-"<SVQ A.N"9@(2=TG)/N..2*]QN70Y)]>1
M)!\0U49:7+"+,,0I&,Z6EC&VH8*@(N6>M5#'".)0=O,H\P"251.CA@31POMJ
M=C(HJM*UZ[==I%%_"A Q[19EY&@TZ&:ZN '+FC[YTN.8"AZILEUT.W[9*8!"
M15QE  B(.WH^@J_2RI8J>_2AX9:=@K)5Q%56MH"XX3L0*SX<V)?2VI8KW-U9
M" I/0=]* BLK7$3=39*/_ZQR(*-L8;E6;$ZY*:A85DQE[7((NTF[\1EWS59&
ML^*"W9Z>4W *NI465'U/SZ%L^&@A7I5_4%B5V67'JS*M[!34K"*NR:I,(^XF
M'4-_91!J6ZXP956>JKZ5!#9:E3D:UTUCP-#X'?B"J@0=9!0N5;857U!V"NI6
M$5=9VP+BKE(0G##VZ2>%\<TI/![?U,)34+B2P";CFTK=-(T 0^6S/4HS&76+
M"W:QGS@%IZ!F:4&55<RC;)H^@+GY'EEF,_;>@G+'K3>SW!1T*RNFQL:;2=A1
M!/WSFWMZ&#Y.D2X2'[7(%%0I(9RR%NDTW430+U#9>P[%_QH^A>*?_N<YR3>
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M)2[N[[C!X(UQ_R)9FB^W]]L6:?5!58G[(U/4"AFN0NIN;E(Z5[-GD.Z^5*@
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M@\K$H#)&C^7R"=[ED@;+98G7)3(1O!GUC<6TP,P&P]B]&^=U;R%I*S^\ 9W
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M(?&_(B* A_05K.[SLF]$^4L!UE7VD*XE+$1TJ E>"*6I30]:!KUEXRU0NN5
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M[+9/ZU]AV5\ &/@R(\+Q#Y0A$CCNK/2-J<>?3(.&099M!:K$VQ"8I:MZ;GW
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M,)T4+]L$@6VS Q] 3+UBET!&H>*4@*;=(=I84VG1U-G'%MR4(*8$J_<$I<O
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M'D\<H(AV. \AV.'T5?.TO@%K@!!876\3M $%PPQ'J4[;#Y)UPMOTCQ4+]7I
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M-#M)!#$%>MYIJ?*VP2G)'R[0Z4M&^82W#S@3IX_N\V&NJ)_;XUIIT646Z'@
M$JFETR$-^EP^\6"8S.\Q/A6&/[(0]J6H .-M.RX@X"*V=JUK]__Q&P. .O !
M$>!+2&.Q-K_(\[VL+N9)#<-;5\H>PMMV788ZCA\@X >:->KSLE9@!6N.(B;
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M4.#'-(OF?BU(#R! '@+>?@:I0YDI?X-Y?HH*IN6!TG):6IM@5]BW/@\ \V?
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M4--=!.K[FFB()'!K&%FXUA1#%_3PTMDL_)DJ^CM*$:()%BADW0P."GTCP C
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MNL;PF.1ZM8N'+/>C)NHV6[P4P).2O\[GZJT\EZ^=<_P8O"A7O52>I<]13L,
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MUH;)Q\R:/0Z;^+<ZAVFE*4#^&WM8GL9I3L]#\&'_O"4H\F/&6#P((XJ)84'
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MVV7>?2%^W4 IQ?M"7#(W0E9I6YMU1]">!S@5.XI+=AO3+HA"1K2 G=^4TU?
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MU(]K%!L91;Y(;'%1[%2B)6%I%N_+.A2L+AG)-S@- /VRH>R#7_'3"Z#?:SU
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MS6/2446Z3 XK#--"BPF!M<,1E;P1<0.;EG\A9/4]WF['M[2E+0?T%+0$X^1
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M3U#9G!]QZ0I4]:%?/E*EDXD_J,X\G:0QSMKU2+;/5SNZO*6?1UM1@<\O>/>
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MU[EY:(8=XC2P?9YJ*>CRUL#F=,"%6UR;V01"+=L!;;5&K#EB[5%+()S3%9-
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MF]48',I"CB:,0Q%IU1[*T^,>2YE#T1K,R1W*S?>$<G(3[X4[&)*GY3<;/'4
M8D\7U*:$6*T,BJ+6B_K#0/8;9&-"1G_(+B![#2M("N5GPJ3@/8;P61^/SF\M
M.IK L:CQCF+8MHW# %Y(B,>ACT'UZX=.LP'^YGK9H-JH4NU/P6U+.>U&2=%G
ML/\DV'8J/PKE+8-R/T%S;TFX>3"^D^09?K<I815:656$.YP^T<Z(TQA&VY5?
M5M'. :)2K5!P'3,@@ZY:;E$]YN<QJP:!3.SC(TH,?OPNUJ4B%>Y'=/J"BM%R
M0[EZ'#5CA9C3&C)MQ+PHP$C6*VZ(F7P=4_;F)BW[(@@=54VZSK+7Q!W\'87
M+E*D>P3K0Q&98PP@TE0.&]'[F870[K3NH5J@R0,*P+V?T((I&&0^[\BQH/9S
M1F"8W+M]H^.'A2L2P9/R^W6>.("WI0?*<PU5RC#:;[FX8P?>LCQ>1EOT!4?9
M(<4L(R20&5DT&D3Y,W;!V&I487 @-P/R!)/IX/,VZIRGS5H+*.(T)LAN.SG:
M O"%PQ$@BA]/@+.VI^O)3(NQNR5.HC0FGTF*EU&6"QV=NE'Y]62-'* H5@F%
M2Z5V&4@50HOJLT#V:49&C>C^QEWXBMM76%9IFP?8OR79'B_C=8Q7PKV<T78]
M> O: 2!\H!4:Y#(#8S@7RRVJQX',_>.#2 Q^;S'@!R)]S$MT3@W[HIKWS7J8
MC\JF3UF6JB#,@%!5D\=%E1._[ W#4="Y#W*6.JH6)'8'$%Z!((_ (J#O%.RU
M-G[#M6=SN9:FD'2R^N]#M(W7SZP,05DR^E.<+;>$Q>OL<FM^M[74LUAK&C@6
M"TT@?L78+FC>EGL_QEV+G>;%W<6OEY]^N[Y$5U?H/?KK^?5OY_=7-U_1^==/
MZ+]_.[^^^OSWJZ^_H/.+BYO?OM[?A>)Q[!$Y<#A.T)#Y&V.E0W=CV:_YZ *2
M& ?0!T]<D5W$4GW 2N\TE[*P?>%&=7UA FJ4H]^9>L3U!S.3S\TKR1;T_,2:
M?$.;;:SQK;1JX2**_55MJKE7W,;%38@T@H7A"N528DME6BO@$ )FY7 1S5^W
MQPQ1\QKS<ET3@_GPD,6KF'8!9^*]2VF#"L:"!BX8'J@# [!,LQ2]8H'%5_S]
M@OP<RBZE?'R(SB_: ^V@;8U8B99IX7K/>GNSODI6\5.\HE/$W^)\\PUO^:S!
M,B_O"2_E\RS<J[24+G\B8VD'%AC:@J*(G5D9?VRT+=K/&?:*%H'LD]H"B#B/
M:I>FAHHJ#EO9GQ;%<&DEEL8!P7SZAF;9Z,X%Y\D7"X,^"A8+RC:RR<=YL2#4
MZ&TBT5@LR&46_!%;QC</@U@WJ$=.QA/UND'87 IYD!P_J5:/WE@GRT\A]$(A
MH>L@M3 QN;-3[]](:OJ;"96_BZZ0 RGT3$ Y3"-K,KX8*#%]O1!,?7)#N!#;
MP>P24$^^8J2)M9 8VNRP7L<)YF43C<BJD-?BK5#>&X4%UJ9AL]RP';%E^A9F
M+SV8<%$V-&B*JT"FQ?:1<3<AOD"5G@^0]B%,=W#/K@*V= 4=64,W4,I.X *X
MI:GIWS;J2OU&ER'MN>"1,+Z+)4.V#X;8CNE<C2G+6[9=&9[AY<^/Y.E_K7#,
M"?ZO_V1_OB_^Y,RF__R?"_*$4TG$+7R65V6T.\\LF3?H 02S9$I%S!&W7?"/
M@@EEQ>- 1GZ^+FH[S1@J);+3H.X361[86\U[JK4'"=&C\JMT'SE KJT("G$"
MG3+ #9HNJD\0^VCFVM:BWY^H?[<NU-JM*J0-):<%VGF24*_[#>])VO=RJB8]
MX'6;  "PK1 :B +=8X <B#3 +!ZAXED8"!4.&-'[@<6(;;?N(W>H:6)7F49)
M%K,00HEB6;.^"QTT@W"G/:7@KE6L?]3-BL1:+K=^'!2ZI0/9]\6*'UWBEWL2
M Q\MU#@-VHOW<%=)CEE($C_A3U$>71S2E/:KASR=IN4/H&[J@'R58BCT:]B0
M,6!4=%&^9VXU0:P-*AO-7%E;9X2)V4AT*:&2JF@QKGD::IQ3;JX8/S]OH\<>
M%H7/RJ_:>^: ]HXF*'B+E,KP/&R[J#]"[+-Y\2H>!3+RXW41V6E605 @.PWF
MKI;K]/RPBJFN\SS'67$3LP" XPW+KZEJZ !-N5HHG(Y:D(%V1'!Q=?'Y&RH;
MH%:+  "M,:K$Y/?O0ETN4^%^3.NT$?CG.%M&V[_C*/U,/^F_\1IIU8N_!ZT
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MO>9=, MU38GFS_$6?SV(+@65/.Y@N/W8&;Z-,ECD#O2J0=MK7N&5?8R*ST-
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M@:IHUP&LL)TS< 5:80$L-Z &LDRN G3YX*3Z [$FZ"8)XGVG:DR)P<\O0KM
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MNV&P%R:,A^W/!+RE8?UMA[3?*M(RA:C0V,3RE+27$M)V5+]Q5 ]L1T)2QQ4
M7$< 5P*PG9J JF=]JL+,KV]4U4/<D5 5="EQN=MOR3,+5,\?4\QW5[_A!'^/
MMO<XW?6HKM>X2J ?:>SB;M2ZP4-U+7-2_Z AS4/KM/@042CL*D[C6A9%E3#Z
M'E.&\PWQPT,6KV*^L<WSQT_85OD?;Y._)U^23_?)K_0_=W]DV1&[*#_A61+X
M1T15XA/:ZO3O?_IR^N'3'ZGA/?VQJ8:,:TUYX6V\0FN6ND,[PLZH/N,HI1HH
M$M&.KG<WV0GW-?DFIDUQ@E;1\]QQNR8ZB3&&>CG]2KF:[SKJ_5( )M[5L^,
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MY;$D2Z7J,TG&2CVD.1OV8:K32';=,LUPMK%B? ZIS':FM'G!9Y!L^3&2">V
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M*[6<L!OQN!ZT98J:%UFSS\2Z8"$VX]EGU(AHBUM:1KSC$FKNUC3EAD@^GU-
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MRQ_,7-R%FZ;6P.,CRPY(J6JE3RM:TDA\GWOKR1IZ!  .7<*;:JIY;]>%J3D
M$U[96@9%/PVVN@>9D&@QGX47<\V"=DD$-BG<'>,Q&Y. 89FM>5#0G_5!'^ .
MUBSXEL1OD^(;.)IC=Q\N<[RZRZE^G<TL$Y$Z:M,1<6/MN 4/T9FV404]-75H
M1F&5-I0Q=;-'7 90(99#V:?BN'2+?KJFIL F5-2D;\T9E3PZJB''VP:[">45
MC-+ QP,:G0,</3.@08V^26=,G@TQ^8*!)XU(/  /-/*X2E8'9C;:7B7_.*3/
MMRE^8@4:27*'TZ=XB;-O[(,#SH1)L+;BY<]D+NY".5-KX)&*90>D7+32MZ@^
M*RX29"FZ<:V'_LD4H7VMJ574DX8\*YS&3Y3/7)0D69QCE)6VV+NYIWA5U 5;
M;F-6!."/53HP?1PGR^UA56Q%]8R<T)!I$SW$V[CX\4X03A])0G;QDI7VH=:+
MNB8LDWZ/4QIC[?BF-=GG\2[^-Y?Y&=5?K.@I=88[VO,5>HBRYI:"Y,#3_VCL
MMJ% *512T.PQ.Q^.$4LO+]\[]K[5SXA5';HHLIG1)J*BCRE=-O".E46'XG3U
MGMVY\LR.6E%?3#^*\DH#5[MOE6C)6_IHLZ*.:H96\7I-EQWLG!;[E6/Z$?4,
M='429QOZ/5@/LZ(ST79+OO,?@JEFI]YW_, !W_:+EOF!#FBT^@<=V\)FG+5^
M"_KK9,4=,;2GM4CQ@VQB&K=27T3EEW0IQ'X;*L*>?$_ID+\GZS7"/]A]R9A:
MGSF\M?9!!, O=/V]J:;:]]MU86IG"!,:VUH&=8,T9&[$4"&'&D%4239.)8QL
MZ%G +@FK)T6[8[AM8Q(P]+8U#XKY,UW,OV*H2P+Y2:$^#/"]0_V#"=3'"M[:
M=@ 4[!_>P*X_ZC."_0-H48LHB1YY2'Y1QK/*U:MN\ZJ$Q6ASIQ/4(]KA"U;H
M&90?F-:17S2MZC4&2KL+M=:2LK-R25-JMUI@;>B2J#Q16JV9=EPUU<)6FPE=
M*K)5$%^$H6(11KZS2QN-%X9/K&ILQOJR.O#=*[HXXR=9"RO%BG%)'I/XWZS>
M[ 8GS6J162A7J'3)./-!;UUX$PL(]DYUCT@VA[FU3/CF$5#5#$U+3@PZ[5"H
M:A?:LL0+U&2%,""QYEKV0L,$9+4+37-.B&,5OS;/&=_]N:=N-]H_(P$$7S3T
M9,4K(*$'6_.T'+%RP&[VK% &G?C%@8]FZZK"Z5AKIUIZ:N7@48^>/7GI/ WQ
MACYY21]2-V-11187-V+M^\U89$&6R\.>MVT]*"*/WG;R/L7O^88XR?+WI84G
M5A>?50"CG^<ICO*BWA>-BTB:;VBC%0U@JNL[5G%&4AI^92<H8Y7[LO?5$[Y!
M'V/ZH-JC+Q7W-^K9U^"-62!$TG_B<D<]P0<Z'.21?[U*V\_-HJM^54!#.N7;
MASJPRO C_R[%6P1<O7P82A3A6?=M@NR= 6\L?-4P=Y%838(2<Q;U"A:J!9LZ
MA3H&//L!H+JO>H9</,"I8 9MV@4R;WJ F*R4*QS&7 NWCEN K->J9\T%::)8
M[34@359^%0YIH-'9#9O(E5M1BA;E5Q2V<"&#0"%XM"6W(46]3&3!'S1[1U4@
M,$P_(,E[%AO0J.:PW-!)'67+#2';(C)I11LL8&$-:9C#7\U71&+1DB@*JRR=
M%$55\\T6YS1JH.%]G%2!S^/S#NUXI[--O$=KS,*>>M5>O'3G$0I[B\]WBW@6
M <^9B).Z4NL#SK]CG'13!%A,1__=['!U8RJFC(XZ^PK;YV83"I$GAGQ>B:WL
M!GMQ3U9EI,1_3I8:P/:TTA6/_GA>:[KB7:GO4UIVOL7/Z&K-/^YN?47QJO4]
M3MKZ5WB-T[3=H;(?I%!4IU,(=]B&I@+995,QE^A1K>O$!(UKQR55Y,$1P(1;
M"N6F+N"T\@&!;7XY($ 2,5E P#$RDF@%C(84%DR!<%8!X9:Z:.8PRB;'CP=)
M7&.!!]#XY3/]7O??R?V&'#+JG.^_TQ_]^7Z3DL/C9O#YY_A)7#'544OYDUAK
M<:&'I5'P>,JM'U*>N:A=7+6+L[ W9EDU4:-G'*5S;Z6XHH[ 0:!+:DN%-?&=
M.C03&6!B"L<.^* !C4V8-*+-4-4.%0U1J4'XC&D)9-H*@"B2<&A&ICB&50Z6
M 4,OQU[XX,M9R1<::_P'7=L5!*'_^-,;&49BP1G) !I37F!VNCK[3-*ZP'^R
M*OZ,5]6FAC".M) L?T(C21?>&Q@"CQ'-;4L);JIJ<9Z@:,\VXEC^UB'?D)1=
M)\]VU^J;,:I-G)G#0AL0$;?1[?+80$G-76/#$V(8)K2S, J%7AK"E1)=P+)H
MK9(*+6UX0A1+8K,)8.P8@QE: XR[+"Q#@9G&5Q=?[EX?2B5!TP0H]7([XS<<
M[QX.%&-LQC]_R/@+F![(M=KV;F&4M(6X 4RH&C#I5L?,Z"5?"NGF2KI.(_1[
MU6SN?$>MX>Y?V34^*N)KNH1R@ZNY5-J]8LK#37)*6_; .GMMP!JY_\T16+#)
MLYCBCZZH'O'-NKI0CJ0WAWQ?O%\JTT0JG]]/IK63KI)K3:6=\I_,C,$GWUK9
MER=(6:A;?&-I"'7]A7VMHJR%T"3,UFH&"2"5<)VWF[&4WBC)Y\X:M40B<8='
M+P_+3%&3EV73@8D) 92%:F<8D@JG_.;&%OIO6^AO).N\PDKVU6%<EM8Z'<A=
MTU[-+4*FP=I9AX3Z61_JFH[^U4%=EE<['=2]!7952%GVXRI9ICC*^GPQD! $
M<%()*/9*#'@-U-0VM6BJ4M%C9KU(JB@:EXW1ZI"RXF%-XFA T=885$24U!A+
M.0LEPD+F*0U-@$SXB&G$F"LFNY'130N4MSU0OE@$:L0\0! $C&T45CS%,R,6
M78$XB%MJ9Q@G0T_)SQ2\6$1JA"9 B 0-0<YY5<>;]3?,4B/9&:.KY#->T;AG
M>[?'":N'V8.U@43Y4VA)N)!,PP!X"*)O4\HR716+HB$C6%HW911;%XU15K8.
M+@8QP0JQ&\PNW32$:[II&YH FC QB($Q5U">UJBD\4?3%ETEJ&R-JN8O%H*2
M(,0#!AV#$$TK@$&(@457)!;7T"B\XHO%GR3D\( _T)#CLBH$W8YW/N$BP+E*
MRHBGAV,SH?('T15RX9:>#?#PP\BLE&(&6A9UV]Y+J15N8OXJU \M#C%$#[$>
MVRX3]>1K,IJ8FP:R,&&)F3T L)ZVT=I=H7YJH;64>.'0E$0IWK#I&*OH&P(,
M5\R, B#TS,B?OG"$2N(8;P@%C6:^XJIV'CNY4FW;])"M;E1^;5DC%S:)=8)'
M(THS4KHHI!;T65V<@Y?>K1[/'$F,C"31_MV[6!>WK[&M4N<''C SOUJ_!3!.
M%<@X<F!(YFEK9#C.PW+%@/.NVH@%/LX*?%0)$T*<5+=BSOPNPADPDFG3&C"^
M<U;K/8:_1:RB>GFF\S*)6!'S:_P89]O.!"//7S75),]EU=<$G."D:WB*'%?#
MOIAD/AFIEB1!U>\\T'>NI#Z/C0LU*%JMXK(6VK91&5#ZA2UL%9E2-O@939K2
M5:I*H#+KV(RL\I8H:]H)7WR2)M#62E"AI:X 4NI!+45O).K#)3@6P6??FECW
MFXEKVA-?7))FZ(Y.3MLW+LDQ$QR78$N(D-T#N\BG5\[W;H_Q<G--87J@W;R-
M\@TK1?]\^6./DVQP?,M-2558Q%*)T[EV*YOPY49<NB$_[FZO=5')#BY8^%\9
M%T?;4IXM8PL%_#9;IB&X-VN.\"1@8.D=J+?2UYRM=^C./)P!*F_B9-\#6TY;
M=!E4DB_D4:4 U1I0I>*5<T-6$V4N<KA62K$V#%DTQ:D3'BARYC:CO'**R JR
MS$41T "TCGRODFJCM\KJ:N+D'M.,9,H?35/&A?M:)L"#1Q.K4FKK*VD2&3L'
M*.KT[E:B0&AQH!ELB.VH=EFJ)5Z3TL#8)$B%"=F,S+EC]+0-TJL62.O4TJ;]
MBT:D)+;R!$G'R$G;#F"@9&33'9CM D:UPUP>\I;3?-%XE 0RGO#H*TP!V3(#
MTS<,;^;82',V[S,L\K.]!F.@&TZ]J&TW.(@+' WT9IRS:I%_FFN+#J0+X*&?
MIXT[( O=D/%X-_0"9=UX*!H"[>!"V"#V <'ZXY=\9[U9<'FT6X6!DF\\[@Z!
M?+ '.*EB]N[<9GO12K8ZSFDFZW0*R<04_.%."^OR0TG&RA:52"N[Y=CV(^UP
M1ER'OW>"R41-<Y#)W/BD4 <Z%&IC%@[DIRV4'\F&YL20EIT;G0;3KJ=(3>U!
M'B:UL0V'[#,;__VJD"T[;SH-LCT=LZGM?R9I6;#T*KE9K^E_;U)^">]7UK>,
M?N=#<5CB#N<Y[9V\7KR[RL'!&Q>5,$G.]CWP>!3'N5,:><^.-MKYSXU;806*
MJ]MTJ8LA7!UB58OY!=@)]SPME;1QH3.X@!$4]L,\:1C8R?*E[;4+$J==NQH"
M3Z$/][CWQCM#N\=]FIB6*JMJX[/XMM"';M+BUG;TE8>];8I62M_X. ZO(R D
MV/$@MVYX.2?DWB7OM#P;GSG?B#:.FB,@6BCGYV]Y.'7_G4@#>W>5[B?J6RIG
M.KU8]R"D,_;]3ODXT-BU\7;J7H9Q@-..0HR!G7JLM4,<?^QU-012SGY$?] ;
M[W0$.;2/"I6(ZGRCXSBZCH"/\YWQ[W0CC,/^@RYY9R7(\?\3%*WI;X*^4.)L
MT(?3$T3#OK-:XO\<$HP^_$?QZ1MMQS%X!+2%7A)0S3?KLC[W)_R07^"8RCVR
MS) DP47WXGSS"=,E2]QT6;#%[ZJI60#8:W+T:+:&?83[CGU1.3 GU8O[39PA
MO,6EM]K3WY3^E;7VW9D[JTKFKZA^M"P,%-EBE0GTG=J@S[F1UC4D)ZS9'V^3
MOR=?DD_WR:_T/W=_9)L;NR@_X9L<^$>TVV_Q"6UU^O<_?3G]\.F/_8[0?Y*4
M><LUNV29]H=05_B,HY1JH&1#.Y+D&VHJ2IB#C6E3G*!5])S-O]IPYA&!!?3
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M)*2UC0P:7Y#GM;]8$S\F7I)$_L,N$1Z,VY&@]"*HC$LO]*G%X],,PO%,@[E
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M17G#W2MMN&\YAY$C7WUTL#XOL&J:G:2YX6D*<0Y$G'A26Y0=!"^A5;(81_A
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M^]PL,A9$\)A<0#\!0U&$YB-:BF60;2$9,9*VU,*%O4!,K&4F)V\3BF!V1)M
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MD=O+1T]9HJFD] M($D2Z<5%ZEJ<45R3*69!(\! 9R*CP,*&X.;;P,'X^1?+
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MHP)61XA@"2SDOJW0+]8+[FB02EC[V\;MDNZ!>7]6]4"[_H JON@A0:>HED:
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M=02PE5+"0(=-C8(_>8*"\JZW/'CDKO)89/V-V(#,70@(5)+=H VXU #XL^,
MJ$XE[J(8/!:'%Y#V&I[UN;;.\+-[#2U00=# P])UP_[%BX9] KL(*Y/DC\&A
MO[#CD70:N$_B:B-S59%JZ#Z'NK%_]J*QKP%^EA/?)QOP_K_ B=K:#)I.<P]H
M7&UOOC)2#3Y@08YF7#]E(\?)(4S1A%,]I<!7&-?X9BX]7<,-O;M+E>C 05#"
M57"H*"H%%0%# AS7#_4J9=;!^_T&J=RX)'*F?P%M!RQ,6E=A(J><%$"8K @T
M7#\"K-18;#9(VZS^ST.4@"]46'#H.I"@TKD*![%24E"@LB$P</U<D*7"3Y(P
M^$D2!C_Y!(.^4IHP^.D, ]=/!SLJ7*,_E^D:OB4\$ RI:!!H4SD. *9"*LW?
M9D(:W_7CP8X"Y6)GF9:Q7*OD,TP$,$AI,!B0.HX%OFHJ@!AP(JAP_;BPH\4*
M9GD0___1D;G7X!'2$-$C=!P//+54T-#C0[#@^LDA'M46*0@HK4_[1&X).Y_<
M:V&.Z*+;P$Y)THJN'Q/BY&'Q:@\3^ODOZW-MDN%G]UI4H(*@58>E2<NZ?B;X
M#,("Q_+Z\M/+&JO::UG6Y]HLP\_NM:Q !4'+#DL31QW7C_[6:8!3$CZ?#B\P
M[C4K]5MMD-XW]QJ4)[R@-7M%25.Z?AA'0'C['I8.\I1;&AY)K[-V2=QK7PE5
M)#MMEP-I;3_.UWX#<?R_$K0;? 9!AB:6S7V6%8RC5P%M9Q'-I'4/""K*22VE
MF:P(-/PX<_L5Q@52-2TOG-.^*PZ7I@.% 8VK$. K(]7T Q:DR?TX7ZN=")N@
MGOAL8."$)4/:O<)ED+J* RG5Y"YT&9P(*OPX>"N?I 9EXI^;( ]JI1@7NCS2
MWDTNG=155$BI)GEW2^=$4.''P5LYPET'.=C!E.[>0:48.&NU*%QM>IXBTBY;
M+0:DH5T_5:N$?SX$<4S>?U,;FDK1:>@>A:L-S5-$JJ%[#$A#NW[P5@E_>P#I
M#LU27U/XEN_KI&_4!N=2=AJ>0>DJ &04DP("@Q$!A.OG=??A-ET4FPCQ6N1Y
MF903:4MY0RDFK*W&(W0/#=)J"<# XT,>9KE^PE>/;'NTJ^6-"32"[AS0(7"O
MS85JR,T G?*DC5T_^JMD7Q4O<13>Q3"@K^XIWSLMW/GN:@.SE9!JWTYQTKQ^
MG/6U N&5\0NS99&C$2G!9]7T/;Y$@>Y.GUO 540HJ"FWZ^?R(YAQ_1"PGK;N
MHO1PO^G!@_JM-E'OFWN-SA->%#FA6Y0TI>N'>[78E/L<RI=N,[IZ>\,67*X)
M.W<U_^+Z.5PM]$.=HXS>B/VOW88\?W6V,1D*R#7HN3!IU+'':/_QP\! #^B'
M"0(SL>-4C437-LA>2A6+[/M=$!Q+B/T XCPCOY1(^_['+]_74:GJG__61"!K
MY;]:P>I5*2. DTH1<E<L561L'].W0ITUG:XO_2/I=;V/MG6H#YFYJC!H.AH-
M:.PIAJ,.XJ#7Z#\XCM]K$ ,<!CN_#M(4!V OT[?U%%4J0[P$Y<I8&U;YC0?U
ME.X.NM0J2C]#.=;ZP<)RD&;@P<Q<.Z(/U;'\GT (D)(XYBS(Z?=@,J2D1W%)
MW<63@HJ2,.)SU ]0YA9Z4$=9YGN0GK7,A#"2*M/#DZ",^\!245H180+6^N'1
MW(!:J5O'"#U<L0EJ>]((W$6,4!U)>-#XZ =.<P,+/!CP3.9-XQMH=WJ3:YSG
MY# /8FJ37]QB0E,Q%O@TDS%M=>;A^]INE<(C2/,33HI2AD9&Z]@CWI.B>8&Q
M75(I4AM7KH@]*]P5:1+A</1(MKOH'?^5?4WAP.%#2%?KRZ&SUCV4F@W*Z]KM
M.#*UX.[$X>Y[ERJ3QNQAO+D_'%/X6D6RIZ%)3$C>=G$(O<&3M+9Z@.*Q]WT+
MQ;0!#55RQ**!V3=T*6FMAS!1%2-V3\SETX4WZL6A*),.W@"D0!B5!D)_QZ!L
M\62S.&!/[BI_"],<P[V\4;;G[;XAMMY@?")+ZO4&<\+XOM/D64QAZ:RP9/8(
MLPH:&QZ5RPH^[)968Q,FVN'*L?1]+56G&TMVY8+Q*=KM\^7VEZS*+-@_+I2A
M)2>'?%H'(:2BG0@[ E[6\V[HX^6<G36[3YJ$K-ES\9)%FRA((Y A)6%8_HIZ
MS7_!*,E_1>1X1]O#DQ%>Q*-\'"\'\6C2.B*\CJS+]R5+/Q-JC<]!@M3*F/W<
MITZAAB&S" #G8B.6"$ZT)24Y[NU[&!?8WY;1SBI%FN%&IHB#^-#053QXR+#4
M3S[B!JY:EX(X1Z_H/G5(,[Q2;=,X"!49;80+(3H/_1PD;H"ATHAZC4J]/W6R
M?:GRRMW[C4DBXL1.4LD]%3*M2+.9#.NS)3_.U>E#%+R@=6,>E2O$\L$+OG]
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M3:5.+V2KHEOZ YUFU(/+(\P!61LSQF@:26^0[I+XA2.QEB,01&7N^R:#:/6
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M8IE)<D[?22&QHDG9JRLILAMX"**$K@Z;KJL3C<Y<(/U'D*]0ET>M_P1>05*
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M.6$;4YVXA'80><NQJJ5[=-&JT[C.<6PM(Z/G(MGT)K(L [1%_EA."OAE<OJ
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M;GYHRCS]@W!FU?T=L5*5OE^EGA6_W6YQ]+U7T)@*CY9/((1)B)07[P9,L!I
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MLE*P.N2EI/"PLUIIH+$=^5)"N_9>O%[;<Z0G&M(W0@H%N[LDJ8+NHU_;#(J
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M<"A[$*%2>H@1L<9C04*M0=_G;II;A"> 3V'1.$ED7(/TT#^XXM&0(RPZC4?
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M[6LR]CD4B"=.%^Z% M$XY;+= ',H$.NA0,Y:XC@@JQ3$T0%9)3UU8@)FYZ"
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M]RS-S:4#/_7DDB,L-S8P@K84GD=OFZ\E/)GDW;N6\#AT[GPM8>U:(ELDF^<
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MO<FOOMS^"O/V62H#L>.8<!Z9RS#Q",E&[&0RE8!,Y;X'I\1//F$<;:I+!V2
M]3Y O1G&\6GYEH#-<_&219L(I\ NFQK_6/?YRA;7>[RRR,@K>IP<LOIP59?H
M'P%>K$)RH'B!"CWJ91>WO_;+Q L(:B.ZI6,=M[H=O%"GY5=FN,.R*ON$G57*
M[K8[*DM(_1B=4X41(TO@ZQAQWU3W,]DSC%E[%29=;VM"H?,(K++:CMUX4/B[
M%A]RL=NE9; 2C.DRL! 2NY2WAQ Q86TT'J%'&)'65Q<DO KTPQE,@Q(<>Z'*
M4X$#G\8X],<:5J-@C>[^-"Q=H!4'0U3 (_0HZS\F*H:H(OV >].@Z1'FX)SU
M1 I/*D4:IRJ9(AYA2L,&VA.85%6NQ90CT^Y]DN5!')?/L^Y@VE7F/L%:\/+"
MC6736RJIL_$)DV9L-7:AI5Z]1FRWB9?J/.?7\P'??=(ZS5XF X?+44R(VZ4F
M$X]P:\1.NJC5K5P_RMTTX^TZ>+_=;D&8+Q.>2CV(*I:J;2U=RB,0ZEE"%W72
MM9&+@OGITOQTZ9,]7?+P];[D0Q/3CY?XU7Z2YTN=&,(4<^@_66*%G;F]N;W]
MMKAZN'U</EXO']=/RX>'^\>O]X_KVZ?;YS7#TT:U&'&NE2XV/U":'RC-#Y0,
MKJSW:*-Z/'%?*'%IR*J93N/2THS]1DE&08U'2@RVKD486Z5PAY3+HE?PGR"(
M\SU.710D$<@>'JZI@% H45M/JH0?8%%77@,Z4I5X[B4_OWGS8Z<TOWGC/.0Y
M.WJ S6V"\[T!6C!8$=G S:=/9E\KZMI&3,C1;,1J9H1NC>L-DH ZN[$)R%J<
M0F"MLTNT )30J=NCV4S+_3:%F;^CI;!K0@68B\U(9B >2W^-.6;JD1PCQ\\]
M[(K<>08V/[B>'US/#Z[G!]?S@^OYP?4'?G#MXRN3^<'U1WEP+7C@>(M^S4_D
MBNT^.3_:*+-X1B]%KOJP58FEW#-729;6C_F,/7K5L>%$3V E17'MQ%^@U4-T
MB)#<G<?LW/@#QOC)(5Z&W\>!N[+U)L*ZC!P6DZ#H0?TK0+H$L3&HR_.3@[H,
MOX\#=67K301U&3GT%[ 7&],[CNBKX(27X6N0'K!#9LY*(Z!<G@UD47F_@:MD
M'8- %=6K_S1X(M_M4K;;PS&&99+U)J%1W\M$1$<\3=AT'@%*5EMM'VPV?]<>
M!E.$?$(#\%L08R5Z*)$CKHTG(O8(+TIZZX)&5(EKCX4?\6C8S9*&!?TE06*B
M87)3CI?++?ZM5KS=)<C?8/,,2F?:YSUJL#V,-[2,=Q-7=([//UE%'J']8O;6
M?[8ZG8#N/:(>Z'H59%%(&9UE2-E(;Y'ZC566S@;1UJK"M<?1[9W4$\[[OH88
MYMVSLF5R&X1[U$/VX%_S_2+9_!O^_TGTBD0J'4OZ+J=&F1*O5$-,/4+K)';4
MQ;4I8?2?6+O1 _Y4ZO5GLSV SU2S!["8?N >(&7'2_4 EC!3/-B>']+.#VG=
M?TBK<<YENP&4'TF:?E(K*X#5Q[4VG!U$SVRO3@]@%\2ET^B)]LI3GP'Q>M1@
M<%E/NB94)<7QE/JMUJSWS9+0U%<,C*]]P<V_ONRT]O6PM>DNLTJ%:+CB%+(V
M*++: &HJW!WQ>MQ+9S1)KIZG5Z9W22@"/<-\Q$UR4-C?Y="((1OR1[S>I*M<
M3\?0KKV.,SZW#M:1DE,J:_VI4,Y=HU0;P>L@34_HU\4!%@DK#[ )5I*FX[/R
MRYH&K&C >@Z/?U*XZ<_2>I93&S!Y@@TF>&F!]$?8(T@CN'G.@S0W?P<#\GND
MPP$\0+0!RRO7TM+S XK47(/#$:9!>JKT[=_8&&=,[G<,,O:^;TQF9;,]QJ28
MUI( ,7K03915^N!CBS7L>;,NDHU(P_ZZQ!S#NBU-,/2^IQBWJMD>8D(\#<_1
MGZN>D911_#?6$V1]BQ*8MBXHJF0E]PE6_E">D_\:Q$7_;$RQU/E-K5PI[Z&O
M9Q^S^):6P6("&D,@7J4P!&"3W:%&7 6E7P[JT<0 +8^<P46L<L%S$"SI@MZC
M6=M*9@&M(H:^8ZSUPQ4U "N!]L,#U2(XY0"IX6]K'9"L,+5A"H(,X-Z(_FXG
M21MZ$NJ5/[L7JI;W'LEC;69X,ZDNC8;GJZF5,3LV9C-]5+'L1==&_.,68_PH
M2PI-?M[#WK1-IUN :$KGFH,O?F>6,9,VC>L@D_!NY>DRR-O[CC.EK4W/)48E
M=<U?F$R*]TDWG]0=3,LQ(QO;JZ:K@)Q=3E"!]_UK<JL;/MN<0%QKB:0FW<8@
M"[5O2I;Y'J2,X]ZSQ:0V.*,X<[<^FIR][X33V?D2VR5-.2=)K/4)/#G^]M/L
MRZ'KRS&PG4/>'%\TKJ$K=X[;A'ZHX%"C/M!>RACT!E-KQX?V8YIQ4MAP=F2F
M)6^+*%X(,7STQK)I4ICKLC%H$5P-XED$\3HZ@%796_XSR!Z"8P8V5T7^G]4I
M]OG5._J(%I97 "3D6?P@NI99IN?4 T:8VHM0/Q8U<"++]J+=:XI9AV0W(IYK
MD189>FV0Z)5JBV1#46VCV5'T^?+[B@[?C]A=1MMW\AZC(Z%KKGJTOGZ6%^G%
M&BUNWX^4D(VFV-5-.)Z=USW#L#7-=8CQ@KD6TE%;(]3'#7>%(<>QO:'-\7-V
M"*9-'>@3;=FF""CI61L;?]LRIE%'G83H1'V$>1#;;D6M0Q!#V^T1!R#Z$DP3
M2MNA%N._J]5]]6GBS:U"W883ACD>A&1$DXX-0Z)3M:'&^8\?!FV#$/#WZAOU
M4Z?=P'L.DLUYDN^T'%[G_3&$AZK:KQ!NWJ(XO@%Y$,79'ZQ=OQ!!T H!&3A(
M=A$RZ"++0)[=1%D8PZQ( >.,4ZMLC0_%LO;NIXB@3PB%=S!]"]+^4IM#T5.V
M0V%?)88>#.$MCF \"T.FX-TAB,(#CS;GLI:? YONSW7Z@ILB16-GM=IG=5\.
M:;^W4DE=QX6$@DI8H?.S=K9F&#F_I5&.YK'E=MMSOB-1P7Y)(M9,H%2VARW)
MLJZ#3<<$2NB3K,#_MZ=$X?O#,8A2?*:!'6,8R*,3]2#6)W(=2UREE$#3YZ1Q
MTN,H.E9%&NZ##"S"$&^\\0Y\\WN1Y>5S*P98I,KTL",HXSJ45%160I: L;44
M))=9*P]<H?Q9+0N\N&37RQI/%IWQM]+;P$*9+1_=F%(5M<W<J<"DR\/ECCKZ
M"I=NKH.?K!^$4&2Z?0_C8H-&M*;YZ.<@.D5KF*@5M3<,GF,#WT5H>0D>HE<P
M@#(M3*YZP=HR*@7MV84CV]7I6_ [3*_C(,LH 70U2M:642KII&G.0CX&!T -
MU*M96FPB>FE[9EJGP08<@O3O&34$,.LS29$W^&QM,M5M,2A4LCN7*M93IL@;
M\+?F/6@(-==HA0T/("V/ '"$JGUTI -(@I)X!/(H?825O.JC$<:MRO>3P?(>
MKIN4BHXU,6'[X1J#T$>D22L^&FB\FJ;P:G/#_LP5$1R[4I!ND+X(N#&4J_8W
M=KK&.I[?-H)%+BNGC*AV0;,,:W4GSKI4>HLG'*6/LIT8_$Z>-9Y_MR H/:O%
M\$M;6/H\,+6XWQ!F#L6!*C#UVSEH9?N;/2<?BE$A7_2>B\Z901T>LEW0L?6R
M7),&[^PFI7TC3=K]YER3<D3G-VFWX!2KTDM;I[\68 \M%,N06;Q3Z+/-T*QY
M8\S\V^)IV&O2D?.K!T8"$Y4BXI.J!Q?2EG#D>P2LQ\]JA<26Z!2R9PN9PWJ-
MJP&-*P$W=VFTMH5:-I#>E;6JQ"./7%7Z8[PK$:TY%EF$87$H2L>@Q0&F>?1/
M6M!5?0;BWLIDX!%F1]M'%\$Z%?M^OLC6^9<,;(OX(=KVKQ55B@@1VR[R(3#*
MM(%Y5+:K^KCGC\/5&W^,8*]RI%O@H?VX3+:JS[9[T5AP3W2P^#!X*:;1#6PW
M@I8C"QSAY-%M#)7JNPFKQ=4:ZAE6W:;:L_[M^Q$D&<AFOZG9;ZICF=EO:O:;
M^@Q^4[,'C'\>,*Y<'\T>,!_; \;;DY#9&=2B,^@'/+>8_:9L;ZEGOZGY9M?-
MF]WV:<)R>U.WX/4^2'<@8^S8E<K4=I LXXHA^FW%M0"+F*KZD-C:J*36CE!1
M[>X8)%47'GY$=5B\MF6E1ROP F*Y)0%!ED>05IN?_K9 2$BV!1Q"?] BK:XF
M4GC\?=\"S)>A.H@;?1<JC;WY*I1R%:JS+M"["96L:=XPN',1ZF'(S/DBU)N+
M4!QI%RL1Q)V3YT6R:0X*HQ(QS6'A?&4Z7YG.5Z;SE>E\93I?F<Y7IO.5Z7QE
MZO$SP/GRR^%MU'SY-5]^N7GYQ9'OKLAQ,,:AK^UUD6*@HYWE'2KW7(0A 'CS
M=!=E81#_-PA2UK79A6H3V]Y,;4XV&T6I1_">K]] _ J^P23?*\!:@9G$>S@9
M9BY.H$:Q*7A4IVQPZ3G8A!:BEWDRTON^H%?3'YMO_09'=;D>#ZV>UO"8.YB<
M>1WO5XW0'_>>EZDVJE_^ZE>*BWZ7JKC,G4K6Q#YTJTIL:[EQK76L.UCT#Z7&
M,='N5A63N5=)&MB#3E5)/45B7<?[%*(=WZ=:3/3[5,ED[E.2!O:A3Y52^YY9
M1DWOQ19);:1C43EI]:X>I[F+J9C:\7[6$UT_V8_KMT3#$VQ^,T]P8&L\)HP9
M&>=[I]F'<O:A_! ^E(LP3 NP<29HS"HX84MB+\U2M"!F79U)4-;-SZ6T^+JL
MRHN8U>(1Z1!>HN EBJ,\ AD9EAF/[O0YD'=H.ASLF>SV<(SA"8 ZO^U0R)Z!
MI.EK<TC0VWOY,J*QH;HI>H]@U"O'0Z=$I=8NOQ@O]U9(8^P%A51$RL(TZ\E^
M&@Q#DO3-8"2D]Q5BJJ8P C&)2O572JY$]:TM<9]D11HD(:"/=@*J\Y!/I_(5
M=G)J&P$;LRK]JQ%7(-92?+F]B;(CS(+X:PJ+XWU2+XYQ0EJ($SD7K8>U="@:
MXE:WW6ANOD+;K!F-=('1(NG?>%CWD%P'[X#8BXY[#@4)Q42C\!6?8G6-8(Y:
MC?XIOSZ.&&O&;V 3A<C&2!D08[R##59M\XKG""1WZ5:_2N$N#0YW1;(ANO3
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M0M$_X. 349>+9R)[@2U&MNE@8<E0O!?Y0J_6X1+T7)O'R]"G:+?/E]M?,K!
MXTR^?,D#-+1L[I/;]W"/CPKO8-I5^P'-Q:578/\.83PG<N<PAI//:#9G0F.0
M'R62O_EC%:9S,S.3\J2O7:WOR=OH:(O*@$_E>'Q3L)(^Z!2E3IZBHFX=B3<]
MLB6KR)-Y)!O.\;D<&VL]7PLCC&->#8MUQP$585B'P')">+R$D56:X=FL5UH1
MX/;]F:?&M8Q_\U1P'O@[?W04TYR<=<OK(-FR:_-%L"QT=9X4S1W79S^/.>6U
MO8-%W\%+M[@&FJOB'QK,% M=#LM5Y1Y'P512-GH=,S*WB^M N2S^L:$\M- %
MH5Q6;O@9@(M0+J-HC,0SE8<BJ'L\/BRR>;:Z#+Q[$NC'T/$&XYJPUD3R!P:O
M%;R.BNS#O#%V!J>_))LH"W'@#["Y?0\1*36TRB@>,@AF\_A8<):TU8389DO@
M>Y@@N?M#N8LM]^[]=.&H<Y&G"CC1S9Q&+"$G\AHI7,^-N/-1OI-3J\O&CICA
MH[-X18+O*N6PCV6V2#8W]6B$@_ZPO'*4R]6652CGRK#U&\ WX6!3B]Z$=6MT
MZ,=KUBU.'>ADBEOKC>HH&/1+9?-T^Z:T!,->*E.SQY=C7&7;)JH# JN F%-<
M!L34XA\(Q&+S3 5B:LV?PAE'=T)2GNH5*O(W:HCDNV2UY[5*KY6%K'U&-<L-
M4#X*!L7%/AMN.!F<_ [)<AW$X8_-JL=L1?<)^A.L@W>07</#$2:@#$]U4]L(
M?2B=(7&?;RWR4:FXV&#?2!RV',;1!GOB705QD(3@>0]0 >OA9!K-V,& ZIE?
M@K(&(9?2WLJ'WW)TI97*D%P <F5L1FGN"86;JO[M]OT($OQXY(#_6PU[R>8*
M)& ;#5X9C&?41'K69V1MO%;#!C1HKNXH+R5'%8=+OW[?$\U)Z/Z$C)J^ CR(
M+\(P+8(X6\0Q?,.C]1U,;V#QDF^+&'W#:SJ-OJ!9@7P?4:[@0_6=<>:=KD\I
MRS5%CGFK?>V\-X496J>EZ6D+T[?_T]Z3+3>.(_E/&S&[T2\;X;/&$R[+;:N[
M8YXF6!(D89HBW#Q4UGS] #PD'K@!$@#-E^JVB#R1 !+(1")*M\)!)(9DC0X>
M9,!F+ZT06_;,(^@B&Y'YKF./[W)OL/H1PWVI J&EL=JS[&O8/F"K$@AORY:&
M9$)_/&\@XK<4#Q.1K74:L0RL;A2P5='$M&5*-6Z#E^I\*!(@LZ=&>KO0KJ(Y
MA,I'UN0(A+X)8(C9.K)1.P;@ /+/ JB 7LQB[1AUBO#:GY]?XRC)L?/Z\%<!
M/VAOU.E!#^<].6C?)D2>$2!3[4A-EQ0.>G.F'&6-X?U+-;P3L"='F_H#7.S5
MM43HAKIZ%](YBZ\R"JZ)BE#,PDZ5]&3?6$7D-7;*MBQVU*EWE1\&%:XE6O+M
MM6HY#[.D2#V"]554-':YGAK9Q0ML"<FP,E[3GIG1FP9J9Q)RVS T.AF-W7#7
MTM;A;VK$/K6-G0V5RHS.7<4#7&IH>S.H)6U*2C@E^V%A-%X4AD-UNKR)5CK#
M>W$\1NEYR4-P(.K#9W2$233(Y>D+RFK7%W/8S@,A;XK\@%*8GRD/XO ;]<7K
M-?))MGM$DH2%TG6;,>5KFKF3\!&E .Z3.Q*03,_4!W=X36K)Z$W<KR&L_D!2
M4C&6CQY2LG;0D06<._Z.I08DQPW3B/]1I##;P@W1 ]5")%LWE5A%K;VV&S59
MY4U(B'<,G]6I;OO/0$G.HB*5-@]$L=&%^_:(V%&@ZE'X<!03+UV1OKTAM;S5
MY_*M/IBPW^JC?6O>ZNM^\^ZM/@[KW<'3?ZNO"^A9)'5Y?M':\XL!7CQ9GE_4
M65#E'E_DKJ'#IQ=#+%1)$_&9\?"B5%O.N<:ST:.+C"@SC9#H\(G3E,.^T?&3
M;.;CI>+W&]@"<"3&]H*2\I$]%&-\^Z<$+R(@RZN,Y+\*F,$R'6^U8[03Y;.-
M1Y&5'#<&1:^F&ZD$N]'U+I[+N$EZ8_#GF>=D,EN6MP/J*S9$6)@46-8ZYP%K
MX6;[[R++26[.,"N/531G+/3#2<T2>N]'W<@:51MB]ID)V/$H;].T8ND@NRO2
M=)B@*&S7%*%AM_/>2F5E5#,W#M: *U$/DC#*NUEEM@_^XPUL #R1M8IN39K0
MK*09$;3WEF>F#ST/0YI6Z/=+?DM2L$'[!/ZGG+R;^[@7^5]!$L5E%DNR;9RD
M>M#VS-8"IKK+C#!Y;\[V]*1FVD9T#:[!^&WFE9RKI#7@:\]'UKS%&$1FS<,0
MKCE+Z\62&?/HZ=>6]L-\:4HAE;-_2[!<K=\D#I-X8)R#)3J8]]:IJ0'M/9.
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M C[*%:J(&4Q2!I3U3KP(+,EXE5=)6JT-'%PI? I>KP"?PWINU(Y?_4SPXG*
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M)9)S'F'ZNI]LT"FQZ/ %1==+7)TDN"KR+,?['YCLJ^G*UC 5X3<=DVS\<QZ
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M@I*68: +U:PY-5*S>?OO$:7EA_;K3^T;T7^/MB\H)_>B[3V<J4/3=&93HQG
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M_/]_ 5!+ 0(4 Q0    ( %);851ZGB:5PLH# !AZ+@ 4              "
M 0    !B<FAC,3 P,S0S,C%?,3!K+FAT;5!+ 0(4 Q0    ( %-;853<211I
M3BH  *;.   8              "  ?3* P!B<FAC,3 P,S0S,C%?97@Q,"TU
M-"YH=&U02P$"% ,4    " !36V%4X\."16)'  !.6 H %P
M@ %X]0, 8G)H8S$P,#,T,S(Q7V5X,C$M,2YH=&U02P$"% ,4    " !36V%4
MH4;:P, #  !G#   %P              @ $//00 8G)H8S$P,#,T,S(Q7V5X
M,C,M,2YH=&U02P$"% ,4    " !36V%44,J]MO$'  !$-0  %P
M    @ $$000 8G)H8S$P,#,T,S(Q7V5X,S$M,2YH=&U02P$"% ,4    " !3
M6V%4]AC)1/8'  !L-0  %P              @ $J200 8G)H8S$P,#,T,S(Q
M7V5X,S$M,BYH=&U02P$"% ,4    " !36V%4)]4&C]X'   7-   %P
M        @ %5400 8G)H8S$P,#,T,S(Q7V5X,S$M,RYH=&U02P$"% ,4
M" !36V%4T^HX2= %  ")(0  %P              @ %H600 8G)H8S$P,#,T
M,S(Q7V5X,S(M,2YH=&U02P$"% ,4    " !36V%4N<2TJ7 %  "#$0  %@
M            @ %M7P0 8G)H8S$P,#,T,S(Q7V5X-"TQ+FAT;5!+ 0(4 Q0
M   ( %-;851);A#S(HH  $?]   .              "  1%E! !I;6%G93 P
M,# R+FIP9U!+ 0(4 Q0    ( %-;852%ZJ/SB2    U] 0 1
M  "  5_O! !U<W!H+3(P,C$Q,C,Q+GAS9%!+ 0(4 Q0    ( %-;852"6+WS
M=!H  .Y[ 0 5              "  1<0!0!U<W!H+3(P,C$Q,C,Q7V-A;"YX
M;6Q02P$"% ,4    " !36V%4@@NI]B%C  !L/0< %0              @ &^
M*@4 =7-P:"TR,#(Q,3(S,5]D968N>&UL4$L! A0#%     @ 4UMA5#'^5((A
M*@$ ?$,2 !4              ( !$HX% '5S<&@M,C R,3$R,S%?;&%B+GAM
M;%!+ 0(4 Q0    ( %-;8538.@*(;Y8  #;8"@ 5              "  6:X
M!@!U<W!H+3(P,C$Q,C,Q7W!R92YX;6Q02P4&      \ #P#Q P  "$\'

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
